data_5o1t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5o1t _Structure_validation_residue.Date_analyzed 2017-07-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 42.0 m80 . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -72.83 138.68 46.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.595 1.158 . . . . 0.0 111.885 171.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.25 -42.78 99.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.913 0.885 . . . . 0.0 110.35 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 124.941 1.296 . . . . 0.0 112.55 -178.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 CA--C 1.553 1.076 0 O-C-N 120.675 -1.265 . . . . 0.0 110.725 167.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.1 m80 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -50.39 135.57 21.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.097 1.317 . . . . 0.0 112.099 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -136.37 151.07 72.48 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 124.029 0.932 . . . . 0.0 110.72 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.81 165.98 21.77 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.014 2.476 . . . . 0.0 110.632 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.38 79.41 1.66 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 166.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.5 115.77 4.21 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.443 2.095 . . . . 0.0 108.451 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.01 142.06 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.761 1.224 . . . . 0.0 109.317 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.68 169.04 18.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.489 1.116 . . . . 0.0 109.92 174.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -140.6 111.18 6.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.811 0.845 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.61 126.78 53.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.796 0.838 . . . . 0.0 111.794 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.4 p -73.76 -7.63 52.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -18.58 65.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.508 2.323 . . . . 0.0 111.915 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.6 153.04 81.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.634 1.174 . . . . 0.0 113.361 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.12 165.1 29.57 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.559 3.506 . . . . 0.0 113.047 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.35 135.6 27.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.399 3.399 . . . . 0.0 112.776 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.28 42.92 14.36 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.694 1.597 . . . . 0.0 111.465 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -127.24 153.04 46.61 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.6 pt -126.2 147.75 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.476 1.91 . . . . 0.0 109.966 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 133.1 51.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.203 1.401 . . . . 0.0 111.331 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.01 102.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.185 0.594 . . . . 0.0 110.996 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -68.62 136.18 52.59 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.396 1.079 . . . . 0.0 111.626 166.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.4 t -78.37 136.37 37.66 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.354 -0.841 . . . . 0.0 111.364 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -103.03 12.3 36.17 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.968 1.707 . . . . 0.0 109.918 162.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 52.5 m -109.98 130.71 55.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.073 1.749 . . . . 0.0 110.127 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 mt -96.01 136.61 36.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 108.932 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -94.83 139.64 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 161.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.2 mm -124.95 107.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.79 1.236 . . . . 0.0 108.209 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.71 176.48 46.17 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 123.882 0.753 . . . . 0.0 111.868 168.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.18 17.4 72.0 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.016 0.766 . . . . 0.0 115.016 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.3 122.15 86.65 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 118.507 1.153 . . . . 0.0 110.525 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.12 137.6 29.22 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.871 2.38 . . . . 0.0 108.931 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.73 -17.43 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.59 -25.66 57.19 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 47.8 mtm -78.46 139.76 38.68 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.861 0.838 . . . . 0.0 112.238 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -116.47 -173.75 2.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.744 2.018 . . . . 0.0 111.657 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -54.07 -48.44 70.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.196 1.798 . . . . 0.0 112.703 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -76.19 -18.4 59.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.01 -40.37 71.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.059 1.299 . . . . 0.0 110.683 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -49.1 78.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.817 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.07 71.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.923 0.783 . . . . 0.0 112.95 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.52 -44.82 70.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.528 1.131 . . . . 0.0 113.964 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.97 -33.89 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.699 1.136 . . . . 0.0 110.683 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 51.5 mt -87.02 -10.59 52.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.037 0.935 . . . . 0.0 113.187 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -48.31 -48.96 64.78 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.669 1.588 . . . . 0.0 114.674 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.34 -6.98 17.66 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.217 1.945 . . . . 0.0 113.375 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.68 -39.99 8.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.47 1.508 . . . . 0.0 112.38 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.39 169.89 3.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.13 1.772 . . . . 0.0 112.712 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.54 125.5 32.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.553 0.741 . . . . 0.0 109.835 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.67 128.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.621 0.768 . . . . 0.0 110.276 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -91.8 -43.38 9.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.123 1.369 . . . . 0.0 112.538 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.92 159.2 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 111.623 -172.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.0 p -160.79 133.7 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.731 -0.606 . . . . 0.0 111.609 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.7 103.31 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.73 133.11 43.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.794 0.837 . . . . 0.0 110.224 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.57 89.47 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.821 1.248 . . . . 0.0 109.565 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -60.24 -38.32 83.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.765 1.226 . . . . 0.0 111.711 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.0 t -58.9 -30.62 67.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.765 1.626 . . . . 0.0 113.23 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.74 -3.15 42.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.359 1.463 . . . . 0.0 113.13 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 58.8 30.85 20.6 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.297 1.839 . . . . 0.0 113.326 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -133.82 169.3 17.26 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.45 42.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.013 1.325 . . . . 0.0 111.159 164.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.28 136.76 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 45.1 t -134.72 113.3 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.428 0.691 . . . . 0.0 110.78 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -92.99 122.89 35.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 0.0 109.734 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.63 164.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.088 0.955 . . . . 0.0 109.97 169.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -73.76 -22.34 59.89 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 p -134.38 154.18 51.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.762 1.165 . . . . 0.0 113.445 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -59.43 -41.75 90.29 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.148 0.979 . . . . 0.0 111.493 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -37.68 88.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.401 0.68 . . . . 0.0 111.853 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.42 -50.65 72.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.752 1.221 . . . . 0.0 111.073 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.03 95.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.919 0.781 . . . . 0.0 112.027 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.98 -42.12 98.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.954 0.502 . . . . 0.0 112.138 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -63.45 -35.02 79.06 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.256 0.935 . . . . 0.0 112.26 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.23 -64.35 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.819 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -49.27 -36.77 21.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.893 1.277 . . . . 0.0 114.153 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.09 -35.88 80.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.918 1.287 . . . . 0.0 113.476 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -111.79 -25.6 9.39 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -72.0 124.17 24.36 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.537 0.735 . . . . 0.0 111.189 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 61.89 30.17 18.08 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.263 1.425 . . . . 0.0 113.904 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -58.33 -36.07 72.84 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.806 -1.184 . . . . 0.0 113.385 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.569 1.148 . . . . 0.0 113.062 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.48 61.55 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.88 1.228 . . . . 0.0 113.737 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.16 -34.68 14.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.379 1.472 . . . . 0.0 114.389 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 24.8 mt -73.67 148.52 87.66 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.099 0.96 . . . . 0.0 109.457 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.71 -29.45 10.61 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.347 2.031 . . . . 0.0 112.181 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.87 139.97 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.959 1.704 . . . . 0.0 111.715 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.26 103.0 10.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.048 1.339 . . . . 0.0 110.08 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.8 m -81.75 124.27 29.48 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.883 1.273 . . . . 0.0 110.571 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -133.39 175.37 9.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.602 2.361 . . . . 0.0 109.248 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -73.51 123.47 24.0 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.25 -0.906 . . . . 0.0 110.889 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -100.66 -164.73 28.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 163.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.49 122.07 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.078 0.951 . . . . 0.0 109.234 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -84.73 -47.4 5.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 162.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.68 120.11 22.32 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.808 0.843 . . . . 0.0 111.732 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.06 131.73 1.54 Allowed Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.529 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.84 130.94 16.33 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 125.161 3.907 . . . . 0.0 110.405 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -36.19 79.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -72.32 -18.79 61.75 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.6 m -124.16 29.9 6.26 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.906 1.683 . . . . 0.0 111.982 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.7 155.55 25.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -139.71 73.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.802 1.641 . . . . 0.0 109.446 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -63.07 -18.62 63.57 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.47 -52.42 32.61 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.109 -0.994 . . . . 0.0 111.077 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -80.78 -17.19 51.68 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 84.43 38.33 9.96 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.964 1.269 . . . . 0.0 113.034 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -145.59 169.7 17.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.63 1.215 . . . . 0.0 112.374 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 46.4 m -141.13 157.13 45.7 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.941 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.53 127.68 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.67 125.51 28.02 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 117.405 -1.283 . . . . 0.0 111.229 -170.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.86 132.21 18.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.078 1.852 . . . . 0.0 110.362 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -20.47 61.64 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.635 1.174 . . . . 0.0 113.735 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -26.26 65.55 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.34 0.973 . . . . 0.0 113.208 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.0 -24.53 16.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.757 1.223 . . . . 0.0 112.802 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.5 116.83 4.62 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.4 p -65.55 176.54 1.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.738 1.215 . . . . 0.0 110.733 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.37 -41.3 93.44 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.502 -0.749 . . . . 0.0 110.99 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.41 -40.99 85.62 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 112.541 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -58.35 -52.55 65.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.889 1.276 . . . . 0.0 111.993 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -66.84 -37.54 84.69 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.771 -0.58 . . . . 0.0 111.566 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -47.91 73.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.212 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.41 -43.35 77.4 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.269 1.395 . . . . 0.0 111.533 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 66.8 m -53.52 -35.8 61.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.59 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.5 m -90.63 -43.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -99.51 -12.91 19.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.289 1.436 . . . . 0.0 114.489 -166.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.79 142.16 46.49 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.162 -0.961 . . . . 0.0 111.062 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -80.82 -45.56 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.509 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -100.31 131.4 46.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.297 1.039 . . . . 0.0 110.181 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.71 -176.57 45.58 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.381 0.991 . . . . 0.0 114.028 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.31 -156.44 52.99 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.417 -0.392 . . . . 0.0 112.265 -170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.8 p -99.43 -4.96 30.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 77.95 17.65 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.788 1.635 . . . . 0.0 113.317 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.44 56.04 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.122 1.344 . . . . 0.0 113.884 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 153.53 95.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.726 1.263 . . . . 0.0 111.593 172.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.84 143.93 81.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.863 2.376 . . . . 0.0 110.423 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 40.6 mt -70.75 110.53 5.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.279 0.562 . . . . 0.0 109.618 170.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.11 152.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 110.235 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.1 m -53.35 130.0 33.7 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.65 0.78 . . . . 0.0 109.71 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.52 -5.6 80.32 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.865 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.45 134.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.807 1.304 . . . . 0.0 111.514 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.5 t -119.99 140.41 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.752 2.021 . . . . 0.0 108.734 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.83 -179.61 7.33 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.691 1.196 . . . . 0.0 111.797 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -92.13 150.3 21.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.212 . . . . 0.0 110.842 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -51.16 132.21 31.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 124.553 1.141 . . . . 0.0 113.703 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.26 148.45 74.39 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.957 1.771 . . . . 0.0 109.253 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -52.96 148.29 7.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.174 0.99 . . . . 0.0 112.858 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -108.09 50.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 123.159 1.456 . . . . 0.0 110.103 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.6 142.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 29.7 m80 . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -64.73 133.28 51.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.708 1.203 . . . . 0.0 111.622 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.6 -20.13 63.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.006 1.322 . . . . 0.0 111.355 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 126.913 2.085 . . . . 0.0 112.183 -172.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 CA--C 1.551 0.991 0 O-C-N 120.665 -1.272 . . . . 0.0 110.744 173.712 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -53.68 117.94 3.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.181 1.392 . . . . 0.0 112.729 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 143.72 50.4 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 125.252 1.421 . . . . 0.0 110.491 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.3 164.85 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.294 2.663 . . . . 0.0 111.217 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 83.74 13.71 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.251 1.02 . . . . 0.0 109.019 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.98 116.37 4.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.531 2.154 . . . . 0.0 108.218 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.8 t -112.35 129.04 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.789 0.835 . . . . 0.0 109.276 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.1 170.26 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 111.0 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -138.47 121.81 17.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.445 1.098 . . . . 0.0 110.082 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -122.14 105.89 10.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.08 0.952 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -7.66 16.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.547 1.539 . . . . 0.0 113.723 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.87 -24.5 64.34 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.788 1.235 . . . . 0.0 112.375 172.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.99 150.14 96.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.633 0.773 . . . . 0.0 111.927 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.67 162.0 33.34 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.138 3.225 . . . . 0.0 112.945 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 133.53 27.24 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.963 3.109 . . . . 0.0 112.49 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.03 26.88 7.19 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.399 1.88 . . . . 0.0 113.015 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -112.58 153.64 27.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.48 151.23 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.019 2.128 . . . . 0.0 109.678 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -114.41 131.8 56.45 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.127 1.33 . . . . 0.0 111.727 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.9 106.57 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 110.794 -171.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.22 129.3 39.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.875 1.27 . . . . 0.0 111.34 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.5 t -69.41 135.1 49.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.776 -0.577 . . . . 0.0 111.973 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -105.37 15.31 27.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.659 1.584 . . . . 0.0 110.487 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 17.5 m -121.16 143.63 49.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.008 1.323 . . . . 0.0 112.054 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -111.1 136.55 49.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.829 2.052 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.96 137.46 32.32 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 166.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.82 117.36 52.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 108.058 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -99.64 174.61 27.08 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.709 1.147 . . . . 0.0 111.012 164.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.44 27.17 70.15 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 119.132 -0.815 . . . . 0.0 114.031 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.22 106.02 18.06 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.504 1.152 . . . . 0.0 110.567 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.97 146.52 87.81 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.798 2.332 . . . . 0.0 111.037 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.49 -19.24 64.58 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.69 -29.6 68.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.078 0.951 . . . . 0.0 112.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 17.6 mtm -85.62 151.8 23.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.037 0.935 . . . . 0.0 112.667 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -175.49 4.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 111.581 -175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -50.33 -35.56 28.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.387 1.875 . . . . 0.0 113.085 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -78.01 -21.24 51.08 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.9 -36.09 62.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.844 1.202 . . . . 0.0 110.639 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.58 -46.94 88.36 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.725 0.693 . . . . 0.0 110.772 169.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.8 70.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.545 0.612 . . . . 0.0 112.437 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -69.49 -41.19 76.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.695 1.198 . . . . 0.0 113.456 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.6 m -73.75 -34.69 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.898 0.772 . . . . 0.0 111.864 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 66.7 mt -86.3 -12.6 49.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.354 1.062 . . . . 0.0 113.397 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -48.3 71.87 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.087 1.755 . . . . 0.0 115.309 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.69 -7.44 17.62 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.66 2.24 . . . . 0.0 113.869 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -96.73 -39.87 9.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.281 1.432 . . . . 0.0 112.401 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.43 171.86 5.35 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.919 1.688 . . . . 0.0 112.747 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.39 130.8 34.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.366 0.666 . . . . 0.0 109.559 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.34 127.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 109.601 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.01 -46.63 10.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 111.699 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 45.2 t -154.57 152.03 29.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 -169.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.9 134.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.42 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 166.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.16 139.07 37.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.244 0.618 . . . . 0.0 110.731 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.28 90.82 3.0 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.546 1.165 . . . . 0.0 109.989 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.46 -31.03 68.95 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 111.82 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 6.7 m -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.544 1.938 . . . . 0.0 114.908 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.67 9.75 17.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.342 1.457 . . . . 0.0 112.932 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 55.5 35.82 25.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.908 1.683 . . . . 0.0 112.9 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -126.9 167.32 16.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.4 164.02 34.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.482 1.113 . . . . 0.0 112.112 165.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.98 123.04 42.52 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.516 1.526 . . . . 0.0 108.155 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.62 116.02 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.257 1.023 . . . . 0.0 110.752 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -91.29 121.04 32.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.922 0.889 . . . . 0.0 110.176 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.15 167.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.052 0.941 . . . . 0.0 109.465 168.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -76.38 -18.91 58.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.11 155.73 45.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.197 169.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -38.9 88.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.126 0.971 . . . . 0.0 111.99 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.2 -48.55 75.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.465 1.106 . . . . 0.0 111.314 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.23 91.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.018 0.527 . . . . 0.0 111.458 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -62.81 -42.28 99.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.25 1.02 . . . . 0.0 112.097 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -65.43 -34.14 77.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.658 1.117 . . . . 0.0 112.78 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.29 -62.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.64 -35.17 40.98 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.826 1.25 . . . . 0.0 114.109 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -67.02 -44.11 81.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.584 1.553 . . . . 0.0 113.266 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -103.58 -29.88 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -72.08 127.87 33.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.338 1.055 . . . . 0.0 111.388 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.72 25.64 15.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.466 . . . . 0.0 114.881 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -51.39 -45.87 62.63 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.09 3.53 38.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.888 2.075 . . . . 0.0 113.287 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.4 30.28 50.18 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.506 1.051 . . . . 0.0 113.81 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.36 65.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.86 162.23 30.29 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 126.335 1.854 . . . . 0.0 110.256 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.63 -22.73 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.328 2.018 . . . . 0.0 113.296 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.53 HD13 ' H ' ' A' ' 402' ' ' LEU . 0.2 OUTLIER -81.91 143.95 31.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.579 1.152 . . . . 0.0 111.724 -172.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -115.24 122.15 45.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.136 1.374 . . . . 0.0 108.919 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.6 m -107.12 128.62 54.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.507 1.123 . . . . 0.0 110.319 -167.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -132.51 175.64 9.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.818 2.047 . . . . 0.0 109.475 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -64.63 134.57 54.58 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.96 -1.087 . . . . 0.0 110.946 164.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.34 -152.82 9.61 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.702 1.62 . . . . 0.0 109.147 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.48 134.27 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.332 0.566 . . . . 0.0 112.262 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.97 -51.61 3.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -126.99 118.58 24.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.229 1.011 . . . . 0.0 112.119 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.96 143.13 4.7 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.857 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.26 130.22 17.19 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 125.686 4.257 . . . . 0.0 110.323 175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -35.29 80.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.646 0.378 . . . . 0.0 111.875 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -76.23 -16.61 59.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.14 1.376 . . . . 0.0 114.565 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.5 m -123.9 31.03 5.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.41 1.484 . . . . 0.0 111.952 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.36 138.26 32.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.632 1.573 . . . . 0.0 111.609 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -124.89 81.67 1.98 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.296 1.438 . . . . 0.0 109.881 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -66.4 -16.37 64.03 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.9 -51.23 23.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.964 1.256 . . . . 0.0 110.295 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -82.38 -12.28 58.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 73.83 42.68 37.57 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.607 1.099 . . . . 0.0 112.464 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -147.01 170.24 17.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.625 1.212 . . . . 0.0 112.836 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 25.5 m -132.57 152.24 51.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.035 0.934 . . . . 0.0 110.709 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.55 134.53 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.51 119.14 21.59 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 119.81 1.187 . . . . 0.0 111.409 -172.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.68 133.53 18.84 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.616 2.211 . . . . 0.0 111.492 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 9.6 mtt -59.5 -30.05 68.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.588 1.555 . . . . 0.0 113.762 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -65.17 -18.76 65.57 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -109.26 6.43 24.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.194 2.198 . . . . 0.0 113.346 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.48 138.34 32.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.409 1.084 . . . . 0.0 111.093 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.5 p -79.65 177.51 8.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.037 1.335 . . . . 0.0 111.356 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.64 -46.3 90.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.579 -0.7 . . . . 0.0 111.323 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.69 88.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.883 0.873 . . . . 0.0 112.059 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.78 -62.54 1.8 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.799 0.84 . . . . 0.0 111.338 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -61.47 -32.19 72.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.738 0.415 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -62.1 1.85 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.566 169.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -58.69 -40.52 83.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.477 1.49 . . . . 0.0 111.937 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 14.9 m -54.0 -29.23 42.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.832 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.14 -42.36 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.999 1.272 . . . . 0.0 114.087 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 20.0 m -93.08 -9.1 40.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.646 1.978 . . . . 0.0 115.033 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.24 145.9 41.24 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.086 1.312 . . . . 0.0 111.652 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.98 -53.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.011 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -97.95 136.65 37.93 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.325 1.05 . . . . 0.0 110.723 166.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 65.15 -170.79 25.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.232 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.35 -164.39 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 -166.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 49.9 p -100.9 14.41 31.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -164.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.5 m 62.22 19.11 10.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.783 1.174 . . . . 0.0 113.498 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.27 4.84 64.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.115 1.341 . . . . 0.0 114.201 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.34 151.57 96.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 118.785 1.292 . . . . 0.0 110.708 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.86 145.71 86.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.791 2.327 . . . . 0.0 110.894 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.66 107.03 3.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.98 157.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.574 1.55 . . . . 0.0 110.238 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 94.5 m -55.14 130.19 41.03 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.757 0.823 . . . . 0.0 110.019 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.77 -5.8 82.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.783 -1.009 . . . . 0.0 114.866 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.92 137.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.188 1.494 . . . . 0.0 111.973 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.7 137.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.422 1.889 . . . . 0.0 109.544 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -161.84 174.51 13.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.958 1.303 . . . . 0.0 112.694 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -87.74 150.32 23.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.801 1.241 . . . . 0.0 111.002 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.99 128.98 29.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.67 150.37 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.902 2.402 . . . . 0.0 110.98 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.1 141.55 58.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.726 1.21 . . . . 0.0 114.059 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.56 53.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 123.433 1.587 . . . . 0.0 110.294 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.549 0.916 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.622 141.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -70.41 140.92 52.17 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.093 -1.004 . . . . 0.0 112.77 171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.41 HD13 ' CZ2' ' A' ' 353' ' ' TRP . 3.3 mm? -65.54 -48.76 71.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 110.543 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 CA--C 1.551 0.989 0 C-N-CA 124.6 1.16 . . . . 0.0 113.013 -176.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 122.07 0.938 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 124.872 1.269 . . . . 0.0 109.064 175.19 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 29.9 m80 . . . . . 0 CA--C 1.549 0.919 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -52.94 131.52 36.0 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.835 -1.166 . . . . 0.0 111.797 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -138.65 147.77 55.99 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.792 1.237 . . . . 0.0 110.083 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.78 159.92 49.06 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.791 2.327 . . . . 0.0 111.116 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 81.82 0.54 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.78 0.832 . . . . 0.0 109.01 162.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.8 121.57 7.75 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 108.539 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 13.8 t -121.54 128.92 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.806 0.842 . . . . 0.0 109.382 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.14 171.72 8.49 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.019 1.727 . . . . 0.0 110.989 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -139.88 120.48 14.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.007 . . . . 0.0 109.928 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -120.04 109.74 15.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.301 1.04 . . . . 0.0 110.609 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 99.1 p -69.06 -7.66 37.82 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.1 t -64.4 -24.91 67.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.278 1.031 . . . . 0.0 112.223 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.37 150.72 95.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.931 0.892 . . . . 0.0 112.237 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.81 161.6 35.49 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.903 3.069 . . . . 0.0 112.64 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.64 134.44 28.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.942 3.094 . . . . 0.0 112.109 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . 0.25 7.0 m-20 68.4 26.03 6.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.675 1.99 . . . . 0.0 113.362 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -111.14 153.3 25.93 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.94 148.77 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.25 1.82 . . . . 0.0 109.872 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.15 132.85 53.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.502 -1.373 . . . . 0.0 110.617 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.93 106.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.341 0.656 . . . . 0.0 111.461 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -68.49 131.59 45.54 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.579 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 32.7 t -73.1 136.57 44.91 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.723 -0.611 . . . . 0.0 111.841 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -106.89 18.64 21.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.187 1.795 . . . . 0.0 109.724 163.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 16.2 m -126.29 141.95 51.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.967 1.307 . . . . 0.0 111.763 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.5 mt -104.16 134.88 46.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 109.351 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -87.27 123.39 32.22 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 163.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.58 107.13 22.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.23 -174.84 50.67 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 166.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.61 70.02 Favored Glycine 0 N--CA 1.475 1.275 0 O-C-N 121.43 -1.041 . . . . 0.0 114.955 170.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 14.9 t -84.71 112.81 45.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 118.78 1.29 . . . . 0.0 110.295 -168.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.95 143.96 62.47 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.984 2.456 . . . . 0.0 109.919 170.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.04 -21.18 63.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.9 -27.49 63.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.859 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 33.9 mtm -80.58 145.86 31.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.59 0.709 . . . . 0.0 112.293 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -129.46 -179.4 5.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.145 2.178 . . . . 0.0 110.976 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -47.68 -40.31 19.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 114.216 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.41 ' CZ2' HD13 ' A' ' 305' ' ' LEU . 78.4 m95 -81.43 -18.63 44.7 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.76 -39.27 66.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.663 1.12 . . . . 0.0 110.185 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.24 -51.26 70.75 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.833 0.453 . . . . 0.0 110.719 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.82 71.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.662 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -68.18 -44.31 76.2 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.135 1.334 . . . . 0.0 113.996 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.82 -35.72 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.507 1.049 . . . . 0.0 110.954 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 mt -83.7 -11.57 57.01 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.459 1.104 . . . . 0.0 113.138 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -48.66 -48.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.849 1.66 . . . . 0.0 114.758 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.12 -6.74 17.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.133 1.889 . . . . 0.0 113.586 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -98.46 -40.93 8.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.5 1.52 . . . . 0.0 112.431 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.68 171.55 3.79 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.915 1.686 . . . . 0.0 113.461 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -85.99 138.35 32.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.661 0.784 . . . . 0.0 110.538 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.1 t -103.7 129.86 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.616 1.166 . . . . 0.0 110.169 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -93.64 -40.23 10.37 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.355 1.862 . . . . 0.0 112.782 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.1 t -152.82 152.04 31.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.404 1.082 . . . . 0.0 110.61 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 70.9 t -146.22 131.99 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.248 0.477 . . . . 0.0 110.417 171.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.24 107.88 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.61 122.06 40.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.066 0.546 . . . . 0.0 110.337 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -106.48 84.9 2.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.822 1.649 . . . . 0.0 109.478 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.72 -33.91 66.96 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.485 1.514 . . . . 0.0 111.354 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 65.6 m -55.72 -32.51 63.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.155 1.782 . . . . 0.0 114.27 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -110.21 9.17 23.86 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 113.191 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt 53.94 37.85 27.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.382 1.473 . . . . 0.0 112.072 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -125.5 153.39 43.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.971 1.708 . . . . 0.0 113.24 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -136.8 132.75 35.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 112.228 164.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.96 117.63 24.92 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 162.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.56 114.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.706 0.803 . . . . 0.0 110.249 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -98.37 121.96 40.95 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 110.299 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.11 164.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.437 1.095 . . . . 0.0 109.553 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.53 -21.22 59.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.4 p -141.74 159.63 41.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.09 1.314 . . . . 0.0 114.234 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -61.54 -45.34 94.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.214 1.006 . . . . 0.0 112.079 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -58.8 -38.22 78.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.239 0.616 . . . . 0.0 112.231 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.47 -54.8 34.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.956 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.0 85.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.888 0.767 . . . . 0.0 112.307 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.69 -44.79 95.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 111.633 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -65.24 -33.79 76.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.204 -0.935 . . . . 0.0 112.654 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.16 -63.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.55 166.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -51.13 -35.81 37.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.877 1.271 . . . . 0.0 114.314 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -63.83 -37.51 87.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.99 1.316 . . . . 0.0 113.085 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -112.83 -26.94 8.32 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.3 123.81 25.28 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 111.308 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.93 27.4 13.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.736 1.614 . . . . 0.0 114.168 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -24.56 66.77 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -100.56 -14.48 18.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.615 1.966 . . . . 0.0 114.524 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.26 24.28 29.55 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.548 1.07 . . . . 0.0 115.291 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.88 -42.01 22.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.562 1.681 . . . . 0.0 115.028 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.8 149.25 90.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.859 0.863 . . . . 0.0 110.57 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.84 -32.89 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.588 2.192 . . . . 0.0 111.71 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.76 163.4 25.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.203 1.801 . . . . 0.0 112.67 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -126.3 101.28 6.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.549 1.54 . . . . 0.0 109.915 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 113.06 21.2 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.115 1.366 . . . . 0.0 109.804 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.42 171.11 11.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.938 1.695 . . . . 0.0 109.178 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -67.29 130.84 44.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.097 -1.002 . . . . 0.0 110.838 163.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -115.66 -148.96 9.39 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 125.865 1.698 . . . . 0.0 109.102 167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.96 132.17 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.29 -46.71 5.47 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 167.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -132.82 121.47 23.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 111.978 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.86 145.79 5.84 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 119.274 -0.736 . . . . 0.0 114.659 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.13 133.61 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 125.048 3.832 . . . . 0.0 109.739 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -37.73 80.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.835 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.21 -20.12 63.11 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.658 -1.276 . . . . 0.0 113.896 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.0 m -123.71 30.19 6.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.817 1.647 . . . . 0.0 112.041 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.1 p -75.65 154.06 36.83 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.969 0.89 . . . . 0.0 112.688 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.07 73.23 1.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.596 1.558 . . . . 0.0 108.837 166.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.62 -19.96 65.29 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.257 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.65 -49.67 65.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.688 -1.258 . . . . 0.0 111.19 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -83.34 -13.79 54.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.7 40.15 12.9 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.844 1.211 . . . . 0.0 112.713 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -146.52 172.19 13.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.76 1.28 . . . . 0.0 112.38 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 50.6 m -139.35 153.31 47.67 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.881 0.872 . . . . 0.0 109.805 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.5 mt -110.73 133.93 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.1 119.16 25.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.517 1.053 . . . . 0.0 111.915 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.05 127.99 14.28 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.915 2.41 . . . . 0.0 110.96 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 42.4 mtm -61.14 -30.38 70.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.576 1.15 . . . . 0.0 113.451 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -65.82 -20.34 66.21 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 11.57 22.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.049 2.14 . . . . 0.0 113.184 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 45.0 mt -92.83 145.44 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.223 1.009 . . . . 0.0 111.316 167.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.1 p -79.76 177.33 8.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.22 -44.39 88.45 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.554 -0.717 . . . . 0.0 111.492 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.05 93.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.948 0.899 . . . . 0.0 112.05 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -63.24 1.26 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.668 1.187 . . . . 0.0 111.405 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.16 -35.0 72.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.128 0.971 . . . . 0.0 111.027 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -56.89 -51.61 68.4 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.197 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -64.56 -41.01 96.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.726 1.603 . . . . 0.0 111.854 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 15.5 m -51.51 -32.6 28.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.016 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.24 -37.93 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.7 t -101.47 -6.68 23.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.649 1.58 . . . . 0.0 114.031 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.4 ' HB2' ' H ' ' A' ' 461' ' ' ASP . . . -57.51 146.52 29.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.169 0.985 . . . . 0.0 112.41 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.88 -50.07 11.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.657 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -98.52 140.3 32.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.603 0.761 . . . . 0.0 111.481 159.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.54 -159.03 48.64 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.695 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 68.5 -168.51 42.51 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 47.4 p -96.14 10.05 38.93 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t 65.83 23.99 11.37 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.877 -1.14 . . . . 0.0 113.495 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.66 65.27 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.672 1.606 . . . . 0.0 114.145 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.73 150.76 96.59 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 118.926 1.363 . . . . 0.0 110.948 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 144.32 79.66 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.861 2.374 . . . . 0.0 110.689 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.7 112.3 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.556 . . . . 0.0 109.568 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.42 157.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.741 1.616 . . . . 0.0 110.279 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 92.3 m -53.59 127.14 24.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 109.81 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 92.08 -5.7 78.66 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.77 -1.017 . . . . 0.0 115.293 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.83 137.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.265 1.532 . . . . 0.0 111.676 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 137.0 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.435 1.894 . . . . 0.0 109.454 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.34 172.93 17.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.341 1.056 . . . . 0.0 112.187 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.51 148.87 25.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.74 1.216 . . . . 0.0 111.525 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.81 129.93 20.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.25 147.72 48.21 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.878 2.385 . . . . 0.0 110.417 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 441' ' ' ALA . 80.1 m-20 -61.78 147.57 45.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 0.0 114.039 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.8 mm -107.37 48.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.734 1.613 . . . . 0.0 109.671 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.474 0.771 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.58 137.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 27.7 m80 . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -81.69 136.52 35.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.358 1.063 . . . . 0.0 113.446 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.79 2.42 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.984 1.714 . . . . 0.0 113.026 171.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 125.25 1.42 . . . . 0.0 111.815 -173.39 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 CA--C 1.549 0.941 0 O-C-N 120.842 -1.161 . . . . 0.0 110.23 175.379 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.72 132.66 31.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.881 1.219 . . . . 0.0 111.894 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.28 146.94 60.11 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 124.502 1.121 . . . . 0.0 109.949 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.26 161.97 40.67 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.773 2.316 . . . . 0.0 110.621 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.17 79.4 1.58 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 165.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.79 126.64 13.52 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.492 2.128 . . . . 0.0 108.606 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.49 116.33 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.206 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.75 167.37 10.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 0.0 110.868 172.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -141.57 124.55 16.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.256 1.023 . . . . 0.0 109.619 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -122.73 114.01 19.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.645 0.778 . . . . 0.0 110.403 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -69.48 -8.64 48.71 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -22.77 66.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.452 171.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.62 150.99 93.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.655 0.782 . . . . 0.0 111.862 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.46 161.66 33.99 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.874 3.049 . . . . 0.0 112.77 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.59 131.62 17.65 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.945 3.097 . . . . 0.0 112.461 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 64.5 45.83 3.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.873 2.069 . . . . 0.0 111.659 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -125.8 152.51 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 17.1 pt -125.21 144.39 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.078 1.751 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.74 54.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.028 1.331 . . . . 0.0 110.378 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.64 105.99 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.055 0.942 . . . . 0.0 110.908 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -72.18 134.82 45.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.562 1.145 . . . . 0.0 111.847 167.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.6 t -76.9 136.49 38.83 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.213 -0.929 . . . . 0.0 111.732 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.4 mtm105 -103.43 15.88 27.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.529 1.932 . . . . 0.0 109.954 163.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 87.3 m -117.48 132.54 56.53 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.714 1.606 . . . . 0.0 110.673 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.29 136.76 38.01 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.185 1.394 . . . . 0.0 108.856 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -92.38 138.83 31.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 26.7 mm -124.26 108.31 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -171.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.69 174.29 46.23 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 165.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.75 30.07 70.78 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.844 -0.798 . . . . 0.0 114.146 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 91.4 t -90.38 109.39 33.38 Favored Pre-proline 0 N--CA 1.478 0.946 0 CA-C-N 118.25 1.025 . . . . 0.0 110.69 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.33 141.97 48.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.401 2.067 . . . . 0.0 110.107 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.04 -17.82 62.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.49 -35.04 79.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.064 0.946 . . . . 0.0 112.617 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 ptp -86.73 152.67 22.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -130.8 -174.44 3.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.229 1.812 . . . . 0.0 111.644 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -55.76 -39.14 70.78 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.176 1.39 . . . . 0.0 112.796 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.98 -23.05 58.21 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.19 -39.13 65.83 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.236 0.926 . . . . 0.0 110.571 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.18 -51.78 68.53 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.547 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.87 67.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.713 173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -46.95 64.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.939 1.245 . . . . 0.0 113.583 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.99 -33.56 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.12 0.873 . . . . 0.0 110.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' A' ' 379' ' ' VAL . 31.0 mt -87.45 -8.05 56.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.367 1.067 . . . . 0.0 113.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -48.67 -49.08 67.66 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.613 1.565 . . . . 0.0 114.988 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.36 -6.46 17.15 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.028 1.819 . . . . 0.0 113.262 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -98.14 -38.53 9.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.465 1.506 . . . . 0.0 112.54 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.8 168.42 5.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.47 1.908 . . . . 0.0 112.537 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.14 136.87 32.77 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.658 0.783 . . . . 0.0 110.051 169.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.89 134.95 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.623 1.169 . . . . 0.0 109.986 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.59 -35.19 9.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.51 150.13 30.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.528 1.058 . . . . 0.0 111.982 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.9 t -146.32 139.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.15 102.39 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.9 tt -97.46 130.72 44.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.918 0.887 . . . . 0.0 109.635 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.68 91.03 3.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.263 1.025 . . . . 0.0 110.085 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.41 -40.23 90.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 111.513 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.7 t -65.17 -25.36 67.69 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.213 1.405 . . . . 0.0 112.938 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -0.67 41.62 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.486 1.515 . . . . 0.0 112.918 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 27.85 16.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.963 1.305 . . . . 0.0 113.772 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.84 170.41 15.89 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.3 40.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.001 1.321 . . . . 0.0 112.314 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.22 128.32 55.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.276 1.43 . . . . 0.0 108.692 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 HG12 ' CD1' ' A' ' 359' ' ' LEU . 88.1 t -124.32 111.32 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 111.004 -173.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 112.92 25.0 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.552 1.541 . . . . 0.0 111.034 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.49 163.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.91 0.884 . . . . 0.0 110.357 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.51 -26.65 63.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.7 p -134.9 155.28 50.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.158 0.98 . . . . 0.0 113.165 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -41.83 92.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.009 0.923 . . . . 0.0 111.35 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -65.63 -36.68 84.4 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.906 -0.497 . . . . 0.0 111.452 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -59.51 -51.26 70.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.517 0.727 . . . . 0.0 111.116 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.77 94.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.635 0.652 . . . . 0.0 111.945 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.81 -43.26 98.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.219 0.608 . . . . 0.0 112.053 171.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -64.38 -34.22 77.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.398 0.999 . . . . 0.0 112.358 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.48 -63.18 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.083 167.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.38 -36.39 43.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.717 1.207 . . . . 0.0 114.036 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.75 -35.34 80.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.99 1.316 . . . . 0.0 113.034 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.23 -25.45 9.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -174.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.77 122.89 22.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.361 0.664 . . . . 0.0 111.528 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 62.44 29.32 17.14 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 114.022 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.62 -31.33 68.0 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -84.8 -16.81 40.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.794 1.638 . . . . 0.0 114.076 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.42 73.74 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.794 1.188 . . . . 0.0 114.114 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.62 -34.2 35.23 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.112 1.456 . . . . 0.0 114.853 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.55 148.56 80.14 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.156 0.982 . . . . 0.0 109.871 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.45 -29.1 13.97 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.717 2.278 . . . . 0.0 112.408 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.61 151.27 42.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.966 1.307 . . . . 0.0 111.778 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 104.74 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.767 0.827 . . . . 0.0 110.681 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.2 m -85.58 121.52 28.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.189 1.396 . . . . 0.0 109.746 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -129.13 178.04 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.628 1.971 . . . . 0.0 108.862 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -72.25 126.3 29.46 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.19 -0.943 . . . . 0.0 111.305 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.01 -156.95 19.37 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 165.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.97 136.72 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 117.117 0.459 . . . . 0.0 111.887 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.99 -44.79 3.75 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.683 1.611 . . . . 0.0 110.464 163.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.48 113.96 18.17 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.018 0.909 . . . . 0.0 113.053 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.82 139.59 4.31 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.92 129.25 15.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.006 3.804 . . . . 0.0 109.974 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -63.49 -38.25 90.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.319 0.648 . . . . 0.0 112.294 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.1 -24.9 66.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.078 1.751 . . . . 0.0 113.345 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 71.8 m -127.35 31.19 5.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.158 1.783 . . . . 0.0 111.277 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.4 t -85.01 140.76 30.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.031 1.333 . . . . 0.0 111.685 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.4 75.82 1.5 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.716 1.606 . . . . 0.0 109.124 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -63.08 -16.49 60.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -70.35 -49.1 52.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.672 1.124 . . . . 0.0 111.023 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -83.81 -16.07 45.98 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.48 38.09 11.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.841 1.21 . . . . 0.0 113.163 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -143.09 174.65 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.338 1.069 . . . . 0.0 112.49 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.3 p -146.27 153.85 41.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.536 1.134 . . . . 0.0 109.964 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.2 mt -114.32 131.14 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.83 123.12 28.1 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 119.433 1.015 . . . . 0.0 111.479 -171.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -69.55 132.03 22.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.69 2.26 . . . . 0.0 111.003 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.53 -32.03 72.9 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 113.236 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.87 -22.44 66.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.7 7.3 37.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.31 1.844 . . . . 0.0 112.636 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 74.6 mt -92.29 142.15 27.78 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.293 1.437 . . . . 0.0 110.969 169.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.8 p -80.05 174.97 11.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.9 1.28 . . . . 0.0 111.048 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.47 -38.99 91.99 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.639 -0.663 . . . . 0.0 111.747 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.53 80.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.026 0.93 . . . . 0.0 112.205 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.82 -54.57 45.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.414 1.086 . . . . 0.0 112.141 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -68.44 -34.31 75.74 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -52.94 -51.78 60.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.243 1.017 . . . . 0.0 111.202 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -68.26 -42.2 79.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.437 1.472 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.2 m -55.52 -30.02 59.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.067 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.7 m -97.84 -40.85 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.4 t -103.13 -9.81 19.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -165.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.62 146.03 37.56 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.906 -1.121 . . . . 0.0 111.581 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -74.79 -52.41 11.53 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.795 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -96.11 133.81 39.92 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.003 0.906 . . . . 0.0 110.984 166.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 -171.26 44.31 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.828 -174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.67 -163.5 54.28 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 115.242 -0.479 . . . . 0.0 112.295 -169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 44.4 p -103.55 11.7 35.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -162.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.62 21.2 5.48 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.792 -1.192 . . . . 0.0 113.064 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.23 4.63 77.41 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 120.768 -1.208 . . . . 0.0 113.874 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -66.42 154.18 91.3 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.591 1.195 . . . . 0.0 110.373 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.1 142.45 80.78 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.151 1.901 . . . . 0.0 110.199 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 50.2 mt -67.67 120.33 13.87 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.53 155.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.304 1.441 . . . . 0.0 109.802 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -59.69 131.82 52.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.067 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.64 -5.78 83.47 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.422 -1.21 . . . . 0.0 115.186 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.8 tt -61.39 143.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.598 1.699 . . . . 0.0 112.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.21 137.0 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.542 1.937 . . . . 0.0 109.33 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -160.63 177.27 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 0.0 112.149 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -95.89 149.47 21.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.714 1.206 . . . . 0.0 111.06 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.91 135.85 56.71 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -162.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.25 153.38 40.56 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.858 2.372 . . . . 0.0 110.786 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.66 142.03 58.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.453 1.101 . . . . 0.0 113.577 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.97 48.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.335 1.54 . . . . 0.0 110.334 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 CA--C 1.547 0.847 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.84 138.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 26.7 m80 . . . . . 0 CA--C 1.552 1.028 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -78.11 140.81 39.06 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.005 -1.06 . . . . 0.0 112.19 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.42 -10.91 58.12 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 112.154 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 126.255 1.822 . . . . 0.0 111.57 -170.316 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.039 0.447 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 CA--C 1.547 0.838 0 O-C-N 121.32 -0.863 . . . . 0.0 111.07 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.9 m80 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -51.92 127.69 21.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.618 1.099 . . . . 0.0 111.447 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.81 145.01 48.43 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 110.24 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.02 144.3 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.459 2.772 . . . . 0.0 111.004 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 83.67 0.77 Allowed Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 165.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.89 113.61 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.296 1.997 . . . . 0.0 108.624 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.3 116.44 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.5 168.45 12.11 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.273 1.429 . . . . 0.0 110.757 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.72 127.27 21.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 110.089 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -122.67 106.62 11.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.926 0.869 . . . . 0.0 111.291 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -10.45 40.39 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.341 1.456 . . . . 0.0 113.674 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 73.0 p -70.82 -22.98 62.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.68 1.592 . . . . 0.0 112.183 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.06 150.29 92.42 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.157 0.983 . . . . 0.0 111.792 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.84 161.5 36.05 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.182 3.254 . . . . 0.0 112.971 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.99 137.11 36.87 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.065 3.176 . . . . 0.0 112.692 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 67.82 24.17 8.26 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.157 1.783 . . . . 0.0 113.134 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -107.94 152.57 24.27 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.818 -1.177 . . . . 0.0 113.825 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.85 144.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 126.238 1.815 . . . . 0.0 110.389 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 128.55 54.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 0.0 111.084 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.11 106.7 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.567 0.747 . . . . 0.0 111.097 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.78 130.12 42.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.42 1.088 . . . . 0.0 111.228 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.6 t -69.69 135.91 50.41 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.852 -0.53 . . . . 0.0 111.594 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -104.48 16.14 26.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.576 1.55 . . . . 0.0 110.858 164.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 21.8 m -123.66 136.19 54.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.286 1.434 . . . . 0.0 112.122 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.61 139.37 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.19 1.396 . . . . 0.0 109.951 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -92.29 139.65 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.79 108.83 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.589 1.156 . . . . 0.0 107.916 -171.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -92.4 -175.9 41.83 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.67 15.9 69.25 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.707 -0.878 . . . . 0.0 114.256 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.4 120.01 79.33 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 118.744 1.272 . . . . 0.0 110.187 -167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 139.42 38.36 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.144 1.896 . . . . 0.0 109.923 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.9 pp -61.82 -18.84 61.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.7 -23.82 49.38 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.3 ptp -87.24 148.47 25.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -125.61 -177.22 3.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.978 1.711 . . . . 0.0 111.908 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -47.15 -42.46 19.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.593 1.957 . . . . 0.0 114.243 174.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.69 -22.05 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.76 -37.06 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.149 0.886 . . . . 0.0 110.852 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -56.84 -51.24 69.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.387 0.54 . . . . 0.0 110.011 168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.94 80.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.015 0.825 . . . . 0.0 112.806 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -66.76 -39.88 88.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.296 1.407 . . . . 0.0 113.097 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.02 -32.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.733 1.151 . . . . 0.0 111.702 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 56.5 mt -86.88 -12.32 48.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.559 1.144 . . . . 0.0 113.88 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -48.89 -47.91 72.56 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.57 -6.22 17.42 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.145 1.897 . . . . 0.0 113.199 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -100.27 -39.12 8.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.397 1.479 . . . . 0.0 112.693 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.48 170.75 4.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.623 . . . . 0.0 114.161 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -81.28 135.16 35.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.556 1.143 . . . . 0.0 110.965 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 88.6 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.744 1.218 . . . . 0.0 110.19 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -91.34 -45.02 8.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.841 1.256 . . . . 0.0 112.46 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.01 149.26 29.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.848 0.859 . . . . 0.0 110.86 -171.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.02 131.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.909 0.777 . . . . 0.0 110.858 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.33 99.39 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.57 145.76 24.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.881 0.872 . . . . 0.0 110.486 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -137.1 89.57 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.556 1.142 . . . . 0.0 110.214 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -61.41 -32.03 71.97 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.238 -0.914 . . . . 0.0 112.061 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.8 t -60.94 -31.64 71.18 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.807 1.243 . . . . 0.0 112.694 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -96.14 -3.81 43.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 113.525 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 60.03 31.31 20.57 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.671 1.589 . . . . 0.0 113.107 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -136.29 170.27 16.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.2 162.99 36.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.963 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -118.33 128.69 54.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.559 1.544 . . . . 0.0 108.268 165.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.15 109.8 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.974 0.909 . . . . 0.0 110.423 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -85.59 117.46 24.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 109.934 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.62 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 165.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.89 -19.1 57.85 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.98 154.78 46.19 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.115 0.871 . . . . 0.0 113.174 -176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -62.99 -41.52 99.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.731 0.812 . . . . 0.0 111.577 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -63.12 -38.64 92.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.859 0.464 . . . . 0.0 110.848 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.22 -49.51 75.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.542 1.137 . . . . 0.0 111.431 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.93 97.91 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.864 -0.523 . . . . 0.0 112.139 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -64.88 -42.66 94.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.655 0.782 . . . . 0.0 111.899 171.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.29 -34.8 78.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.188 0.904 . . . . 0.0 112.045 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.3 -63.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.894 165.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.85 -32.63 53.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -65.07 -31.78 73.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.996 1.319 . . . . 0.0 113.466 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -120.18 -28.97 4.97 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -74.33 125.47 28.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.64 20.15 11.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.308 1.443 . . . . 0.0 114.164 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.34 65.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -111.13 4.26 19.19 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.577 2.351 . . . . 0.0 112.796 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 75.21 32.59 55.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.315 0.959 . . . . 0.0 113.368 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.69 59.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.77 161.68 36.73 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.061 1.345 . . . . 0.0 110.172 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.97 -7.09 18.04 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.574 2.849 . . . . 0.0 113.901 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.96 166.04 8.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.139 2.176 . . . . 0.0 112.441 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 90.1 2.49 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.0 110.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 127.98 34.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.425 1.49 . . . . 0.0 111.209 -172.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.26 170.37 15.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.257 1.823 . . . . 0.0 108.808 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -68.52 126.64 30.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.419 -0.801 . . . . 0.0 110.579 164.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.39 -152.25 17.87 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.5 136.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 117.564 0.682 . . . . 0.0 111.68 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -89.92 -48.72 3.54 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 166.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -129.26 120.29 25.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.896 0.848 . . . . 0.0 111.811 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 178.74 140.87 4.11 Favored Glycine 0 CA--C 1.542 1.746 0 CA-C-O 119.153 -0.804 . . . . 0.0 114.635 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -70.5 133.72 24.83 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.827 3.684 . . . . 0.0 110.181 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -67.12 -35.37 79.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.995 0.426 . . . . 0.0 111.904 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.07 -26.34 66.68 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.457 1.903 . . . . 0.0 113.403 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.1 m -126.78 31.82 5.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.379 1.872 . . . . 0.0 111.054 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.57 138.35 33.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.425 1.49 . . . . 0.0 111.033 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.32 77.83 1.6 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.22 1.408 . . . . 0.0 109.292 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -62.84 -19.76 64.42 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.362 -0.836 . . . . 0.0 113.133 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.96 -47.25 66.11 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.123 1.329 . . . . 0.0 111.194 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -83.23 -16.08 47.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.98 38.32 11.55 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.805 1.193 . . . . 0.0 112.919 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -146.37 169.88 17.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.931 1.366 . . . . 0.0 112.809 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.2 m -137.68 151.3 48.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.824 0.85 . . . . 0.0 110.631 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.24 130.38 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.28 115.78 28.63 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 119.493 1.042 . . . . 0.0 111.15 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -69.71 130.33 19.21 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.065 2.51 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 30.0 mtt -59.84 -32.28 70.53 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.939 1.296 . . . . 0.0 113.243 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -65.08 -22.41 66.96 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.213 0.915 . . . . 0.0 113.039 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -105.14 8.16 34.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.87 1.668 . . . . 0.0 113.601 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.8 146.68 23.56 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.29 1.036 . . . . 0.0 111.784 169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.7 p -83.41 174.45 10.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.727 1.211 . . . . 0.0 110.805 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.2 -41.75 99.2 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.769 -0.582 . . . . 0.0 111.391 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.54 92.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.119 0.968 . . . . 0.0 111.862 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.59 -61.29 2.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.471 1.109 . . . . 0.0 111.626 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -57.54 -37.84 73.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 111.45 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -57.93 -45.59 86.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.927 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -66.78 -41.49 87.6 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 120.729 1.604 . . . . 0.0 112.107 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 8.3 m -54.56 -33.2 59.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.401 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 m -98.01 -48.59 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 16.7 m -89.46 -9.32 50.54 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.13 56.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.26 1.391 . . . . 0.0 112.319 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -74.98 -48.33 24.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.968 0.907 . . . . 0.0 110.511 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -101.0 121.12 41.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.212 1.006 . . . . 0.0 110.75 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 84.87 -173.88 49.32 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.426 1.489 . . . . 0.0 112.987 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.48 -159.44 53.67 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 57.0 p -100.22 8.03 44.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.103 1.361 . . . . 0.0 114.646 -163.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.02 22.4 4.55 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.934 -1.104 . . . . 0.0 112.499 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.56 3.59 71.42 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.892 1.235 . . . . 0.0 113.859 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.68 153.24 96.09 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 118.355 1.078 . . . . 0.0 110.796 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -63.87 145.95 91.02 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.551 2.167 . . . . 0.0 110.588 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.16 121.27 19.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.378 0.609 . . . . 0.0 110.005 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.4 t -110.88 152.2 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.604 1.962 . . . . 0.0 108.715 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 74.2 m -49.41 122.6 6.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.281 0.632 . . . . 0.0 110.055 165.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 86.68 1.25 85.55 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.935 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.79 131.59 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.588 1.694 . . . . 0.0 111.532 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.02 138.7 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.045 2.138 . . . . 0.0 109.302 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -161.97 179.99 7.59 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.474 1.509 . . . . 0.0 112.604 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -95.77 145.6 25.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.241 1.416 . . . . 0.0 110.421 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -47.68 128.42 10.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.63 152.07 64.56 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 111.249 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.43 147.97 34.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.443 1.097 . . . . 0.0 113.498 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.1 mm -110.79 49.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 123.251 1.501 . . . . 0.0 110.01 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.548 0.87 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.927 137.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.3 m80 . . . . . 0 CA--C 1.552 1.036 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -62.71 136.78 58.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.369 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.0 mp -82.13 -63.94 1.28 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.264 0.626 . . . . 0.0 110.679 -177.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 . . . . . 0 CA--C 1.555 1.157 0 O-C-N 121.386 -0.821 . . . . 0.0 111.96 -170.304 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.74 131.6 25.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.725 1.21 . . . . 0.0 111.863 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.85 154.11 68.29 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.278 1.031 . . . . 0.0 109.722 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -65.27 168.42 14.33 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 110.91 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 83.37 60.72 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.21 1.404 . . . . 0.0 107.325 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 137.61 30.94 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.176 2.584 . . . . 0.0 109.052 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.8 t -138.72 136.14 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.389 1.076 . . . . 0.0 108.751 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 172.01 13.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.956 0.902 . . . . 0.0 110.806 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.12 120.1 22.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.596 1.158 . . . . 0.0 109.667 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -117.83 108.54 15.46 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.808 1.643 . . . . 0.0 110.633 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 62.7 p -70.77 -3.57 19.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.926 1.291 . . . . 0.0 114.169 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -69.86 -19.85 63.42 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.266 1.026 . . . . 0.0 112.786 173.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.43 151.57 94.04 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.043 0.937 . . . . 0.0 112.361 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.31 160.79 33.46 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.9 3.067 . . . . 0.0 112.529 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.83 133.83 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 112.376 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 64.4 36.0 9.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.759 2.024 . . . . 0.0 112.511 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.93 152.49 38.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.8 pt -125.04 149.53 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.596 1.958 . . . . 0.0 112.111 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 111.19 23.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.445 1.498 . . . . 0.0 110.54 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 108.78 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.147 0.885 . . . . 0.0 111.884 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -72.03 135.02 46.21 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.856 1.262 . . . . 0.0 111.437 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.7 t -71.48 137.83 48.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.607 -0.683 . . . . 0.0 112.036 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -105.37 17.48 23.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.934 1.694 . . . . 0.0 110.447 160.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 57.3 m -120.8 138.95 53.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.727 1.611 . . . . 0.0 111.487 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 21.5 mt -105.71 132.14 52.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.046 2.138 . . . . 0.0 108.556 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -89.89 123.85 34.19 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 30.4 mm -114.38 109.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.841 0.857 . . . . 0.0 109.088 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.47 175.58 49.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.815 0.722 . . . . 0.0 112.07 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.14 13.57 70.21 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.29 0.948 . . . . 0.0 115.086 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.28 121.8 84.36 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-N 118.459 1.129 . . . . 0.0 110.452 -167.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.5 134.7 22.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.794 2.33 . . . . 0.0 109.633 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.16 -18.82 63.88 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.21 -33.29 75.47 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.592 1.157 . . . . 0.0 112.948 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -86.62 157.97 19.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -133.89 -177.7 4.68 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.064 1.746 . . . . 0.0 111.761 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -55.81 -35.73 66.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.36 1.464 . . . . 0.0 112.856 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -74.96 -25.21 58.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.53 -34.99 65.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.371 0.987 . . . . 0.0 110.616 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.02 -48.86 79.97 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.232 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.5 78.15 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.437 1.017 . . . . 0.0 112.466 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.42 -40.66 85.56 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.848 1.204 . . . . 0.0 112.92 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.37 -36.59 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.176 0.898 . . . . 0.0 112.192 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 67.7 mt -84.42 -13.15 52.95 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -46.05 -49.51 40.0 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 126.529 1.932 . . . . 0.0 115.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.2 -8.19 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.137 1.891 . . . . 0.0 113.705 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -97.24 -41.22 8.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.547 1.539 . . . . 0.0 112.155 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.65 172.52 4.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.672 1.589 . . . . 0.0 113.312 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -91.17 135.11 34.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.495 1.118 . . . . 0.0 111.074 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.6 131.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.146 1.378 . . . . 0.0 110.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -93.74 -42.89 8.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.081 1.352 . . . . 0.0 112.609 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 30.6 t -156.79 150.86 25.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 109.948 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -149.25 134.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.466 0.707 . . . . 0.0 109.823 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.44 107.79 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 166.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.9 tt -102.37 118.11 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 0.0 110.865 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -106.33 81.64 1.64 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.004 1.722 . . . . 0.0 109.223 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.66 -34.16 61.79 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.605 1.562 . . . . 0.0 111.411 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -60.66 -30.83 70.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.489 1.916 . . . . 0.0 113.632 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 3.32 20.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.239 1.416 . . . . 0.0 113.196 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 61.65 36.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.099 1.759 . . . . 0.0 111.57 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -124.1 154.25 40.26 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.857 2.063 . . . . 0.0 113.3 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.72 135.39 34.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.618 1.167 . . . . 0.0 111.772 161.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.64 121.19 29.75 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 160.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.71 119.46 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.127 0.971 . . . . 0.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -96.96 128.8 44.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.364 1.065 . . . . 0.0 111.213 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.83 165.7 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.452 1.101 . . . . 0.0 110.196 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -69.95 -14.58 62.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -170.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.98 159.16 40.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.546 -1.346 . . . . 0.0 113.256 -176.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -41.58 99.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.986 0.914 . . . . 0.0 109.87 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -64.97 -36.71 85.28 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.493 -0.754 . . . . 0.0 112.203 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -56.19 -53.18 60.22 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.932 0.787 . . . . 0.0 109.409 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.71 97.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.524 0.73 . . . . 0.0 112.819 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.57 -42.73 99.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.115 0.566 . . . . 0.0 111.352 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -67.86 -31.56 71.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.581 1.082 . . . . 0.0 112.368 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.9 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.918 164.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.2 -33.67 63.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.716 1.206 . . . . 0.0 114.145 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.36 -23.77 65.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.577 1.551 . . . . 0.0 113.995 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -122.14 -26.62 4.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.67 121.93 21.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.817 0.818 . . . . 0.0 112.276 -166.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 28.8 t30 59.25 28.79 18.21 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.349 1.86 . . . . 0.0 115.089 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -56.71 -32.5 65.57 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.34 -8.79 31.66 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 114.698 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 6.78 65.45 Favored Glycine 0 CA--C 1.548 2.142 0 C-N-CA 125.195 1.379 . . . . 0.0 114.899 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -70.44 -36.52 74.01 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.75 151.64 71.29 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.849 0.859 . . . . 0.0 110.608 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.69 -26.77 9.53 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.643 2.229 . . . . 0.0 112.204 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.71 150.4 41.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.751 1.22 . . . . 0.0 111.723 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -120.59 92.14 3.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.841 1.256 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -74.43 119.99 19.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.104 0.961 . . . . 0.0 110.527 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 170.28 12.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.2 2.2 . . . . 0.0 108.882 172.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -65.77 131.67 46.87 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.169 -0.957 . . . . 0.0 111.013 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.7 -154.99 12.95 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 164.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 132.75 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.057 0.429 . . . . 0.0 112.1 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.14 -50.72 3.56 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -124.17 114.79 20.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.918 0.887 . . . . 0.0 113.036 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.26 143.72 3.97 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 118.704 -1.053 . . . . 0.0 114.846 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.85 144.54 30.95 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.856 3.704 . . . . 0.0 110.032 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -69.24 -30.57 68.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.636 0.774 . . . . 0.0 112.071 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.67 -33.5 72.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.459 2.303 . . . . 0.0 113.309 -175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.8 m -123.89 34.86 4.96 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.041 2.136 . . . . 0.0 111.211 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.2 139.75 34.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.876 1.671 . . . . 0.0 111.74 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.75 77.8 1.81 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.757 1.623 . . . . 0.0 109.047 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -65.4 -10.53 34.4 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -75.03 -48.25 24.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.249 0.931 . . . . 0.0 110.056 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -84.0 -11.11 57.29 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.62 42.36 21.96 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.045 1.307 . . . . 0.0 112.936 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.36 169.55 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 113.291 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.2 m -137.96 152.37 48.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.897 0.879 . . . . 0.0 111.09 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.1 mm -105.43 119.1 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.42 120.42 42.82 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 120.388 1.449 . . . . 0.0 110.331 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.77 146.87 26.97 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.16 -26.98 68.63 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -65.45 -21.46 66.65 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.985 1.266 . . . . 0.0 113.302 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -97.83 0.2 46.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.095 1.758 . . . . 0.0 113.394 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.63 122.66 34.4 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.147 0.979 . . . . 0.0 110.082 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 33.7 p -76.32 179.46 5.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.14 1.376 . . . . 0.0 111.667 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -39.55 91.42 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.651 -0.655 . . . . 0.0 111.601 170.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.092 0.957 . . . . 0.0 111.975 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.27 -52.18 65.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.775 1.63 . . . . 0.0 112.172 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -61.66 -40.89 96.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.928 0.891 . . . . 0.0 111.318 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.86 -36.21 83.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.201 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -68.21 -44.9 74.74 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.574 1.534 . . . . 0.0 110.837 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.3 m -54.08 -37.51 64.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.516 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.13 -46.4 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.9 t -96.0 -8.99 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -162.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.456 ' HB2' ' H ' ' A' ' 461' ' ' ASP . . . -58.77 147.98 31.36 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.187 -0.945 . . . . 0.0 111.951 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.78 -38.55 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.33 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -103.55 135.58 44.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.83 1.252 . . . . 0.0 110.209 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 60.61 -159.02 27.03 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.387 -170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 63.64 -154.15 46.08 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.9 p -106.63 1.02 24.87 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -164.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.8 t 69.42 24.68 5.68 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.932 1.293 . . . . 0.0 112.095 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.74 9.86 63.82 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.058 1.313 . . . . 0.0 114.132 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -81.14 141.34 50.05 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.185 0.992 . . . . 0.0 110.822 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.24 112.23 2.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.966 2.444 . . . . 0.0 109.0 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.76 37.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.451 0.643 . . . . 0.0 112.012 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.5 m -122.98 171.29 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.004 1.722 . . . . 0.0 111.578 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 87.3 m -49.7 123.08 7.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.33 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 103.2 -14.6 55.12 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.725 -1.042 . . . . 0.0 115.096 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.5 tp -52.79 130.76 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.484 1.642 . . . . 0.0 111.532 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.87 131.38 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.145 2.178 . . . . 0.0 108.326 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.2 177.65 11.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.805 1.242 . . . . 0.0 112.605 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -99.74 154.01 18.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.709 1.604 . . . . 0.0 110.0 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.85 132.56 28.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -164.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.05 154.11 71.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.12 1.88 . . . . 0.0 110.631 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . 0.456 ' H ' ' HB2' ' A' ' 441' ' ' ALA . 73.2 m-20 -59.14 129.23 41.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.56 1.544 . . . . 0.0 113.348 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.65 55.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 123.308 1.528 . . . . 0.0 110.593 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.0 pt . . . . . 0 CA--C 1.551 0.984 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.53 146.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -70.25 138.33 51.56 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.308 1.043 . . . . 0.0 112.781 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mp -79.75 0.73 29.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.589 1.155 . . . . 0.0 113.232 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 125.468 1.507 . . . . 0.0 111.321 -176.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 CA--C 1.547 0.833 0 O-C-N 121.377 -0.827 . . . . 0.0 110.276 176.523 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 24.0 m80 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -52.87 127.11 22.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.412 1.46 . . . . 0.0 111.498 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -125.6 152.99 72.75 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.035 1.334 . . . . 0.0 110.606 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.42 158.92 55.6 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.296 2.664 . . . . 0.0 110.891 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.26 70.29 5.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 110.179 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.98 121.92 8.79 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.292 1.994 . . . . 0.0 108.994 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.37 127.69 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 109.316 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.93 163.95 28.38 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.151 1.38 . . . . 0.0 109.991 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -144.01 116.36 8.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.167 0.987 . . . . 0.0 109.34 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -121.54 107.79 12.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.069 0.938 . . . . 0.0 111.108 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -8.54 12.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.109 1.764 . . . . 0.0 113.923 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -68.31 -25.07 64.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.394 1.078 . . . . 0.0 112.651 172.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.03 150.55 96.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.63 0.772 . . . . 0.0 112.06 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.02 160.85 35.82 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.087 3.191 . . . . 0.0 112.934 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.46 134.14 27.87 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.958 3.105 . . . . 0.0 112.33 -171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.55 40.02 11.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.698 1.599 . . . . 0.0 112.298 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -121.35 151.8 39.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 172.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.3 pt -123.12 151.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.744 2.018 . . . . 0.0 110.492 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.69 126.76 55.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.494 1.518 . . . . 0.0 110.184 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.95 109.64 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.715 0.689 . . . . 0.0 111.495 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -72.97 131.7 42.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.156 1.382 . . . . 0.0 112.079 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.9 m -70.26 138.18 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.532 -0.73 . . . . 0.0 112.482 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.523 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.8 mtm105 -109.3 13.46 24.26 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.539 1.936 . . . . 0.0 110.944 164.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 32.7 m -118.97 141.89 48.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.671 1.588 . . . . 0.0 110.974 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.69 133.2 49.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.579 1.952 . . . . 0.0 108.754 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -92.59 112.86 24.96 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 165.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.4 mm -97.87 120.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 179.41 37.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.618 1.104 . . . . 0.0 111.32 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.77 60.77 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 114.751 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.3 125.64 90.65 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 118.417 1.109 . . . . 0.0 109.951 -168.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 135.53 31.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.798 2.332 . . . . 0.0 109.671 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 348' ' ' LEU . 1.9 mp -67.96 -10.83 56.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 -25.06 22.55 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.516 1.126 . . . . 0.0 112.985 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 19.4 mtm -79.91 149.02 31.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.885 0.85 . . . . 0.0 112.651 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -125.8 -176.01 3.5 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.504 1.921 . . . . 0.0 111.473 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 2.4 mp0 -49.88 -44.86 50.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.485 2.314 . . . . 0.0 113.062 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -77.34 -20.53 54.72 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.67 -37.33 59.68 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.048 0.84 . . . . 0.0 110.54 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.2 -49.55 77.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.524 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.77 -39.26 73.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.228 0.922 . . . . 0.0 112.732 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.02 -44.36 76.66 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.701 1.137 . . . . 0.0 113.587 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.09 -32.44 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 119.837 1.199 . . . . 0.0 111.725 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 62.0 mt -89.76 -10.58 45.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -46.89 -47.47 52.91 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.021 1.728 . . . . 0.0 115.37 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -6.98 16.77 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.203 1.935 . . . . 0.0 113.585 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -98.11 -39.2 9.02 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.609 1.563 . . . . 0.0 112.486 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.89 168.58 4.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.09 1.756 . . . . 0.0 113.31 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.36 129.47 34.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.856 0.862 . . . . 0.0 110.095 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.66 130.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.77 0.828 . . . . 0.0 110.206 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -95.0 -44.4 7.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.803 1.241 . . . . 0.0 112.536 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.3 m -144.13 152.63 41.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.474 1.109 . . . . 0.0 111.363 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 59.9 t -143.67 114.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.243 0.928 . . . . 0.0 110.936 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.6 93.46 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.14 129.27 45.38 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.513 0.725 . . . . 0.0 110.585 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -123.43 90.96 3.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.424 1.09 . . . . 0.0 109.932 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -58.57 -28.23 65.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.38 1.072 . . . . 0.0 112.266 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 22.7 t -56.44 -38.11 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.382 1.873 . . . . 0.0 114.178 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -107.04 6.98 29.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.867 1.267 . . . . 0.0 113.058 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 59.28 36.43 23.61 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.627 1.571 . . . . 0.0 111.412 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -124.18 164.06 20.27 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.28 33.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.759 1.224 . . . . 0.0 112.544 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.93 104.81 14.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.3 1.04 . . . . 0.0 108.654 164.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.87 100.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.111 1.364 . . . . 0.0 109.837 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -80.74 123.47 28.24 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.204 0.602 . . . . 0.0 110.277 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.53 168.01 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.346 166.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.73 -22.16 54.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.39 156.52 48.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 120.064 1.302 . . . . 0.0 113.704 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.49 -44.67 96.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.65 0.78 . . . . 0.0 112.322 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -66.46 -31.14 71.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.045 -0.41 . . . . 0.0 111.674 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.08 -53.89 42.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.755 1.222 . . . . 0.0 111.06 167.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.03 84.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.867 0.758 . . . . 0.0 112.133 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.77 -42.68 97.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.26 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -66.72 -30.69 70.98 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 120.126 1.33 . . . . 0.0 112.738 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.68 -63.56 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.736 0.698 . . . . 0.0 109.497 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.5 mt -52.25 -36.12 51.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.02 -42.95 88.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.046 1.338 . . . . 0.0 112.474 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -105.32 -23.5 12.85 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.11 123.55 24.64 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.484 -0.76 . . . . 0.0 111.489 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 61.79 29.27 17.94 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.807 1.643 . . . . 0.0 114.48 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.95 -34.69 65.91 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.804 -1.185 . . . . 0.0 113.396 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.37 -19.53 53.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.324 1.05 . . . . 0.0 113.525 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.03 70.18 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.65 1.119 . . . . 0.0 114.046 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.08 -31.53 20.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.6 1.56 . . . . 0.0 114.802 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 19.7 mt -80.62 150.78 70.53 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.351 1.06 . . . . 0.0 109.706 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.93 -32.47 7.13 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.405 2.07 . . . . 0.0 112.169 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.32 151.65 45.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.286 1.434 . . . . 0.0 111.756 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -127.94 96.38 4.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.768 1.227 . . . . 0.0 109.739 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 32.8 m -73.28 123.78 24.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.357 1.063 . . . . 0.0 110.634 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -126.52 173.63 9.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.703 2.001 . . . . 0.0 108.817 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -72.11 133.48 45.23 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.94 -1.1 . . . . 0.0 111.574 164.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.94 -153.09 9.54 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 125.777 1.656 . . . . 0.0 109.295 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.35 137.06 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.13 -52.98 2.93 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.723 1.63 . . . . 0.0 109.784 167.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.89 117.85 25.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.37 142.79 4.65 Favored Glycine 0 CA--C 1.543 1.836 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.96 130.28 15.34 Favored 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 125.746 4.297 . . . . 0.0 110.849 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -67.23 -32.09 72.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.42 -18.66 54.65 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.93 1.692 . . . . 0.0 113.83 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 77.8 m -122.9 28.73 7.11 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.586 1.555 . . . . 0.0 111.881 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.5 t -84.4 141.81 30.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.073 1.349 . . . . 0.0 111.429 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.37 80.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.779 1.631 . . . . 0.0 108.915 167.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -63.95 -20.51 65.93 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.547 -0.721 . . . . 0.0 112.904 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.32 -47.62 69.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.529 1.513 . . . . 0.0 111.266 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -83.2 -13.59 55.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.4 42.54 18.11 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.809 1.195 . . . . 0.0 112.374 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -147.27 168.74 20.97 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.026 1.413 . . . . 0.0 113.151 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.5 m -131.17 152.35 50.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.285 1.034 . . . . 0.0 110.704 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.2 mm -106.29 133.06 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.55 118.96 22.94 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 120.116 1.326 . . . . 0.0 110.981 -173.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -73.96 139.01 26.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.44 2.093 . . . . 0.0 111.121 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 10.9 mtt -63.02 -28.81 70.35 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.41 -19.29 65.88 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -104.85 3.81 31.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.562 1.945 . . . . 0.0 113.642 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.9 mt -92.05 136.32 33.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 110.395 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.2 p -79.94 178.77 7.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.514 1.126 . . . . 0.0 111.51 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.595 -0.691 . . . . 0.0 111.633 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.59 88.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.889 0.875 . . . . 0.0 112.025 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.69 -52.76 63.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.517 1.127 . . . . 0.0 112.284 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -65.56 -37.5 86.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.859 -0.526 . . . . 0.0 111.102 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -60.16 -42.17 94.39 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.78 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -66.59 -44.3 82.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.041 1.746 . . . . 0.0 111.271 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.2 m -56.59 -32.38 65.17 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.332 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.68 -39.75 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.8 m -103.26 -7.75 20.89 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -168.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.82 147.06 39.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.211 1.368 . . . . 0.0 111.604 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -77.11 -55.29 5.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.33 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -92.78 132.45 36.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.346 0.975 . . . . 0.0 110.533 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.81 179.34 10.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.015 0.817 . . . . 0.0 113.459 -173.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.67 -163.88 34.02 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 122.242 -0.563 . . . . 0.0 113.114 -168.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.1 p -109.78 7.44 24.17 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -163.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 37.4 p 76.74 15.81 1.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.972 2.109 . . . . 0.0 113.901 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.49 4.08 64.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.988 1.28 . . . . 0.0 113.352 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -66.01 138.34 96.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.901 1.28 . . . . 0.0 109.446 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -60.19 140.91 94.57 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.177 1.918 . . . . 0.0 110.176 169.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.04 130.24 43.22 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.29 159.69 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.473 1.509 . . . . 0.0 110.089 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 78.2 m -56.61 124.92 19.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.75 -2.05 76.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.593 -1.115 . . . . 0.0 115.541 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.4 tt -62.96 140.42 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.494 1.647 . . . . 0.0 112.127 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.56 136.78 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.829 2.052 . . . . 0.0 109.61 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -162.47 175.46 11.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.097 1.359 . . . . 0.0 113.104 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.72 148.69 21.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 111.397 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -51.47 126.25 29.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -168.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.78 152.84 64.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.073 2.515 . . . . 0.0 110.539 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -63.55 144.5 56.94 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.34 52.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.337 1.541 . . . . 0.0 110.133 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.549 0.938 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.79 141.469 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.1 m80 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.0 133.32 46.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.16 0.984 . . . . 0.0 112.258 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.1 mp -81.53 -41.74 21.21 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.968 1.307 . . . . 0.0 111.116 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . 0.449 ' HB2' ' HH ' ' A' ' 382' ' ' TYR . 67.8 m-85 . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 123.962 0.905 . . . . 0.0 110.876 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.591 0.71 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 . . . . . 0 CA--C 1.551 1.002 0 C-N-CA 123.938 0.895 . . . . 0.0 110.386 174.304 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.2 m80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -49.31 134.02 18.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.593 1.542 . . . . 0.0 111.919 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 81.4 mmt-85 -136.82 144.88 48.53 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.242 1.017 . . . . 0.0 110.054 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.98 161.87 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 110.827 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -117.04 66.78 4.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.629 1.171 . . . . 0.0 109.729 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.31 115.08 4.01 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.906 2.404 . . . . 0.0 109.487 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.3 m -92.84 139.99 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.912 0.885 . . . . 0.0 110.083 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.43 164.07 29.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.022 1.329 . . . . 0.0 110.301 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -143.77 120.57 11.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.132 0.973 . . . . 0.0 109.426 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.33 110.53 17.08 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.581 0.705 . . . . 0.0 110.656 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -8.49 44.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.952 0.901 . . . . 0.0 113.299 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 64.2 p -70.54 -24.44 62.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.479 1.512 . . . . 0.0 112.174 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.0 150.53 88.1 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.958 0.903 . . . . 0.0 111.576 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 161.32 38.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.055 3.17 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.48 136.63 37.18 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.157 3.238 . . . . 0.0 112.038 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.71 33.64 10.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.428 1.491 . . . . 0.0 113.024 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.23 151.52 32.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.634 -1.291 . . . . 0.0 114.353 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.0 pt -120.62 142.1 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.159 1.784 . . . . 0.0 110.485 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -107.75 111.54 23.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.672 -1.267 . . . . 0.0 110.63 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 25.4 t -105.69 101.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.865 0.866 . . . . 0.0 110.29 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -67.32 123.08 19.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.194 0.997 . . . . 0.0 111.477 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.2 t -69.74 134.66 48.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.625 -0.672 . . . . 0.0 111.425 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.5 mtm105 -101.93 9.98 40.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.891 1.677 . . . . 0.0 109.986 164.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 54.2 m -112.97 138.45 49.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.449 1.499 . . . . 0.0 111.041 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 40.1 mt -100.51 139.69 35.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.848 1.659 . . . . 0.0 109.503 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -95.27 138.44 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 164.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.45 114.57 44.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 166.28 26.34 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.484 1.04 . . . . 0.0 110.6 163.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.24 43.39 32.27 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 121.972 -0.722 . . . . 0.0 112.929 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.17 84.54 2.86 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.132 1.373 . . . . 0.0 110.875 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.31 173.28 11.69 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.287 2.658 . . . . 0.0 112.044 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.28 -21.75 50.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -18.9 61.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.19 0.996 . . . . 0.0 112.915 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.7 mtp -100.67 131.73 46.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.107 1.763 . . . . 0.0 109.921 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -141.23 170.07 16.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.082 1.753 . . . . 0.0 111.286 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.7 -42.66 62.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.631 1.172 . . . . 0.0 113.843 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -76.87 -27.65 55.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -38.59 84.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.663 167.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.82 -47.96 83.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.747 0.703 . . . . 0.0 110.974 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.51 83.3 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.163 0.892 . . . . 0.0 112.884 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.38 -39.69 89.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.929 1.241 . . . . 0.0 113.226 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.3 -35.35 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.539 1.063 . . . . 0.0 111.528 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.65 -11.27 54.23 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.187 0.903 . . . . 0.0 112.819 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -48.3 82.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 126.187 1.795 . . . . 0.0 115.166 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.52 -7.35 18.62 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.023 1.815 . . . . 0.0 112.985 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -96.86 -40.14 9.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.297 1.439 . . . . 0.0 112.369 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.41 172.86 3.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.116 1.766 . . . . 0.0 113.484 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 116.88 24.93 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.868 . . . . 0.0 110.506 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 75.3 t -77.82 133.55 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.148 0.979 . . . . 0.0 110.184 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -94.05 -54.17 3.69 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.372 1.469 . . . . 0.0 112.269 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.5 m -140.07 155.11 47.18 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.823 1.249 . . . . 0.0 111.28 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.56 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.059 0.544 . . . . 0.0 110.514 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.56 105.64 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.873 1.269 . . . . 0.0 107.666 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.44 125.8 43.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.396 0.678 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 83.45 2.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.945 1.355 . . . . 0.0 109.706 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -21.61 66.29 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.595 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.5 t -57.26 -31.75 65.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.848 1.659 . . . . 0.0 113.718 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -112.3 10.89 20.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.931 1.692 . . . . 0.0 113.179 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.3 mttt 58.74 32.81 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.159 1.384 . . . . 0.0 113.171 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -126.19 169.5 12.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.23 158.63 43.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 163.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -114.05 128.9 56.59 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.267 1.427 . . . . 0.0 108.641 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 63.9 t -128.08 105.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.896 0.878 . . . . 0.0 111.079 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.71 119.03 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.335 1.054 . . . . 0.0 109.791 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.65 152.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.723 1.609 . . . . 0.0 107.517 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.449 ' HH ' ' HB2' ' A' ' 306' ' ' TYR . 27.3 m-85 -66.33 -19.89 65.93 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.66 156.94 43.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.586 1.085 . . . . 0.0 112.427 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -44.55 96.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.215 1.006 . . . . 0.0 109.975 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -38.84 90.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.877 0.871 . . . . 0.0 111.566 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -63.92 -53.02 56.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.526 1.13 . . . . 0.0 111.361 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.34 73.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.841 0.746 . . . . 0.0 112.284 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.21 -45.4 91.18 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.175 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -61.55 -36.01 79.4 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.257 0.935 . . . . 0.0 112.187 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.74 -61.04 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.469 169.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.05 -37.9 35.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.041 1.337 . . . . 0.0 113.73 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -69.67 -29.43 66.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.869 1.268 . . . . 0.0 113.666 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -111.79 -26.28 9.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.556 1.071 . . . . 0.0 113.709 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.98 119.3 13.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.545 0.688 . . . . 0.0 111.698 -167.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 60.29 35.77 20.74 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.349 1.46 . . . . 0.0 113.532 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -62.72 -36.08 81.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.58 -14.85 31.68 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.444 1.498 . . . . 0.0 113.93 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.76 29.57 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.519 1.057 . . . . 0.0 114.666 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.5 -41.75 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.181 1.491 . . . . 0.0 114.581 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.2 mt -75.38 150.46 84.92 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.11 0.964 . . . . 0.0 109.802 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.18 -28.04 13.1 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.459 2.106 . . . . 0.0 112.436 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.8 141.76 28.35 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.448 0.699 . . . . 0.0 111.287 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.6 126.12 54.12 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 109.92 172.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 m -106.41 129.82 54.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.55 1.14 . . . . 0.0 109.922 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.72 175.17 9.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.46 1.904 . . . . 0.0 109.257 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -65.55 125.03 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.593 163.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -109.41 -157.21 17.37 Favored Glycine 0 N--CA 1.463 0.483 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.77 136.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.75 -51.23 2.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.736 1.636 . . . . 0.0 109.952 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -119.85 109.39 15.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.417 0.687 . . . . 0.0 112.753 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.95 136.29 3.53 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.049 -0.862 . . . . 0.0 115.222 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 132.08 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.589 4.193 . . . . 0.0 109.89 171.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -65.37 -36.86 85.27 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.626 -0.671 . . . . 0.0 112.74 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -73.33 -20.62 60.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 46.2 m -117.36 19.06 14.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.122 1.769 . . . . 0.0 112.599 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.82 153.15 35.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.945 0.879 . . . . 0.0 112.429 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.26 78.97 1.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.91 1.684 . . . . 0.0 108.704 166.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.67 -19.22 64.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 113.275 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -70.81 -50.75 32.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.024 0.829 . . . . 0.0 110.774 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -81.27 -15.91 54.11 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.83 21.36 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.016 1.293 . . . . 0.0 113.254 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -146.78 172.81 13.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.603 1.202 . . . . 0.0 113.35 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 30.0 m -133.83 146.05 50.28 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.173 0.989 . . . . 0.0 110.74 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 14.6 mm -107.0 95.86 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.542 0.737 . . . . 0.0 109.487 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.57 123.54 57.92 Favored Pre-proline 0 N--CA 1.474 0.726 0 O-C-N 121.029 -1.045 . . . . 0.0 111.193 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.59 132.85 22.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.526 2.15 . . . . 0.0 111.109 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 17.6 mtt -60.71 -30.8 70.18 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.026 1.331 . . . . 0.0 113.363 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.49 -16.8 64.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 8.15 24.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.845 2.058 . . . . 0.0 113.554 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.35 140.12 29.82 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.233 0.924 . . . . 0.0 110.211 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 20.7 p -75.88 178.33 6.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.57 1.148 . . . . 0.0 111.232 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.47 -46.17 87.46 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.42 -0.8 . . . . 0.0 111.073 169.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.876 0.87 . . . . 0.0 112.234 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.78 -55.41 35.47 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.286 1.434 . . . . 0.0 112.475 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -65.88 -36.67 84.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.845 -0.534 . . . . 0.0 110.791 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -59.12 -41.43 88.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.499 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -68.28 -45.97 71.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.423 1.465 . . . . 0.0 111.232 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 49.6 m -53.48 -36.13 61.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.612 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.62 -42.92 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.0 t -101.13 -9.06 21.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.739 1.216 . . . . 0.0 114.141 -167.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.21 146.68 27.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.427 1.108 . . . . 0.0 112.079 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.1 -57.9 3.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.734 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -91.46 132.69 36.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.273 1.029 . . . . 0.0 110.934 163.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 63.93 176.28 4.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.803 1.192 . . . . 0.0 114.094 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.1 -165.95 36.48 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.515 1.055 . . . . 0.0 112.748 -167.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 58.4 p -106.71 16.29 24.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -158.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.1 p 60.4 26.86 16.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.95 1.3 . . . . 0.0 113.441 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.0 77.03 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.506 1.527 . . . . 0.0 114.207 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -66.84 135.67 94.3 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.795 1.297 . . . . 0.0 110.13 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -59.51 144.04 99.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.534 2.156 . . . . 0.0 110.077 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.38 123.88 20.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.113 0.483 . . . . 0.0 110.493 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.06 157.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.002 2.121 . . . . 0.0 109.422 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.7 m -52.28 117.71 3.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 110.064 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 75.56 17.94 79.97 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.531 -1.15 . . . . 0.0 115.01 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 20.6 tt -62.5 126.91 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.231 1.516 . . . . 0.0 111.003 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.36 141.2 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.948 2.099 . . . . 0.0 109.501 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -166.29 171.93 11.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.36 1.464 . . . . 0.0 113.118 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.77 145.14 26.75 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.653 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -56.05 136.61 73.79 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -165.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.39 150.42 46.54 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.156 2.571 . . . . 0.0 110.992 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.82 142.04 54.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.964 1.305 . . . . 0.0 113.881 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.35 52.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.635 1.683 . . . . 0.0 110.144 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.549 0.914 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.003 141.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.2 m80 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -72.37 140.34 48.38 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.059 0.943 . . . . 0.0 113.072 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.56 8.22 10.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.955 1.302 . . . . 0.0 113.089 171.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 124.803 1.241 . . . . 0.0 111.585 -170.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.549 0.905 0 O-C-N 120.897 -1.127 . . . . 0.0 110.202 172.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -53.42 124.38 14.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.731 -1.231 . . . . 0.0 110.937 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -128.81 139.21 34.98 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 124.932 1.293 . . . . 0.0 109.223 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.9 156.93 59.47 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.884 2.389 . . . . 0.0 110.415 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 74.17 3.03 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.35 1.06 . . . . 0.0 109.962 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.6 111.59 3.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.613 2.209 . . . . 0.0 109.098 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.89 131.42 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.436 0.695 . . . . 0.0 110.042 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.41 169.57 15.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.635 1.574 . . . . 0.0 110.552 173.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -139.99 125.35 18.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.427 1.091 . . . . 0.0 110.108 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -121.23 107.38 12.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.877 0.871 . . . . 0.0 110.839 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.7 m -68.81 -5.58 21.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 55.7 p -71.33 -22.25 61.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.499 1.12 . . . . 0.0 112.188 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.1 mt -71.27 152.73 94.37 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.962 0.905 . . . . 0.0 112.247 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.81 162.17 33.06 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.113 3.208 . . . . 0.0 112.899 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.43 136.84 32.18 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.139 3.226 . . . . 0.0 112.389 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.72 47.35 10.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 111.798 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -126.12 152.91 45.28 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.337 1.055 . . . . 0.0 113.568 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.02 144.16 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.346 1.858 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -117.29 133.27 56.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.569 -1.332 . . . . 0.0 111.613 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.72 101.86 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.957 0.903 . . . . 0.0 110.582 -169.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -68.72 127.07 31.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.63 1.172 . . . . 0.0 112.024 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.3 m -70.22 135.49 49.07 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.523 -0.736 . . . . 0.0 112.275 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.4 mtm105 -102.42 10.24 39.14 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.881 1.673 . . . . 0.0 110.608 164.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 19.4 m -117.42 145.52 44.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.319 1.448 . . . . 0.0 112.141 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 52.9 mt -105.9 136.26 45.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.181 1.792 . . . . 0.0 109.552 172.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -88.98 140.95 28.91 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 162.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 18.3 mm -125.93 116.41 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 108.484 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -98.55 -177.11 32.67 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.313 0.959 . . . . 0.0 111.943 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.22 64.73 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 121.826 -0.808 . . . . 0.0 114.979 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.69 116.41 53.3 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-O 117.665 -1.16 . . . . 0.0 110.061 -166.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.23 135.29 33.87 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.305 2.003 . . . . 0.0 109.596 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.09 -20.26 63.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.38 -33.46 75.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.146 0.979 . . . . 0.0 111.949 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 3.8 ptp -82.6 151.58 26.29 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.527 0.68 . . . . 0.0 112.81 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -129.76 -175.71 3.68 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.169 1.788 . . . . 0.0 111.555 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.26 -39.79 57.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.753 1.221 . . . . 0.0 113.791 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -75.93 -21.64 56.85 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -74.52 -39.15 62.56 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.841 . . . . 0.0 110.568 169.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.07 -50.4 73.59 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.353 0.524 . . . . 0.0 110.569 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.89 80.24 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.596 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -68.46 -40.65 80.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.945 1.248 . . . . 0.0 113.512 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.51 -37.33 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.083 0.856 . . . . 0.0 111.493 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . 0.407 ' CD1' HG12 ' A' ' 379' ' ' VAL . 27.3 mt -83.83 -9.25 58.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.056 0.942 . . . . 0.0 112.75 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.66 -49.43 65.58 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 126.152 1.781 . . . . 0.0 114.889 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -7.32 18.61 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.076 1.851 . . . . 0.0 113.185 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.83 -41.32 8.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.274 1.43 . . . . 0.0 112.3 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.73 172.85 3.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 113.743 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.27 111.87 23.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 111.43 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.82 131.25 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.983 0.913 . . . . 0.0 110.991 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.85 -46.16 8.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.106 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -151.22 152.52 33.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.604 1.162 . . . . 0.0 111.482 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.84 137.21 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.646 . . . . 0.0 110.963 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.81 106.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.638 1.175 . . . . 0.0 107.846 166.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.19 133.0 45.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.003 0.921 . . . . 0.0 110.254 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.55 91.47 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.727 1.211 . . . . 0.0 110.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.0 -27.32 68.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.489 1.116 . . . . 0.0 111.89 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 71.4 m -57.62 -32.05 66.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.025 1.73 . . . . 0.0 114.269 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 8.9 17.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.0 112.729 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.4 mttt 51.99 40.84 29.12 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.704 1.602 . . . . 0.0 112.754 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -127.33 166.7 17.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.27 161.0 41.24 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.44 130.93 57.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.985 1.314 . . . . 0.0 108.379 164.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 359' ' ' LEU . 57.3 t -123.24 102.25 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.945 0.898 . . . . 0.0 110.191 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -74.74 111.02 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.699 1.2 . . . . 0.0 110.127 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.86 153.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.68 1.592 . . . . 0.0 107.85 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.38 -17.88 64.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.81 159.24 44.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.135 1.334 . . . . 0.0 113.004 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.98 77.62 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.741 0.816 . . . . 0.0 110.305 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.7 -36.0 79.66 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.682 0.793 . . . . 0.0 111.64 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.91 -55.55 21.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 111.543 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.4 72.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.061 0.846 . . . . 0.0 112.954 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -60.53 -47.69 85.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.385 1.074 . . . . 0.0 111.878 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.03 -34.51 76.37 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.569 -0.707 . . . . 0.0 112.053 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.63 -62.03 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.502 167.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -51.31 -35.28 37.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.789 1.236 . . . . 0.0 114.291 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.87 -33.11 75.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.938 1.295 . . . . 0.0 113.532 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -117.2 -27.68 6.4 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -74.93 123.18 24.64 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.627 0.771 . . . . 0.0 110.919 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.61 23.96 12.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -30.92 63.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.535 1.134 . . . . 0.0 113.766 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.16 -14.43 15.15 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.729 2.012 . . . . 0.0 114.229 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.29 35.48 7.0 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.716 1.15 . . . . 0.0 114.385 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.73 83.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.66 156.37 38.95 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.626 1.57 . . . . 0.0 110.497 -174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.84 -19.13 24.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.723 2.282 . . . . 0.0 113.908 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.2 mt -62.82 166.76 5.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.903 2.081 . . . . 0.0 113.072 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -137.16 95.0 3.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.46 1.104 . . . . 0.0 110.313 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.5 122.51 28.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.283 1.833 . . . . 0.0 111.063 -172.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 170.44 14.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.596 1.958 . . . . 0.0 109.28 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -64.22 120.17 11.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.336 -0.853 . . . . 0.0 110.424 161.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.1 -155.52 25.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.0 p -167.35 136.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.441 1.096 . . . . 0.0 110.167 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -80.14 -49.67 5.84 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.423 1.011 . . . . 0.0 110.96 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -115.2 96.65 5.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 111.08 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -158.65 122.58 1.16 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.768 -1.018 . . . . 0.0 114.772 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.85 125.23 9.27 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.531 3.487 . . . . 0.0 110.24 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -56.37 -40.45 74.58 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.91 -15.04 61.15 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.26 16.48 13.14 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 112.224 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 138.47 31.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.406 1.482 . . . . 0.0 111.776 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -118.63 86.52 2.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.997 1.719 . . . . 0.0 108.708 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -69.36 -15.57 63.34 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.66 -48.79 58.57 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.947 -1.095 . . . . 0.0 110.602 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -84.65 -16.92 40.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.22 44.83 10.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.575 1.083 . . . . 0.0 112.431 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.61 158.17 42.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.059 0.93 . . . . 0.0 113.491 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.81 151.62 28.83 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.967 -1.083 . . . . 0.0 110.69 168.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.89 104.03 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 0.0 109.015 172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.27 131.17 22.16 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.846 -167.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.73 138.66 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.172 1.914 . . . . 0.0 110.748 168.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 4.9 mtm -61.66 -32.92 73.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.344 1.058 . . . . 0.0 112.601 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -68.81 -11.01 59.95 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -110.11 8.12 23.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.309 1.443 . . . . 0.0 113.488 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 76.2 mt -91.33 135.88 33.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.409 0.684 . . . . 0.0 110.35 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 26.3 p -72.73 175.94 6.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.424 1.09 . . . . 0.0 110.749 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -42.67 98.16 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.633 -0.667 . . . . 0.0 111.046 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.18 82.67 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 112.365 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.47 -53.82 53.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.563 1.145 . . . . 0.0 111.677 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -67.77 -35.83 79.39 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.864 -0.522 . . . . 0.0 111.615 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -54.26 -51.93 62.98 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.587 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -68.5 -40.97 80.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.472 1.487 . . . . 0.0 111.683 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -54.68 -29.62 53.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.083 -0.96 . . . . 0.0 113.138 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.48 -40.9 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 171.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.0 t -104.23 -4.76 22.64 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.136 1.374 . . . . 0.0 114.458 -165.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.72 145.88 32.96 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.995 -1.066 . . . . 0.0 111.761 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -53.13 9.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.734 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -95.23 136.52 35.46 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.808 0.843 . . . . 0.0 111.326 162.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.29 -164.07 53.92 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.392 0.996 . . . . 0.0 113.053 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.17 -168.08 52.51 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.183 0.42 . . . . 0.0 112.202 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 73.3 p -98.51 7.79 45.71 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 74.7 25.72 1.49 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.797 1.239 . . . . 0.0 112.808 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.93 82.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.07 1.319 . . . . 0.0 114.007 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -68.31 149.05 98.21 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.3 1.05 . . . . 0.0 110.219 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.28 147.57 93.68 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.341 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.17 122.88 20.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.64 153.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.557 1.943 . . . . 0.0 109.025 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 63.9 m -51.91 125.38 15.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.74 0.416 . . . . 0.0 110.096 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.31 89.1 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.503 -1.165 . . . . 0.0 114.848 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.2 tt -60.03 139.48 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.487 1.644 . . . . 0.0 111.414 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.62 139.55 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.245 1.818 . . . . 0.0 109.457 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -159.89 172.88 16.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.421 1.488 . . . . 0.0 112.193 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.34 150.56 22.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.264 1.026 . . . . 0.0 110.826 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.34 127.79 23.45 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.84 150.29 55.36 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.544 2.163 . . . . 0.0 111.115 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -61.76 146.21 50.09 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.0 113.819 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.3 50.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 123.194 1.473 . . . . 0.0 110.32 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.954 139.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.2 m80 . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -79.68 142.43 35.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.709 1.203 . . . . 0.0 111.901 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' A' ' 356' ' ' ALA . 5.2 mp -90.81 7.01 41.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.603 1.561 . . . . 0.0 112.68 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.948 1.299 . . . . 0.0 111.542 -169.42 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.538 0.685 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.5 t30 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.384 1.073 . . . . 0.0 110.23 177.657 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.6 m80 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.33 133.8 34.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.391 1.451 . . . . 0.0 111.988 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -136.29 149.79 68.9 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 124.058 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -68.71 153.17 73.73 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.705 2.27 . . . . 0.0 110.318 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 78.35 8.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.383 1.073 . . . . 0.0 108.673 168.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.44 118.49 5.62 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.731 2.288 . . . . 0.0 108.798 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.52 136.44 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.911 0.884 . . . . 0.0 109.529 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.64 175.0 9.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.563 1.145 . . . . 0.0 110.496 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.63 121.72 20.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.969 0.908 . . . . 0.0 110.102 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -115.68 108.93 17.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.011 0.91 . . . . 0.0 111.096 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.1 p -65.76 -7.49 16.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.495 1.518 . . . . 0.0 114.038 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.49 -23.04 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.699 0.799 . . . . 0.0 112.324 169.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.96 151.02 86.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 112.182 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.88 161.36 36.77 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.882 3.054 . . . . 0.0 112.574 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.06 135.13 28.97 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.132 3.222 . . . . 0.0 112.552 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.8 34.64 9.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.8 1.64 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -119.49 158.86 25.4 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.78 150.72 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.545 1.938 . . . . 0.0 110.263 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.98 127.67 54.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.895 1.678 . . . . 0.0 110.672 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.26 104.19 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.571 0.749 . . . . 0.0 111.414 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -70.09 137.72 51.41 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.452 1.101 . . . . 0.0 112.323 169.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 m -78.39 129.92 35.51 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.442 -0.786 . . . . 0.0 112.095 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -95.65 18.06 13.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.263 1.425 . . . . 0.0 110.958 162.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 97.4 m -130.96 142.68 50.37 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 111.412 -168.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 25.6 mt -107.11 133.29 51.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.684 1.994 . . . . 0.0 108.669 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -84.65 118.74 24.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.48 108.55 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.22 -175.96 49.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.51 0.576 . . . . 0.0 111.786 167.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.84 9.43 59.41 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.439 -1.036 . . . . 0.0 114.97 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.38 118.52 68.25 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.724 1.262 . . . . 0.0 110.2 -165.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.32 136.19 33.5 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.535 2.157 . . . . 0.0 109.017 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -18.96 50.0 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -73.9 -33.99 64.22 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.699 -0.626 . . . . 0.0 112.662 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 41.3 mtm -72.98 146.19 46.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.12 0.962 . . . . 0.0 112.424 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -126.9 179.86 5.18 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 127.406 2.282 . . . . 0.0 110.911 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.69 -46.24 29.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.645 1.578 . . . . 0.0 113.483 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -76.09 -18.89 58.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.743 1.156 . . . . 0.0 110.391 168.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.86 -42.35 84.32 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.244 0.618 . . . . 0.0 110.832 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.404 ' HB3' ' CD2' ' A' ' 305' ' ' LEU . . . -55.89 -52.09 65.3 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 119.1 0.864 . . . . 0.0 112.369 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.5 -38.65 91.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 26.4 m -72.11 -35.94 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.758 0.708 . . . . 0.0 111.533 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.43 -12.88 50.94 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -46.68 87.17 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.259 1.824 . . . . 0.0 114.649 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.38 -7.03 17.67 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.011 1.807 . . . . 0.0 113.434 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.79 -39.44 9.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.499 1.52 . . . . 0.0 112.614 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.0 167.0 3.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.856 1.662 . . . . 0.0 113.916 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.29 107.49 17.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.792 0.837 . . . . 0.0 110.647 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.56 144.21 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.027 0.931 . . . . 0.0 111.257 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -111.46 -38.57 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.093 1.357 . . . . 0.0 112.092 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.5 155.33 39.29 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.821 1.191 . . . . 0.0 111.757 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 84.0 t -147.1 127.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.844 0.858 . . . . 0.0 110.056 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.65 105.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.29 112.51 25.03 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.732 0.813 . . . . 0.0 110.41 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.56 86.06 3.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 109.851 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.02 -32.63 66.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.941 1.296 . . . . 0.0 111.629 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 34.9 m -59.06 -27.2 65.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.915 1.686 . . . . 0.0 114.378 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -114.56 10.58 16.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.112 1.365 . . . . 0.0 112.406 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 51.29 37.8 19.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.094 1.758 . . . . 0.0 113.042 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -125.27 153.79 42.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.046 1.338 . . . . 0.0 113.661 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -139.53 131.75 28.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.641 1.176 . . . . 0.0 112.168 164.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -83.75 115.48 22.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 162.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 99.2 t -122.76 107.42 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.607 . . . . 0.0 110.986 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 125.77 51.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.13 0.972 . . . . 0.0 111.979 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.75 168.72 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.458 1.503 . . . . 0.0 110.018 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -70.39 -24.13 62.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 2.8 p -137.18 156.05 48.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.351 1.432 . . . . 0.0 113.515 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -43.5 98.7 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.613 -0.679 . . . . 0.0 109.895 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -58.41 -37.37 75.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.602 0.761 . . . . 0.0 112.933 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.41 -49.68 72.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.941 0.897 . . . . 0.0 111.168 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.44 93.34 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.806 0.73 . . . . 0.0 112.383 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -61.07 -48.64 80.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.047 0.939 . . . . 0.0 111.15 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -62.81 -34.12 76.62 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.492 -0.755 . . . . 0.0 112.812 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.27 -64.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.656 -0.688 . . . . 0.0 109.582 166.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.38 -35.59 28.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.531 1.132 . . . . 0.0 113.646 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.35 -30.8 71.27 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.682 1.193 . . . . 0.0 113.469 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -117.22 -27.68 6.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -73.48 125.41 27.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.673 0.749 . . . . 0.0 111.28 -167.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.4 30.05 19.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.762 1.625 . . . . 0.0 113.937 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -56.23 -36.07 68.08 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.18 -0.95 . . . . 0.0 113.457 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.18 -21.35 46.51 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.566 1.146 . . . . 0.0 113.103 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.18 27.28 49.73 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.941 1.258 . . . . 0.0 113.712 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.93 -34.93 14.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.559 1.544 . . . . 0.0 114.768 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.3 mt -72.95 149.57 89.97 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.12 0.968 . . . . 0.0 109.698 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.54 -30.01 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.657 2.238 . . . . 0.0 112.532 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.22 149.84 47.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.752 2.021 . . . . 0.0 112.399 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -119.37 98.34 6.1 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.572 1.149 . . . . 0.0 110.421 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.85 107.65 16.38 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.197 1.799 . . . . 0.0 109.542 -169.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -117.91 166.91 11.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 108.89 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -65.59 132.53 49.09 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.203 -0.935 . . . . 0.0 111.217 163.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.49 -146.56 8.29 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.416 1.484 . . . . 0.0 109.527 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.81 143.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.398 1.479 . . . . 0.0 108.594 167.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -75.47 -82.11 0.48 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 165.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -94.74 105.75 17.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.559 0.744 . . . . 0.0 111.074 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -169.56 140.67 6.22 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.304 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.4 125.84 11.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 125.16 3.906 . . . . 0.0 109.985 174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 -65.31 -36.68 84.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.08 -18.4 62.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.501 1.921 . . . . 0.0 114.029 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.29 30.16 6.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 111.995 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.9 t -89.62 135.87 33.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.558 1.143 . . . . 0.0 111.806 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -116.96 89.38 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.249 1.82 . . . . 0.0 108.762 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -69.7 -20.87 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.33 -46.39 80.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.594 1.543 . . . . 0.0 111.187 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -86.45 -17.54 33.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.61 48.05 8.29 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.532 1.063 . . . . 0.0 112.401 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -150.08 169.74 20.55 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.284 1.042 . . . . 0.0 112.834 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 15.9 p -137.96 151.96 48.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.71 1.204 . . . . 0.0 110.802 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 22.0 mt -110.23 130.62 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.96 127.16 25.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 119.701 1.137 . . . . 0.0 111.634 -172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.31 132.79 21.51 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.875 2.383 . . . . 0.0 111.635 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 14.5 mtm -64.32 -28.22 69.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.34 1.456 . . . . 0.0 114.048 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -68.37 -23.72 64.7 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.747 0.703 . . . . 0.0 112.893 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.07 -36.55 15.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.588 1.555 . . . . 0.0 111.923 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.2 mt -53.0 117.98 3.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.987 0.812 . . . . 0.0 109.139 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.0 p -64.62 176.17 1.21 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.758 1.223 . . . . 0.0 110.753 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -62.1 -38.85 90.43 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.693 -0.63 . . . . 0.0 111.571 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.53 -40.67 80.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.822 0.849 . . . . 0.0 112.141 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.68 -58.79 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.369 1.067 . . . . 0.0 111.608 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -61.43 -36.04 79.24 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.705 0.402 . . . . 0.0 111.927 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.14 -40.3 89.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.996 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -67.45 -45.47 75.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.539 1.518 . . . . 0.0 111.456 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -52.89 -37.63 60.81 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.496 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.76 -43.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -97.45 -12.55 22.56 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.37 142.5 43.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.183 -0.948 . . . . 0.0 111.989 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -76.34 -53.49 8.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.782 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -92.97 128.32 38.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.285 1.034 . . . . 0.0 110.415 166.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.13 -173.36 45.7 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.479 1.038 . . . . 0.0 114.324 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.19 -158.96 53.8 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.469 -0.365 . . . . 0.0 112.617 -170.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.0 p -97.64 7.52 46.3 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -164.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 p 68.93 7.06 5.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.766 1.626 . . . . 0.0 114.422 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.53 1.78 32.82 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.941 1.734 . . . . 0.0 113.973 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -66.46 153.61 92.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 118.603 1.201 . . . . 0.0 110.823 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.12 147.64 94.03 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.404 2.07 . . . . 0.0 110.038 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 27.2 mt -68.74 124.52 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.865 -0.522 . . . . 0.0 109.761 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.8 t -117.53 148.89 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.292 1.837 . . . . 0.0 108.552 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 99.7 m -50.17 122.96 7.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.18 0.592 . . . . 0.0 109.806 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.57 -2.68 77.75 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.204 -1.331 . . . . 0.0 115.265 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.89 123.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.708 1.754 . . . . 0.0 111.592 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.68 138.22 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 109.243 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.6 -178.36 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.5 1.52 . . . . 0.0 112.25 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -93.57 153.26 18.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.626 1.17 . . . . 0.0 111.791 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -49.14 130.32 16.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.542 1.137 . . . . 0.0 113.206 -168.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.68 150.58 68.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.116 1.878 . . . . 0.0 109.689 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -55.66 156.42 4.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.227 1.011 . . . . 0.0 113.72 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mt -121.52 46.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 123.58 1.657 . . . . 0.0 109.56 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.527 135.257 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -79.64 142.24 35.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.257 1.023 . . . . 0.0 111.938 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.65 -42.53 97.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.705 1.202 . . . . 0.0 111.325 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.559 1.3 0 C-N-CA 125.252 1.421 . . . . 0.0 113.129 -169.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 . . . . . 0 CA--C 1.55 0.949 0 O-C-N 120.989 -1.07 . . . . 0.0 110.346 177.777 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.8 m80 . . . . . 0 CA--C 1.548 0.901 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -50.57 131.7 25.28 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.149 1.341 . . . . 0.0 111.209 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.37 140.81 26.9 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 123.861 0.864 . . . . 0.0 109.951 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.9 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.217 2.612 . . . . 0.0 111.026 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 66.28 49.92 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.985 1.314 . . . . 0.0 110.442 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.38 113.15 2.79 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.113 2.542 . . . . 0.0 109.734 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.02 127.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.787 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.68 167.3 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.284 1.434 . . . . 0.0 110.367 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -139.38 122.84 17.24 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.879 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.93 115.02 23.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.803 0.841 . . . . 0.0 110.373 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.4 p -70.4 -11.14 60.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 70.5 p -67.32 -22.38 65.61 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 112.365 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -69.34 147.61 97.13 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.364 0.666 . . . . 0.0 111.478 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.84 164.26 27.71 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.821 3.014 . . . . 0.0 112.65 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.47 133.75 21.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.775 2.983 . . . . 0.0 112.07 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 69.17 30.47 4.32 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.992 2.117 . . . . 0.0 112.123 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -119.97 142.28 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.9 pt -115.31 149.15 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.458 1.503 . . . . 0.0 110.294 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 128.46 53.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.491 1.116 . . . . 0.0 110.645 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.06 104.73 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.185 0.448 . . . . 0.0 111.618 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -67.13 138.88 57.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.96 167.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 t -81.66 136.17 35.51 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.353 -0.842 . . . . 0.0 112.432 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -105.43 18.89 21.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.944 1.697 . . . . 0.0 110.42 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 92.5 m -125.26 140.69 52.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 111.523 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.18 136.06 47.66 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.143 1.777 . . . . 0.0 108.891 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.69 122.08 33.92 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.37 109.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.29 50.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.646 0.641 . . . . 0.0 111.746 168.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.25 16.02 68.51 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.697 -0.884 . . . . 0.0 114.9 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 28.7 t -78.55 116.58 60.56 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.634 1.217 . . . . 0.0 110.021 -168.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 135.86 31.08 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.325 2.016 . . . . 0.0 108.699 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.2 -15.88 38.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.01 -27.07 61.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.788 0.835 . . . . 0.0 113.106 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.4 ptp -84.55 147.46 27.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.542 0.737 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -124.96 -167.77 1.72 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.824 1.65 . . . . 0.0 111.741 -173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -60.24 -41.71 93.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.592 1.157 . . . . 0.0 111.957 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -73.8 -24.24 59.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.0 -41.85 70.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.882 1.219 . . . . 0.0 110.757 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -56.14 -53.24 59.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 122.977 0.511 . . . . 0.0 110.486 170.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.35 -32.9 67.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.238 -0.887 . . . . 0.0 113.086 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -70.28 -46.16 64.9 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.996 1.271 . . . . 0.0 113.032 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.56 -36.18 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.164 0.893 . . . . 0.0 111.077 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 11.3 mp -78.65 -6.55 56.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.078 0.951 . . . . 0.0 113.342 173.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -49.93 -50.94 65.45 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-N 120.719 1.6 . . . . 0.0 114.843 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.7 -6.34 17.47 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.088 1.859 . . . . 0.0 113.207 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -97.13 -43.04 7.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.547 1.539 . . . . 0.0 112.398 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.26 169.36 2.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 113.868 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.79 119.52 32.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.443 1.097 . . . . 0.0 111.057 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.39 129.18 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.911 1.284 . . . . 0.0 109.411 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.7 -28.63 14.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 t -153.8 149.89 27.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.752 1.221 . . . . 0.0 110.828 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.32 139.45 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.614 0.765 . . . . 0.0 109.836 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.09 104.85 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 166.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.25 118.3 30.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.105 0.478 . . . . 0.0 109.913 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -102.63 79.45 1.81 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.222 1.409 . . . . 0.0 109.058 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.66 -33.49 64.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.167 1.387 . . . . 0.0 111.4 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -32.29 66.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.953 1.701 . . . . 0.0 113.443 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.29 6.79 24.85 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.397 1.479 . . . . 0.0 113.832 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.7 mttt 56.09 38.3 29.75 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.751 1.621 . . . . 0.0 112.436 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -121.66 154.31 37.0 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.03 1.732 . . . . 0.0 113.144 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.46 130.58 28.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.577 1.151 . . . . 0.0 111.698 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -84.36 123.13 29.86 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 162.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 53.0 t -122.96 118.22 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.013 0.925 . . . . 0.0 110.059 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.45 121.1 42.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 109.68 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.96 163.34 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 110.114 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -73.71 -17.71 61.09 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 6.3 p -140.8 156.69 46.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.297 . . . . 0.0 113.154 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -43.43 96.74 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.764 -0.585 . . . . 0.0 110.6 171.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -59.15 -42.08 89.87 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.887 -0.508 . . . . 0.0 111.132 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.0 -50.0 74.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.097 0.959 . . . . 0.0 112.022 171.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.12 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.624 0.647 . . . . 0.0 111.568 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -60.94 -41.31 95.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.423 0.689 . . . . 0.0 112.356 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -66.64 -33.48 75.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.309 0.959 . . . . 0.0 112.134 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.0 -64.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.351 164.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -49.82 -35.57 23.42 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -63.99 -42.19 97.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.909 1.684 . . . . 0.0 113.369 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -110.55 -26.91 9.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -171.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -70.58 122.66 20.15 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.944 0.897 . . . . 0.0 111.095 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.07 31.77 17.77 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.843 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -34.29 73.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.1 -21.18 54.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.826 1.251 . . . . 0.0 113.073 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.99 28.04 55.11 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.933 1.254 . . . . 0.0 113.685 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -92.64 -35.12 13.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.473 1.509 . . . . 0.0 114.566 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.4 mt -72.0 150.38 92.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.431 1.092 . . . . 0.0 109.789 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.93 -34.35 8.69 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.476 2.117 . . . . 0.0 112.045 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.76 151.61 46.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 112.575 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -127.19 94.64 4.06 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.068 1.347 . . . . 0.0 108.946 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -77.94 116.9 18.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.027 0.931 . . . . 0.0 110.389 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -120.37 171.27 8.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.933 2.093 . . . . 0.0 108.941 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -69.63 127.46 33.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.046 -1.034 . . . . 0.0 111.273 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.23 -155.68 15.1 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 125.532 1.539 . . . . 0.0 109.27 166.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.64 134.3 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.111 0.456 . . . . 0.0 111.953 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.54 -51.06 3.79 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 166.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -123.64 112.66 17.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 112.454 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.65 2.93 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.131 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.71 128.81 14.71 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 125.195 3.93 . . . . 0.0 110.48 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -34.32 76.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.04 -19.07 60.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.297 1.039 . . . . 0.0 113.756 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.76 29.47 6.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.158 1.783 . . . . 0.0 111.654 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.4 t -83.74 136.01 34.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.886 1.274 . . . . 0.0 111.301 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -121.41 76.89 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.39 1.476 . . . . 0.0 109.087 167.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -61.71 -26.68 68.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.562 -0.711 . . . . 0.0 112.553 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.6 -49.92 74.66 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.235 1.379 . . . . 0.0 111.684 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -82.44 -13.41 56.81 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.98 39.92 18.53 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 124.803 1.192 . . . . 0.0 112.749 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.87 167.02 24.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.621 1.211 . . . . 0.0 112.946 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.9 m -130.25 153.82 48.22 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.397 -0.814 . . . . 0.0 110.465 167.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 mm -106.09 133.8 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.58 115.61 28.26 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 120.228 1.376 . . . . 0.0 112.014 -171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -71.45 133.08 21.79 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.195 2.596 . . . . 0.0 111.492 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.9 mtt -61.81 -28.94 69.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.459 1.104 . . . . 0.0 113.316 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -65.59 -19.07 65.77 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.43 16.43 16.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 112.908 176.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.96 173.55 8.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.863 1.265 . . . . 0.0 112.513 170.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.4 p -127.12 169.1 13.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.039 1.336 . . . . 0.0 110.632 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.31 -33.25 69.52 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.748 -1.22 . . . . 0.0 111.166 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.83 84.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.458 1.103 . . . . 0.0 112.014 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -45.14 84.51 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.656 0.662 . . . . 0.0 112.478 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -62.33 -41.74 98.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -59.84 -32.36 70.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.339 1.056 . . . . 0.0 113.106 171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -72.05 -50.45 28.27 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.007 1.731 . . . . 0.0 111.877 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.7 m -51.58 -39.55 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.314 0.961 . . . . 0.0 111.715 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.3 m -82.64 -50.52 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.5 t -91.07 -13.78 32.52 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.612 -1.305 . . . . 0.0 114.27 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.4 137.69 47.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.027 0.917 . . . . 0.0 111.702 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -78.05 -44.97 24.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.883 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -102.82 140.0 37.66 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.968 1.307 . . . . 0.0 111.617 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.02 -167.5 34.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.056 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.92 -146.21 47.83 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -171.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 18.7 p -117.21 1.18 12.45 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -153.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.77 18.01 1.3 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.29 1.836 . . . . 0.0 112.849 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.19 12.4 61.72 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.602 1.096 . . . . 0.0 113.659 -172.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -78.56 136.93 59.3 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.032 1.333 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.18 99.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.069 2.513 . . . . 0.0 109.059 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.61 147.68 52.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.625 0.77 . . . . 0.0 112.189 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.3 163.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.785 1.234 . . . . 0.0 111.235 -173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.8 t -51.43 127.35 19.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.916 0.886 . . . . 0.0 110.641 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 97.03 -14.39 63.9 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.938 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.26 147.33 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.077 1.939 . . . . 0.0 112.164 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.94 132.93 69.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.759 2.024 . . . . 0.0 109.052 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -153.36 178.05 10.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.415 1.486 . . . . 0.0 111.752 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.99 151.26 19.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.163 1.385 . . . . 0.0 109.631 171.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.31 129.26 5.98 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.888 1.275 . . . . 0.0 112.371 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.57 150.54 80.0 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.293 1.328 . . . . 0.0 110.077 168.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.24 142.87 24.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 51.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.632 1.682 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.549 0.911 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.499 138.688 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.9 m80 . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.15 143.23 52.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.384 1.074 . . . . 0.0 112.322 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.91 -46.29 88.51 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.034 0.934 . . . . 0.0 112.183 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 CA--C 1.549 0.938 0 C-N-CA 125.193 1.397 . . . . 0.0 112.522 -175.11 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 122.301 1.048 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 124.734 1.214 . . . . 0.0 111.307 179.027 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -55.12 125.17 19.41 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.253 -1.529 . . . . 0.0 111.471 171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.4 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.7 mmt-85 -160.24 148.33 13.11 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.758 1.623 . . . . 0.0 110.693 -170.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.06 173.47 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.644 2.229 . . . . 0.0 111.611 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -114.84 99.32 51.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.192 0.597 . . . . 0.0 109.504 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.03 154.79 25.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.522 2.815 . . . . 0.0 110.821 171.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.08 142.06 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.329 1.452 . . . . 0.0 108.967 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.74 168.09 17.77 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.388 1.075 . . . . 0.0 111.166 171.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.12 121.98 15.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.766 1.226 . . . . 0.0 109.996 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.23 107.18 12.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.822 1.249 . . . . 0.0 110.164 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 50.3 p -71.55 -4.13 25.19 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -24.59 66.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.94 1.296 . . . . 0.0 112.175 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.16 151.21 97.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.064 0.946 . . . . 0.0 112.001 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.26 161.74 32.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.826 3.017 . . . . 0.0 112.659 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.56 131.19 18.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.746 2.964 . . . . 0.0 112.057 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.05 36.21 4.28 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.074 2.15 . . . . 0.0 111.807 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -122.57 155.26 36.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.649 1.18 . . . . 0.0 113.74 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.6 pt -123.61 154.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.652 1.981 . . . . 0.0 110.546 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -110.55 125.17 53.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.118 0.967 . . . . 0.0 110.946 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.11 105.1 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.505 1.122 . . . . 0.0 109.785 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.93 136.28 52.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.627 1.171 . . . . 0.0 111.218 168.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.7 t -73.96 138.84 44.46 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 121.325 -0.859 . . . . 0.0 112.203 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -107.37 -1.27 21.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.889 1.676 . . . . 0.0 111.815 164.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 23.1 m -100.54 123.62 45.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.072 1.349 . . . . 0.0 109.093 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.45 141.46 28.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.568 1.547 . . . . 0.0 108.751 168.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -93.93 142.99 26.75 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.47 111.93 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.169 1.388 . . . . 0.0 108.441 -172.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -91.01 172.75 37.14 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.197 0.904 . . . . 0.0 111.768 168.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.6 23.36 78.04 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.316 -0.713 . . . . 0.0 114.736 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.0 t -84.26 115.72 61.55 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 118.491 1.146 . . . . 0.0 110.405 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.87 142.24 61.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.924 2.416 . . . . 0.0 110.032 170.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.08 -20.12 50.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -21.34 52.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 22.9 mtm -83.94 144.06 29.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.949 0.881 . . . . 0.0 112.165 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -128.31 -177.16 4.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.832 2.053 . . . . 0.0 110.624 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -49.41 -39.26 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.73 1.612 . . . . 0.0 114.713 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -79.36 -17.77 53.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -75.75 -38.54 58.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.549 1.068 . . . . 0.0 110.519 168.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.87 -49.07 79.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.582 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.36 -33.56 69.7 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.102 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -73.97 -42.45 60.45 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.923 1.238 . . . . 0.0 114.314 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.29 -35.19 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.029 1.286 . . . . 0.0 111.459 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 37.8 mt -87.97 -5.63 58.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.455 1.102 . . . . 0.0 113.081 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -52.53 -49.0 88.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.88 -6.17 17.77 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.616 2.21 . . . . 0.0 113.379 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -98.5 -35.91 10.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.332 1.453 . . . . 0.0 112.871 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.55 3.5 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.214 1.805 . . . . 0.0 113.936 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 122.23 30.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.184 1.394 . . . . 0.0 110.61 169.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.46 122.74 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.693 0.797 . . . . 0.0 109.592 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -96.72 -35.5 10.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.588 1.555 . . . . 0.0 112.459 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.95 155.57 44.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.36 1.064 . . . . 0.0 111.907 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 27.0 t -149.22 140.18 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 0.0 110.621 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.26 101.48 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.392 1.477 . . . . 0.0 108.254 168.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.63 131.11 49.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.174 0.59 . . . . 0.0 110.823 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 87.49 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.394 1.092 . . . . 0.0 109.96 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.42 -29.54 67.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.273 1.429 . . . . 0.0 112.237 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.3 t -59.27 -28.28 66.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.888 1.675 . . . . 0.0 114.092 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.22 1.38 16.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.083 1.753 . . . . 0.0 112.727 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 59.51 37.46 22.84 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.318 1.447 . . . . 0.0 112.26 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -125.51 167.0 15.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.42 164.76 29.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.501 1.12 . . . . 0.0 112.315 163.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.94 135.38 54.92 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.331 1.453 . . . . 0.0 108.396 162.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 73.0 t -128.44 118.03 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.116 0.966 . . . . 0.0 110.92 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -101.67 120.3 40.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.786 1.234 . . . . 0.0 112.059 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.9 m -100.99 -179.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.136 0.974 . . . . 0.0 111.429 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -64.93 -37.4 87.53 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.928 1.24 . . . . 0.0 114.155 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 60.3 p -149.06 166.42 28.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -167.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -39.25 89.62 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.175 169.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -62.39 -40.36 96.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.917 0.78 . . . . 0.0 112.352 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.62 -47.76 71.61 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.37 0.668 . . . . 0.0 110.488 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.92 98.65 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.383 -0.823 . . . . 0.0 112.107 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -65.5 -40.52 93.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.935 171.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.99 -33.38 75.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.946 1.248 . . . . 0.0 112.333 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.99 -65.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 118.461 0.573 . . . . 0.0 109.886 164.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.48 -33.22 43.76 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -69.29 -35.3 75.87 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 113.454 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -111.49 -26.04 9.28 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -72.6 124.25 24.87 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.415 0.686 . . . . 0.0 111.872 -168.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 60.67 28.77 18.48 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.712 1.605 . . . . 0.0 114.134 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -31.03 70.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.791 -1.193 . . . . 0.0 113.737 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.16 -18.3 50.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.601 1.16 . . . . 0.0 113.382 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.72 17.69 69.92 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.848 1.213 . . . . 0.0 114.001 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.55 -31.27 19.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.54 1.536 . . . . 0.0 114.845 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.22 149.18 72.37 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.195 0.998 . . . . 0.0 109.895 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.33 -27.84 11.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.689 2.26 . . . . 0.0 112.394 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.17 147.04 45.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.806 1.242 . . . . 0.0 111.863 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.89 103.25 8.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.564 1.146 . . . . 0.0 110.592 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -86.84 122.4 30.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 111.401 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -129.35 177.09 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.304 2.642 . . . . 0.0 109.146 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -76.05 130.84 38.98 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.777 -1.202 . . . . 0.0 111.651 162.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.0 -160.56 21.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.274 1.892 . . . . 0.0 109.594 162.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.61 125.94 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.892 1.277 . . . . 0.0 109.47 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -90.21 -43.49 4.97 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 162.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -137.66 124.4 21.11 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.168 0.987 . . . . 0.0 110.866 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 174.09 129.92 1.23 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.068 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.27 123.51 10.0 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.78 3.654 . . . . 0.0 109.797 172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.7 -37.89 74.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.279 0.561 . . . . 0.0 112.476 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.79 -18.6 62.09 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.026 2.13 . . . . 0.0 114.545 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.66 24.21 8.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.844 1.658 . . . . 0.0 112.084 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.65 140.99 29.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.309 1.444 . . . . 0.0 111.776 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.81 88.8 3.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.376 1.471 . . . . 0.0 109.199 166.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -65.78 -20.76 66.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.42 -51.51 23.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.637 0.775 . . . . 0.0 110.347 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.87 -17.67 55.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.42 36.18 27.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 124.967 1.27 . . . . 0.0 113.294 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -144.33 164.89 29.47 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.165 0.986 . . . . 0.0 112.893 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.6 m -129.73 150.52 51.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.296 1.038 . . . . 0.0 110.521 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.48 139.38 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.99 126.65 19.77 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 120.017 1.28 . . . . 0.0 111.608 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.25 135.74 27.61 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.565 2.176 . . . . 0.0 111.097 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 5.3 mtm -61.7 -33.78 74.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.498 1.119 . . . . 0.0 113.096 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -68.04 -21.91 64.99 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 119.249 0.931 . . . . 0.0 113.506 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -83.48 -38.84 21.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.184 1.393 . . . . 0.0 111.543 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.97 124.04 13.18 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.728 0.695 . . . . 0.0 109.224 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.5 p -70.77 174.7 5.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.652 1.181 . . . . 0.0 110.942 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -44.0 76.03 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.759 -0.588 . . . . 0.0 111.012 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.66 82.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.291 1.036 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.0 -51.29 70.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.7 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -63.24 -42.94 99.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -52.68 -49.74 64.67 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -69.14 -44.78 71.64 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.494 1.043 . . . . 0.0 111.55 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 64.3 m -52.63 -35.74 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.637 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.38 -42.67 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.2 t -97.63 -9.95 25.95 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -165.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.42 141.02 48.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.975 -1.078 . . . . 0.0 112.279 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -75.67 -22.78 56.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.707 0.803 . . . . 0.0 111.693 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -131.34 144.77 51.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.086 2.155 . . . . 0.0 110.566 167.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.41 -176.89 41.0 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.978 0.799 . . . . 0.0 113.014 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.13 -153.3 49.54 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 122.25 -0.559 . . . . 0.0 113.941 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.6 p -102.76 7.64 39.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.769 1.627 . . . . 0.0 115.173 -163.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.1 m 73.58 8.31 5.04 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.83 2.85 59.51 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.326 1.441 . . . . 0.0 113.58 -170.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -68.33 154.97 93.45 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.754 1.277 . . . . 0.0 110.454 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.01 141.41 83.72 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.062 1.842 . . . . 0.0 110.198 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 118.47 10.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 166.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.83 154.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.189 1.396 . . . . 0.0 109.671 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -57.27 133.63 55.26 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.806 0.442 . . . . 0.0 110.049 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.45 -8.79 79.09 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.449 -1.195 . . . . 0.0 115.181 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.41 138.82 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.985 1.892 . . . . 0.0 111.749 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.12 137.93 55.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 108.875 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.63 -179.27 7.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.149 1.38 . . . . 0.0 110.858 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -99.87 146.01 27.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.513 1.925 . . . . 0.0 110.68 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -44.32 131.87 4.6 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.451 1.5 . . . . 0.0 114.313 -166.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.36 163.99 36.74 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.143 1.895 . . . . 0.0 111.804 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.53 137.04 56.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 112.613 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.52 54.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 123.581 1.658 . . . . 0.0 109.531 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.544 0.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.245 140.624 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 8.4 m80 . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -89.11 147.94 23.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.971 1.709 . . . . 0.0 113.026 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.8 18.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.062 2.145 . . . . 0.0 113.029 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 4.1 p90 . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 125.915 1.686 . . . . 0.0 112.275 -168.013 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 CA--C 1.548 0.886 0 O-C-N 121.34 -0.85 . . . . 0.0 110.302 173.776 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 61.1 m170 . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -48.42 131.08 17.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.761 1.164 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 134.45 11.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.77 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.73 168.49 22.68 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.235 2.623 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.87 70.59 10.27 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.602 1.561 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.77 115.15 3.43 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.099 2.533 . . . . 0.0 110.004 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.79 144.45 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.552 1.141 . . . . 0.0 109.362 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.7 173.17 11.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.265 1.026 . . . . 0.0 110.899 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.4 121.11 18.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.472 1.109 . . . . 0.0 109.634 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -115.55 108.02 15.9 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.826 1.251 . . . . 0.0 110.444 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.7 p -66.67 -8.93 31.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -25.07 67.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.088 1.355 . . . . 0.0 112.439 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.26 151.94 96.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.636 0.774 . . . . 0.0 111.927 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.54 162.41 31.16 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.891 3.061 . . . . 0.0 112.722 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 131.95 19.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.813 3.009 . . . . 0.0 112.176 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 68.38 33.7 4.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.744 2.018 . . . . 0.0 112.162 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -121.47 151.14 40.58 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.43 146.11 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.128 1.771 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -110.25 128.72 55.66 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.5 1.046 . . . . 0.0 111.529 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.3 t -125.01 104.47 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.5 0.72 . . . . 0.0 111.112 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.72 134.54 54.42 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.644 1.177 . . . . 0.0 111.589 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 33.3 t -76.34 138.99 40.81 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.193 -0.942 . . . . 0.0 111.651 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.5 mtm105 -109.63 13.96 23.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.102 1.761 . . . . 0.0 110.835 163.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.0 m -113.95 136.23 53.12 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.125 1.77 . . . . 0.0 111.052 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.7 mt -102.61 137.41 40.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.057 1.743 . . . . 0.0 110.131 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -84.12 138.84 32.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 158.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 22.9 mm -127.67 105.16 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.168 1.387 . . . . 0.0 108.346 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -81.35 178.8 53.77 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 121.366 -0.834 . . . . 0.0 111.506 165.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.33 37.28 86.03 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.72 -0.871 . . . . 0.0 113.822 173.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.08 85.14 6.34 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 125.553 1.541 . . . . 0.0 110.358 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.43 161.18 42.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.547 . . . . 0.0 111.012 171.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.8 -20.31 48.96 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -28.52 69.72 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.211 1.005 . . . . 0.0 113.058 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.5 ptm -110.9 135.93 50.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.221 1.01 . . . . 0.0 112.097 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -116.97 -176.05 2.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.257 1.823 . . . . 0.0 111.24 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.92 -34.6 68.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.535 1.134 . . . . 0.0 113.238 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -78.43 -24.18 46.28 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.11 -43.34 71.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.052 0.842 . . . . 0.0 109.851 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 37.3 mt -57.74 -52.89 63.58 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.997 0.519 . . . . 0.0 109.927 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.96 -37.25 63.72 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -72.04 -39.55 69.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.13 -30.98 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.974 1.261 . . . . 0.0 111.653 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.8 mt -81.21 -13.75 58.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.29 1.436 . . . . 0.0 112.916 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -48.09 -48.93 62.69 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.41 -4.64 15.59 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.351 2.034 . . . . 0.0 113.533 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -101.89 -41.28 6.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.62 1.568 . . . . 0.0 112.643 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.75 168.05 4.38 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 111.704 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 132.94 34.7 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.852 -0.53 . . . . 0.0 109.624 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.76 136.28 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.835 0.854 . . . . 0.0 110.133 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -41.54 6.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.339 1.456 . . . . 0.0 112.531 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.28 157.6 43.48 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.827 1.251 . . . . 0.0 109.743 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.92 133.41 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.81 99.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 165.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 137.7 37.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.7 64.77 1.6 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.388 1.075 . . . . 0.0 110.785 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -56.48 -34.4 66.88 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 0.0 112.249 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 m -61.34 -31.41 71.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.799 1.239 . . . . 0.0 113.737 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -96.77 6.99 47.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.366 1.466 . . . . 0.0 113.239 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 63.02 21.2 12.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.247 1.819 . . . . 0.0 113.463 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -135.85 175.52 9.52 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.87 167.01 24.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.104 1.762 . . . . 0.0 111.44 166.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.81 131.69 54.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.015 1.326 . . . . 0.0 108.393 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 60.4 t -122.98 132.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.628 1.171 . . . . 0.0 109.642 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -111.87 126.84 55.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.618 1.567 . . . . 0.0 110.68 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 166.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 0.0 109.812 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -78.7 -23.2 45.72 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -167.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.53 149.46 50.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.781 1.232 . . . . 0.0 111.948 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -55.3 -41.73 72.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.288 1.035 . . . . 0.0 111.777 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -66.24 -36.65 83.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.736 -0.602 . . . . 0.0 112.058 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.72 -49.28 78.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.609 0.764 . . . . 0.0 110.771 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.73 98.23 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.638 -0.664 . . . . 0.0 111.962 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.23 -42.14 98.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.282 1.033 . . . . 0.0 111.556 170.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -67.06 -32.29 73.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.553 1.069 . . . . 0.0 112.757 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.31 -63.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 118.69 -0.671 . . . . 0.0 109.956 165.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.11 -32.99 50.26 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.92 -34.52 74.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.55 1.54 . . . . 0.0 113.377 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -124.39 -31.19 3.31 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -71.77 119.38 15.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.313 1.045 . . . . 0.0 111.159 -167.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 32.4 t30 58.07 25.48 12.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.535 1.534 . . . . 0.0 114.39 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -34.12 77.41 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.66 -1.275 . . . . 0.0 113.251 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.75 -18.32 61.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 112.775 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.19 22.29 63.38 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.067 1.318 . . . . 0.0 113.689 -172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -85.25 -31.5 23.09 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.096 1.359 . . . . 0.0 114.506 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.47 151.94 59.86 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.402 1.081 . . . . 0.0 110.017 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.0 -22.95 22.33 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.722 2.281 . . . . 0.0 113.54 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.95 168.43 5.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.789 1.636 . . . . 0.0 112.957 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 84.97 2.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.401 1.08 . . . . 0.0 110.797 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 117.07 20.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.873 1.669 . . . . 0.0 110.372 -171.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -135.18 169.11 17.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.144 1.378 . . . . 0.0 109.791 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -63.94 119.74 10.65 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.494 -0.754 . . . . 0.0 110.654 165.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.55 -155.44 29.28 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 163.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.7 137.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.869 0.468 . . . . 0.0 111.742 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.91 -52.93 2.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -122.82 111.53 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 111.362 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.7 140.34 4.23 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.126 -0.819 . . . . 0.0 114.861 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.65 131.96 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 125.178 3.919 . . . . 0.0 110.264 174.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -65.24 -34.24 77.89 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.47 -18.64 58.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 89.8 m -123.3 29.75 6.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.141 1.776 . . . . 0.0 112.137 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 14.4 p -76.55 149.5 36.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.867 0.841 . . . . 0.0 112.138 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -132.82 72.6 1.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.475 1.51 . . . . 0.0 108.798 166.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.47 -19.63 63.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.34 -51.85 53.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.899 1.227 . . . . 0.0 110.975 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -80.36 -16.2 55.1 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.01 37.59 12.57 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.054 1.312 . . . . 0.0 112.98 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -145.98 170.31 16.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.01 1.405 . . . . 0.0 112.525 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 37.9 m -136.21 151.39 49.65 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 121.649 -0.657 . . . . 0.0 110.243 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.54 128.65 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.01 121.29 28.86 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.178 -171.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.03 141.65 36.92 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.99 1.793 . . . . 0.0 110.269 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 7.3 mtt -59.04 -31.22 68.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.356 1.062 . . . . 0.0 113.411 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.7 -21.92 66.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.05 0.841 . . . . 0.0 113.265 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.44 5.63 50.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.561 1.944 . . . . 0.0 113.741 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.1 126.38 39.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.323 171.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.8 p -77.47 -179.93 6.09 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.309 1.444 . . . . 0.0 111.343 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -62.5 -42.09 99.26 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.518 -0.739 . . . . 0.0 111.527 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.67 -40.7 92.67 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.137 0.975 . . . . 0.0 112.031 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.99 -51.94 67.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -66.42 -40.45 89.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.921 0.888 . . . . 0.0 111.339 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -58.34 -38.93 78.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.212 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -72.29 -44.77 62.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.818 1.644 . . . . 0.0 111.63 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 62.6 m -50.91 -38.43 49.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.815 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.6 m -87.31 -51.95 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.2 t -92.79 -9.33 40.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 461' ' ' ASP . . . -55.82 141.29 39.33 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.218 -0.926 . . . . 0.0 111.653 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -73.72 -57.6 3.88 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.622 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -93.81 137.03 33.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.051 . . . . 0.0 111.367 167.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 67.44 -169.09 37.56 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.277 0.942 . . . . 0.0 113.755 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 67.01 -150.03 51.67 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.4 p -112.26 9.85 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.6 m 69.82 14.38 8.02 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.12 1.368 . . . . 0.0 113.238 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.59 41.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.805 1.193 . . . . 0.0 113.829 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.7 144.86 37.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.906 1.353 . . . . 0.0 111.353 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.5 104.39 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.457 2.772 . . . . 0.0 108.883 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.63 142.22 39.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.8 m -130.42 168.15 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.165 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 10.7 t -48.66 127.34 13.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.306 1.042 . . . . 0.0 111.296 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 96.51 -14.36 64.34 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.264 -1.298 . . . . 0.0 115.204 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.83 136.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.921 1.86 . . . . 0.0 112.252 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.32 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 126.624 1.97 . . . . 0.0 108.787 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -152.36 179.31 8.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.453 1.501 . . . . 0.0 111.086 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -99.21 154.29 18.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.846 1.258 . . . . 0.0 110.569 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -46.58 129.5 8.23 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.971 1.308 . . . . 0.0 112.446 -166.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.54 152.87 70.51 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.822 1.681 . . . . 0.0 110.019 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 441' ' ' ALA . 82.7 m-20 -57.96 135.35 56.91 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.467 1.107 . . . . 0.0 113.29 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.47 50.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 123.306 1.527 . . . . 0.0 109.923 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.546 0.8 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.932 137.736 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 7.4 m80 . . . . . 0 CA--C 1.55 0.978 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -76.52 149.33 36.72 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.065 1.346 . . . . 0.0 112.583 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.07 -39.85 8.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.232 1.013 . . . . 0.0 111.596 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 124.137 0.975 . . . . 0.0 110.142 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.235 0.313 0 CA-C-O 122.22 1.01 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 CA--C 1.552 1.024 0 C-N-CA 124.408 1.083 . . . . 0.0 110.616 174.125 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 22.7 m80 . . . . . 0 CA--C 1.548 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.41 135.47 17.61 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.559 1.527 . . . . 0.0 112.044 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -140.73 149.96 58.43 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 124.273 1.029 . . . . 0.0 111.04 174.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.38 169.34 21.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.834 3.023 . . . . 0.0 111.639 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -124.17 71.32 54.05 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.435 1.094 . . . . 0.0 110.5 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.03 108.21 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.617 2.211 . . . . 0.0 109.288 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.0 139.29 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.349 1.06 . . . . 0.0 109.527 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.44 172.61 12.67 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.651 1.581 . . . . 0.0 109.878 174.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.97 124.09 13.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.026 -1.047 . . . . 0.0 109.103 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -121.69 110.42 15.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.9 t -70.16 -6.14 32.17 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -24.99 67.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.08 . . . . 0.0 112.13 170.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 150.47 90.72 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 111.669 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.31 164.09 26.97 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.974 3.116 . . . . 0.0 113.3 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.64 136.83 28.97 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 112.375 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.13 38.55 16.87 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.596 1.559 . . . . 0.0 112.786 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -124.25 158.17 33.13 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.971 1.308 . . . . 0.0 113.834 171.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 2.7 pt -128.53 152.64 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.785 2.034 . . . . 0.0 110.69 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.32 132.05 54.49 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.575 -1.328 . . . . 0.0 111.449 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.4 t -126.59 105.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 -171.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -68.74 129.72 40.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 111.915 168.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 2.4 m -71.43 134.62 46.74 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.802 -0.561 . . . . 0.0 111.65 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.4 mtm105 -102.98 16.3 27.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.696 1.999 . . . . 0.0 110.614 162.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 93.6 m -123.91 133.94 53.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.66 1.584 . . . . 0.0 110.623 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 46.5 mt -101.11 138.36 38.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.755 2.422 . . . . 0.0 109.785 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -86.31 124.16 32.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 162.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.38 103.05 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.061 0.944 . . . . 0.0 108.466 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -82.17 -175.89 50.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 164.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.0 30.1 75.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.665 -0.903 . . . . 0.0 113.854 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.73 103.68 12.15 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.446 1.098 . . . . 0.0 110.045 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 144.73 64.88 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.277 1.985 . . . . 0.0 109.918 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.24 -19.67 66.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -63.76 -32.54 74.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.764 1.226 . . . . 0.0 112.858 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -87.84 154.79 20.26 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -134.13 -175.99 4.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.499 1.519 . . . . 0.0 111.312 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 1.7 mp0 -52.93 -38.4 61.9 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.167 2.187 . . . . 0.0 112.441 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -75.98 -26.61 56.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.58 -43.25 81.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.633 1.106 . . . . 0.0 109.679 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.72 -48.41 81.27 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.669 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.2 68.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.397 0.999 . . . . 0.0 113.023 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.56 -37.64 80.08 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.45 -33.09 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.095 0.861 . . . . 0.0 111.887 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.58 -14.13 55.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -49.86 -48.92 76.69 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.943 1.697 . . . . 0.0 115.426 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.71 -6.39 18.14 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.008 1.806 . . . . 0.0 112.955 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.33 -46.49 5.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.281 1.433 . . . . 0.0 112.12 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.24 1.69 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.062 1.745 . . . . 0.0 113.469 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.74 133.8 34.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.001 . . . . 0.0 110.913 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.05 130.02 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.707 1.203 . . . . 0.0 109.579 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -91.52 -44.39 9.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.087 0.955 . . . . 0.0 111.69 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.5 p -161.26 163.47 30.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.822 1.249 . . . . 0.0 111.25 -171.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -165.44 132.52 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.57 0.748 . . . . 0.0 111.767 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.93 105.42 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.43 115.52 29.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.103 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.88 83.64 2.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.617 1.567 . . . . 0.0 109.205 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -55.5 -37.93 68.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.174 0.99 . . . . 0.0 111.418 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 m -61.38 -28.89 69.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.872 2.069 . . . . 0.0 113.877 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.95 4.5 34.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.991 1.716 . . . . 0.0 112.817 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 79.9 mttt 55.38 34.6 23.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.178 1.791 . . . . 0.0 112.897 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -131.82 156.48 45.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.66 1.584 . . . . 0.0 113.59 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.76 134.25 28.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.125 1.37 . . . . 0.0 112.637 166.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -88.74 102.43 14.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 166.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 38.8 t -99.38 120.52 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.983 0.913 . . . . 0.0 110.964 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -106.19 126.33 52.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.078 0.951 . . . . 0.0 111.898 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.7 169.13 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.934 1.294 . . . . 0.0 110.168 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -75.48 -15.63 60.39 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -168.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.0 160.9 43.05 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.258 -0.901 . . . . 0.0 112.421 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.36 -41.99 98.85 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.594 0.758 . . . . 0.0 111.456 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.92 -41.64 87.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.346 0.521 . . . . 0.0 111.299 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.66 -51.84 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.08 0.952 . . . . 0.0 109.692 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.27 95.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.557 0.743 . . . . 0.0 112.633 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.3 -43.07 99.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.173 0.989 . . . . 0.0 111.267 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -66.52 -34.19 77.37 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.407 -0.808 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 66.2 t -60.37 -65.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.766 164.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.1 mt -51.95 -35.23 45.35 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -60.16 -37.48 80.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.837 1.255 . . . . 0.0 112.906 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.23 -27.41 7.64 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.56 125.87 28.2 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.78 23.06 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -53.83 -48.04 70.32 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.064 -1.023 . . . . 0.0 113.607 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.45 5.55 49.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.555 1.942 . . . . 0.0 112.806 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 72.62 38.71 57.16 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.566 1.079 . . . . 0.0 112.922 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -57.48 -29.52 64.32 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.232 1.013 . . . . 0.0 113.569 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.12 162.98 25.06 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.763 1.625 . . . . 0.0 110.045 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 -15.73 21.43 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.98 2.453 . . . . 0.0 113.408 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.68 161.01 21.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.342 2.257 . . . . 0.0 112.455 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -128.46 97.08 4.6 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.845 1.258 . . . . 0.0 109.995 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.98 21.24 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.46 1.904 . . . . 0.0 111.739 -177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.18 173.2 11.27 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.295 1.838 . . . . 0.0 108.999 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -70.18 125.44 26.78 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.154 -0.966 . . . . 0.0 110.902 163.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.46 -154.38 14.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.606 1.574 . . . . 0.0 109.174 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -163.49 136.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.646 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -94.42 -45.21 3.29 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.114 1.34 . . . . 0.0 110.296 163.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -124.29 109.99 14.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.148 0.979 . . . . 0.0 113.401 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -176.52 136.4 3.21 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.487 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.57 126.56 12.91 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.094 3.862 . . . . 0.0 110.194 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -36.6 80.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 112.404 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.07 -18.23 60.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.63 1.572 . . . . 0.0 114.285 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.2 27.18 8.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.753 1.621 . . . . 0.0 111.885 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.5 t -84.83 135.42 34.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.59 1.156 . . . . 0.0 111.69 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.05 79.6 1.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.349 1.46 . . . . 0.0 109.34 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -62.83 -24.05 67.58 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.517 -0.74 . . . . 0.0 112.926 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -64.22 -49.36 72.25 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.827 1.194 . . . . 0.0 111.321 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -81.72 -17.38 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 81.77 41.02 10.05 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 124.844 1.212 . . . . 0.0 112.624 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -147.54 165.79 29.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.62 1.21 . . . . 0.0 112.978 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 22.4 m -129.49 152.48 48.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.556 0.742 . . . . 0.0 110.368 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.76 136.24 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.43 120.04 21.97 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 120.331 1.423 . . . . 0.0 112.004 -173.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -69.31 126.64 13.86 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.981 2.454 . . . . 0.0 111.341 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -33.65 74.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.03 0.932 . . . . 0.0 113.069 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -65.65 -17.87 64.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -109.39 11.04 25.32 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 113.691 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 47.9 mt -90.37 145.28 25.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.885 0.874 . . . . 0.0 111.052 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 16.7 p -77.0 179.06 6.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.577 1.151 . . . . 0.0 111.175 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.11 -41.77 76.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.598 -0.689 . . . . 0.0 111.364 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.16 94.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.89 1.276 . . . . 0.0 111.901 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.92 -64.32 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.257 1.423 . . . . 0.0 111.923 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -63.29 -35.23 79.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.63 0.772 . . . . 0.0 111.472 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -53.1 -56.82 13.32 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.504 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -59.59 -39.77 85.28 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.742 1.61 . . . . 0.0 112.734 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.1 m -50.1 -43.48 51.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.426 1.012 . . . . 0.0 112.149 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.12 -21.22 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.6 t -117.68 -17.44 9.91 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.713 1.605 . . . . 0.0 113.905 -165.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.08 139.73 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.179 -0.951 . . . . 0.0 111.186 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -65.27 -49.39 69.75 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.901 0.48 . . . . 0.0 110.667 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -103.66 110.17 22.14 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.592 1.187 . . . . 0.0 108.92 163.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -175.7 -171.49 39.65 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.422 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -74.95 -64.69 2.27 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.101 -1.049 . . . . 0.0 113.642 -164.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 17.4 p -113.65 41.94 2.09 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.107 0.963 . . . . 0.0 110.005 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.8 m -55.74 100.75 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.271 -0.893 . . . . 0.0 111.986 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.97 -8.04 59.22 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 125.817 1.675 . . . . 0.0 115.895 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -110.14 146.39 34.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.264 2.225 . . . . 0.0 111.029 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.76 168.08 25.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.69 2.927 . . . . 0.0 112.21 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.32 121.52 30.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.652 0.781 . . . . 0.0 110.967 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.28 160.46 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.299 1.44 . . . . 0.0 110.602 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.6 m -58.31 125.75 24.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.558 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 83.85 6.34 87.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.846 1.212 . . . . 0.0 114.847 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.32 137.67 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.371 1.586 . . . . 0.0 111.115 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.55 138.52 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.164 2.185 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -165.45 -176.96 4.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.012 0.925 . . . . 0.0 113.169 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -100.2 146.54 26.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.575 1.55 . . . . 0.0 111.091 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.19 138.24 27.11 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -167.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.32 156.54 50.62 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.685 2.257 . . . . 0.0 112.419 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.84 142.66 58.35 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.917 0.887 . . . . 0.0 112.363 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.44 45.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 123.639 1.685 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.475 0.789 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.249 143.13 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.4 m80 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.87 137.49 41.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.437 1.095 . . . . 0.0 113.282 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.2 -35.19 23.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.978 1.311 . . . . 0.0 111.564 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 123.951 0.9 . . . . 0.0 110.698 -178.668 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.533 0.682 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.101 0.961 . . . . 0.0 110.507 177.152 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m80 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.5 134.87 56.35 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.268 -1.52 . . . . 0.0 112.676 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -149.38 151.27 33.31 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.197 1.399 . . . . 0.0 110.013 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 159.86 50.59 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.07 2.514 . . . . 0.0 111.593 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -112.71 83.25 5.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.74 109.36 2.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.195 1.93 . . . . 0.0 109.799 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.42 132.6 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.479 1.112 . . . . 0.0 108.592 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 79.6 p -129.26 176.25 8.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.716 0.806 . . . . 0.0 111.06 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.16 124.18 18.85 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.533 1.133 . . . . 0.0 110.29 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -126.46 106.66 9.62 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.087 0.946 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.5 m -67.12 -2.9 6.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 114.118 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 -20.39 61.26 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.493 1.042 . . . . 0.0 112.391 170.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.09 151.09 90.32 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.72 0.691 . . . . 0.0 112.071 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.8 162.66 30.93 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.805 3.003 . . . . 0.0 113.04 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.6 133.55 28.1 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.539 2.826 . . . . 0.0 112.699 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.12 20.07 6.52 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 126.275 1.83 . . . . 0.0 112.808 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -106.47 155.49 19.53 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.78 154.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.94 2.096 . . . . 0.0 110.478 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -117.59 126.26 52.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.497 1.499 . . . . 0.0 111.855 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.86 107.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.748 0.819 . . . . 0.0 110.498 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -73.59 134.49 43.74 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.07 1.348 . . . . 0.0 111.658 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 38.3 t -70.44 144.29 51.52 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.557 -0.714 . . . . 0.0 111.322 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -123.88 28.91 6.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.816 1.646 . . . . 0.0 110.213 162.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.1 m -127.43 143.14 51.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.393 1.877 . . . . 0.0 109.556 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.57 126.4 55.3 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.239 1.816 . . . . 0.0 108.708 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.09 119.45 27.33 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.6 110.04 30.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.86 37.07 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.494 0.568 . . . . 0.0 112.441 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.38 21.19 70.24 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 169.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.97 128.63 93.2 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.383 1.073 . . . . 0.0 109.928 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.29 130.49 18.77 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.333 2.022 . . . . 0.0 109.396 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 pp -61.13 -20.18 62.37 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -166.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 -21.55 59.28 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.29 147.43 22.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.277 0.944 . . . . 0.0 113.23 -173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -120.47 -179.77 4.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 112.441 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -49.67 -39.17 35.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.613 1.565 . . . . 0.0 114.467 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.92 -14.95 57.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -79.39 -36.56 39.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.264 0.938 . . . . 0.0 110.791 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.48 -51.05 69.94 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.17 -39.14 69.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.21 -42.59 75.53 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.48 -32.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.182 1.356 . . . . 0.0 111.686 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 44.1 mt -81.81 -14.5 56.27 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.196 0.999 . . . . 0.0 112.824 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -43.23 -50.27 15.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.523 1.929 . . . . 0.0 116.193 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.45 -8.34 17.19 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.29 1.994 . . . . 0.0 114.12 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.64 -38.73 9.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.071 1.748 . . . . 0.0 112.236 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.04 160.46 2.77 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.442 1.897 . . . . 0.0 112.776 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.15 106.76 18.7 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.655 0.74 . . . . 0.0 109.033 162.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.77 137.65 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.67 1.188 . . . . 0.0 111.133 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -89.59 -41.84 11.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.436 1.094 . . . . 0.0 111.602 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.59 148.7 28.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.768 1.227 . . . . 0.0 111.031 -170.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.0 t -144.96 137.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 119.171 0.896 . . . . 0.0 110.877 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.86 104.32 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 165.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.85 98.96 11.72 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.588 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -83.25 75.07 9.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.433 1.111 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -56.39 -32.25 64.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.1 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -59.51 -23.44 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.445 1.498 . . . . 0.0 113.786 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.08 13.23 12.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 112.912 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.86 34.05 23.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.328 1.451 . . . . 0.0 112.222 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -117.27 156.55 27.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.415 1.886 . . . . 0.0 112.741 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.5 135.39 28.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 112.112 161.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.11 124.31 31.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 162.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.5 101.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 108.846 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -90.21 116.47 28.22 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.116 1.366 . . . . 0.0 110.019 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.69 149.22 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.313 1.045 . . . . 0.0 108.347 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -74.97 3.57 8.09 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 t -160.32 147.15 15.82 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.25 -1.531 . . . . 0.0 112.903 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -59.89 -39.69 86.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.213 1.405 . . . . 0.0 111.085 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.85 -35.05 79.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.932 0.493 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -68.26 -53.36 25.06 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.796 0.838 . . . . 0.0 110.696 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.14 87.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -64.9 -44.09 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.484 168.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -65.34 -29.03 69.73 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.058 1.299 . . . . 0.0 112.555 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.2 -67.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 118.872 0.76 . . . . 0.0 109.672 161.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.98 -30.87 62.44 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.1 -35.7 81.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.049 1.74 . . . . 0.0 112.756 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.95 -25.76 7.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -75.17 124.57 27.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.327 1.051 . . . . 0.0 111.26 -167.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 59.76 28.35 17.79 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.253 1.821 . . . . 0.0 114.067 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -62.43 -25.88 68.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.716 -1.24 . . . . 0.0 114.186 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.56 -15.12 46.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.447 1.099 . . . . 0.0 113.42 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.01 83.69 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.703 1.144 . . . . 0.0 114.098 -173.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.0 29.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.815 1.646 . . . . 0.0 115.375 -171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.18 151.09 59.37 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.215 0.916 . . . . 0.0 110.39 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.65 -23.75 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.832 2.355 . . . . 0.0 112.736 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.71 142.36 51.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.594 1.958 . . . . 0.0 112.423 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -115.92 90.28 3.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.047 0.939 . . . . 0.0 109.836 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.1 m -79.04 116.28 19.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.542 1.137 . . . . 0.0 109.867 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -116.38 165.88 12.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.681 1.993 . . . . 0.0 108.846 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -63.43 131.19 47.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.741 -1.225 . . . . 0.0 109.992 158.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -112.41 -155.19 12.4 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 125.555 1.55 . . . . 0.0 109.799 164.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.0 p -165.6 141.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 117.798 0.799 . . . . 0.0 111.365 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.31 -45.34 4.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.009 163.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -118.42 102.52 8.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.742 1.217 . . . . 0.0 112.916 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.33 123.73 1.13 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 118.789 -1.006 . . . . 0.0 115.284 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.84 128.92 10.36 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.473 3.449 . . . . 0.0 111.302 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -61.19 -32.6 72.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.34 -24.56 66.54 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.762 1.625 . . . . 0.0 113.205 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 23.1 m -134.84 32.42 3.25 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 112.255 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.72 140.97 49.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.999 1.319 . . . . 0.0 111.476 171.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -131.75 78.69 1.83 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.023 1.729 . . . . 0.0 109.338 163.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -64.41 -12.88 47.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 113.375 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.85 -47.49 18.68 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.685 1.129 . . . . 0.0 111.152 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -80.59 -17.13 52.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.305 0.642 . . . . 0.0 112.623 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.72 47.53 9.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.082 1.325 . . . . 0.0 112.083 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -147.65 171.81 15.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.771 1.286 . . . . 0.0 112.376 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 20.3 m -141.24 150.35 42.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.993 1.317 . . . . 0.0 110.591 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.49 132.37 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.11 124.41 25.34 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 119.537 1.062 . . . . 0.0 111.768 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.05 140.05 17.65 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.549 2.833 . . . . 0.0 112.636 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.81 -19.85 66.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.767 1.627 . . . . 0.0 113.985 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -74.58 -21.66 59.38 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.93 0.786 . . . . 0.0 112.911 172.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -95.51 -26.43 15.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.38 112.62 2.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.684 1.129 . . . . 0.0 109.506 169.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 36.6 p -66.93 177.33 1.73 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.29 1.436 . . . . 0.0 111.491 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -59.97 -38.9 83.85 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.056 -1.028 . . . . 0.0 111.905 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.39 -37.9 65.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.624 0.77 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.31 -51.43 69.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.746 1.218 . . . . 0.0 111.286 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -65.93 -36.27 82.91 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.621 -0.674 . . . . 0.0 111.535 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -51.94 67.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.076 0.853 . . . . 0.0 111.515 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.17 -44.61 94.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.226 1.375 . . . . 0.0 110.667 175.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 m -56.37 -32.84 65.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.249 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.41 -34.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 47.6 m -102.3 -9.27 20.52 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -168.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.63 152.19 27.03 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.952 1.251 . . . . 0.0 112.768 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -81.35 -38.77 26.14 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.135 0.574 . . . . 0.0 110.922 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -116.48 137.3 52.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.247 1.019 . . . . 0.0 110.749 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.43 -169.9 51.2 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.361 -168.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 69.54 -162.11 52.27 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.293 0.949 . . . . 0.0 113.266 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 29.3 p -95.11 1.76 54.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.549 1.54 . . . . 0.0 114.373 -168.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 19.7 m 66.89 11.93 8.62 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.46 1.027 . . . . 0.0 113.655 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.22 48.23 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.303 1.43 . . . . 0.0 114.33 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.7 154.23 93.09 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.469 1.135 . . . . 0.0 110.725 169.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.12 148.7 81.54 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.901 2.4 . . . . 0.0 111.051 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.1 105.53 5.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.547 -0.721 . . . . 0.0 110.011 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.39 158.91 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.653 1.581 . . . . 0.0 110.73 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 76.2 m -60.15 133.13 55.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.02 84.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.491 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.99 135.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.937 1.868 . . . . 0.0 111.78 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 36.3 t -120.01 139.45 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 126.376 1.87 . . . . 0.0 109.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -163.52 -176.1 4.53 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.237 1.015 . . . . 0.0 112.743 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.54 148.2 22.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.341 1.457 . . . . 0.0 109.434 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -49.16 131.03 16.35 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.44 157.25 56.91 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.729 2.286 . . . . 0.0 111.612 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -58.38 134.78 56.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.582 1.153 . . . . 0.0 112.757 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.32 58.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 123.572 1.653 . . . . 0.0 109.966 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.068 140.412 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.5 m170 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -63.73 138.1 58.35 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.57 0.748 . . . . 0.0 111.414 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.55 -43.75 93.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.154 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.835 -175.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.238 0.461 0 CA-C-O 122.319 1.057 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.865 0.866 . . . . 0.0 111.596 -178.438 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 7.8 m80 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -51.08 127.42 18.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.682 1.583 . . . . 0.0 111.645 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -157.19 147.35 15.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.56 1.544 . . . . 0.0 110.85 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.7 173.76 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.67 2.247 . . . . 0.0 111.541 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -108.55 83.3 1.95 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.941 0.896 . . . . 0.0 110.194 167.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.55 141.08 30.73 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.26 2.64 . . . . 0.0 110.303 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.72 145.19 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.208 1.403 . . . . 0.0 108.524 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 75.9 p -140.39 179.78 6.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.178 0.991 . . . . 0.0 111.084 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -143.92 130.77 20.36 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.093 -1.005 . . . . 0.0 110.085 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -107.64 102.93 12.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.274 1.03 . . . . 0.0 109.643 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -12.77 17.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.002 1.321 . . . . 0.0 113.667 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.88 0.92 54.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.691 1.597 . . . . 0.0 113.018 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.6 154.61 50.86 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.644 1.111 . . . . 0.0 113.688 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 162.73 40.98 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.948 3.766 . . . . 0.0 113.191 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.03 138.98 34.9 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.445 3.43 . . . . 0.0 112.937 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.04 37.33 18.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.921 1.288 . . . . 0.0 111.744 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -115.61 140.24 49.36 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.62 -1.3 . . . . 0.0 112.763 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 25.6 pt -106.81 146.15 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.387 1.475 . . . . 0.0 109.591 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 117.96 33.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.504 1.121 . . . . 0.0 109.494 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.7 106.93 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 O-C-N 122.096 -0.377 . . . . 0.0 110.568 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.08 128.84 36.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.811 1.244 . . . . 0.0 111.793 170.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 66.1 m -69.16 144.7 53.73 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -131.72 16.02 4.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.484 2.714 . . . . 0.0 110.843 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 13.3 m -110.27 129.68 55.69 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.117 1.767 . . . . 0.0 108.786 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.08 136.44 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.615 1.566 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -93.63 142.87 26.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 159.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.79 106.32 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.98 1.312 . . . . 0.0 108.709 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.41 41.81 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.831 0.729 . . . . 0.0 111.966 168.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.6 78.65 Favored Glycine 0 N--CA 1.475 1.234 0 O-C-N 122.054 -0.674 . . . . 0.0 114.651 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.4 t -78.79 119.97 79.19 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.532 1.166 . . . . 0.0 110.358 -171.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 138.53 34.42 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.721 2.28 . . . . 0.0 109.609 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -16.81 54.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -29.48 63.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.139 0.976 . . . . 0.0 112.557 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.9 mtm -78.79 149.33 32.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.63 0.728 . . . . 0.0 112.735 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -127.83 -178.33 4.46 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.878 2.071 . . . . 0.0 111.222 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -51.08 -41.55 60.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.844 1.658 . . . . 0.0 114.449 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -77.12 -17.63 58.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.69 -40.31 61.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.272 0.942 . . . . 0.0 110.545 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.26 -47.35 86.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.497 0.59 . . . . 0.0 110.939 170.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.33 -34.16 72.01 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.717 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.72 -42.42 64.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.954 1.252 . . . . 0.0 114.376 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.27 -37.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.964 0.802 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 32.6 mt -85.75 -5.32 59.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.893 0.877 . . . . 0.0 112.479 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -52.85 -49.83 84.72 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.966 1.707 . . . . 0.0 115.161 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.67 -5.01 16.39 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.457 2.105 . . . . 0.0 113.431 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -101.23 -39.56 7.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.191 1.396 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.5 167.28 5.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.643 1.977 . . . . 0.0 113.111 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -92.67 102.1 14.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.67 1.188 . . . . 0.0 111.642 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.51 118.58 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.883 0.873 . . . . 0.0 110.929 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -91.95 -36.13 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.897 1.679 . . . . 0.0 112.778 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.7 t -144.16 153.16 41.83 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.318 0.963 . . . . 0.0 112.169 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -144.81 140.35 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.855 0.862 . . . . 0.0 111.259 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.61 97.79 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.313 1.445 . . . . 0.0 108.019 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -97.3 132.99 42.5 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.858 0.463 . . . . 0.0 110.734 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.05 89.09 2.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.976 1.31 . . . . 0.0 109.769 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.46 -37.45 83.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.087 1.355 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.1 t -58.47 -32.43 68.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.055 1.742 . . . . 0.0 113.064 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -98.45 -1.0 42.39 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.151 1.38 . . . . 0.0 113.197 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 59.03 30.95 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.399 1.88 . . . . 0.0 113.408 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.29 170.5 15.62 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.66 24.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 111.68 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.14 140.12 53.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.377 1.471 . . . . 0.0 108.895 164.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.77 111.96 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.493 1.117 . . . . 0.0 109.705 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -92.45 119.97 32.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.565 0.746 . . . . 0.0 110.239 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.27 176.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.907 0.883 . . . . 0.0 108.918 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 147.4 46.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.601 -0.687 . . . . 0.0 111.268 -164.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.65 81.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.759 0.824 . . . . 0.0 110.652 166.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -39.93 80.53 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.053 0.842 . . . . 0.0 112.435 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -65.63 -52.38 52.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.674 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.56 80.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.411 1.085 . . . . 0.0 113.037 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.47 -41.57 98.88 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -61.72 -32.61 72.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.645 1.111 . . . . 0.0 111.916 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.73 -62.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.858 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.61 -36.98 26.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.208 1.403 . . . . 0.0 114.111 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.56 -38.59 70.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.377 1.471 . . . . 0.0 112.885 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -106.73 -26.31 11.36 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . 0.409 ' CZ ' HD11 ' A' ' 400' ' ' LEU . 25.4 t80 -70.89 127.7 33.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -171.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 29.0 t30 60.66 28.42 18.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.39 1.476 . . . . 0.0 113.9 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -59.64 -34.75 73.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.853 -1.154 . . . . 0.0 113.325 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.32 -20.14 60.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.883 1.273 . . . . 0.0 113.063 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.86 19.61 75.06 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.929 1.252 . . . . 0.0 113.725 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.78 -32.67 17.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.242 1.417 . . . . 0.0 114.291 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 394' ' ' PHE . 20.0 mt -77.48 146.77 74.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.859 0.864 . . . . 0.0 109.093 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.79 -18.9 28.0 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.17 1.913 . . . . 0.0 112.718 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.8 mt -82.27 144.43 30.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.048 0.939 . . . . 0.0 112.524 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.14 9.71 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 110.245 174.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 33.3 m -83.11 125.12 31.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.237 1.415 . . . . 0.0 110.628 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.83 174.98 9.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.022 2.129 . . . . 0.0 109.661 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -72.53 122.87 22.06 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.207 -0.933 . . . . 0.0 111.398 163.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.83 -177.72 35.08 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.281 1.419 . . . . 0.0 110.551 163.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.64 119.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.679 0.791 . . . . 0.0 109.619 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.49 -36.78 10.26 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.759 1.647 . . . . 0.0 110.943 161.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -145.99 109.19 4.65 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.921 0.861 . . . . 0.0 112.149 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.34 133.74 2.13 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.821 -0.988 . . . . 0.0 115.467 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.25 122.17 7.79 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 125.268 3.978 . . . . 0.0 110.83 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -55.27 -37.18 66.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -74.99 -16.41 60.62 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.694 1.598 . . . . 0.0 114.16 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.7 m -127.21 27.82 5.84 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.916 1.686 . . . . 0.0 111.93 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.65 140.48 29.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.201 1.401 . . . . 0.0 111.669 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -126.12 87.78 2.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.444 1.116 . . . . 0.0 109.567 167.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.25 -22.0 65.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.835 0.854 . . . . 0.0 113.181 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -68.77 -51.97 35.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.077 0.853 . . . . 0.0 110.232 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.09 -18.72 59.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.11 45.55 8.86 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.415 1.007 . . . . 0.0 112.459 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -154.6 175.33 13.79 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.306 1.05 . . . . 0.0 112.99 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 35.2 p -147.22 153.32 39.67 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.414 1.086 . . . . 0.0 110.967 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mm -108.33 135.34 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.42 109.73 17.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 119.843 1.201 . . . . 0.0 110.523 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.65 131.94 27.43 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.595 2.197 . . . . 0.0 110.917 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 45.7 mtt -64.7 -15.72 61.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.687 1.195 . . . . 0.0 113.132 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -65.35 -25.16 67.47 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 113.038 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 13.08 14.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.426 2.29 . . . . 0.0 113.243 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.4 mt -85.0 176.41 8.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.521 1.528 . . . . 0.0 111.706 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 2.3 p -127.87 165.06 20.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 110.759 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -65.92 -37.28 85.67 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.041 -1.037 . . . . 0.0 111.41 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.83 -42.21 90.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.771 0.829 . . . . 0.0 112.071 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -48.48 70.0 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.022 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.45 -38.12 86.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.017 0.826 . . . . 0.0 110.107 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.06 -33.05 71.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.659 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -72.56 -45.32 59.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.266 1.394 . . . . 0.0 111.858 168.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 m -53.21 -39.7 63.9 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.767 1.167 . . . . 0.0 111.402 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.24 -48.12 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.2 m -93.49 -5.95 47.97 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.22 138.19 45.55 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.896 1.225 . . . . 0.0 112.533 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -78.02 -27.36 48.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.569 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -124.89 138.46 54.25 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.611 1.564 . . . . 0.0 111.221 164.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.02 -168.64 47.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.396 -172.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.18 -156.91 53.5 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.23 0.443 . . . . 0.0 112.556 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.6 p -107.27 11.77 28.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.24 1.416 . . . . 0.0 114.746 -159.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.5 t 66.19 14.87 9.86 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.911 -1.118 . . . . 0.0 113.21 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.08 61.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.281 1.42 . . . . 0.0 114.233 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -68.19 145.37 97.51 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 119.309 1.555 . . . . 0.0 111.126 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.32 148.27 90.94 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.981 2.454 . . . . 0.0 110.976 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.1 109.4 8.55 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.047 0.451 . . . . 0.0 110.448 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.75 170.87 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.966 1.706 . . . . 0.0 111.471 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.9 m -57.23 119.36 6.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.29 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.19 79.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.283 0.945 . . . . 0.0 115.123 172.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.6 tt -58.27 125.01 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.176 1.488 . . . . 0.0 111.184 172.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.08 132.93 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.707 1.603 . . . . 0.0 109.003 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.79 170.52 21.44 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.154 0.982 . . . . 0.0 112.071 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.91 147.59 25.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.593 1.157 . . . . 0.0 108.982 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -40.0 125.17 1.63 Allowed Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.529 1.132 . . . . 0.0 113.966 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.07 150.6 85.15 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.489 1.459 . . . . 0.0 110.111 172.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -56.7 161.4 2.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.504 1.145 . . . . 0.0 113.52 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 1.4 mt -118.94 47.49 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 123.231 1.491 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.7 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.58 140.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 18.7 m80 . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -79.54 140.12 37.32 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.361 1.064 . . . . 0.0 111.388 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.74 -47.03 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.182 0.593 . . . . 0.0 110.609 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 CA--C 1.548 0.904 0 C-N-CA 125.139 1.376 . . . . 0.0 110.231 -176.332 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.238 0.451 0 CA-C-O 121.549 0.69 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 CA--C 1.552 1.039 0 O-C-N 121.524 -0.735 . . . . 0.0 110.805 -178.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.57 125.63 23.03 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 120.685 -1.259 . . . . 0.0 111.654 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.5 mmt-85 -156.09 147.16 16.52 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 111.358 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.01 174.28 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.916 2.411 . . . . 0.0 111.145 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -115.98 77.72 7.04 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.999 0.92 . . . . 0.0 110.084 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.39 135.84 23.01 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.485 2.79 . . . . 0.0 110.306 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 t -147.46 140.64 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.055 1.342 . . . . 0.0 108.866 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.04 173.4 10.76 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.984 1.314 . . . . 0.0 111.043 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -137.17 124.64 22.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.31 1.044 . . . . 0.0 109.988 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -119.36 103.07 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.216 1.008 . . . . 0.0 110.589 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.0 p -66.8 -5.03 10.61 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.499 1.519 . . . . 0.0 113.972 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -22.4 64.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.802 0.841 . . . . 0.0 112.509 168.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.92 153.04 95.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.875 0.87 . . . . 0.0 112.179 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.13 161.99 31.49 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.799 2.999 . . . . 0.0 112.557 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.78 131.54 18.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.894 3.062 . . . . 0.0 112.122 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.88 44.89 3.42 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.254 1.822 . . . . 0.0 111.558 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -130.33 155.26 46.64 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.5 pt -128.25 144.77 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.101 1.761 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -100.43 115.86 31.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.232 1.413 . . . . 0.0 109.659 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.6 102.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.475 0.71 . . . . 0.0 110.384 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -71.17 136.2 47.98 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.401 1.08 . . . . 0.0 111.776 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.2 t -75.48 140.23 42.71 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.16 -0.962 . . . . 0.0 112.173 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.4 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 4.7 mtm180 -110.32 2.34 19.07 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.896 1.678 . . . . 0.0 111.288 165.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 35.9 m -104.65 129.32 52.82 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.084 1.353 . . . . 0.0 109.567 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.33 137.43 34.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.064 1.746 . . . . 0.0 108.604 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -91.79 137.82 32.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 159.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 19.8 mm -127.69 108.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 108.398 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.82 -177.55 38.09 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.328 0.966 . . . . 0.0 112.229 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.01 16.58 64.39 Favored Glycine 0 N--CA 1.477 1.402 0 C-N-CA 124.189 0.9 . . . . 0.0 114.87 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.2 t -71.85 129.16 88.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 118.141 0.971 . . . . 0.0 110.262 -164.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.94 130.21 22.53 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.366 2.044 . . . . 0.0 109.278 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.41 -19.09 54.87 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.24 -29.56 64.05 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.517 -0.739 . . . . 0.0 112.906 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.4 ptp -84.5 145.93 27.86 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -120.25 -177.83 3.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.231 1.812 . . . . 0.0 112.494 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.86 -41.04 44.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.288 1.435 . . . . 0.0 113.559 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -76.47 -22.55 54.41 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.49 -35.27 65.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.76 0.709 . . . . 0.0 110.79 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.55 -51.18 70.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.987 0.812 . . . . 0.0 110.437 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.11 -38.23 67.89 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.464 0.574 . . . . 0.0 112.416 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -72.53 -42.96 64.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.115 1.366 . . . . 0.0 114.474 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.32 -31.94 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 120.462 1.483 . . . . 0.0 111.049 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 35.7 mt -89.22 -9.36 51.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.26 1.024 . . . . 0.0 112.885 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -49.45 -49.04 73.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.705 1.602 . . . . 0.0 114.828 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.05 -6.24 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.089 1.859 . . . . 0.0 113.202 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -100.73 -33.91 10.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.45 1.5 . . . . 0.0 112.983 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.88 168.08 3.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 113.946 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 113.03 20.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.838 1.255 . . . . 0.0 110.81 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.63 121.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.65 . . . . 0.0 109.547 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -92.81 -37.05 12.52 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.412 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.71 158.66 43.69 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.085 -1.01 . . . . 0.0 112.094 -174.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.4 p -166.05 136.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.688 0.795 . . . . 0.0 111.378 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.51 97.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.137 1.375 . . . . 0.0 107.578 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.4 HD22 HD22 ' A' ' 372' ' ' ASN . 5.5 tt -89.96 126.87 35.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.615 0.366 . . . . 0.0 110.07 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 83.16 1.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.035 1.334 . . . . 0.0 109.02 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . 0.4 HD22 HD22 ' A' ' 370' ' ' LEU . 3.8 t-20 -63.3 -30.35 71.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.864 0.865 . . . . 0.0 112.694 -173.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 9.0 t -48.08 -39.06 19.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.658 1.983 . . . . 0.0 113.596 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -103.87 8.61 36.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.548 1.539 . . . . 0.0 113.682 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 56.68 36.6 27.9 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.98 1.312 . . . . 0.0 112.221 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -133.29 165.33 25.07 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.53 163.0 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.736 1.214 . . . . 0.0 111.699 165.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.48 141.73 47.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 108.543 162.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.9 t -138.43 118.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.026 0.53 . . . . 0.0 111.775 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -99.4 126.06 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 112.836 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.63 179.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.395 1.078 . . . . 0.0 111.296 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -65.35 -35.47 81.06 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 57.5 p -149.01 168.62 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.054 1.297 . . . . 0.0 114.384 -168.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.62 98.1 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.734 169.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -58.1 -45.01 87.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.063 0.847 . . . . 0.0 111.953 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.74 -47.06 79.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.375 0.67 . . . . 0.0 110.519 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.91 96.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 111.759 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.81 -40.96 97.87 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.005 0.922 . . . . 0.0 111.169 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.65 -33.49 75.15 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.792 1.633 . . . . 0.0 112.239 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.91 -64.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 118.883 -0.579 . . . . 0.0 110.512 165.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.45 -29.33 49.29 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -67.89 -34.49 76.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.651 1.98 . . . . 0.0 112.998 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -123.49 -27.25 4.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.34 121.41 16.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.954 0.902 . . . . 0.0 111.06 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 38.0 t30 57.97 27.91 15.44 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.435 1.494 . . . . 0.0 114.398 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -62.62 -32.78 73.86 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.362 -1.461 . . . . 0.0 113.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.86 -19.02 62.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 113.076 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.02 80.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.014 1.292 . . . . 0.0 113.563 -171.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.94 34.69 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.392 1.477 . . . . 0.0 114.052 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.21 149.44 55.53 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.512 1.125 . . . . 0.0 109.672 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.79 -23.73 13.98 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.593 2.195 . . . . 0.0 113.417 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.81 150.72 27.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.101 2.161 . . . . 0.0 113.101 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.7 91.36 3.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.543 1.137 . . . . 0.0 110.683 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 25.8 m -85.27 127.73 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.199 1.4 . . . . 0.0 111.14 -170.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -137.77 172.83 12.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.908 2.083 . . . . 0.0 109.622 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -70.98 120.39 16.48 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.04 -1.037 . . . . 0.0 111.005 164.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.36 -161.73 32.71 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 162.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 16.9 t -143.22 122.54 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.566 1.146 . . . . 0.0 108.903 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -86.15 -40.79 7.32 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 164.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -142.4 125.13 15.93 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.181 0.992 . . . . 0.0 111.265 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.99 132.17 1.66 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.676 -1.069 . . . . 0.0 114.37 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.53 123.83 10.21 Favored 'Trans proline' 0 C--N 1.349 0.566 1 C-N-CA 125.316 4.011 . . . . 0.0 109.698 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.43 -39.49 79.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.141 0.496 . . . . 0.0 112.104 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.78 -24.03 66.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.511 1.924 . . . . 0.0 113.501 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 6.4 m -119.96 20.9 12.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.542 1.537 . . . . 0.0 111.896 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.95 139.62 30.42 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.291 1.436 . . . . 0.0 111.973 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.85 90.65 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.954 1.302 . . . . 0.0 109.43 166.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -67.71 -21.73 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -69.52 -51.14 38.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.643 0.656 . . . . 0.0 110.489 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -78.57 -19.8 51.98 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.12 38.32 19.15 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.88 1.228 . . . . 0.0 113.12 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.64 167.06 26.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.185 0.993 . . . . 0.0 113.4 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.2 m -132.24 149.86 52.28 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.331 1.053 . . . . 0.0 111.035 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 10.0 mm -107.55 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.3 mt -97.55 122.56 55.04 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 121.007 -1.058 . . . . 0.0 111.056 -169.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.43 131.94 21.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.44 2.093 . . . . 0.0 111.25 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -27.7 68.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.522 1.129 . . . . 0.0 113.446 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.24 -20.99 63.94 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.426 1.012 . . . . 0.0 113.568 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.15 8.79 28.2 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.323 1.849 . . . . 0.0 112.699 -176.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 38.4 mt -92.6 147.69 22.68 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.991 1.716 . . . . 0.0 110.81 168.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 21.9 p -83.61 175.15 9.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.595 1.158 . . . . 0.0 111.155 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.92 -41.65 97.59 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.757 -0.589 . . . . 0.0 111.42 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.97 -40.55 95.16 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.952 0.901 . . . . 0.0 112.028 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.64 -53.16 61.43 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.593 1.157 . . . . 0.0 112.279 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.05 -40.66 96.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.812 0.845 . . . . 0.0 111.001 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -58.01 -41.78 83.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.243 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -69.93 -44.82 68.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.824 1.647 . . . . 0.0 111.758 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.4 m -52.7 -35.43 55.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.423 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.15 -43.74 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.6 t -96.68 -11.19 25.49 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.573 -1.329 . . . . 0.0 114.429 -166.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.49 139.39 53.45 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.048 -1.032 . . . . 0.0 111.943 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -77.08 -25.24 52.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.456 0.703 . . . . 0.0 112.02 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -125.97 140.12 52.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.294 1.838 . . . . 0.0 110.293 166.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.86 -179.81 40.77 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.051 0.834 . . . . 0.0 113.266 -174.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.79 -152.72 47.86 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 122.282 -0.54 . . . . 0.0 113.401 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.0 p -102.64 0.29 33.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -161.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.3 t 71.14 22.83 4.31 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 120.364 1.438 . . . . 0.0 113.556 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 85.77 3.63 85.74 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 120.594 -1.316 . . . . 0.0 113.406 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.92 151.51 89.3 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 118.74 1.27 . . . . 0.0 110.119 166.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -61.96 142.88 94.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.27 1.98 . . . . 0.0 109.865 169.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.66 109.2 3.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 32.1 m -105.72 154.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.225 1.41 . . . . 0.0 110.091 174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -59.72 131.73 51.82 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.64 -13.0 67.09 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.22 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.08 130.67 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.119 1.96 . . . . 0.0 111.558 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.4 t -116.54 130.72 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.515 1.926 . . . . 0.0 108.81 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.31 -175.69 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.0 111.372 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.32 149.36 26.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.484 1.914 . . . . 0.0 111.134 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 4.5 pt-20 -44.79 129.47 5.19 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.789 1.636 . . . . 0.0 114.274 -165.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 162.75 41.53 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.43 2.087 . . . . 0.0 111.949 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -68.34 138.72 55.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.7 mm -103.67 47.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 123.404 1.573 . . . . 0.0 109.739 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.549 0.937 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.865 141.044 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.0 m80 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -67.54 133.66 49.86 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.908 0.883 . . . . 0.0 110.493 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.0 mp -68.49 -43.94 75.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.207 0.527 . . . . 0.0 112.181 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.786 1.234 . . . . 0.0 112.858 -179.036 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.922 0.868 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 121.791 0.805 . . . . 0.0 110.901 -179.517 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -52.43 129.72 29.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.226 1.376 . . . . 0.0 111.233 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -156.36 146.02 15.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.961 1.305 . . . . 0.0 111.025 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.67 176.9 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.523 2.149 . . . . 0.0 111.432 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -121.02 76.4 30.24 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.535 1.134 . . . . 0.0 109.798 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.01 142.31 38.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.137 2.558 . . . . 0.0 110.517 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.7 t -148.28 145.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.927 1.291 . . . . 0.0 109.351 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 172.88 12.14 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.946 1.298 . . . . 0.0 110.766 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.52 127.48 25.76 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.3 1.04 . . . . 0.0 110.042 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.48 104.53 10.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 109.861 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.5 p -70.29 -9.07 54.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 32.8 p -68.96 -19.33 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.169 1.388 . . . . 0.0 112.429 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.39 153.21 96.05 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.996 0.918 . . . . 0.0 112.383 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.39 162.45 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.925 3.083 . . . . 0.0 112.607 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.33 130.47 17.48 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.91 3.074 . . . . 0.0 112.345 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 66.66 39.25 3.71 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 111.833 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -123.42 152.18 41.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.84 147.24 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.901 1.68 . . . . 0.0 110.944 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 123.2 45.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.024 1.33 . . . . 0.0 110.289 177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 50.1 t -120.85 104.28 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.02 0.528 . . . . 0.0 110.911 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -72.76 132.86 44.16 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 111.864 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 31.2 t -74.31 141.87 45.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.814 0.816 . . . . 0.0 112.846 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -121.47 16.24 11.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.837 2.455 . . . . 0.0 110.724 166.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 22.3 m -108.7 126.03 52.55 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.156 1.383 . . . . 0.0 108.63 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.1 mt -92.76 140.08 29.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.443 1.497 . . . . 0.0 109.166 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -100.42 144.72 29.08 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 158.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 14.1 mm -128.87 112.16 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 108.574 -172.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -90.96 173.52 38.06 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.02 0.819 . . . . 0.0 112.064 166.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.54 16.45 75.81 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.4 t -73.04 126.33 90.49 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 118.723 1.261 . . . . 0.0 111.335 -165.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.01 132.86 36.01 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.477 2.785 . . . . 0.0 110.233 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.84 -6.32 20.92 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -92.48 -25.23 18.52 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.69 1.196 . . . . 0.0 113.691 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.6 mtm -77.22 146.12 37.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.41 1.005 . . . . 0.0 112.506 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -122.1 -179.9 4.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.652 1.581 . . . . 0.0 111.841 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -41.68 -44.73 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.829 2.051 . . . . 0.0 114.075 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -77.96 -21.6 50.76 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -73.56 -39.61 64.55 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.349 0.977 . . . . 0.0 110.435 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.85 -46.39 89.43 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.716 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.8 76.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.44 1.018 . . . . 0.0 111.698 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.13 -44.09 96.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.108 1.322 . . . . 0.0 114.283 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.7 m -71.23 -34.74 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.388 0.994 . . . . 0.0 111.287 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 50.0 mt -87.54 -7.51 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.923 0.889 . . . . 0.0 112.887 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -47.59 96.77 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.346 1.458 . . . . 0.0 114.399 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.59 -7.54 20.37 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.296 1.998 . . . . 0.0 113.31 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -98.45 -38.78 9.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.09 1.356 . . . . 0.0 112.705 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.71 172.75 2.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.145 1.778 . . . . 0.0 113.712 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 123.29 32.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.256 1.422 . . . . 0.0 111.442 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.71 120.25 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.591 0.756 . . . . 0.0 110.314 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -94.77 -41.73 9.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.668 1.187 . . . . 0.0 112.083 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.31 161.99 35.5 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.376 -0.828 . . . . 0.0 112.3 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -162.69 138.01 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.887 0.875 . . . . 0.0 111.101 176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.69 88.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.112 1.365 . . . . 0.0 108.018 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.08 137.99 31.94 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.834 -0.541 . . . . 0.0 110.94 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.47 85.85 2.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.824 1.25 . . . . 0.0 110.243 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -57.65 -38.24 74.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.844 0.857 . . . . 0.0 112.562 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 t -56.2 -33.02 64.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.968 1.307 . . . . 0.0 112.571 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -95.75 2.17 53.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.755 1.222 . . . . 0.0 113.87 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 27.57 17.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 113.612 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -133.83 169.26 17.34 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.47 43.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.707 1.203 . . . . 0.0 111.506 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.08 141.55 47.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.757 1.223 . . . . 0.0 108.089 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.8 118.09 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.782 0.719 . . . . 0.0 110.615 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -104.1 120.33 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.666 0.786 . . . . 0.0 112.059 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 19.8 m -95.24 -172.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.975 0.91 . . . . 0.0 110.113 174.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -40.46 79.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.945 1.248 . . . . 0.0 113.949 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 60.6 p -148.66 167.45 25.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.192 -0.943 . . . . 0.0 112.717 -164.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.88 91.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.358 167.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -42.07 85.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.004 0.82 . . . . 0.0 112.59 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.21 -51.22 64.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.905 1.282 . . . . 0.0 110.254 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.36 97.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.475 -0.766 . . . . 0.0 112.439 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -62.77 -42.44 99.69 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.929 0.892 . . . . 0.0 111.373 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.39 -34.18 76.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.196 1.362 . . . . 0.0 112.064 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.0 -65.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.717 166.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -50.65 -34.32 25.93 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.596 1.558 . . . . 0.0 114.152 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.51 -40.81 93.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.51 1.524 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -109.2 -27.3 9.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.41 123.95 22.99 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.463 0.705 . . . . 0.0 111.112 -169.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.86 29.16 18.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.131 1.372 . . . . 0.0 114.047 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -59.85 -36.33 76.62 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.201 -0.937 . . . . 0.0 113.16 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.79 -20.55 60.44 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.764 1.226 . . . . 0.0 112.893 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.54 23.22 65.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.819 1.2 . . . . 0.0 113.663 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -89.97 -33.78 16.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.15 1.38 . . . . 0.0 114.343 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.17 148.38 77.99 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.039 0.936 . . . . 0.0 109.445 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.37 -19.91 24.78 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.502 2.135 . . . . 0.0 112.732 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.75 144.0 35.62 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.62 1.168 . . . . 0.0 112.58 -170.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -119.28 93.38 4.06 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.638 1.175 . . . . 0.0 109.562 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 85.3 m -81.08 125.0 29.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.738 1.215 . . . . 0.0 111.178 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 175.15 9.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.97 2.508 . . . . 0.0 109.852 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -74.5 121.59 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.224 -0.923 . . . . 0.0 111.206 163.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.86 -164.83 30.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.116 1.817 . . . . 0.0 110.581 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.17 137.4 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.343 0.592 . . . . 0.0 111.107 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -99.95 -46.63 1.87 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.751 2.119 . . . . 0.0 109.945 163.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.65 110.26 8.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.375 1.07 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.04 140.83 5.66 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.682 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.62 123.24 9.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.931 3.754 . . . . 0.0 109.393 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -57.48 -45.46 84.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.883 0.473 . . . . 0.0 111.878 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.37 -18.67 63.81 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.1 m -120.99 27.96 8.17 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.086 1.755 . . . . 0.0 112.276 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.22 138.12 32.11 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.233 1.013 . . . . 0.0 111.546 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -121.66 79.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.117 1.367 . . . . 0.0 109.503 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -64.24 -22.3 66.89 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -67.47 -53.5 28.26 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.689 0.677 . . . . 0.0 110.357 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -77.41 -18.37 57.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.92 40.97 8.98 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 124.756 1.17 . . . . 0.0 112.851 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.57 172.45 16.01 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.309 1.055 . . . . 0.0 112.831 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.0 p -143.26 151.37 40.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.362 1.065 . . . . 0.0 110.673 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -110.2 125.61 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.09 123.77 28.66 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.667 -1.158 . . . . 0.0 110.364 -172.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 142.91 43.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.64 1.56 . . . . 0.0 110.457 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 20.6 mtt -58.01 -35.4 71.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.378 1.071 . . . . 0.0 112.973 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -63.51 -18.67 64.05 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 17.4 mmm-85 -97.24 3.2 51.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.589 1.956 . . . . 0.0 113.821 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.28 121.28 35.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.896 0.878 . . . . 0.0 109.747 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.6 p -72.21 -179.28 2.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.488 1.515 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -41.82 99.14 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.635 -0.665 . . . . 0.0 111.217 170.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.66 92.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.395 1.078 . . . . 0.0 111.968 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.54 -52.4 65.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.941 1.296 . . . . 0.0 112.381 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -38.56 85.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.679 -0.638 . . . . 0.0 112.225 173.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -56.11 -41.71 75.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.385 -0.816 . . . . 0.0 111.848 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -70.99 -45.63 63.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.494 1.497 . . . . 0.0 111.733 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 50.2 m -51.16 -35.55 36.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.956 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 5.7 m -90.81 -58.06 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 14.5 m -86.08 -7.38 58.64 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -166.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -52.86 145.49 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.76 1.163 . . . . 0.0 111.301 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -83.98 -27.24 28.59 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.843 -0.536 . . . . 0.0 111.204 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -125.67 136.88 53.71 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.237 2.215 . . . . 0.0 110.708 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.65 -179.92 32.97 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.001 0.81 . . . . 0.0 113.204 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.38 -150.43 48.45 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.263 -1.14 . . . . 0.0 112.29 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 43.0 p -116.07 17.18 15.91 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -153.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 t 65.26 17.88 11.18 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.947 -1.096 . . . . 0.0 113.25 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.05 59.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.498 1.047 . . . . 0.0 113.788 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -84.73 145.93 45.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.84 1.32 . . . . 0.0 111.338 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.89 107.33 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.057 2.505 . . . . 0.0 109.198 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 131.1 38.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.37 0.605 . . . . 0.0 111.595 -176.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.68 168.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.629 1.572 . . . . 0.0 110.733 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -47.25 127.0 10.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.986 0.915 . . . . 0.0 110.747 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.92 65.86 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.251 -1.305 . . . . 0.0 115.306 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 1.7 tp -50.48 133.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 120.239 2.02 . . . . 0.0 111.719 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.23 127.78 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.274 1.829 . . . . 0.0 108.345 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -152.03 179.52 8.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.174 1.39 . . . . 0.0 111.715 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -102.34 153.09 20.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.706 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -38.11 121.0 1.04 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.606 1.562 . . . . 0.0 114.529 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 160.35 50.18 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.224 1.95 . . . . 0.0 111.728 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -67.86 127.54 33.19 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.846 1.258 . . . . 0.0 113.907 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.16 46.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 123.415 1.579 . . . . 0.0 110.215 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 N--CA 1.477 0.918 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.681 140.559 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 30.2 m80 . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -72.73 141.02 48.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.54 -31.1 71.6 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.419 1.088 . . . . 0.0 111.661 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 124.898 1.279 . . . . 0.0 109.637 -176.126 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.935 0.874 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 124.145 0.978 . . . . 0.0 111.098 176.384 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.0 m80 . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -53.63 129.72 33.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.788 -1.195 . . . . 0.0 111.72 170.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -156.04 143.54 13.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.194 1.398 . . . . 0.0 110.847 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.84 172.36 14.69 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.672 2.248 . . . . 0.0 111.102 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 83.59 9.36 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 109.867 168.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.47 150.48 63.97 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.296 2.664 . . . . 0.0 110.534 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 10.8 t -144.33 133.41 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 109.662 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.09 167.75 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 110.845 174.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -143.88 121.79 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.971 0.908 . . . . 0.0 110.289 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.72 108.76 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.447 0.699 . . . . 0.0 111.156 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.9 p -69.35 -8.55 47.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -25.19 67.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.651 1.181 . . . . 0.0 112.235 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.53 150.49 95.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.794 0.838 . . . . 0.0 112.068 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.06 161.27 34.17 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.18 3.253 . . . . 0.0 112.539 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.17 134.65 32.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.059 3.173 . . . . 0.0 112.029 -173.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.99 44.53 4.65 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.633 1.573 . . . . 0.0 112.046 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -126.75 153.68 45.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.818 1.247 . . . . 0.0 114.141 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.37 145.74 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.615 1.966 . . . . 0.0 110.697 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -106.77 111.16 23.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.018 1.727 . . . . 0.0 109.863 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.81 97.08 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.194 0.598 . . . . 0.0 110.295 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.45 138.92 57.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.935 0.874 . . . . 0.0 111.706 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 41.4 t -75.48 136.84 40.63 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.191 -0.943 . . . . 0.0 112.577 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 18.82 14.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.51 2.324 . . . . 0.0 111.305 163.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 62.4 m -119.34 133.44 55.72 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.146 1.378 . . . . 0.0 110.293 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.36 134.87 42.66 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.34 1.056 . . . . 0.0 108.817 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.11 120.82 32.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 161.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.9 106.53 20.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -84.24 -178.23 51.49 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 168.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.12 11.78 59.32 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.377 -1.072 . . . . 0.0 115.067 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.01 130.12 91.7 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.965 1.383 . . . . 0.0 110.153 -166.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.94 128.01 18.9 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.923 2.415 . . . . 0.0 109.062 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.1 pp -59.17 -18.7 38.6 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.1 -25.95 31.5 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 9.1 mtm -73.52 146.48 44.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 0.0 112.293 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -118.13 178.97 4.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.115 1.766 . . . . 0.0 111.715 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.83 -36.47 67.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.617 1.167 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -73.88 -30.9 62.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.47 -35.85 81.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.547 1.067 . . . . 0.0 110.93 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.33 -51.27 70.49 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.285 0.493 . . . . 0.0 110.438 169.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.75 69.65 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.38 -40.09 64.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.46 1.482 . . . . 0.0 112.883 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.0 -36.72 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 111.249 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.1 mt -85.99 -8.08 58.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -50.44 75.17 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.08 -7.12 19.49 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.609 2.206 . . . . 0.0 113.128 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -98.69 -37.5 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.107 1.363 . . . . 0.0 112.867 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.16 168.82 3.37 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.541 1.937 . . . . 0.0 114.05 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.08 116.08 22.7 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.787 1.635 . . . . 0.0 112.051 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 97.5 t -87.88 113.48 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.133 0.973 . . . . 0.0 109.853 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.32 -37.84 15.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.502 1.121 . . . . 0.0 111.675 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.36 150.13 35.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 0.0 111.656 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.06 141.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.899 0.88 . . . . 0.0 110.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.91 105.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.355 1.062 . . . . 0.0 108.303 167.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.57 124.52 41.86 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.275 0.559 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -112.91 84.11 1.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.972 1.709 . . . . 0.0 109.258 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.71 -28.59 65.94 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.795 1.238 . . . . 0.0 111.648 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 97.2 p -61.01 -31.83 71.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.962 1.705 . . . . 0.0 113.853 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -110.28 6.82 22.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.113 1.765 . . . . 0.0 113.099 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? 56.98 40.33 28.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.995 1.318 . . . . 0.0 111.314 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -123.7 151.61 42.96 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.28 1.832 . . . . 0.0 113.464 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.25 128.28 25.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.13 1.372 . . . . 0.0 111.289 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -81.75 131.62 35.27 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.989 -1.069 . . . . 0.0 108.853 161.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 70.3 t -129.84 117.24 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.915 0.886 . . . . 0.0 109.707 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -104.24 116.13 31.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.928 1.291 . . . . 0.0 110.273 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.92 -179.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.529 0.732 . . . . 0.0 109.557 167.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -49.55 71.98 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 82.2 p -139.15 165.95 25.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.216 1.008 . . . . 0.0 112.941 -163.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -42.77 93.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.838 167.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -43.02 91.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.909 0.777 . . . . 0.0 112.277 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.5 -48.18 70.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.079 0.551 . . . . 0.0 111.763 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.2 95.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.162 0.892 . . . . 0.0 112.917 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -64.37 -40.8 96.53 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.784 0.834 . . . . 0.0 111.747 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.44 -35.33 77.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.473 1.033 . . . . 0.0 111.654 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.2 -65.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 119.043 -0.503 . . . . 0.0 110.524 166.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.3 mt -49.46 -35.78 20.6 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.323 1.449 . . . . 0.0 114.624 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.14 -33.55 71.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.275 1.43 . . . . 0.0 113.794 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -112.18 -28.28 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.215 1.006 . . . . 0.0 113.121 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.14 123.5 21.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.52 0.728 . . . . 0.0 111.202 -170.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.02 30.7 18.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.414 1.486 . . . . 0.0 114.121 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -33.98 76.76 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.47 -19.68 55.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.536 1.134 . . . . 0.0 112.883 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.2 22.69 60.35 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.817 1.199 . . . . 0.0 113.686 -173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.9 -32.93 17.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.13 1.372 . . . . 0.0 114.495 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.61 148.4 73.12 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.118 0.967 . . . . 0.0 109.586 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.83 -32.2 7.57 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.684 2.256 . . . . 0.0 112.249 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.36 149.61 50.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.852 1.261 . . . . 0.0 112.066 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.07 102.14 7.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.581 1.153 . . . . 0.0 110.718 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.6 m -80.18 124.58 28.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.817 1.247 . . . . 0.0 110.776 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -132.64 172.21 12.82 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.633 1.973 . . . . 0.0 109.939 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.55 121.67 20.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.062 -1.023 . . . . 0.0 111.295 166.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.15 -166.84 19.62 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.626 1.584 . . . . 0.0 110.052 167.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.5 p -165.53 136.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.323 0.649 . . . . 0.0 111.628 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.63 -47.09 3.29 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.34 1.924 . . . . 0.0 111.249 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -111.19 93.07 4.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.082 0.941 . . . . 0.0 112.254 173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.91 121.05 1.12 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.319 -1.267 . . . . 0.0 113.901 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 125.37 10.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.019 3.146 . . . . 0.0 109.5 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.33 -44.07 88.52 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.83 -12.44 59.97 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 53.5 m -117.71 12.67 14.02 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.881 1.672 . . . . 0.0 112.901 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 140.82 31.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.348 1.459 . . . . 0.0 111.926 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -123.5 86.35 2.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.65 1.58 . . . . 0.0 109.137 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.62 -20.93 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -69.72 -52.52 24.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.507 0.594 . . . . 0.0 110.368 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -79.53 -16.17 56.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.94 43.33 14.36 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.693 1.139 . . . . 0.0 112.772 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.23 167.08 31.11 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.573 1.187 . . . . 0.0 113.529 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.05 146.09 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.891 -1.131 . . . . 0.0 110.82 171.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -109.67 94.25 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.43 124.15 56.28 Favored Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.094 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.31 147.67 42.28 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.826 1.684 . . . . 0.0 110.998 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.5 mmt -57.82 -36.58 72.44 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.264 1.426 . . . . 0.0 112.363 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -68.24 -11.94 60.18 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -107.11 12.21 28.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.297 1.839 . . . . 0.0 113.312 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.84 135.49 49.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.544 1.138 . . . . 0.0 109.87 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.3 p -79.85 175.1 10.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 110.974 171.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.31 -45.9 87.16 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.523 -0.736 . . . . 0.0 110.763 171.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.15 90.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.648 1.179 . . . . 0.0 112.829 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.24 -51.22 70.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.147 0.979 . . . . 0.0 111.984 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.39 -37.61 80.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.33 0.652 . . . . 0.0 110.953 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -51.68 -52.41 48.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.861 1.264 . . . . 0.0 110.828 173.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -67.19 -41.98 84.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.22 1.373 . . . . 0.0 111.821 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 63.4 m -55.65 -28.63 56.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.768 -1.11 . . . . 0.0 112.802 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.05 -44.5 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.901 1.228 . . . . 0.0 113.945 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 31.2 m -94.68 -11.29 29.47 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.15 143.93 51.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.898 1.226 . . . . 0.0 111.839 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -72.35 -42.73 64.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.675 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -112.12 140.61 46.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.698 1.599 . . . . 0.0 110.98 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.4 176.8 25.35 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.128 -171.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.01 -164.6 51.62 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 122.023 -0.692 . . . . 0.0 113.252 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.7 p -106.87 18.96 21.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -157.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 p 69.69 13.54 8.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.563 1.145 . . . . 0.0 114.027 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 92.39 2.0 68.48 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.063 1.316 . . . . 0.0 113.504 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -67.11 150.52 97.87 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.86 1.33 . . . . 0.0 110.426 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.33 142.3 90.62 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.4 2.066 . . . . 0.0 110.215 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.7 114.87 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.04 159.23 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.614 1.566 . . . . 0.0 110.184 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 97.9 m -56.41 130.74 46.07 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.849 0.46 . . . . 0.0 109.905 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.42 84.4 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.351 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.24 137.19 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.021 1.41 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.03 132.68 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.262 1.825 . . . . 0.0 109.342 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -158.07 171.3 20.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.469 1.507 . . . . 0.0 110.79 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.07 142.06 27.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.809 0.444 . . . . 0.0 111.302 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.68 126.12 2.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.212 1.405 . . . . 0.0 114.499 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.76 166.22 30.57 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.603 3.535 . . . . 0.0 112.442 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -66.65 142.84 57.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.789 1.236 . . . . 0.0 113.897 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.76 52.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.244 1.497 . . . . 0.0 109.753 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.791 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.713 138.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.7 m80 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -75.92 142.6 42.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.733 1.213 . . . . 0.0 112.462 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.533 0.733 . . . . 0.0 112.023 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 CA--C 1.556 1.206 0 C-N-CA 125.152 1.381 . . . . 0.0 111.95 179.624 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.383 0.611 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.842 0.857 . . . . 0.0 110.779 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.358 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -55.02 130.99 43.86 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.875 1.671 . . . . 0.0 112.439 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -156.3 153.84 26.02 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.111 1.765 . . . . 0.0 111.352 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.55 168.06 24.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.174 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 81.07 4.2 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.513 1.125 . . . . 0.0 109.604 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.05 147.34 33.6 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.192 2.595 . . . . 0.0 111.035 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.6 t -147.28 137.88 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.351 1.46 . . . . 0.0 108.444 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.05 167.79 19.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.585 1.554 . . . . 0.0 110.746 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -141.57 122.82 14.8 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.036 -1.04 . . . . 0.0 111.064 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -114.4 101.16 8.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.427 1.491 . . . . 0.0 109.921 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.4 p -67.04 -14.12 62.59 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.358 1.063 . . . . 0.0 113.731 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -10.52 59.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.11 1.764 . . . . 0.0 113.908 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.39 156.99 80.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 119.88 1.218 . . . . 0.0 113.312 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.57 163.47 32.58 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.224 3.283 . . . . 0.0 113.293 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.68 134.67 24.49 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.212 3.275 . . . . 0.0 112.627 -172.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.68 34.24 12.41 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.148 1.379 . . . . 0.0 112.476 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -121.3 154.31 36.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.935 1.294 . . . . 0.0 114.401 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 pt -124.61 157.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.869 1.668 . . . . 0.0 111.891 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.58 118.9 37.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.865 1.266 . . . . 0.0 110.613 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.74 107.42 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.604 0.638 . . . . 0.0 110.451 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.1 132.27 45.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 111.148 167.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.6 t -67.18 138.9 57.34 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.897 0.856 . . . . 0.0 112.064 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.17 21.13 8.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.44 2.696 . . . . 0.0 109.805 168.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 48.3 m -125.67 132.87 52.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.3 1.44 . . . . 0.0 109.014 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.51 133.41 46.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.66 1.584 . . . . 0.0 109.443 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -86.24 126.31 34.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 163.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 17.4 mm -114.67 107.46 22.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.81 170.08 47.45 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 123.168 0.414 . . . . 0.0 112.496 167.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.96 19.56 79.76 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.35 118.36 71.65 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.115 -171.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.39 147.87 47.69 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.291 2.661 . . . . 0.0 110.565 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.23 -18.61 65.45 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.28 -26.63 62.05 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.509 1.124 . . . . 0.0 113.381 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 12.4 mtm -75.46 152.55 37.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.6 1.091 . . . . 0.0 112.286 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -133.34 -177.67 4.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.231 2.212 . . . . 0.0 111.127 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -55.59 -39.9 71.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 112.144 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -79.14 -14.91 58.82 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.31 -40.0 52.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.161 1.346 . . . . 0.0 110.515 168.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.33 -51.16 70.0 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.454 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.31 66.94 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.814 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -70.16 -47.4 61.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.013 1.278 . . . . 0.0 114.172 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.22 -32.37 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.583 1.538 . . . . 0.0 111.524 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 39.5 mt -87.09 -11.51 49.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.072 0.949 . . . . 0.0 113.102 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -47.16 -49.1 53.16 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 126.224 1.809 . . . . 0.0 115.076 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.45 -3.31 13.51 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.199 1.933 . . . . 0.0 113.515 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.56 -36.15 7.61 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.611 1.565 . . . . 0.0 112.747 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.17 165.94 7.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.718 2.007 . . . . 0.0 112.741 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.52 100.34 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.866 1.666 . . . . 0.0 110.466 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.23 126.42 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.583 0.753 . . . . 0.0 109.835 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -95.71 -32.07 12.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.125 1.37 . . . . 0.0 112.419 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 42.3 t -152.83 155.72 37.64 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.747 1.158 . . . . 0.0 110.997 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 55.3 t -146.68 131.32 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.233 1.013 . . . . 0.0 109.324 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.09 107.93 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.35 117.08 33.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.193 0.597 . . . . 0.0 110.339 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -100.68 84.24 2.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 109.523 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.49 -38.81 69.62 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.405 1.482 . . . . 0.0 111.07 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 11.9 m -62.25 -21.82 65.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.826 2.05 . . . . 0.0 114.736 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -113.0 6.88 17.92 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.678 1.591 . . . . 0.0 112.484 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.2 mttt 52.61 35.06 17.15 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 126.562 1.945 . . . . 0.0 113.744 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -127.96 153.52 46.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.105 1.362 . . . . 0.0 113.008 -169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -134.92 131.89 37.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.814 0.846 . . . . 0.0 111.986 162.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -83.25 121.65 27.39 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.49 125.83 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.392 1.477 . . . . 0.0 108.692 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -114.61 115.51 27.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.136 1.374 . . . . 0.0 110.199 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.67 -166.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.877 0.871 . . . . 0.0 110.155 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -48.83 66.38 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.196 1.362 . . . . 0.0 113.197 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.9 p -152.15 173.04 15.43 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -160.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -45.82 80.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.057 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -53.85 -42.17 68.26 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.239 0.927 . . . . 0.0 112.674 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.28 -43.74 49.58 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.01 92.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.038 1.29 . . . . 0.0 113.011 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.52 -40.96 96.6 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.259 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.97 -31.63 72.0 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.81 1.186 . . . . 0.0 112.253 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.62 -64.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.324 164.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.81 -32.12 42.49 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -74.54 -23.86 58.86 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.764 1.626 . . . . 0.0 113.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -120.91 -28.49 4.8 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.35 122.45 21.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.959 0.904 . . . . 0.0 111.378 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 24.5 t30 59.5 29.11 18.64 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.531 1.933 . . . . 0.0 114.861 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -55.88 -34.34 65.42 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.746 -1.221 . . . . 0.0 113.646 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -79.29 -17.13 55.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 113.603 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 11.35 83.33 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.117 1.341 . . . . 0.0 113.728 -173.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -84.49 -31.97 24.21 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.087 1.755 . . . . 0.0 115.073 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.16 152.07 76.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.679 0.792 . . . . 0.0 109.929 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.86 -18.04 24.98 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.258 1.972 . . . . 0.0 113.011 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.99 150.72 23.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -123.41 83.04 2.08 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 109.907 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.3 m -72.39 122.78 21.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.066 1.746 . . . . 0.0 110.602 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 173.47 11.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.218 2.207 . . . . 0.0 109.375 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -66.87 123.69 20.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.168 -0.957 . . . . 0.0 111.205 162.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.85 -164.1 21.43 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 126.191 1.853 . . . . 0.0 109.663 163.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.11 134.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.66 0.784 . . . . 0.0 111.376 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -93.99 -38.87 5.03 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.182 1.849 . . . . 0.0 111.641 167.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -125.99 105.64 9.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.621 2.368 . . . . 0.0 113.475 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.96 137.68 3.97 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 118.472 -1.182 . . . . 0.0 114.567 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.37 132.26 16.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.878 3.719 . . . . 0.0 110.842 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -21.3 61.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.75 -21.42 37.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.807 1.185 . . . . 0.0 113.828 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 54.1 m -124.47 31.12 5.81 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.854 1.661 . . . . 0.0 111.693 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 19.4 t -84.83 138.97 32.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.786 1.234 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -125.69 86.8 2.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.621 1.569 . . . . 0.0 109.073 165.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -67.35 -14.77 63.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.74 -46.96 28.03 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.092 1.315 . . . . 0.0 110.426 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -81.26 -14.37 57.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 75.68 44.39 20.66 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.342 0.972 . . . . 0.0 112.919 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.48 174.5 12.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.526 1.163 . . . . 0.0 112.79 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 56.7 p -147.35 147.62 30.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.354 1.062 . . . . 0.0 111.114 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.12 124.71 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -118.98 118.42 32.96 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 119.635 1.107 . . . . 0.0 111.743 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -72.71 128.99 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 111.498 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -64.69 -23.93 67.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.859 1.263 . . . . 0.0 113.228 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.43 -24.4 67.61 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.835 1.198 . . . . 0.0 114.024 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -1.16 13.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.284 1.434 . . . . 0.0 114.562 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 136.48 58.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.163 0.892 . . . . 0.0 110.001 168.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 27.8 p -72.7 174.22 7.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.759 0.79 . . . . 0.0 111.293 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.97 -39.86 87.08 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.778 -0.576 . . . . 0.0 111.869 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.75 -36.62 65.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.242 0.617 . . . . 0.0 112.313 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -55.59 -60.03 4.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 111.283 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.71 -39.91 82.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.907 1.283 . . . . 0.0 112.25 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -47.92 70.67 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.088 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -66.12 -47.57 73.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.805 1.184 . . . . 0.0 110.972 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 13.1 m -52.33 -40.55 62.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.388 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.67 -44.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.7 t -97.23 -3.06 41.47 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -166.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.401 ' CB ' ' H ' ' A' ' 461' ' ' ASP . . . -61.03 145.08 52.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.825 -1.172 . . . . 0.0 112.846 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.75 -28.74 36.4 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.827 1.251 . . . . 0.0 110.468 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -132.37 143.76 50.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.643 2.777 . . . . 0.0 110.75 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 175.53 18.51 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 123.704 0.669 . . . . 0.0 113.833 -171.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 73.52 -161.58 54.22 Favored Glycine 0 CA--C 1.546 1.973 0 O-C-N 121.501 -1.0 . . . . 0.0 114.424 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 21.1 p -93.36 3.07 56.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.962 2.105 . . . . 0.0 116.418 -160.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.4 m 78.05 6.31 2.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.83 1.252 . . . . 0.0 113.036 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.26 5.33 59.36 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.014 1.292 . . . . 0.0 113.438 -169.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -71.92 153.45 92.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.578 1.189 . . . . 0.0 109.834 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.58 146.97 93.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.086 2.524 . . . . 0.0 110.897 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 54.5 mt -70.66 104.32 2.8 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.65 158.21 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.045 1.338 . . . . 0.0 111.647 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.0 m -59.05 131.65 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.09 -1.15 79.82 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.85 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.718 1.759 . . . . 0.0 112.683 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.44 137.06 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.348 2.259 . . . . 0.0 109.452 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -164.55 178.02 7.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.602 1.161 . . . . 0.0 111.715 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -97.54 151.69 19.78 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.107 . . . . 0.0 110.109 169.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -44.98 130.16 5.39 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -167.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.81 168.04 24.92 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.927 3.085 . . . . 0.0 111.175 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ASP . . . . . 0.401 ' H ' ' CB ' ' A' ' 441' ' ' ALA . 67.4 m-20 -74.18 120.0 19.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.59 46.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.183 1.468 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.474 0.756 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 142.125 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.75 111.09 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.494 1.043 . . . . 0.0 110.327 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 70.06 -177.66 31.37 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.684 1.135 . . . . 0.0 113.821 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -109.25 155.99 40.12 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 111.339 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.75 -79.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.488 3.459 . . . . 0.0 111.444 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.2 -31.15 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.571 1.949 . . . . 0.0 112.513 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . 0.25 5.0 p 72.22 5.91 5.41 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 128.96 2.904 . . . . 0.0 115.191 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.99 -30.37 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 128.162 2.585 . . . . 0.0 113.003 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.252 0.0 OUTLIER 58.07 -156.03 0.33 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.474 1.91 . . . . 0.0 111.724 176.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.56 -25.53 7.25 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.802 1.192 . . . . 0.0 115.284 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 10.8 t -59.83 -40.71 89.37 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.413 1.107 . . . . 0.0 111.955 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -109.54 -73.51 0.68 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.315 1.446 . . . . 0.0 110.482 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.72 -178.66 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.532 1.533 . . . . 0.0 111.49 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -79.79 22.14 0.5 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -168.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -72.83 138.68 46.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.595 1.158 . . . . 0.0 111.885 171.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.25 -42.78 99.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.913 0.885 . . . . 0.0 110.35 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.6 160.65 34.08 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.941 1.296 . . . . 0.0 112.55 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.36 -158.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.486 3.457 . . . . 0.0 111.296 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -49.06 -40.25 30.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.678 1.191 . . . . 0.0 113.623 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 41.12 -150.04 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.164 2.186 . . . . 0.0 113.527 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.78 141.58 10.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 110.567 162.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -73.33 66.21 0.91 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 120.675 -1.265 . . . . 0.0 110.725 167.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 6.2 m -111.28 153.69 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 127.312 2.245 . . . . 0.0 111.783 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 61.1 p -62.27 -27.1 68.78 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.26 -20.34 60.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 173.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.74 122.27 80.19 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.379 1.072 . . . . 0.0 109.888 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.49 -16.24 42.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.448 2.099 . . . . 0.0 113.011 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -73.86 -0.52 16.2 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 167.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -50.39 135.57 21.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.097 1.317 . . . . 0.0 112.099 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -136.37 151.07 72.48 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 124.029 0.932 . . . . 0.0 110.72 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.81 165.98 21.77 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.014 2.476 . . . . 0.0 110.632 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.38 79.41 1.66 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 166.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.5 115.77 4.21 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.443 2.095 . . . . 0.0 108.451 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.01 142.06 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.761 1.224 . . . . 0.0 109.317 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.68 169.04 18.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.489 1.116 . . . . 0.0 109.92 174.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -140.6 111.18 6.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.811 0.845 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.61 126.78 53.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.796 0.838 . . . . 0.0 111.794 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.4 p -73.76 -7.63 52.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -18.58 65.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.508 2.323 . . . . 0.0 111.915 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.6 153.04 81.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.634 1.174 . . . . 0.0 113.361 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.12 165.1 29.57 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.559 3.506 . . . . 0.0 113.047 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.35 135.6 27.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.399 3.399 . . . . 0.0 112.776 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.28 42.92 14.36 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.694 1.597 . . . . 0.0 111.465 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -127.24 153.04 46.61 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.6 pt -126.2 147.75 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.476 1.91 . . . . 0.0 109.966 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 133.1 51.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.203 1.401 . . . . 0.0 111.331 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.01 102.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.185 0.594 . . . . 0.0 110.996 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -68.62 136.18 52.59 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.396 1.079 . . . . 0.0 111.626 166.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.4 t -78.37 136.37 37.66 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.354 -0.841 . . . . 0.0 111.364 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -103.03 12.3 36.17 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.968 1.707 . . . . 0.0 109.918 162.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 52.5 m -109.98 130.71 55.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.073 1.749 . . . . 0.0 110.127 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 mt -96.01 136.61 36.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 108.932 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -94.83 139.64 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 161.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.2 mm -124.95 107.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.79 1.236 . . . . 0.0 108.209 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.71 176.48 46.17 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 123.882 0.753 . . . . 0.0 111.868 168.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.18 17.4 72.0 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.016 0.766 . . . . 0.0 115.016 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.3 122.15 86.65 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 118.507 1.153 . . . . 0.0 110.525 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.12 137.6 29.22 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.871 2.38 . . . . 0.0 108.931 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.4 mp -64.73 -17.43 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.59 -25.66 57.19 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 47.8 mtm -78.46 139.76 38.68 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.861 0.838 . . . . 0.0 112.238 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -116.47 -173.75 2.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.744 2.018 . . . . 0.0 111.657 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -54.07 -48.44 70.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.196 1.798 . . . . 0.0 112.703 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -76.19 -18.4 59.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.01 -40.37 71.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.059 1.299 . . . . 0.0 110.683 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -49.1 78.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.817 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.07 71.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.923 0.783 . . . . 0.0 112.95 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.52 -44.82 70.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.528 1.131 . . . . 0.0 113.964 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.97 -33.89 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.699 1.136 . . . . 0.0 110.683 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 51.5 mt -87.02 -10.59 52.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.037 0.935 . . . . 0.0 113.187 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -48.31 -48.96 64.78 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.669 1.588 . . . . 0.0 114.674 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.34 -6.98 17.66 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.217 1.945 . . . . 0.0 113.375 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.68 -39.99 8.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.47 1.508 . . . . 0.0 112.38 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.39 169.89 3.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.13 1.772 . . . . 0.0 112.712 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.54 125.5 32.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.553 0.741 . . . . 0.0 109.835 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.67 128.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.621 0.768 . . . . 0.0 110.276 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -91.8 -43.38 9.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.123 1.369 . . . . 0.0 112.538 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.92 159.2 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 111.623 -172.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.0 p -160.79 133.7 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.731 -0.606 . . . . 0.0 111.609 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.7 103.31 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.73 133.11 43.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.794 0.837 . . . . 0.0 110.224 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.57 89.47 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.821 1.248 . . . . 0.0 109.565 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -60.24 -38.32 83.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.765 1.226 . . . . 0.0 111.711 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.0 t -58.9 -30.62 67.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.765 1.626 . . . . 0.0 113.23 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.74 -3.15 42.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.359 1.463 . . . . 0.0 113.13 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 58.8 30.85 20.6 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.297 1.839 . . . . 0.0 113.326 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -133.82 169.3 17.26 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.45 42.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.013 1.325 . . . . 0.0 111.159 164.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.28 136.76 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 45.1 t -134.72 113.3 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.428 0.691 . . . . 0.0 110.78 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -92.99 122.89 35.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 0.0 109.734 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.63 164.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.088 0.955 . . . . 0.0 109.97 169.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -73.76 -22.34 59.89 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 p -134.38 154.18 51.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.762 1.165 . . . . 0.0 113.445 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -59.43 -41.75 90.29 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.148 0.979 . . . . 0.0 111.493 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -37.68 88.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.401 0.68 . . . . 0.0 111.853 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.42 -50.65 72.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.752 1.221 . . . . 0.0 111.073 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.03 95.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.919 0.781 . . . . 0.0 112.027 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.98 -42.12 98.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.954 0.502 . . . . 0.0 112.138 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -63.45 -35.02 79.06 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.256 0.935 . . . . 0.0 112.26 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.23 -64.35 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.819 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -49.27 -36.77 21.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.893 1.277 . . . . 0.0 114.153 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.09 -35.88 80.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.918 1.287 . . . . 0.0 113.476 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -111.79 -25.6 9.39 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -72.0 124.17 24.36 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.537 0.735 . . . . 0.0 111.189 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 61.89 30.17 18.08 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.263 1.425 . . . . 0.0 113.904 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -58.33 -36.07 72.84 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.806 -1.184 . . . . 0.0 113.385 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.569 1.148 . . . . 0.0 113.062 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.48 61.55 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.88 1.228 . . . . 0.0 113.737 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.16 -34.68 14.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.379 1.472 . . . . 0.0 114.389 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 24.8 mt -73.67 148.52 87.66 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.099 0.96 . . . . 0.0 109.457 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.71 -29.45 10.61 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.347 2.031 . . . . 0.0 112.181 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.87 139.97 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.959 1.704 . . . . 0.0 111.715 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.26 103.0 10.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.048 1.339 . . . . 0.0 110.08 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.8 m -81.75 124.27 29.48 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.883 1.273 . . . . 0.0 110.571 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -133.39 175.37 9.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.602 2.361 . . . . 0.0 109.248 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -73.51 123.47 24.0 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.25 -0.906 . . . . 0.0 110.889 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -100.66 -164.73 28.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 163.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.49 122.07 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.078 0.951 . . . . 0.0 109.234 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -84.73 -47.4 5.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 162.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.68 120.11 22.32 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.808 0.843 . . . . 0.0 111.732 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.06 131.73 1.54 Allowed Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.529 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.84 130.94 16.33 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 125.161 3.907 . . . . 0.0 110.405 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -36.19 79.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -72.32 -18.79 61.75 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.6 m -124.16 29.9 6.26 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.906 1.683 . . . . 0.0 111.982 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.7 155.55 25.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -139.71 73.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.802 1.641 . . . . 0.0 109.446 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -63.07 -18.62 63.57 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.47 -52.42 32.61 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.109 -0.994 . . . . 0.0 111.077 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -80.78 -17.19 51.68 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 84.43 38.33 9.96 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.964 1.269 . . . . 0.0 113.034 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -145.59 169.7 17.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.63 1.215 . . . . 0.0 112.374 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 46.4 m -141.13 157.13 45.7 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.941 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.53 127.68 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.67 125.51 28.02 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 117.405 -1.283 . . . . 0.0 111.229 -170.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.86 132.21 18.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.078 1.852 . . . . 0.0 110.362 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -20.47 61.64 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.635 1.174 . . . . 0.0 113.735 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -26.26 65.55 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.34 0.973 . . . . 0.0 113.208 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.0 -24.53 16.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.757 1.223 . . . . 0.0 112.802 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.5 116.83 4.62 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.4 p -65.55 176.54 1.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.738 1.215 . . . . 0.0 110.733 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.37 -41.3 93.44 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.502 -0.749 . . . . 0.0 110.99 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.41 -40.99 85.62 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 112.541 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -58.35 -52.55 65.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.889 1.276 . . . . 0.0 111.993 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -66.84 -37.54 84.69 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.771 -0.58 . . . . 0.0 111.566 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -47.91 73.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.212 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 464' ' ' VAL . 6.3 m0 -68.41 -43.35 77.4 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.269 1.395 . . . . 0.0 111.533 174.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 66.8 m -53.52 -35.8 61.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.59 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.5 m -90.63 -43.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -99.51 -12.91 19.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.289 1.436 . . . . 0.0 114.489 -166.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.79 142.16 46.49 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.162 -0.961 . . . . 0.0 111.062 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -80.82 -45.56 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.509 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -100.31 131.4 46.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.297 1.039 . . . . 0.0 110.181 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.71 -176.57 45.58 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.381 0.991 . . . . 0.0 114.028 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.31 -156.44 52.99 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.417 -0.392 . . . . 0.0 112.265 -170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.8 p -99.43 -4.96 30.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 77.95 17.65 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.788 1.635 . . . . 0.0 113.317 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.44 56.04 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.122 1.344 . . . . 0.0 113.884 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 153.53 95.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.726 1.263 . . . . 0.0 111.593 172.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.84 143.93 81.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.863 2.376 . . . . 0.0 110.423 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 40.6 mt -70.75 110.53 5.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.279 0.562 . . . . 0.0 109.618 170.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.11 152.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 110.235 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.1 m -53.35 130.0 33.7 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.65 0.78 . . . . 0.0 109.71 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.52 -5.6 80.32 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.865 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.45 134.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.807 1.304 . . . . 0.0 111.514 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.5 t -119.99 140.41 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.752 2.021 . . . . 0.0 108.734 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.83 -179.61 7.33 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.691 1.196 . . . . 0.0 111.797 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -92.13 150.3 21.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.212 . . . . 0.0 110.842 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -51.16 132.21 31.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 124.553 1.141 . . . . 0.0 113.703 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.26 148.45 74.39 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.957 1.771 . . . . 0.0 109.253 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -52.96 148.29 7.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.174 0.99 . . . . 0.0 112.858 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -108.09 50.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 123.159 1.456 . . . . 0.0 110.103 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -179.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.6 142.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.403 ' HA ' ' HE1' ' A' ' 437' ' ' TRP . 7.6 p -150.74 -48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.943 -1.098 . . . . 0.0 110.929 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.29 -177.49 20.44 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.86 -163.62 0.27 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.775 0.83 . . . . 0.0 111.931 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.64 -126.65 5.66 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.32 1.438 . . . . 0.0 111.164 167.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 128.672 2.789 . . . . 0.0 111.898 174.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.99 138.03 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 119.446 1.021 . . . . 0.0 110.339 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -85.57 31.84 3.79 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.423 1.487 . . . . 0.0 114.133 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . 70.25 168.4 0.12 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 127.462 2.305 . . . . 0.0 111.974 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.23 -155.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.368 2.712 . . . . 0.0 111.503 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -57.17 -31.16 65.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.519 1.128 . . . . 0.0 113.457 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 70.9 p 46.7 27.18 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 128.731 2.812 . . . . 0.0 114.918 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -75.18 -21.28 58.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 112.918 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -48.83 -32.91 9.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.59 2.356 . . . . 0.0 115.67 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.16 73.29 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.218 0.913 . . . . 0.0 114.266 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.86 -146.65 0.26 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.438 1.895 . . . . 0.0 109.401 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -64.18 159.95 19.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.14 1.376 . . . . 0.0 112.895 168.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.3 163.47 0.24 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.95 1.7 . . . . 0.0 112.844 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -143.9 0.21 1.07 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -64.73 133.28 51.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.708 1.203 . . . . 0.0 111.622 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.6 -20.13 63.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.006 1.322 . . . . 0.0 111.355 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -115.53 162.71 23.53 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.913 2.085 . . . . 0.0 112.183 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.91 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.739 3.626 . . . . 0.0 111.686 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.16 56.05 0.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.224 1.409 . . . . 0.0 111.481 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.04 135.24 57.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.084 1.354 . . . . 0.0 110.858 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.0 133.33 34.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.333 0.653 . . . . 0.0 110.102 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -74.84 70.48 1.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 O-C-N 120.665 -1.272 . . . . 0.0 110.744 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.25 160.7 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 127.568 2.347 . . . . 0.0 111.178 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 39.8 t -51.12 -35.23 34.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.36 -27.11 67.63 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.246 -0.909 . . . . 0.0 113.327 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -80.11 124.36 82.89 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.015 1.326 . . . . 0.0 110.334 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.34 -19.48 61.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.529 2.153 . . . . 0.0 113.241 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.28 3.79 19.82 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.765 1.226 . . . . 0.0 113.757 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -53.68 117.94 3.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.181 1.392 . . . . 0.0 112.729 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 143.72 50.4 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 125.252 1.421 . . . . 0.0 110.491 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.3 164.85 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.294 2.663 . . . . 0.0 111.217 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 83.74 13.71 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.251 1.02 . . . . 0.0 109.019 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.98 116.37 4.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.531 2.154 . . . . 0.0 108.218 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.8 t -112.35 129.04 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.789 0.835 . . . . 0.0 109.276 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.1 170.26 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 111.0 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -138.47 121.81 17.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.445 1.098 . . . . 0.0 110.082 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -122.14 105.89 10.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.08 0.952 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -7.66 16.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.547 1.539 . . . . 0.0 113.723 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.87 -24.5 64.34 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.788 1.235 . . . . 0.0 112.375 172.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.99 150.14 96.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.633 0.773 . . . . 0.0 111.927 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.67 162.0 33.34 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.138 3.225 . . . . 0.0 112.945 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 133.53 27.24 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.963 3.109 . . . . 0.0 112.49 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.03 26.88 7.19 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.399 1.88 . . . . 0.0 113.015 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -112.58 153.64 27.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.48 151.23 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.019 2.128 . . . . 0.0 109.678 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -114.41 131.8 56.45 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.127 1.33 . . . . 0.0 111.727 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.9 106.57 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 110.794 -171.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.22 129.3 39.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.875 1.27 . . . . 0.0 111.34 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.5 t -69.41 135.1 49.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.776 -0.577 . . . . 0.0 111.973 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.9 mtm105 -105.37 15.31 27.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.659 1.584 . . . . 0.0 110.487 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 17.5 m -121.16 143.63 49.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.008 1.323 . . . . 0.0 112.054 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -111.1 136.55 49.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.829 2.052 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.96 137.46 32.32 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 166.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.82 117.36 52.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 108.058 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -99.64 174.61 27.08 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.709 1.147 . . . . 0.0 111.012 164.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.44 27.17 70.15 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 119.132 -0.815 . . . . 0.0 114.031 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.22 106.02 18.06 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.504 1.152 . . . . 0.0 110.567 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.97 146.52 87.81 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.798 2.332 . . . . 0.0 111.037 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.49 -19.24 64.58 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.69 -29.6 68.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.078 0.951 . . . . 0.0 112.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 17.6 mtm -85.62 151.8 23.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.037 0.935 . . . . 0.0 112.667 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -175.49 4.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 111.581 -175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -50.33 -35.56 28.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.387 1.875 . . . . 0.0 113.085 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -78.01 -21.24 51.08 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.9 -36.09 62.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.844 1.202 . . . . 0.0 110.639 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.58 -46.94 88.36 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.725 0.693 . . . . 0.0 110.772 169.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.8 70.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.545 0.612 . . . . 0.0 112.437 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -69.49 -41.19 76.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.695 1.198 . . . . 0.0 113.456 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.6 m -73.75 -34.69 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.898 0.772 . . . . 0.0 111.864 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 66.7 mt -86.3 -12.6 49.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.354 1.062 . . . . 0.0 113.397 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -48.3 71.87 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.087 1.755 . . . . 0.0 115.309 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.69 -7.44 17.62 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.66 2.24 . . . . 0.0 113.869 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -96.73 -39.87 9.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.281 1.432 . . . . 0.0 112.401 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.43 171.86 5.35 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.919 1.688 . . . . 0.0 112.747 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.39 130.8 34.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.366 0.666 . . . . 0.0 109.559 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.34 127.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 109.601 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.01 -46.63 10.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 111.699 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 45.2 t -154.57 152.03 29.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 -169.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.9 134.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.42 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 166.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.16 139.07 37.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.244 0.618 . . . . 0.0 110.731 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.28 90.82 3.0 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.546 1.165 . . . . 0.0 109.989 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.46 -31.03 68.95 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 111.82 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 6.7 m -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.544 1.938 . . . . 0.0 114.908 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.67 9.75 17.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.342 1.457 . . . . 0.0 112.932 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 55.5 35.82 25.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.908 1.683 . . . . 0.0 112.9 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -126.9 167.32 16.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.4 164.02 34.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.482 1.113 . . . . 0.0 112.112 165.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.98 123.04 42.52 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.516 1.526 . . . . 0.0 108.155 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.62 116.02 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.257 1.023 . . . . 0.0 110.752 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -91.29 121.04 32.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.922 0.889 . . . . 0.0 110.176 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.15 167.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.052 0.941 . . . . 0.0 109.465 168.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -76.38 -18.91 58.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.11 155.73 45.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.197 169.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -38.9 88.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.126 0.971 . . . . 0.0 111.99 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.2 -48.55 75.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.465 1.106 . . . . 0.0 111.314 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.23 91.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.018 0.527 . . . . 0.0 111.458 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -62.81 -42.28 99.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.25 1.02 . . . . 0.0 112.097 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -65.43 -34.14 77.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.658 1.117 . . . . 0.0 112.78 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.29 -62.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.64 -35.17 40.98 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.826 1.25 . . . . 0.0 114.109 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -67.02 -44.11 81.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.584 1.553 . . . . 0.0 113.266 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -103.58 -29.88 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -72.08 127.87 33.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.338 1.055 . . . . 0.0 111.388 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.72 25.64 15.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.466 . . . . 0.0 114.881 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -51.39 -45.87 62.63 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.09 3.53 38.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.888 2.075 . . . . 0.0 113.287 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.4 30.28 50.18 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.506 1.051 . . . . 0.0 113.81 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.36 65.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.86 162.23 30.29 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 126.335 1.854 . . . . 0.0 110.256 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.63 -22.73 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.328 2.018 . . . . 0.0 113.296 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.53 HD13 ' H ' ' A' ' 402' ' ' LEU . 0.2 OUTLIER -81.91 143.95 31.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.579 1.152 . . . . 0.0 111.724 -172.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -115.24 122.15 45.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.136 1.374 . . . . 0.0 108.919 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.6 m -107.12 128.62 54.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.507 1.123 . . . . 0.0 110.319 -167.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -132.51 175.64 9.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.818 2.047 . . . . 0.0 109.475 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -64.63 134.57 54.58 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.96 -1.087 . . . . 0.0 110.946 164.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.34 -152.82 9.61 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.702 1.62 . . . . 0.0 109.147 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.48 134.27 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.332 0.566 . . . . 0.0 112.262 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.97 -51.61 3.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -126.99 118.58 24.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.229 1.011 . . . . 0.0 112.119 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.96 143.13 4.7 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.857 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.26 130.22 17.19 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 125.686 4.257 . . . . 0.0 110.323 175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -35.29 80.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.646 0.378 . . . . 0.0 111.875 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -76.23 -16.61 59.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.14 1.376 . . . . 0.0 114.565 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.5 m -123.9 31.03 5.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.41 1.484 . . . . 0.0 111.952 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.36 138.26 32.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.632 1.573 . . . . 0.0 111.609 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -124.89 81.67 1.98 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.296 1.438 . . . . 0.0 109.881 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -66.4 -16.37 64.03 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.9 -51.23 23.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.964 1.256 . . . . 0.0 110.295 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -82.38 -12.28 58.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 73.83 42.68 37.57 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.607 1.099 . . . . 0.0 112.464 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -147.01 170.24 17.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.625 1.212 . . . . 0.0 112.836 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 25.5 m -132.57 152.24 51.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.035 0.934 . . . . 0.0 110.709 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.55 134.53 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.51 119.14 21.59 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 119.81 1.187 . . . . 0.0 111.409 -172.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.68 133.53 18.84 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.616 2.211 . . . . 0.0 111.492 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 9.6 mtt -59.5 -30.05 68.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.588 1.555 . . . . 0.0 113.762 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -65.17 -18.76 65.57 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -109.26 6.43 24.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.194 2.198 . . . . 0.0 113.346 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.48 138.34 32.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.409 1.084 . . . . 0.0 111.093 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.5 p -79.65 177.51 8.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.037 1.335 . . . . 0.0 111.356 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.64 -46.3 90.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.579 -0.7 . . . . 0.0 111.323 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.69 88.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.883 0.873 . . . . 0.0 112.059 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.78 -62.54 1.8 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.799 0.84 . . . . 0.0 111.338 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -61.47 -32.19 72.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.738 0.415 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -62.1 1.85 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.566 169.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -58.69 -40.52 83.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.477 1.49 . . . . 0.0 111.937 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 14.9 m -54.0 -29.23 42.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.832 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.14 -42.36 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.999 1.272 . . . . 0.0 114.087 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 20.0 m -93.08 -9.1 40.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.646 1.978 . . . . 0.0 115.033 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.24 145.9 41.24 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.086 1.312 . . . . 0.0 111.652 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.98 -53.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.011 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -97.95 136.65 37.93 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.325 1.05 . . . . 0.0 110.723 166.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 65.15 -170.79 25.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.232 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.35 -164.39 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 -166.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 49.9 p -100.9 14.41 31.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -164.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.5 m 62.22 19.11 10.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.783 1.174 . . . . 0.0 113.498 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.27 4.84 64.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.115 1.341 . . . . 0.0 114.201 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.34 151.57 96.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 118.785 1.292 . . . . 0.0 110.708 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.86 145.71 86.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.791 2.327 . . . . 0.0 110.894 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.66 107.03 3.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.98 157.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.574 1.55 . . . . 0.0 110.238 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 94.5 m -55.14 130.19 41.03 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.757 0.823 . . . . 0.0 110.019 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.77 -5.8 82.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.783 -1.009 . . . . 0.0 114.866 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.92 137.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.188 1.494 . . . . 0.0 111.973 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.7 137.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.422 1.889 . . . . 0.0 109.544 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -161.84 174.51 13.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.958 1.303 . . . . 0.0 112.694 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -87.74 150.32 23.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.801 1.241 . . . . 0.0 111.002 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.99 128.98 29.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -167.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.67 150.37 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.902 2.402 . . . . 0.0 110.98 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.1 141.55 58.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.726 1.21 . . . . 0.0 114.059 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.56 53.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 123.433 1.587 . . . . 0.0 110.294 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.74 -178.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.622 141.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.99 -48.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.688 -1.257 . . . . 0.0 111.971 172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.11 78.44 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.725 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 76.23 165.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.805 2.442 . . . . 0.0 111.469 -170.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 178.91 131.0 1.51 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 121.14 -0.975 . . . . 0.0 113.057 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 111.917 178.447 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.91 93.45 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 120.433 1.47 . . . . 0.0 110.386 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 76.08 132.47 0.41 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.223 0.916 . . . . 0.0 111.52 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -130.44 159.67 69.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.628 1.171 . . . . 0.0 110.604 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.98 -164.19 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.46 2.774 . . . . 0.0 111.916 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -52.24 -40.97 62.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.459 1.104 . . . . 0.0 113.271 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p 53.91 26.65 6.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.641 2.376 . . . . 0.0 114.62 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -3.38 50.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.37 1.468 . . . . 0.0 114.348 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -50.32 121.18 5.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.143 1.377 . . . . 0.0 110.923 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 97.04 -56.79 1.26 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.18 1.371 . . . . 0.0 113.23 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 10.9 t -68.25 -41.22 81.46 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.5 1.15 . . . . 0.0 112.365 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -105.73 -73.5 0.68 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.5 0.72 . . . . 0.0 110.876 171.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.99 166.79 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 111.58 -166.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -77.57 12.37 1.65 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -70.41 140.92 52.17 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.093 -1.004 . . . . 0.0 112.77 171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.41 HD13 ' CZ2' ' A' ' 353' ' ' TRP . 3.3 mm? -65.54 -48.76 71.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 110.543 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.35 157.34 50.44 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.6 1.16 . . . . 0.0 113.013 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.96 69.2 4.7 Favored 'Trans proline' 0 C--N 1.357 0.984 1 C-N-CA 125.397 4.065 . . . . 0.0 111.983 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 71.12 -66.76 0.28 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 128.808 2.843 . . . . 0.0 111.142 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 44.5 -172.79 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.288 3.035 . . . . 0.0 113.973 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -131.35 156.41 45.55 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.889 -1.132 . . . . 0.0 110.329 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.52 63.84 6.87 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.872 1.269 . . . . 0.0 109.064 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 m -111.19 154.86 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.526 2.331 . . . . 0.0 110.881 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 23.6 t -60.35 -30.06 69.3 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -70.39 -19.07 63.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -77.51 123.54 86.76 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.247 1.019 . . . . 0.0 110.56 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.36 -21.08 54.54 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.436 2.091 . . . . 0.0 112.71 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -82.72 6.94 16.34 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 113.48 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -52.94 131.52 36.0 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.835 -1.166 . . . . 0.0 111.797 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -138.65 147.77 55.99 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.792 1.237 . . . . 0.0 110.083 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.78 159.92 49.06 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.791 2.327 . . . . 0.0 111.116 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 81.82 0.54 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.78 0.832 . . . . 0.0 109.01 162.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.8 121.57 7.75 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 108.539 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 13.8 t -121.54 128.92 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.806 0.842 . . . . 0.0 109.382 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.14 171.72 8.49 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.019 1.727 . . . . 0.0 110.989 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -139.88 120.48 14.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.007 . . . . 0.0 109.928 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -120.04 109.74 15.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.301 1.04 . . . . 0.0 110.609 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 99.1 p -69.06 -7.66 37.82 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.1 t -64.4 -24.91 67.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.278 1.031 . . . . 0.0 112.223 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.37 150.72 95.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.931 0.892 . . . . 0.0 112.237 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.81 161.6 35.49 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.903 3.069 . . . . 0.0 112.64 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.64 134.44 28.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.942 3.094 . . . . 0.0 112.109 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . 0.25 7.0 m-20 68.4 26.03 6.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.675 1.99 . . . . 0.0 113.362 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -111.14 153.3 25.93 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.94 148.77 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.25 1.82 . . . . 0.0 109.872 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.15 132.85 53.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.502 -1.373 . . . . 0.0 110.617 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.93 106.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.341 0.656 . . . . 0.0 111.461 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -68.49 131.59 45.54 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.579 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 32.7 t -73.1 136.57 44.91 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.723 -0.611 . . . . 0.0 111.841 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -106.89 18.64 21.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.187 1.795 . . . . 0.0 109.724 163.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 16.2 m -126.29 141.95 51.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.967 1.307 . . . . 0.0 111.763 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.5 mt -104.16 134.88 46.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 109.351 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -87.27 123.39 32.22 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 163.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.58 107.13 22.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.23 -174.84 50.67 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 166.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.61 70.02 Favored Glycine 0 N--CA 1.475 1.275 0 O-C-N 121.43 -1.041 . . . . 0.0 114.955 170.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 14.9 t -84.71 112.81 45.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 118.78 1.29 . . . . 0.0 110.295 -168.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.95 143.96 62.47 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.984 2.456 . . . . 0.0 109.919 170.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.04 -21.18 63.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.9 -27.49 63.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.859 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 33.9 mtm -80.58 145.86 31.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.59 0.709 . . . . 0.0 112.293 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -129.46 -179.4 5.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.145 2.178 . . . . 0.0 110.976 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -47.68 -40.31 19.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 114.216 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.41 ' CZ2' HD13 ' A' ' 305' ' ' LEU . 78.4 m95 -81.43 -18.63 44.7 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.76 -39.27 66.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.663 1.12 . . . . 0.0 110.185 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.24 -51.26 70.75 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.833 0.453 . . . . 0.0 110.719 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.82 71.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.662 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -68.18 -44.31 76.2 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.135 1.334 . . . . 0.0 113.996 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.82 -35.72 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.507 1.049 . . . . 0.0 110.954 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 mt -83.7 -11.57 57.01 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.459 1.104 . . . . 0.0 113.138 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -48.66 -48.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.849 1.66 . . . . 0.0 114.758 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.12 -6.74 17.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.133 1.889 . . . . 0.0 113.586 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -98.46 -40.93 8.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.5 1.52 . . . . 0.0 112.431 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.68 171.55 3.79 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.915 1.686 . . . . 0.0 113.461 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -85.99 138.35 32.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.661 0.784 . . . . 0.0 110.538 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.1 t -103.7 129.86 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.616 1.166 . . . . 0.0 110.169 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -93.64 -40.23 10.37 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.355 1.862 . . . . 0.0 112.782 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.1 t -152.82 152.04 31.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.404 1.082 . . . . 0.0 110.61 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 70.9 t -146.22 131.99 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.248 0.477 . . . . 0.0 110.417 171.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.24 107.88 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.61 122.06 40.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.066 0.546 . . . . 0.0 110.337 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -106.48 84.9 2.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.822 1.649 . . . . 0.0 109.478 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.72 -33.91 66.96 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.485 1.514 . . . . 0.0 111.354 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 65.6 m -55.72 -32.51 63.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.155 1.782 . . . . 0.0 114.27 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -110.21 9.17 23.86 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 113.191 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt 53.94 37.85 27.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.382 1.473 . . . . 0.0 112.072 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -125.5 153.39 43.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.971 1.708 . . . . 0.0 113.24 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -136.8 132.75 35.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 112.228 164.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.96 117.63 24.92 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 162.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.56 114.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.706 0.803 . . . . 0.0 110.249 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -98.37 121.96 40.95 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 110.299 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.11 164.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.437 1.095 . . . . 0.0 109.553 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.53 -21.22 59.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.4 p -141.74 159.63 41.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.09 1.314 . . . . 0.0 114.234 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -61.54 -45.34 94.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.214 1.006 . . . . 0.0 112.079 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -58.8 -38.22 78.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.239 0.616 . . . . 0.0 112.231 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.47 -54.8 34.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.956 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.0 85.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.888 0.767 . . . . 0.0 112.307 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.69 -44.79 95.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 111.633 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -65.24 -33.79 76.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.204 -0.935 . . . . 0.0 112.654 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.16 -63.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.55 166.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -51.13 -35.81 37.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.877 1.271 . . . . 0.0 114.314 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -63.83 -37.51 87.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.99 1.316 . . . . 0.0 113.085 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -112.83 -26.94 8.32 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.3 123.81 25.28 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 111.308 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.93 27.4 13.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.736 1.614 . . . . 0.0 114.168 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -24.56 66.77 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -100.56 -14.48 18.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.615 1.966 . . . . 0.0 114.524 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.26 24.28 29.55 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.548 1.07 . . . . 0.0 115.291 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.88 -42.01 22.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.562 1.681 . . . . 0.0 115.028 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.8 149.25 90.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.859 0.863 . . . . 0.0 110.57 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.84 -32.89 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.588 2.192 . . . . 0.0 111.71 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.76 163.4 25.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.203 1.801 . . . . 0.0 112.67 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -126.3 101.28 6.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.549 1.54 . . . . 0.0 109.915 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 113.06 21.2 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.115 1.366 . . . . 0.0 109.804 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.42 171.11 11.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.938 1.695 . . . . 0.0 109.178 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -67.29 130.84 44.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.097 -1.002 . . . . 0.0 110.838 163.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -115.66 -148.96 9.39 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 125.865 1.698 . . . . 0.0 109.102 167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.96 132.17 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.29 -46.71 5.47 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 167.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -132.82 121.47 23.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 111.978 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.86 145.79 5.84 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 119.274 -0.736 . . . . 0.0 114.659 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.13 133.61 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 125.048 3.832 . . . . 0.0 109.739 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -37.73 80.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.835 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.21 -20.12 63.11 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.658 -1.276 . . . . 0.0 113.896 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.0 m -123.71 30.19 6.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.817 1.647 . . . . 0.0 112.041 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.1 p -75.65 154.06 36.83 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.969 0.89 . . . . 0.0 112.688 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.07 73.23 1.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.596 1.558 . . . . 0.0 108.837 166.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.62 -19.96 65.29 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.257 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.65 -49.67 65.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.688 -1.258 . . . . 0.0 111.19 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -83.34 -13.79 54.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.7 40.15 12.9 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.844 1.211 . . . . 0.0 112.713 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -146.52 172.19 13.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.76 1.28 . . . . 0.0 112.38 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 50.6 m -139.35 153.31 47.67 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.881 0.872 . . . . 0.0 109.805 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.5 mt -110.73 133.93 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.1 119.16 25.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.517 1.053 . . . . 0.0 111.915 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.05 127.99 14.28 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.915 2.41 . . . . 0.0 110.96 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 42.4 mtm -61.14 -30.38 70.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.576 1.15 . . . . 0.0 113.451 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -65.82 -20.34 66.21 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 11.57 22.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.049 2.14 . . . . 0.0 113.184 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 45.0 mt -92.83 145.44 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.223 1.009 . . . . 0.0 111.316 167.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.1 p -79.76 177.33 8.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.22 -44.39 88.45 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.554 -0.717 . . . . 0.0 111.492 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.05 93.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.948 0.899 . . . . 0.0 112.05 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -63.24 1.26 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.668 1.187 . . . . 0.0 111.405 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.16 -35.0 72.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.128 0.971 . . . . 0.0 111.027 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -56.89 -51.61 68.4 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.197 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -64.56 -41.01 96.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.726 1.603 . . . . 0.0 111.854 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 15.5 m -51.51 -32.6 28.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.016 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.24 -37.93 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.7 t -101.47 -6.68 23.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.649 1.58 . . . . 0.0 114.031 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.4 ' HB2' ' H ' ' A' ' 461' ' ' ASP . . . -57.51 146.52 29.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.169 0.985 . . . . 0.0 112.41 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.88 -50.07 11.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.657 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -98.52 140.3 32.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.603 0.761 . . . . 0.0 111.481 159.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.54 -159.03 48.64 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.695 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 68.5 -168.51 42.51 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 47.4 p -96.14 10.05 38.93 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t 65.83 23.99 11.37 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.877 -1.14 . . . . 0.0 113.495 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.66 65.27 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.672 1.606 . . . . 0.0 114.145 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.73 150.76 96.59 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 118.926 1.363 . . . . 0.0 110.948 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 144.32 79.66 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.861 2.374 . . . . 0.0 110.689 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.7 112.3 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.556 . . . . 0.0 109.568 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.42 157.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.741 1.616 . . . . 0.0 110.279 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 92.3 m -53.59 127.14 24.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 109.81 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 92.08 -5.7 78.66 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.77 -1.017 . . . . 0.0 115.293 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.83 137.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.265 1.532 . . . . 0.0 111.676 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 137.0 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.435 1.894 . . . . 0.0 109.454 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.34 172.93 17.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.341 1.056 . . . . 0.0 112.187 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.51 148.87 25.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.74 1.216 . . . . 0.0 111.525 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.81 129.93 20.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.25 147.72 48.21 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.878 2.385 . . . . 0.0 110.417 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 441' ' ' ALA . 80.1 m-20 -61.78 147.57 45.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 0.0 114.039 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.8 mm -107.37 48.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.734 1.613 . . . . 0.0 109.671 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp -57.32 169.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.58 137.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.7 t -139.57 -47.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.886 -1.134 . . . . 0.0 111.085 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.21 -53.82 4.65 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.478 1.037 . . . . 0.0 111.942 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.43 151.2 7.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.266 1.426 . . . . 0.0 111.217 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -132.19 161.92 23.91 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.598 1.57 . . . . 0.0 113.264 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.297 1.439 . . . . 0.0 111.665 -179.41 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.4 pt -130.07 43.51 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 125.456 1.503 . . . . 0.0 112.358 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.02 -165.77 53.64 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.562 -0.711 . . . . 0.0 111.825 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -165.2 158.97 14.24 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.205 1.402 . . . . 0.0 111.372 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -69.26 170.77 15.21 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.146 3.231 . . . . 0.0 112.666 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -74.94 -0.8 19.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.546 1.139 . . . . 0.0 114.065 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 72.16 5.84 5.4 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.021 2.128 . . . . 0.0 113.027 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -172.82 -35.2 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.412 2.285 . . . . 0.0 112.705 -175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 48.58 67.56 0.84 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.921 1.688 . . . . 0.0 112.222 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.36 -11.22 52.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.781 1.181 . . . . 0.0 115.126 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 18.8 m -62.54 -46.12 89.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.603 1.561 . . . . 0.0 112.404 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 176.55 -38.53 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.808 2.043 . . . . 0.0 112.612 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.92 168.58 19.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.982 0.913 . . . . 0.0 112.026 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -143.29 15.05 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -167.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -81.69 136.52 35.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.358 1.063 . . . . 0.0 113.446 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.79 2.42 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.984 1.714 . . . . 0.0 113.026 171.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -141.07 162.32 48.75 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.25 1.42 . . . . 0.0 111.815 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -68.82 -169.87 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.638 3.559 . . . . 0.0 112.037 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -72.6 60.65 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.003 1.321 . . . . 0.0 111.509 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.38 150.59 46.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.388 . . . . 0.0 112.438 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 142.2 38.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.84 1.656 . . . . 0.0 109.426 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -79.35 66.67 4.87 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.842 -1.161 . . . . 0.0 110.23 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.78 152.88 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.357 2.263 . . . . 0.0 111.105 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 85.6 p -62.05 -25.67 67.81 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -71.3 -25.18 62.32 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.76 0.824 . . . . 0.0 112.834 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -76.31 122.54 86.96 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.389 1.076 . . . . 0.0 109.956 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.86 -19.4 52.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.386 2.057 . . . . 0.0 112.825 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -76.65 3.37 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 170.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.72 132.66 31.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.881 1.219 . . . . 0.0 111.894 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.28 146.94 60.11 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 124.502 1.121 . . . . 0.0 109.949 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.26 161.97 40.67 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.773 2.316 . . . . 0.0 110.621 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.17 79.4 1.58 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 165.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.79 126.64 13.52 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.492 2.128 . . . . 0.0 108.606 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.49 116.33 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.206 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.75 167.37 10.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 0.0 110.868 172.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -141.57 124.55 16.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.256 1.023 . . . . 0.0 109.619 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -122.73 114.01 19.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.645 0.778 . . . . 0.0 110.403 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -69.48 -8.64 48.71 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -22.77 66.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.452 171.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.62 150.99 93.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.655 0.782 . . . . 0.0 111.862 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.46 161.66 33.99 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.874 3.049 . . . . 0.0 112.77 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.59 131.62 17.65 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.945 3.097 . . . . 0.0 112.461 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 64.5 45.83 3.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.873 2.069 . . . . 0.0 111.659 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -125.8 152.51 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 17.1 pt -125.21 144.39 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.078 1.751 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.74 54.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.028 1.331 . . . . 0.0 110.378 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.64 105.99 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.055 0.942 . . . . 0.0 110.908 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -72.18 134.82 45.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.562 1.145 . . . . 0.0 111.847 167.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.6 t -76.9 136.49 38.83 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.213 -0.929 . . . . 0.0 111.732 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.4 mtm105 -103.43 15.88 27.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.529 1.932 . . . . 0.0 109.954 163.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 87.3 m -117.48 132.54 56.53 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.714 1.606 . . . . 0.0 110.673 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.29 136.76 38.01 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.185 1.394 . . . . 0.0 108.856 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -92.38 138.83 31.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 26.7 mm -124.26 108.31 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -171.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.69 174.29 46.23 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 165.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.75 30.07 70.78 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.844 -0.798 . . . . 0.0 114.146 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 91.4 t -90.38 109.39 33.38 Favored Pre-proline 0 N--CA 1.478 0.946 0 CA-C-N 118.25 1.025 . . . . 0.0 110.69 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.33 141.97 48.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.401 2.067 . . . . 0.0 110.107 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.04 -17.82 62.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.49 -35.04 79.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.064 0.946 . . . . 0.0 112.617 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 ptp -86.73 152.67 22.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -130.8 -174.44 3.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.229 1.812 . . . . 0.0 111.644 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -55.76 -39.14 70.78 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.176 1.39 . . . . 0.0 112.796 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.98 -23.05 58.21 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.19 -39.13 65.83 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.236 0.926 . . . . 0.0 110.571 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.18 -51.78 68.53 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.547 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.87 67.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.713 173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -46.95 64.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.939 1.245 . . . . 0.0 113.583 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.99 -33.56 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.12 0.873 . . . . 0.0 110.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' A' ' 379' ' ' VAL . 31.0 mt -87.45 -8.05 56.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.367 1.067 . . . . 0.0 113.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -48.67 -49.08 67.66 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.613 1.565 . . . . 0.0 114.988 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.36 -6.46 17.15 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.028 1.819 . . . . 0.0 113.262 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -98.14 -38.53 9.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.465 1.506 . . . . 0.0 112.54 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.8 168.42 5.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.47 1.908 . . . . 0.0 112.537 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.14 136.87 32.77 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.658 0.783 . . . . 0.0 110.051 169.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.89 134.95 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.623 1.169 . . . . 0.0 109.986 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.59 -35.19 9.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.51 150.13 30.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.528 1.058 . . . . 0.0 111.982 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.9 t -146.32 139.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.15 102.39 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.9 tt -97.46 130.72 44.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.918 0.887 . . . . 0.0 109.635 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.68 91.03 3.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.263 1.025 . . . . 0.0 110.085 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.41 -40.23 90.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 111.513 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.7 t -65.17 -25.36 67.69 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.213 1.405 . . . . 0.0 112.938 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -0.67 41.62 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.486 1.515 . . . . 0.0 112.918 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 27.85 16.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.963 1.305 . . . . 0.0 113.772 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.84 170.41 15.89 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.3 40.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.001 1.321 . . . . 0.0 112.314 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.22 128.32 55.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.276 1.43 . . . . 0.0 108.692 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 HG12 ' CD1' ' A' ' 359' ' ' LEU . 88.1 t -124.32 111.32 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 111.004 -173.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 112.92 25.0 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.552 1.541 . . . . 0.0 111.034 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.49 163.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.91 0.884 . . . . 0.0 110.357 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.51 -26.65 63.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.7 p -134.9 155.28 50.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.158 0.98 . . . . 0.0 113.165 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -41.83 92.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.009 0.923 . . . . 0.0 111.35 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -65.63 -36.68 84.4 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.906 -0.497 . . . . 0.0 111.452 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -59.51 -51.26 70.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.517 0.727 . . . . 0.0 111.116 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.77 94.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.635 0.652 . . . . 0.0 111.945 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.81 -43.26 98.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.219 0.608 . . . . 0.0 112.053 171.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -64.38 -34.22 77.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.398 0.999 . . . . 0.0 112.358 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.48 -63.18 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.083 167.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.38 -36.39 43.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.717 1.207 . . . . 0.0 114.036 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.75 -35.34 80.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.99 1.316 . . . . 0.0 113.034 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.23 -25.45 9.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -174.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.77 122.89 22.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.361 0.664 . . . . 0.0 111.528 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 62.44 29.32 17.14 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 114.022 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.62 -31.33 68.0 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -84.8 -16.81 40.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.794 1.638 . . . . 0.0 114.076 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.42 73.74 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.794 1.188 . . . . 0.0 114.114 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.62 -34.2 35.23 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.112 1.456 . . . . 0.0 114.853 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.55 148.56 80.14 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.156 0.982 . . . . 0.0 109.871 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.45 -29.1 13.97 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.717 2.278 . . . . 0.0 112.408 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.61 151.27 42.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.966 1.307 . . . . 0.0 111.778 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 104.74 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.767 0.827 . . . . 0.0 110.681 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.2 m -85.58 121.52 28.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.189 1.396 . . . . 0.0 109.746 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -129.13 178.04 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.628 1.971 . . . . 0.0 108.862 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -72.25 126.3 29.46 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.19 -0.943 . . . . 0.0 111.305 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.01 -156.95 19.37 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 165.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.97 136.72 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 117.117 0.459 . . . . 0.0 111.887 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.99 -44.79 3.75 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.683 1.611 . . . . 0.0 110.464 163.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.48 113.96 18.17 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.018 0.909 . . . . 0.0 113.053 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.82 139.59 4.31 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.92 129.25 15.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.006 3.804 . . . . 0.0 109.974 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -63.49 -38.25 90.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.319 0.648 . . . . 0.0 112.294 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.1 -24.9 66.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.078 1.751 . . . . 0.0 113.345 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 71.8 m -127.35 31.19 5.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.158 1.783 . . . . 0.0 111.277 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.4 t -85.01 140.76 30.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.031 1.333 . . . . 0.0 111.685 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.4 75.82 1.5 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.716 1.606 . . . . 0.0 109.124 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -63.08 -16.49 60.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -70.35 -49.1 52.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.672 1.124 . . . . 0.0 111.023 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -83.81 -16.07 45.98 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.48 38.09 11.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.841 1.21 . . . . 0.0 113.163 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -143.09 174.65 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.338 1.069 . . . . 0.0 112.49 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.3 p -146.27 153.85 41.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.536 1.134 . . . . 0.0 109.964 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.2 mt -114.32 131.14 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.83 123.12 28.1 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 119.433 1.015 . . . . 0.0 111.479 -171.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -69.55 132.03 22.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.69 2.26 . . . . 0.0 111.003 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.53 -32.03 72.9 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 113.236 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.87 -22.44 66.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.7 7.3 37.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.31 1.844 . . . . 0.0 112.636 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 74.6 mt -92.29 142.15 27.78 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.293 1.437 . . . . 0.0 110.969 169.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.8 p -80.05 174.97 11.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.9 1.28 . . . . 0.0 111.048 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.47 -38.99 91.99 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.639 -0.663 . . . . 0.0 111.747 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.53 80.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.026 0.93 . . . . 0.0 112.205 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.82 -54.57 45.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.414 1.086 . . . . 0.0 112.141 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -68.44 -34.31 75.74 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -52.94 -51.78 60.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.243 1.017 . . . . 0.0 111.202 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -68.26 -42.2 79.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.437 1.472 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.2 m -55.52 -30.02 59.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.067 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.7 m -97.84 -40.85 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.4 t -103.13 -9.81 19.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -165.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.62 146.03 37.56 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.906 -1.121 . . . . 0.0 111.581 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -74.79 -52.41 11.53 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.795 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -96.11 133.81 39.92 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.003 0.906 . . . . 0.0 110.984 166.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 -171.26 44.31 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.828 -174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.67 -163.5 54.28 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 115.242 -0.479 . . . . 0.0 112.295 -169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 44.4 p -103.55 11.7 35.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -162.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.62 21.2 5.48 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.792 -1.192 . . . . 0.0 113.064 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.23 4.63 77.41 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 120.768 -1.208 . . . . 0.0 113.874 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -66.42 154.18 91.3 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.591 1.195 . . . . 0.0 110.373 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.1 142.45 80.78 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.151 1.901 . . . . 0.0 110.199 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 50.2 mt -67.67 120.33 13.87 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.53 155.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.304 1.441 . . . . 0.0 109.802 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -59.69 131.82 52.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.067 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.64 -5.78 83.47 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.422 -1.21 . . . . 0.0 115.186 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.8 tt -61.39 143.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.598 1.699 . . . . 0.0 112.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.21 137.0 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.542 1.937 . . . . 0.0 109.33 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -160.63 177.27 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 0.0 112.149 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -95.89 149.47 21.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.714 1.206 . . . . 0.0 111.06 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.91 135.85 56.71 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -162.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.25 153.38 40.56 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.858 2.372 . . . . 0.0 110.786 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.66 142.03 58.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.453 1.101 . . . . 0.0 113.577 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.97 48.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.335 1.54 . . . . 0.0 110.334 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.93 168.82 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.84 138.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.29 -54.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 121.028 -1.045 . . . . 0.0 110.382 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.6 -71.78 2.88 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.526 1.06 . . . . 0.0 111.706 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -163.25 162.18 25.17 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.135 1.774 . . . . 0.0 111.531 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.39 175.52 47.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.418 1.485 . . . . 0.0 112.878 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.876 1.67 . . . . 0.0 112.162 177.746 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.396 0.141 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.09 123.56 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.735 1.214 . . . . 0.0 108.651 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 95.96 146.37 20.77 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.873 1.225 . . . . 0.0 113.372 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -91.15 165.56 21.23 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.845 1.658 . . . . 0.0 111.314 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.5 -157.57 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 123.574 2.85 . . . . 0.0 111.744 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.99 -28.06 67.38 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.645 -1.284 . . . . 0.0 113.883 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 82.5 p 48.66 26.65 1.28 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.386 2.675 . . . . 0.0 114.225 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -76.67 -24.2 53.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.29 1.036 . . . . 0.0 112.668 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -47.91 128.94 14.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.421 1.489 . . . . 0.0 113.634 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 110.88 151.93 12.57 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.437 1.018 . . . . 0.0 112.1 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 3.5 m 61.91 53.81 2.99 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.665 1.586 . . . . 0.0 111.233 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 57.72 52.77 7.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.503 1.521 . . . . 0.0 112.392 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -152.42 138.43 18.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.912 . . . . 0.0 111.9 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -151.68 9.88 0.54 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -78.11 140.81 39.06 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.005 -1.06 . . . . 0.0 112.19 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.42 -10.91 58.12 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 112.154 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.72 155.37 52.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 126.255 1.822 . . . . 0.0 111.57 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.47 160.36 36.06 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.575 2.85 . . . . 0.0 112.141 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -76.86 66.22 2.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.502 1.144 . . . . 0.0 110.413 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.93 -173.11 1.16 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.376 2.67 . . . . 0.0 113.108 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.85 129.2 55.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.214 -0.928 . . . . 0.0 111.034 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -78.74 69.28 4.89 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.32 -0.863 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 32.8 t -119.95 147.5 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 127.058 2.143 . . . . 0.0 110.273 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.3 p -58.14 -25.83 61.94 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.033 0.833 . . . . 0.0 112.604 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -81.23 122.77 81.68 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.776 1.23 . . . . 0.0 109.83 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 -17.26 52.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.589 2.193 . . . . 0.0 113.204 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -74.04 -0.96 18.03 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -51.92 127.69 21.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.618 1.099 . . . . 0.0 111.447 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.81 145.01 48.43 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 110.24 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.02 144.3 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.459 2.772 . . . . 0.0 111.004 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 83.67 0.77 Allowed Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 165.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.89 113.61 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.296 1.997 . . . . 0.0 108.624 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.3 116.44 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.5 168.45 12.11 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.273 1.429 . . . . 0.0 110.757 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.72 127.27 21.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 110.089 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -122.67 106.62 11.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.926 0.869 . . . . 0.0 111.291 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -10.45 40.39 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.341 1.456 . . . . 0.0 113.674 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 73.0 p -70.82 -22.98 62.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.68 1.592 . . . . 0.0 112.183 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.06 150.29 92.42 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.157 0.983 . . . . 0.0 111.792 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.84 161.5 36.05 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.182 3.254 . . . . 0.0 112.971 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.99 137.11 36.87 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.065 3.176 . . . . 0.0 112.692 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 67.82 24.17 8.26 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.157 1.783 . . . . 0.0 113.134 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -107.94 152.57 24.27 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.818 -1.177 . . . . 0.0 113.825 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.85 144.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 126.238 1.815 . . . . 0.0 110.389 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 128.55 54.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 0.0 111.084 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.11 106.7 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.567 0.747 . . . . 0.0 111.097 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.78 130.12 42.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.42 1.088 . . . . 0.0 111.228 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.6 t -69.69 135.91 50.41 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.852 -0.53 . . . . 0.0 111.594 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -104.48 16.14 26.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.576 1.55 . . . . 0.0 110.858 164.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 21.8 m -123.66 136.19 54.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.286 1.434 . . . . 0.0 112.122 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.61 139.37 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.19 1.396 . . . . 0.0 109.951 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -92.29 139.65 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.79 108.83 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.589 1.156 . . . . 0.0 107.916 -171.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -92.4 -175.9 41.83 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.67 15.9 69.25 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.707 -0.878 . . . . 0.0 114.256 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.4 120.01 79.33 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 118.744 1.272 . . . . 0.0 110.187 -167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 139.42 38.36 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.144 1.896 . . . . 0.0 109.923 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.9 pp -61.82 -18.84 61.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.7 -23.82 49.38 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.3 ptp -87.24 148.47 25.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -125.61 -177.22 3.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.978 1.711 . . . . 0.0 111.908 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -47.15 -42.46 19.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.593 1.957 . . . . 0.0 114.243 174.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.69 -22.05 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.76 -37.06 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.149 0.886 . . . . 0.0 110.852 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -56.84 -51.24 69.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.387 0.54 . . . . 0.0 110.011 168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.94 80.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.015 0.825 . . . . 0.0 112.806 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -66.76 -39.88 88.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.296 1.407 . . . . 0.0 113.097 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.02 -32.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.733 1.151 . . . . 0.0 111.702 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 56.5 mt -86.88 -12.32 48.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.559 1.144 . . . . 0.0 113.88 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -48.89 -47.91 72.56 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.57 -6.22 17.42 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.145 1.897 . . . . 0.0 113.199 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -100.27 -39.12 8.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.397 1.479 . . . . 0.0 112.693 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.48 170.75 4.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.623 . . . . 0.0 114.161 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -81.28 135.16 35.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.556 1.143 . . . . 0.0 110.965 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 88.6 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.744 1.218 . . . . 0.0 110.19 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -91.34 -45.02 8.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.841 1.256 . . . . 0.0 112.46 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.01 149.26 29.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.848 0.859 . . . . 0.0 110.86 -171.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.02 131.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.909 0.777 . . . . 0.0 110.858 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.33 99.39 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.57 145.76 24.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.881 0.872 . . . . 0.0 110.486 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -137.1 89.57 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.556 1.142 . . . . 0.0 110.214 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -61.41 -32.03 71.97 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.238 -0.914 . . . . 0.0 112.061 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.8 t -60.94 -31.64 71.18 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.807 1.243 . . . . 0.0 112.694 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -96.14 -3.81 43.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 113.525 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 60.03 31.31 20.57 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.671 1.589 . . . . 0.0 113.107 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -136.29 170.27 16.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.2 162.99 36.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.963 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -118.33 128.69 54.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.559 1.544 . . . . 0.0 108.268 165.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.15 109.8 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.974 0.909 . . . . 0.0 110.423 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -85.59 117.46 24.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 109.934 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.62 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 165.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.89 -19.1 57.85 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.98 154.78 46.19 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.115 0.871 . . . . 0.0 113.174 -176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -62.99 -41.52 99.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.731 0.812 . . . . 0.0 111.577 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -63.12 -38.64 92.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.859 0.464 . . . . 0.0 110.848 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.22 -49.51 75.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.542 1.137 . . . . 0.0 111.431 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.93 97.91 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.864 -0.523 . . . . 0.0 112.139 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -64.88 -42.66 94.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.655 0.782 . . . . 0.0 111.899 171.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.29 -34.8 78.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.188 0.904 . . . . 0.0 112.045 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.3 -63.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.894 165.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.85 -32.63 53.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -65.07 -31.78 73.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.996 1.319 . . . . 0.0 113.466 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -120.18 -28.97 4.97 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -74.33 125.47 28.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.64 20.15 11.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.308 1.443 . . . . 0.0 114.164 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.34 65.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -111.13 4.26 19.19 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.577 2.351 . . . . 0.0 112.796 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 75.21 32.59 55.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.315 0.959 . . . . 0.0 113.368 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.69 59.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.77 161.68 36.73 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.061 1.345 . . . . 0.0 110.172 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.97 -7.09 18.04 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.574 2.849 . . . . 0.0 113.901 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.96 166.04 8.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.139 2.176 . . . . 0.0 112.441 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 90.1 2.49 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.0 110.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 127.98 34.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.425 1.49 . . . . 0.0 111.209 -172.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.26 170.37 15.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.257 1.823 . . . . 0.0 108.808 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -68.52 126.64 30.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.419 -0.801 . . . . 0.0 110.579 164.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.39 -152.25 17.87 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.5 136.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 117.564 0.682 . . . . 0.0 111.68 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -89.92 -48.72 3.54 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 166.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -129.26 120.29 25.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.896 0.848 . . . . 0.0 111.811 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 178.74 140.87 4.11 Favored Glycine 0 CA--C 1.542 1.746 0 CA-C-O 119.153 -0.804 . . . . 0.0 114.635 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -70.5 133.72 24.83 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.827 3.684 . . . . 0.0 110.181 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -67.12 -35.37 79.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.995 0.426 . . . . 0.0 111.904 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.07 -26.34 66.68 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.457 1.903 . . . . 0.0 113.403 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.1 m -126.78 31.82 5.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.379 1.872 . . . . 0.0 111.054 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.57 138.35 33.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.425 1.49 . . . . 0.0 111.033 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.32 77.83 1.6 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.22 1.408 . . . . 0.0 109.292 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -62.84 -19.76 64.42 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.362 -0.836 . . . . 0.0 113.133 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.96 -47.25 66.11 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.123 1.329 . . . . 0.0 111.194 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -83.23 -16.08 47.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.98 38.32 11.55 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.805 1.193 . . . . 0.0 112.919 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -146.37 169.88 17.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.931 1.366 . . . . 0.0 112.809 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.2 m -137.68 151.3 48.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.824 0.85 . . . . 0.0 110.631 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.24 130.38 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.28 115.78 28.63 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 119.493 1.042 . . . . 0.0 111.15 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -69.71 130.33 19.21 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.065 2.51 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 30.0 mtt -59.84 -32.28 70.53 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.939 1.296 . . . . 0.0 113.243 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -65.08 -22.41 66.96 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.213 0.915 . . . . 0.0 113.039 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -105.14 8.16 34.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.87 1.668 . . . . 0.0 113.601 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.8 146.68 23.56 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.29 1.036 . . . . 0.0 111.784 169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.7 p -83.41 174.45 10.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.727 1.211 . . . . 0.0 110.805 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.2 -41.75 99.2 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.769 -0.582 . . . . 0.0 111.391 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.54 92.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.119 0.968 . . . . 0.0 111.862 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -57.59 -61.29 2.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.471 1.109 . . . . 0.0 111.626 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -57.54 -37.84 73.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 111.45 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -57.93 -45.59 86.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.927 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -66.78 -41.49 87.6 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 120.729 1.604 . . . . 0.0 112.107 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 8.3 m -54.56 -33.2 59.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.401 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 m -98.01 -48.59 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 16.7 m -89.46 -9.32 50.54 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.13 56.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.26 1.391 . . . . 0.0 112.319 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -74.98 -48.33 24.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.968 0.907 . . . . 0.0 110.511 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -101.0 121.12 41.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.212 1.006 . . . . 0.0 110.75 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 84.87 -173.88 49.32 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.426 1.489 . . . . 0.0 112.987 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.48 -159.44 53.67 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 57.0 p -100.22 8.03 44.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.103 1.361 . . . . 0.0 114.646 -163.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.02 22.4 4.55 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.934 -1.104 . . . . 0.0 112.499 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.56 3.59 71.42 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.892 1.235 . . . . 0.0 113.859 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.68 153.24 96.09 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 118.355 1.078 . . . . 0.0 110.796 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -63.87 145.95 91.02 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.551 2.167 . . . . 0.0 110.588 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.16 121.27 19.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.378 0.609 . . . . 0.0 110.005 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.4 t -110.88 152.2 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.604 1.962 . . . . 0.0 108.715 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 74.2 m -49.41 122.6 6.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.281 0.632 . . . . 0.0 110.055 165.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 86.68 1.25 85.55 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.935 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.79 131.59 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.588 1.694 . . . . 0.0 111.532 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.02 138.7 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.045 2.138 . . . . 0.0 109.302 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -161.97 179.99 7.59 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.474 1.509 . . . . 0.0 112.604 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -95.77 145.6 25.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.241 1.416 . . . . 0.0 110.421 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -47.68 128.42 10.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.63 152.07 64.56 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 111.249 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.43 147.97 34.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.443 1.097 . . . . 0.0 113.498 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.1 mm -110.79 49.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 123.251 1.501 . . . . 0.0 110.01 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.62 171.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.927 137.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.27 -58.46 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.66 -1.275 . . . . 0.0 110.762 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.64 -55.37 3.44 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.917 1.246 . . . . 0.0 111.666 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -165.03 143.26 6.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 112.138 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -96.69 -154.89 30.39 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.187 1.375 . . . . 0.0 113.447 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.258 1.503 0 C-N-CA 125.572 1.549 . . . . 0.0 113.965 176.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 45.2 mt 69.1 75.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 126.826 2.051 . . . . 0.0 109.333 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 70.59 -154.89 52.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.386 0.993 . . . . 0.0 112.818 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -113.5 158.5 38.4 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.052 1.741 . . . . 0.0 110.926 172.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.55 -158.31 0.08 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.517 3.478 . . . . 0.0 110.656 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -71.87 98.93 2.1 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.717 -1.239 . . . . 0.0 111.52 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 11.1 p -81.01 48.5 1.11 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.303 1.841 . . . . 0.0 112.487 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 6.4 t -89.05 -21.58 23.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.802 1.641 . . . . 0.0 113.536 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -55.91 -36.07 67.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.648 1.579 . . . . 0.0 113.612 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.84 3.82 86.73 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.871 1.701 . . . . 0.0 114.334 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 54.7 m -117.02 -76.23 0.57 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.817 1.647 . . . . 0.0 110.891 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -164.85 -52.94 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -83.12 -177.49 6.78 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.553 0.741 . . . . 0.0 111.119 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -142.4 4.32 1.57 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -169.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -62.71 136.78 58.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.369 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.0 mp -82.13 -63.94 1.28 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -82.88 127.99 67.5 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.264 0.626 . . . . 0.0 110.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.44 172.89 13.88 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.896 3.064 . . . . 0.0 111.391 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 64.63 25.06 13.07 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.697 1.599 . . . . 0.0 113.094 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.5 110.96 9.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.967 0.907 . . . . 0.0 112.438 -160.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 126.02 15.22 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.533 1.533 . . . . 0.0 110.719 -172.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -78.84 65.81 4.15 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 121.386 -0.821 . . . . 0.0 111.96 -170.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.37 151.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.901 2.481 . . . . 0.0 111.053 -170.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 48.3 t -53.36 -36.78 61.73 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.791 1.236 . . . . 0.0 114.138 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -78.2 -0.17 27.45 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.65 124.73 38.05 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.552 1.541 . . . . 0.0 111.009 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.74 -21.56 58.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.458 2.772 . . . . 0.0 113.556 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -75.53 -4.49 40.15 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.74 131.6 25.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.725 1.21 . . . . 0.0 111.863 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.85 154.11 68.29 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.278 1.031 . . . . 0.0 109.722 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -65.27 168.42 14.33 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 110.91 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 83.37 60.72 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.21 1.404 . . . . 0.0 107.325 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 137.61 30.94 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.176 2.584 . . . . 0.0 109.052 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.8 t -138.72 136.14 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.389 1.076 . . . . 0.0 108.751 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 172.01 13.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.956 0.902 . . . . 0.0 110.806 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.12 120.1 22.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.596 1.158 . . . . 0.0 109.667 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -117.83 108.54 15.46 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.808 1.643 . . . . 0.0 110.633 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 62.7 p -70.77 -3.57 19.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.926 1.291 . . . . 0.0 114.169 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -69.86 -19.85 63.42 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.266 1.026 . . . . 0.0 112.786 173.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.43 151.57 94.04 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.043 0.937 . . . . 0.0 112.361 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.31 160.79 33.46 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.9 3.067 . . . . 0.0 112.529 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.83 133.83 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 112.376 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 64.4 36.0 9.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.759 2.024 . . . . 0.0 112.511 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.93 152.49 38.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.8 pt -125.04 149.53 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.596 1.958 . . . . 0.0 112.111 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 111.19 23.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.445 1.498 . . . . 0.0 110.54 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 108.78 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.147 0.885 . . . . 0.0 111.884 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -72.03 135.02 46.21 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.856 1.262 . . . . 0.0 111.437 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.7 t -71.48 137.83 48.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.607 -0.683 . . . . 0.0 112.036 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -105.37 17.48 23.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.934 1.694 . . . . 0.0 110.447 160.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 57.3 m -120.8 138.95 53.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.727 1.611 . . . . 0.0 111.487 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 21.5 mt -105.71 132.14 52.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.046 2.138 . . . . 0.0 108.556 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -89.89 123.85 34.19 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 30.4 mm -114.38 109.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.841 0.857 . . . . 0.0 109.088 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.47 175.58 49.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.815 0.722 . . . . 0.0 112.07 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.14 13.57 70.21 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.29 0.948 . . . . 0.0 115.086 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.28 121.8 84.36 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-N 118.459 1.129 . . . . 0.0 110.452 -167.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.5 134.7 22.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.794 2.33 . . . . 0.0 109.633 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.16 -18.82 63.88 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.21 -33.29 75.47 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.592 1.157 . . . . 0.0 112.948 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -86.62 157.97 19.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -133.89 -177.7 4.68 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.064 1.746 . . . . 0.0 111.761 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -55.81 -35.73 66.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.36 1.464 . . . . 0.0 112.856 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -74.96 -25.21 58.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.53 -34.99 65.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.371 0.987 . . . . 0.0 110.616 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.02 -48.86 79.97 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.232 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.5 78.15 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.437 1.017 . . . . 0.0 112.466 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.42 -40.66 85.56 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.848 1.204 . . . . 0.0 112.92 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.37 -36.59 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.176 0.898 . . . . 0.0 112.192 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 67.7 mt -84.42 -13.15 52.95 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -46.05 -49.51 40.0 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 126.529 1.932 . . . . 0.0 115.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.2 -8.19 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.137 1.891 . . . . 0.0 113.705 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -97.24 -41.22 8.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.547 1.539 . . . . 0.0 112.155 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.65 172.52 4.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.672 1.589 . . . . 0.0 113.312 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -91.17 135.11 34.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.495 1.118 . . . . 0.0 111.074 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.6 131.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.146 1.378 . . . . 0.0 110.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -93.74 -42.89 8.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.081 1.352 . . . . 0.0 112.609 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 30.6 t -156.79 150.86 25.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 109.948 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -149.25 134.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.466 0.707 . . . . 0.0 109.823 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.44 107.79 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 166.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.9 tt -102.37 118.11 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 0.0 110.865 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -106.33 81.64 1.64 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.004 1.722 . . . . 0.0 109.223 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.66 -34.16 61.79 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.605 1.562 . . . . 0.0 111.411 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -60.66 -30.83 70.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.489 1.916 . . . . 0.0 113.632 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 3.32 20.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.239 1.416 . . . . 0.0 113.196 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 61.65 36.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.099 1.759 . . . . 0.0 111.57 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -124.1 154.25 40.26 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.857 2.063 . . . . 0.0 113.3 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.72 135.39 34.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.618 1.167 . . . . 0.0 111.772 161.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.64 121.19 29.75 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 160.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.71 119.46 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.127 0.971 . . . . 0.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -96.96 128.8 44.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.364 1.065 . . . . 0.0 111.213 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.83 165.7 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.452 1.101 . . . . 0.0 110.196 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -69.95 -14.58 62.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -170.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.98 159.16 40.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.546 -1.346 . . . . 0.0 113.256 -176.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -41.58 99.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.986 0.914 . . . . 0.0 109.87 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -64.97 -36.71 85.28 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.493 -0.754 . . . . 0.0 112.203 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -56.19 -53.18 60.22 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.932 0.787 . . . . 0.0 109.409 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.71 97.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.524 0.73 . . . . 0.0 112.819 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.57 -42.73 99.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.115 0.566 . . . . 0.0 111.352 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -67.86 -31.56 71.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.581 1.082 . . . . 0.0 112.368 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.9 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.918 164.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.2 -33.67 63.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.716 1.206 . . . . 0.0 114.145 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.36 -23.77 65.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.577 1.551 . . . . 0.0 113.995 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -122.14 -26.62 4.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.67 121.93 21.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.817 0.818 . . . . 0.0 112.276 -166.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 28.8 t30 59.25 28.79 18.21 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.349 1.86 . . . . 0.0 115.089 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -56.71 -32.5 65.57 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.34 -8.79 31.66 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 114.698 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 6.78 65.45 Favored Glycine 0 CA--C 1.548 2.142 0 C-N-CA 125.195 1.379 . . . . 0.0 114.899 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -70.44 -36.52 74.01 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.75 151.64 71.29 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.849 0.859 . . . . 0.0 110.608 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.69 -26.77 9.53 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.643 2.229 . . . . 0.0 112.204 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.71 150.4 41.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.751 1.22 . . . . 0.0 111.723 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -120.59 92.14 3.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.841 1.256 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -74.43 119.99 19.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.104 0.961 . . . . 0.0 110.527 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 170.28 12.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.2 2.2 . . . . 0.0 108.882 172.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -65.77 131.67 46.87 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.169 -0.957 . . . . 0.0 111.013 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.7 -154.99 12.95 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 164.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 132.75 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.057 0.429 . . . . 0.0 112.1 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.14 -50.72 3.56 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -124.17 114.79 20.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.918 0.887 . . . . 0.0 113.036 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.26 143.72 3.97 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 118.704 -1.053 . . . . 0.0 114.846 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.85 144.54 30.95 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.856 3.704 . . . . 0.0 110.032 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -69.24 -30.57 68.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.636 0.774 . . . . 0.0 112.071 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.67 -33.5 72.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.459 2.303 . . . . 0.0 113.309 -175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.8 m -123.89 34.86 4.96 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.041 2.136 . . . . 0.0 111.211 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.2 139.75 34.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.876 1.671 . . . . 0.0 111.74 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.75 77.8 1.81 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.757 1.623 . . . . 0.0 109.047 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -65.4 -10.53 34.4 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -75.03 -48.25 24.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.249 0.931 . . . . 0.0 110.056 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -84.0 -11.11 57.29 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.62 42.36 21.96 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.045 1.307 . . . . 0.0 112.936 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.36 169.55 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 113.291 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.2 m -137.96 152.37 48.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.897 0.879 . . . . 0.0 111.09 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.1 mm -105.43 119.1 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.42 120.42 42.82 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 120.388 1.449 . . . . 0.0 110.331 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.77 146.87 26.97 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.16 -26.98 68.63 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -65.45 -21.46 66.65 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.985 1.266 . . . . 0.0 113.302 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -97.83 0.2 46.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.095 1.758 . . . . 0.0 113.394 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.63 122.66 34.4 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.147 0.979 . . . . 0.0 110.082 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 33.7 p -76.32 179.46 5.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.14 1.376 . . . . 0.0 111.667 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -39.55 91.42 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.651 -0.655 . . . . 0.0 111.601 170.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.092 0.957 . . . . 0.0 111.975 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.27 -52.18 65.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.775 1.63 . . . . 0.0 112.172 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -61.66 -40.89 96.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.928 0.891 . . . . 0.0 111.318 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.86 -36.21 83.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.201 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -68.21 -44.9 74.74 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.574 1.534 . . . . 0.0 110.837 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.3 m -54.08 -37.51 64.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.516 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.13 -46.4 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.9 t -96.0 -8.99 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -162.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.456 ' HB2' ' H ' ' A' ' 461' ' ' ASP . . . -58.77 147.98 31.36 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.187 -0.945 . . . . 0.0 111.951 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.78 -38.55 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.33 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -103.55 135.58 44.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.83 1.252 . . . . 0.0 110.209 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 60.61 -159.02 27.03 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.387 -170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 63.64 -154.15 46.08 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.9 p -106.63 1.02 24.87 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -164.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.8 t 69.42 24.68 5.68 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.932 1.293 . . . . 0.0 112.095 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.74 9.86 63.82 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.058 1.313 . . . . 0.0 114.132 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -81.14 141.34 50.05 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.185 0.992 . . . . 0.0 110.822 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.24 112.23 2.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.966 2.444 . . . . 0.0 109.0 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.76 37.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.451 0.643 . . . . 0.0 112.012 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.5 m -122.98 171.29 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.004 1.722 . . . . 0.0 111.578 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 87.3 m -49.7 123.08 7.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.33 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 103.2 -14.6 55.12 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.725 -1.042 . . . . 0.0 115.096 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.5 tp -52.79 130.76 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.484 1.642 . . . . 0.0 111.532 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.87 131.38 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.145 2.178 . . . . 0.0 108.326 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.2 177.65 11.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.805 1.242 . . . . 0.0 112.605 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -99.74 154.01 18.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.709 1.604 . . . . 0.0 110.0 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.85 132.56 28.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -164.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.05 154.11 71.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.12 1.88 . . . . 0.0 110.631 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . 0.456 ' H ' ' HB2' ' A' ' 441' ' ' ALA . 73.2 m-20 -59.14 129.23 41.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.56 1.544 . . . . 0.0 113.348 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.65 55.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 123.308 1.528 . . . . 0.0 110.593 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.81 -176.6 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.53 146.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.61 -49.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.025 -1.047 . . . . 0.0 112.652 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.5 18.12 73.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 119.108 0.867 . . . . 0.0 114.088 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -172.02 177.5 3.22 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.424 1.89 . . . . 0.0 110.948 -161.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 172.36 148.06 6.05 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.347 1.451 . . . . 0.0 112.542 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.252 1.192 0 C-N-CA 125.834 1.653 . . . . 0.0 110.972 -176.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.713 0.292 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.18 -24.04 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.268 -0.895 . . . . 0.0 113.396 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -171.17 -167.22 31.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 126.434 1.969 . . . . 0.0 111.326 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -153.82 157.42 32.58 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.426 1.09 . . . . 0.0 111.604 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.52 166.21 29.3 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.925 3.083 . . . . 0.0 112.544 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.92 -1.43 28.48 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.1 m 72.87 4.45 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.983 2.113 . . . . 0.0 113.108 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.23 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 128.669 2.787 . . . . 0.0 112.337 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 62.8 -148.99 0.36 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.615 1.566 . . . . 0.0 111.637 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.48 -41.59 2.1 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.225 1.393 . . . . 0.0 114.26 167.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 12.1 t -67.48 -37.26 82.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.268 1.027 . . . . 0.0 112.251 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -97.32 -78.84 0.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.261 1.424 . . . . 0.0 110.87 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.119 1.768 . . . . 0.0 110.281 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -87.65 27.13 1.17 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -159.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -70.25 138.33 51.56 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.308 1.043 . . . . 0.0 112.781 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mp -79.75 0.73 29.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.589 1.155 . . . . 0.0 113.232 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.76 161.08 65.84 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.468 1.507 . . . . 0.0 111.321 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -68.85 -172.27 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.883 3.056 . . . . 0.0 111.324 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -74.0 64.76 1.04 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.866 1.266 . . . . 0.0 111.325 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.5 169.28 17.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.609 1.964 . . . . 0.0 113.271 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.46 136.52 53.74 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.632 1.573 . . . . 0.0 111.492 -172.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -81.36 63.41 5.67 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.377 -0.827 . . . . 0.0 110.276 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 16.5 m -108.28 149.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.041 2.136 . . . . 0.0 110.669 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 78.7 p -62.22 -25.33 67.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -74.56 -20.49 59.93 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.8 0.84 . . . . 0.0 113.115 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -82.59 122.9 78.91 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.043 1.337 . . . . 0.0 109.683 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.93 -16.79 46.06 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.523 2.149 . . . . 0.0 113.112 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -72.72 1.34 8.62 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 166.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -52.87 127.11 22.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.412 1.46 . . . . 0.0 111.498 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -125.6 152.99 72.75 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.035 1.334 . . . . 0.0 110.606 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.42 158.92 55.6 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.296 2.664 . . . . 0.0 110.891 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.26 70.29 5.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 110.179 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.98 121.92 8.79 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.292 1.994 . . . . 0.0 108.994 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.37 127.69 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 109.316 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.93 163.95 28.38 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.151 1.38 . . . . 0.0 109.991 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -144.01 116.36 8.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.167 0.987 . . . . 0.0 109.34 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -121.54 107.79 12.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.069 0.938 . . . . 0.0 111.108 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -8.54 12.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.109 1.764 . . . . 0.0 113.923 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -68.31 -25.07 64.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.394 1.078 . . . . 0.0 112.651 172.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.03 150.55 96.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.63 0.772 . . . . 0.0 112.06 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.02 160.85 35.82 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.087 3.191 . . . . 0.0 112.934 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.46 134.14 27.87 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.958 3.105 . . . . 0.0 112.33 -171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.55 40.02 11.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.698 1.599 . . . . 0.0 112.298 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -121.35 151.8 39.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 172.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.3 pt -123.12 151.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.744 2.018 . . . . 0.0 110.492 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.69 126.76 55.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.494 1.518 . . . . 0.0 110.184 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.95 109.64 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.715 0.689 . . . . 0.0 111.495 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -72.97 131.7 42.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.156 1.382 . . . . 0.0 112.079 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.9 m -70.26 138.18 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.532 -0.73 . . . . 0.0 112.482 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.523 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.8 mtm105 -109.3 13.46 24.26 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.539 1.936 . . . . 0.0 110.944 164.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 32.7 m -118.97 141.89 48.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.671 1.588 . . . . 0.0 110.974 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.69 133.2 49.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.579 1.952 . . . . 0.0 108.754 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -92.59 112.86 24.96 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 165.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.4 mm -97.87 120.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 179.41 37.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.618 1.104 . . . . 0.0 111.32 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.77 60.77 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 114.751 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.3 125.64 90.65 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 118.417 1.109 . . . . 0.0 109.951 -168.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 135.53 31.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.798 2.332 . . . . 0.0 109.671 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 348' ' ' LEU . 1.9 mp -67.96 -10.83 56.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 -25.06 22.55 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.516 1.126 . . . . 0.0 112.985 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 19.4 mtm -79.91 149.02 31.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.885 0.85 . . . . 0.0 112.651 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -125.8 -176.01 3.5 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.504 1.921 . . . . 0.0 111.473 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 2.4 mp0 -49.88 -44.86 50.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.485 2.314 . . . . 0.0 113.062 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -77.34 -20.53 54.72 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.67 -37.33 59.68 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.048 0.84 . . . . 0.0 110.54 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.2 -49.55 77.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.524 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.77 -39.26 73.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.228 0.922 . . . . 0.0 112.732 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.02 -44.36 76.66 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.701 1.137 . . . . 0.0 113.587 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.09 -32.44 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 119.837 1.199 . . . . 0.0 111.725 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 62.0 mt -89.76 -10.58 45.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -46.89 -47.47 52.91 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.021 1.728 . . . . 0.0 115.37 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -6.98 16.77 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.203 1.935 . . . . 0.0 113.585 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -98.11 -39.2 9.02 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.609 1.563 . . . . 0.0 112.486 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.89 168.58 4.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.09 1.756 . . . . 0.0 113.31 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.36 129.47 34.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.856 0.862 . . . . 0.0 110.095 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.66 130.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.77 0.828 . . . . 0.0 110.206 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -95.0 -44.4 7.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.803 1.241 . . . . 0.0 112.536 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.3 m -144.13 152.63 41.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.474 1.109 . . . . 0.0 111.363 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 59.9 t -143.67 114.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.243 0.928 . . . . 0.0 110.936 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.6 93.46 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.14 129.27 45.38 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.513 0.725 . . . . 0.0 110.585 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -123.43 90.96 3.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.424 1.09 . . . . 0.0 109.932 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -58.57 -28.23 65.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.38 1.072 . . . . 0.0 112.266 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 22.7 t -56.44 -38.11 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.382 1.873 . . . . 0.0 114.178 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -107.04 6.98 29.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.867 1.267 . . . . 0.0 113.058 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 59.28 36.43 23.61 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.627 1.571 . . . . 0.0 111.412 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -124.18 164.06 20.27 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.28 33.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.759 1.224 . . . . 0.0 112.544 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.93 104.81 14.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.3 1.04 . . . . 0.0 108.654 164.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.87 100.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.111 1.364 . . . . 0.0 109.837 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -80.74 123.47 28.24 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.204 0.602 . . . . 0.0 110.277 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.53 168.01 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.346 166.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.73 -22.16 54.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.39 156.52 48.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 120.064 1.302 . . . . 0.0 113.704 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.49 -44.67 96.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.65 0.78 . . . . 0.0 112.322 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -66.46 -31.14 71.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.045 -0.41 . . . . 0.0 111.674 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.08 -53.89 42.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.755 1.222 . . . . 0.0 111.06 167.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.03 84.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.867 0.758 . . . . 0.0 112.133 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.77 -42.68 97.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.26 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -66.72 -30.69 70.98 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 120.126 1.33 . . . . 0.0 112.738 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.68 -63.56 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.736 0.698 . . . . 0.0 109.497 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.5 mt -52.25 -36.12 51.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.02 -42.95 88.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.046 1.338 . . . . 0.0 112.474 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -105.32 -23.5 12.85 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.11 123.55 24.64 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.484 -0.76 . . . . 0.0 111.489 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 61.79 29.27 17.94 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.807 1.643 . . . . 0.0 114.48 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.95 -34.69 65.91 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.804 -1.185 . . . . 0.0 113.396 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.37 -19.53 53.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.324 1.05 . . . . 0.0 113.525 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.03 70.18 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.65 1.119 . . . . 0.0 114.046 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.08 -31.53 20.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.6 1.56 . . . . 0.0 114.802 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 19.7 mt -80.62 150.78 70.53 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.351 1.06 . . . . 0.0 109.706 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.93 -32.47 7.13 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.405 2.07 . . . . 0.0 112.169 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.32 151.65 45.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.286 1.434 . . . . 0.0 111.756 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -127.94 96.38 4.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.768 1.227 . . . . 0.0 109.739 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 32.8 m -73.28 123.78 24.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.357 1.063 . . . . 0.0 110.634 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -126.52 173.63 9.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.703 2.001 . . . . 0.0 108.817 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -72.11 133.48 45.23 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.94 -1.1 . . . . 0.0 111.574 164.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.94 -153.09 9.54 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 125.777 1.656 . . . . 0.0 109.295 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.35 137.06 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.13 -52.98 2.93 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.723 1.63 . . . . 0.0 109.784 167.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.89 117.85 25.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.37 142.79 4.65 Favored Glycine 0 CA--C 1.543 1.836 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.96 130.28 15.34 Favored 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 125.746 4.297 . . . . 0.0 110.849 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -67.23 -32.09 72.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.42 -18.66 54.65 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.93 1.692 . . . . 0.0 113.83 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 77.8 m -122.9 28.73 7.11 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.586 1.555 . . . . 0.0 111.881 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.5 t -84.4 141.81 30.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.073 1.349 . . . . 0.0 111.429 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.37 80.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.779 1.631 . . . . 0.0 108.915 167.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -63.95 -20.51 65.93 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.547 -0.721 . . . . 0.0 112.904 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.32 -47.62 69.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.529 1.513 . . . . 0.0 111.266 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -83.2 -13.59 55.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.4 42.54 18.11 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.809 1.195 . . . . 0.0 112.374 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -147.27 168.74 20.97 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.026 1.413 . . . . 0.0 113.151 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.5 m -131.17 152.35 50.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.285 1.034 . . . . 0.0 110.704 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.2 mm -106.29 133.06 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.55 118.96 22.94 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 120.116 1.326 . . . . 0.0 110.981 -173.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -73.96 139.01 26.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.44 2.093 . . . . 0.0 111.121 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 10.9 mtt -63.02 -28.81 70.35 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.41 -19.29 65.88 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -104.85 3.81 31.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.562 1.945 . . . . 0.0 113.642 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.9 mt -92.05 136.32 33.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 110.395 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.2 p -79.94 178.77 7.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.514 1.126 . . . . 0.0 111.51 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.595 -0.691 . . . . 0.0 111.633 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.59 88.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.889 0.875 . . . . 0.0 112.025 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.69 -52.76 63.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.517 1.127 . . . . 0.0 112.284 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -65.56 -37.5 86.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.859 -0.526 . . . . 0.0 111.102 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -60.16 -42.17 94.39 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.78 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -66.59 -44.3 82.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.041 1.746 . . . . 0.0 111.271 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.2 m -56.59 -32.38 65.17 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.332 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.68 -39.75 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.8 m -103.26 -7.75 20.89 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -168.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.82 147.06 39.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.211 1.368 . . . . 0.0 111.604 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -77.11 -55.29 5.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.33 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -92.78 132.45 36.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.346 0.975 . . . . 0.0 110.533 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.81 179.34 10.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.015 0.817 . . . . 0.0 113.459 -173.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.67 -163.88 34.02 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 122.242 -0.563 . . . . 0.0 113.114 -168.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.1 p -109.78 7.44 24.17 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -163.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 37.4 p 76.74 15.81 1.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.972 2.109 . . . . 0.0 113.901 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.49 4.08 64.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.988 1.28 . . . . 0.0 113.352 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -66.01 138.34 96.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.901 1.28 . . . . 0.0 109.446 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -60.19 140.91 94.57 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.177 1.918 . . . . 0.0 110.176 169.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.04 130.24 43.22 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.29 159.69 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.473 1.509 . . . . 0.0 110.089 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 78.2 m -56.61 124.92 19.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.75 -2.05 76.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.593 -1.115 . . . . 0.0 115.541 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.4 tt -62.96 140.42 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.494 1.647 . . . . 0.0 112.127 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.56 136.78 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.829 2.052 . . . . 0.0 109.61 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -162.47 175.46 11.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.097 1.359 . . . . 0.0 113.104 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.72 148.69 21.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 111.397 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -51.47 126.25 29.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -168.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.78 152.84 64.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.073 2.515 . . . . 0.0 110.539 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -63.55 144.5 56.94 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.34 52.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.337 1.541 . . . . 0.0 110.133 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.37 -178.16 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.79 141.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.63 -39.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.636 -1.29 . . . . 0.0 112.904 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 83.16 -54.64 4.99 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.202 0.906 . . . . 0.0 112.063 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.68 141.93 3.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -162.72 161.72 33.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.199 1.38 . . . . 0.0 113.323 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.001 1.32 . . . . 0.0 113.377 -172.752 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.799 -0.074 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.5 pp -118.2 161.85 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.363 1.465 . . . . 0.0 110.94 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.48 110.26 0.45 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.57 1.081 . . . . 0.0 110.796 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -147.51 153.79 44.13 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.882 1.273 . . . . 0.0 110.537 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.03 173.81 8.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.898 3.065 . . . . 0.0 111.39 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -55.1 127.63 30.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 111.71 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.169 1.388 . . . . 0.0 112.949 173.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.76 60.15 1.13 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 0.0 109.391 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -32.86 -64.36 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.139 2.176 . . . . 0.0 112.671 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.89 -146.11 3.8 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.158 1.361 . . . . 0.0 113.126 169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 24.0 m 69.64 -74.98 0.08 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.266 1.827 . . . . 0.0 110.479 170.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -150.63 17.08 0.8 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 127.467 2.307 . . . . 0.0 113.246 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -153.65 156.61 38.22 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.668 -1.27 . . . . 0.0 113.259 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.1 8.74 3.22 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -166.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.0 133.32 46.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.16 0.984 . . . . 0.0 112.258 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.1 mp -81.53 -41.74 21.21 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.968 1.307 . . . . 0.0 111.116 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . 0.449 ' HB2' ' HH ' ' A' ' 382' ' ' TYR . 67.8 m-85 -116.14 65.99 2.96 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.962 0.905 . . . . 0.0 110.876 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.17 -172.99 0.97 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.2 3.267 . . . . 0.0 110.887 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 77.27 36.91 0.28 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.294 1.838 . . . . 0.0 112.5 170.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.0 159.41 39.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 112.504 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.75 162.67 18.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.665 1.186 . . . . 0.0 111.606 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -77.94 62.68 2.79 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.938 0.895 . . . . 0.0 110.386 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.79 149.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.359 2.263 . . . . 0.0 110.671 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 18.2 t -61.47 -26.79 68.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -67.41 -27.95 67.51 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.224 -0.923 . . . . 0.0 112.869 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -78.93 123.35 85.15 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.766 1.226 . . . . 0.0 110.191 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.1 -18.0 51.08 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.663 2.242 . . . . 0.0 113.305 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -77.8 1.07 21.41 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 169.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -49.31 134.02 18.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.593 1.542 . . . . 0.0 111.919 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 81.4 mmt-85 -136.82 144.88 48.53 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.242 1.017 . . . . 0.0 110.054 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.98 161.87 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 110.827 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -117.04 66.78 4.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.629 1.171 . . . . 0.0 109.729 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.31 115.08 4.01 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.906 2.404 . . . . 0.0 109.487 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.3 m -92.84 139.99 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.912 0.885 . . . . 0.0 110.083 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.43 164.07 29.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.022 1.329 . . . . 0.0 110.301 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -143.77 120.57 11.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.132 0.973 . . . . 0.0 109.426 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.33 110.53 17.08 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.581 0.705 . . . . 0.0 110.656 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -8.49 44.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.952 0.901 . . . . 0.0 113.299 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 64.2 p -70.54 -24.44 62.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.479 1.512 . . . . 0.0 112.174 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.0 150.53 88.1 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.958 0.903 . . . . 0.0 111.576 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 161.32 38.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.055 3.17 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.48 136.63 37.18 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.157 3.238 . . . . 0.0 112.038 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.71 33.64 10.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.428 1.491 . . . . 0.0 113.024 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.23 151.52 32.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.634 -1.291 . . . . 0.0 114.353 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.0 pt -120.62 142.1 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.159 1.784 . . . . 0.0 110.485 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -107.75 111.54 23.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.672 -1.267 . . . . 0.0 110.63 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 25.4 t -105.69 101.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.865 0.866 . . . . 0.0 110.29 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -67.32 123.08 19.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.194 0.997 . . . . 0.0 111.477 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.2 t -69.74 134.66 48.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.625 -0.672 . . . . 0.0 111.425 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.5 mtm105 -101.93 9.98 40.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.891 1.677 . . . . 0.0 109.986 164.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 54.2 m -112.97 138.45 49.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.449 1.499 . . . . 0.0 111.041 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 40.1 mt -100.51 139.69 35.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.848 1.659 . . . . 0.0 109.503 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -95.27 138.44 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 164.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.45 114.57 44.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 166.28 26.34 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.484 1.04 . . . . 0.0 110.6 163.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.24 43.39 32.27 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 121.972 -0.722 . . . . 0.0 112.929 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.17 84.54 2.86 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.132 1.373 . . . . 0.0 110.875 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.31 173.28 11.69 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.287 2.658 . . . . 0.0 112.044 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.28 -21.75 50.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -18.9 61.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.19 0.996 . . . . 0.0 112.915 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.7 mtp -100.67 131.73 46.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.107 1.763 . . . . 0.0 109.921 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -141.23 170.07 16.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.082 1.753 . . . . 0.0 111.286 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.7 -42.66 62.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.631 1.172 . . . . 0.0 113.843 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -76.87 -27.65 55.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -38.59 84.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.663 167.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.82 -47.96 83.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.747 0.703 . . . . 0.0 110.974 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.51 83.3 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.163 0.892 . . . . 0.0 112.884 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.38 -39.69 89.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.929 1.241 . . . . 0.0 113.226 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.3 -35.35 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.539 1.063 . . . . 0.0 111.528 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.9 mt -85.65 -11.27 54.23 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.187 0.903 . . . . 0.0 112.819 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -48.3 82.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 126.187 1.795 . . . . 0.0 115.166 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.52 -7.35 18.62 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.023 1.815 . . . . 0.0 112.985 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -96.86 -40.14 9.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.297 1.439 . . . . 0.0 112.369 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.41 172.86 3.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.116 1.766 . . . . 0.0 113.484 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 116.88 24.93 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.868 . . . . 0.0 110.506 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 75.3 t -77.82 133.55 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.148 0.979 . . . . 0.0 110.184 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -94.05 -54.17 3.69 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.372 1.469 . . . . 0.0 112.269 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.5 m -140.07 155.11 47.18 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.823 1.249 . . . . 0.0 111.28 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.56 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.059 0.544 . . . . 0.0 110.514 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.56 105.64 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.873 1.269 . . . . 0.0 107.666 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.44 125.8 43.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.396 0.678 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 83.45 2.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.945 1.355 . . . . 0.0 109.706 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -21.61 66.29 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.595 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.5 t -57.26 -31.75 65.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.848 1.659 . . . . 0.0 113.718 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -112.3 10.89 20.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.931 1.692 . . . . 0.0 113.179 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.3 mttt 58.74 32.81 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.159 1.384 . . . . 0.0 113.171 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -126.19 169.5 12.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.23 158.63 43.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 163.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -114.05 128.9 56.59 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.267 1.427 . . . . 0.0 108.641 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 63.9 t -128.08 105.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.896 0.878 . . . . 0.0 111.079 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.71 119.03 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.335 1.054 . . . . 0.0 109.791 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.65 152.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.723 1.609 . . . . 0.0 107.517 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.449 ' HH ' ' HB2' ' A' ' 306' ' ' TYR . 27.3 m-85 -66.33 -19.89 65.93 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.66 156.94 43.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.586 1.085 . . . . 0.0 112.427 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -44.55 96.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.215 1.006 . . . . 0.0 109.975 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -38.84 90.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.877 0.871 . . . . 0.0 111.566 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -63.92 -53.02 56.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.526 1.13 . . . . 0.0 111.361 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.34 73.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.841 0.746 . . . . 0.0 112.284 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.21 -45.4 91.18 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.175 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -61.55 -36.01 79.4 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.257 0.935 . . . . 0.0 112.187 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.74 -61.04 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.469 169.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.05 -37.9 35.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.041 1.337 . . . . 0.0 113.73 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -69.67 -29.43 66.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.869 1.268 . . . . 0.0 113.666 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -111.79 -26.28 9.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.556 1.071 . . . . 0.0 113.709 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.98 119.3 13.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.545 0.688 . . . . 0.0 111.698 -167.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 60.29 35.77 20.74 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.349 1.46 . . . . 0.0 113.532 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -62.72 -36.08 81.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.58 -14.85 31.68 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.444 1.498 . . . . 0.0 113.93 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.76 29.57 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.519 1.057 . . . . 0.0 114.666 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.5 -41.75 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.181 1.491 . . . . 0.0 114.581 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.2 mt -75.38 150.46 84.92 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.11 0.964 . . . . 0.0 109.802 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.18 -28.04 13.1 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.459 2.106 . . . . 0.0 112.436 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.8 141.76 28.35 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.448 0.699 . . . . 0.0 111.287 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.6 126.12 54.12 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 109.92 172.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 m -106.41 129.82 54.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.55 1.14 . . . . 0.0 109.922 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.72 175.17 9.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.46 1.904 . . . . 0.0 109.257 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -65.55 125.03 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.593 163.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -109.41 -157.21 17.37 Favored Glycine 0 N--CA 1.463 0.483 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.77 136.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.75 -51.23 2.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.736 1.636 . . . . 0.0 109.952 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -119.85 109.39 15.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.417 0.687 . . . . 0.0 112.753 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.95 136.29 3.53 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.049 -0.862 . . . . 0.0 115.222 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 132.08 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.589 4.193 . . . . 0.0 109.89 171.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -65.37 -36.86 85.27 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.626 -0.671 . . . . 0.0 112.74 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -73.33 -20.62 60.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 46.2 m -117.36 19.06 14.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.122 1.769 . . . . 0.0 112.599 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.82 153.15 35.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.945 0.879 . . . . 0.0 112.429 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.26 78.97 1.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.91 1.684 . . . . 0.0 108.704 166.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.67 -19.22 64.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 113.275 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -70.81 -50.75 32.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.024 0.829 . . . . 0.0 110.774 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -81.27 -15.91 54.11 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.83 21.36 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.016 1.293 . . . . 0.0 113.254 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -146.78 172.81 13.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.603 1.202 . . . . 0.0 113.35 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 30.0 m -133.83 146.05 50.28 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.173 0.989 . . . . 0.0 110.74 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 14.6 mm -107.0 95.86 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.542 0.737 . . . . 0.0 109.487 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.57 123.54 57.92 Favored Pre-proline 0 N--CA 1.474 0.726 0 O-C-N 121.029 -1.045 . . . . 0.0 111.193 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.59 132.85 22.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.526 2.15 . . . . 0.0 111.109 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 17.6 mtt -60.71 -30.8 70.18 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.026 1.331 . . . . 0.0 113.363 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.49 -16.8 64.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 8.15 24.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.845 2.058 . . . . 0.0 113.554 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.35 140.12 29.82 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.233 0.924 . . . . 0.0 110.211 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 20.7 p -75.88 178.33 6.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.57 1.148 . . . . 0.0 111.232 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.47 -46.17 87.46 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.42 -0.8 . . . . 0.0 111.073 169.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.876 0.87 . . . . 0.0 112.234 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.78 -55.41 35.47 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.286 1.434 . . . . 0.0 112.475 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -65.88 -36.67 84.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.845 -0.534 . . . . 0.0 110.791 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -59.12 -41.43 88.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.499 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -68.28 -45.97 71.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.423 1.465 . . . . 0.0 111.232 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 49.6 m -53.48 -36.13 61.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.612 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.62 -42.92 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.0 t -101.13 -9.06 21.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.739 1.216 . . . . 0.0 114.141 -167.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.21 146.68 27.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.427 1.108 . . . . 0.0 112.079 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.1 -57.9 3.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.734 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -91.46 132.69 36.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.273 1.029 . . . . 0.0 110.934 163.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 63.93 176.28 4.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.803 1.192 . . . . 0.0 114.094 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.1 -165.95 36.48 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.515 1.055 . . . . 0.0 112.748 -167.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 58.4 p -106.71 16.29 24.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -158.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.1 p 60.4 26.86 16.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.95 1.3 . . . . 0.0 113.441 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.0 77.03 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.506 1.527 . . . . 0.0 114.207 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -66.84 135.67 94.3 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.795 1.297 . . . . 0.0 110.13 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -59.51 144.04 99.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.534 2.156 . . . . 0.0 110.077 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.38 123.88 20.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.113 0.483 . . . . 0.0 110.493 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.06 157.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.002 2.121 . . . . 0.0 109.422 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.7 m -52.28 117.71 3.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 110.064 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 75.56 17.94 79.97 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.531 -1.15 . . . . 0.0 115.01 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 20.6 tt -62.5 126.91 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.231 1.516 . . . . 0.0 111.003 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.36 141.2 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.948 2.099 . . . . 0.0 109.501 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -166.29 171.93 11.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.36 1.464 . . . . 0.0 113.118 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.77 145.14 26.75 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.653 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -56.05 136.61 73.79 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -165.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.39 150.42 46.54 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.156 2.571 . . . . 0.0 110.992 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -59.82 142.04 54.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.964 1.305 . . . . 0.0 113.881 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.35 52.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.635 1.683 . . . . 0.0 110.144 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -178.6 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.003 141.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.97 -44.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.759 -1.213 . . . . 0.0 111.886 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 79.07 -76.92 1.87 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.43 174.29 6.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.511 1.524 . . . . 0.0 111.72 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -176.25 164.61 34.59 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.949 1.261 . . . . 0.0 113.528 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 125.557 1.543 . . . . 0.0 111.879 -179.305 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.908 0.385 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 74.2 mt -138.81 -62.79 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.516 1.127 . . . . 0.0 109.987 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.48 175.17 23.63 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.756 1.646 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.91 32.83 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.998 1.319 . . . . 0.0 111.344 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 170.01 20.31 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 124.312 3.342 . . . . 0.0 112.195 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.16 14.0 1.3 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.146 1.378 . . . . 0.0 114.24 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 21.7 p 55.84 11.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 128.84 2.856 . . . . 0.0 115.574 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.88 -35.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.318 2.647 . . . . 0.0 111.748 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER 47.86 -103.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.514 1.525 . . . . 0.0 110.447 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 68.27 179.14 16.95 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.878 0.751 . . . . 0.0 111.767 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 87.1 m 66.66 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.971 1.708 . . . . 0.0 110.761 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -103.9 108.14 19.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.969 1.707 . . . . 0.0 110.238 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 68.37 171.92 0.28 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.792 1.637 . . . . 0.0 113.334 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -146.17 16.74 1.36 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -72.37 140.34 48.38 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.059 0.943 . . . . 0.0 113.072 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.56 8.22 10.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.955 1.302 . . . . 0.0 113.089 171.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.28 160.42 59.88 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.803 1.241 . . . . 0.0 111.585 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.14 -171.56 0.52 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.917 3.078 . . . . 0.0 111.412 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -76.32 55.4 0.98 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.378 1.071 . . . . 0.0 111.641 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.48 143.17 48.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.197 1.399 . . . . 0.0 111.964 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.0 mt -89.82 144.62 25.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.48 0.712 . . . . 0.0 111.46 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -79.8 64.3 4.61 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.897 -1.127 . . . . 0.0 110.202 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.63 154.86 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.979 2.112 . . . . 0.0 110.681 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 83.6 p -62.98 -23.26 67.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -69.17 -28.25 66.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.961 0.905 . . . . 0.0 113.201 171.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -74.92 123.15 88.8 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.867 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.04 -17.6 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.467 2.111 . . . . 0.0 113.051 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -81.82 7.17 13.43 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.828 1.251 . . . . 0.0 113.978 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -53.42 124.38 14.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.731 -1.231 . . . . 0.0 110.937 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -128.81 139.21 34.98 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 124.932 1.293 . . . . 0.0 109.223 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.9 156.93 59.47 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.884 2.389 . . . . 0.0 110.415 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 74.17 3.03 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.35 1.06 . . . . 0.0 109.962 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.6 111.59 3.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.613 2.209 . . . . 0.0 109.098 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.89 131.42 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.436 0.695 . . . . 0.0 110.042 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.41 169.57 15.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.635 1.574 . . . . 0.0 110.552 173.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -139.99 125.35 18.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.427 1.091 . . . . 0.0 110.108 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -121.23 107.38 12.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.877 0.871 . . . . 0.0 110.839 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.7 m -68.81 -5.58 21.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 55.7 p -71.33 -22.25 61.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.499 1.12 . . . . 0.0 112.188 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.1 mt -71.27 152.73 94.37 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.962 0.905 . . . . 0.0 112.247 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.81 162.17 33.06 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.113 3.208 . . . . 0.0 112.899 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.43 136.84 32.18 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.139 3.226 . . . . 0.0 112.389 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.72 47.35 10.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 111.798 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -126.12 152.91 45.28 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.337 1.055 . . . . 0.0 113.568 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.02 144.16 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.346 1.858 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -117.29 133.27 56.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.569 -1.332 . . . . 0.0 111.613 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.72 101.86 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.957 0.903 . . . . 0.0 110.582 -169.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -68.72 127.07 31.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.63 1.172 . . . . 0.0 112.024 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.3 m -70.22 135.49 49.07 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.523 -0.736 . . . . 0.0 112.275 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.4 mtm105 -102.42 10.24 39.14 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.881 1.673 . . . . 0.0 110.608 164.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 19.4 m -117.42 145.52 44.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.319 1.448 . . . . 0.0 112.141 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 52.9 mt -105.9 136.26 45.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.181 1.792 . . . . 0.0 109.552 172.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -88.98 140.95 28.91 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 162.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 18.3 mm -125.93 116.41 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 108.484 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -98.55 -177.11 32.67 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.313 0.959 . . . . 0.0 111.943 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.22 64.73 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 121.826 -0.808 . . . . 0.0 114.979 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.69 116.41 53.3 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-O 117.665 -1.16 . . . . 0.0 110.061 -166.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.23 135.29 33.87 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.305 2.003 . . . . 0.0 109.596 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.09 -20.26 63.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.38 -33.46 75.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.146 0.979 . . . . 0.0 111.949 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 3.8 ptp -82.6 151.58 26.29 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.527 0.68 . . . . 0.0 112.81 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -129.76 -175.71 3.68 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.169 1.788 . . . . 0.0 111.555 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.26 -39.79 57.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.753 1.221 . . . . 0.0 113.791 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -75.93 -21.64 56.85 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -74.52 -39.15 62.56 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.841 . . . . 0.0 110.568 169.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.07 -50.4 73.59 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.353 0.524 . . . . 0.0 110.569 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.89 80.24 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.596 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -68.46 -40.65 80.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.945 1.248 . . . . 0.0 113.512 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.51 -37.33 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.083 0.856 . . . . 0.0 111.493 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . 0.407 ' CD1' HG12 ' A' ' 379' ' ' VAL . 27.3 mt -83.83 -9.25 58.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.056 0.942 . . . . 0.0 112.75 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.66 -49.43 65.58 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 126.152 1.781 . . . . 0.0 114.889 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -7.32 18.61 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.076 1.851 . . . . 0.0 113.185 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.83 -41.32 8.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.274 1.43 . . . . 0.0 112.3 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.73 172.85 3.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 113.743 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.27 111.87 23.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 111.43 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.82 131.25 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.983 0.913 . . . . 0.0 110.991 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.85 -46.16 8.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.106 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -151.22 152.52 33.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.604 1.162 . . . . 0.0 111.482 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.84 137.21 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.646 . . . . 0.0 110.963 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.81 106.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.638 1.175 . . . . 0.0 107.846 166.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.19 133.0 45.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.003 0.921 . . . . 0.0 110.254 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.55 91.47 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.727 1.211 . . . . 0.0 110.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.0 -27.32 68.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.489 1.116 . . . . 0.0 111.89 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 71.4 m -57.62 -32.05 66.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.025 1.73 . . . . 0.0 114.269 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 8.9 17.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.0 112.729 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.4 mttt 51.99 40.84 29.12 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.704 1.602 . . . . 0.0 112.754 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -127.33 166.7 17.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.27 161.0 41.24 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.44 130.93 57.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.985 1.314 . . . . 0.0 108.379 164.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 359' ' ' LEU . 57.3 t -123.24 102.25 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.945 0.898 . . . . 0.0 110.191 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -74.74 111.02 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.699 1.2 . . . . 0.0 110.127 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.86 153.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.68 1.592 . . . . 0.0 107.85 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.38 -17.88 64.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.81 159.24 44.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.135 1.334 . . . . 0.0 113.004 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.98 77.62 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.741 0.816 . . . . 0.0 110.305 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.7 -36.0 79.66 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.682 0.793 . . . . 0.0 111.64 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.91 -55.55 21.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 111.543 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.4 72.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.061 0.846 . . . . 0.0 112.954 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -60.53 -47.69 85.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.385 1.074 . . . . 0.0 111.878 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.03 -34.51 76.37 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.569 -0.707 . . . . 0.0 112.053 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.63 -62.03 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.502 167.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -51.31 -35.28 37.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.789 1.236 . . . . 0.0 114.291 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.87 -33.11 75.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.938 1.295 . . . . 0.0 113.532 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -117.2 -27.68 6.4 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -74.93 123.18 24.64 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.627 0.771 . . . . 0.0 110.919 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.61 23.96 12.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -30.92 63.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.535 1.134 . . . . 0.0 113.766 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.16 -14.43 15.15 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.729 2.012 . . . . 0.0 114.229 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.29 35.48 7.0 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.716 1.15 . . . . 0.0 114.385 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.73 83.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.66 156.37 38.95 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.626 1.57 . . . . 0.0 110.497 -174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.84 -19.13 24.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.723 2.282 . . . . 0.0 113.908 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.2 mt -62.82 166.76 5.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.903 2.081 . . . . 0.0 113.072 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -137.16 95.0 3.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.46 1.104 . . . . 0.0 110.313 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.5 122.51 28.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.283 1.833 . . . . 0.0 111.063 -172.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 170.44 14.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.596 1.958 . . . . 0.0 109.28 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -64.22 120.17 11.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.336 -0.853 . . . . 0.0 110.424 161.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.1 -155.52 25.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.0 p -167.35 136.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.441 1.096 . . . . 0.0 110.167 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -80.14 -49.67 5.84 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.423 1.011 . . . . 0.0 110.96 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -115.2 96.65 5.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 111.08 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -158.65 122.58 1.16 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.768 -1.018 . . . . 0.0 114.772 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.85 125.23 9.27 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.531 3.487 . . . . 0.0 110.24 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -56.37 -40.45 74.58 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.91 -15.04 61.15 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.26 16.48 13.14 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 112.224 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 138.47 31.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.406 1.482 . . . . 0.0 111.776 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -118.63 86.52 2.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.997 1.719 . . . . 0.0 108.708 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -69.36 -15.57 63.34 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.66 -48.79 58.57 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.947 -1.095 . . . . 0.0 110.602 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -84.65 -16.92 40.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.22 44.83 10.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.575 1.083 . . . . 0.0 112.431 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.61 158.17 42.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.059 0.93 . . . . 0.0 113.491 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.81 151.62 28.83 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.967 -1.083 . . . . 0.0 110.69 168.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.89 104.03 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 0.0 109.015 172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.27 131.17 22.16 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.846 -167.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.73 138.66 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.172 1.914 . . . . 0.0 110.748 168.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 4.9 mtm -61.66 -32.92 73.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.344 1.058 . . . . 0.0 112.601 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -68.81 -11.01 59.95 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -110.11 8.12 23.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.309 1.443 . . . . 0.0 113.488 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 76.2 mt -91.33 135.88 33.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.409 0.684 . . . . 0.0 110.35 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 26.3 p -72.73 175.94 6.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.424 1.09 . . . . 0.0 110.749 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -42.67 98.16 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.633 -0.667 . . . . 0.0 111.046 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.18 82.67 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 112.365 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.47 -53.82 53.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.563 1.145 . . . . 0.0 111.677 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -67.77 -35.83 79.39 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.864 -0.522 . . . . 0.0 111.615 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -54.26 -51.93 62.98 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.587 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -68.5 -40.97 80.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.472 1.487 . . . . 0.0 111.683 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -54.68 -29.62 53.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.083 -0.96 . . . . 0.0 113.138 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.48 -40.9 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 171.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.0 t -104.23 -4.76 22.64 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.136 1.374 . . . . 0.0 114.458 -165.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.72 145.88 32.96 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.995 -1.066 . . . . 0.0 111.761 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -53.13 9.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.734 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -95.23 136.52 35.46 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.808 0.843 . . . . 0.0 111.326 162.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.29 -164.07 53.92 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.392 0.996 . . . . 0.0 113.053 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.17 -168.08 52.51 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.183 0.42 . . . . 0.0 112.202 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 73.3 p -98.51 7.79 45.71 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 74.7 25.72 1.49 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.797 1.239 . . . . 0.0 112.808 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.93 82.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.07 1.319 . . . . 0.0 114.007 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -68.31 149.05 98.21 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.3 1.05 . . . . 0.0 110.219 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.28 147.57 93.68 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.341 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.17 122.88 20.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.64 153.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.557 1.943 . . . . 0.0 109.025 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 63.9 m -51.91 125.38 15.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.74 0.416 . . . . 0.0 110.096 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.31 89.1 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.503 -1.165 . . . . 0.0 114.848 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.2 tt -60.03 139.48 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.487 1.644 . . . . 0.0 111.414 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.62 139.55 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.245 1.818 . . . . 0.0 109.457 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -159.89 172.88 16.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.421 1.488 . . . . 0.0 112.193 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.34 150.56 22.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.264 1.026 . . . . 0.0 110.826 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.34 127.79 23.45 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.84 150.29 55.36 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.544 2.163 . . . . 0.0 111.115 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -61.76 146.21 50.09 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.0 113.819 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.3 50.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 123.194 1.473 . . . . 0.0 110.32 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.21 171.15 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.954 139.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 34.9 t -139.5 -43.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.0 -1.063 . . . . 0.0 111.446 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.79 -111.73 3.92 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -152.26 134.32 14.97 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.19 -175.08 21.33 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.135 1.35 . . . . 0.0 113.604 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.255 1.37 0 C-N-CA 127.184 2.194 . . . . 0.0 111.448 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.594 0.235 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.2 pt -84.96 -179.74 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.702 1.201 . . . . 0.0 112.191 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 100.54 52.06 1.16 Allowed Glycine 0 N--CA 1.472 1.059 0 C-N-CA 124.68 1.133 . . . . 0.0 112.994 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -157.95 157.03 29.19 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.47 1.908 . . . . 0.0 110.069 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.14 -74.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.45 2.766 . . . . 0.0 111.692 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 31.9 t30 42.49 88.87 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.378 1.871 . . . . 0.0 114.548 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -48.62 66.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.401 1.081 . . . . 0.0 111.89 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 15.0 t -171.07 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.768 1.627 . . . . 0.0 113.62 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -67.67 144.12 55.65 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.519 -1.363 . . . . 0.0 112.536 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.23 0.38 Allowed Glycine 0 N--CA 1.474 1.233 0 C-N-CA 123.922 0.772 . . . . 0.0 114.698 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 7.6 t -131.12 -42.06 1.1 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.352 1.461 . . . . 0.0 112.542 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -150.77 155.38 39.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.414 1.885 . . . . 0.0 110.386 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 72.65 145.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.7 2.0 . . . . 0.0 111.714 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -148.4 16.54 1.03 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -158.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -79.68 142.43 35.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.709 1.203 . . . . 0.0 111.901 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' A' ' 356' ' ' ALA . 5.2 mp -90.81 7.01 41.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.603 1.561 . . . . 0.0 112.68 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -152.37 157.44 33.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.948 1.299 . . . . 0.0 111.542 -169.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.59 176.91 3.75 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.947 3.098 . . . . 0.0 112.078 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.41 62.19 1.81 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.651 1.215 . . . . 0.0 110.892 172.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.55 164.85 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.197 1.799 . . . . 0.0 112.704 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.71 147.22 36.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.031 1.332 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -80.23 68.84 6.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.384 1.073 . . . . 0.0 110.23 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 19.2 t -113.44 148.89 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 127.183 2.193 . . . . 0.0 110.122 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 88.4 p -60.22 -25.5 65.67 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -69.8 -27.1 64.61 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.346 -0.846 . . . . 0.0 112.829 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -75.83 122.22 86.6 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.271 1.028 . . . . 0.0 109.964 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.99 -17.09 51.08 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.403 2.069 . . . . 0.0 112.99 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -78.41 2.0 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.33 133.8 34.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.391 1.451 . . . . 0.0 111.988 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -136.29 149.79 68.9 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 124.058 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -68.71 153.17 73.73 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.705 2.27 . . . . 0.0 110.318 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 78.35 8.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.383 1.073 . . . . 0.0 108.673 168.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.44 118.49 5.62 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.731 2.288 . . . . 0.0 108.798 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.52 136.44 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.911 0.884 . . . . 0.0 109.529 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.64 175.0 9.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.563 1.145 . . . . 0.0 110.496 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.63 121.72 20.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.969 0.908 . . . . 0.0 110.102 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -115.68 108.93 17.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.011 0.91 . . . . 0.0 111.096 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.1 p -65.76 -7.49 16.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.495 1.518 . . . . 0.0 114.038 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.49 -23.04 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.699 0.799 . . . . 0.0 112.324 169.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.96 151.02 86.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 112.182 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.88 161.36 36.77 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.882 3.054 . . . . 0.0 112.574 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.06 135.13 28.97 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.132 3.222 . . . . 0.0 112.552 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.8 34.64 9.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.8 1.64 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -119.49 158.86 25.4 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.78 150.72 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.545 1.938 . . . . 0.0 110.263 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.98 127.67 54.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.895 1.678 . . . . 0.0 110.672 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.26 104.19 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.571 0.749 . . . . 0.0 111.414 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -70.09 137.72 51.41 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.452 1.101 . . . . 0.0 112.323 169.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 m -78.39 129.92 35.51 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.442 -0.786 . . . . 0.0 112.095 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -95.65 18.06 13.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.263 1.425 . . . . 0.0 110.958 162.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 97.4 m -130.96 142.68 50.37 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 111.412 -168.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 25.6 mt -107.11 133.29 51.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.684 1.994 . . . . 0.0 108.669 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -84.65 118.74 24.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.48 108.55 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.22 -175.96 49.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.51 0.576 . . . . 0.0 111.786 167.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.84 9.43 59.41 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.439 -1.036 . . . . 0.0 114.97 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.38 118.52 68.25 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.724 1.262 . . . . 0.0 110.2 -165.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.32 136.19 33.5 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.535 2.157 . . . . 0.0 109.017 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -18.96 50.0 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -73.9 -33.99 64.22 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.699 -0.626 . . . . 0.0 112.662 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 41.3 mtm -72.98 146.19 46.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.12 0.962 . . . . 0.0 112.424 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -126.9 179.86 5.18 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 127.406 2.282 . . . . 0.0 110.911 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.69 -46.24 29.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.645 1.578 . . . . 0.0 113.483 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -76.09 -18.89 58.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.743 1.156 . . . . 0.0 110.391 168.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.86 -42.35 84.32 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.244 0.618 . . . . 0.0 110.832 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.404 ' HB3' ' CD2' ' A' ' 305' ' ' LEU . . . -55.89 -52.09 65.3 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 119.1 0.864 . . . . 0.0 112.369 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.5 -38.65 91.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 26.4 m -72.11 -35.94 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.758 0.708 . . . . 0.0 111.533 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.43 -12.88 50.94 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -46.68 87.17 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.259 1.824 . . . . 0.0 114.649 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.38 -7.03 17.67 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.011 1.807 . . . . 0.0 113.434 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.79 -39.44 9.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.499 1.52 . . . . 0.0 112.614 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.0 167.0 3.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.856 1.662 . . . . 0.0 113.916 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.29 107.49 17.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.792 0.837 . . . . 0.0 110.647 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.56 144.21 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.027 0.931 . . . . 0.0 111.257 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -111.46 -38.57 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.093 1.357 . . . . 0.0 112.092 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.5 155.33 39.29 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.821 1.191 . . . . 0.0 111.757 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 84.0 t -147.1 127.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.844 0.858 . . . . 0.0 110.056 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.65 105.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.29 112.51 25.03 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.732 0.813 . . . . 0.0 110.41 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.56 86.06 3.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 109.851 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.02 -32.63 66.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.941 1.296 . . . . 0.0 111.629 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 34.9 m -59.06 -27.2 65.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.915 1.686 . . . . 0.0 114.378 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -114.56 10.58 16.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.112 1.365 . . . . 0.0 112.406 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 51.29 37.8 19.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.094 1.758 . . . . 0.0 113.042 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -125.27 153.79 42.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.046 1.338 . . . . 0.0 113.661 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -139.53 131.75 28.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.641 1.176 . . . . 0.0 112.168 164.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -83.75 115.48 22.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 162.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 99.2 t -122.76 107.42 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.607 . . . . 0.0 110.986 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 125.77 51.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.13 0.972 . . . . 0.0 111.979 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.75 168.72 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.458 1.503 . . . . 0.0 110.018 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -70.39 -24.13 62.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 2.8 p -137.18 156.05 48.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.351 1.432 . . . . 0.0 113.515 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -43.5 98.7 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.613 -0.679 . . . . 0.0 109.895 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -58.41 -37.37 75.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.602 0.761 . . . . 0.0 112.933 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.41 -49.68 72.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.941 0.897 . . . . 0.0 111.168 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.44 93.34 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.806 0.73 . . . . 0.0 112.383 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -61.07 -48.64 80.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.047 0.939 . . . . 0.0 111.15 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -62.81 -34.12 76.62 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.492 -0.755 . . . . 0.0 112.812 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.27 -64.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.656 -0.688 . . . . 0.0 109.582 166.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.38 -35.59 28.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.531 1.132 . . . . 0.0 113.646 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.35 -30.8 71.27 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.682 1.193 . . . . 0.0 113.469 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -117.22 -27.68 6.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -73.48 125.41 27.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.673 0.749 . . . . 0.0 111.28 -167.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.4 30.05 19.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.762 1.625 . . . . 0.0 113.937 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -56.23 -36.07 68.08 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.18 -0.95 . . . . 0.0 113.457 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.18 -21.35 46.51 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.566 1.146 . . . . 0.0 113.103 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.18 27.28 49.73 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.941 1.258 . . . . 0.0 113.712 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.93 -34.93 14.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.559 1.544 . . . . 0.0 114.768 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.3 mt -72.95 149.57 89.97 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.12 0.968 . . . . 0.0 109.698 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.54 -30.01 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.657 2.238 . . . . 0.0 112.532 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.22 149.84 47.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.752 2.021 . . . . 0.0 112.399 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -119.37 98.34 6.1 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.572 1.149 . . . . 0.0 110.421 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.85 107.65 16.38 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.197 1.799 . . . . 0.0 109.542 -169.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -117.91 166.91 11.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 108.89 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -65.59 132.53 49.09 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.203 -0.935 . . . . 0.0 111.217 163.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.49 -146.56 8.29 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.416 1.484 . . . . 0.0 109.527 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.81 143.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.398 1.479 . . . . 0.0 108.594 167.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -75.47 -82.11 0.48 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 165.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -94.74 105.75 17.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.559 0.744 . . . . 0.0 111.074 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -169.56 140.67 6.22 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.304 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.4 125.84 11.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 125.16 3.906 . . . . 0.0 109.985 174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 -65.31 -36.68 84.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.08 -18.4 62.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.501 1.921 . . . . 0.0 114.029 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.29 30.16 6.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 111.995 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.9 t -89.62 135.87 33.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.558 1.143 . . . . 0.0 111.806 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -116.96 89.38 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.249 1.82 . . . . 0.0 108.762 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -69.7 -20.87 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.33 -46.39 80.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.594 1.543 . . . . 0.0 111.187 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -86.45 -17.54 33.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.61 48.05 8.29 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.532 1.063 . . . . 0.0 112.401 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -150.08 169.74 20.55 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.284 1.042 . . . . 0.0 112.834 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 15.9 p -137.96 151.96 48.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.71 1.204 . . . . 0.0 110.802 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 22.0 mt -110.23 130.62 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.96 127.16 25.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 119.701 1.137 . . . . 0.0 111.634 -172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.31 132.79 21.51 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.875 2.383 . . . . 0.0 111.635 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 14.5 mtm -64.32 -28.22 69.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.34 1.456 . . . . 0.0 114.048 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -68.37 -23.72 64.7 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.747 0.703 . . . . 0.0 112.893 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.07 -36.55 15.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.588 1.555 . . . . 0.0 111.923 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.2 mt -53.0 117.98 3.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.987 0.812 . . . . 0.0 109.139 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.0 p -64.62 176.17 1.21 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.758 1.223 . . . . 0.0 110.753 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -62.1 -38.85 90.43 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.693 -0.63 . . . . 0.0 111.571 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.53 -40.67 80.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.822 0.849 . . . . 0.0 112.141 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.68 -58.79 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.369 1.067 . . . . 0.0 111.608 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -61.43 -36.04 79.24 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.705 0.402 . . . . 0.0 111.927 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.14 -40.3 89.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.996 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -67.45 -45.47 75.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.539 1.518 . . . . 0.0 111.456 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -52.89 -37.63 60.81 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.496 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.76 -43.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -97.45 -12.55 22.56 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.37 142.5 43.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.183 -0.948 . . . . 0.0 111.989 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -76.34 -53.49 8.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.782 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -92.97 128.32 38.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.285 1.034 . . . . 0.0 110.415 166.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.13 -173.36 45.7 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.479 1.038 . . . . 0.0 114.324 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.19 -158.96 53.8 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.469 -0.365 . . . . 0.0 112.617 -170.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.0 p -97.64 7.52 46.3 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -164.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 p 68.93 7.06 5.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.766 1.626 . . . . 0.0 114.422 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.53 1.78 32.82 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.941 1.734 . . . . 0.0 113.973 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -66.46 153.61 92.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 118.603 1.201 . . . . 0.0 110.823 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.12 147.64 94.03 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.404 2.07 . . . . 0.0 110.038 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 27.2 mt -68.74 124.52 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.865 -0.522 . . . . 0.0 109.761 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.8 t -117.53 148.89 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.292 1.837 . . . . 0.0 108.552 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 99.7 m -50.17 122.96 7.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.18 0.592 . . . . 0.0 109.806 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.57 -2.68 77.75 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.204 -1.331 . . . . 0.0 115.265 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.89 123.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.708 1.754 . . . . 0.0 111.592 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.68 138.22 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 109.243 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.6 -178.36 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.5 1.52 . . . . 0.0 112.25 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -93.57 153.26 18.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.626 1.17 . . . . 0.0 111.791 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -49.14 130.32 16.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.542 1.137 . . . . 0.0 113.206 -168.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.68 150.58 68.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.116 1.878 . . . . 0.0 109.689 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -55.66 156.42 4.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.227 1.011 . . . . 0.0 113.72 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mt -121.52 46.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 123.58 1.657 . . . . 0.0 109.56 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -54.25 171.22 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.527 135.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.29 -54.8 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 120.976 -1.078 . . . . 0.0 110.557 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.18 68.89 1.45 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 75.64 -55.11 0.62 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.991 2.516 . . . . 0.0 112.917 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.12 -135.23 12.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.898 1.237 . . . . 0.0 112.191 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.252 1.203 0 C-N-CA 125.783 1.633 . . . . 0.0 112.178 -177.358 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.7 mp 53.59 81.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.796 2.039 . . . . 0.0 112.006 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -177.58 43.76 0.1 OUTLIER Glycine 0 N--CA 1.473 1.155 0 O-C-N 121.538 -0.726 . . . . 0.0 114.131 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -147.94 160.21 38.38 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.289 1.436 . . . . 0.0 111.059 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.29 -159.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.815 3.677 . . . . 0.0 111.955 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -57.7 -35.36 70.52 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.915 -1.115 . . . . 0.0 113.031 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 58.3 p 50.81 27.03 2.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 127.685 2.394 . . . . 0.0 114.387 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 6.1 t -69.73 -18.69 63.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 113.742 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -46.53 124.95 6.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 0.0 111.895 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 100.87 24.21 9.32 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.343 -1.254 . . . . 0.0 114.916 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.3 m -131.57 -68.57 0.65 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.947 1.373 . . . . 0.0 111.943 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.06 -42.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.345 1.458 . . . . 0.0 112.727 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -80.25 155.56 27.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.92 0.888 . . . . 0.0 110.042 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -143.51 12.17 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -164.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -79.64 142.24 35.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.257 1.023 . . . . 0.0 111.938 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.65 -42.53 97.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.705 1.202 . . . . 0.0 111.325 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.63 61.98 1.61 Allowed Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 125.252 1.421 . . . . 0.0 113.129 -169.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.22 76.33 3.52 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.342 4.028 . . . . 0.0 111.431 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -147.92 22.92 1.1 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.68 1.592 . . . . 0.0 112.213 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.67 146.32 51.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.132 1.773 . . . . 0.0 111.464 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.88 152.68 24.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.676 1.19 . . . . 0.0 110.877 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -79.63 67.93 5.54 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 120.989 -1.07 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.2 147.9 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 127.476 2.311 . . . . 0.0 109.612 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 85.1 p -58.66 -27.55 64.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -66.02 -33.77 76.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.251 1.02 . . . . 0.0 112.683 172.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -71.4 121.96 85.77 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.899 0.88 . . . . 0.0 110.266 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.31 -17.08 49.5 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.608 2.205 . . . . 0.0 113.085 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -79.07 2.84 19.25 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -50.57 131.7 25.28 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.149 1.341 . . . . 0.0 111.209 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.37 140.81 26.9 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 123.861 0.864 . . . . 0.0 109.951 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.9 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.217 2.612 . . . . 0.0 111.026 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 66.28 49.92 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.985 1.314 . . . . 0.0 110.442 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.38 113.15 2.79 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.113 2.542 . . . . 0.0 109.734 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.02 127.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.787 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.68 167.3 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.284 1.434 . . . . 0.0 110.367 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -139.38 122.84 17.24 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.879 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.93 115.02 23.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.803 0.841 . . . . 0.0 110.373 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.4 p -70.4 -11.14 60.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 70.5 p -67.32 -22.38 65.61 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 112.365 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -69.34 147.61 97.13 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.364 0.666 . . . . 0.0 111.478 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.84 164.26 27.71 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.821 3.014 . . . . 0.0 112.65 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.47 133.75 21.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.775 2.983 . . . . 0.0 112.07 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 69.17 30.47 4.32 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.992 2.117 . . . . 0.0 112.123 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -119.97 142.28 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.9 pt -115.31 149.15 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.458 1.503 . . . . 0.0 110.294 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 128.46 53.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.491 1.116 . . . . 0.0 110.645 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.06 104.73 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.185 0.448 . . . . 0.0 111.618 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -67.13 138.88 57.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.96 167.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 t -81.66 136.17 35.51 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.353 -0.842 . . . . 0.0 112.432 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -105.43 18.89 21.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.944 1.697 . . . . 0.0 110.42 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 92.5 m -125.26 140.69 52.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 111.523 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.18 136.06 47.66 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.143 1.777 . . . . 0.0 108.891 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.69 122.08 33.92 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.37 109.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.29 50.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.646 0.641 . . . . 0.0 111.746 168.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.25 16.02 68.51 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.697 -0.884 . . . . 0.0 114.9 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 28.7 t -78.55 116.58 60.56 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.634 1.217 . . . . 0.0 110.021 -168.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 135.86 31.08 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.325 2.016 . . . . 0.0 108.699 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.2 -15.88 38.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.01 -27.07 61.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.788 0.835 . . . . 0.0 113.106 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.4 ptp -84.55 147.46 27.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.542 0.737 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -124.96 -167.77 1.72 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.824 1.65 . . . . 0.0 111.741 -173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -60.24 -41.71 93.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.592 1.157 . . . . 0.0 111.957 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -73.8 -24.24 59.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.0 -41.85 70.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.882 1.219 . . . . 0.0 110.757 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -56.14 -53.24 59.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 122.977 0.511 . . . . 0.0 110.486 170.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.35 -32.9 67.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.238 -0.887 . . . . 0.0 113.086 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -70.28 -46.16 64.9 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.996 1.271 . . . . 0.0 113.032 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.56 -36.18 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.164 0.893 . . . . 0.0 111.077 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 11.3 mp -78.65 -6.55 56.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.078 0.951 . . . . 0.0 113.342 173.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -49.93 -50.94 65.45 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-N 120.719 1.6 . . . . 0.0 114.843 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.7 -6.34 17.47 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.088 1.859 . . . . 0.0 113.207 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -97.13 -43.04 7.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.547 1.539 . . . . 0.0 112.398 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.26 169.36 2.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 113.868 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.79 119.52 32.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.443 1.097 . . . . 0.0 111.057 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.39 129.18 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.911 1.284 . . . . 0.0 109.411 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.7 -28.63 14.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 t -153.8 149.89 27.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.752 1.221 . . . . 0.0 110.828 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.32 139.45 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.614 0.765 . . . . 0.0 109.836 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.09 104.85 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 166.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.25 118.3 30.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.105 0.478 . . . . 0.0 109.913 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -102.63 79.45 1.81 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.222 1.409 . . . . 0.0 109.058 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.66 -33.49 64.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.167 1.387 . . . . 0.0 111.4 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -32.29 66.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.953 1.701 . . . . 0.0 113.443 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.29 6.79 24.85 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.397 1.479 . . . . 0.0 113.832 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.7 mttt 56.09 38.3 29.75 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.751 1.621 . . . . 0.0 112.436 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -121.66 154.31 37.0 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.03 1.732 . . . . 0.0 113.144 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.46 130.58 28.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.577 1.151 . . . . 0.0 111.698 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -84.36 123.13 29.86 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 162.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 53.0 t -122.96 118.22 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.013 0.925 . . . . 0.0 110.059 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.45 121.1 42.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 109.68 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.96 163.34 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 110.114 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -73.71 -17.71 61.09 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 6.3 p -140.8 156.69 46.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.297 . . . . 0.0 113.154 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -43.43 96.74 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.764 -0.585 . . . . 0.0 110.6 171.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -59.15 -42.08 89.87 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.887 -0.508 . . . . 0.0 111.132 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.0 -50.0 74.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.097 0.959 . . . . 0.0 112.022 171.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.12 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.624 0.647 . . . . 0.0 111.568 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -60.94 -41.31 95.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.423 0.689 . . . . 0.0 112.356 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -66.64 -33.48 75.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.309 0.959 . . . . 0.0 112.134 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.0 -64.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.351 164.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -49.82 -35.57 23.42 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -63.99 -42.19 97.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.909 1.684 . . . . 0.0 113.369 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -110.55 -26.91 9.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -171.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -70.58 122.66 20.15 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.944 0.897 . . . . 0.0 111.095 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.07 31.77 17.77 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.843 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -34.29 73.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.1 -21.18 54.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.826 1.251 . . . . 0.0 113.073 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.99 28.04 55.11 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.933 1.254 . . . . 0.0 113.685 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -92.64 -35.12 13.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.473 1.509 . . . . 0.0 114.566 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.4 mt -72.0 150.38 92.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.431 1.092 . . . . 0.0 109.789 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.93 -34.35 8.69 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.476 2.117 . . . . 0.0 112.045 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.76 151.61 46.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 112.575 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -127.19 94.64 4.06 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.068 1.347 . . . . 0.0 108.946 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -77.94 116.9 18.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.027 0.931 . . . . 0.0 110.389 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -120.37 171.27 8.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.933 2.093 . . . . 0.0 108.941 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -69.63 127.46 33.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.046 -1.034 . . . . 0.0 111.273 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.23 -155.68 15.1 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 125.532 1.539 . . . . 0.0 109.27 166.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.64 134.3 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.111 0.456 . . . . 0.0 111.953 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.54 -51.06 3.79 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 166.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -123.64 112.66 17.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 112.454 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.65 2.93 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.131 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.71 128.81 14.71 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 125.195 3.93 . . . . 0.0 110.48 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -34.32 76.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.04 -19.07 60.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.297 1.039 . . . . 0.0 113.756 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.76 29.47 6.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.158 1.783 . . . . 0.0 111.654 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.4 t -83.74 136.01 34.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.886 1.274 . . . . 0.0 111.301 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -121.41 76.89 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.39 1.476 . . . . 0.0 109.087 167.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -61.71 -26.68 68.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.562 -0.711 . . . . 0.0 112.553 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.6 -49.92 74.66 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.235 1.379 . . . . 0.0 111.684 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -82.44 -13.41 56.81 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.98 39.92 18.53 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 124.803 1.192 . . . . 0.0 112.749 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.87 167.02 24.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.621 1.211 . . . . 0.0 112.946 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.9 m -130.25 153.82 48.22 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.397 -0.814 . . . . 0.0 110.465 167.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 mm -106.09 133.8 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.58 115.61 28.26 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 120.228 1.376 . . . . 0.0 112.014 -171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -71.45 133.08 21.79 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.195 2.596 . . . . 0.0 111.492 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.9 mtt -61.81 -28.94 69.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.459 1.104 . . . . 0.0 113.316 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -65.59 -19.07 65.77 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.43 16.43 16.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 112.908 176.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.96 173.55 8.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.863 1.265 . . . . 0.0 112.513 170.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.4 p -127.12 169.1 13.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.039 1.336 . . . . 0.0 110.632 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.31 -33.25 69.52 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.748 -1.22 . . . . 0.0 111.166 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.83 84.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.458 1.103 . . . . 0.0 112.014 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -45.14 84.51 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.656 0.662 . . . . 0.0 112.478 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -62.33 -41.74 98.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -59.84 -32.36 70.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.339 1.056 . . . . 0.0 113.106 171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -72.05 -50.45 28.27 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.007 1.731 . . . . 0.0 111.877 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.7 m -51.58 -39.55 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.314 0.961 . . . . 0.0 111.715 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.3 m -82.64 -50.52 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.5 t -91.07 -13.78 32.52 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.612 -1.305 . . . . 0.0 114.27 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.4 137.69 47.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.027 0.917 . . . . 0.0 111.702 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -78.05 -44.97 24.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.883 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -102.82 140.0 37.66 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.968 1.307 . . . . 0.0 111.617 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.02 -167.5 34.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.056 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.92 -146.21 47.83 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -171.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 18.7 p -117.21 1.18 12.45 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -153.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.77 18.01 1.3 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.29 1.836 . . . . 0.0 112.849 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.19 12.4 61.72 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.602 1.096 . . . . 0.0 113.659 -172.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -78.56 136.93 59.3 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.032 1.333 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.18 99.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.069 2.513 . . . . 0.0 109.059 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.61 147.68 52.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.625 0.77 . . . . 0.0 112.189 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.3 163.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.785 1.234 . . . . 0.0 111.235 -173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.8 t -51.43 127.35 19.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.916 0.886 . . . . 0.0 110.641 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 97.03 -14.39 63.9 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.938 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.26 147.33 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.077 1.939 . . . . 0.0 112.164 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.94 132.93 69.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.759 2.024 . . . . 0.0 109.052 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -153.36 178.05 10.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.415 1.486 . . . . 0.0 111.752 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.99 151.26 19.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.163 1.385 . . . . 0.0 109.631 171.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.31 129.26 5.98 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.888 1.275 . . . . 0.0 112.371 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.57 150.54 80.0 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.293 1.328 . . . . 0.0 110.077 168.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -54.24 142.87 24.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 51.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.632 1.682 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.2 173.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.499 138.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.92 -60.35 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.106 -0.996 . . . . 0.0 110.507 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.86 -71.37 2.97 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -169.81 160.73 8.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.115 1.366 . . . . 0.0 111.751 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -142.89 -162.64 9.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.636 1.589 . . . . 0.0 113.136 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.412 1.485 . . . . 0.0 110.902 179.376 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.362 0.125 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.65 -53.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.52 1.128 . . . . 0.0 110.536 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 115.75 -167.34 12.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.794 1.664 . . . . 0.0 112.19 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.74 28.85 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.745 1.618 . . . . 0.0 110.984 -175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.04 -156.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.55 3.5 . . . . 0.0 111.688 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -54.15 -41.5 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.036 -1.04 . . . . 0.0 113.061 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 72.3 p 50.9 26.72 2.78 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 127.837 2.455 . . . . 0.0 114.378 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.6 t -74.22 -11.92 60.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.884 1.674 . . . . 0.0 113.545 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -51.26 129.64 25.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.49 1.516 . . . . 0.0 111.616 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.34 78.92 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.5 -1.167 . . . . 0.0 114.799 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 6.5 m -122.2 -65.11 1.14 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.86 1.264 . . . . 0.0 110.866 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -172.4 137.47 0.86 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.366 1.867 . . . . 0.0 110.754 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.42 165.8 0.15 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.526 1.53 . . . . 0.0 113.176 -174.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -136.56 9.74 3.15 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.15 143.23 52.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.384 1.074 . . . . 0.0 112.322 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.91 -46.29 88.51 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.034 0.934 . . . . 0.0 112.183 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.01 155.75 37.92 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.193 1.397 . . . . 0.0 112.522 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.08 79.71 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.886 3.058 . . . . 0.0 111.402 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 t70 74.76 -62.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.882 2.873 . . . . 0.0 111.222 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . 0.25 21.2 pt-20 44.58 -173.33 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.114 2.966 . . . . 0.0 114.801 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mp -143.74 165.85 26.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.653 1.181 . . . . 0.0 110.245 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.06 62.8 3.56 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.734 1.214 . . . . 0.0 111.307 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.22 152.37 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 127.166 2.186 . . . . 0.0 111.415 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 60.0 p -67.06 -22.68 65.85 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.81 -23.89 61.63 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.181 0.992 . . . . 0.0 112.9 172.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -78.87 126.12 82.86 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.155 0.982 . . . . 0.0 110.309 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.26 -17.45 49.94 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.782 2.322 . . . . 0.0 113.589 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -79.02 7.1 7.86 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.743 1.217 . . . . 0.0 114.083 166.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -55.12 125.17 19.41 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.253 -1.529 . . . . 0.0 111.471 171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.4 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.7 mmt-85 -160.24 148.33 13.11 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.758 1.623 . . . . 0.0 110.693 -170.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.06 173.47 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.644 2.229 . . . . 0.0 111.611 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -114.84 99.32 51.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.192 0.597 . . . . 0.0 109.504 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.03 154.79 25.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.522 2.815 . . . . 0.0 110.821 171.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.08 142.06 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.329 1.452 . . . . 0.0 108.967 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.74 168.09 17.77 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.388 1.075 . . . . 0.0 111.166 171.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.12 121.98 15.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.766 1.226 . . . . 0.0 109.996 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.23 107.18 12.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.822 1.249 . . . . 0.0 110.164 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 50.3 p -71.55 -4.13 25.19 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -24.59 66.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.94 1.296 . . . . 0.0 112.175 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.16 151.21 97.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.064 0.946 . . . . 0.0 112.001 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.26 161.74 32.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.826 3.017 . . . . 0.0 112.659 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.56 131.19 18.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.746 2.964 . . . . 0.0 112.057 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.05 36.21 4.28 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.074 2.15 . . . . 0.0 111.807 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -122.57 155.26 36.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.649 1.18 . . . . 0.0 113.74 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.6 pt -123.61 154.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.652 1.981 . . . . 0.0 110.546 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -110.55 125.17 53.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.118 0.967 . . . . 0.0 110.946 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.11 105.1 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.505 1.122 . . . . 0.0 109.785 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.93 136.28 52.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.627 1.171 . . . . 0.0 111.218 168.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.7 t -73.96 138.84 44.46 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 121.325 -0.859 . . . . 0.0 112.203 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -107.37 -1.27 21.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.889 1.676 . . . . 0.0 111.815 164.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 23.1 m -100.54 123.62 45.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.072 1.349 . . . . 0.0 109.093 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.45 141.46 28.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.568 1.547 . . . . 0.0 108.751 168.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -93.93 142.99 26.75 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.47 111.93 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.169 1.388 . . . . 0.0 108.441 -172.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -91.01 172.75 37.14 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.197 0.904 . . . . 0.0 111.768 168.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.6 23.36 78.04 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.316 -0.713 . . . . 0.0 114.736 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.0 t -84.26 115.72 61.55 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 118.491 1.146 . . . . 0.0 110.405 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.87 142.24 61.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.924 2.416 . . . . 0.0 110.032 170.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.08 -20.12 50.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -21.34 52.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 22.9 mtm -83.94 144.06 29.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.949 0.881 . . . . 0.0 112.165 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -128.31 -177.16 4.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.832 2.053 . . . . 0.0 110.624 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -49.41 -39.26 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.73 1.612 . . . . 0.0 114.713 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -79.36 -17.77 53.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -75.75 -38.54 58.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.549 1.068 . . . . 0.0 110.519 168.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.87 -49.07 79.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.582 168.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.36 -33.56 69.7 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.102 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -73.97 -42.45 60.45 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.923 1.238 . . . . 0.0 114.314 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.29 -35.19 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.029 1.286 . . . . 0.0 111.459 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 37.8 mt -87.97 -5.63 58.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.455 1.102 . . . . 0.0 113.081 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -52.53 -49.0 88.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.88 -6.17 17.77 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.616 2.21 . . . . 0.0 113.379 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -98.5 -35.91 10.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.332 1.453 . . . . 0.0 112.871 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.55 3.5 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.214 1.805 . . . . 0.0 113.936 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 122.23 30.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.184 1.394 . . . . 0.0 110.61 169.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.46 122.74 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.693 0.797 . . . . 0.0 109.592 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -96.72 -35.5 10.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.588 1.555 . . . . 0.0 112.459 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.95 155.57 44.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.36 1.064 . . . . 0.0 111.907 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 27.0 t -149.22 140.18 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 0.0 110.621 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.26 101.48 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.392 1.477 . . . . 0.0 108.254 168.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.63 131.11 49.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.174 0.59 . . . . 0.0 110.823 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 87.49 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.394 1.092 . . . . 0.0 109.96 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.42 -29.54 67.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.273 1.429 . . . . 0.0 112.237 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.3 t -59.27 -28.28 66.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.888 1.675 . . . . 0.0 114.092 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.22 1.38 16.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.083 1.753 . . . . 0.0 112.727 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 59.51 37.46 22.84 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.318 1.447 . . . . 0.0 112.26 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -125.51 167.0 15.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.42 164.76 29.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.501 1.12 . . . . 0.0 112.315 163.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.94 135.38 54.92 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.331 1.453 . . . . 0.0 108.396 162.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 73.0 t -128.44 118.03 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.116 0.966 . . . . 0.0 110.92 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -101.67 120.3 40.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.786 1.234 . . . . 0.0 112.059 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.9 m -100.99 -179.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.136 0.974 . . . . 0.0 111.429 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -64.93 -37.4 87.53 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.928 1.24 . . . . 0.0 114.155 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 60.3 p -149.06 166.42 28.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -167.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -39.25 89.62 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.175 169.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -62.39 -40.36 96.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.917 0.78 . . . . 0.0 112.352 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.62 -47.76 71.61 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.37 0.668 . . . . 0.0 110.488 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.92 98.65 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.383 -0.823 . . . . 0.0 112.107 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -65.5 -40.52 93.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.935 171.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.99 -33.38 75.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.946 1.248 . . . . 0.0 112.333 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.99 -65.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 118.461 0.573 . . . . 0.0 109.886 164.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.48 -33.22 43.76 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -69.29 -35.3 75.87 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 113.454 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -111.49 -26.04 9.28 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -72.6 124.25 24.87 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.415 0.686 . . . . 0.0 111.872 -168.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 60.67 28.77 18.48 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.712 1.605 . . . . 0.0 114.134 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -31.03 70.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.791 -1.193 . . . . 0.0 113.737 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.16 -18.3 50.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.601 1.16 . . . . 0.0 113.382 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.72 17.69 69.92 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.848 1.213 . . . . 0.0 114.001 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.55 -31.27 19.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.54 1.536 . . . . 0.0 114.845 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.22 149.18 72.37 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.195 0.998 . . . . 0.0 109.895 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.33 -27.84 11.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.689 2.26 . . . . 0.0 112.394 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.17 147.04 45.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.806 1.242 . . . . 0.0 111.863 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.89 103.25 8.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.564 1.146 . . . . 0.0 110.592 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -86.84 122.4 30.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 111.401 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -129.35 177.09 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.304 2.642 . . . . 0.0 109.146 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -76.05 130.84 38.98 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.777 -1.202 . . . . 0.0 111.651 162.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.0 -160.56 21.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.274 1.892 . . . . 0.0 109.594 162.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.61 125.94 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.892 1.277 . . . . 0.0 109.47 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -90.21 -43.49 4.97 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 162.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -137.66 124.4 21.11 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.168 0.987 . . . . 0.0 110.866 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 174.09 129.92 1.23 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.068 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.27 123.51 10.0 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.78 3.654 . . . . 0.0 109.797 172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.7 -37.89 74.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.279 0.561 . . . . 0.0 112.476 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.79 -18.6 62.09 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.026 2.13 . . . . 0.0 114.545 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.66 24.21 8.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.844 1.658 . . . . 0.0 112.084 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.65 140.99 29.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.309 1.444 . . . . 0.0 111.776 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.81 88.8 3.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.376 1.471 . . . . 0.0 109.199 166.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -65.78 -20.76 66.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.42 -51.51 23.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.637 0.775 . . . . 0.0 110.347 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.87 -17.67 55.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.42 36.18 27.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 124.967 1.27 . . . . 0.0 113.294 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -144.33 164.89 29.47 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.165 0.986 . . . . 0.0 112.893 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.6 m -129.73 150.52 51.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.296 1.038 . . . . 0.0 110.521 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.48 139.38 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.99 126.65 19.77 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 120.017 1.28 . . . . 0.0 111.608 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.25 135.74 27.61 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.565 2.176 . . . . 0.0 111.097 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 5.3 mtm -61.7 -33.78 74.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.498 1.119 . . . . 0.0 113.096 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -68.04 -21.91 64.99 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 119.249 0.931 . . . . 0.0 113.506 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -83.48 -38.84 21.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.184 1.393 . . . . 0.0 111.543 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.97 124.04 13.18 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.728 0.695 . . . . 0.0 109.224 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.5 p -70.77 174.7 5.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.652 1.181 . . . . 0.0 110.942 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -44.0 76.03 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.759 -0.588 . . . . 0.0 111.012 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.66 82.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.291 1.036 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.0 -51.29 70.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.7 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -63.24 -42.94 99.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -52.68 -49.74 64.67 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -69.14 -44.78 71.64 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.494 1.043 . . . . 0.0 111.55 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 64.3 m -52.63 -35.74 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.637 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.38 -42.67 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.2 t -97.63 -9.95 25.95 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -165.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.42 141.02 48.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.975 -1.078 . . . . 0.0 112.279 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -75.67 -22.78 56.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.707 0.803 . . . . 0.0 111.693 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -131.34 144.77 51.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.086 2.155 . . . . 0.0 110.566 167.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.41 -176.89 41.0 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.978 0.799 . . . . 0.0 113.014 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.13 -153.3 49.54 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 122.25 -0.559 . . . . 0.0 113.941 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.6 p -102.76 7.64 39.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.769 1.627 . . . . 0.0 115.173 -163.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.1 m 73.58 8.31 5.04 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.83 2.85 59.51 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.326 1.441 . . . . 0.0 113.58 -170.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -68.33 154.97 93.45 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.754 1.277 . . . . 0.0 110.454 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.01 141.41 83.72 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.062 1.842 . . . . 0.0 110.198 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 118.47 10.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 166.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.83 154.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.189 1.396 . . . . 0.0 109.671 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -57.27 133.63 55.26 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.806 0.442 . . . . 0.0 110.049 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.45 -8.79 79.09 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.449 -1.195 . . . . 0.0 115.181 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.41 138.82 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.985 1.892 . . . . 0.0 111.749 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.12 137.93 55.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 108.875 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.63 -179.27 7.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.149 1.38 . . . . 0.0 110.858 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -99.87 146.01 27.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.513 1.925 . . . . 0.0 110.68 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -44.32 131.87 4.6 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.451 1.5 . . . . 0.0 114.313 -166.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.36 163.99 36.74 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.143 1.895 . . . . 0.0 111.804 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.53 137.04 56.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 112.613 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.52 54.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 123.581 1.658 . . . . 0.0 109.531 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.86 178.87 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.245 140.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.05 -45.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.282 -0.886 . . . . 0.0 112.099 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.09 -59.42 4.54 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.688 1.137 . . . . 0.0 111.832 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.44 159.78 17.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.122 1.769 . . . . 0.0 110.901 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -134.31 -179.84 16.84 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.766 1.65 . . . . 0.0 113.016 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.445 1.498 . . . . 0.0 111.32 177.212 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.448 0.642 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 46.8 pt -87.94 153.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.662 -1.274 . . . . 0.0 111.535 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 75.99 120.15 0.14 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.863 1.221 . . . . 0.0 111.943 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -158.7 156.1 26.34 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.141 0.976 . . . . 0.0 111.551 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.95 178.27 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.081 3.188 . . . . 0.0 111.373 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.85 -4.67 7.17 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.4 p 64.48 6.99 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 129.697 3.199 . . . . 0.0 115.071 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.57 -33.98 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.737 2.815 . . . . 0.0 111.849 -172.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.256 0.1 OUTLIER 55.32 -154.28 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.344 1.458 . . . . 0.0 111.817 176.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 125.74 121.55 2.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 125.303 1.43 . . . . 0.0 112.693 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.5 m 74.99 -46.6 0.6 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 128.023 2.529 . . . . 0.0 112.603 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.25 -25.1 63.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.462 1.505 . . . . 0.0 113.165 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -176.47 -41.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 113.813 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 8.4 m80 56.41 17.42 2.92 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.743 1.217 . . . . 0.0 113.349 -160.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -89.11 147.94 23.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.971 1.709 . . . . 0.0 113.026 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.8 18.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.062 2.145 . . . . 0.0 113.029 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.58 162.29 23.51 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.915 1.686 . . . . 0.0 112.275 -168.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.48 -157.92 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.828 3.686 . . . . 0.0 111.58 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -49.44 -51.81 33.08 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.419 -1.425 . . . . 0.0 112.799 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 37.94 -151.26 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.293 2.237 . . . . 0.0 114.17 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.75 156.51 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.462 1.505 . . . . 0.0 111.236 173.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -79.47 65.22 4.58 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.34 -0.85 . . . . 0.0 110.302 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.04 149.49 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 126.775 2.03 . . . . 0.0 111.827 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 87.6 p -61.21 -26.88 68.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -70.89 -25.28 62.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.968 0.907 . . . . 0.0 113.016 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -79.26 122.08 83.75 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.078 0.951 . . . . 0.0 110.067 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.67 -16.14 45.99 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.657 2.238 . . . . 0.0 113.175 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -73.02 -6.2 43.9 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -48.42 131.08 17.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.761 1.164 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 134.45 11.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.77 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.73 168.49 22.68 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.235 2.623 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.87 70.59 10.27 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.602 1.561 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.77 115.15 3.43 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.099 2.533 . . . . 0.0 110.004 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.79 144.45 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.552 1.141 . . . . 0.0 109.362 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.7 173.17 11.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.265 1.026 . . . . 0.0 110.899 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -136.4 121.11 18.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.472 1.109 . . . . 0.0 109.634 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -115.55 108.02 15.9 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.826 1.251 . . . . 0.0 110.444 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.7 p -66.67 -8.93 31.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -25.07 67.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.088 1.355 . . . . 0.0 112.439 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.26 151.94 96.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.636 0.774 . . . . 0.0 111.927 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.54 162.41 31.16 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.891 3.061 . . . . 0.0 112.722 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 131.95 19.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.813 3.009 . . . . 0.0 112.176 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 68.38 33.7 4.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.744 2.018 . . . . 0.0 112.162 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -121.47 151.14 40.58 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.43 146.11 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.128 1.771 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -110.25 128.72 55.66 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.5 1.046 . . . . 0.0 111.529 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.3 t -125.01 104.47 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.5 0.72 . . . . 0.0 111.112 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.72 134.54 54.42 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.644 1.177 . . . . 0.0 111.589 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 33.3 t -76.34 138.99 40.81 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.193 -0.942 . . . . 0.0 111.651 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.5 mtm105 -109.63 13.96 23.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.102 1.761 . . . . 0.0 110.835 163.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.0 m -113.95 136.23 53.12 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.125 1.77 . . . . 0.0 111.052 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.7 mt -102.61 137.41 40.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.057 1.743 . . . . 0.0 110.131 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -84.12 138.84 32.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 158.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 22.9 mm -127.67 105.16 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.168 1.387 . . . . 0.0 108.346 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -81.35 178.8 53.77 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 121.366 -0.834 . . . . 0.0 111.506 165.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.33 37.28 86.03 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.72 -0.871 . . . . 0.0 113.822 173.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.08 85.14 6.34 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 125.553 1.541 . . . . 0.0 110.358 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.43 161.18 42.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.547 . . . . 0.0 111.012 171.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.8 -20.31 48.96 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -28.52 69.72 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.211 1.005 . . . . 0.0 113.058 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.5 ptm -110.9 135.93 50.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.221 1.01 . . . . 0.0 112.097 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -116.97 -176.05 2.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.257 1.823 . . . . 0.0 111.24 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.92 -34.6 68.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.535 1.134 . . . . 0.0 113.238 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -78.43 -24.18 46.28 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.11 -43.34 71.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.052 0.842 . . . . 0.0 109.851 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 37.3 mt -57.74 -52.89 63.58 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.997 0.519 . . . . 0.0 109.927 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.96 -37.25 63.72 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -72.04 -39.55 69.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.13 -30.98 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.974 1.261 . . . . 0.0 111.653 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.8 mt -81.21 -13.75 58.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.29 1.436 . . . . 0.0 112.916 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -48.09 -48.93 62.69 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.41 -4.64 15.59 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.351 2.034 . . . . 0.0 113.533 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -101.89 -41.28 6.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.62 1.568 . . . . 0.0 112.643 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.75 168.05 4.38 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 111.704 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 132.94 34.7 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.852 -0.53 . . . . 0.0 109.624 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.76 136.28 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.835 0.854 . . . . 0.0 110.133 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -41.54 6.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.339 1.456 . . . . 0.0 112.531 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.28 157.6 43.48 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.827 1.251 . . . . 0.0 109.743 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.92 133.41 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.81 99.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 165.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 137.7 37.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.7 64.77 1.6 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.388 1.075 . . . . 0.0 110.785 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -56.48 -34.4 66.88 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 0.0 112.249 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 m -61.34 -31.41 71.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.799 1.239 . . . . 0.0 113.737 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -96.77 6.99 47.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.366 1.466 . . . . 0.0 113.239 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 63.02 21.2 12.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.247 1.819 . . . . 0.0 113.463 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -135.85 175.52 9.52 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.87 167.01 24.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.104 1.762 . . . . 0.0 111.44 166.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.81 131.69 54.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.015 1.326 . . . . 0.0 108.393 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 60.4 t -122.98 132.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.628 1.171 . . . . 0.0 109.642 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -111.87 126.84 55.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.618 1.567 . . . . 0.0 110.68 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 166.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 0.0 109.812 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -78.7 -23.2 45.72 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -167.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.53 149.46 50.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.781 1.232 . . . . 0.0 111.948 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -55.3 -41.73 72.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.288 1.035 . . . . 0.0 111.777 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -66.24 -36.65 83.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.736 -0.602 . . . . 0.0 112.058 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.72 -49.28 78.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.609 0.764 . . . . 0.0 110.771 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.73 98.23 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.638 -0.664 . . . . 0.0 111.962 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.23 -42.14 98.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.282 1.033 . . . . 0.0 111.556 170.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -67.06 -32.29 73.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.553 1.069 . . . . 0.0 112.757 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.31 -63.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 118.69 -0.671 . . . . 0.0 109.956 165.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.11 -32.99 50.26 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.92 -34.52 74.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.55 1.54 . . . . 0.0 113.377 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -124.39 -31.19 3.31 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -71.77 119.38 15.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.313 1.045 . . . . 0.0 111.159 -167.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 32.4 t30 58.07 25.48 12.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.535 1.534 . . . . 0.0 114.39 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -34.12 77.41 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.66 -1.275 . . . . 0.0 113.251 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.75 -18.32 61.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 112.775 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.19 22.29 63.38 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.067 1.318 . . . . 0.0 113.689 -172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -85.25 -31.5 23.09 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.096 1.359 . . . . 0.0 114.506 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.47 151.94 59.86 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.402 1.081 . . . . 0.0 110.017 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.0 -22.95 22.33 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.722 2.281 . . . . 0.0 113.54 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.95 168.43 5.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.789 1.636 . . . . 0.0 112.957 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 84.97 2.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.401 1.08 . . . . 0.0 110.797 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 117.07 20.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.873 1.669 . . . . 0.0 110.372 -171.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -135.18 169.11 17.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.144 1.378 . . . . 0.0 109.791 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -63.94 119.74 10.65 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.494 -0.754 . . . . 0.0 110.654 165.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.55 -155.44 29.28 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 163.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.7 137.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.869 0.468 . . . . 0.0 111.742 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.91 -52.93 2.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -122.82 111.53 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 111.362 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.7 140.34 4.23 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.126 -0.819 . . . . 0.0 114.861 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.65 131.96 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 125.178 3.919 . . . . 0.0 110.264 174.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -65.24 -34.24 77.89 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.47 -18.64 58.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 89.8 m -123.3 29.75 6.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.141 1.776 . . . . 0.0 112.137 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 14.4 p -76.55 149.5 36.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.867 0.841 . . . . 0.0 112.138 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -132.82 72.6 1.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.475 1.51 . . . . 0.0 108.798 166.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.47 -19.63 63.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.34 -51.85 53.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.899 1.227 . . . . 0.0 110.975 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -80.36 -16.2 55.1 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.01 37.59 12.57 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.054 1.312 . . . . 0.0 112.98 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -145.98 170.31 16.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.01 1.405 . . . . 0.0 112.525 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 37.9 m -136.21 151.39 49.65 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 121.649 -0.657 . . . . 0.0 110.243 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.54 128.65 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.01 121.29 28.86 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.178 -171.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.03 141.65 36.92 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.99 1.793 . . . . 0.0 110.269 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 7.3 mtt -59.04 -31.22 68.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.356 1.062 . . . . 0.0 113.411 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.7 -21.92 66.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.05 0.841 . . . . 0.0 113.265 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.44 5.63 50.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.561 1.944 . . . . 0.0 113.741 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.1 126.38 39.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.323 171.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.8 p -77.47 -179.93 6.09 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.309 1.444 . . . . 0.0 111.343 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -62.5 -42.09 99.26 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.518 -0.739 . . . . 0.0 111.527 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.67 -40.7 92.67 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.137 0.975 . . . . 0.0 112.031 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.99 -51.94 67.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -66.42 -40.45 89.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.921 0.888 . . . . 0.0 111.339 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -58.34 -38.93 78.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.212 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -72.29 -44.77 62.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.818 1.644 . . . . 0.0 111.63 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 62.6 m -50.91 -38.43 49.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.815 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.6 m -87.31 -51.95 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.2 t -92.79 -9.33 40.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 461' ' ' ASP . . . -55.82 141.29 39.33 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.218 -0.926 . . . . 0.0 111.653 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -73.72 -57.6 3.88 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.622 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -93.81 137.03 33.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.051 . . . . 0.0 111.367 167.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 67.44 -169.09 37.56 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.277 0.942 . . . . 0.0 113.755 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 67.01 -150.03 51.67 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.4 p -112.26 9.85 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.6 m 69.82 14.38 8.02 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.12 1.368 . . . . 0.0 113.238 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.59 41.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.805 1.193 . . . . 0.0 113.829 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.7 144.86 37.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.906 1.353 . . . . 0.0 111.353 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.5 104.39 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.457 2.772 . . . . 0.0 108.883 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.63 142.22 39.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.8 m -130.42 168.15 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.165 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 10.7 t -48.66 127.34 13.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.306 1.042 . . . . 0.0 111.296 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 96.51 -14.36 64.34 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.264 -1.298 . . . . 0.0 115.204 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.83 136.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.921 1.86 . . . . 0.0 112.252 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.32 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 126.624 1.97 . . . . 0.0 108.787 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -152.36 179.31 8.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.453 1.501 . . . . 0.0 111.086 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -99.21 154.29 18.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.846 1.258 . . . . 0.0 110.569 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -46.58 129.5 8.23 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.971 1.308 . . . . 0.0 112.446 -166.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.54 152.87 70.51 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.822 1.681 . . . . 0.0 110.019 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 441' ' ' ALA . 82.7 m-20 -57.96 135.35 56.91 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.467 1.107 . . . . 0.0 113.29 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.47 50.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 123.306 1.527 . . . . 0.0 109.923 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.8 pt -54.92 170.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.932 137.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 42.2 t -138.36 -38.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.109 -0.995 . . . . 0.0 111.296 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -117.54 5.76 Favored Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -167.52 176.06 6.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.705 1.202 . . . . 0.0 111.052 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.65 -129.82 1.34 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.458 1.028 . . . . 0.0 112.064 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.437 1.495 . . . . 0.0 110.224 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.484 0.183 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.69 27.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.88 1.672 . . . . 0.0 112.214 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.32 162.05 32.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.312 0.958 . . . . 0.0 111.784 -167.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -148.61 162.37 30.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.496 1.518 . . . . 0.0 109.802 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -72.1 -157.64 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.324 2.683 . . . . 0.0 111.021 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -52.37 -36.44 53.81 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 57.8 p 45.47 28.06 0.45 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.721 2.808 . . . . 0.0 115.709 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 24.9 p -74.24 -16.02 60.97 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.498 1.519 . . . . 0.0 113.192 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -55.79 163.35 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.032 1.733 . . . . 0.0 113.474 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.04 -12.93 68.28 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.642 1.115 . . . . 0.0 113.567 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.94 -164.23 0.97 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.331 1.853 . . . . 0.0 109.972 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -63.84 -26.12 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -79.43 143.53 34.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.987 0.915 . . . . 0.0 111.95 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -154.82 16.97 0.44 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -162.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -76.52 149.33 36.72 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.065 1.346 . . . . 0.0 112.583 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.07 -39.85 8.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.232 1.013 . . . . 0.0 111.596 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -127.91 65.59 68.92 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.137 0.975 . . . . 0.0 110.142 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.9 -175.74 1.54 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.825 3.016 . . . . 0.0 110.948 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.9 t0 66.52 54.64 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.643 1.577 . . . . 0.0 111.709 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -158.33 157.41 32.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.778 1.631 . . . . 0.0 112.033 -173.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.07 163.73 17.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.771 1.228 . . . . 0.0 110.832 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.0 64.34 3.18 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.408 1.083 . . . . 0.0 110.616 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.89 150.09 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 127.336 2.254 . . . . 0.0 111.425 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 78.4 p -63.42 -26.2 68.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -70.76 -25.94 63.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -79.26 122.83 84.61 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.069 0.948 . . . . 0.0 110.185 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.23 -16.75 49.26 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.53 2.153 . . . . 0.0 113.164 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.11 0.51 18.59 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 168.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.41 135.47 17.61 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.559 1.527 . . . . 0.0 112.044 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -140.73 149.96 58.43 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 124.273 1.029 . . . . 0.0 111.04 174.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.38 169.34 21.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.834 3.023 . . . . 0.0 111.639 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -124.17 71.32 54.05 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.435 1.094 . . . . 0.0 110.5 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.03 108.21 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.617 2.211 . . . . 0.0 109.288 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.0 139.29 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.349 1.06 . . . . 0.0 109.527 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.44 172.61 12.67 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.651 1.581 . . . . 0.0 109.878 174.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.97 124.09 13.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.026 -1.047 . . . . 0.0 109.103 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -121.69 110.42 15.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.9 t -70.16 -6.14 32.17 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -24.99 67.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.08 . . . . 0.0 112.13 170.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 150.47 90.72 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 111.669 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.31 164.09 26.97 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.974 3.116 . . . . 0.0 113.3 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.64 136.83 28.97 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 112.375 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.13 38.55 16.87 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.596 1.559 . . . . 0.0 112.786 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -124.25 158.17 33.13 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.971 1.308 . . . . 0.0 113.834 171.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 2.7 pt -128.53 152.64 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.785 2.034 . . . . 0.0 110.69 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.32 132.05 54.49 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.575 -1.328 . . . . 0.0 111.449 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.4 t -126.59 105.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 -171.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -68.74 129.72 40.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 111.915 168.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 2.4 m -71.43 134.62 46.74 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.802 -0.561 . . . . 0.0 111.65 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.4 mtm105 -102.98 16.3 27.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.696 1.999 . . . . 0.0 110.614 162.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 93.6 m -123.91 133.94 53.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.66 1.584 . . . . 0.0 110.623 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 46.5 mt -101.11 138.36 38.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.755 2.422 . . . . 0.0 109.785 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -86.31 124.16 32.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 162.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.38 103.05 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.061 0.944 . . . . 0.0 108.466 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -82.17 -175.89 50.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 164.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.0 30.1 75.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.665 -0.903 . . . . 0.0 113.854 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.73 103.68 12.15 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.446 1.098 . . . . 0.0 110.045 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 144.73 64.88 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.277 1.985 . . . . 0.0 109.918 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.24 -19.67 66.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -63.76 -32.54 74.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.764 1.226 . . . . 0.0 112.858 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -87.84 154.79 20.26 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -134.13 -175.99 4.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.499 1.519 . . . . 0.0 111.312 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 1.7 mp0 -52.93 -38.4 61.9 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.167 2.187 . . . . 0.0 112.441 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -75.98 -26.61 56.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.58 -43.25 81.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.633 1.106 . . . . 0.0 109.679 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.72 -48.41 81.27 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.669 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.2 68.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.397 0.999 . . . . 0.0 113.023 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.56 -37.64 80.08 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.45 -33.09 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.095 0.861 . . . . 0.0 111.887 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.58 -14.13 55.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -49.86 -48.92 76.69 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.943 1.697 . . . . 0.0 115.426 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.71 -6.39 18.14 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.008 1.806 . . . . 0.0 112.955 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.33 -46.49 5.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.281 1.433 . . . . 0.0 112.12 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.24 1.69 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.062 1.745 . . . . 0.0 113.469 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.74 133.8 34.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.001 . . . . 0.0 110.913 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.05 130.02 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.707 1.203 . . . . 0.0 109.579 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -91.52 -44.39 9.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.087 0.955 . . . . 0.0 111.69 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.5 p -161.26 163.47 30.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.822 1.249 . . . . 0.0 111.25 -171.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -165.44 132.52 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.57 0.748 . . . . 0.0 111.767 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.93 105.42 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.43 115.52 29.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.103 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.88 83.64 2.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.617 1.567 . . . . 0.0 109.205 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -55.5 -37.93 68.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.174 0.99 . . . . 0.0 111.418 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 m -61.38 -28.89 69.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.872 2.069 . . . . 0.0 113.877 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.95 4.5 34.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.991 1.716 . . . . 0.0 112.817 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 79.9 mttt 55.38 34.6 23.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.178 1.791 . . . . 0.0 112.897 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -131.82 156.48 45.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.66 1.584 . . . . 0.0 113.59 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.76 134.25 28.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.125 1.37 . . . . 0.0 112.637 166.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -88.74 102.43 14.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 166.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 38.8 t -99.38 120.52 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.983 0.913 . . . . 0.0 110.964 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -106.19 126.33 52.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.078 0.951 . . . . 0.0 111.898 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.7 169.13 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.934 1.294 . . . . 0.0 110.168 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -75.48 -15.63 60.39 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -168.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.0 160.9 43.05 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.258 -0.901 . . . . 0.0 112.421 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.36 -41.99 98.85 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.594 0.758 . . . . 0.0 111.456 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.92 -41.64 87.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.346 0.521 . . . . 0.0 111.299 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.66 -51.84 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.08 0.952 . . . . 0.0 109.692 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.27 95.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.557 0.743 . . . . 0.0 112.633 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.3 -43.07 99.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.173 0.989 . . . . 0.0 111.267 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -66.52 -34.19 77.37 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.407 -0.808 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 66.2 t -60.37 -65.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.766 164.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.1 mt -51.95 -35.23 45.35 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -60.16 -37.48 80.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.837 1.255 . . . . 0.0 112.906 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.23 -27.41 7.64 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.56 125.87 28.2 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.78 23.06 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -53.83 -48.04 70.32 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.064 -1.023 . . . . 0.0 113.607 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.45 5.55 49.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.555 1.942 . . . . 0.0 112.806 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 72.62 38.71 57.16 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.566 1.079 . . . . 0.0 112.922 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -57.48 -29.52 64.32 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.232 1.013 . . . . 0.0 113.569 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.12 162.98 25.06 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.763 1.625 . . . . 0.0 110.045 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 -15.73 21.43 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.98 2.453 . . . . 0.0 113.408 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.68 161.01 21.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.342 2.257 . . . . 0.0 112.455 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -128.46 97.08 4.6 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.845 1.258 . . . . 0.0 109.995 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.98 21.24 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.46 1.904 . . . . 0.0 111.739 -177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.18 173.2 11.27 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.295 1.838 . . . . 0.0 108.999 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -70.18 125.44 26.78 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.154 -0.966 . . . . 0.0 110.902 163.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.46 -154.38 14.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.606 1.574 . . . . 0.0 109.174 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -163.49 136.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.646 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -94.42 -45.21 3.29 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.114 1.34 . . . . 0.0 110.296 163.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -124.29 109.99 14.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.148 0.979 . . . . 0.0 113.401 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -176.52 136.4 3.21 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.487 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.57 126.56 12.91 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.094 3.862 . . . . 0.0 110.194 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -36.6 80.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 112.404 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.07 -18.23 60.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.63 1.572 . . . . 0.0 114.285 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.2 27.18 8.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.753 1.621 . . . . 0.0 111.885 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.5 t -84.83 135.42 34.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.59 1.156 . . . . 0.0 111.69 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.05 79.6 1.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.349 1.46 . . . . 0.0 109.34 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -62.83 -24.05 67.58 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.517 -0.74 . . . . 0.0 112.926 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -64.22 -49.36 72.25 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.827 1.194 . . . . 0.0 111.321 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -81.72 -17.38 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 81.77 41.02 10.05 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 124.844 1.212 . . . . 0.0 112.624 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -147.54 165.79 29.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.62 1.21 . . . . 0.0 112.978 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 22.4 m -129.49 152.48 48.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.556 0.742 . . . . 0.0 110.368 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.76 136.24 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.43 120.04 21.97 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 120.331 1.423 . . . . 0.0 112.004 -173.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -69.31 126.64 13.86 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.981 2.454 . . . . 0.0 111.341 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -33.65 74.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.03 0.932 . . . . 0.0 113.069 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -65.65 -17.87 64.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -109.39 11.04 25.32 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 113.691 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 47.9 mt -90.37 145.28 25.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.885 0.874 . . . . 0.0 111.052 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 16.7 p -77.0 179.06 6.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.577 1.151 . . . . 0.0 111.175 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.11 -41.77 76.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.598 -0.689 . . . . 0.0 111.364 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.16 94.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.89 1.276 . . . . 0.0 111.901 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.92 -64.32 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.257 1.423 . . . . 0.0 111.923 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -63.29 -35.23 79.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.63 0.772 . . . . 0.0 111.472 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -53.1 -56.82 13.32 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.504 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -59.59 -39.77 85.28 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.742 1.61 . . . . 0.0 112.734 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.1 m -50.1 -43.48 51.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.426 1.012 . . . . 0.0 112.149 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.12 -21.22 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.6 t -117.68 -17.44 9.91 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.713 1.605 . . . . 0.0 113.905 -165.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.08 139.73 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.179 -0.951 . . . . 0.0 111.186 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -65.27 -49.39 69.75 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.901 0.48 . . . . 0.0 110.667 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -103.66 110.17 22.14 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.592 1.187 . . . . 0.0 108.92 163.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -175.7 -171.49 39.65 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.422 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -74.95 -64.69 2.27 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.101 -1.049 . . . . 0.0 113.642 -164.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 17.4 p -113.65 41.94 2.09 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.107 0.963 . . . . 0.0 110.005 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.8 m -55.74 100.75 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.271 -0.893 . . . . 0.0 111.986 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.97 -8.04 59.22 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 125.817 1.675 . . . . 0.0 115.895 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -110.14 146.39 34.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.264 2.225 . . . . 0.0 111.029 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.76 168.08 25.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.69 2.927 . . . . 0.0 112.21 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.32 121.52 30.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.652 0.781 . . . . 0.0 110.967 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.28 160.46 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.299 1.44 . . . . 0.0 110.602 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.6 m -58.31 125.75 24.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.558 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 83.85 6.34 87.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.846 1.212 . . . . 0.0 114.847 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.32 137.67 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.371 1.586 . . . . 0.0 111.115 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.55 138.52 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.164 2.185 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -165.45 -176.96 4.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.012 0.925 . . . . 0.0 113.169 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -100.2 146.54 26.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.575 1.55 . . . . 0.0 111.091 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.19 138.24 27.11 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -167.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.32 156.54 50.62 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.685 2.257 . . . . 0.0 112.419 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.84 142.66 58.35 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.917 0.887 . . . . 0.0 112.363 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.44 45.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 123.639 1.685 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 2.7 pt -49.75 149.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.249 143.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 5.5 t 64.5 12.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 120.052 1.296 . . . . 0.0 111.523 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -57.68 121.03 24.27 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.348 1.452 . . . . 0.0 113.316 -170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -166.95 165.67 15.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.066 0.947 . . . . 0.0 111.446 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -153.59 -158.88 8.81 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.152 1.358 . . . . 0.0 112.997 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.42 1.488 . . . . 0.0 111.514 178.606 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 19.0 tt -57.08 -31.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 120.449 1.477 . . . . 0.0 113.505 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 98.31 149.73 25.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.053 1.311 . . . . 0.0 111.986 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -153.53 158.02 32.7 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.248 1.419 . . . . 0.0 110.659 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.38 -178.74 3.12 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.187 2.591 . . . . 0.0 110.939 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -62.67 -14.58 45.3 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . 0.271 1.8 p 71.42 1.18 3.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.572 3.149 . . . . 0.0 114.378 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.13 -31.65 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 10.6 p90 48.17 -150.61 0.14 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.358 1.863 . . . . 0.0 113.663 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.77 -17.85 23.83 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.788 1.185 . . . . 0.0 115.217 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.8 m -66.47 -42.49 87.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.728 1.611 . . . . 0.0 111.48 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -107.74 -48.27 3.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.501 1.12 . . . . 0.0 112.046 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.51 171.57 16.83 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.303 1.441 . . . . 0.0 110.765 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -102.4 18.27 21.49 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -165.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.87 137.49 41.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.437 1.095 . . . . 0.0 113.282 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.2 -35.19 23.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.978 1.311 . . . . 0.0 111.564 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -120.19 73.58 20.35 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.951 0.9 . . . . 0.0 110.698 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.05 177.08 8.66 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.587 2.858 . . . . 0.0 111.591 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 61.61 59.32 1.85 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.446 1.498 . . . . 0.0 111.452 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -153.62 168.4 26.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.492 1.117 . . . . 0.0 113.158 -175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 92.4 mt -140.57 158.93 43.26 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.153 1.781 . . . . 0.0 110.497 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -79.16 71.68 5.67 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.101 0.961 . . . . 0.0 110.507 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.84 146.01 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.151 2.181 . . . . 0.0 110.724 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 72.1 p -60.97 -24.2 65.92 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.46 -26.48 62.73 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.253 -0.904 . . . . 0.0 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -79.47 124.34 83.99 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.788 1.235 . . . . 0.0 110.394 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.74 -18.78 63.6 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.941 1.761 . . . . 0.0 113.141 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -77.36 -2.51 35.41 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.711 1.204 . . . . 0.0 113.79 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.5 134.87 56.35 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.268 -1.52 . . . . 0.0 112.676 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -149.38 151.27 33.31 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.197 1.399 . . . . 0.0 110.013 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 159.86 50.59 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.07 2.514 . . . . 0.0 111.593 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -112.71 83.25 5.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.74 109.36 2.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.195 1.93 . . . . 0.0 109.799 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.42 132.6 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.479 1.112 . . . . 0.0 108.592 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 79.6 p -129.26 176.25 8.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.716 0.806 . . . . 0.0 111.06 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.16 124.18 18.85 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.533 1.133 . . . . 0.0 110.29 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -126.46 106.66 9.62 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.087 0.946 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.5 m -67.12 -2.9 6.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 114.118 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 -20.39 61.26 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.493 1.042 . . . . 0.0 112.391 170.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.09 151.09 90.32 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.72 0.691 . . . . 0.0 112.071 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.8 162.66 30.93 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.805 3.003 . . . . 0.0 113.04 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.6 133.55 28.1 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.539 2.826 . . . . 0.0 112.699 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.12 20.07 6.52 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 126.275 1.83 . . . . 0.0 112.808 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -106.47 155.49 19.53 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.78 154.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.94 2.096 . . . . 0.0 110.478 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -117.59 126.26 52.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.497 1.499 . . . . 0.0 111.855 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.86 107.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.748 0.819 . . . . 0.0 110.498 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -73.59 134.49 43.74 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.07 1.348 . . . . 0.0 111.658 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 38.3 t -70.44 144.29 51.52 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.557 -0.714 . . . . 0.0 111.322 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -123.88 28.91 6.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.816 1.646 . . . . 0.0 110.213 162.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.1 m -127.43 143.14 51.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.393 1.877 . . . . 0.0 109.556 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.57 126.4 55.3 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.239 1.816 . . . . 0.0 108.708 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.09 119.45 27.33 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.6 110.04 30.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.86 37.07 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.494 0.568 . . . . 0.0 112.441 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.38 21.19 70.24 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 169.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.97 128.63 93.2 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.383 1.073 . . . . 0.0 109.928 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.29 130.49 18.77 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.333 2.022 . . . . 0.0 109.396 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 pp -61.13 -20.18 62.37 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -166.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 -21.55 59.28 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.29 147.43 22.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.277 0.944 . . . . 0.0 113.23 -173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -120.47 -179.77 4.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 112.441 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -49.67 -39.17 35.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.613 1.565 . . . . 0.0 114.467 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.92 -14.95 57.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -79.39 -36.56 39.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.264 0.938 . . . . 0.0 110.791 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.48 -51.05 69.94 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.17 -39.14 69.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.21 -42.59 75.53 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.48 -32.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.182 1.356 . . . . 0.0 111.686 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 44.1 mt -81.81 -14.5 56.27 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.196 0.999 . . . . 0.0 112.824 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -43.23 -50.27 15.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.523 1.929 . . . . 0.0 116.193 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.45 -8.34 17.19 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.29 1.994 . . . . 0.0 114.12 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.64 -38.73 9.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.071 1.748 . . . . 0.0 112.236 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.04 160.46 2.77 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.442 1.897 . . . . 0.0 112.776 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.15 106.76 18.7 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.655 0.74 . . . . 0.0 109.033 162.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.77 137.65 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.67 1.188 . . . . 0.0 111.133 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -89.59 -41.84 11.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.436 1.094 . . . . 0.0 111.602 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.59 148.7 28.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.768 1.227 . . . . 0.0 111.031 -170.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.0 t -144.96 137.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 119.171 0.896 . . . . 0.0 110.877 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.86 104.32 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 165.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.85 98.96 11.72 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.588 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -83.25 75.07 9.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.433 1.111 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -56.39 -32.25 64.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.1 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -59.51 -23.44 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.445 1.498 . . . . 0.0 113.786 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.08 13.23 12.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 112.912 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.86 34.05 23.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.328 1.451 . . . . 0.0 112.222 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -117.27 156.55 27.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.415 1.886 . . . . 0.0 112.741 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.5 135.39 28.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 112.112 161.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.11 124.31 31.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 162.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.5 101.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 108.846 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -90.21 116.47 28.22 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.116 1.366 . . . . 0.0 110.019 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.69 149.22 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.313 1.045 . . . . 0.0 108.347 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -74.97 3.57 8.09 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 t -160.32 147.15 15.82 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.25 -1.531 . . . . 0.0 112.903 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -59.89 -39.69 86.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.213 1.405 . . . . 0.0 111.085 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.85 -35.05 79.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.932 0.493 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -68.26 -53.36 25.06 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.796 0.838 . . . . 0.0 110.696 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.14 87.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -64.9 -44.09 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.484 168.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -65.34 -29.03 69.73 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.058 1.299 . . . . 0.0 112.555 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.2 -67.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 118.872 0.76 . . . . 0.0 109.672 161.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.98 -30.87 62.44 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.1 -35.7 81.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.049 1.74 . . . . 0.0 112.756 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.95 -25.76 7.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -75.17 124.57 27.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.327 1.051 . . . . 0.0 111.26 -167.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 59.76 28.35 17.79 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.253 1.821 . . . . 0.0 114.067 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -62.43 -25.88 68.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.716 -1.24 . . . . 0.0 114.186 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.56 -15.12 46.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.447 1.099 . . . . 0.0 113.42 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.01 83.69 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.703 1.144 . . . . 0.0 114.098 -173.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.0 29.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.815 1.646 . . . . 0.0 115.375 -171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.18 151.09 59.37 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.215 0.916 . . . . 0.0 110.39 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.65 -23.75 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.832 2.355 . . . . 0.0 112.736 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.71 142.36 51.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.594 1.958 . . . . 0.0 112.423 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -115.92 90.28 3.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.047 0.939 . . . . 0.0 109.836 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.1 m -79.04 116.28 19.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.542 1.137 . . . . 0.0 109.867 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -116.38 165.88 12.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.681 1.993 . . . . 0.0 108.846 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -63.43 131.19 47.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.741 -1.225 . . . . 0.0 109.992 158.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -112.41 -155.19 12.4 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 125.555 1.55 . . . . 0.0 109.799 164.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.0 p -165.6 141.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 117.798 0.799 . . . . 0.0 111.365 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.31 -45.34 4.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.009 163.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -118.42 102.52 8.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.742 1.217 . . . . 0.0 112.916 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.33 123.73 1.13 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 118.789 -1.006 . . . . 0.0 115.284 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.84 128.92 10.36 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.473 3.449 . . . . 0.0 111.302 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -61.19 -32.6 72.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.34 -24.56 66.54 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.762 1.625 . . . . 0.0 113.205 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 23.1 m -134.84 32.42 3.25 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 112.255 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.72 140.97 49.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.999 1.319 . . . . 0.0 111.476 171.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -131.75 78.69 1.83 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.023 1.729 . . . . 0.0 109.338 163.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -64.41 -12.88 47.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 113.375 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.85 -47.49 18.68 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.685 1.129 . . . . 0.0 111.152 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -80.59 -17.13 52.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.305 0.642 . . . . 0.0 112.623 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.72 47.53 9.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.082 1.325 . . . . 0.0 112.083 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -147.65 171.81 15.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.771 1.286 . . . . 0.0 112.376 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 20.3 m -141.24 150.35 42.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.993 1.317 . . . . 0.0 110.591 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.49 132.37 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.11 124.41 25.34 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 119.537 1.062 . . . . 0.0 111.768 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.05 140.05 17.65 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.549 2.833 . . . . 0.0 112.636 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.81 -19.85 66.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.767 1.627 . . . . 0.0 113.985 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -74.58 -21.66 59.38 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.93 0.786 . . . . 0.0 112.911 172.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -95.51 -26.43 15.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.38 112.62 2.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.684 1.129 . . . . 0.0 109.506 169.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 36.6 p -66.93 177.33 1.73 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.29 1.436 . . . . 0.0 111.491 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -59.97 -38.9 83.85 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.056 -1.028 . . . . 0.0 111.905 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.39 -37.9 65.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.624 0.77 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.31 -51.43 69.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.746 1.218 . . . . 0.0 111.286 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -65.93 -36.27 82.91 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.621 -0.674 . . . . 0.0 111.535 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -51.94 67.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.076 0.853 . . . . 0.0 111.515 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.17 -44.61 94.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.226 1.375 . . . . 0.0 110.667 175.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 m -56.37 -32.84 65.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.249 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.41 -34.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 47.6 m -102.3 -9.27 20.52 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -168.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.63 152.19 27.03 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.952 1.251 . . . . 0.0 112.768 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -81.35 -38.77 26.14 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.135 0.574 . . . . 0.0 110.922 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -116.48 137.3 52.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.247 1.019 . . . . 0.0 110.749 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.43 -169.9 51.2 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.361 -168.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 69.54 -162.11 52.27 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.293 0.949 . . . . 0.0 113.266 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 29.3 p -95.11 1.76 54.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.549 1.54 . . . . 0.0 114.373 -168.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 19.7 m 66.89 11.93 8.62 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.46 1.027 . . . . 0.0 113.655 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.22 48.23 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.303 1.43 . . . . 0.0 114.33 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.7 154.23 93.09 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.469 1.135 . . . . 0.0 110.725 169.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.12 148.7 81.54 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.901 2.4 . . . . 0.0 111.051 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.1 105.53 5.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.547 -0.721 . . . . 0.0 110.011 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.39 158.91 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.653 1.581 . . . . 0.0 110.73 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 76.2 m -60.15 133.13 55.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.02 84.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.491 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.99 135.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.937 1.868 . . . . 0.0 111.78 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 36.3 t -120.01 139.45 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 126.376 1.87 . . . . 0.0 109.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -163.52 -176.1 4.53 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.237 1.015 . . . . 0.0 112.743 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.54 148.2 22.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.341 1.457 . . . . 0.0 109.434 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -49.16 131.03 16.35 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.44 157.25 56.91 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.729 2.286 . . . . 0.0 111.612 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -58.38 134.78 56.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.582 1.153 . . . . 0.0 112.757 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.32 58.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 123.572 1.653 . . . . 0.0 109.966 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.96 174.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.068 140.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.51 -66.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 O-C-N 121.06 -1.025 . . . . 0.0 110.195 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.09 -66.7 3.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.195 0.902 . . . . 0.0 112.117 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -166.17 153.39 9.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.879 1.672 . . . . 0.0 110.387 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -172.82 160.62 31.65 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.483 1.039 . . . . 0.0 113.248 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.211 1.404 . . . . 0.0 112.16 177.255 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 26.2 mm 71.42 145.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 127.475 2.31 . . . . 0.0 111.595 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -100.27 51.2 1.04 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.152 1.358 . . . . 0.0 112.895 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . 69.52 169.32 0.11 Allowed Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 126.789 2.036 . . . . 0.0 111.759 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.78 -157.6 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.478 2.786 . . . . 0.0 112.246 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -53.34 -41.06 65.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.247 1.019 . . . . 0.0 113.047 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.4 p 48.25 29.53 1.92 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.014 2.526 . . . . 0.0 113.989 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -77.22 -13.69 59.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.824 1.65 . . . . 0.0 113.391 -174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -50.05 138.34 15.86 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 112.485 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 133.41 -67.32 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.7 1.143 . . . . 0.0 112.148 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.0 t -153.06 8.81 0.42 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -106.9 -66.91 0.98 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.013 -1.054 . . . . 0.0 112.074 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.7 177.37 11.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.663 1.185 . . . . 0.0 112.216 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -122.93 -10.51 8.2 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -63.73 138.1 58.35 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.57 0.748 . . . . 0.0 111.414 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.55 -43.75 93.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.154 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.86 156.87 35.51 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.835 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.46 89.66 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.271 3.314 . . . . 0.0 112.156 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 50.7 41.09 25.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.166 1.387 . . . . 0.0 111.106 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -55.15 150.44 10.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.377 1.471 . . . . 0.0 113.031 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.89 161.23 17.87 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.513 1.125 . . . . 0.0 110.417 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -79.02 68.7 5.04 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.865 0.866 . . . . 0.0 111.596 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 146.9 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 127.132 2.173 . . . . 0.0 110.237 -170.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 87.8 p -63.17 -25.4 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -69.9 -23.34 63.22 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.269 -0.894 . . . . 0.0 112.705 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -83.28 122.78 77.45 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.915 1.286 . . . . 0.0 110.564 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.27 -17.89 50.13 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.398 2.066 . . . . 0.0 113.125 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -74.52 1.44 11.95 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -51.08 127.42 18.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.682 1.583 . . . . 0.0 111.645 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -157.19 147.35 15.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.56 1.544 . . . . 0.0 110.85 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.7 173.76 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.67 2.247 . . . . 0.0 111.541 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -108.55 83.3 1.95 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.941 0.896 . . . . 0.0 110.194 167.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.55 141.08 30.73 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.26 2.64 . . . . 0.0 110.303 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.72 145.19 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.208 1.403 . . . . 0.0 108.524 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 75.9 p -140.39 179.78 6.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.178 0.991 . . . . 0.0 111.084 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -143.92 130.77 20.36 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.093 -1.005 . . . . 0.0 110.085 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -107.64 102.93 12.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.274 1.03 . . . . 0.0 109.643 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -12.77 17.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.002 1.321 . . . . 0.0 113.667 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.88 0.92 54.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.691 1.597 . . . . 0.0 113.018 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.6 154.61 50.86 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.644 1.111 . . . . 0.0 113.688 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 162.73 40.98 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.948 3.766 . . . . 0.0 113.191 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.03 138.98 34.9 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.445 3.43 . . . . 0.0 112.937 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.04 37.33 18.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.921 1.288 . . . . 0.0 111.744 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -115.61 140.24 49.36 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.62 -1.3 . . . . 0.0 112.763 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 25.6 pt -106.81 146.15 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.387 1.475 . . . . 0.0 109.591 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 117.96 33.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.504 1.121 . . . . 0.0 109.494 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.7 106.93 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 O-C-N 122.096 -0.377 . . . . 0.0 110.568 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.08 128.84 36.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.811 1.244 . . . . 0.0 111.793 170.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 66.1 m -69.16 144.7 53.73 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -131.72 16.02 4.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.484 2.714 . . . . 0.0 110.843 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 13.3 m -110.27 129.68 55.69 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.117 1.767 . . . . 0.0 108.786 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.08 136.44 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.615 1.566 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -93.63 142.87 26.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 159.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.79 106.32 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.98 1.312 . . . . 0.0 108.709 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.41 41.81 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.831 0.729 . . . . 0.0 111.966 168.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.6 78.65 Favored Glycine 0 N--CA 1.475 1.234 0 O-C-N 122.054 -0.674 . . . . 0.0 114.651 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.4 t -78.79 119.97 79.19 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.532 1.166 . . . . 0.0 110.358 -171.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 138.53 34.42 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.721 2.28 . . . . 0.0 109.609 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -16.81 54.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -29.48 63.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.139 0.976 . . . . 0.0 112.557 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.9 mtm -78.79 149.33 32.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.63 0.728 . . . . 0.0 112.735 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -127.83 -178.33 4.46 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.878 2.071 . . . . 0.0 111.222 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -51.08 -41.55 60.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.844 1.658 . . . . 0.0 114.449 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -77.12 -17.63 58.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.69 -40.31 61.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.272 0.942 . . . . 0.0 110.545 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.26 -47.35 86.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.497 0.59 . . . . 0.0 110.939 170.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.33 -34.16 72.01 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.717 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.72 -42.42 64.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.954 1.252 . . . . 0.0 114.376 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.27 -37.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.964 0.802 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 32.6 mt -85.75 -5.32 59.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.893 0.877 . . . . 0.0 112.479 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -52.85 -49.83 84.72 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.966 1.707 . . . . 0.0 115.161 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.67 -5.01 16.39 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.457 2.105 . . . . 0.0 113.431 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -101.23 -39.56 7.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.191 1.396 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.5 167.28 5.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.643 1.977 . . . . 0.0 113.111 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -92.67 102.1 14.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.67 1.188 . . . . 0.0 111.642 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.51 118.58 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.883 0.873 . . . . 0.0 110.929 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -91.95 -36.13 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.897 1.679 . . . . 0.0 112.778 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.7 t -144.16 153.16 41.83 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.318 0.963 . . . . 0.0 112.169 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -144.81 140.35 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.855 0.862 . . . . 0.0 111.259 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.61 97.79 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.313 1.445 . . . . 0.0 108.019 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -97.3 132.99 42.5 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.858 0.463 . . . . 0.0 110.734 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.05 89.09 2.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.976 1.31 . . . . 0.0 109.769 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.46 -37.45 83.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.087 1.355 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.1 t -58.47 -32.43 68.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.055 1.742 . . . . 0.0 113.064 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -98.45 -1.0 42.39 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.151 1.38 . . . . 0.0 113.197 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 59.03 30.95 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.399 1.88 . . . . 0.0 113.408 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.29 170.5 15.62 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.66 24.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 111.68 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.14 140.12 53.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.377 1.471 . . . . 0.0 108.895 164.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.77 111.96 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.493 1.117 . . . . 0.0 109.705 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -92.45 119.97 32.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.565 0.746 . . . . 0.0 110.239 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.27 176.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.907 0.883 . . . . 0.0 108.918 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 147.4 46.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.601 -0.687 . . . . 0.0 111.268 -164.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.65 81.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.759 0.824 . . . . 0.0 110.652 166.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -39.93 80.53 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.053 0.842 . . . . 0.0 112.435 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -65.63 -52.38 52.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.674 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.56 80.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.411 1.085 . . . . 0.0 113.037 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.47 -41.57 98.88 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -61.72 -32.61 72.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.645 1.111 . . . . 0.0 111.916 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.73 -62.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.858 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.61 -36.98 26.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.208 1.403 . . . . 0.0 114.111 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.56 -38.59 70.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.377 1.471 . . . . 0.0 112.885 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -106.73 -26.31 11.36 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . 0.409 ' CZ ' HD11 ' A' ' 400' ' ' LEU . 25.4 t80 -70.89 127.7 33.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -171.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 29.0 t30 60.66 28.42 18.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.39 1.476 . . . . 0.0 113.9 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -59.64 -34.75 73.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.853 -1.154 . . . . 0.0 113.325 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.32 -20.14 60.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.883 1.273 . . . . 0.0 113.063 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.86 19.61 75.06 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.929 1.252 . . . . 0.0 113.725 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.78 -32.67 17.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.242 1.417 . . . . 0.0 114.291 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 394' ' ' PHE . 20.0 mt -77.48 146.77 74.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.859 0.864 . . . . 0.0 109.093 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.79 -18.9 28.0 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.17 1.913 . . . . 0.0 112.718 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.8 mt -82.27 144.43 30.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.048 0.939 . . . . 0.0 112.524 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.14 9.71 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 110.245 174.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 33.3 m -83.11 125.12 31.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.237 1.415 . . . . 0.0 110.628 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.83 174.98 9.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.022 2.129 . . . . 0.0 109.661 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -72.53 122.87 22.06 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.207 -0.933 . . . . 0.0 111.398 163.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.83 -177.72 35.08 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.281 1.419 . . . . 0.0 110.551 163.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.64 119.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.679 0.791 . . . . 0.0 109.619 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.49 -36.78 10.26 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.759 1.647 . . . . 0.0 110.943 161.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -145.99 109.19 4.65 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.921 0.861 . . . . 0.0 112.149 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.34 133.74 2.13 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.821 -0.988 . . . . 0.0 115.467 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.25 122.17 7.79 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 125.268 3.978 . . . . 0.0 110.83 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -55.27 -37.18 66.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -74.99 -16.41 60.62 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.694 1.598 . . . . 0.0 114.16 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.7 m -127.21 27.82 5.84 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.916 1.686 . . . . 0.0 111.93 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.65 140.48 29.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.201 1.401 . . . . 0.0 111.669 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -126.12 87.78 2.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.444 1.116 . . . . 0.0 109.567 167.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.25 -22.0 65.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.835 0.854 . . . . 0.0 113.181 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -68.77 -51.97 35.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.077 0.853 . . . . 0.0 110.232 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.09 -18.72 59.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.11 45.55 8.86 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.415 1.007 . . . . 0.0 112.459 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -154.6 175.33 13.79 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.306 1.05 . . . . 0.0 112.99 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 35.2 p -147.22 153.32 39.67 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.414 1.086 . . . . 0.0 110.967 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mm -108.33 135.34 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.42 109.73 17.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 119.843 1.201 . . . . 0.0 110.523 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.65 131.94 27.43 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.595 2.197 . . . . 0.0 110.917 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 45.7 mtt -64.7 -15.72 61.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.687 1.195 . . . . 0.0 113.132 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -65.35 -25.16 67.47 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 113.038 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 13.08 14.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.426 2.29 . . . . 0.0 113.243 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.4 mt -85.0 176.41 8.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.521 1.528 . . . . 0.0 111.706 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 2.3 p -127.87 165.06 20.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 110.759 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -65.92 -37.28 85.67 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.041 -1.037 . . . . 0.0 111.41 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.83 -42.21 90.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.771 0.829 . . . . 0.0 112.071 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -48.48 70.0 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.022 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.45 -38.12 86.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.017 0.826 . . . . 0.0 110.107 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.06 -33.05 71.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.659 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -72.56 -45.32 59.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.266 1.394 . . . . 0.0 111.858 168.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 m -53.21 -39.7 63.9 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.767 1.167 . . . . 0.0 111.402 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.24 -48.12 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.2 m -93.49 -5.95 47.97 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.22 138.19 45.55 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.896 1.225 . . . . 0.0 112.533 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -78.02 -27.36 48.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.569 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -124.89 138.46 54.25 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.611 1.564 . . . . 0.0 111.221 164.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.02 -168.64 47.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.396 -172.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.18 -156.91 53.5 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.23 0.443 . . . . 0.0 112.556 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.6 p -107.27 11.77 28.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.24 1.416 . . . . 0.0 114.746 -159.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.5 t 66.19 14.87 9.86 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.911 -1.118 . . . . 0.0 113.21 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.08 61.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.281 1.42 . . . . 0.0 114.233 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -68.19 145.37 97.51 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 119.309 1.555 . . . . 0.0 111.126 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.32 148.27 90.94 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.981 2.454 . . . . 0.0 110.976 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.1 109.4 8.55 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.047 0.451 . . . . 0.0 110.448 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.75 170.87 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.966 1.706 . . . . 0.0 111.471 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.9 m -57.23 119.36 6.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.29 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.19 79.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.283 0.945 . . . . 0.0 115.123 172.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.6 tt -58.27 125.01 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.176 1.488 . . . . 0.0 111.184 172.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.08 132.93 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.707 1.603 . . . . 0.0 109.003 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.79 170.52 21.44 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.154 0.982 . . . . 0.0 112.071 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.91 147.59 25.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.593 1.157 . . . . 0.0 108.982 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -40.0 125.17 1.63 Allowed Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.529 1.132 . . . . 0.0 113.966 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.07 150.6 85.15 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.489 1.459 . . . . 0.0 110.111 172.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -56.7 161.4 2.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.504 1.145 . . . . 0.0 113.52 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 1.4 mt -118.94 47.49 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 123.231 1.491 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.58 140.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.24 -47.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.673 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.68 -99.68 1.38 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.19 134.97 7.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.972 1.309 . . . . 0.0 110.431 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -127.05 -160.82 10.66 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.779 1.657 . . . . 0.0 112.997 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.177 1.391 . . . . 0.0 110.833 178.209 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.22 145.25 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.085 1.354 . . . . 0.0 110.473 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -74.76 165.07 54.73 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.746 0.689 . . . . 0.0 111.867 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -131.96 154.93 81.88 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.583 1.153 . . . . 0.0 111.764 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.72 178.56 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 124.481 3.454 . . . . 0.0 112.326 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -24.3 67.72 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.748 0.819 . . . . 0.0 112.851 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.3 m 76.93 9.0 2.88 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 127.482 2.313 . . . . 0.0 112.399 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.47 -32.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.173 2.189 . . . . 0.0 114.101 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 50.42 63.73 2.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.324 1.85 . . . . 0.0 112.877 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -100.42 17.97 56.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.469 1.509 . . . . 0.0 115.482 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 9.6 t -118.53 -52.73 2.35 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.089 1.356 . . . . 0.0 113.203 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.2 -64.44 1.15 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.843 0.857 . . . . 0.0 112.384 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -159.82 -102.77 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.218 1.407 . . . . 0.0 110.526 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -160.13 18.65 0.15 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 113.681 -164.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -79.54 140.12 37.32 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.361 1.064 . . . . 0.0 111.388 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.74 -47.03 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.182 0.593 . . . . 0.0 110.609 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -119.53 81.3 23.6 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.139 1.376 . . . . 0.0 110.231 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.71 -28.3 14.08 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.711 2.274 . . . . 0.0 112.028 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.92 56.39 3.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.104 1.362 . . . . 0.0 110.844 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.39 144.02 28.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.818 1.247 . . . . 0.0 111.225 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.16 165.84 18.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.47 1.508 . . . . 0.0 110.096 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -77.06 73.74 3.64 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.524 -0.735 . . . . 0.0 110.805 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 38.8 t -133.19 145.68 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.432 2.293 . . . . 0.0 110.196 -171.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.6 t -53.94 -31.19 49.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -66.49 -27.12 67.54 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.937 -1.102 . . . . 0.0 112.781 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -81.7 126.74 74.94 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.681 1.193 . . . . 0.0 110.685 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.84 -17.17 55.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.715 2.277 . . . . 0.0 113.677 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.35 6.94 5.93 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.57 125.63 23.03 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 120.685 -1.259 . . . . 0.0 111.654 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.5 mmt-85 -156.09 147.16 16.52 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 111.358 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.01 174.28 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.916 2.411 . . . . 0.0 111.145 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -115.98 77.72 7.04 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.999 0.92 . . . . 0.0 110.084 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.39 135.84 23.01 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.485 2.79 . . . . 0.0 110.306 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 t -147.46 140.64 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.055 1.342 . . . . 0.0 108.866 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.04 173.4 10.76 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.984 1.314 . . . . 0.0 111.043 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -137.17 124.64 22.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.31 1.044 . . . . 0.0 109.988 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -119.36 103.07 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.216 1.008 . . . . 0.0 110.589 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.0 p -66.8 -5.03 10.61 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.499 1.519 . . . . 0.0 113.972 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -22.4 64.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.802 0.841 . . . . 0.0 112.509 168.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.92 153.04 95.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.875 0.87 . . . . 0.0 112.179 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.13 161.99 31.49 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.799 2.999 . . . . 0.0 112.557 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.78 131.54 18.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.894 3.062 . . . . 0.0 112.122 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.88 44.89 3.42 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.254 1.822 . . . . 0.0 111.558 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -130.33 155.26 46.64 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.5 pt -128.25 144.77 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.101 1.761 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -100.43 115.86 31.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.232 1.413 . . . . 0.0 109.659 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.6 102.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.475 0.71 . . . . 0.0 110.384 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -71.17 136.2 47.98 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.401 1.08 . . . . 0.0 111.776 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.2 t -75.48 140.23 42.71 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.16 -0.962 . . . . 0.0 112.173 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.4 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 4.7 mtm180 -110.32 2.34 19.07 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.896 1.678 . . . . 0.0 111.288 165.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 35.9 m -104.65 129.32 52.82 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.084 1.353 . . . . 0.0 109.567 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.33 137.43 34.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.064 1.746 . . . . 0.0 108.604 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -91.79 137.82 32.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 159.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 19.8 mm -127.69 108.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 108.398 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.82 -177.55 38.09 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.328 0.966 . . . . 0.0 112.229 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.01 16.58 64.39 Favored Glycine 0 N--CA 1.477 1.402 0 C-N-CA 124.189 0.9 . . . . 0.0 114.87 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.2 t -71.85 129.16 88.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 118.141 0.971 . . . . 0.0 110.262 -164.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.94 130.21 22.53 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.366 2.044 . . . . 0.0 109.278 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.41 -19.09 54.87 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.24 -29.56 64.05 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.517 -0.739 . . . . 0.0 112.906 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.4 ptp -84.5 145.93 27.86 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -120.25 -177.83 3.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.231 1.812 . . . . 0.0 112.494 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.86 -41.04 44.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.288 1.435 . . . . 0.0 113.559 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -76.47 -22.55 54.41 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.49 -35.27 65.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.76 0.709 . . . . 0.0 110.79 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.55 -51.18 70.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.987 0.812 . . . . 0.0 110.437 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.11 -38.23 67.89 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.464 0.574 . . . . 0.0 112.416 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -72.53 -42.96 64.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.115 1.366 . . . . 0.0 114.474 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.32 -31.94 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 120.462 1.483 . . . . 0.0 111.049 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 35.7 mt -89.22 -9.36 51.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.26 1.024 . . . . 0.0 112.885 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -49.45 -49.04 73.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.705 1.602 . . . . 0.0 114.828 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.05 -6.24 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.089 1.859 . . . . 0.0 113.202 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -100.73 -33.91 10.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.45 1.5 . . . . 0.0 112.983 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.88 168.08 3.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 113.946 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 113.03 20.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.838 1.255 . . . . 0.0 110.81 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.63 121.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.65 . . . . 0.0 109.547 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -92.81 -37.05 12.52 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.412 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.71 158.66 43.69 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.085 -1.01 . . . . 0.0 112.094 -174.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.4 p -166.05 136.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.688 0.795 . . . . 0.0 111.378 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.51 97.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.137 1.375 . . . . 0.0 107.578 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.4 HD22 HD22 ' A' ' 372' ' ' ASN . 5.5 tt -89.96 126.87 35.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.615 0.366 . . . . 0.0 110.07 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 83.16 1.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.035 1.334 . . . . 0.0 109.02 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . 0.4 HD22 HD22 ' A' ' 370' ' ' LEU . 3.8 t-20 -63.3 -30.35 71.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.864 0.865 . . . . 0.0 112.694 -173.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 9.0 t -48.08 -39.06 19.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.658 1.983 . . . . 0.0 113.596 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -103.87 8.61 36.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.548 1.539 . . . . 0.0 113.682 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 56.68 36.6 27.9 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.98 1.312 . . . . 0.0 112.221 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -133.29 165.33 25.07 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.53 163.0 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.736 1.214 . . . . 0.0 111.699 165.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.48 141.73 47.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 108.543 162.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.9 t -138.43 118.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.026 0.53 . . . . 0.0 111.775 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -99.4 126.06 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 112.836 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.63 179.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.395 1.078 . . . . 0.0 111.296 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -65.35 -35.47 81.06 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 57.5 p -149.01 168.62 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.054 1.297 . . . . 0.0 114.384 -168.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.62 98.1 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.734 169.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -58.1 -45.01 87.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.063 0.847 . . . . 0.0 111.953 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.74 -47.06 79.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.375 0.67 . . . . 0.0 110.519 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.91 96.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 111.759 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.81 -40.96 97.87 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.005 0.922 . . . . 0.0 111.169 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.65 -33.49 75.15 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.792 1.633 . . . . 0.0 112.239 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.91 -64.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 118.883 -0.579 . . . . 0.0 110.512 165.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.45 -29.33 49.29 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -67.89 -34.49 76.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.651 1.98 . . . . 0.0 112.998 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -123.49 -27.25 4.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.34 121.41 16.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.954 0.902 . . . . 0.0 111.06 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 38.0 t30 57.97 27.91 15.44 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.435 1.494 . . . . 0.0 114.398 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -62.62 -32.78 73.86 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.362 -1.461 . . . . 0.0 113.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.86 -19.02 62.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 113.076 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.02 80.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.014 1.292 . . . . 0.0 113.563 -171.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.94 34.69 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.392 1.477 . . . . 0.0 114.052 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.21 149.44 55.53 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.512 1.125 . . . . 0.0 109.672 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.79 -23.73 13.98 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.593 2.195 . . . . 0.0 113.417 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.81 150.72 27.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.101 2.161 . . . . 0.0 113.101 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.7 91.36 3.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.543 1.137 . . . . 0.0 110.683 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 25.8 m -85.27 127.73 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.199 1.4 . . . . 0.0 111.14 -170.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -137.77 172.83 12.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.908 2.083 . . . . 0.0 109.622 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -70.98 120.39 16.48 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.04 -1.037 . . . . 0.0 111.005 164.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.36 -161.73 32.71 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 162.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 16.9 t -143.22 122.54 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.566 1.146 . . . . 0.0 108.903 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -86.15 -40.79 7.32 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 164.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -142.4 125.13 15.93 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.181 0.992 . . . . 0.0 111.265 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.99 132.17 1.66 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.676 -1.069 . . . . 0.0 114.37 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.53 123.83 10.21 Favored 'Trans proline' 0 C--N 1.349 0.566 1 C-N-CA 125.316 4.011 . . . . 0.0 109.698 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.43 -39.49 79.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.141 0.496 . . . . 0.0 112.104 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.78 -24.03 66.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.511 1.924 . . . . 0.0 113.501 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 6.4 m -119.96 20.9 12.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.542 1.537 . . . . 0.0 111.896 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.95 139.62 30.42 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.291 1.436 . . . . 0.0 111.973 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.85 90.65 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.954 1.302 . . . . 0.0 109.43 166.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -67.71 -21.73 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -69.52 -51.14 38.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.643 0.656 . . . . 0.0 110.489 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -78.57 -19.8 51.98 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.12 38.32 19.15 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.88 1.228 . . . . 0.0 113.12 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.64 167.06 26.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.185 0.993 . . . . 0.0 113.4 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.2 m -132.24 149.86 52.28 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.331 1.053 . . . . 0.0 111.035 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 10.0 mm -107.55 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.3 mt -97.55 122.56 55.04 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 121.007 -1.058 . . . . 0.0 111.056 -169.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.43 131.94 21.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.44 2.093 . . . . 0.0 111.25 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -27.7 68.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.522 1.129 . . . . 0.0 113.446 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.24 -20.99 63.94 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.426 1.012 . . . . 0.0 113.568 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.15 8.79 28.2 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.323 1.849 . . . . 0.0 112.699 -176.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 38.4 mt -92.6 147.69 22.68 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.991 1.716 . . . . 0.0 110.81 168.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 21.9 p -83.61 175.15 9.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.595 1.158 . . . . 0.0 111.155 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.92 -41.65 97.59 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.757 -0.589 . . . . 0.0 111.42 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.97 -40.55 95.16 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.952 0.901 . . . . 0.0 112.028 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.64 -53.16 61.43 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.593 1.157 . . . . 0.0 112.279 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.05 -40.66 96.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.812 0.845 . . . . 0.0 111.001 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -58.01 -41.78 83.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.243 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -69.93 -44.82 68.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.824 1.647 . . . . 0.0 111.758 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.4 m -52.7 -35.43 55.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.423 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.15 -43.74 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.6 t -96.68 -11.19 25.49 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.573 -1.329 . . . . 0.0 114.429 -166.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.49 139.39 53.45 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.048 -1.032 . . . . 0.0 111.943 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -77.08 -25.24 52.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.456 0.703 . . . . 0.0 112.02 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -125.97 140.12 52.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.294 1.838 . . . . 0.0 110.293 166.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.86 -179.81 40.77 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.051 0.834 . . . . 0.0 113.266 -174.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.79 -152.72 47.86 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 122.282 -0.54 . . . . 0.0 113.401 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.0 p -102.64 0.29 33.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -161.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.3 t 71.14 22.83 4.31 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 120.364 1.438 . . . . 0.0 113.556 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 85.77 3.63 85.74 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 120.594 -1.316 . . . . 0.0 113.406 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.92 151.51 89.3 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 118.74 1.27 . . . . 0.0 110.119 166.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -61.96 142.88 94.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.27 1.98 . . . . 0.0 109.865 169.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.66 109.2 3.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 32.1 m -105.72 154.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.225 1.41 . . . . 0.0 110.091 174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -59.72 131.73 51.82 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.64 -13.0 67.09 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.22 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.08 130.67 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.119 1.96 . . . . 0.0 111.558 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.4 t -116.54 130.72 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.515 1.926 . . . . 0.0 108.81 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.31 -175.69 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.0 111.372 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.32 149.36 26.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.484 1.914 . . . . 0.0 111.134 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 4.5 pt-20 -44.79 129.47 5.19 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.789 1.636 . . . . 0.0 114.274 -165.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 162.75 41.53 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.43 2.087 . . . . 0.0 111.949 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -68.34 138.72 55.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.7 mm -103.67 47.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 123.404 1.573 . . . . 0.0 109.739 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pt -54.37 179.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.865 141.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.18 -41.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 120.206 -1.559 . . . . 0.0 112.687 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.92 -45.58 2.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.687 1.137 . . . . 0.0 112.895 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -153.25 -67.24 0.15 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.692 1.597 . . . . 0.0 111.141 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.47 17.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.949 1.261 . . . . 0.0 112.835 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.279 1.431 . . . . 0.0 112.799 177.764 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 40.4 mt 55.99 73.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 126.021 1.729 . . . . 0.0 110.716 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 168.85 151.06 6.99 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.059 0.837 . . . . 0.0 112.824 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -138.12 161.4 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.893 1.677 . . . . 0.0 109.947 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.25 -155.41 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.061 3.174 . . . . 0.0 111.807 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.44 -33.49 67.97 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.947 -1.096 . . . . 0.0 113.468 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 77.2 p 50.0 30.03 3.82 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 127.857 2.463 . . . . 0.0 114.027 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.26 -7.63 59.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.13 1.772 . . . . 0.0 113.976 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -57.97 127.1 30.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.351 1.46 . . . . 0.0 111.286 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 73.68 13.07 80.61 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.987 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.4 m -128.88 -46.5 1.26 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.382 1.473 . . . . 0.0 111.42 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -130.48 -70.96 0.6 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.816 0.846 . . . . 0.0 111.914 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -134.29 -167.73 2.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.231 1.412 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -117.63 -1.43 11.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -67.54 133.66 49.86 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.908 0.883 . . . . 0.0 110.493 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.0 mp -68.49 -43.94 75.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.207 0.527 . . . . 0.0 112.181 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 159.19 86.21 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.786 1.234 . . . . 0.0 112.858 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.73 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.754 3.636 . . . . 0.0 111.897 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -132.64 46.82 2.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.95 1.7 . . . . 0.0 108.317 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.65 147.68 21.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.225 1.012 . . . . 0.0 111.697 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 160.86 30.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.701 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -79.49 64.68 4.44 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.791 0.805 . . . . 0.0 110.901 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 16.4 m -117.54 146.38 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 127.138 2.175 . . . . 0.0 111.343 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 86.6 p -61.47 -25.34 67.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -71.36 -26.23 62.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.227 1.011 . . . . 0.0 112.48 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -78.81 123.34 85.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.333 1.053 . . . . 0.0 109.997 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.19 -16.43 48.69 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.464 2.109 . . . . 0.0 112.902 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 4.23 10.79 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 167.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -52.43 129.72 29.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.226 1.376 . . . . 0.0 111.233 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -156.36 146.02 15.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.961 1.305 . . . . 0.0 111.025 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.67 176.9 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.523 2.149 . . . . 0.0 111.432 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -121.02 76.4 30.24 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.535 1.134 . . . . 0.0 109.798 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.01 142.31 38.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.137 2.558 . . . . 0.0 110.517 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.7 t -148.28 145.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.927 1.291 . . . . 0.0 109.351 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 172.88 12.14 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.946 1.298 . . . . 0.0 110.766 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.52 127.48 25.76 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.3 1.04 . . . . 0.0 110.042 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.48 104.53 10.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 109.861 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.5 p -70.29 -9.07 54.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 32.8 p -68.96 -19.33 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.169 1.388 . . . . 0.0 112.429 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.39 153.21 96.05 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.996 0.918 . . . . 0.0 112.383 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.39 162.45 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.925 3.083 . . . . 0.0 112.607 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.33 130.47 17.48 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.91 3.074 . . . . 0.0 112.345 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 66.66 39.25 3.71 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 111.833 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -123.42 152.18 41.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.84 147.24 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.901 1.68 . . . . 0.0 110.944 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 123.2 45.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.024 1.33 . . . . 0.0 110.289 177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 50.1 t -120.85 104.28 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.02 0.528 . . . . 0.0 110.911 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -72.76 132.86 44.16 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 111.864 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 31.2 t -74.31 141.87 45.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.814 0.816 . . . . 0.0 112.846 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -121.47 16.24 11.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.837 2.455 . . . . 0.0 110.724 166.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 22.3 m -108.7 126.03 52.55 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.156 1.383 . . . . 0.0 108.63 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.1 mt -92.76 140.08 29.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.443 1.497 . . . . 0.0 109.166 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -100.42 144.72 29.08 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 158.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 14.1 mm -128.87 112.16 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 108.574 -172.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -90.96 173.52 38.06 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.02 0.819 . . . . 0.0 112.064 166.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.54 16.45 75.81 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.4 t -73.04 126.33 90.49 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 118.723 1.261 . . . . 0.0 111.335 -165.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.01 132.86 36.01 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.477 2.785 . . . . 0.0 110.233 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.84 -6.32 20.92 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -92.48 -25.23 18.52 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.69 1.196 . . . . 0.0 113.691 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.6 mtm -77.22 146.12 37.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.41 1.005 . . . . 0.0 112.506 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -122.1 -179.9 4.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.652 1.581 . . . . 0.0 111.841 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -41.68 -44.73 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.829 2.051 . . . . 0.0 114.075 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -77.96 -21.6 50.76 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -73.56 -39.61 64.55 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.349 0.977 . . . . 0.0 110.435 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.85 -46.39 89.43 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.716 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.8 76.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.44 1.018 . . . . 0.0 111.698 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.13 -44.09 96.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.108 1.322 . . . . 0.0 114.283 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.7 m -71.23 -34.74 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.388 0.994 . . . . 0.0 111.287 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 50.0 mt -87.54 -7.51 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.923 0.889 . . . . 0.0 112.887 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -47.59 96.77 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.346 1.458 . . . . 0.0 114.399 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.59 -7.54 20.37 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.296 1.998 . . . . 0.0 113.31 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -98.45 -38.78 9.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.09 1.356 . . . . 0.0 112.705 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.71 172.75 2.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.145 1.778 . . . . 0.0 113.712 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 123.29 32.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.256 1.422 . . . . 0.0 111.442 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.71 120.25 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.591 0.756 . . . . 0.0 110.314 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -94.77 -41.73 9.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.668 1.187 . . . . 0.0 112.083 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.31 161.99 35.5 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.376 -0.828 . . . . 0.0 112.3 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -162.69 138.01 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.887 0.875 . . . . 0.0 111.101 176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.69 88.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.112 1.365 . . . . 0.0 108.018 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.08 137.99 31.94 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.834 -0.541 . . . . 0.0 110.94 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.47 85.85 2.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.824 1.25 . . . . 0.0 110.243 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -57.65 -38.24 74.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.844 0.857 . . . . 0.0 112.562 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 t -56.2 -33.02 64.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.968 1.307 . . . . 0.0 112.571 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -95.75 2.17 53.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.755 1.222 . . . . 0.0 113.87 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 27.57 17.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 113.612 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -133.83 169.26 17.34 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.47 43.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.707 1.203 . . . . 0.0 111.506 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.08 141.55 47.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.757 1.223 . . . . 0.0 108.089 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.8 118.09 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.782 0.719 . . . . 0.0 110.615 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -104.1 120.33 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.666 0.786 . . . . 0.0 112.059 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 19.8 m -95.24 -172.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.975 0.91 . . . . 0.0 110.113 174.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -40.46 79.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.945 1.248 . . . . 0.0 113.949 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 60.6 p -148.66 167.45 25.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.192 -0.943 . . . . 0.0 112.717 -164.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.88 91.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.358 167.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -42.07 85.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.004 0.82 . . . . 0.0 112.59 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.21 -51.22 64.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.905 1.282 . . . . 0.0 110.254 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.36 97.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.475 -0.766 . . . . 0.0 112.439 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -62.77 -42.44 99.69 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.929 0.892 . . . . 0.0 111.373 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.39 -34.18 76.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.196 1.362 . . . . 0.0 112.064 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.0 -65.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.717 166.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -50.65 -34.32 25.93 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.596 1.558 . . . . 0.0 114.152 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.51 -40.81 93.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.51 1.524 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -109.2 -27.3 9.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.41 123.95 22.99 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.463 0.705 . . . . 0.0 111.112 -169.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.86 29.16 18.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.131 1.372 . . . . 0.0 114.047 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -59.85 -36.33 76.62 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.201 -0.937 . . . . 0.0 113.16 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.79 -20.55 60.44 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.764 1.226 . . . . 0.0 112.893 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.54 23.22 65.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.819 1.2 . . . . 0.0 113.663 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -89.97 -33.78 16.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.15 1.38 . . . . 0.0 114.343 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.17 148.38 77.99 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.039 0.936 . . . . 0.0 109.445 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.37 -19.91 24.78 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.502 2.135 . . . . 0.0 112.732 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.75 144.0 35.62 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.62 1.168 . . . . 0.0 112.58 -170.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -119.28 93.38 4.06 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.638 1.175 . . . . 0.0 109.562 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 85.3 m -81.08 125.0 29.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.738 1.215 . . . . 0.0 111.178 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 175.15 9.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.97 2.508 . . . . 0.0 109.852 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -74.5 121.59 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.224 -0.923 . . . . 0.0 111.206 163.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.86 -164.83 30.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.116 1.817 . . . . 0.0 110.581 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.17 137.4 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.343 0.592 . . . . 0.0 111.107 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -99.95 -46.63 1.87 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.751 2.119 . . . . 0.0 109.945 163.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.65 110.26 8.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.375 1.07 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.04 140.83 5.66 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.682 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.62 123.24 9.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.931 3.754 . . . . 0.0 109.393 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -57.48 -45.46 84.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.883 0.473 . . . . 0.0 111.878 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.37 -18.67 63.81 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.1 m -120.99 27.96 8.17 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.086 1.755 . . . . 0.0 112.276 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.22 138.12 32.11 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.233 1.013 . . . . 0.0 111.546 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -121.66 79.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.117 1.367 . . . . 0.0 109.503 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -64.24 -22.3 66.89 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -67.47 -53.5 28.26 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.689 0.677 . . . . 0.0 110.357 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -77.41 -18.37 57.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.92 40.97 8.98 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 124.756 1.17 . . . . 0.0 112.851 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.57 172.45 16.01 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.309 1.055 . . . . 0.0 112.831 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.0 p -143.26 151.37 40.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.362 1.065 . . . . 0.0 110.673 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -110.2 125.61 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.09 123.77 28.66 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.667 -1.158 . . . . 0.0 110.364 -172.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 142.91 43.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.64 1.56 . . . . 0.0 110.457 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 20.6 mtt -58.01 -35.4 71.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.378 1.071 . . . . 0.0 112.973 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -63.51 -18.67 64.05 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 17.4 mmm-85 -97.24 3.2 51.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.589 1.956 . . . . 0.0 113.821 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.28 121.28 35.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.896 0.878 . . . . 0.0 109.747 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.6 p -72.21 -179.28 2.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.488 1.515 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -41.82 99.14 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.635 -0.665 . . . . 0.0 111.217 170.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.66 92.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.395 1.078 . . . . 0.0 111.968 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.54 -52.4 65.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.941 1.296 . . . . 0.0 112.381 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -38.56 85.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.679 -0.638 . . . . 0.0 112.225 173.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -56.11 -41.71 75.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.385 -0.816 . . . . 0.0 111.848 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -70.99 -45.63 63.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.494 1.497 . . . . 0.0 111.733 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 50.2 m -51.16 -35.55 36.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.956 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 5.7 m -90.81 -58.06 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 14.5 m -86.08 -7.38 58.64 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -166.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -52.86 145.49 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.76 1.163 . . . . 0.0 111.301 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -83.98 -27.24 28.59 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.843 -0.536 . . . . 0.0 111.204 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -125.67 136.88 53.71 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.237 2.215 . . . . 0.0 110.708 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.65 -179.92 32.97 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.001 0.81 . . . . 0.0 113.204 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.38 -150.43 48.45 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.263 -1.14 . . . . 0.0 112.29 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 43.0 p -116.07 17.18 15.91 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -153.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 t 65.26 17.88 11.18 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.947 -1.096 . . . . 0.0 113.25 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.05 59.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.498 1.047 . . . . 0.0 113.788 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -84.73 145.93 45.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.84 1.32 . . . . 0.0 111.338 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.89 107.33 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.057 2.505 . . . . 0.0 109.198 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 131.1 38.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.37 0.605 . . . . 0.0 111.595 -176.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.68 168.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.629 1.572 . . . . 0.0 110.733 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -47.25 127.0 10.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.986 0.915 . . . . 0.0 110.747 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.92 65.86 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.251 -1.305 . . . . 0.0 115.306 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 1.7 tp -50.48 133.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 120.239 2.02 . . . . 0.0 111.719 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.23 127.78 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.274 1.829 . . . . 0.0 108.345 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -152.03 179.52 8.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.174 1.39 . . . . 0.0 111.715 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -102.34 153.09 20.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.706 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -38.11 121.0 1.04 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.606 1.562 . . . . 0.0 114.529 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 160.35 50.18 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.224 1.95 . . . . 0.0 111.728 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -67.86 127.54 33.19 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.846 1.258 . . . . 0.0 113.907 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.16 46.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 123.415 1.579 . . . . 0.0 110.215 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.5 pt -52.03 157.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.681 140.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 3.3 t 68.03 7.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.443 -1.411 . . . . 0.0 111.222 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.42 157.04 53.01 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.331 1.443 . . . . 0.0 112.985 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -164.79 -59.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.761 1.224 . . . . 0.0 110.83 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.61 113.95 0.79 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.814 1.197 . . . . 0.0 111.795 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . 0.312 29.7 m . . . . . 0 N--CA 1.49 1.573 0 C-N-CA 130.663 3.585 . . . . 0.0 117.21 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 119.915 -0.088 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 31.3 pt -115.72 -26.13 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 71.33 27.19 72.01 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.063 0.847 . . . . 0.0 114.682 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.11 79.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.87 -172.02 1.13 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.613 2.875 . . . . 0.0 111.569 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -59.72 -22.9 62.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.878 0.871 . . . . 0.0 113.299 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.0 p 78.99 -1.64 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 129.764 3.226 . . . . 0.0 113.709 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.02 -34.39 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.623 1.969 . . . . 0.0 113.393 -176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 305' ' ' LEU . 6.4 p90 46.2 75.74 0.11 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.768 2.027 . . . . 0.0 112.231 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -77.68 -100.58 0.19 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.857 1.218 . . . . 0.0 112.573 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 74.7 p -73.37 -22.35 60.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.59 1.156 . . . . 0.0 112.985 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -80.08 51.52 1.38 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.538 1.935 . . . . 0.0 112.892 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 64.93 -175.51 0.17 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.276 1.831 . . . . 0.0 111.487 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -124.41 12.64 8.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -168.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -72.73 141.02 48.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.465 ' HA ' ' CE2' ' A' ' 298' ' ' PHE . 9.1 mp -66.54 -31.1 71.6 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.419 1.088 . . . . 0.0 111.661 172.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.72 73.98 65.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.898 1.279 . . . . 0.0 109.637 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 -27.83 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.773 2.316 . . . . 0.0 111.551 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -82.35 46.64 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.032 1.733 . . . . 0.0 111.497 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.24 160.83 39.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.022 1.729 . . . . 0.0 110.578 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 95.0 mt -136.83 171.6 14.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.885 1.274 . . . . 0.0 110.331 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -78.23 63.33 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.145 0.978 . . . . 0.0 111.098 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 14.4 m -125.04 149.11 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.313 2.245 . . . . 0.0 111.199 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.3 p -63.01 -23.98 67.71 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.34 -22.89 65.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.528 0.731 . . . . 0.0 112.865 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -84.66 125.45 71.27 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.801 1.24 . . . . 0.0 110.493 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.22 -17.84 50.38 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.552 2.168 . . . . 0.0 113.123 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -78.38 5.28 10.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.911 1.284 . . . . 0.0 114.431 168.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -53.63 129.72 33.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.788 -1.195 . . . . 0.0 111.72 170.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -156.04 143.54 13.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.194 1.398 . . . . 0.0 110.847 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.84 172.36 14.69 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.672 2.248 . . . . 0.0 111.102 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 83.59 9.36 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 109.867 168.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.47 150.48 63.97 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.296 2.664 . . . . 0.0 110.534 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 10.8 t -144.33 133.41 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 109.662 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.09 167.75 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 110.845 174.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -143.88 121.79 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.971 0.908 . . . . 0.0 110.289 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.72 108.76 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.447 0.699 . . . . 0.0 111.156 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.9 p -69.35 -8.55 47.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -25.19 67.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.651 1.181 . . . . 0.0 112.235 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.53 150.49 95.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.794 0.838 . . . . 0.0 112.068 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.06 161.27 34.17 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.18 3.253 . . . . 0.0 112.539 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.17 134.65 32.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.059 3.173 . . . . 0.0 112.029 -173.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.99 44.53 4.65 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.633 1.573 . . . . 0.0 112.046 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -126.75 153.68 45.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.818 1.247 . . . . 0.0 114.141 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.37 145.74 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.615 1.966 . . . . 0.0 110.697 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -106.77 111.16 23.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.018 1.727 . . . . 0.0 109.863 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.81 97.08 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.194 0.598 . . . . 0.0 110.295 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.45 138.92 57.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.935 0.874 . . . . 0.0 111.706 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 41.4 t -75.48 136.84 40.63 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.191 -0.943 . . . . 0.0 112.577 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 18.82 14.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.51 2.324 . . . . 0.0 111.305 163.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 62.4 m -119.34 133.44 55.72 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.146 1.378 . . . . 0.0 110.293 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.36 134.87 42.66 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.34 1.056 . . . . 0.0 108.817 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.11 120.82 32.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 161.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.9 106.53 20.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -84.24 -178.23 51.49 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 168.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.12 11.78 59.32 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.377 -1.072 . . . . 0.0 115.067 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.01 130.12 91.7 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.965 1.383 . . . . 0.0 110.153 -166.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.94 128.01 18.9 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.923 2.415 . . . . 0.0 109.062 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.1 pp -59.17 -18.7 38.6 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.1 -25.95 31.5 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 9.1 mtm -73.52 146.48 44.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 0.0 112.293 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -118.13 178.97 4.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.115 1.766 . . . . 0.0 111.715 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.83 -36.47 67.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.617 1.167 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -73.88 -30.9 62.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.47 -35.85 81.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.547 1.067 . . . . 0.0 110.93 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.33 -51.27 70.49 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.285 0.493 . . . . 0.0 110.438 169.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.75 69.65 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.38 -40.09 64.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.46 1.482 . . . . 0.0 112.883 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.0 -36.72 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 111.249 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.1 mt -85.99 -8.08 58.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -50.44 75.17 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.08 -7.12 19.49 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.609 2.206 . . . . 0.0 113.128 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -98.69 -37.5 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.107 1.363 . . . . 0.0 112.867 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.16 168.82 3.37 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.541 1.937 . . . . 0.0 114.05 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.08 116.08 22.7 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.787 1.635 . . . . 0.0 112.051 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 97.5 t -87.88 113.48 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.133 0.973 . . . . 0.0 109.853 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.32 -37.84 15.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.502 1.121 . . . . 0.0 111.675 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.36 150.13 35.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 0.0 111.656 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.06 141.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.899 0.88 . . . . 0.0 110.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.91 105.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.355 1.062 . . . . 0.0 108.303 167.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.57 124.52 41.86 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.275 0.559 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -112.91 84.11 1.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.972 1.709 . . . . 0.0 109.258 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.71 -28.59 65.94 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.795 1.238 . . . . 0.0 111.648 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 97.2 p -61.01 -31.83 71.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.962 1.705 . . . . 0.0 113.853 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -110.28 6.82 22.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.113 1.765 . . . . 0.0 113.099 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? 56.98 40.33 28.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.995 1.318 . . . . 0.0 111.314 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -123.7 151.61 42.96 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.28 1.832 . . . . 0.0 113.464 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.25 128.28 25.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.13 1.372 . . . . 0.0 111.289 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -81.75 131.62 35.27 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.989 -1.069 . . . . 0.0 108.853 161.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 70.3 t -129.84 117.24 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.915 0.886 . . . . 0.0 109.707 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -104.24 116.13 31.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.928 1.291 . . . . 0.0 110.273 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.92 -179.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.529 0.732 . . . . 0.0 109.557 167.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -49.55 71.98 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 82.2 p -139.15 165.95 25.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.216 1.008 . . . . 0.0 112.941 -163.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -42.77 93.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.838 167.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -43.02 91.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.909 0.777 . . . . 0.0 112.277 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.5 -48.18 70.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.079 0.551 . . . . 0.0 111.763 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.2 95.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.162 0.892 . . . . 0.0 112.917 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -64.37 -40.8 96.53 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.784 0.834 . . . . 0.0 111.747 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.44 -35.33 77.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.473 1.033 . . . . 0.0 111.654 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.2 -65.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 119.043 -0.503 . . . . 0.0 110.524 166.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.3 mt -49.46 -35.78 20.6 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.323 1.449 . . . . 0.0 114.624 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.14 -33.55 71.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.275 1.43 . . . . 0.0 113.794 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -112.18 -28.28 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.215 1.006 . . . . 0.0 113.121 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.14 123.5 21.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.52 0.728 . . . . 0.0 111.202 -170.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.02 30.7 18.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.414 1.486 . . . . 0.0 114.121 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -33.98 76.76 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.47 -19.68 55.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.536 1.134 . . . . 0.0 112.883 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.2 22.69 60.35 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.817 1.199 . . . . 0.0 113.686 -173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.9 -32.93 17.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.13 1.372 . . . . 0.0 114.495 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.61 148.4 73.12 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.118 0.967 . . . . 0.0 109.586 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.83 -32.2 7.57 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.684 2.256 . . . . 0.0 112.249 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.36 149.61 50.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.852 1.261 . . . . 0.0 112.066 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.07 102.14 7.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.581 1.153 . . . . 0.0 110.718 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.6 m -80.18 124.58 28.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.817 1.247 . . . . 0.0 110.776 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -132.64 172.21 12.82 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.633 1.973 . . . . 0.0 109.939 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.55 121.67 20.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.062 -1.023 . . . . 0.0 111.295 166.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.15 -166.84 19.62 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.626 1.584 . . . . 0.0 110.052 167.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.5 p -165.53 136.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.323 0.649 . . . . 0.0 111.628 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.63 -47.09 3.29 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.34 1.924 . . . . 0.0 111.249 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -111.19 93.07 4.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.082 0.941 . . . . 0.0 112.254 173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.91 121.05 1.12 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.319 -1.267 . . . . 0.0 113.901 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 125.37 10.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.019 3.146 . . . . 0.0 109.5 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.33 -44.07 88.52 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.83 -12.44 59.97 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 53.5 m -117.71 12.67 14.02 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.881 1.672 . . . . 0.0 112.901 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 140.82 31.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.348 1.459 . . . . 0.0 111.926 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -123.5 86.35 2.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.65 1.58 . . . . 0.0 109.137 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.62 -20.93 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -69.72 -52.52 24.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.507 0.594 . . . . 0.0 110.368 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -79.53 -16.17 56.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.94 43.33 14.36 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.693 1.139 . . . . 0.0 112.772 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.23 167.08 31.11 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.573 1.187 . . . . 0.0 113.529 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.05 146.09 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.891 -1.131 . . . . 0.0 110.82 171.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -109.67 94.25 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.43 124.15 56.28 Favored Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.094 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.31 147.67 42.28 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.826 1.684 . . . . 0.0 110.998 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.5 mmt -57.82 -36.58 72.44 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.264 1.426 . . . . 0.0 112.363 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -68.24 -11.94 60.18 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -107.11 12.21 28.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.297 1.839 . . . . 0.0 113.312 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.84 135.49 49.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.544 1.138 . . . . 0.0 109.87 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.3 p -79.85 175.1 10.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 110.974 171.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.31 -45.9 87.16 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.523 -0.736 . . . . 0.0 110.763 171.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.15 90.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.648 1.179 . . . . 0.0 112.829 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.24 -51.22 70.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.147 0.979 . . . . 0.0 111.984 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.39 -37.61 80.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.33 0.652 . . . . 0.0 110.953 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -51.68 -52.41 48.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.861 1.264 . . . . 0.0 110.828 173.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -67.19 -41.98 84.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.22 1.373 . . . . 0.0 111.821 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 63.4 m -55.65 -28.63 56.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.768 -1.11 . . . . 0.0 112.802 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.05 -44.5 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.901 1.228 . . . . 0.0 113.945 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 31.2 m -94.68 -11.29 29.47 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.15 143.93 51.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.898 1.226 . . . . 0.0 111.839 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -72.35 -42.73 64.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.675 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -112.12 140.61 46.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.698 1.599 . . . . 0.0 110.98 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.4 176.8 25.35 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.128 -171.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.01 -164.6 51.62 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 122.023 -0.692 . . . . 0.0 113.252 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.7 p -106.87 18.96 21.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -157.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 p 69.69 13.54 8.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.563 1.145 . . . . 0.0 114.027 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 92.39 2.0 68.48 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.063 1.316 . . . . 0.0 113.504 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -67.11 150.52 97.87 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.86 1.33 . . . . 0.0 110.426 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.33 142.3 90.62 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.4 2.066 . . . . 0.0 110.215 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.7 114.87 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.04 159.23 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.614 1.566 . . . . 0.0 110.184 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 97.9 m -56.41 130.74 46.07 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.849 0.46 . . . . 0.0 109.905 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.42 84.4 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.351 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.24 137.19 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.021 1.41 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.03 132.68 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.262 1.825 . . . . 0.0 109.342 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -158.07 171.3 20.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.469 1.507 . . . . 0.0 110.79 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.07 142.06 27.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.809 0.444 . . . . 0.0 111.302 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.68 126.12 2.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.212 1.405 . . . . 0.0 114.499 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.76 166.22 30.57 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.603 3.535 . . . . 0.0 112.442 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -66.65 142.84 57.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.789 1.236 . . . . 0.0 113.897 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.76 52.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.244 1.497 . . . . 0.0 109.753 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.55 172.81 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.713 138.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.19 -48.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 120.984 -1.073 . . . . 0.0 110.98 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.41 -51.75 4.4 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.745 1.165 . . . . 0.0 112.171 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.31 156.74 2.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.598 1.959 . . . . 0.0 111.202 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 171.84 162.24 23.75 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.305 1.431 . . . . 0.0 113.676 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.862 1.665 . . . . 0.0 112.198 -177.57 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.605 0.24 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 28.0 pt -136.7 159.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.189 1.395 . . . . 0.0 111.859 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.72 140.72 4.38 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.229 1.395 . . . . 0.0 112.22 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -116.83 152.53 48.67 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.464 1.506 . . . . 0.0 111.232 173.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.96 -62.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.24 2.627 . . . . 0.0 112.831 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 52.6 t30 34.37 77.22 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.479 2.312 . . . . 0.0 114.657 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.6 m -63.41 -52.14 62.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.684 1.594 . . . . 0.0 112.45 -170.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.6 t -170.15 13.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.356 1.862 . . . . 0.0 113.673 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -62.35 119.63 9.45 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.909 -1.119 . . . . 0.0 111.141 -174.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 133.05 -13.53 4.97 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 117.711 -1.605 . . . . 0.0 116.631 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 13.4 t -160.63 67.43 0.33 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.972 1.886 . . . . 0.0 112.053 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 70.54 161.51 0.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.789 2.436 . . . . 0.0 112.401 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 6.6 m120 64.54 147.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.841 2.057 . . . . 0.0 113.418 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -144.96 11.51 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -75.92 142.6 42.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.733 1.213 . . . . 0.0 112.462 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.533 0.733 . . . . 0.0 112.023 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.84 159.51 50.89 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.152 1.381 . . . . 0.0 111.95 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.57 -156.64 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.818 3.679 . . . . 0.0 111.617 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.18 62.1 0.9 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.384 1.474 . . . . 0.0 110.534 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -74.56 159.65 31.91 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 128.478 2.711 . . . . 0.0 113.279 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.25 155.4 33.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.791 1.636 . . . . 0.0 111.041 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -80.22 69.31 6.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.842 0.857 . . . . 0.0 110.779 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.02 147.5 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.262 2.225 . . . . 0.0 109.22 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.1 p -60.37 -25.06 65.59 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -68.85 -25.23 64.54 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.41 127.24 76.68 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.986 1.314 . . . . 0.0 110.563 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.29 -18.58 55.72 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.833 1.689 . . . . 0.0 113.323 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.26 9.68 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 168.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -55.02 130.99 43.86 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.875 1.671 . . . . 0.0 112.439 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -156.3 153.84 26.02 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.111 1.765 . . . . 0.0 111.352 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.55 168.06 24.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.174 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 81.07 4.2 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.513 1.125 . . . . 0.0 109.604 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.05 147.34 33.6 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.192 2.595 . . . . 0.0 111.035 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.6 t -147.28 137.88 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.351 1.46 . . . . 0.0 108.444 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.05 167.79 19.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.585 1.554 . . . . 0.0 110.746 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -141.57 122.82 14.8 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.036 -1.04 . . . . 0.0 111.064 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -114.4 101.16 8.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.427 1.491 . . . . 0.0 109.921 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.4 p -67.04 -14.12 62.59 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.358 1.063 . . . . 0.0 113.731 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -10.52 59.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.11 1.764 . . . . 0.0 113.908 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.39 156.99 80.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 119.88 1.218 . . . . 0.0 113.312 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.57 163.47 32.58 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.224 3.283 . . . . 0.0 113.293 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.68 134.67 24.49 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.212 3.275 . . . . 0.0 112.627 -172.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.68 34.24 12.41 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.148 1.379 . . . . 0.0 112.476 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -121.3 154.31 36.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.935 1.294 . . . . 0.0 114.401 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 pt -124.61 157.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.869 1.668 . . . . 0.0 111.891 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.58 118.9 37.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.865 1.266 . . . . 0.0 110.613 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.74 107.42 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.604 0.638 . . . . 0.0 110.451 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.1 132.27 45.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 111.148 167.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.6 t -67.18 138.9 57.34 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.897 0.856 . . . . 0.0 112.064 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.17 21.13 8.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.44 2.696 . . . . 0.0 109.805 168.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 48.3 m -125.67 132.87 52.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.3 1.44 . . . . 0.0 109.014 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.51 133.41 46.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.66 1.584 . . . . 0.0 109.443 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -86.24 126.31 34.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 163.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 17.4 mm -114.67 107.46 22.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.81 170.08 47.45 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 123.168 0.414 . . . . 0.0 112.496 167.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.96 19.56 79.76 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.35 118.36 71.65 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.115 -171.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.39 147.87 47.69 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.291 2.661 . . . . 0.0 110.565 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.23 -18.61 65.45 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.28 -26.63 62.05 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.509 1.124 . . . . 0.0 113.381 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 12.4 mtm -75.46 152.55 37.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.6 1.091 . . . . 0.0 112.286 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -133.34 -177.67 4.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.231 2.212 . . . . 0.0 111.127 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -55.59 -39.9 71.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 112.144 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -79.14 -14.91 58.82 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.31 -40.0 52.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.161 1.346 . . . . 0.0 110.515 168.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.33 -51.16 70.0 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.454 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.31 66.94 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.814 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -70.16 -47.4 61.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.013 1.278 . . . . 0.0 114.172 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.22 -32.37 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.583 1.538 . . . . 0.0 111.524 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 39.5 mt -87.09 -11.51 49.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.072 0.949 . . . . 0.0 113.102 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -47.16 -49.1 53.16 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 126.224 1.809 . . . . 0.0 115.076 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.45 -3.31 13.51 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.199 1.933 . . . . 0.0 113.515 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.56 -36.15 7.61 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.611 1.565 . . . . 0.0 112.747 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.17 165.94 7.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.718 2.007 . . . . 0.0 112.741 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.52 100.34 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.866 1.666 . . . . 0.0 110.466 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.23 126.42 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.583 0.753 . . . . 0.0 109.835 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -95.71 -32.07 12.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.125 1.37 . . . . 0.0 112.419 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 42.3 t -152.83 155.72 37.64 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.747 1.158 . . . . 0.0 110.997 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 55.3 t -146.68 131.32 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.233 1.013 . . . . 0.0 109.324 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.09 107.93 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.35 117.08 33.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.193 0.597 . . . . 0.0 110.339 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -100.68 84.24 2.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 109.523 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.49 -38.81 69.62 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.405 1.482 . . . . 0.0 111.07 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 11.9 m -62.25 -21.82 65.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.826 2.05 . . . . 0.0 114.736 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -113.0 6.88 17.92 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.678 1.591 . . . . 0.0 112.484 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.2 mttt 52.61 35.06 17.15 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 126.562 1.945 . . . . 0.0 113.744 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -127.96 153.52 46.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.105 1.362 . . . . 0.0 113.008 -169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -134.92 131.89 37.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.814 0.846 . . . . 0.0 111.986 162.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -83.25 121.65 27.39 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.49 125.83 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.392 1.477 . . . . 0.0 108.692 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -114.61 115.51 27.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.136 1.374 . . . . 0.0 110.199 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.67 -166.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.877 0.871 . . . . 0.0 110.155 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -48.83 66.38 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.196 1.362 . . . . 0.0 113.197 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.9 p -152.15 173.04 15.43 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -160.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -45.82 80.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.057 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -53.85 -42.17 68.26 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.239 0.927 . . . . 0.0 112.674 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.28 -43.74 49.58 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.01 92.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.038 1.29 . . . . 0.0 113.011 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.52 -40.96 96.6 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.259 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.97 -31.63 72.0 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.81 1.186 . . . . 0.0 112.253 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -63.62 -64.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.324 164.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.81 -32.12 42.49 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -74.54 -23.86 58.86 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.764 1.626 . . . . 0.0 113.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -120.91 -28.49 4.8 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.35 122.45 21.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.959 0.904 . . . . 0.0 111.378 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 24.5 t30 59.5 29.11 18.64 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.531 1.933 . . . . 0.0 114.861 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -55.88 -34.34 65.42 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.746 -1.221 . . . . 0.0 113.646 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -79.29 -17.13 55.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 113.603 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 11.35 83.33 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.117 1.341 . . . . 0.0 113.728 -173.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -84.49 -31.97 24.21 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.087 1.755 . . . . 0.0 115.073 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.16 152.07 76.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.679 0.792 . . . . 0.0 109.929 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.86 -18.04 24.98 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.258 1.972 . . . . 0.0 113.011 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.99 150.72 23.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -123.41 83.04 2.08 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 109.907 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.3 m -72.39 122.78 21.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.066 1.746 . . . . 0.0 110.602 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 173.47 11.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.218 2.207 . . . . 0.0 109.375 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -66.87 123.69 20.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.168 -0.957 . . . . 0.0 111.205 162.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.85 -164.1 21.43 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 126.191 1.853 . . . . 0.0 109.663 163.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.11 134.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.66 0.784 . . . . 0.0 111.376 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -93.99 -38.87 5.03 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.182 1.849 . . . . 0.0 111.641 167.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -125.99 105.64 9.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.621 2.368 . . . . 0.0 113.475 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.96 137.68 3.97 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 118.472 -1.182 . . . . 0.0 114.567 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.37 132.26 16.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.878 3.719 . . . . 0.0 110.842 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -21.3 61.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.75 -21.42 37.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.807 1.185 . . . . 0.0 113.828 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 54.1 m -124.47 31.12 5.81 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.854 1.661 . . . . 0.0 111.693 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 19.4 t -84.83 138.97 32.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.786 1.234 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -125.69 86.8 2.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.621 1.569 . . . . 0.0 109.073 165.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -67.35 -14.77 63.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.74 -46.96 28.03 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.092 1.315 . . . . 0.0 110.426 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -81.26 -14.37 57.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 75.68 44.39 20.66 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.342 0.972 . . . . 0.0 112.919 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.48 174.5 12.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.526 1.163 . . . . 0.0 112.79 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 56.7 p -147.35 147.62 30.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.354 1.062 . . . . 0.0 111.114 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.12 124.71 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -118.98 118.42 32.96 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 119.635 1.107 . . . . 0.0 111.743 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -72.71 128.99 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 111.498 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -64.69 -23.93 67.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.859 1.263 . . . . 0.0 113.228 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.43 -24.4 67.61 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.835 1.198 . . . . 0.0 114.024 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -1.16 13.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.284 1.434 . . . . 0.0 114.562 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 136.48 58.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.163 0.892 . . . . 0.0 110.001 168.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 27.8 p -72.7 174.22 7.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.759 0.79 . . . . 0.0 111.293 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.97 -39.86 87.08 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.778 -0.576 . . . . 0.0 111.869 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.75 -36.62 65.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.242 0.617 . . . . 0.0 112.313 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -55.59 -60.03 4.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 111.283 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.71 -39.91 82.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.907 1.283 . . . . 0.0 112.25 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -47.92 70.67 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.088 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -66.12 -47.57 73.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.805 1.184 . . . . 0.0 110.972 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 13.1 m -52.33 -40.55 62.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.388 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.67 -44.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.7 t -97.23 -3.06 41.47 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -166.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.401 ' CB ' ' H ' ' A' ' 461' ' ' ASP . . . -61.03 145.08 52.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.825 -1.172 . . . . 0.0 112.846 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.75 -28.74 36.4 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.827 1.251 . . . . 0.0 110.468 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -132.37 143.76 50.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.643 2.777 . . . . 0.0 110.75 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 175.53 18.51 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 123.704 0.669 . . . . 0.0 113.833 -171.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 73.52 -161.58 54.22 Favored Glycine 0 CA--C 1.546 1.973 0 O-C-N 121.501 -1.0 . . . . 0.0 114.424 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 21.1 p -93.36 3.07 56.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.962 2.105 . . . . 0.0 116.418 -160.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.4 m 78.05 6.31 2.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.83 1.252 . . . . 0.0 113.036 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.26 5.33 59.36 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.014 1.292 . . . . 0.0 113.438 -169.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -71.92 153.45 92.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.578 1.189 . . . . 0.0 109.834 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.58 146.97 93.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.086 2.524 . . . . 0.0 110.897 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 54.5 mt -70.66 104.32 2.8 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.65 158.21 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.045 1.338 . . . . 0.0 111.647 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.0 m -59.05 131.65 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.09 -1.15 79.82 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.85 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.718 1.759 . . . . 0.0 112.683 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.44 137.06 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.348 2.259 . . . . 0.0 109.452 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -164.55 178.02 7.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.602 1.161 . . . . 0.0 111.715 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -97.54 151.69 19.78 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.107 . . . . 0.0 110.109 169.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -44.98 130.16 5.39 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -167.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.81 168.04 24.92 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.927 3.085 . . . . 0.0 111.175 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ASP . . . . . 0.401 ' H ' ' CB ' ' A' ' 441' ' ' ALA . 67.4 m-20 -74.18 120.0 19.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.59 46.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.183 1.468 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 6.2 pt -54.03 156.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 142.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 3.5 t 67.16 9.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.917 -1.114 . . . . 0.0 111.48 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -57.5 138.95 47.43 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.339 -1.476 . . . . 0.0 113.88 -168.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -158.24 157.44 32.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.057 0.943 . . . . 0.0 112.198 -166.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -91.21 -174.93 43.68 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.602 1.572 . . . . 0.0 113.907 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 125.579 1.551 . . . . 0.0 111.298 177.799 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 42.0 m80 . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -72.83 138.68 46.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.595 1.158 . . . . 0.0 111.885 171.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.25 -42.78 99.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.913 0.885 . . . . 0.0 110.35 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 124.941 1.296 . . . . 0.0 112.55 -178.891 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 CA--C 1.553 1.076 0 O-C-N 120.675 -1.265 . . . . 0.0 110.725 167.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -50.39 135.57 21.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.097 1.317 . . . . 0.0 112.099 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -136.37 151.07 72.48 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 124.029 0.932 . . . . 0.0 110.72 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.81 165.98 21.77 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.014 2.476 . . . . 0.0 110.632 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.38 79.41 1.66 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 166.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.5 115.77 4.21 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.443 2.095 . . . . 0.0 108.451 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.01 142.06 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.761 1.224 . . . . 0.0 109.317 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.68 169.04 18.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.489 1.116 . . . . 0.0 109.92 174.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -140.6 111.18 6.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.811 0.845 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.61 126.78 53.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.796 0.838 . . . . 0.0 111.794 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.4 p -73.76 -7.63 52.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -18.58 65.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.508 2.323 . . . . 0.0 111.915 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.6 153.04 81.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.634 1.174 . . . . 0.0 113.361 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.12 165.1 29.57 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.559 3.506 . . . . 0.0 113.047 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.35 135.6 27.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.399 3.399 . . . . 0.0 112.776 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.28 42.92 14.36 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.694 1.597 . . . . 0.0 111.465 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -127.24 153.04 46.61 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.6 pt -126.2 147.75 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.476 1.91 . . . . 0.0 109.966 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 133.1 51.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.203 1.401 . . . . 0.0 111.331 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.01 102.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.185 0.594 . . . . 0.0 110.996 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -68.62 136.18 52.59 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.396 1.079 . . . . 0.0 111.626 166.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.4 t -78.37 136.37 37.66 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.354 -0.841 . . . . 0.0 111.364 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -103.03 12.3 36.17 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.968 1.707 . . . . 0.0 109.918 162.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 52.5 m -109.98 130.71 55.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.073 1.749 . . . . 0.0 110.127 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 mt -96.01 136.61 36.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 108.932 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -94.83 139.64 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 161.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.2 mm -124.95 107.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.79 1.236 . . . . 0.0 108.209 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.71 176.48 46.17 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 123.882 0.753 . . . . 0.0 111.868 168.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.18 17.4 72.0 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.016 0.766 . . . . 0.0 115.016 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.3 122.15 86.65 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 118.507 1.153 . . . . 0.0 110.525 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.12 137.6 29.22 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.871 2.38 . . . . 0.0 108.931 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.4 mp -64.73 -17.43 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.59 -25.66 57.19 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 47.8 mtm -78.46 139.76 38.68 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.861 0.838 . . . . 0.0 112.238 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -116.47 -173.75 2.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.744 2.018 . . . . 0.0 111.657 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -54.07 -48.44 70.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.196 1.798 . . . . 0.0 112.703 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -76.19 -18.4 59.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.01 -40.37 71.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.059 1.299 . . . . 0.0 110.683 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.2 mm? -60.01 -49.1 78.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.817 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.07 71.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.923 0.783 . . . . 0.0 112.95 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.52 -44.82 70.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.528 1.131 . . . . 0.0 113.964 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.97 -33.89 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.699 1.136 . . . . 0.0 110.683 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 394' ' ' PHE . 51.5 mt -87.02 -10.59 52.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.037 0.935 . . . . 0.0 113.187 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -48.31 -48.96 64.78 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.669 1.588 . . . . 0.0 114.674 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.34 -6.98 17.66 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.217 1.945 . . . . 0.0 113.375 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.68 -39.99 8.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.47 1.508 . . . . 0.0 112.38 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.39 169.89 3.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.13 1.772 . . . . 0.0 112.712 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.54 125.5 32.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.553 0.741 . . . . 0.0 109.835 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.67 128.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.621 0.768 . . . . 0.0 110.276 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -91.8 -43.38 9.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.123 1.369 . . . . 0.0 112.538 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.92 159.2 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 111.623 -172.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.0 p -160.79 133.7 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.731 -0.606 . . . . 0.0 111.609 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.7 103.31 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.73 133.11 43.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.794 0.837 . . . . 0.0 110.224 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.57 89.47 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.821 1.248 . . . . 0.0 109.565 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -60.24 -38.32 83.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.765 1.226 . . . . 0.0 111.711 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.0 t -58.9 -30.62 67.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.765 1.626 . . . . 0.0 113.23 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.74 -3.15 42.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.359 1.463 . . . . 0.0 113.13 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 58.8 30.85 20.6 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.297 1.839 . . . . 0.0 113.326 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -133.82 169.3 17.26 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.45 42.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.013 1.325 . . . . 0.0 111.159 164.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.28 136.76 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 45.1 t -134.72 113.3 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.428 0.691 . . . . 0.0 110.78 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -92.99 122.89 35.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 0.0 109.734 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.63 164.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.088 0.955 . . . . 0.0 109.97 169.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -73.76 -22.34 59.89 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 p -134.38 154.18 51.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.762 1.165 . . . . 0.0 113.445 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -59.43 -41.75 90.29 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.148 0.979 . . . . 0.0 111.493 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -37.68 88.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.401 0.68 . . . . 0.0 111.853 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.42 -50.65 72.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.752 1.221 . . . . 0.0 111.073 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.03 95.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.919 0.781 . . . . 0.0 112.027 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.98 -42.12 98.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.954 0.502 . . . . 0.0 112.138 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -63.45 -35.02 79.06 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.256 0.935 . . . . 0.0 112.26 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.23 -64.35 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.819 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -49.27 -36.77 21.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.893 1.277 . . . . 0.0 114.153 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.09 -35.88 80.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.918 1.287 . . . . 0.0 113.476 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -111.79 -25.6 9.39 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 18.1 t80 -72.0 124.17 24.36 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.537 0.735 . . . . 0.0 111.189 -169.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 61.89 30.17 18.08 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.263 1.425 . . . . 0.0 113.904 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -58.33 -36.07 72.84 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.806 -1.184 . . . . 0.0 113.385 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.569 1.148 . . . . 0.0 113.062 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.48 61.55 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.88 1.228 . . . . 0.0 113.737 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.16 -34.68 14.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.379 1.472 . . . . 0.0 114.389 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 24.8 mt -73.67 148.52 87.66 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.099 0.96 . . . . 0.0 109.457 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.71 -29.45 10.61 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.347 2.031 . . . . 0.0 112.181 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.87 139.97 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.959 1.704 . . . . 0.0 111.715 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.26 103.0 10.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.048 1.339 . . . . 0.0 110.08 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.8 m -81.75 124.27 29.48 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.883 1.273 . . . . 0.0 110.571 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -133.39 175.37 9.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.602 2.361 . . . . 0.0 109.248 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -73.51 123.47 24.0 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.25 -0.906 . . . . 0.0 110.889 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -100.66 -164.73 28.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 163.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.49 122.07 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.078 0.951 . . . . 0.0 109.234 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -84.73 -47.4 5.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 162.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.68 120.11 22.32 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.808 0.843 . . . . 0.0 111.732 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.06 131.73 1.54 Allowed Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.529 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.84 130.94 16.33 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 125.161 3.907 . . . . 0.0 110.405 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -36.19 79.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -72.32 -18.79 61.75 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.6 m -124.16 29.9 6.26 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.906 1.683 . . . . 0.0 111.982 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.7 155.55 25.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -139.71 73.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.802 1.641 . . . . 0.0 109.446 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -63.07 -18.62 63.57 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.47 -52.42 32.61 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.109 -0.994 . . . . 0.0 111.077 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -80.78 -17.19 51.68 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 84.43 38.33 9.96 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.964 1.269 . . . . 0.0 113.034 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -145.59 169.7 17.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.63 1.215 . . . . 0.0 112.374 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 46.4 m -141.13 157.13 45.7 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.941 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.53 127.68 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.67 125.51 28.02 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 117.405 -1.283 . . . . 0.0 111.229 -170.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.86 132.21 18.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.078 1.852 . . . . 0.0 110.362 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -20.47 61.64 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.635 1.174 . . . . 0.0 113.735 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -26.26 65.55 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.34 0.973 . . . . 0.0 113.208 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.0 -24.53 16.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.757 1.223 . . . . 0.0 112.802 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.5 116.83 4.62 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.4 p -65.55 176.54 1.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.738 1.215 . . . . 0.0 110.733 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.37 -41.3 93.44 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.502 -0.749 . . . . 0.0 110.99 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.41 -40.99 85.62 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 112.541 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -58.35 -52.55 65.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.889 1.276 . . . . 0.0 111.993 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -66.84 -37.54 84.69 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.771 -0.58 . . . . 0.0 111.566 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -47.91 73.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.212 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.41 -43.35 77.4 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.269 1.395 . . . . 0.0 111.533 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 66.8 m -53.52 -35.8 61.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.59 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.5 m -90.63 -43.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -99.51 -12.91 19.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.289 1.436 . . . . 0.0 114.489 -166.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.79 142.16 46.49 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.162 -0.961 . . . . 0.0 111.062 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -80.82 -45.56 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.509 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -100.31 131.4 46.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.297 1.039 . . . . 0.0 110.181 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.71 -176.57 45.58 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.381 0.991 . . . . 0.0 114.028 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.31 -156.44 52.99 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.417 -0.392 . . . . 0.0 112.265 -170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.8 p -99.43 -4.96 30.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 77.95 17.65 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.788 1.635 . . . . 0.0 113.317 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.44 56.04 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.122 1.344 . . . . 0.0 113.884 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 153.53 95.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.726 1.263 . . . . 0.0 111.593 172.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.84 143.93 81.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.863 2.376 . . . . 0.0 110.423 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 40.6 mt -70.75 110.53 5.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.279 0.562 . . . . 0.0 109.618 170.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.11 152.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 110.235 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.1 m -53.35 130.0 33.7 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.65 0.78 . . . . 0.0 109.71 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.52 -5.6 80.32 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.865 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.45 134.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.807 1.304 . . . . 0.0 111.514 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.5 t -119.99 140.41 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.752 2.021 . . . . 0.0 108.734 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.83 -179.61 7.33 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.691 1.196 . . . . 0.0 111.797 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -92.13 150.3 21.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.212 . . . . 0.0 110.842 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -51.16 132.21 31.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 124.553 1.141 . . . . 0.0 113.703 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.26 148.45 74.39 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.957 1.771 . . . . 0.0 109.253 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -52.96 148.29 7.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.174 0.99 . . . . 0.0 112.858 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -108.09 50.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 123.159 1.456 . . . . 0.0 110.103 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.6 142.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 29.7 m80 . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -64.73 133.28 51.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.708 1.203 . . . . 0.0 111.622 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 356' ' ' ALA . 10.9 mp -69.6 -20.13 63.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.006 1.322 . . . . 0.0 111.355 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 126.913 2.085 . . . . 0.0 112.183 -172.709 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 CA--C 1.551 0.991 0 O-C-N 120.665 -1.272 . . . . 0.0 110.744 173.712 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -53.68 117.94 3.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.181 1.392 . . . . 0.0 112.729 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 143.72 50.4 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 125.252 1.421 . . . . 0.0 110.491 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.3 164.85 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.294 2.663 . . . . 0.0 111.217 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 83.74 13.71 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.251 1.02 . . . . 0.0 109.019 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.98 116.37 4.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.531 2.154 . . . . 0.0 108.218 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.8 t -112.35 129.04 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.789 0.835 . . . . 0.0 109.276 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.1 170.26 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 111.0 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -138.47 121.81 17.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.445 1.098 . . . . 0.0 110.082 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -122.14 105.89 10.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.08 0.952 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -7.66 16.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.547 1.539 . . . . 0.0 113.723 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.87 -24.5 64.34 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.788 1.235 . . . . 0.0 112.375 172.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.99 150.14 96.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.633 0.773 . . . . 0.0 111.927 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.67 162.0 33.34 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.138 3.225 . . . . 0.0 112.945 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 133.53 27.24 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.963 3.109 . . . . 0.0 112.49 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.03 26.88 7.19 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.399 1.88 . . . . 0.0 113.015 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -112.58 153.64 27.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.48 151.23 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.019 2.128 . . . . 0.0 109.678 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -114.41 131.8 56.45 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.127 1.33 . . . . 0.0 111.727 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.9 106.57 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 110.794 -171.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.22 129.3 39.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.875 1.27 . . . . 0.0 111.34 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.5 t -69.41 135.1 49.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.776 -0.577 . . . . 0.0 111.973 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.412 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 32.9 mtm105 -105.37 15.31 27.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.659 1.584 . . . . 0.0 110.487 162.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 17.5 m -121.16 143.63 49.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.008 1.323 . . . . 0.0 112.054 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -111.1 136.55 49.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.829 2.052 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.96 137.46 32.32 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 166.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.82 117.36 52.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 108.058 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -99.64 174.61 27.08 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.709 1.147 . . . . 0.0 111.012 164.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.44 27.17 70.15 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 119.132 -0.815 . . . . 0.0 114.031 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.22 106.02 18.06 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.504 1.152 . . . . 0.0 110.567 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.97 146.52 87.81 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.798 2.332 . . . . 0.0 111.037 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.49 -19.24 64.58 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.69 -29.6 68.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.078 0.951 . . . . 0.0 112.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 17.6 mtm -85.62 151.8 23.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.037 0.935 . . . . 0.0 112.667 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -175.49 4.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 111.581 -175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -50.33 -35.56 28.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.387 1.875 . . . . 0.0 113.085 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -78.01 -21.24 51.08 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.9 -36.09 62.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.844 1.202 . . . . 0.0 110.639 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 355' ' ' LEU . 3.8 mm? -60.58 -46.94 88.36 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.725 0.693 . . . . 0.0 110.772 169.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 305' ' ' LEU . . . -53.86 -44.8 70.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.545 0.612 . . . . 0.0 112.437 169.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -69.49 -41.19 76.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.695 1.198 . . . . 0.0 113.456 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.6 m -73.75 -34.69 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.898 0.772 . . . . 0.0 111.864 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 379' ' ' VAL . 66.7 mt -86.3 -12.6 49.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.354 1.062 . . . . 0.0 113.397 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -48.3 71.87 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.087 1.755 . . . . 0.0 115.309 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.69 -7.44 17.62 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.66 2.24 . . . . 0.0 113.869 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -96.73 -39.87 9.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.281 1.432 . . . . 0.0 112.401 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.43 171.86 5.35 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.919 1.688 . . . . 0.0 112.747 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.39 130.8 34.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.366 0.666 . . . . 0.0 109.559 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.34 127.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 109.601 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.01 -46.63 10.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 111.699 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 45.2 t -154.57 152.03 29.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 -169.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.9 134.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.42 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 166.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.16 139.07 37.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.244 0.618 . . . . 0.0 110.731 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.28 90.82 3.0 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.546 1.165 . . . . 0.0 109.989 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.46 -31.03 68.95 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 111.82 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 6.7 m -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.544 1.938 . . . . 0.0 114.908 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.67 9.75 17.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.342 1.457 . . . . 0.0 112.932 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 55.5 35.82 25.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.908 1.683 . . . . 0.0 112.9 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -126.9 167.32 16.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.4 164.02 34.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.482 1.113 . . . . 0.0 112.112 165.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.98 123.04 42.52 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.516 1.526 . . . . 0.0 108.155 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 359' ' ' LEU . 94.1 t -117.62 116.02 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.257 1.023 . . . . 0.0 110.752 -175.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -91.29 121.04 32.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.922 0.889 . . . . 0.0 110.176 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.15 167.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.052 0.941 . . . . 0.0 109.465 168.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -76.38 -18.91 58.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.11 155.73 45.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.197 169.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -38.9 88.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.126 0.971 . . . . 0.0 111.99 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.2 -48.55 75.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.465 1.106 . . . . 0.0 111.314 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.23 91.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.018 0.527 . . . . 0.0 111.458 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -62.81 -42.28 99.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.25 1.02 . . . . 0.0 112.097 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -65.43 -34.14 77.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.658 1.117 . . . . 0.0 112.78 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.29 -62.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.64 -35.17 40.98 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.826 1.25 . . . . 0.0 114.109 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -67.02 -44.11 81.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.584 1.553 . . . . 0.0 113.266 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -103.58 -29.88 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -72.08 127.87 33.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.338 1.055 . . . . 0.0 111.388 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.72 25.64 15.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.466 . . . . 0.0 114.881 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -51.39 -45.87 62.63 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.09 3.53 38.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.888 2.075 . . . . 0.0 113.287 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.4 30.28 50.18 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.506 1.051 . . . . 0.0 113.81 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.36 65.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.86 162.23 30.29 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 126.335 1.854 . . . . 0.0 110.256 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.63 -22.73 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.328 2.018 . . . . 0.0 113.296 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 402' ' ' LEU . 0.2 OUTLIER -81.91 143.95 31.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.579 1.152 . . . . 0.0 111.724 -172.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -115.24 122.15 45.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.136 1.374 . . . . 0.0 108.919 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.6 m -107.12 128.62 54.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.507 1.123 . . . . 0.0 110.319 -167.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -132.51 175.64 9.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.818 2.047 . . . . 0.0 109.475 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -64.63 134.57 54.58 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.96 -1.087 . . . . 0.0 110.946 164.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.34 -152.82 9.61 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.702 1.62 . . . . 0.0 109.147 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.48 134.27 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.332 0.566 . . . . 0.0 112.262 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.97 -51.61 3.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -126.99 118.58 24.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.229 1.011 . . . . 0.0 112.119 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.96 143.13 4.7 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.857 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.26 130.22 17.19 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 125.686 4.257 . . . . 0.0 110.323 175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -35.29 80.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.646 0.378 . . . . 0.0 111.875 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -76.23 -16.61 59.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.14 1.376 . . . . 0.0 114.565 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.5 m -123.9 31.03 5.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.41 1.484 . . . . 0.0 111.952 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.36 138.26 32.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.632 1.573 . . . . 0.0 111.609 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -124.89 81.67 1.98 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.296 1.438 . . . . 0.0 109.881 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -66.4 -16.37 64.03 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.9 -51.23 23.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.964 1.256 . . . . 0.0 110.295 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -82.38 -12.28 58.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 73.83 42.68 37.57 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.607 1.099 . . . . 0.0 112.464 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -147.01 170.24 17.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.625 1.212 . . . . 0.0 112.836 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 25.5 m -132.57 152.24 51.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.035 0.934 . . . . 0.0 110.709 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.55 134.53 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.77 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.51 119.14 21.59 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 119.81 1.187 . . . . 0.0 111.409 -172.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.68 133.53 18.84 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.616 2.211 . . . . 0.0 111.492 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 9.6 mtt -59.5 -30.05 68.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.588 1.555 . . . . 0.0 113.762 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -65.17 -18.76 65.57 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -109.26 6.43 24.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.194 2.198 . . . . 0.0 113.346 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 425' ' ' ILE . 75.8 mt -94.48 138.34 32.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.409 1.084 . . . . 0.0 111.093 170.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.5 p -79.65 177.51 8.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.037 1.335 . . . . 0.0 111.356 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.64 -46.3 90.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.579 -0.7 . . . . 0.0 111.323 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.69 88.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.883 0.873 . . . . 0.0 112.059 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.78 -62.54 1.8 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.799 0.84 . . . . 0.0 111.338 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -61.47 -32.19 72.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.738 0.415 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -62.1 1.85 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.566 169.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -58.69 -40.52 83.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.477 1.49 . . . . 0.0 111.937 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 14.9 m -54.0 -29.23 42.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.832 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.14 -42.36 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.999 1.272 . . . . 0.0 114.087 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 20.0 m -93.08 -9.1 40.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.646 1.978 . . . . 0.0 115.033 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.24 145.9 41.24 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.086 1.312 . . . . 0.0 111.652 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.98 -53.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.011 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -97.95 136.65 37.93 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.325 1.05 . . . . 0.0 110.723 166.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 65.15 -170.79 25.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.232 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.35 -164.39 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 -166.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 49.9 p -100.9 14.41 31.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -164.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.5 m 62.22 19.11 10.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.783 1.174 . . . . 0.0 113.498 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.27 4.84 64.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.115 1.341 . . . . 0.0 114.201 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.34 151.57 96.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 118.785 1.292 . . . . 0.0 110.708 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.86 145.71 86.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.791 2.327 . . . . 0.0 110.894 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.66 107.03 3.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.98 157.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.574 1.55 . . . . 0.0 110.238 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 94.5 m -55.14 130.19 41.03 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.757 0.823 . . . . 0.0 110.019 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.77 -5.8 82.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.783 -1.009 . . . . 0.0 114.866 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.92 137.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.188 1.494 . . . . 0.0 111.973 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.7 137.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.422 1.889 . . . . 0.0 109.544 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -161.84 174.51 13.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.958 1.303 . . . . 0.0 112.694 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -87.74 150.32 23.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.801 1.241 . . . . 0.0 111.002 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 10.9 pt-20 -50.99 128.98 29.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.67 150.37 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.902 2.402 . . . . 0.0 110.98 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.1 141.55 58.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.726 1.21 . . . . 0.0 114.059 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.56 53.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 123.433 1.587 . . . . 0.0 110.294 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.549 0.916 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.622 141.744 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -70.41 140.92 52.17 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.093 -1.004 . . . . 0.0 112.77 171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.409 HD12 ' CZ2' ' A' ' 353' ' ' TRP . 3.3 mm? -65.54 -48.76 71.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 110.543 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 CA--C 1.551 0.989 0 C-N-CA 124.6 1.16 . . . . 0.0 113.013 -176.579 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 122.07 0.938 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 124.872 1.269 . . . . 0.0 109.064 175.19 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 29.9 m80 . . . . . 0 CA--C 1.549 0.919 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -52.94 131.52 36.0 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.835 -1.166 . . . . 0.0 111.797 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -138.65 147.77 55.99 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.792 1.237 . . . . 0.0 110.083 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.78 159.92 49.06 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.791 2.327 . . . . 0.0 111.116 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 81.82 0.54 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.78 0.832 . . . . 0.0 109.01 162.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.8 121.57 7.75 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 108.539 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 13.8 t -121.54 128.92 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.806 0.842 . . . . 0.0 109.382 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.14 171.72 8.49 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.019 1.727 . . . . 0.0 110.989 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -139.88 120.48 14.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.007 . . . . 0.0 109.928 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -120.04 109.74 15.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.301 1.04 . . . . 0.0 110.609 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 99.1 p -69.06 -7.66 37.82 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.1 t -64.4 -24.91 67.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.278 1.031 . . . . 0.0 112.223 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.37 150.72 95.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.931 0.892 . . . . 0.0 112.237 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.81 161.6 35.49 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.903 3.069 . . . . 0.0 112.64 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.64 134.44 28.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.942 3.094 . . . . 0.0 112.109 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . 0.25 7.0 m-20 68.4 26.03 6.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.675 1.99 . . . . 0.0 113.362 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -111.14 153.3 25.93 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.94 148.77 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.25 1.82 . . . . 0.0 109.872 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.15 132.85 53.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.502 -1.373 . . . . 0.0 110.617 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.93 106.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.341 0.656 . . . . 0.0 111.461 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -68.49 131.59 45.54 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.579 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 32.7 t -73.1 136.57 44.91 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.723 -0.611 . . . . 0.0 111.841 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -106.89 18.64 21.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.187 1.795 . . . . 0.0 109.724 163.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 16.2 m -126.29 141.95 51.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.967 1.307 . . . . 0.0 111.763 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.5 mt -104.16 134.88 46.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 109.351 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -87.27 123.39 32.22 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 163.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.58 107.13 22.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.23 -174.84 50.67 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 166.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.61 70.02 Favored Glycine 0 N--CA 1.475 1.275 0 O-C-N 121.43 -1.041 . . . . 0.0 114.955 170.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 14.9 t -84.71 112.81 45.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 118.78 1.29 . . . . 0.0 110.295 -168.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.95 143.96 62.47 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.984 2.456 . . . . 0.0 109.919 170.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.04 -21.18 63.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.9 -27.49 63.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.859 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 33.9 mtm -80.58 145.86 31.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.59 0.709 . . . . 0.0 112.293 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -129.46 -179.4 5.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.145 2.178 . . . . 0.0 110.976 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -47.68 -40.31 19.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 114.216 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.409 ' CZ2' HD12 ' A' ' 305' ' ' LEU . 78.4 m95 -81.43 -18.63 44.7 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.76 -39.27 66.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.663 1.12 . . . . 0.0 110.185 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.24 -51.26 70.75 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.833 0.453 . . . . 0.0 110.719 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.82 71.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.662 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -68.18 -44.31 76.2 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.135 1.334 . . . . 0.0 113.996 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.82 -35.72 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.507 1.049 . . . . 0.0 110.954 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.524 HD23 ' CE1' ' A' ' 394' ' ' PHE . 30.6 mt -83.7 -11.57 57.01 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.459 1.104 . . . . 0.0 113.138 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -48.66 -48.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.849 1.66 . . . . 0.0 114.758 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.12 -6.74 17.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.133 1.889 . . . . 0.0 113.586 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -98.46 -40.93 8.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.5 1.52 . . . . 0.0 112.431 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.68 171.55 3.79 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.915 1.686 . . . . 0.0 113.461 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -85.99 138.35 32.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.661 0.784 . . . . 0.0 110.538 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.1 t -103.7 129.86 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.616 1.166 . . . . 0.0 110.169 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLN . . . . . 0.415 ' HG3' ' CE1' ' A' ' 382' ' ' TYR . 45.7 tt0 -93.64 -40.23 10.37 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.355 1.862 . . . . 0.0 112.782 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.1 t -152.82 152.04 31.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.404 1.082 . . . . 0.0 110.61 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 70.9 t -146.22 131.99 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.248 0.477 . . . . 0.0 110.417 171.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.24 107.88 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.61 122.06 40.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.066 0.546 . . . . 0.0 110.337 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -106.48 84.9 2.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.822 1.649 . . . . 0.0 109.478 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.72 -33.91 66.96 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.485 1.514 . . . . 0.0 111.354 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 65.6 m -55.72 -32.51 63.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.155 1.782 . . . . 0.0 114.27 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -110.21 9.17 23.86 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 113.191 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt 53.94 37.85 27.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.382 1.473 . . . . 0.0 112.072 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -125.5 153.39 43.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.971 1.708 . . . . 0.0 113.24 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -136.8 132.75 35.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 112.228 164.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.96 117.63 24.92 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 162.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 359' ' ' LEU . 54.8 t -118.56 114.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.706 0.803 . . . . 0.0 110.249 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -98.37 121.96 40.95 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 110.299 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.11 164.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.437 1.095 . . . . 0.0 109.553 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 366' ' ' GLN . 70.7 m-85 -74.53 -21.22 59.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.4 p -141.74 159.63 41.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.09 1.314 . . . . 0.0 114.234 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -61.54 -45.34 94.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.214 1.006 . . . . 0.0 112.079 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -58.8 -38.22 78.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.239 0.616 . . . . 0.0 112.231 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.47 -54.8 34.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.956 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.0 85.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.888 0.767 . . . . 0.0 112.307 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.69 -44.79 95.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 111.633 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -65.24 -33.79 76.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.204 -0.935 . . . . 0.0 112.654 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 359' ' ' LEU . 49.3 t -60.16 -63.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.55 166.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -51.13 -35.81 37.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.877 1.271 . . . . 0.0 114.314 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -63.83 -37.51 87.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.99 1.316 . . . . 0.0 113.085 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -112.83 -26.94 8.32 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.524 ' CE1' HD23 ' A' ' 359' ' ' LEU . 11.2 t80 -74.3 123.81 25.28 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 111.308 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.93 27.4 13.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.736 1.614 . . . . 0.0 114.168 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -24.56 66.77 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -100.56 -14.48 18.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.615 1.966 . . . . 0.0 114.524 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.26 24.28 29.55 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.548 1.07 . . . . 0.0 115.291 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.88 -42.01 22.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.562 1.681 . . . . 0.0 115.028 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.8 149.25 90.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.859 0.863 . . . . 0.0 110.57 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.84 -32.89 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.588 2.192 . . . . 0.0 111.71 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.76 163.4 25.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.203 1.801 . . . . 0.0 112.67 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -126.3 101.28 6.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.549 1.54 . . . . 0.0 109.915 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 113.06 21.2 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.115 1.366 . . . . 0.0 109.804 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.42 171.11 11.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.938 1.695 . . . . 0.0 109.178 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -67.29 130.84 44.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.097 -1.002 . . . . 0.0 110.838 163.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -115.66 -148.96 9.39 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 125.865 1.698 . . . . 0.0 109.102 167.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.96 132.17 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.29 -46.71 5.47 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 167.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -132.82 121.47 23.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 111.978 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.86 145.79 5.84 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 119.274 -0.736 . . . . 0.0 114.659 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.13 133.61 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 125.048 3.832 . . . . 0.0 109.739 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -37.73 80.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.835 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.21 -20.12 63.11 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.658 -1.276 . . . . 0.0 113.896 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.0 m -123.71 30.19 6.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.817 1.647 . . . . 0.0 112.041 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.1 p -75.65 154.06 36.83 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.969 0.89 . . . . 0.0 112.688 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.07 73.23 1.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.596 1.558 . . . . 0.0 108.837 166.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.62 -19.96 65.29 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.257 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.65 -49.67 65.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.688 -1.258 . . . . 0.0 111.19 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -83.34 -13.79 54.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.7 40.15 12.9 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.844 1.211 . . . . 0.0 112.713 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -146.52 172.19 13.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.76 1.28 . . . . 0.0 112.38 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 50.6 m -139.35 153.31 47.67 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.881 0.872 . . . . 0.0 109.805 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.5 mt -110.73 133.93 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.839 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -125.1 119.16 25.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.517 1.053 . . . . 0.0 111.915 -170.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.05 127.99 14.28 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.915 2.41 . . . . 0.0 110.96 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 42.4 mtm -61.14 -30.38 70.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.576 1.15 . . . . 0.0 113.451 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -65.82 -20.34 66.21 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 11.57 22.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.049 2.14 . . . . 0.0 113.184 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 425' ' ' ILE . 45.0 mt -92.83 145.44 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.223 1.009 . . . . 0.0 111.316 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.1 p -79.76 177.33 8.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.22 -44.39 88.45 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.554 -0.717 . . . . 0.0 111.492 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.05 93.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.948 0.899 . . . . 0.0 112.05 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.449 ' HB3' HD22 ' A' ' 430' ' ' LEU . 96.7 m-20 -56.42 -63.24 1.26 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.668 1.187 . . . . 0.0 111.405 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.16 -35.0 72.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.128 0.971 . . . . 0.0 111.027 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -56.89 -51.61 68.4 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.197 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -64.56 -41.01 96.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.726 1.603 . . . . 0.0 111.854 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 15.5 m -51.51 -32.6 28.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.016 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.24 -37.93 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.7 t -101.47 -6.68 23.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.649 1.58 . . . . 0.0 114.031 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.442 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.51 146.52 29.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.169 0.985 . . . . 0.0 112.41 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.88 -50.07 11.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.657 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -98.52 140.3 32.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.603 0.761 . . . . 0.0 111.481 159.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.54 -159.03 48.64 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.695 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 68.5 -168.51 42.51 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 47.4 p -96.14 10.05 38.93 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t 65.83 23.99 11.37 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.877 -1.14 . . . . 0.0 113.495 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.66 65.27 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.672 1.606 . . . . 0.0 114.145 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.73 150.76 96.59 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 118.926 1.363 . . . . 0.0 110.948 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 144.32 79.66 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.861 2.374 . . . . 0.0 110.689 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.7 112.3 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.556 . . . . 0.0 109.568 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.42 157.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.741 1.616 . . . . 0.0 110.279 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 92.3 m -53.59 127.14 24.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 109.81 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 92.08 -5.7 78.66 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.77 -1.017 . . . . 0.0 115.293 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.83 137.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.265 1.532 . . . . 0.0 111.676 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 137.0 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.435 1.894 . . . . 0.0 109.454 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.34 172.93 17.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.341 1.056 . . . . 0.0 112.187 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.51 148.87 25.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.74 1.216 . . . . 0.0 111.525 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.81 129.93 20.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.25 147.72 48.21 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.878 2.385 . . . . 0.0 110.417 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.442 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.1 m-20 -61.78 147.57 45.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 0.0 114.039 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.8 mm -107.37 48.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.734 1.613 . . . . 0.0 109.671 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.474 0.771 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.58 137.868 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 27.7 m80 . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -81.69 136.52 35.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.358 1.063 . . . . 0.0 113.446 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 368' ' ' VAL . 1.1 mt -76.79 2.42 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.984 1.714 . . . . 0.0 113.026 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 125.25 1.42 . . . . 0.0 111.815 -173.39 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 CA--C 1.549 0.941 0 O-C-N 120.842 -1.161 . . . . 0.0 110.23 175.379 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.72 132.66 31.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.881 1.219 . . . . 0.0 111.894 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.28 146.94 60.11 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 124.502 1.121 . . . . 0.0 109.949 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.26 161.97 40.67 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.773 2.316 . . . . 0.0 110.621 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.17 79.4 1.58 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 165.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.79 126.64 13.52 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.492 2.128 . . . . 0.0 108.606 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.49 116.33 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.206 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.75 167.37 10.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 0.0 110.868 172.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -141.57 124.55 16.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.256 1.023 . . . . 0.0 109.619 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -122.73 114.01 19.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.645 0.778 . . . . 0.0 110.403 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -69.48 -8.64 48.71 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -22.77 66.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.452 171.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.62 150.99 93.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.655 0.782 . . . . 0.0 111.862 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.46 161.66 33.99 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.874 3.049 . . . . 0.0 112.77 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.59 131.62 17.65 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.945 3.097 . . . . 0.0 112.461 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 64.5 45.83 3.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.873 2.069 . . . . 0.0 111.659 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -125.8 152.51 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 17.1 pt -125.21 144.39 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.078 1.751 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.74 54.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.028 1.331 . . . . 0.0 110.378 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.64 105.99 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.055 0.942 . . . . 0.0 110.908 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -72.18 134.82 45.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.562 1.145 . . . . 0.0 111.847 167.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.6 t -76.9 136.49 38.83 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.213 -0.929 . . . . 0.0 111.732 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.4 mtm105 -103.43 15.88 27.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.529 1.932 . . . . 0.0 109.954 163.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 87.3 m -117.48 132.54 56.53 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.714 1.606 . . . . 0.0 110.673 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.29 136.76 38.01 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.185 1.394 . . . . 0.0 108.856 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -92.38 138.83 31.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 26.7 mm -124.26 108.31 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -171.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.69 174.29 46.23 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 165.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.75 30.07 70.78 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.844 -0.798 . . . . 0.0 114.146 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 91.4 t -90.38 109.39 33.38 Favored Pre-proline 0 N--CA 1.478 0.946 0 CA-C-N 118.25 1.025 . . . . 0.0 110.69 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.33 141.97 48.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.401 2.067 . . . . 0.0 110.107 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.04 -17.82 62.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.49 -35.04 79.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.064 0.946 . . . . 0.0 112.617 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 ptp -86.73 152.67 22.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -130.8 -174.44 3.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.229 1.812 . . . . 0.0 111.644 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -55.76 -39.14 70.78 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.176 1.39 . . . . 0.0 112.796 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.98 -23.05 58.21 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.19 -39.13 65.83 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.236 0.926 . . . . 0.0 110.571 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.18 -51.78 68.53 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.547 168.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.87 67.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.713 173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -46.95 64.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.939 1.245 . . . . 0.0 113.583 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.99 -33.56 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.12 0.873 . . . . 0.0 110.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.575 HD23 ' CE1' ' A' ' 394' ' ' PHE . 31.0 mt -87.45 -8.05 56.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.367 1.067 . . . . 0.0 113.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -48.67 -49.08 67.66 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.613 1.565 . . . . 0.0 114.988 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.36 -6.46 17.15 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.028 1.819 . . . . 0.0 113.262 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -98.14 -38.53 9.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.465 1.506 . . . . 0.0 112.54 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.8 168.42 5.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.47 1.908 . . . . 0.0 112.537 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.14 136.87 32.77 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.658 0.783 . . . . 0.0 110.051 169.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.89 134.95 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.623 1.169 . . . . 0.0 109.986 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.59 -35.19 9.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.51 150.13 30.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.528 1.058 . . . . 0.0 111.982 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 305' ' ' LEU . 88.9 t -146.32 139.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.15 102.39 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.9 tt -97.46 130.72 44.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.918 0.887 . . . . 0.0 109.635 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.68 91.03 3.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.263 1.025 . . . . 0.0 110.085 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.41 -40.23 90.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 111.513 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.7 t -65.17 -25.36 67.69 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.213 1.405 . . . . 0.0 112.938 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -0.67 41.62 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.486 1.515 . . . . 0.0 112.918 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 27.85 16.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.963 1.305 . . . . 0.0 113.772 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.84 170.41 15.89 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.3 40.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.001 1.321 . . . . 0.0 112.314 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.22 128.32 55.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.276 1.43 . . . . 0.0 108.692 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 359' ' ' LEU . 88.1 t -124.32 111.32 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 111.004 -173.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 112.92 25.0 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.552 1.541 . . . . 0.0 111.034 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.49 163.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.91 0.884 . . . . 0.0 110.357 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.51 -26.65 63.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.7 p -134.9 155.28 50.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.158 0.98 . . . . 0.0 113.165 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -41.83 92.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.009 0.923 . . . . 0.0 111.35 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -65.63 -36.68 84.4 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.906 -0.497 . . . . 0.0 111.452 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -59.51 -51.26 70.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.517 0.727 . . . . 0.0 111.116 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.77 94.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.635 0.652 . . . . 0.0 111.945 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.81 -43.26 98.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.219 0.608 . . . . 0.0 112.053 171.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -64.38 -34.22 77.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.398 0.999 . . . . 0.0 112.358 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 359' ' ' LEU . 34.5 t -61.48 -63.18 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.083 167.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.38 -36.39 43.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.717 1.207 . . . . 0.0 114.036 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.75 -35.34 80.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.99 1.316 . . . . 0.0 113.034 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.23 -25.45 9.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -174.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.575 ' CE1' HD23 ' A' ' 359' ' ' LEU . 13.6 t80 -72.77 122.89 22.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.361 0.664 . . . . 0.0 111.528 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 62.44 29.32 17.14 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 114.022 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.62 -31.33 68.0 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -84.8 -16.81 40.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.794 1.638 . . . . 0.0 114.076 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.42 73.74 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.794 1.188 . . . . 0.0 114.114 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.62 -34.2 35.23 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.112 1.456 . . . . 0.0 114.853 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.405 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 15.6 mt -76.55 148.56 80.14 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.156 0.982 . . . . 0.0 109.871 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.45 -29.1 13.97 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.717 2.278 . . . . 0.0 112.408 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.61 151.27 42.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.966 1.307 . . . . 0.0 111.778 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 104.74 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.767 0.827 . . . . 0.0 110.681 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.2 m -85.58 121.52 28.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.189 1.396 . . . . 0.0 109.746 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -129.13 178.04 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.628 1.971 . . . . 0.0 108.862 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -72.25 126.3 29.46 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.19 -0.943 . . . . 0.0 111.305 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.01 -156.95 19.37 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 165.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.97 136.72 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 117.117 0.459 . . . . 0.0 111.887 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.99 -44.79 3.75 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.683 1.611 . . . . 0.0 110.464 163.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.48 113.96 18.17 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.018 0.909 . . . . 0.0 113.053 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.82 139.59 4.31 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.92 129.25 15.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.006 3.804 . . . . 0.0 109.974 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -63.49 -38.25 90.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.319 0.648 . . . . 0.0 112.294 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.1 -24.9 66.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.078 1.751 . . . . 0.0 113.345 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 71.8 m -127.35 31.19 5.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.158 1.783 . . . . 0.0 111.277 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.4 t -85.01 140.76 30.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.031 1.333 . . . . 0.0 111.685 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.4 75.82 1.5 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.716 1.606 . . . . 0.0 109.124 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -63.08 -16.49 60.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -70.35 -49.1 52.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.672 1.124 . . . . 0.0 111.023 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -83.81 -16.07 45.98 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.48 38.09 11.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.841 1.21 . . . . 0.0 113.163 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -143.09 174.65 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.338 1.069 . . . . 0.0 112.49 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.3 p -146.27 153.85 41.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.536 1.134 . . . . 0.0 109.964 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.2 mt -114.32 131.14 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -120.83 123.12 28.1 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 119.433 1.015 . . . . 0.0 111.479 -171.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -69.55 132.03 22.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.69 2.26 . . . . 0.0 111.003 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.53 -32.03 72.9 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 113.236 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.87 -22.44 66.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.7 7.3 37.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.31 1.844 . . . . 0.0 112.636 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 425' ' ' ILE . 74.6 mt -92.29 142.15 27.78 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.293 1.437 . . . . 0.0 110.969 169.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.8 p -80.05 174.97 11.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.9 1.28 . . . . 0.0 111.048 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.47 -38.99 91.99 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.639 -0.663 . . . . 0.0 111.747 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.53 80.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.026 0.93 . . . . 0.0 112.205 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.82 -54.57 45.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.414 1.086 . . . . 0.0 112.141 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -68.44 -34.31 75.74 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -52.94 -51.78 60.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.243 1.017 . . . . 0.0 111.202 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -68.26 -42.2 79.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.437 1.472 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.2 m -55.52 -30.02 59.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.067 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.7 m -97.84 -40.85 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.4 t -103.13 -9.81 19.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -165.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.62 146.03 37.56 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.906 -1.121 . . . . 0.0 111.581 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -74.79 -52.41 11.53 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.795 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -96.11 133.81 39.92 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.003 0.906 . . . . 0.0 110.984 166.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 -171.26 44.31 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.828 -174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.67 -163.5 54.28 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 115.242 -0.479 . . . . 0.0 112.295 -169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 44.4 p -103.55 11.7 35.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -162.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.62 21.2 5.48 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.792 -1.192 . . . . 0.0 113.064 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.23 4.63 77.41 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 120.768 -1.208 . . . . 0.0 113.874 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -66.42 154.18 91.3 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.591 1.195 . . . . 0.0 110.373 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.1 142.45 80.78 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.151 1.901 . . . . 0.0 110.199 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 50.2 mt -67.67 120.33 13.87 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.53 155.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.304 1.441 . . . . 0.0 109.802 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -59.69 131.82 52.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.067 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.64 -5.78 83.47 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.422 -1.21 . . . . 0.0 115.186 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.8 tt -61.39 143.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.598 1.699 . . . . 0.0 112.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.21 137.0 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.542 1.937 . . . . 0.0 109.33 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -160.63 177.27 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 0.0 112.149 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -95.89 149.47 21.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.714 1.206 . . . . 0.0 111.06 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.91 135.85 56.71 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -162.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.25 153.38 40.56 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.858 2.372 . . . . 0.0 110.786 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.66 142.03 58.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.453 1.101 . . . . 0.0 113.577 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.97 48.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.335 1.54 . . . . 0.0 110.334 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 CA--C 1.547 0.847 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.84 138.751 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 26.7 m80 . . . . . 0 CA--C 1.552 1.028 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -78.11 140.81 39.06 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.005 -1.06 . . . . 0.0 112.19 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 7.1 mp -83.42 -10.91 58.12 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 112.154 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 126.255 1.822 . . . . 0.0 111.57 -170.316 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.039 0.447 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 CA--C 1.547 0.838 0 O-C-N 121.32 -0.863 . . . . 0.0 111.07 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.9 m80 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -51.92 127.69 21.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.618 1.099 . . . . 0.0 111.447 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.81 145.01 48.43 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 110.24 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.02 144.3 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.459 2.772 . . . . 0.0 111.004 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 83.67 0.77 Allowed Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 165.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.89 113.61 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.296 1.997 . . . . 0.0 108.624 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.3 116.44 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.5 168.45 12.11 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.273 1.429 . . . . 0.0 110.757 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.72 127.27 21.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 110.089 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -122.67 106.62 11.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.926 0.869 . . . . 0.0 111.291 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -10.45 40.39 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.341 1.456 . . . . 0.0 113.674 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 73.0 p -70.82 -22.98 62.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.68 1.592 . . . . 0.0 112.183 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.06 150.29 92.42 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.157 0.983 . . . . 0.0 111.792 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.84 161.5 36.05 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.182 3.254 . . . . 0.0 112.971 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.99 137.11 36.87 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.065 3.176 . . . . 0.0 112.692 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 67.82 24.17 8.26 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.157 1.783 . . . . 0.0 113.134 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -107.94 152.57 24.27 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.818 -1.177 . . . . 0.0 113.825 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.85 144.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 126.238 1.815 . . . . 0.0 110.389 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 128.55 54.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 0.0 111.084 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 457' ' ' PHE . 47.2 t -125.11 106.7 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.567 0.747 . . . . 0.0 111.097 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.78 130.12 42.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.42 1.088 . . . . 0.0 111.228 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.6 t -69.69 135.91 50.41 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.852 -0.53 . . . . 0.0 111.594 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.425 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 33.2 mtm105 -104.48 16.14 26.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.576 1.55 . . . . 0.0 110.858 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 21.8 m -123.66 136.19 54.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.286 1.434 . . . . 0.0 112.122 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.61 139.37 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.19 1.396 . . . . 0.0 109.951 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -92.29 139.65 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.79 108.83 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.589 1.156 . . . . 0.0 107.916 -171.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -92.4 -175.9 41.83 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.67 15.9 69.25 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.707 -0.878 . . . . 0.0 114.256 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.4 120.01 79.33 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 118.744 1.272 . . . . 0.0 110.187 -167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 139.42 38.36 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.144 1.896 . . . . 0.0 109.923 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.9 pp -61.82 -18.84 61.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.7 -23.82 49.38 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.3 ptp -87.24 148.47 25.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -125.61 -177.22 3.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.978 1.711 . . . . 0.0 111.908 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -47.15 -42.46 19.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.593 1.957 . . . . 0.0 114.243 174.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.69 -22.05 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.76 -37.06 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.149 0.886 . . . . 0.0 110.852 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.4 mm? -56.84 -51.24 69.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.387 0.54 . . . . 0.0 110.011 168.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -58.24 -39.94 80.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.015 0.825 . . . . 0.0 112.806 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -66.76 -39.88 88.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.296 1.407 . . . . 0.0 113.097 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.02 -32.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.733 1.151 . . . . 0.0 111.702 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.406 ' CD1' HG11 ' A' ' 379' ' ' VAL . 56.5 mt -86.88 -12.32 48.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.559 1.144 . . . . 0.0 113.88 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -48.89 -47.91 72.56 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.57 -6.22 17.42 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.145 1.897 . . . . 0.0 113.199 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -100.27 -39.12 8.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.397 1.479 . . . . 0.0 112.693 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.48 170.75 4.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.623 . . . . 0.0 114.161 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -81.28 135.16 35.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.556 1.143 . . . . 0.0 110.965 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 88.6 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.744 1.218 . . . . 0.0 110.19 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -91.34 -45.02 8.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.841 1.256 . . . . 0.0 112.46 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.01 149.26 29.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.848 0.859 . . . . 0.0 110.86 -171.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.02 131.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.909 0.777 . . . . 0.0 110.858 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.33 99.39 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.57 145.76 24.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.881 0.872 . . . . 0.0 110.486 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -137.1 89.57 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.556 1.142 . . . . 0.0 110.214 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.41 -32.03 71.97 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.238 -0.914 . . . . 0.0 112.061 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.8 t -60.94 -31.64 71.18 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.807 1.243 . . . . 0.0 112.694 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -96.14 -3.81 43.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 113.525 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 60.03 31.31 20.57 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.671 1.589 . . . . 0.0 113.107 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -136.29 170.27 16.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.2 162.99 36.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.963 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -118.33 128.69 54.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.559 1.544 . . . . 0.0 108.268 165.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.406 HG11 ' CD1' ' A' ' 359' ' ' LEU . 61.2 t -123.15 109.8 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.974 0.909 . . . . 0.0 110.423 -176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -85.59 117.46 24.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 109.934 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.62 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 165.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.89 -19.1 57.85 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.98 154.78 46.19 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.115 0.871 . . . . 0.0 113.174 -176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -62.99 -41.52 99.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.731 0.812 . . . . 0.0 111.577 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -63.12 -38.64 92.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.859 0.464 . . . . 0.0 110.848 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.22 -49.51 75.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.542 1.137 . . . . 0.0 111.431 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.93 97.91 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.864 -0.523 . . . . 0.0 112.139 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -64.88 -42.66 94.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.655 0.782 . . . . 0.0 111.899 171.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.29 -34.8 78.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.188 0.904 . . . . 0.0 112.045 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.3 -63.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.894 165.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.85 -32.63 53.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -65.07 -31.78 73.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.996 1.319 . . . . 0.0 113.466 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -120.18 -28.97 4.97 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -74.33 125.47 28.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.64 20.15 11.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.308 1.443 . . . . 0.0 114.164 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.34 65.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -111.13 4.26 19.19 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.577 2.351 . . . . 0.0 112.796 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 75.21 32.59 55.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.315 0.959 . . . . 0.0 113.368 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.69 59.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.77 161.68 36.73 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.061 1.345 . . . . 0.0 110.172 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.97 -7.09 18.04 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.574 2.849 . . . . 0.0 113.901 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.96 166.04 8.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.139 2.176 . . . . 0.0 112.441 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 90.1 2.49 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.0 110.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 127.98 34.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.425 1.49 . . . . 0.0 111.209 -172.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.26 170.37 15.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.257 1.823 . . . . 0.0 108.808 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -68.52 126.64 30.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.419 -0.801 . . . . 0.0 110.579 164.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.39 -152.25 17.87 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.5 136.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 117.564 0.682 . . . . 0.0 111.68 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -89.92 -48.72 3.54 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 166.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -129.26 120.29 25.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.896 0.848 . . . . 0.0 111.811 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 178.74 140.87 4.11 Favored Glycine 0 CA--C 1.542 1.746 0 CA-C-O 119.153 -0.804 . . . . 0.0 114.635 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -70.5 133.72 24.83 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.827 3.684 . . . . 0.0 110.181 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -67.12 -35.37 79.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.995 0.426 . . . . 0.0 111.904 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.07 -26.34 66.68 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.457 1.903 . . . . 0.0 113.403 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.1 m -126.78 31.82 5.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.379 1.872 . . . . 0.0 111.054 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.57 138.35 33.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.425 1.49 . . . . 0.0 111.033 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.32 77.83 1.6 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.22 1.408 . . . . 0.0 109.292 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -62.84 -19.76 64.42 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.362 -0.836 . . . . 0.0 113.133 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.96 -47.25 66.11 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.123 1.329 . . . . 0.0 111.194 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -83.23 -16.08 47.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.98 38.32 11.55 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.805 1.193 . . . . 0.0 112.919 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -146.37 169.88 17.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.931 1.366 . . . . 0.0 112.809 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.2 m -137.68 151.3 48.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.824 0.85 . . . . 0.0 110.631 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.24 130.38 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.822 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -123.28 115.78 28.63 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 119.493 1.042 . . . . 0.0 111.15 -168.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -69.71 130.33 19.21 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.065 2.51 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 30.0 mtt -59.84 -32.28 70.53 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.939 1.296 . . . . 0.0 113.243 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -65.08 -22.41 66.96 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.213 0.915 . . . . 0.0 113.039 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -105.14 8.16 34.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.87 1.668 . . . . 0.0 113.601 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 425' ' ' ILE . 53.2 mt -91.8 146.68 23.56 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.29 1.036 . . . . 0.0 111.784 169.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.7 p -83.41 174.45 10.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.727 1.211 . . . . 0.0 110.805 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.2 -41.75 99.2 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.769 -0.582 . . . . 0.0 111.391 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.54 92.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.119 0.968 . . . . 0.0 111.862 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 430' ' ' LEU . 94.3 m-20 -57.59 -61.29 2.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.471 1.109 . . . . 0.0 111.626 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -57.54 -37.84 73.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 111.45 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -57.93 -45.59 86.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.927 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -66.78 -41.49 87.6 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 120.729 1.604 . . . . 0.0 112.107 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 8.3 m -54.56 -33.2 59.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.401 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 m -98.01 -48.59 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 16.7 m -89.46 -9.32 50.54 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.13 56.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.26 1.391 . . . . 0.0 112.319 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -74.98 -48.33 24.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.968 0.907 . . . . 0.0 110.511 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -101.0 121.12 41.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.212 1.006 . . . . 0.0 110.75 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 84.87 -173.88 49.32 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.426 1.489 . . . . 0.0 112.987 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.48 -159.44 53.67 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 57.0 p -100.22 8.03 44.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.103 1.361 . . . . 0.0 114.646 -163.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.02 22.4 4.55 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.934 -1.104 . . . . 0.0 112.499 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.56 3.59 71.42 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.892 1.235 . . . . 0.0 113.859 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.68 153.24 96.09 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 118.355 1.078 . . . . 0.0 110.796 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -63.87 145.95 91.02 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.551 2.167 . . . . 0.0 110.588 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.16 121.27 19.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.378 0.609 . . . . 0.0 110.005 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.4 t -110.88 152.2 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.604 1.962 . . . . 0.0 108.715 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 74.2 m -49.41 122.6 6.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.281 0.632 . . . . 0.0 110.055 165.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 86.68 1.25 85.55 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.935 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.79 131.59 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.588 1.694 . . . . 0.0 111.532 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.02 138.7 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.045 2.138 . . . . 0.0 109.302 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.407 ' CE1' HG22 ' A' ' 336' ' ' VAL . 32.8 p90 -161.97 179.99 7.59 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.474 1.509 . . . . 0.0 112.604 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -95.77 145.6 25.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.241 1.416 . . . . 0.0 110.421 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 9.2 pt-20 -47.68 128.42 10.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.63 152.07 64.56 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 111.249 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.43 147.97 34.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.443 1.097 . . . . 0.0 113.498 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.1 mm -110.79 49.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 123.251 1.501 . . . . 0.0 110.01 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.548 0.87 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.927 137.928 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.3 m80 . . . . . 0 CA--C 1.552 1.036 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -62.71 136.78 58.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.369 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.0 mp -82.13 -63.94 1.28 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.264 0.626 . . . . 0.0 110.679 -177.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 . . . . . 0 CA--C 1.555 1.157 0 O-C-N 121.386 -0.821 . . . . 0.0 111.96 -170.304 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.74 131.6 25.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.725 1.21 . . . . 0.0 111.863 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.85 154.11 68.29 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.278 1.031 . . . . 0.0 109.722 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -65.27 168.42 14.33 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 110.91 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 83.37 60.72 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.21 1.404 . . . . 0.0 107.325 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 137.61 30.94 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.176 2.584 . . . . 0.0 109.052 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.8 t -138.72 136.14 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.389 1.076 . . . . 0.0 108.751 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 172.01 13.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.956 0.902 . . . . 0.0 110.806 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.12 120.1 22.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.596 1.158 . . . . 0.0 109.667 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -117.83 108.54 15.46 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.808 1.643 . . . . 0.0 110.633 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 62.7 p -70.77 -3.57 19.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.926 1.291 . . . . 0.0 114.169 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -69.86 -19.85 63.42 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.266 1.026 . . . . 0.0 112.786 173.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.43 151.57 94.04 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.043 0.937 . . . . 0.0 112.361 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.31 160.79 33.46 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.9 3.067 . . . . 0.0 112.529 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.83 133.83 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 112.376 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 64.4 36.0 9.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.759 2.024 . . . . 0.0 112.511 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.93 152.49 38.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 455' ' ' ILE . 18.8 pt -125.04 149.53 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.596 1.958 . . . . 0.0 112.111 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 111.19 23.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.445 1.498 . . . . 0.0 110.54 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.401 HG22 ' CE2' ' A' ' 457' ' ' PHE . 21.8 t -114.92 108.78 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.147 0.885 . . . . 0.0 111.884 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -72.03 135.02 46.21 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.856 1.262 . . . . 0.0 111.437 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.7 t -71.48 137.83 48.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.607 -0.683 . . . . 0.0 112.036 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -105.37 17.48 23.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.934 1.694 . . . . 0.0 110.447 160.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 57.3 m -120.8 138.95 53.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.727 1.611 . . . . 0.0 111.487 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 21.5 mt -105.71 132.14 52.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.046 2.138 . . . . 0.0 108.556 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -89.89 123.85 34.19 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 30.4 mm -114.38 109.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.841 0.857 . . . . 0.0 109.088 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.47 175.58 49.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.815 0.722 . . . . 0.0 112.07 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.14 13.57 70.21 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.29 0.948 . . . . 0.0 115.086 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.28 121.8 84.36 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-N 118.459 1.129 . . . . 0.0 110.452 -167.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.5 134.7 22.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.794 2.33 . . . . 0.0 109.633 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.16 -18.82 63.88 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.21 -33.29 75.47 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.592 1.157 . . . . 0.0 112.948 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -86.62 157.97 19.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -133.89 -177.7 4.68 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.064 1.746 . . . . 0.0 111.761 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -55.81 -35.73 66.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.36 1.464 . . . . 0.0 112.856 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -74.96 -25.21 58.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.53 -34.99 65.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.371 0.987 . . . . 0.0 110.616 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.2 mm? -60.02 -48.86 79.97 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.232 169.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.5 78.15 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.437 1.017 . . . . 0.0 112.466 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.42 -40.66 85.56 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.848 1.204 . . . . 0.0 112.92 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.37 -36.59 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.176 0.898 . . . . 0.0 112.192 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.471 HD23 ' CE2' ' A' ' 394' ' ' PHE . 67.7 mt -84.42 -13.15 52.95 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -46.05 -49.51 40.0 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 126.529 1.932 . . . . 0.0 115.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.2 -8.19 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.137 1.891 . . . . 0.0 113.705 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -97.24 -41.22 8.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.547 1.539 . . . . 0.0 112.155 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.65 172.52 4.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.672 1.589 . . . . 0.0 113.312 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -91.17 135.11 34.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.495 1.118 . . . . 0.0 111.074 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.6 131.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.146 1.378 . . . . 0.0 110.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -93.74 -42.89 8.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.081 1.352 . . . . 0.0 112.609 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 30.6 t -156.79 150.86 25.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 109.948 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -149.25 134.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.466 0.707 . . . . 0.0 109.823 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.44 107.79 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 166.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.9 tt -102.37 118.11 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 0.0 110.865 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -106.33 81.64 1.64 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.004 1.722 . . . . 0.0 109.223 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.66 -34.16 61.79 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.605 1.562 . . . . 0.0 111.411 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -60.66 -30.83 70.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.489 1.916 . . . . 0.0 113.632 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 3.32 20.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.239 1.416 . . . . 0.0 113.196 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 61.65 36.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.099 1.759 . . . . 0.0 111.57 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -124.1 154.25 40.26 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.857 2.063 . . . . 0.0 113.3 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.72 135.39 34.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.618 1.167 . . . . 0.0 111.772 161.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.64 121.19 29.75 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 160.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.71 119.46 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.127 0.971 . . . . 0.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -96.96 128.8 44.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.364 1.065 . . . . 0.0 111.213 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.83 165.7 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.452 1.101 . . . . 0.0 110.196 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -69.95 -14.58 62.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -170.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.98 159.16 40.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.546 -1.346 . . . . 0.0 113.256 -176.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -41.58 99.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.986 0.914 . . . . 0.0 109.87 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -64.97 -36.71 85.28 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.493 -0.754 . . . . 0.0 112.203 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -56.19 -53.18 60.22 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.932 0.787 . . . . 0.0 109.409 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.71 97.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.524 0.73 . . . . 0.0 112.819 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.57 -42.73 99.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.115 0.566 . . . . 0.0 111.352 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -67.86 -31.56 71.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.581 1.082 . . . . 0.0 112.368 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.9 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.918 164.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.2 -33.67 63.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.716 1.206 . . . . 0.0 114.145 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.36 -23.77 65.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.577 1.551 . . . . 0.0 113.995 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -122.14 -26.62 4.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 359' ' ' LEU . 13.3 t80 -73.67 121.93 21.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.817 0.818 . . . . 0.0 112.276 -166.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 28.8 t30 59.25 28.79 18.21 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.349 1.86 . . . . 0.0 115.089 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -56.71 -32.5 65.57 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.34 -8.79 31.66 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 114.698 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 6.78 65.45 Favored Glycine 0 CA--C 1.548 2.142 0 C-N-CA 125.195 1.379 . . . . 0.0 114.899 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -70.44 -36.52 74.01 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.75 151.64 71.29 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.849 0.859 . . . . 0.0 110.608 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.69 -26.77 9.53 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.643 2.229 . . . . 0.0 112.204 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.71 150.4 41.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.751 1.22 . . . . 0.0 111.723 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -120.59 92.14 3.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.841 1.256 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -74.43 119.99 19.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.104 0.961 . . . . 0.0 110.527 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 170.28 12.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.2 2.2 . . . . 0.0 108.882 172.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -65.77 131.67 46.87 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.169 -0.957 . . . . 0.0 111.013 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.7 -154.99 12.95 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 164.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 132.75 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.057 0.429 . . . . 0.0 112.1 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.14 -50.72 3.56 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -124.17 114.79 20.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.918 0.887 . . . . 0.0 113.036 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.26 143.72 3.97 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 118.704 -1.053 . . . . 0.0 114.846 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.85 144.54 30.95 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.856 3.704 . . . . 0.0 110.032 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -69.24 -30.57 68.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.636 0.774 . . . . 0.0 112.071 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.67 -33.5 72.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.459 2.303 . . . . 0.0 113.309 -175.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.8 m -123.89 34.86 4.96 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.041 2.136 . . . . 0.0 111.211 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.2 139.75 34.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.876 1.671 . . . . 0.0 111.74 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.75 77.8 1.81 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.757 1.623 . . . . 0.0 109.047 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -65.4 -10.53 34.4 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -75.03 -48.25 24.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.249 0.931 . . . . 0.0 110.056 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -84.0 -11.11 57.29 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.62 42.36 21.96 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.045 1.307 . . . . 0.0 112.936 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.36 169.55 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 113.291 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.2 m -137.96 152.37 48.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.897 0.879 . . . . 0.0 111.09 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.1 mm -105.43 119.1 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.42 120.42 42.82 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 120.388 1.449 . . . . 0.0 110.331 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.77 146.87 26.97 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.16 -26.98 68.63 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -65.45 -21.46 66.65 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.985 1.266 . . . . 0.0 113.302 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -97.83 0.2 46.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.095 1.758 . . . . 0.0 113.394 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.63 122.66 34.4 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.147 0.979 . . . . 0.0 110.082 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 33.7 p -76.32 179.46 5.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.14 1.376 . . . . 0.0 111.667 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -39.55 91.42 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.651 -0.655 . . . . 0.0 111.601 170.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.092 0.957 . . . . 0.0 111.975 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.27 -52.18 65.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.775 1.63 . . . . 0.0 112.172 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -61.66 -40.89 96.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.928 0.891 . . . . 0.0 111.318 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.86 -36.21 83.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.201 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -68.21 -44.9 74.74 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.574 1.534 . . . . 0.0 110.837 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.3 m -54.08 -37.51 64.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.516 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.13 -46.4 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.9 t -96.0 -8.99 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -162.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.547 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -58.77 147.98 31.36 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.187 -0.945 . . . . 0.0 111.951 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.78 -38.55 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.33 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -103.55 135.58 44.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.83 1.252 . . . . 0.0 110.209 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 60.61 -159.02 27.03 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.387 -170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 63.64 -154.15 46.08 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.44 HG21 ' HB3' ' A' ' 451' ' ' LEU . 24.9 p -106.63 1.02 24.87 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -164.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.8 t 69.42 24.68 5.68 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.932 1.293 . . . . 0.0 112.095 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.74 9.86 63.82 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.058 1.313 . . . . 0.0 114.132 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -81.14 141.34 50.05 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.185 0.992 . . . . 0.0 110.822 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.24 112.23 2.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.966 2.444 . . . . 0.0 109.0 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -78.82 133.76 37.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.451 0.643 . . . . 0.0 112.012 -174.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.5 m -122.98 171.29 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.004 1.722 . . . . 0.0 111.578 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 87.3 m -49.7 123.08 7.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.33 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 103.2 -14.6 55.12 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.725 -1.042 . . . . 0.0 115.096 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 334' ' ' ILE . 2.5 tp -52.79 130.76 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.484 1.642 . . . . 0.0 111.532 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.87 131.38 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.145 2.178 . . . . 0.0 108.326 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.401 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.1 p90 -156.2 177.65 11.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.805 1.242 . . . . 0.0 112.605 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -99.74 154.01 18.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.709 1.604 . . . . 0.0 110.0 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.85 132.56 28.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -164.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.05 154.11 71.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.12 1.88 . . . . 0.0 110.631 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.547 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 73.2 m-20 -59.14 129.23 41.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.56 1.544 . . . . 0.0 113.348 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.65 55.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 123.308 1.528 . . . . 0.0 110.593 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.0 pt . . . . . 0 CA--C 1.551 0.984 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.53 146.831 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -70.25 138.33 51.56 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.308 1.043 . . . . 0.0 112.781 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mp -79.75 0.73 29.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.589 1.155 . . . . 0.0 113.232 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 125.468 1.507 . . . . 0.0 111.321 -176.931 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 CA--C 1.547 0.833 0 O-C-N 121.377 -0.827 . . . . 0.0 110.276 176.523 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 24.0 m80 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -52.87 127.11 22.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.412 1.46 . . . . 0.0 111.498 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -125.6 152.99 72.75 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.035 1.334 . . . . 0.0 110.606 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.42 158.92 55.6 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.296 2.664 . . . . 0.0 110.891 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.26 70.29 5.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 110.179 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.98 121.92 8.79 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.292 1.994 . . . . 0.0 108.994 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.37 127.69 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 109.316 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.93 163.95 28.38 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.151 1.38 . . . . 0.0 109.991 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -144.01 116.36 8.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.167 0.987 . . . . 0.0 109.34 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -121.54 107.79 12.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.069 0.938 . . . . 0.0 111.108 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -8.54 12.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.109 1.764 . . . . 0.0 113.923 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -68.31 -25.07 64.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.394 1.078 . . . . 0.0 112.651 172.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.03 150.55 96.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.63 0.772 . . . . 0.0 112.06 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.02 160.85 35.82 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.087 3.191 . . . . 0.0 112.934 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.46 134.14 27.87 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.958 3.105 . . . . 0.0 112.33 -171.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.55 40.02 11.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.698 1.599 . . . . 0.0 112.298 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -121.35 151.8 39.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 172.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.3 pt -123.12 151.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.744 2.018 . . . . 0.0 110.492 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.69 126.76 55.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.494 1.518 . . . . 0.0 110.184 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.95 109.64 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.715 0.689 . . . . 0.0 111.495 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -72.97 131.7 42.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.156 1.382 . . . . 0.0 112.079 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.9 m -70.26 138.18 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.532 -0.73 . . . . 0.0 112.482 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.54 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.8 mtm105 -109.3 13.46 24.26 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.539 1.936 . . . . 0.0 110.944 164.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 32.7 m -118.97 141.89 48.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.671 1.588 . . . . 0.0 110.974 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.69 133.2 49.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.579 1.952 . . . . 0.0 108.754 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -92.59 112.86 24.96 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 165.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.4 mm -97.87 120.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 179.41 37.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.618 1.104 . . . . 0.0 111.32 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.77 60.77 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 114.751 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.3 125.64 90.65 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 118.417 1.109 . . . . 0.0 109.951 -168.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 135.53 31.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.798 2.332 . . . . 0.0 109.671 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.9 mp -67.96 -10.83 56.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 -25.06 22.55 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.516 1.126 . . . . 0.0 112.985 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 19.4 mtm -79.91 149.02 31.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.885 0.85 . . . . 0.0 112.651 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -125.8 -176.01 3.5 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.504 1.921 . . . . 0.0 111.473 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 2.4 mp0 -49.88 -44.86 50.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.485 2.314 . . . . 0.0 113.062 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -77.34 -20.53 54.72 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.67 -37.33 59.68 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.048 0.84 . . . . 0.0 110.54 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.2 -49.55 77.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.524 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.77 -39.26 73.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.228 0.922 . . . . 0.0 112.732 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.02 -44.36 76.66 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.701 1.137 . . . . 0.0 113.587 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.09 -32.44 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 119.837 1.199 . . . . 0.0 111.725 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.478 HD23 ' CE2' ' A' ' 394' ' ' PHE . 62.0 mt -89.76 -10.58 45.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -46.89 -47.47 52.91 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.021 1.728 . . . . 0.0 115.37 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -6.98 16.77 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.203 1.935 . . . . 0.0 113.585 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -98.11 -39.2 9.02 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.609 1.563 . . . . 0.0 112.486 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.89 168.58 4.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.09 1.756 . . . . 0.0 113.31 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.36 129.47 34.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.856 0.862 . . . . 0.0 110.095 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.66 130.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.77 0.828 . . . . 0.0 110.206 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -95.0 -44.4 7.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.803 1.241 . . . . 0.0 112.536 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.3 m -144.13 152.63 41.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.474 1.109 . . . . 0.0 111.363 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 59.9 t -143.67 114.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.243 0.928 . . . . 0.0 110.936 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.6 93.46 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.14 129.27 45.38 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.513 0.725 . . . . 0.0 110.585 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -123.43 90.96 3.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.424 1.09 . . . . 0.0 109.932 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -58.57 -28.23 65.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.38 1.072 . . . . 0.0 112.266 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 22.7 t -56.44 -38.11 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.382 1.873 . . . . 0.0 114.178 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -107.04 6.98 29.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.867 1.267 . . . . 0.0 113.058 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 59.28 36.43 23.61 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.627 1.571 . . . . 0.0 111.412 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -124.18 164.06 20.27 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.28 33.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.759 1.224 . . . . 0.0 112.544 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.93 104.81 14.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.3 1.04 . . . . 0.0 108.654 164.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.87 100.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.111 1.364 . . . . 0.0 109.837 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -80.74 123.47 28.24 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.204 0.602 . . . . 0.0 110.277 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.53 168.01 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.346 166.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.73 -22.16 54.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.39 156.52 48.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 120.064 1.302 . . . . 0.0 113.704 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.49 -44.67 96.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.65 0.78 . . . . 0.0 112.322 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -66.46 -31.14 71.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.045 -0.41 . . . . 0.0 111.674 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.08 -53.89 42.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.755 1.222 . . . . 0.0 111.06 167.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.03 84.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.867 0.758 . . . . 0.0 112.133 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.77 -42.68 97.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.26 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -66.72 -30.69 70.98 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 120.126 1.33 . . . . 0.0 112.738 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.68 -63.56 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.736 0.698 . . . . 0.0 109.497 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.5 mt -52.25 -36.12 51.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.02 -42.95 88.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.046 1.338 . . . . 0.0 112.474 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -105.32 -23.5 12.85 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 359' ' ' LEU . 20.4 t80 -74.11 123.55 24.64 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.484 -0.76 . . . . 0.0 111.489 -168.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 61.79 29.27 17.94 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.807 1.643 . . . . 0.0 114.48 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.95 -34.69 65.91 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.804 -1.185 . . . . 0.0 113.396 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.37 -19.53 53.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.324 1.05 . . . . 0.0 113.525 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.03 70.18 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.65 1.119 . . . . 0.0 114.046 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.08 -31.53 20.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.6 1.56 . . . . 0.0 114.802 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 19.7 mt -80.62 150.78 70.53 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.351 1.06 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.93 -32.47 7.13 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.405 2.07 . . . . 0.0 112.169 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.32 151.65 45.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.286 1.434 . . . . 0.0 111.756 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -127.94 96.38 4.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.768 1.227 . . . . 0.0 109.739 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 32.8 m -73.28 123.78 24.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.357 1.063 . . . . 0.0 110.634 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -126.52 173.63 9.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.703 2.001 . . . . 0.0 108.817 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -72.11 133.48 45.23 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.94 -1.1 . . . . 0.0 111.574 164.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.94 -153.09 9.54 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 125.777 1.656 . . . . 0.0 109.295 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.35 137.06 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.13 -52.98 2.93 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.723 1.63 . . . . 0.0 109.784 167.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.89 117.85 25.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.37 142.79 4.65 Favored Glycine 0 CA--C 1.543 1.836 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.96 130.28 15.34 Favored 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 125.746 4.297 . . . . 0.0 110.849 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -67.23 -32.09 72.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.42 -18.66 54.65 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.93 1.692 . . . . 0.0 113.83 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 77.8 m -122.9 28.73 7.11 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.586 1.555 . . . . 0.0 111.881 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.5 t -84.4 141.81 30.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.073 1.349 . . . . 0.0 111.429 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.37 80.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.779 1.631 . . . . 0.0 108.915 167.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -63.95 -20.51 65.93 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.547 -0.721 . . . . 0.0 112.904 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.32 -47.62 69.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.529 1.513 . . . . 0.0 111.266 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -83.2 -13.59 55.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.4 42.54 18.11 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.809 1.195 . . . . 0.0 112.374 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -147.27 168.74 20.97 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.026 1.413 . . . . 0.0 113.151 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.5 m -131.17 152.35 50.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.285 1.034 . . . . 0.0 110.704 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.2 mm -106.29 133.06 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.531 HG21 HD21 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -126.55 118.96 22.94 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 120.116 1.326 . . . . 0.0 110.981 -173.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -73.96 139.01 26.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.44 2.093 . . . . 0.0 111.121 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 10.9 mtt -63.02 -28.81 70.35 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.41 -19.29 65.88 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -104.85 3.81 31.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.562 1.945 . . . . 0.0 113.642 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.531 HD21 HG21 ' A' ' 425' ' ' ILE . 97.9 mt -92.05 136.32 33.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 110.395 170.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.2 p -79.94 178.77 7.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.514 1.126 . . . . 0.0 111.51 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.595 -0.691 . . . . 0.0 111.633 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.59 88.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.889 0.875 . . . . 0.0 112.025 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.69 -52.76 63.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.517 1.127 . . . . 0.0 112.284 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -65.56 -37.5 86.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.859 -0.526 . . . . 0.0 111.102 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -60.16 -42.17 94.39 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.78 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -66.59 -44.3 82.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.041 1.746 . . . . 0.0 111.271 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.2 m -56.59 -32.38 65.17 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.332 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.68 -39.75 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.8 m -103.26 -7.75 20.89 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -168.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.82 147.06 39.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.211 1.368 . . . . 0.0 111.604 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -77.11 -55.29 5.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.33 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -92.78 132.45 36.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.346 0.975 . . . . 0.0 110.533 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.81 179.34 10.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.015 0.817 . . . . 0.0 113.459 -173.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.67 -163.88 34.02 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 122.242 -0.563 . . . . 0.0 113.114 -168.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.1 p -109.78 7.44 24.17 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -163.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 37.4 p 76.74 15.81 1.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.972 2.109 . . . . 0.0 113.901 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.49 4.08 64.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.988 1.28 . . . . 0.0 113.352 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -66.01 138.34 96.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.901 1.28 . . . . 0.0 109.446 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -60.19 140.91 94.57 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.177 1.918 . . . . 0.0 110.176 169.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.04 130.24 43.22 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.29 159.69 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.473 1.509 . . . . 0.0 110.089 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 78.2 m -56.61 124.92 19.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.75 -2.05 76.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.593 -1.115 . . . . 0.0 115.541 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.4 tt -62.96 140.42 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.494 1.647 . . . . 0.0 112.127 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.56 136.78 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.829 2.052 . . . . 0.0 109.61 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -162.47 175.46 11.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.097 1.359 . . . . 0.0 113.104 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.72 148.69 21.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 111.397 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -51.47 126.25 29.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -168.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.78 152.84 64.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.073 2.515 . . . . 0.0 110.539 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -63.55 144.5 56.94 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.34 52.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.337 1.541 . . . . 0.0 110.133 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.549 0.938 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.79 141.469 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.1 m80 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.0 133.32 46.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.16 0.984 . . . . 0.0 112.258 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.1 mp -81.53 -41.74 21.21 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.968 1.307 . . . . 0.0 111.116 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 123.962 0.905 . . . . 0.0 110.876 -179.275 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.591 0.71 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 . . . . . 0 CA--C 1.551 1.002 0 C-N-CA 123.938 0.895 . . . . 0.0 110.386 174.304 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.2 m80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -49.31 134.02 18.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.593 1.542 . . . . 0.0 111.919 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 81.4 mmt-85 -136.82 144.88 48.53 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.242 1.017 . . . . 0.0 110.054 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.98 161.87 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 110.827 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -117.04 66.78 4.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.629 1.171 . . . . 0.0 109.729 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.31 115.08 4.01 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.906 2.404 . . . . 0.0 109.487 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.3 m -92.84 139.99 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.912 0.885 . . . . 0.0 110.083 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.43 164.07 29.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.022 1.329 . . . . 0.0 110.301 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -143.77 120.57 11.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.132 0.973 . . . . 0.0 109.426 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.33 110.53 17.08 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.581 0.705 . . . . 0.0 110.656 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -8.49 44.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.952 0.901 . . . . 0.0 113.299 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 64.2 p -70.54 -24.44 62.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.479 1.512 . . . . 0.0 112.174 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.0 150.53 88.1 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.958 0.903 . . . . 0.0 111.576 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 161.32 38.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.055 3.17 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.48 136.63 37.18 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.157 3.238 . . . . 0.0 112.038 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.71 33.64 10.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.428 1.491 . . . . 0.0 113.024 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.23 151.52 32.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.634 -1.291 . . . . 0.0 114.353 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 451' ' ' LEU . 12.0 pt -120.62 142.1 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.159 1.784 . . . . 0.0 110.485 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -107.75 111.54 23.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.672 -1.267 . . . . 0.0 110.63 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 25.4 t -105.69 101.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.865 0.866 . . . . 0.0 110.29 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -67.32 123.08 19.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.194 0.997 . . . . 0.0 111.477 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.2 t -69.74 134.66 48.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.625 -0.672 . . . . 0.0 111.425 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.5 mtm105 -101.93 9.98 40.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.891 1.677 . . . . 0.0 109.986 164.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 54.2 m -112.97 138.45 49.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.449 1.499 . . . . 0.0 111.041 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 40.1 mt -100.51 139.69 35.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.848 1.659 . . . . 0.0 109.503 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -95.27 138.44 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 164.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.45 114.57 44.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 166.28 26.34 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.484 1.04 . . . . 0.0 110.6 163.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.24 43.39 32.27 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 121.972 -0.722 . . . . 0.0 112.929 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.17 84.54 2.86 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.132 1.373 . . . . 0.0 110.875 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.31 173.28 11.69 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.287 2.658 . . . . 0.0 112.044 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.28 -21.75 50.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -18.9 61.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.19 0.996 . . . . 0.0 112.915 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.7 mtp -100.67 131.73 46.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.107 1.763 . . . . 0.0 109.921 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -141.23 170.07 16.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.082 1.753 . . . . 0.0 111.286 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.7 -42.66 62.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.631 1.172 . . . . 0.0 113.843 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -76.87 -27.65 55.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -38.59 84.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.663 167.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 355' ' ' LEU . 2.1 mm? -59.82 -47.96 83.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.747 0.703 . . . . 0.0 110.974 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -57.59 -42.51 83.3 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.163 0.892 . . . . 0.0 112.884 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.38 -39.69 89.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.929 1.241 . . . . 0.0 113.226 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.3 -35.35 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.539 1.063 . . . . 0.0 111.528 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.697 HD22 HG11 ' A' ' 390' ' ' VAL . 25.9 mt -85.65 -11.27 54.23 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.187 0.903 . . . . 0.0 112.819 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -48.3 82.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 126.187 1.795 . . . . 0.0 115.166 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.52 -7.35 18.62 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.023 1.815 . . . . 0.0 112.985 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -96.86 -40.14 9.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.297 1.439 . . . . 0.0 112.369 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.41 172.86 3.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.116 1.766 . . . . 0.0 113.484 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 116.88 24.93 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.868 . . . . 0.0 110.506 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 75.3 t -77.82 133.55 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.148 0.979 . . . . 0.0 110.184 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -94.05 -54.17 3.69 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.372 1.469 . . . . 0.0 112.269 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.5 m -140.07 155.11 47.18 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.823 1.249 . . . . 0.0 111.28 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.411 HG22 HG13 ' A' ' 379' ' ' VAL . 57.8 t -144.56 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.059 0.544 . . . . 0.0 110.514 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.56 105.64 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.873 1.269 . . . . 0.0 107.666 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.44 125.8 43.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.396 0.678 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 83.45 2.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.945 1.355 . . . . 0.0 109.706 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -21.61 66.29 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.595 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.5 t -57.26 -31.75 65.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.848 1.659 . . . . 0.0 113.718 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -112.3 10.89 20.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.931 1.692 . . . . 0.0 113.179 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.3 mttt 58.74 32.81 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.159 1.384 . . . . 0.0 113.171 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -126.19 169.5 12.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.23 158.63 43.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 163.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -114.05 128.9 56.59 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.267 1.427 . . . . 0.0 108.641 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 359' ' ' LEU . 63.9 t -128.08 105.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.896 0.878 . . . . 0.0 111.079 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.71 119.03 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.335 1.054 . . . . 0.0 109.791 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.65 152.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.723 1.609 . . . . 0.0 107.517 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -66.33 -19.89 65.93 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.66 156.94 43.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.586 1.085 . . . . 0.0 112.427 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -44.55 96.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.215 1.006 . . . . 0.0 109.975 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -38.84 90.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.877 0.871 . . . . 0.0 111.566 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -63.92 -53.02 56.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.526 1.13 . . . . 0.0 111.361 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.34 73.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.841 0.746 . . . . 0.0 112.284 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.21 -45.4 91.18 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.175 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -61.55 -36.01 79.4 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.257 0.935 . . . . 0.0 112.187 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.697 HG11 HD22 ' A' ' 359' ' ' LEU . 19.1 t -62.74 -61.04 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.469 169.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.05 -37.9 35.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.041 1.337 . . . . 0.0 113.73 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -69.67 -29.43 66.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.869 1.268 . . . . 0.0 113.666 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -111.79 -26.28 9.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.556 1.071 . . . . 0.0 113.709 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 359' ' ' LEU . 15.7 t80 -69.98 119.3 13.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.545 0.688 . . . . 0.0 111.698 -167.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 60.29 35.77 20.74 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.349 1.46 . . . . 0.0 113.532 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -62.72 -36.08 81.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.58 -14.85 31.68 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.444 1.498 . . . . 0.0 113.93 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.76 29.57 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.519 1.057 . . . . 0.0 114.666 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.5 -41.75 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.181 1.491 . . . . 0.0 114.581 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.2 mt -75.38 150.46 84.92 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.11 0.964 . . . . 0.0 109.802 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.18 -28.04 13.1 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.459 2.106 . . . . 0.0 112.436 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.8 141.76 28.35 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.448 0.699 . . . . 0.0 111.287 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.6 126.12 54.12 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 109.92 172.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 m -106.41 129.82 54.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.55 1.14 . . . . 0.0 109.922 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.72 175.17 9.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.46 1.904 . . . . 0.0 109.257 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -65.55 125.03 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.593 163.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -109.41 -157.21 17.37 Favored Glycine 0 N--CA 1.463 0.483 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.77 136.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.75 -51.23 2.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.736 1.636 . . . . 0.0 109.952 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -119.85 109.39 15.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.417 0.687 . . . . 0.0 112.753 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.95 136.29 3.53 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.049 -0.862 . . . . 0.0 115.222 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.444 ' HG3' HG23 ' A' ' 425' ' ' ILE . 95.8 Cg_endo -71.02 132.08 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.589 4.193 . . . . 0.0 109.89 171.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -65.37 -36.86 85.27 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.626 -0.671 . . . . 0.0 112.74 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -73.33 -20.62 60.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 46.2 m -117.36 19.06 14.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.122 1.769 . . . . 0.0 112.599 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.82 153.15 35.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.945 0.879 . . . . 0.0 112.429 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.26 78.97 1.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.91 1.684 . . . . 0.0 108.704 166.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.67 -19.22 64.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 113.275 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -70.81 -50.75 32.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.024 0.829 . . . . 0.0 110.774 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -81.27 -15.91 54.11 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.83 21.36 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.016 1.293 . . . . 0.0 113.254 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -146.78 172.81 13.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.603 1.202 . . . . 0.0 113.35 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 30.0 m -133.83 146.05 50.28 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.173 0.989 . . . . 0.0 110.74 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 14.6 mm -107.0 95.86 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.542 0.737 . . . . 0.0 109.487 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.554 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -94.57 123.54 57.92 Favored Pre-proline 0 N--CA 1.474 0.726 0 O-C-N 121.029 -1.045 . . . . 0.0 111.193 -168.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.59 132.85 22.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.526 2.15 . . . . 0.0 111.109 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 17.6 mtt -60.71 -30.8 70.18 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.026 1.331 . . . . 0.0 113.363 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.49 -16.8 64.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 8.15 24.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.845 2.058 . . . . 0.0 113.554 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 425' ' ' ILE . 96.0 mt -89.35 140.12 29.82 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.233 0.924 . . . . 0.0 110.211 169.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 20.7 p -75.88 178.33 6.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.57 1.148 . . . . 0.0 111.232 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.47 -46.17 87.46 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.42 -0.8 . . . . 0.0 111.073 169.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.876 0.87 . . . . 0.0 112.234 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.78 -55.41 35.47 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.286 1.434 . . . . 0.0 112.475 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -65.88 -36.67 84.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.845 -0.534 . . . . 0.0 110.791 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -59.12 -41.43 88.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.499 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -68.28 -45.97 71.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.423 1.465 . . . . 0.0 111.232 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 49.6 m -53.48 -36.13 61.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.612 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.62 -42.92 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.0 t -101.13 -9.06 21.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.739 1.216 . . . . 0.0 114.141 -167.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.21 146.68 27.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.427 1.108 . . . . 0.0 112.079 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.1 -57.9 3.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.734 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -91.46 132.69 36.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.273 1.029 . . . . 0.0 110.934 163.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 63.93 176.28 4.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.803 1.192 . . . . 0.0 114.094 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.1 -165.95 36.48 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.515 1.055 . . . . 0.0 112.748 -167.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 58.4 p -106.71 16.29 24.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -158.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.1 p 60.4 26.86 16.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.95 1.3 . . . . 0.0 113.441 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.0 77.03 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.506 1.527 . . . . 0.0 114.207 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -66.84 135.67 94.3 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.795 1.297 . . . . 0.0 110.13 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -59.51 144.04 99.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.534 2.156 . . . . 0.0 110.077 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 334' ' ' ILE . 80.7 mt -65.38 123.88 20.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.113 0.483 . . . . 0.0 110.493 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.06 157.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.002 2.121 . . . . 0.0 109.422 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.7 m -52.28 117.71 3.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 110.064 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 75.56 17.94 79.97 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.531 -1.15 . . . . 0.0 115.01 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 20.6 tt -62.5 126.91 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.231 1.516 . . . . 0.0 111.003 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.36 141.2 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.948 2.099 . . . . 0.0 109.501 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -166.29 171.93 11.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.36 1.464 . . . . 0.0 113.118 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.77 145.14 26.75 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.653 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -56.05 136.61 73.79 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -165.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.39 150.42 46.54 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.156 2.571 . . . . 0.0 110.992 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.414 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 85.9 m-20 -59.82 142.04 54.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.964 1.305 . . . . 0.0 113.881 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.35 52.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.635 1.683 . . . . 0.0 110.144 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.549 0.914 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.003 141.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.2 m80 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -72.37 140.34 48.38 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.059 0.943 . . . . 0.0 113.072 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.56 8.22 10.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.955 1.302 . . . . 0.0 113.089 171.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 124.803 1.241 . . . . 0.0 111.585 -170.678 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.549 0.905 0 O-C-N 120.897 -1.127 . . . . 0.0 110.202 172.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -53.42 124.38 14.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.731 -1.231 . . . . 0.0 110.937 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -128.81 139.21 34.98 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 124.932 1.293 . . . . 0.0 109.223 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.9 156.93 59.47 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.884 2.389 . . . . 0.0 110.415 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 74.17 3.03 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.35 1.06 . . . . 0.0 109.962 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.6 111.59 3.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.613 2.209 . . . . 0.0 109.098 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.89 131.42 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.436 0.695 . . . . 0.0 110.042 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.41 169.57 15.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.635 1.574 . . . . 0.0 110.552 173.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -139.99 125.35 18.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.427 1.091 . . . . 0.0 110.108 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -121.23 107.38 12.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.877 0.871 . . . . 0.0 110.839 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.7 m -68.81 -5.58 21.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 55.7 p -71.33 -22.25 61.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.499 1.12 . . . . 0.0 112.188 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.1 mt -71.27 152.73 94.37 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.962 0.905 . . . . 0.0 112.247 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.81 162.17 33.06 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.113 3.208 . . . . 0.0 112.899 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.43 136.84 32.18 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.139 3.226 . . . . 0.0 112.389 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.72 47.35 10.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 111.798 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -126.12 152.91 45.28 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.337 1.055 . . . . 0.0 113.568 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.02 144.16 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.346 1.858 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -117.29 133.27 56.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.569 -1.332 . . . . 0.0 111.613 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.72 101.86 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.957 0.903 . . . . 0.0 110.582 -169.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -68.72 127.07 31.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.63 1.172 . . . . 0.0 112.024 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.3 m -70.22 135.49 49.07 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.523 -0.736 . . . . 0.0 112.275 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.4 mtm105 -102.42 10.24 39.14 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.881 1.673 . . . . 0.0 110.608 164.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 19.4 m -117.42 145.52 44.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.319 1.448 . . . . 0.0 112.141 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 52.9 mt -105.9 136.26 45.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.181 1.792 . . . . 0.0 109.552 172.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -88.98 140.95 28.91 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 162.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 18.3 mm -125.93 116.41 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 108.484 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -98.55 -177.11 32.67 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.313 0.959 . . . . 0.0 111.943 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.22 64.73 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 121.826 -0.808 . . . . 0.0 114.979 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.69 116.41 53.3 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-O 117.665 -1.16 . . . . 0.0 110.061 -166.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.23 135.29 33.87 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.305 2.003 . . . . 0.0 109.596 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.09 -20.26 63.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.38 -33.46 75.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.146 0.979 . . . . 0.0 111.949 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 3.8 ptp -82.6 151.58 26.29 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.527 0.68 . . . . 0.0 112.81 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -129.76 -175.71 3.68 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.169 1.788 . . . . 0.0 111.555 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.26 -39.79 57.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.753 1.221 . . . . 0.0 113.791 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -75.93 -21.64 56.85 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -74.52 -39.15 62.56 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.841 . . . . 0.0 110.568 169.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.8 mm? -58.07 -50.4 73.59 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.353 0.524 . . . . 0.0 110.569 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.89 80.24 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.596 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -68.46 -40.65 80.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.945 1.248 . . . . 0.0 113.512 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.51 -37.33 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.083 0.856 . . . . 0.0 111.493 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.653 HD23 ' CE1' ' A' ' 394' ' ' PHE . 27.3 mt -83.83 -9.25 58.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.056 0.942 . . . . 0.0 112.75 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.66 -49.43 65.58 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 126.152 1.781 . . . . 0.0 114.889 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -7.32 18.61 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.076 1.851 . . . . 0.0 113.185 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.83 -41.32 8.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.274 1.43 . . . . 0.0 112.3 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.73 172.85 3.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 113.743 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.27 111.87 23.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 111.43 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.82 131.25 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.983 0.913 . . . . 0.0 110.991 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.85 -46.16 8.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.106 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -151.22 152.52 33.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.604 1.162 . . . . 0.0 111.482 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.84 137.21 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.646 . . . . 0.0 110.963 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.81 106.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.638 1.175 . . . . 0.0 107.846 166.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.19 133.0 45.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.003 0.921 . . . . 0.0 110.254 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.55 91.47 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.727 1.211 . . . . 0.0 110.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.0 -27.32 68.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.489 1.116 . . . . 0.0 111.89 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 71.4 m -57.62 -32.05 66.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.025 1.73 . . . . 0.0 114.269 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 8.9 17.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.0 112.729 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.4 mttt 51.99 40.84 29.12 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.704 1.602 . . . . 0.0 112.754 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -127.33 166.7 17.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.27 161.0 41.24 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.44 130.93 57.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.985 1.314 . . . . 0.0 108.379 164.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 359' ' ' LEU . 57.3 t -123.24 102.25 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.945 0.898 . . . . 0.0 110.191 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -74.74 111.02 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.699 1.2 . . . . 0.0 110.127 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.86 153.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.68 1.592 . . . . 0.0 107.85 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.38 -17.88 64.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.81 159.24 44.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.135 1.334 . . . . 0.0 113.004 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.98 77.62 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.741 0.816 . . . . 0.0 110.305 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.7 -36.0 79.66 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.682 0.793 . . . . 0.0 111.64 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.91 -55.55 21.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 111.543 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.4 72.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.061 0.846 . . . . 0.0 112.954 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -60.53 -47.69 85.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.385 1.074 . . . . 0.0 111.878 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.03 -34.51 76.37 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.569 -0.707 . . . . 0.0 112.053 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 359' ' ' LEU . 21.7 t -61.63 -62.03 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.502 167.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -51.31 -35.28 37.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.789 1.236 . . . . 0.0 114.291 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.87 -33.11 75.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.938 1.295 . . . . 0.0 113.532 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -117.2 -27.68 6.4 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 359' ' ' LEU . 20.3 t80 -74.93 123.18 24.64 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.627 0.771 . . . . 0.0 110.919 -169.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.61 23.96 12.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -30.92 63.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.535 1.134 . . . . 0.0 113.766 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.16 -14.43 15.15 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.729 2.012 . . . . 0.0 114.229 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.29 35.48 7.0 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.716 1.15 . . . . 0.0 114.385 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.73 83.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.66 156.37 38.95 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.626 1.57 . . . . 0.0 110.497 -174.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.84 -19.13 24.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.723 2.282 . . . . 0.0 113.908 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.2 mt -62.82 166.76 5.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.903 2.081 . . . . 0.0 113.072 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -137.16 95.0 3.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.46 1.104 . . . . 0.0 110.313 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.5 122.51 28.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.283 1.833 . . . . 0.0 111.063 -172.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 170.44 14.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.596 1.958 . . . . 0.0 109.28 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -64.22 120.17 11.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.336 -0.853 . . . . 0.0 110.424 161.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.1 -155.52 25.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 411' ' ' GLY . 11.0 p -167.35 136.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.441 1.096 . . . . 0.0 110.167 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -80.14 -49.67 5.84 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.423 1.011 . . . . 0.0 110.96 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -115.2 96.65 5.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 111.08 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 408' ' ' VAL . . . -158.65 122.58 1.16 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.768 -1.018 . . . . 0.0 114.772 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.85 125.23 9.27 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.531 3.487 . . . . 0.0 110.24 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -56.37 -40.45 74.58 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.91 -15.04 61.15 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.26 16.48 13.14 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 112.224 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 138.47 31.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.406 1.482 . . . . 0.0 111.776 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -118.63 86.52 2.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.997 1.719 . . . . 0.0 108.708 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -69.36 -15.57 63.34 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.66 -48.79 58.57 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.947 -1.095 . . . . 0.0 110.602 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -84.65 -16.92 40.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.22 44.83 10.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.575 1.083 . . . . 0.0 112.431 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.61 158.17 42.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.059 0.93 . . . . 0.0 113.491 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.81 151.62 28.83 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.967 -1.083 . . . . 0.0 110.69 168.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.89 104.03 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 0.0 109.015 172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.27 131.17 22.16 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.846 -167.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.73 138.66 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.172 1.914 . . . . 0.0 110.748 168.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 4.9 mtm -61.66 -32.92 73.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.344 1.058 . . . . 0.0 112.601 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -68.81 -11.01 59.95 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -110.11 8.12 23.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.309 1.443 . . . . 0.0 113.488 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 76.2 mt -91.33 135.88 33.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.409 0.684 . . . . 0.0 110.35 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 26.3 p -72.73 175.94 6.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.424 1.09 . . . . 0.0 110.749 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -42.67 98.16 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.633 -0.667 . . . . 0.0 111.046 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.18 82.67 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 112.365 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.47 -53.82 53.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.563 1.145 . . . . 0.0 111.677 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -67.77 -35.83 79.39 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.864 -0.522 . . . . 0.0 111.615 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -54.26 -51.93 62.98 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.587 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -68.5 -40.97 80.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.472 1.487 . . . . 0.0 111.683 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -54.68 -29.62 53.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.083 -0.96 . . . . 0.0 113.138 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.48 -40.9 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 171.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.0 t -104.23 -4.76 22.64 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.136 1.374 . . . . 0.0 114.458 -165.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.72 145.88 32.96 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.995 -1.066 . . . . 0.0 111.761 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -53.13 9.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.734 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -95.23 136.52 35.46 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.808 0.843 . . . . 0.0 111.326 162.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.29 -164.07 53.92 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.392 0.996 . . . . 0.0 113.053 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.17 -168.08 52.51 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.183 0.42 . . . . 0.0 112.202 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 73.3 p -98.51 7.79 45.71 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 74.7 25.72 1.49 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.797 1.239 . . . . 0.0 112.808 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.93 82.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.07 1.319 . . . . 0.0 114.007 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -68.31 149.05 98.21 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.3 1.05 . . . . 0.0 110.219 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.28 147.57 93.68 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.341 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.17 122.88 20.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.64 153.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.557 1.943 . . . . 0.0 109.025 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 63.9 m -51.91 125.38 15.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.74 0.416 . . . . 0.0 110.096 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.31 89.1 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.503 -1.165 . . . . 0.0 114.848 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.2 tt -60.03 139.48 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.487 1.644 . . . . 0.0 111.414 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.62 139.55 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.245 1.818 . . . . 0.0 109.457 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -159.89 172.88 16.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.421 1.488 . . . . 0.0 112.193 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.34 150.56 22.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.264 1.026 . . . . 0.0 110.826 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.34 127.79 23.45 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.84 150.29 55.36 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.544 2.163 . . . . 0.0 111.115 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -61.76 146.21 50.09 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.0 113.819 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.3 50.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 123.194 1.473 . . . . 0.0 110.32 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.954 139.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.2 m80 . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -79.68 142.43 35.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.709 1.203 . . . . 0.0 111.901 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.542 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 5.2 mp -90.81 7.01 41.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.603 1.561 . . . . 0.0 112.68 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.948 1.299 . . . . 0.0 111.542 -169.42 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.538 0.685 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.5 t30 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.384 1.073 . . . . 0.0 110.23 177.657 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.6 m80 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.33 133.8 34.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.391 1.451 . . . . 0.0 111.988 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -136.29 149.79 68.9 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 124.058 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -68.71 153.17 73.73 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.705 2.27 . . . . 0.0 110.318 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 78.35 8.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.383 1.073 . . . . 0.0 108.673 168.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.44 118.49 5.62 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.731 2.288 . . . . 0.0 108.798 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.52 136.44 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.911 0.884 . . . . 0.0 109.529 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.64 175.0 9.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.563 1.145 . . . . 0.0 110.496 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.505 ' CE2' HD12 ' A' ' 455' ' ' ILE . 54.5 m-85 -135.63 121.72 20.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.969 0.908 . . . . 0.0 110.102 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -115.68 108.93 17.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.011 0.91 . . . . 0.0 111.096 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.1 p -65.76 -7.49 16.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.495 1.518 . . . . 0.0 114.038 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.49 -23.04 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.699 0.799 . . . . 0.0 112.324 169.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.96 151.02 86.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 112.182 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.88 161.36 36.77 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.882 3.054 . . . . 0.0 112.574 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.06 135.13 28.97 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.132 3.222 . . . . 0.0 112.552 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.8 34.64 9.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.8 1.64 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -119.49 158.86 25.4 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.78 150.72 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.545 1.938 . . . . 0.0 110.263 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.98 127.67 54.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.895 1.678 . . . . 0.0 110.672 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 457' ' ' PHE . 38.1 t -127.26 104.19 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.571 0.749 . . . . 0.0 111.414 -174.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -70.09 137.72 51.41 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.452 1.101 . . . . 0.0 112.323 169.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 m -78.39 129.92 35.51 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.442 -0.786 . . . . 0.0 112.095 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -95.65 18.06 13.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.263 1.425 . . . . 0.0 110.958 162.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 97.4 m -130.96 142.68 50.37 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 111.412 -168.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 25.6 mt -107.11 133.29 51.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.684 1.994 . . . . 0.0 108.669 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -84.65 118.74 24.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.48 108.55 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.22 -175.96 49.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.51 0.576 . . . . 0.0 111.786 167.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.84 9.43 59.41 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.439 -1.036 . . . . 0.0 114.97 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.38 118.52 68.25 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.724 1.262 . . . . 0.0 110.2 -165.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.32 136.19 33.5 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.535 2.157 . . . . 0.0 109.017 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -18.96 50.0 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -73.9 -33.99 64.22 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.699 -0.626 . . . . 0.0 112.662 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 41.3 mtm -72.98 146.19 46.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.12 0.962 . . . . 0.0 112.424 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -126.9 179.86 5.18 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 127.406 2.282 . . . . 0.0 110.911 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.69 -46.24 29.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.645 1.578 . . . . 0.0 113.483 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -76.09 -18.89 58.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.743 1.156 . . . . 0.0 110.391 168.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.86 -42.35 84.32 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.244 0.618 . . . . 0.0 110.832 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -55.89 -52.09 65.3 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 119.1 0.864 . . . . 0.0 112.369 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.5 -38.65 91.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 26.4 m -72.11 -35.94 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.758 0.708 . . . . 0.0 111.533 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' A' ' 379' ' ' VAL . 76.8 mt -85.43 -12.88 50.94 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -46.68 87.17 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.259 1.824 . . . . 0.0 114.649 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.38 -7.03 17.67 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.011 1.807 . . . . 0.0 113.434 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.79 -39.44 9.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.499 1.52 . . . . 0.0 112.614 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.0 167.0 3.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.856 1.662 . . . . 0.0 113.916 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.29 107.49 17.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.792 0.837 . . . . 0.0 110.647 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.56 144.21 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.027 0.931 . . . . 0.0 111.257 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -111.46 -38.57 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.093 1.357 . . . . 0.0 112.092 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' SER . . . . . 0.4 ' HA ' HD12 ' A' ' 305' ' ' LEU . 0.0 OUTLIER -150.5 155.33 39.29 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.821 1.191 . . . . 0.0 111.757 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 379' ' ' VAL . 84.0 t -147.1 127.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.844 0.858 . . . . 0.0 110.056 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.65 105.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.29 112.51 25.03 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.732 0.813 . . . . 0.0 110.41 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.56 86.06 3.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 109.851 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.02 -32.63 66.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.941 1.296 . . . . 0.0 111.629 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 34.9 m -59.06 -27.2 65.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.915 1.686 . . . . 0.0 114.378 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -114.56 10.58 16.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.112 1.365 . . . . 0.0 112.406 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 51.29 37.8 19.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.094 1.758 . . . . 0.0 113.042 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -125.27 153.79 42.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.046 1.338 . . . . 0.0 113.661 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -139.53 131.75 28.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.641 1.176 . . . . 0.0 112.168 164.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -83.75 115.48 22.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 162.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 359' ' ' LEU . 99.2 t -122.76 107.42 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.607 . . . . 0.0 110.986 -173.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 125.77 51.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.13 0.972 . . . . 0.0 111.979 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.75 168.72 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.458 1.503 . . . . 0.0 110.018 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -70.39 -24.13 62.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 2.8 p -137.18 156.05 48.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.351 1.432 . . . . 0.0 113.515 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -43.5 98.7 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.613 -0.679 . . . . 0.0 109.895 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -58.41 -37.37 75.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.602 0.761 . . . . 0.0 112.933 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.41 -49.68 72.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.941 0.897 . . . . 0.0 111.168 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.44 93.34 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.806 0.73 . . . . 0.0 112.383 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -61.07 -48.64 80.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.047 0.939 . . . . 0.0 111.15 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -62.81 -34.12 76.62 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.492 -0.755 . . . . 0.0 112.812 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.27 -64.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.656 -0.688 . . . . 0.0 109.582 166.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.38 -35.59 28.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.531 1.132 . . . . 0.0 113.646 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.35 -30.8 71.27 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.682 1.193 . . . . 0.0 113.469 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -117.22 -27.68 6.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 14.7 t80 -73.48 125.41 27.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.673 0.749 . . . . 0.0 111.28 -167.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.4 30.05 19.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.762 1.625 . . . . 0.0 113.937 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -56.23 -36.07 68.08 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.18 -0.95 . . . . 0.0 113.457 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.18 -21.35 46.51 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.566 1.146 . . . . 0.0 113.103 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.18 27.28 49.73 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.941 1.258 . . . . 0.0 113.712 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.93 -34.93 14.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.559 1.544 . . . . 0.0 114.768 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.407 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 22.3 mt -72.95 149.57 89.97 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.12 0.968 . . . . 0.0 109.698 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.54 -30.01 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.657 2.238 . . . . 0.0 112.532 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.22 149.84 47.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.752 2.021 . . . . 0.0 112.399 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -119.37 98.34 6.1 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.572 1.149 . . . . 0.0 110.421 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.85 107.65 16.38 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.197 1.799 . . . . 0.0 109.542 -169.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -117.91 166.91 11.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 108.89 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -65.59 132.53 49.09 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.203 -0.935 . . . . 0.0 111.217 163.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.49 -146.56 8.29 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.416 1.484 . . . . 0.0 109.527 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.81 143.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.398 1.479 . . . . 0.0 108.594 167.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -75.47 -82.11 0.48 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 165.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -94.74 105.75 17.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.559 0.744 . . . . 0.0 111.074 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -169.56 140.67 6.22 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.304 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.4 125.84 11.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 125.16 3.906 . . . . 0.0 109.985 174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 -65.31 -36.68 84.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.08 -18.4 62.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.501 1.921 . . . . 0.0 114.029 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.29 30.16 6.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 111.995 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.9 t -89.62 135.87 33.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.558 1.143 . . . . 0.0 111.806 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -116.96 89.38 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.249 1.82 . . . . 0.0 108.762 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -69.7 -20.87 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.33 -46.39 80.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.594 1.543 . . . . 0.0 111.187 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -86.45 -17.54 33.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.61 48.05 8.29 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.532 1.063 . . . . 0.0 112.401 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -150.08 169.74 20.55 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.284 1.042 . . . . 0.0 112.834 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 15.9 p -137.96 151.96 48.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.71 1.204 . . . . 0.0 110.802 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 22.0 mt -110.23 130.62 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.96 127.16 25.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 119.701 1.137 . . . . 0.0 111.634 -172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.31 132.79 21.51 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.875 2.383 . . . . 0.0 111.635 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 14.5 mtm -64.32 -28.22 69.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.34 1.456 . . . . 0.0 114.048 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -68.37 -23.72 64.7 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.747 0.703 . . . . 0.0 112.893 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.07 -36.55 15.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.588 1.555 . . . . 0.0 111.923 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.2 mt -53.0 117.98 3.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.987 0.812 . . . . 0.0 109.139 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.0 p -64.62 176.17 1.21 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.758 1.223 . . . . 0.0 110.753 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -62.1 -38.85 90.43 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.693 -0.63 . . . . 0.0 111.571 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.53 -40.67 80.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.822 0.849 . . . . 0.0 112.141 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.68 -58.79 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.369 1.067 . . . . 0.0 111.608 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -61.43 -36.04 79.24 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.705 0.402 . . . . 0.0 111.927 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.14 -40.3 89.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.996 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -67.45 -45.47 75.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.539 1.518 . . . . 0.0 111.456 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -52.89 -37.63 60.81 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.496 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.76 -43.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -97.45 -12.55 22.56 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.37 142.5 43.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.183 -0.948 . . . . 0.0 111.989 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -76.34 -53.49 8.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.782 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -92.97 128.32 38.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.285 1.034 . . . . 0.0 110.415 166.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.13 -173.36 45.7 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.479 1.038 . . . . 0.0 114.324 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.19 -158.96 53.8 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.469 -0.365 . . . . 0.0 112.617 -170.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.0 p -97.64 7.52 46.3 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -164.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 p 68.93 7.06 5.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.766 1.626 . . . . 0.0 114.422 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.53 1.78 32.82 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.941 1.734 . . . . 0.0 113.973 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -66.46 153.61 92.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 118.603 1.201 . . . . 0.0 110.823 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.12 147.64 94.03 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.404 2.07 . . . . 0.0 110.038 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 27.2 mt -68.74 124.52 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.865 -0.522 . . . . 0.0 109.761 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.8 t -117.53 148.89 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.292 1.837 . . . . 0.0 108.552 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 99.7 m -50.17 122.96 7.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.18 0.592 . . . . 0.0 109.806 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.57 -2.68 77.75 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.204 -1.331 . . . . 0.0 115.265 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.505 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.8 OUTLIER -54.89 123.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.708 1.754 . . . . 0.0 111.592 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.68 138.22 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 109.243 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 336' ' ' VAL . 6.3 p90 -164.6 -178.36 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.5 1.52 . . . . 0.0 112.25 175.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -93.57 153.26 18.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.626 1.17 . . . . 0.0 111.791 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -49.14 130.32 16.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.542 1.137 . . . . 0.0 113.206 -168.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.68 150.58 68.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.116 1.878 . . . . 0.0 109.689 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -55.66 156.42 4.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.227 1.011 . . . . 0.0 113.72 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mt -121.52 46.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 123.58 1.657 . . . . 0.0 109.56 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.527 135.257 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -79.64 142.24 35.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.257 1.023 . . . . 0.0 111.938 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.65 -42.53 97.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.705 1.202 . . . . 0.0 111.325 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.559 1.3 0 C-N-CA 125.252 1.421 . . . . 0.0 113.129 -169.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 . . . . . 0 CA--C 1.55 0.949 0 O-C-N 120.989 -1.07 . . . . 0.0 110.346 177.777 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.8 m80 . . . . . 0 CA--C 1.548 0.901 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -50.57 131.7 25.28 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.149 1.341 . . . . 0.0 111.209 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.37 140.81 26.9 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 123.861 0.864 . . . . 0.0 109.951 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.9 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.217 2.612 . . . . 0.0 111.026 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 66.28 49.92 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.985 1.314 . . . . 0.0 110.442 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.38 113.15 2.79 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.113 2.542 . . . . 0.0 109.734 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.02 127.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.787 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.68 167.3 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.284 1.434 . . . . 0.0 110.367 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -139.38 122.84 17.24 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.879 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.93 115.02 23.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.803 0.841 . . . . 0.0 110.373 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.4 p -70.4 -11.14 60.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 70.5 p -67.32 -22.38 65.61 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 112.365 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -69.34 147.61 97.13 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.364 0.666 . . . . 0.0 111.478 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.84 164.26 27.71 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.821 3.014 . . . . 0.0 112.65 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.47 133.75 21.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.775 2.983 . . . . 0.0 112.07 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 69.17 30.47 4.32 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.992 2.117 . . . . 0.0 112.123 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -119.97 142.28 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 451' ' ' LEU . 16.9 pt -115.31 149.15 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.458 1.503 . . . . 0.0 110.294 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 128.46 53.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.491 1.116 . . . . 0.0 110.645 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.06 104.73 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.185 0.448 . . . . 0.0 111.618 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -67.13 138.88 57.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.96 167.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 t -81.66 136.17 35.51 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.353 -0.842 . . . . 0.0 112.432 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -105.43 18.89 21.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.944 1.697 . . . . 0.0 110.42 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 92.5 m -125.26 140.69 52.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 111.523 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.18 136.06 47.66 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.143 1.777 . . . . 0.0 108.891 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.69 122.08 33.92 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.37 109.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.29 50.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.646 0.641 . . . . 0.0 111.746 168.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.25 16.02 68.51 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.697 -0.884 . . . . 0.0 114.9 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 28.7 t -78.55 116.58 60.56 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.634 1.217 . . . . 0.0 110.021 -168.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 135.86 31.08 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.325 2.016 . . . . 0.0 108.699 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.2 -15.88 38.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.01 -27.07 61.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.788 0.835 . . . . 0.0 113.106 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.5 ' SD ' HD21 ' A' ' 402' ' ' LEU . 5.4 ptp -84.55 147.46 27.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.542 0.737 . . . . 0.0 111.753 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -124.96 -167.77 1.72 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.824 1.65 . . . . 0.0 111.741 -173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -60.24 -41.71 93.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.592 1.157 . . . . 0.0 111.957 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -73.8 -24.24 59.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.0 -41.85 70.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.882 1.219 . . . . 0.0 110.757 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.1 mm? -56.14 -53.24 59.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 122.977 0.511 . . . . 0.0 110.486 170.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.35 -32.9 67.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.238 -0.887 . . . . 0.0 113.086 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -70.28 -46.16 64.9 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.996 1.271 . . . . 0.0 113.032 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.56 -36.18 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.164 0.893 . . . . 0.0 111.077 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 11.3 mp -78.65 -6.55 56.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.078 0.951 . . . . 0.0 113.342 173.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -49.93 -50.94 65.45 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-N 120.719 1.6 . . . . 0.0 114.843 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.7 -6.34 17.47 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.088 1.859 . . . . 0.0 113.207 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -97.13 -43.04 7.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.547 1.539 . . . . 0.0 112.398 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.26 169.36 2.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 113.868 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.79 119.52 32.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.443 1.097 . . . . 0.0 111.057 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.39 129.18 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.911 1.284 . . . . 0.0 109.411 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.7 -28.63 14.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 t -153.8 149.89 27.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.752 1.221 . . . . 0.0 110.828 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.32 139.45 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.614 0.765 . . . . 0.0 109.836 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.09 104.85 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 166.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.25 118.3 30.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.105 0.478 . . . . 0.0 109.913 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -102.63 79.45 1.81 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.222 1.409 . . . . 0.0 109.058 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.66 -33.49 64.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.167 1.387 . . . . 0.0 111.4 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -32.29 66.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.953 1.701 . . . . 0.0 113.443 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.29 6.79 24.85 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.397 1.479 . . . . 0.0 113.832 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.7 mttt 56.09 38.3 29.75 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.751 1.621 . . . . 0.0 112.436 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -121.66 154.31 37.0 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.03 1.732 . . . . 0.0 113.144 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.46 130.58 28.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.577 1.151 . . . . 0.0 111.698 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -84.36 123.13 29.86 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 162.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 53.0 t -122.96 118.22 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.013 0.925 . . . . 0.0 110.059 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.45 121.1 42.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 109.68 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.96 163.34 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 110.114 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -73.71 -17.71 61.09 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 6.3 p -140.8 156.69 46.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.297 . . . . 0.0 113.154 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -43.43 96.74 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.764 -0.585 . . . . 0.0 110.6 171.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -59.15 -42.08 89.87 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.887 -0.508 . . . . 0.0 111.132 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.0 -50.0 74.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.097 0.959 . . . . 0.0 112.022 171.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.12 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.624 0.647 . . . . 0.0 111.568 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -60.94 -41.31 95.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.423 0.689 . . . . 0.0 112.356 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -66.64 -33.48 75.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.309 0.959 . . . . 0.0 112.134 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.0 -64.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.351 164.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -49.82 -35.57 23.42 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -63.99 -42.19 97.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.909 1.684 . . . . 0.0 113.369 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -110.55 -26.91 9.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -171.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -70.58 122.66 20.15 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.944 0.897 . . . . 0.0 111.095 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.07 31.77 17.77 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.843 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -34.29 73.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.1 -21.18 54.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.826 1.251 . . . . 0.0 113.073 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.99 28.04 55.11 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.933 1.254 . . . . 0.0 113.685 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -92.64 -35.12 13.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.473 1.509 . . . . 0.0 114.566 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.4 mt -72.0 150.38 92.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.431 1.092 . . . . 0.0 109.789 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.93 -34.35 8.69 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.476 2.117 . . . . 0.0 112.045 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.5 HD21 ' SD ' ' A' ' 350' ' ' MET . 1.1 mp -65.76 151.61 46.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 112.575 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -127.19 94.64 4.06 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.068 1.347 . . . . 0.0 108.946 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -77.94 116.9 18.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.027 0.931 . . . . 0.0 110.389 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -120.37 171.27 8.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.933 2.093 . . . . 0.0 108.941 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -69.63 127.46 33.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.046 -1.034 . . . . 0.0 111.273 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.23 -155.68 15.1 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 125.532 1.539 . . . . 0.0 109.27 166.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.64 134.3 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.111 0.456 . . . . 0.0 111.953 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.54 -51.06 3.79 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 166.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -123.64 112.66 17.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 112.454 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.65 2.93 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.131 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.71 128.81 14.71 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 125.195 3.93 . . . . 0.0 110.48 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -34.32 76.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.04 -19.07 60.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.297 1.039 . . . . 0.0 113.756 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.76 29.47 6.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.158 1.783 . . . . 0.0 111.654 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.4 t -83.74 136.01 34.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.886 1.274 . . . . 0.0 111.301 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -121.41 76.89 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.39 1.476 . . . . 0.0 109.087 167.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -61.71 -26.68 68.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.562 -0.711 . . . . 0.0 112.553 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.6 -49.92 74.66 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.235 1.379 . . . . 0.0 111.684 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -82.44 -13.41 56.81 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.98 39.92 18.53 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 124.803 1.192 . . . . 0.0 112.749 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.87 167.02 24.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.621 1.211 . . . . 0.0 112.946 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.9 m -130.25 153.82 48.22 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.397 -0.814 . . . . 0.0 110.465 167.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 mm -106.09 133.8 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -123.58 115.61 28.26 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 120.228 1.376 . . . . 0.0 112.014 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -71.45 133.08 21.79 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.195 2.596 . . . . 0.0 111.492 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.9 mtt -61.81 -28.94 69.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.459 1.104 . . . . 0.0 113.316 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -65.59 -19.07 65.77 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.43 16.43 16.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 112.908 176.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 425' ' ' ILE . 10.4 mt -89.96 173.55 8.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.863 1.265 . . . . 0.0 112.513 170.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.4 p -127.12 169.1 13.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.039 1.336 . . . . 0.0 110.632 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.31 -33.25 69.52 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.748 -1.22 . . . . 0.0 111.166 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.83 84.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.458 1.103 . . . . 0.0 112.014 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.499 ' CG ' HD22 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -65.55 -45.14 84.51 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.656 0.662 . . . . 0.0 112.478 179.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -62.33 -41.74 98.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -59.84 -32.36 70.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.339 1.056 . . . . 0.0 113.106 171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -72.05 -50.45 28.27 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.007 1.731 . . . . 0.0 111.877 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.7 m -51.58 -39.55 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.314 0.961 . . . . 0.0 111.715 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.3 m -82.64 -50.52 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.5 t -91.07 -13.78 32.52 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.612 -1.305 . . . . 0.0 114.27 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.4 137.69 47.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.027 0.917 . . . . 0.0 111.702 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -78.05 -44.97 24.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.883 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -102.82 140.0 37.66 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.968 1.307 . . . . 0.0 111.617 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.02 -167.5 34.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.056 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.92 -146.21 47.83 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -171.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 451' ' ' LEU . 18.7 p -117.21 1.18 12.45 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -153.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.77 18.01 1.3 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.29 1.836 . . . . 0.0 112.849 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.19 12.4 61.72 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.602 1.096 . . . . 0.0 113.659 -172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -78.56 136.93 59.3 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.032 1.333 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.18 99.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.069 2.513 . . . . 0.0 109.059 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.7 OUTLIER -67.61 147.68 52.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.625 0.77 . . . . 0.0 112.189 -176.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.3 163.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.785 1.234 . . . . 0.0 111.235 -173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.8 t -51.43 127.35 19.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.916 0.886 . . . . 0.0 110.641 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 97.03 -14.39 63.9 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.938 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.26 147.33 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.077 1.939 . . . . 0.0 112.164 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.94 132.93 69.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.759 2.024 . . . . 0.0 109.052 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 446' ' ' THR . 16.4 p90 -153.36 178.05 10.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.415 1.486 . . . . 0.0 111.752 174.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.99 151.26 19.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.163 1.385 . . . . 0.0 109.631 171.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.31 129.26 5.98 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.888 1.275 . . . . 0.0 112.371 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.57 150.54 80.0 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.293 1.328 . . . . 0.0 110.077 168.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.451 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.4 m-20 -54.24 142.87 24.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 51.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.632 1.682 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.549 0.911 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.499 138.688 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.9 m80 . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.15 143.23 52.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.384 1.074 . . . . 0.0 112.322 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.4 mm? -62.91 -46.29 88.51 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.034 0.934 . . . . 0.0 112.183 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 CA--C 1.549 0.938 0 C-N-CA 125.193 1.397 . . . . 0.0 112.522 -175.11 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 122.301 1.048 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 124.734 1.214 . . . . 0.0 111.307 179.027 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -55.12 125.17 19.41 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.253 -1.529 . . . . 0.0 111.471 171.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.7 mmt-85 -160.24 148.33 13.11 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.758 1.623 . . . . 0.0 110.693 -170.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.06 173.47 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.644 2.229 . . . . 0.0 111.611 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -114.84 99.32 51.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.192 0.597 . . . . 0.0 109.504 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.03 154.79 25.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.522 2.815 . . . . 0.0 110.821 171.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.08 142.06 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.329 1.452 . . . . 0.0 108.967 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.74 168.09 17.77 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.388 1.075 . . . . 0.0 111.166 171.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.12 121.98 15.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.766 1.226 . . . . 0.0 109.996 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.23 107.18 12.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.822 1.249 . . . . 0.0 110.164 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 50.3 p -71.55 -4.13 25.19 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -24.59 66.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.94 1.296 . . . . 0.0 112.175 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.16 151.21 97.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.064 0.946 . . . . 0.0 112.001 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.26 161.74 32.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.826 3.017 . . . . 0.0 112.659 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.56 131.19 18.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.746 2.964 . . . . 0.0 112.057 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.05 36.21 4.28 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.074 2.15 . . . . 0.0 111.807 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -122.57 155.26 36.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.649 1.18 . . . . 0.0 113.74 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 455' ' ' ILE . 16.6 pt -123.61 154.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.652 1.981 . . . . 0.0 110.546 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -110.55 125.17 53.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.118 0.967 . . . . 0.0 110.946 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.11 105.1 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.505 1.122 . . . . 0.0 109.785 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.93 136.28 52.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.627 1.171 . . . . 0.0 111.218 168.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.7 t -73.96 138.84 44.46 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 121.325 -0.859 . . . . 0.0 112.203 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.5 mtm180 -107.37 -1.27 21.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.889 1.676 . . . . 0.0 111.815 164.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 23.1 m -100.54 123.62 45.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.072 1.349 . . . . 0.0 109.093 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.45 141.46 28.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.568 1.547 . . . . 0.0 108.751 168.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -93.93 142.99 26.75 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.47 111.93 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.169 1.388 . . . . 0.0 108.441 -172.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -91.01 172.75 37.14 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.197 0.904 . . . . 0.0 111.768 168.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.6 23.36 78.04 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.316 -0.713 . . . . 0.0 114.736 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.0 t -84.26 115.72 61.55 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 118.491 1.146 . . . . 0.0 110.405 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.87 142.24 61.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.924 2.416 . . . . 0.0 110.032 170.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.08 -20.12 50.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -21.34 52.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 22.9 mtm -83.94 144.06 29.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.949 0.881 . . . . 0.0 112.165 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -128.31 -177.16 4.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.832 2.053 . . . . 0.0 110.624 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -49.41 -39.26 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.73 1.612 . . . . 0.0 114.713 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 305' ' ' LEU . 98.5 m95 -79.36 -17.77 53.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -75.75 -38.54 58.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.549 1.068 . . . . 0.0 110.519 168.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.8 mm? -59.87 -49.07 79.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.582 168.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.36 -33.56 69.7 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.102 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -73.97 -42.45 60.45 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.923 1.238 . . . . 0.0 114.314 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.29 -35.19 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.029 1.286 . . . . 0.0 111.459 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.546 HD23 ' CE1' ' A' ' 394' ' ' PHE . 37.8 mt -87.97 -5.63 58.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.455 1.102 . . . . 0.0 113.081 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -52.53 -49.0 88.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.88 -6.17 17.77 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.616 2.21 . . . . 0.0 113.379 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -98.5 -35.91 10.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.332 1.453 . . . . 0.0 112.871 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.55 3.5 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.214 1.805 . . . . 0.0 113.936 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 122.23 30.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.184 1.394 . . . . 0.0 110.61 169.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.46 122.74 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.693 0.797 . . . . 0.0 109.592 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -96.72 -35.5 10.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.588 1.555 . . . . 0.0 112.459 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.95 155.57 44.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.36 1.064 . . . . 0.0 111.907 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 27.0 t -149.22 140.18 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 0.0 110.621 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.26 101.48 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.392 1.477 . . . . 0.0 108.254 168.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.63 131.11 49.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.174 0.59 . . . . 0.0 110.823 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 87.49 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.394 1.092 . . . . 0.0 109.96 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.42 -29.54 67.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.273 1.429 . . . . 0.0 112.237 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.3 t -59.27 -28.28 66.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.888 1.675 . . . . 0.0 114.092 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.22 1.38 16.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.083 1.753 . . . . 0.0 112.727 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 59.51 37.46 22.84 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.318 1.447 . . . . 0.0 112.26 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -125.51 167.0 15.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.42 164.76 29.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.501 1.12 . . . . 0.0 112.315 163.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.94 135.38 54.92 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.331 1.453 . . . . 0.0 108.396 162.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 359' ' ' LEU . 73.0 t -128.44 118.03 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.116 0.966 . . . . 0.0 110.92 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -101.67 120.3 40.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.786 1.234 . . . . 0.0 112.059 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.9 m -100.99 -179.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.136 0.974 . . . . 0.0 111.429 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -64.93 -37.4 87.53 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.928 1.24 . . . . 0.0 114.155 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 383' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 60.3 p -149.06 166.42 28.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -167.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -39.25 89.62 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.175 169.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -62.39 -40.36 96.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.917 0.78 . . . . 0.0 112.352 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.62 -47.76 71.61 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.37 0.668 . . . . 0.0 110.488 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.92 98.65 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.383 -0.823 . . . . 0.0 112.107 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -65.5 -40.52 93.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.935 171.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.99 -33.38 75.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.946 1.248 . . . . 0.0 112.333 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.99 -65.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 118.461 0.573 . . . . 0.0 109.886 164.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.48 -33.22 43.76 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -69.29 -35.3 75.87 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 113.454 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -111.49 -26.04 9.28 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.7 t80 -72.6 124.25 24.87 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.415 0.686 . . . . 0.0 111.872 -168.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 60.67 28.77 18.48 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.712 1.605 . . . . 0.0 114.134 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -31.03 70.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.791 -1.193 . . . . 0.0 113.737 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.16 -18.3 50.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.601 1.16 . . . . 0.0 113.382 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.72 17.69 69.92 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.848 1.213 . . . . 0.0 114.001 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.55 -31.27 19.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.54 1.536 . . . . 0.0 114.845 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 42.8 mt -79.22 149.18 72.37 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.195 0.998 . . . . 0.0 109.895 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.33 -27.84 11.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.689 2.26 . . . . 0.0 112.394 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.17 147.04 45.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.806 1.242 . . . . 0.0 111.863 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.89 103.25 8.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.564 1.146 . . . . 0.0 110.592 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -86.84 122.4 30.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 111.401 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -129.35 177.09 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.304 2.642 . . . . 0.0 109.146 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -76.05 130.84 38.98 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.777 -1.202 . . . . 0.0 111.651 162.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.0 -160.56 21.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.274 1.892 . . . . 0.0 109.594 162.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.61 125.94 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.892 1.277 . . . . 0.0 109.47 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -90.21 -43.49 4.97 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 162.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -137.66 124.4 21.11 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.168 0.987 . . . . 0.0 110.866 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 174.09 129.92 1.23 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.068 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.27 123.51 10.0 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.78 3.654 . . . . 0.0 109.797 172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.7 -37.89 74.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.279 0.561 . . . . 0.0 112.476 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.79 -18.6 62.09 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.026 2.13 . . . . 0.0 114.545 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.66 24.21 8.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.844 1.658 . . . . 0.0 112.084 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.65 140.99 29.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.309 1.444 . . . . 0.0 111.776 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.81 88.8 3.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.376 1.471 . . . . 0.0 109.199 166.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -65.78 -20.76 66.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.42 -51.51 23.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.637 0.775 . . . . 0.0 110.347 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.87 -17.67 55.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.42 36.18 27.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 124.967 1.27 . . . . 0.0 113.294 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -144.33 164.89 29.47 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.165 0.986 . . . . 0.0 112.893 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.6 m -129.73 150.52 51.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.296 1.038 . . . . 0.0 110.521 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.48 139.38 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.99 126.65 19.77 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 120.017 1.28 . . . . 0.0 111.608 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.25 135.74 27.61 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.565 2.176 . . . . 0.0 111.097 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 5.3 mtm -61.7 -33.78 74.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.498 1.119 . . . . 0.0 113.096 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -68.04 -21.91 64.99 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 119.249 0.931 . . . . 0.0 113.506 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -83.48 -38.84 21.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.184 1.393 . . . . 0.0 111.543 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.97 124.04 13.18 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.728 0.695 . . . . 0.0 109.224 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.5 p -70.77 174.7 5.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.652 1.181 . . . . 0.0 110.942 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -44.0 76.03 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.759 -0.588 . . . . 0.0 111.012 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.66 82.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.291 1.036 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.0 -51.29 70.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.7 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -63.24 -42.94 99.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -52.68 -49.74 64.67 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -69.14 -44.78 71.64 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.494 1.043 . . . . 0.0 111.55 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 64.3 m -52.63 -35.74 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.637 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.38 -42.67 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.2 t -97.63 -9.95 25.95 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -165.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.42 141.02 48.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.975 -1.078 . . . . 0.0 112.279 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -75.67 -22.78 56.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.707 0.803 . . . . 0.0 111.693 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -131.34 144.77 51.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.086 2.155 . . . . 0.0 110.566 167.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.41 -176.89 41.0 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.978 0.799 . . . . 0.0 113.014 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.13 -153.3 49.54 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 122.25 -0.559 . . . . 0.0 113.941 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.6 p -102.76 7.64 39.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.769 1.627 . . . . 0.0 115.173 -163.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.1 m 73.58 8.31 5.04 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.83 2.85 59.51 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.326 1.441 . . . . 0.0 113.58 -170.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -68.33 154.97 93.45 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.754 1.277 . . . . 0.0 110.454 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.01 141.41 83.72 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.062 1.842 . . . . 0.0 110.198 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 118.47 10.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 166.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.83 154.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.189 1.396 . . . . 0.0 109.671 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -57.27 133.63 55.26 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.806 0.442 . . . . 0.0 110.049 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.45 -8.79 79.09 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.449 -1.195 . . . . 0.0 115.181 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 334' ' ' ILE . 15.6 tt -62.41 138.82 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.985 1.892 . . . . 0.0 111.749 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.12 137.93 55.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 108.875 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.63 -179.27 7.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.149 1.38 . . . . 0.0 110.858 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -99.87 146.01 27.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.513 1.925 . . . . 0.0 110.68 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -44.32 131.87 4.6 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.451 1.5 . . . . 0.0 114.313 -166.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.36 163.99 36.74 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.143 1.895 . . . . 0.0 111.804 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.53 137.04 56.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 112.613 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.52 54.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 123.581 1.658 . . . . 0.0 109.531 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.544 0.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.245 140.624 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 8.4 m80 . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 304' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 367' ' ' SER . 31.5 m80 -89.11 147.94 23.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.971 1.709 . . . . 0.0 113.026 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.8 18.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.062 2.145 . . . . 0.0 113.029 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 4.1 p90 . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 125.915 1.686 . . . . 0.0 112.275 -168.013 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 CA--C 1.548 0.886 0 O-C-N 121.34 -0.85 . . . . 0.0 110.302 173.776 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 61.1 m170 . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -48.42 131.08 17.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.761 1.164 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 134.45 11.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.77 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.73 168.49 22.68 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.235 2.623 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.87 70.59 10.27 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.602 1.561 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.77 115.15 3.43 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.099 2.533 . . . . 0.0 110.004 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.79 144.45 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.552 1.141 . . . . 0.0 109.362 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.7 173.17 11.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.265 1.026 . . . . 0.0 110.899 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 455' ' ' ILE . 44.4 m-85 -136.4 121.11 18.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.472 1.109 . . . . 0.0 109.634 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -115.55 108.02 15.9 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.826 1.251 . . . . 0.0 110.444 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.7 p -66.67 -8.93 31.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -25.07 67.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.088 1.355 . . . . 0.0 112.439 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.26 151.94 96.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.636 0.774 . . . . 0.0 111.927 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.54 162.41 31.16 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.891 3.061 . . . . 0.0 112.722 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 131.95 19.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.813 3.009 . . . . 0.0 112.176 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 68.38 33.7 4.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.744 2.018 . . . . 0.0 112.162 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -121.47 151.14 40.58 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.43 146.11 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.128 1.771 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -110.25 128.72 55.66 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.5 1.046 . . . . 0.0 111.529 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.3 t -125.01 104.47 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.5 0.72 . . . . 0.0 111.112 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.72 134.54 54.42 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.644 1.177 . . . . 0.0 111.589 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 33.3 t -76.34 138.99 40.81 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.193 -0.942 . . . . 0.0 111.651 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.5 mtm105 -109.63 13.96 23.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.102 1.761 . . . . 0.0 110.835 163.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.0 m -113.95 136.23 53.12 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.125 1.77 . . . . 0.0 111.052 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.7 mt -102.61 137.41 40.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.057 1.743 . . . . 0.0 110.131 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -84.12 138.84 32.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 158.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 22.9 mm -127.67 105.16 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.168 1.387 . . . . 0.0 108.346 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -81.35 178.8 53.77 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 121.366 -0.834 . . . . 0.0 111.506 165.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.33 37.28 86.03 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.72 -0.871 . . . . 0.0 113.822 173.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.08 85.14 6.34 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 125.553 1.541 . . . . 0.0 110.358 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.43 161.18 42.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.547 . . . . 0.0 111.012 171.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.8 -20.31 48.96 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -28.52 69.72 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.211 1.005 . . . . 0.0 113.058 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.5 ptm -110.9 135.93 50.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.221 1.01 . . . . 0.0 112.097 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -116.97 -176.05 2.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.257 1.823 . . . . 0.0 111.24 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.92 -34.6 68.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.535 1.134 . . . . 0.0 113.238 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -78.43 -24.18 46.28 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.11 -43.34 71.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.052 0.842 . . . . 0.0 109.851 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 37.3 mt -57.74 -52.89 63.58 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.997 0.519 . . . . 0.0 109.927 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.96 -37.25 63.72 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -72.04 -39.55 69.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.13 -30.98 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.974 1.261 . . . . 0.0 111.653 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.8 mt -81.21 -13.75 58.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.29 1.436 . . . . 0.0 112.916 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -48.09 -48.93 62.69 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.41 -4.64 15.59 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.351 2.034 . . . . 0.0 113.533 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -101.89 -41.28 6.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.62 1.568 . . . . 0.0 112.643 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.75 168.05 4.38 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 111.704 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 132.94 34.7 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.852 -0.53 . . . . 0.0 109.624 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.76 136.28 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.835 0.854 . . . . 0.0 110.133 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -41.54 6.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.339 1.456 . . . . 0.0 112.531 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 304' ' ' HIS . 0.1 OUTLIER -149.28 157.6 43.48 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.827 1.251 . . . . 0.0 109.743 -176.239 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.92 133.41 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.81 99.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 165.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 137.7 37.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.7 64.77 1.6 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.388 1.075 . . . . 0.0 110.785 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -56.48 -34.4 66.88 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 0.0 112.249 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 m -61.34 -31.41 71.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.799 1.239 . . . . 0.0 113.737 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -96.77 6.99 47.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.366 1.466 . . . . 0.0 113.239 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 63.02 21.2 12.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.247 1.819 . . . . 0.0 113.463 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -135.85 175.52 9.52 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.87 167.01 24.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.104 1.762 . . . . 0.0 111.44 166.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.81 131.69 54.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.015 1.326 . . . . 0.0 108.393 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 60.4 t -122.98 132.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.628 1.171 . . . . 0.0 109.642 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -111.87 126.84 55.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.618 1.567 . . . . 0.0 110.68 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 166.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 0.0 109.812 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -78.7 -23.2 45.72 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -167.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.53 149.46 50.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.781 1.232 . . . . 0.0 111.948 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -55.3 -41.73 72.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.288 1.035 . . . . 0.0 111.777 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -66.24 -36.65 83.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.736 -0.602 . . . . 0.0 112.058 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.72 -49.28 78.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.609 0.764 . . . . 0.0 110.771 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.73 98.23 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.638 -0.664 . . . . 0.0 111.962 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.23 -42.14 98.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.282 1.033 . . . . 0.0 111.556 170.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -67.06 -32.29 73.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.553 1.069 . . . . 0.0 112.757 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.31 -63.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 118.69 -0.671 . . . . 0.0 109.956 165.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.11 -32.99 50.26 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.92 -34.52 74.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.55 1.54 . . . . 0.0 113.377 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -124.39 -31.19 3.31 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -71.77 119.38 15.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.313 1.045 . . . . 0.0 111.159 -167.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 32.4 t30 58.07 25.48 12.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.535 1.534 . . . . 0.0 114.39 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -34.12 77.41 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.66 -1.275 . . . . 0.0 113.251 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.75 -18.32 61.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 112.775 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.19 22.29 63.38 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.067 1.318 . . . . 0.0 113.689 -172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -85.25 -31.5 23.09 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.096 1.359 . . . . 0.0 114.506 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.47 151.94 59.86 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.402 1.081 . . . . 0.0 110.017 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.0 -22.95 22.33 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.722 2.281 . . . . 0.0 113.54 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 402' ' ' LEU . 1.6 mm? -63.95 168.43 5.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.789 1.636 . . . . 0.0 112.957 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 84.97 2.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.401 1.08 . . . . 0.0 110.797 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 117.07 20.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.873 1.669 . . . . 0.0 110.372 -171.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -135.18 169.11 17.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.144 1.378 . . . . 0.0 109.791 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -63.94 119.74 10.65 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.494 -0.754 . . . . 0.0 110.654 165.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.55 -155.44 29.28 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 163.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.7 137.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.869 0.468 . . . . 0.0 111.742 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.91 -52.93 2.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -122.82 111.53 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 111.362 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.7 140.34 4.23 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.126 -0.819 . . . . 0.0 114.861 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.65 131.96 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 125.178 3.919 . . . . 0.0 110.264 174.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -65.24 -34.24 77.89 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.47 -18.64 58.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 89.8 m -123.3 29.75 6.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.141 1.776 . . . . 0.0 112.137 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 14.4 p -76.55 149.5 36.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.867 0.841 . . . . 0.0 112.138 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -132.82 72.6 1.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.475 1.51 . . . . 0.0 108.798 166.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.47 -19.63 63.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.34 -51.85 53.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.899 1.227 . . . . 0.0 110.975 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -80.36 -16.2 55.1 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.01 37.59 12.57 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.054 1.312 . . . . 0.0 112.98 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -145.98 170.31 16.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.01 1.405 . . . . 0.0 112.525 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 37.9 m -136.21 151.39 49.65 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 121.649 -0.657 . . . . 0.0 110.243 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.54 128.65 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.01 121.29 28.86 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.178 -171.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.03 141.65 36.92 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.99 1.793 . . . . 0.0 110.269 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 7.3 mtt -59.04 -31.22 68.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.356 1.062 . . . . 0.0 113.411 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.7 -21.92 66.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.05 0.841 . . . . 0.0 113.265 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.44 5.63 50.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.561 1.944 . . . . 0.0 113.741 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.1 126.38 39.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.323 171.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.8 p -77.47 -179.93 6.09 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.309 1.444 . . . . 0.0 111.343 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -62.5 -42.09 99.26 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.518 -0.739 . . . . 0.0 111.527 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.67 -40.7 92.67 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.137 0.975 . . . . 0.0 112.031 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.99 -51.94 67.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -66.42 -40.45 89.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.921 0.888 . . . . 0.0 111.339 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -58.34 -38.93 78.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.212 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -72.29 -44.77 62.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.818 1.644 . . . . 0.0 111.63 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 62.6 m -50.91 -38.43 49.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.815 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.6 m -87.31 -51.95 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.2 t -92.79 -9.33 40.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.48 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.82 141.29 39.33 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.218 -0.926 . . . . 0.0 111.653 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -73.72 -57.6 3.88 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.622 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -93.81 137.03 33.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.051 . . . . 0.0 111.367 167.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 67.44 -169.09 37.56 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.277 0.942 . . . . 0.0 113.755 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 67.01 -150.03 51.67 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 451' ' ' LEU . 23.4 p -112.26 9.85 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.6 m 69.82 14.38 8.02 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.12 1.368 . . . . 0.0 113.238 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.59 41.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.805 1.193 . . . . 0.0 113.829 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.7 144.86 37.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.906 1.353 . . . . 0.0 111.353 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.5 104.39 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.457 2.772 . . . . 0.0 108.883 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -77.63 142.22 39.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.8 m -130.42 168.15 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.165 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 10.7 t -48.66 127.34 13.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.306 1.042 . . . . 0.0 111.296 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 96.51 -14.36 64.34 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.264 -1.298 . . . . 0.0 115.204 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.6 OUTLIER -53.83 136.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.921 1.86 . . . . 0.0 112.252 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.32 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 126.624 1.97 . . . . 0.0 108.787 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -152.36 179.31 8.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.453 1.501 . . . . 0.0 111.086 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -99.21 154.29 18.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.846 1.258 . . . . 0.0 110.569 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -46.58 129.5 8.23 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.971 1.308 . . . . 0.0 112.446 -166.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.54 152.87 70.51 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.822 1.681 . . . . 0.0 110.019 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.48 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 82.7 m-20 -57.96 135.35 56.91 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.467 1.107 . . . . 0.0 113.29 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.47 50.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 123.306 1.527 . . . . 0.0 109.923 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.546 0.8 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.932 137.736 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 7.4 m80 . . . . . 0 CA--C 1.55 0.978 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -76.52 149.33 36.72 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.065 1.346 . . . . 0.0 112.583 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.4 mp -98.07 -39.85 8.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.232 1.013 . . . . 0.0 111.596 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 124.137 0.975 . . . . 0.0 110.142 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.235 0.313 0 CA-C-O 122.22 1.01 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 CA--C 1.552 1.024 0 C-N-CA 124.408 1.083 . . . . 0.0 110.616 174.125 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 . . . . . 0 CA--C 1.548 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.41 135.47 17.61 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.559 1.527 . . . . 0.0 112.044 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -140.73 149.96 58.43 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 124.273 1.029 . . . . 0.0 111.04 174.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.38 169.34 21.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.834 3.023 . . . . 0.0 111.639 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -124.17 71.32 54.05 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.435 1.094 . . . . 0.0 110.5 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.03 108.21 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.617 2.211 . . . . 0.0 109.288 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.0 139.29 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.349 1.06 . . . . 0.0 109.527 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.44 172.61 12.67 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.651 1.581 . . . . 0.0 109.878 174.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.97 124.09 13.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.026 -1.047 . . . . 0.0 109.103 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -121.69 110.42 15.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.9 t -70.16 -6.14 32.17 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -24.99 67.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.08 . . . . 0.0 112.13 170.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 150.47 90.72 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 111.669 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.31 164.09 26.97 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.974 3.116 . . . . 0.0 113.3 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.64 136.83 28.97 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 112.375 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.13 38.55 16.87 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.596 1.559 . . . . 0.0 112.786 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -124.25 158.17 33.13 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.971 1.308 . . . . 0.0 113.834 171.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 455' ' ' ILE . 2.7 pt -128.53 152.64 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.785 2.034 . . . . 0.0 110.69 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.32 132.05 54.49 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.575 -1.328 . . . . 0.0 111.449 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.499 HG22 ' CE2' ' A' ' 457' ' ' PHE . 61.4 t -126.59 105.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 -171.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -68.74 129.72 40.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 111.915 168.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 2.4 m -71.43 134.62 46.74 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.802 -0.561 . . . . 0.0 111.65 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.4 mtm105 -102.98 16.3 27.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.696 1.999 . . . . 0.0 110.614 162.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 93.6 m -123.91 133.94 53.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.66 1.584 . . . . 0.0 110.623 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 46.5 mt -101.11 138.36 38.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.755 2.422 . . . . 0.0 109.785 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -86.31 124.16 32.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 162.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.38 103.05 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.061 0.944 . . . . 0.0 108.466 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -82.17 -175.89 50.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 164.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.0 30.1 75.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.665 -0.903 . . . . 0.0 113.854 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.73 103.68 12.15 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.446 1.098 . . . . 0.0 110.045 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 144.73 64.88 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.277 1.985 . . . . 0.0 109.918 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.8 mp -65.24 -19.67 66.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -63.76 -32.54 74.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.764 1.226 . . . . 0.0 112.858 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -87.84 154.79 20.26 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -134.13 -175.99 4.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.499 1.519 . . . . 0.0 111.312 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 1.7 mp0 -52.93 -38.4 61.9 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.167 2.187 . . . . 0.0 112.441 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -75.98 -26.61 56.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.58 -43.25 81.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.633 1.106 . . . . 0.0 109.679 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.72 -48.41 81.27 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.669 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -53.0 -46.2 68.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.397 0.999 . . . . 0.0 113.023 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.56 -37.64 80.08 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.45 -33.09 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.095 0.861 . . . . 0.0 111.887 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.58 -14.13 55.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -49.86 -48.92 76.69 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.943 1.697 . . . . 0.0 115.426 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.71 -6.39 18.14 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.008 1.806 . . . . 0.0 112.955 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.33 -46.49 5.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.281 1.433 . . . . 0.0 112.12 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.24 1.69 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.062 1.745 . . . . 0.0 113.469 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.74 133.8 34.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.001 . . . . 0.0 110.913 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.05 130.02 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.707 1.203 . . . . 0.0 109.579 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -91.52 -44.39 9.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.087 0.955 . . . . 0.0 111.69 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.5 p -161.26 163.47 30.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.822 1.249 . . . . 0.0 111.25 -171.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 305' ' ' LEU . 0.6 OUTLIER -165.44 132.52 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.57 0.748 . . . . 0.0 111.767 174.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.93 105.42 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 377' ' ' ALA . 0.9 OUTLIER -99.43 115.52 29.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.103 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.88 83.64 2.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.617 1.567 . . . . 0.0 109.205 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -55.5 -37.93 68.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.174 0.99 . . . . 0.0 111.418 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 m -61.38 -28.89 69.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.872 2.069 . . . . 0.0 113.877 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.95 4.5 34.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.991 1.716 . . . . 0.0 112.817 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 79.9 mttt 55.38 34.6 23.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.178 1.791 . . . . 0.0 112.897 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -131.82 156.48 45.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.66 1.584 . . . . 0.0 113.59 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.439 ' HB2' ' HG ' ' A' ' 370' ' ' LEU . . . -141.76 134.25 28.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.125 1.37 . . . . 0.0 112.637 166.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -88.74 102.43 14.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 166.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 38.8 t -99.38 120.52 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.983 0.913 . . . . 0.0 110.964 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -106.19 126.33 52.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.078 0.951 . . . . 0.0 111.898 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.7 169.13 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.934 1.294 . . . . 0.0 110.168 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -75.48 -15.63 60.39 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -168.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.0 160.9 43.05 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.258 -0.901 . . . . 0.0 112.421 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.36 -41.99 98.85 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.594 0.758 . . . . 0.0 111.456 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.92 -41.64 87.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.346 0.521 . . . . 0.0 111.299 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.66 -51.84 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.08 0.952 . . . . 0.0 109.692 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.27 95.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.557 0.743 . . . . 0.0 112.633 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.3 -43.07 99.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.173 0.989 . . . . 0.0 111.267 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -66.52 -34.19 77.37 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.407 -0.808 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 66.2 t -60.37 -65.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.766 164.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.1 mt -51.95 -35.23 45.35 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -60.16 -37.48 80.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.837 1.255 . . . . 0.0 112.906 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.23 -27.41 7.64 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.56 125.87 28.2 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.78 23.06 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -53.83 -48.04 70.32 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.064 -1.023 . . . . 0.0 113.607 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.45 5.55 49.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.555 1.942 . . . . 0.0 112.806 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 72.62 38.71 57.16 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.566 1.079 . . . . 0.0 112.922 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -57.48 -29.52 64.32 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.232 1.013 . . . . 0.0 113.569 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.12 162.98 25.06 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.763 1.625 . . . . 0.0 110.045 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 -15.73 21.43 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.98 2.453 . . . . 0.0 113.408 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.68 161.01 21.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.342 2.257 . . . . 0.0 112.455 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -128.46 97.08 4.6 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.845 1.258 . . . . 0.0 109.995 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.98 21.24 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.46 1.904 . . . . 0.0 111.739 -177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.18 173.2 11.27 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.295 1.838 . . . . 0.0 108.999 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -70.18 125.44 26.78 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.154 -0.966 . . . . 0.0 110.902 163.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.46 -154.38 14.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.606 1.574 . . . . 0.0 109.174 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -163.49 136.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.646 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -94.42 -45.21 3.29 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.114 1.34 . . . . 0.0 110.296 163.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -124.29 109.99 14.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.148 0.979 . . . . 0.0 113.401 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -176.52 136.4 3.21 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.487 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.57 126.56 12.91 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.094 3.862 . . . . 0.0 110.194 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -36.6 80.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 112.404 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.07 -18.23 60.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.63 1.572 . . . . 0.0 114.285 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.2 27.18 8.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.753 1.621 . . . . 0.0 111.885 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.5 t -84.83 135.42 34.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.59 1.156 . . . . 0.0 111.69 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.05 79.6 1.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.349 1.46 . . . . 0.0 109.34 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -62.83 -24.05 67.58 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.517 -0.74 . . . . 0.0 112.926 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -64.22 -49.36 72.25 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.827 1.194 . . . . 0.0 111.321 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -81.72 -17.38 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 81.77 41.02 10.05 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 124.844 1.212 . . . . 0.0 112.624 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -147.54 165.79 29.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.62 1.21 . . . . 0.0 112.978 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 22.4 m -129.49 152.48 48.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.556 0.742 . . . . 0.0 110.368 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.76 136.24 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.795 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.43 120.04 21.97 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 120.331 1.423 . . . . 0.0 112.004 -173.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -69.31 126.64 13.86 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.981 2.454 . . . . 0.0 111.341 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -33.65 74.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.03 0.932 . . . . 0.0 113.069 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -65.65 -17.87 64.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -109.39 11.04 25.32 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 113.691 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 425' ' ' ILE . 47.9 mt -90.37 145.28 25.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.885 0.874 . . . . 0.0 111.052 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 16.7 p -77.0 179.06 6.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.577 1.151 . . . . 0.0 111.175 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.11 -41.77 76.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.598 -0.689 . . . . 0.0 111.364 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.16 94.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.89 1.276 . . . . 0.0 111.901 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.92 -64.32 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.257 1.423 . . . . 0.0 111.923 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -63.29 -35.23 79.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.63 0.772 . . . . 0.0 111.472 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -53.1 -56.82 13.32 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.504 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -59.59 -39.77 85.28 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.742 1.61 . . . . 0.0 112.734 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.1 m -50.1 -43.48 51.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.426 1.012 . . . . 0.0 112.149 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.12 -21.22 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.6 t -117.68 -17.44 9.91 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.713 1.605 . . . . 0.0 113.905 -165.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.08 139.73 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.179 -0.951 . . . . 0.0 111.186 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -65.27 -49.39 69.75 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.901 0.48 . . . . 0.0 110.667 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -103.66 110.17 22.14 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.592 1.187 . . . . 0.0 108.92 163.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -175.7 -171.49 39.65 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.422 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -74.95 -64.69 2.27 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.101 -1.049 . . . . 0.0 113.642 -164.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 17.4 p -113.65 41.94 2.09 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.107 0.963 . . . . 0.0 110.005 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.8 m -55.74 100.75 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.271 -0.893 . . . . 0.0 111.986 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.97 -8.04 59.22 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 125.817 1.675 . . . . 0.0 115.895 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -110.14 146.39 34.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.264 2.225 . . . . 0.0 111.029 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.76 168.08 25.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.69 2.927 . . . . 0.0 112.21 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.32 121.52 30.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.652 0.781 . . . . 0.0 110.967 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.28 160.46 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.299 1.44 . . . . 0.0 110.602 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.6 m -58.31 125.75 24.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.558 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 83.85 6.34 87.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.846 1.212 . . . . 0.0 114.847 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 334' ' ' ILE . 14.9 tt -62.32 137.67 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.371 1.586 . . . . 0.0 111.115 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.55 138.52 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.164 2.185 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.499 ' CE2' HG22 ' A' ' 336' ' ' VAL . 9.4 p90 -165.45 -176.96 4.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.012 0.925 . . . . 0.0 113.169 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -100.2 146.54 26.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.575 1.55 . . . . 0.0 111.091 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.19 138.24 27.11 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -167.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.32 156.54 50.62 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.685 2.257 . . . . 0.0 112.419 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.84 142.66 58.35 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.917 0.887 . . . . 0.0 112.363 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.44 45.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 123.639 1.685 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.475 0.789 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.249 143.13 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.4 m80 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.87 137.49 41.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.437 1.095 . . . . 0.0 113.282 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.2 -35.19 23.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.978 1.311 . . . . 0.0 111.564 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 123.951 0.9 . . . . 0.0 110.698 -178.668 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.533 0.682 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.101 0.961 . . . . 0.0 110.507 177.152 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m80 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.5 134.87 56.35 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.268 -1.52 . . . . 0.0 112.676 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -149.38 151.27 33.31 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.197 1.399 . . . . 0.0 110.013 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 159.86 50.59 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.07 2.514 . . . . 0.0 111.593 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -112.71 83.25 5.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.74 109.36 2.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.195 1.93 . . . . 0.0 109.799 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.42 132.6 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.479 1.112 . . . . 0.0 108.592 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 79.6 p -129.26 176.25 8.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.716 0.806 . . . . 0.0 111.06 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.16 124.18 18.85 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.533 1.133 . . . . 0.0 110.29 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -126.46 106.66 9.62 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.087 0.946 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.5 m -67.12 -2.9 6.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 114.118 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 -20.39 61.26 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.493 1.042 . . . . 0.0 112.391 170.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.09 151.09 90.32 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.72 0.691 . . . . 0.0 112.071 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.8 162.66 30.93 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.805 3.003 . . . . 0.0 113.04 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.6 133.55 28.1 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.539 2.826 . . . . 0.0 112.699 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.12 20.07 6.52 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 126.275 1.83 . . . . 0.0 112.808 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -106.47 155.49 19.53 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 455' ' ' ILE . 16.1 pt -126.78 154.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.94 2.096 . . . . 0.0 110.478 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -117.59 126.26 52.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.497 1.499 . . . . 0.0 111.855 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.86 107.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.748 0.819 . . . . 0.0 110.498 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -73.59 134.49 43.74 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.07 1.348 . . . . 0.0 111.658 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 38.3 t -70.44 144.29 51.52 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.557 -0.714 . . . . 0.0 111.322 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -123.88 28.91 6.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.816 1.646 . . . . 0.0 110.213 162.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.1 m -127.43 143.14 51.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.393 1.877 . . . . 0.0 109.556 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.57 126.4 55.3 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.239 1.816 . . . . 0.0 108.708 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.09 119.45 27.33 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.6 110.04 30.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.86 37.07 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.494 0.568 . . . . 0.0 112.441 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.38 21.19 70.24 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 169.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.97 128.63 93.2 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.383 1.073 . . . . 0.0 109.928 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.29 130.49 18.77 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.333 2.022 . . . . 0.0 109.396 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 pp -61.13 -20.18 62.37 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -166.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 -21.55 59.28 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.29 147.43 22.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.277 0.944 . . . . 0.0 113.23 -173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -120.47 -179.77 4.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 112.441 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -49.67 -39.17 35.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.613 1.565 . . . . 0.0 114.467 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.92 -14.95 57.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -79.39 -36.56 39.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.264 0.938 . . . . 0.0 110.791 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.48 -51.05 69.94 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.17 -39.14 69.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.21 -42.59 75.53 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.48 -32.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.182 1.356 . . . . 0.0 111.686 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 44.1 mt -81.81 -14.5 56.27 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.196 0.999 . . . . 0.0 112.824 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -43.23 -50.27 15.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.523 1.929 . . . . 0.0 116.193 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.45 -8.34 17.19 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.29 1.994 . . . . 0.0 114.12 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.64 -38.73 9.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.071 1.748 . . . . 0.0 112.236 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.04 160.46 2.77 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.442 1.897 . . . . 0.0 112.776 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.15 106.76 18.7 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.655 0.74 . . . . 0.0 109.033 162.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.77 137.65 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.67 1.188 . . . . 0.0 111.133 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -89.59 -41.84 11.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.436 1.094 . . . . 0.0 111.602 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.59 148.7 28.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.768 1.227 . . . . 0.0 111.031 -170.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.0 t -144.96 137.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 119.171 0.896 . . . . 0.0 110.877 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.86 104.32 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 165.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.85 98.96 11.72 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.588 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -83.25 75.07 9.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.433 1.111 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -56.39 -32.25 64.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.1 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -59.51 -23.44 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.445 1.498 . . . . 0.0 113.786 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.08 13.23 12.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 112.912 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.86 34.05 23.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.328 1.451 . . . . 0.0 112.222 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -117.27 156.55 27.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.415 1.886 . . . . 0.0 112.741 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.5 135.39 28.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 112.112 161.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.11 124.31 31.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 162.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.5 101.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 108.846 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -90.21 116.47 28.22 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.116 1.366 . . . . 0.0 110.019 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.69 149.22 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.313 1.045 . . . . 0.0 108.347 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -74.97 3.57 8.09 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 t -160.32 147.15 15.82 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.25 -1.531 . . . . 0.0 112.903 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -59.89 -39.69 86.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.213 1.405 . . . . 0.0 111.085 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.85 -35.05 79.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.932 0.493 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -68.26 -53.36 25.06 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.796 0.838 . . . . 0.0 110.696 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.14 87.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -64.9 -44.09 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.484 168.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -65.34 -29.03 69.73 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.058 1.299 . . . . 0.0 112.555 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.2 -67.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 118.872 0.76 . . . . 0.0 109.672 161.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.98 -30.87 62.44 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.1 -35.7 81.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.049 1.74 . . . . 0.0 112.756 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.95 -25.76 7.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -75.17 124.57 27.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.327 1.051 . . . . 0.0 111.26 -167.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 59.76 28.35 17.79 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.253 1.821 . . . . 0.0 114.067 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -62.43 -25.88 68.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.716 -1.24 . . . . 0.0 114.186 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.56 -15.12 46.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.447 1.099 . . . . 0.0 113.42 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.01 83.69 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.703 1.144 . . . . 0.0 114.098 -173.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.0 29.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.815 1.646 . . . . 0.0 115.375 -171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.18 151.09 59.37 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.215 0.916 . . . . 0.0 110.39 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.65 -23.75 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.832 2.355 . . . . 0.0 112.736 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.71 142.36 51.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.594 1.958 . . . . 0.0 112.423 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -115.92 90.28 3.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.047 0.939 . . . . 0.0 109.836 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.1 m -79.04 116.28 19.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.542 1.137 . . . . 0.0 109.867 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -116.38 165.88 12.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.681 1.993 . . . . 0.0 108.846 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -63.43 131.19 47.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.741 -1.225 . . . . 0.0 109.992 158.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -112.41 -155.19 12.4 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 125.555 1.55 . . . . 0.0 109.799 164.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.0 p -165.6 141.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 117.798 0.799 . . . . 0.0 111.365 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.31 -45.34 4.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.009 163.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -118.42 102.52 8.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.742 1.217 . . . . 0.0 112.916 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.33 123.73 1.13 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 118.789 -1.006 . . . . 0.0 115.284 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.84 128.92 10.36 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.473 3.449 . . . . 0.0 111.302 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -61.19 -32.6 72.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.34 -24.56 66.54 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.762 1.625 . . . . 0.0 113.205 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 23.1 m -134.84 32.42 3.25 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 112.255 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.72 140.97 49.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.999 1.319 . . . . 0.0 111.476 171.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -131.75 78.69 1.83 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.023 1.729 . . . . 0.0 109.338 163.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -64.41 -12.88 47.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 113.375 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.85 -47.49 18.68 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.685 1.129 . . . . 0.0 111.152 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -80.59 -17.13 52.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.305 0.642 . . . . 0.0 112.623 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.72 47.53 9.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.082 1.325 . . . . 0.0 112.083 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -147.65 171.81 15.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.771 1.286 . . . . 0.0 112.376 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 20.3 m -141.24 150.35 42.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.993 1.317 . . . . 0.0 110.591 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.49 132.37 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.11 124.41 25.34 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 119.537 1.062 . . . . 0.0 111.768 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.05 140.05 17.65 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.549 2.833 . . . . 0.0 112.636 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.81 -19.85 66.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.767 1.627 . . . . 0.0 113.985 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -74.58 -21.66 59.38 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.93 0.786 . . . . 0.0 112.911 172.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -95.51 -26.43 15.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.38 112.62 2.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.684 1.129 . . . . 0.0 109.506 169.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 36.6 p -66.93 177.33 1.73 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.29 1.436 . . . . 0.0 111.491 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -59.97 -38.9 83.85 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.056 -1.028 . . . . 0.0 111.905 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.39 -37.9 65.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.624 0.77 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.31 -51.43 69.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.746 1.218 . . . . 0.0 111.286 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -65.93 -36.27 82.91 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.621 -0.674 . . . . 0.0 111.535 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -51.94 67.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.076 0.853 . . . . 0.0 111.515 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.17 -44.61 94.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.226 1.375 . . . . 0.0 110.667 175.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 m -56.37 -32.84 65.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.249 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.41 -34.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 47.6 m -102.3 -9.27 20.52 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -168.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.63 152.19 27.03 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.952 1.251 . . . . 0.0 112.768 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -81.35 -38.77 26.14 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.135 0.574 . . . . 0.0 110.922 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -116.48 137.3 52.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.247 1.019 . . . . 0.0 110.749 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.43 -169.9 51.2 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.361 -168.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 69.54 -162.11 52.27 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.293 0.949 . . . . 0.0 113.266 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 29.3 p -95.11 1.76 54.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.549 1.54 . . . . 0.0 114.373 -168.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 19.7 m 66.89 11.93 8.62 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.46 1.027 . . . . 0.0 113.655 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.22 48.23 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.303 1.43 . . . . 0.0 114.33 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.7 154.23 93.09 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.469 1.135 . . . . 0.0 110.725 169.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.12 148.7 81.54 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.901 2.4 . . . . 0.0 111.051 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.1 105.53 5.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.547 -0.721 . . . . 0.0 110.011 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.39 158.91 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.653 1.581 . . . . 0.0 110.73 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 76.2 m -60.15 133.13 55.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.02 84.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.491 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 334' ' ' ILE . 15.8 tt -63.99 135.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.937 1.868 . . . . 0.0 111.78 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 36.3 t -120.01 139.45 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 126.376 1.87 . . . . 0.0 109.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -163.52 -176.1 4.53 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.237 1.015 . . . . 0.0 112.743 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.54 148.2 22.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.341 1.457 . . . . 0.0 109.434 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -49.16 131.03 16.35 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.44 157.25 56.91 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.729 2.286 . . . . 0.0 111.612 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -58.38 134.78 56.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.582 1.153 . . . . 0.0 112.757 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.32 58.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 123.572 1.653 . . . . 0.0 109.966 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.068 140.412 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.5 m170 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -63.73 138.1 58.35 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.57 0.748 . . . . 0.0 111.414 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.9 mm? -59.55 -43.75 93.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.154 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.835 -175.978 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.238 0.461 0 CA-C-O 122.319 1.057 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.865 0.866 . . . . 0.0 111.596 -178.438 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 7.8 m80 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -51.08 127.42 18.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.682 1.583 . . . . 0.0 111.645 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -157.19 147.35 15.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.56 1.544 . . . . 0.0 110.85 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.7 173.76 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.67 2.247 . . . . 0.0 111.541 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -108.55 83.3 1.95 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.941 0.896 . . . . 0.0 110.194 167.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.55 141.08 30.73 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.26 2.64 . . . . 0.0 110.303 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.72 145.19 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.208 1.403 . . . . 0.0 108.524 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 75.9 p -140.39 179.78 6.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.178 0.991 . . . . 0.0 111.084 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -143.92 130.77 20.36 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.093 -1.005 . . . . 0.0 110.085 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -107.64 102.93 12.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.274 1.03 . . . . 0.0 109.643 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -12.77 17.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.002 1.321 . . . . 0.0 113.667 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.88 0.92 54.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.691 1.597 . . . . 0.0 113.018 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.6 154.61 50.86 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.644 1.111 . . . . 0.0 113.688 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 162.73 40.98 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.948 3.766 . . . . 0.0 113.191 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.03 138.98 34.9 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.445 3.43 . . . . 0.0 112.937 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.04 37.33 18.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.921 1.288 . . . . 0.0 111.744 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -115.61 140.24 49.36 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.62 -1.3 . . . . 0.0 112.763 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 425' ' ' ILE . 25.6 pt -106.81 146.15 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.387 1.475 . . . . 0.0 109.591 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 117.96 33.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.504 1.121 . . . . 0.0 109.494 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.7 106.93 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 O-C-N 122.096 -0.377 . . . . 0.0 110.568 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.08 128.84 36.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.811 1.244 . . . . 0.0 111.793 170.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 66.1 m -69.16 144.7 53.73 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -131.72 16.02 4.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.484 2.714 . . . . 0.0 110.843 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 13.3 m -110.27 129.68 55.69 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.117 1.767 . . . . 0.0 108.786 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.08 136.44 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.615 1.566 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -93.63 142.87 26.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 159.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.79 106.32 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.98 1.312 . . . . 0.0 108.709 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.41 41.81 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.831 0.729 . . . . 0.0 111.966 168.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.6 78.65 Favored Glycine 0 N--CA 1.475 1.234 0 O-C-N 122.054 -0.674 . . . . 0.0 114.651 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.4 t -78.79 119.97 79.19 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.532 1.166 . . . . 0.0 110.358 -171.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 138.53 34.42 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.721 2.28 . . . . 0.0 109.609 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -16.81 54.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -29.48 63.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.139 0.976 . . . . 0.0 112.557 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.406 ' CE ' HD21 ' A' ' 402' ' ' LEU . 5.9 mtm -78.79 149.33 32.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.63 0.728 . . . . 0.0 112.735 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -127.83 -178.33 4.46 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.878 2.071 . . . . 0.0 111.222 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.466 ' HA ' HG11 ' A' ' 368' ' ' VAL . 10.6 pm0 -51.08 -41.55 60.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.844 1.658 . . . . 0.0 114.449 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.499 ' CE2' HD12 ' A' ' 305' ' ' LEU . 96.1 m95 -77.12 -17.63 58.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.69 -40.31 61.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.272 0.942 . . . . 0.0 110.545 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.7 mm? -60.26 -47.35 86.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.497 0.59 . . . . 0.0 110.939 170.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.33 -34.16 72.01 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.717 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.72 -42.42 64.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.954 1.252 . . . . 0.0 114.376 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.27 -37.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.964 0.802 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 394' ' ' PHE . 32.6 mt -85.75 -5.32 59.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.893 0.877 . . . . 0.0 112.479 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -52.85 -49.83 84.72 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.966 1.707 . . . . 0.0 115.161 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.67 -5.01 16.39 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.457 2.105 . . . . 0.0 113.431 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -101.23 -39.56 7.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.191 1.396 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.5 167.28 5.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.643 1.977 . . . . 0.0 113.111 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -92.67 102.1 14.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.67 1.188 . . . . 0.0 111.642 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 379' ' ' VAL . 59.4 t -70.51 118.58 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.883 0.873 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -91.95 -36.13 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.897 1.679 . . . . 0.0 112.778 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.7 t -144.16 153.16 41.83 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.318 0.963 . . . . 0.0 112.169 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 352' ' ' GLU . 49.0 t -144.81 140.35 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.855 0.862 . . . . 0.0 111.259 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.61 97.79 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.313 1.445 . . . . 0.0 108.019 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -97.3 132.99 42.5 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.858 0.463 . . . . 0.0 110.734 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.05 89.09 2.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.976 1.31 . . . . 0.0 109.769 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.46 -37.45 83.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.087 1.355 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.1 t -58.47 -32.43 68.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.055 1.742 . . . . 0.0 113.064 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -98.45 -1.0 42.39 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.151 1.38 . . . . 0.0 113.197 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 59.03 30.95 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.399 1.88 . . . . 0.0 113.408 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.29 170.5 15.62 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.66 24.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 111.68 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.14 140.12 53.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.377 1.471 . . . . 0.0 108.895 164.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 365' ' ' VAL . 95.1 t -132.77 111.96 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.493 1.117 . . . . 0.0 109.705 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -92.45 119.97 32.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.565 0.746 . . . . 0.0 110.239 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.27 176.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.907 0.883 . . . . 0.0 108.918 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 147.4 46.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.601 -0.687 . . . . 0.0 111.268 -164.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.65 81.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.759 0.824 . . . . 0.0 110.652 166.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -39.93 80.53 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.053 0.842 . . . . 0.0 112.435 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -65.63 -52.38 52.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.674 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.56 80.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.411 1.085 . . . . 0.0 113.037 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.47 -41.57 98.88 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -61.72 -32.61 72.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.645 1.111 . . . . 0.0 111.916 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 359' ' ' LEU . 3.7 t -63.73 -62.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.858 166.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.61 -36.98 26.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.208 1.403 . . . . 0.0 114.111 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.56 -38.59 70.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.377 1.471 . . . . 0.0 112.885 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -106.73 -26.31 11.36 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.56 ' CE1' HD23 ' A' ' 359' ' ' LEU . 25.4 t80 -70.89 127.7 33.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -171.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 29.0 t30 60.66 28.42 18.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.39 1.476 . . . . 0.0 113.9 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -59.64 -34.75 73.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.853 -1.154 . . . . 0.0 113.325 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.32 -20.14 60.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.883 1.273 . . . . 0.0 113.063 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.86 19.61 75.06 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.929 1.252 . . . . 0.0 113.725 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.78 -32.67 17.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.242 1.417 . . . . 0.0 114.291 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.49 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 20.0 mt -77.48 146.77 74.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.859 0.864 . . . . 0.0 109.093 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.79 -18.9 28.0 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.17 1.913 . . . . 0.0 112.718 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.406 HD21 ' CE ' ' A' ' 350' ' ' MET . 3.8 mt -82.27 144.43 30.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.048 0.939 . . . . 0.0 112.524 -169.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.14 9.71 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 110.245 174.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 33.3 m -83.11 125.12 31.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.237 1.415 . . . . 0.0 110.628 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.83 174.98 9.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.022 2.129 . . . . 0.0 109.661 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -72.53 122.87 22.06 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.207 -0.933 . . . . 0.0 111.398 163.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.83 -177.72 35.08 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.281 1.419 . . . . 0.0 110.551 163.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.64 119.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.679 0.791 . . . . 0.0 109.619 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.49 -36.78 10.26 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.759 1.647 . . . . 0.0 110.943 161.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -145.99 109.19 4.65 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.921 0.861 . . . . 0.0 112.149 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.34 133.74 2.13 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.821 -0.988 . . . . 0.0 115.467 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.25 122.17 7.79 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 125.268 3.978 . . . . 0.0 110.83 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -55.27 -37.18 66.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -74.99 -16.41 60.62 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.694 1.598 . . . . 0.0 114.16 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.7 m -127.21 27.82 5.84 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.916 1.686 . . . . 0.0 111.93 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.65 140.48 29.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.201 1.401 . . . . 0.0 111.669 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -126.12 87.78 2.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.444 1.116 . . . . 0.0 109.567 167.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.25 -22.0 65.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.835 0.854 . . . . 0.0 113.181 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -68.77 -51.97 35.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.077 0.853 . . . . 0.0 110.232 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.09 -18.72 59.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.11 45.55 8.86 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.415 1.007 . . . . 0.0 112.459 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -154.6 175.33 13.79 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.306 1.05 . . . . 0.0 112.99 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 35.2 p -147.22 153.32 39.67 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.414 1.086 . . . . 0.0 110.967 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mm -108.33 135.34 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -129.42 109.73 17.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 119.843 1.201 . . . . 0.0 110.523 -172.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.65 131.94 27.43 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.595 2.197 . . . . 0.0 110.917 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 45.7 mtt -64.7 -15.72 61.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.687 1.195 . . . . 0.0 113.132 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -65.35 -25.16 67.47 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 113.038 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 13.08 14.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.426 2.29 . . . . 0.0 113.243 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 425' ' ' ILE . 9.4 mt -85.0 176.41 8.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.521 1.528 . . . . 0.0 111.706 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 2.3 p -127.87 165.06 20.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 110.759 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -65.92 -37.28 85.67 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.041 -1.037 . . . . 0.0 111.41 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.83 -42.21 90.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.771 0.829 . . . . 0.0 112.071 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -48.48 70.0 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.022 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.45 -38.12 86.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.017 0.826 . . . . 0.0 110.107 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.06 -33.05 71.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.659 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -72.56 -45.32 59.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.266 1.394 . . . . 0.0 111.858 168.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 m -53.21 -39.7 63.9 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.767 1.167 . . . . 0.0 111.402 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.24 -48.12 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.2 m -93.49 -5.95 47.97 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.22 138.19 45.55 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.896 1.225 . . . . 0.0 112.533 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -78.02 -27.36 48.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.569 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -124.89 138.46 54.25 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.611 1.564 . . . . 0.0 111.221 164.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.02 -168.64 47.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.396 -172.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.18 -156.91 53.5 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.23 0.443 . . . . 0.0 112.556 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.6 p -107.27 11.77 28.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.24 1.416 . . . . 0.0 114.746 -159.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.5 t 66.19 14.87 9.86 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.911 -1.118 . . . . 0.0 113.21 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.08 61.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.281 1.42 . . . . 0.0 114.233 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -68.19 145.37 97.51 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 119.309 1.555 . . . . 0.0 111.126 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.32 148.27 90.94 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.981 2.454 . . . . 0.0 110.976 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.1 109.4 8.55 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.047 0.451 . . . . 0.0 110.448 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.75 170.87 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.966 1.706 . . . . 0.0 111.471 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.9 m -57.23 119.36 6.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.29 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.19 79.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.283 0.945 . . . . 0.0 115.123 172.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.6 tt -58.27 125.01 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.176 1.488 . . . . 0.0 111.184 172.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.08 132.93 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.707 1.603 . . . . 0.0 109.003 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.79 170.52 21.44 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.154 0.982 . . . . 0.0 112.071 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.91 147.59 25.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.593 1.157 . . . . 0.0 108.982 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -40.0 125.17 1.63 Allowed Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.529 1.132 . . . . 0.0 113.966 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.07 150.6 85.15 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.489 1.459 . . . . 0.0 110.111 172.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -56.7 161.4 2.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.504 1.145 . . . . 0.0 113.52 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 1.4 mt -118.94 47.49 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 123.231 1.491 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.7 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.58 140.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 18.7 m80 . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -79.54 140.12 37.32 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.361 1.064 . . . . 0.0 111.388 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.74 -47.03 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.182 0.593 . . . . 0.0 110.609 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 CA--C 1.548 0.904 0 C-N-CA 125.139 1.376 . . . . 0.0 110.231 -176.332 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.238 0.451 0 CA-C-O 121.549 0.69 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 CA--C 1.552 1.039 0 O-C-N 121.524 -0.735 . . . . 0.0 110.805 -178.618 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.57 125.63 23.03 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 120.685 -1.259 . . . . 0.0 111.654 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.5 mmt-85 -156.09 147.16 16.52 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 111.358 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.01 174.28 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.916 2.411 . . . . 0.0 111.145 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -115.98 77.72 7.04 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.999 0.92 . . . . 0.0 110.084 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.39 135.84 23.01 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.485 2.79 . . . . 0.0 110.306 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 t -147.46 140.64 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.055 1.342 . . . . 0.0 108.866 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.04 173.4 10.76 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.984 1.314 . . . . 0.0 111.043 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.493 ' CE2' HD12 ' A' ' 455' ' ' ILE . 42.5 m-85 -137.17 124.64 22.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.31 1.044 . . . . 0.0 109.988 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -119.36 103.07 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.216 1.008 . . . . 0.0 110.589 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.0 p -66.8 -5.03 10.61 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.499 1.519 . . . . 0.0 113.972 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -22.4 64.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.802 0.841 . . . . 0.0 112.509 168.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.92 153.04 95.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.875 0.87 . . . . 0.0 112.179 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.13 161.99 31.49 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.799 2.999 . . . . 0.0 112.557 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.78 131.54 18.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.894 3.062 . . . . 0.0 112.122 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.88 44.89 3.42 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.254 1.822 . . . . 0.0 111.558 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -130.33 155.26 46.64 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.5 pt -128.25 144.77 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.101 1.761 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -100.43 115.86 31.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.232 1.413 . . . . 0.0 109.659 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.6 102.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.475 0.71 . . . . 0.0 110.384 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -71.17 136.2 47.98 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.401 1.08 . . . . 0.0 111.776 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.2 t -75.48 140.23 42.71 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.16 -0.962 . . . . 0.0 112.173 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.436 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 4.7 mtm180 -110.32 2.34 19.07 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.896 1.678 . . . . 0.0 111.288 165.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 35.9 m -104.65 129.32 52.82 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.084 1.353 . . . . 0.0 109.567 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.33 137.43 34.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.064 1.746 . . . . 0.0 108.604 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -91.79 137.82 32.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 159.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 19.8 mm -127.69 108.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 108.398 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.82 -177.55 38.09 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.328 0.966 . . . . 0.0 112.229 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.01 16.58 64.39 Favored Glycine 0 N--CA 1.477 1.402 0 C-N-CA 124.189 0.9 . . . . 0.0 114.87 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.2 t -71.85 129.16 88.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 118.141 0.971 . . . . 0.0 110.262 -164.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.94 130.21 22.53 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.366 2.044 . . . . 0.0 109.278 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.41 -19.09 54.87 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.24 -29.56 64.05 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.517 -0.739 . . . . 0.0 112.906 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.4 ptp -84.5 145.93 27.86 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -120.25 -177.83 3.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.231 1.812 . . . . 0.0 112.494 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.86 -41.04 44.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.288 1.435 . . . . 0.0 113.559 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -76.47 -22.55 54.41 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.49 -35.27 65.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.76 0.709 . . . . 0.0 110.79 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 355' ' ' LEU . 1.4 mm? -59.55 -51.18 70.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.987 0.812 . . . . 0.0 110.437 168.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.11 -38.23 67.89 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.464 0.574 . . . . 0.0 112.416 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -72.53 -42.96 64.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.115 1.366 . . . . 0.0 114.474 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.32 -31.94 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 120.462 1.483 . . . . 0.0 111.049 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.441 HD23 ' CE1' ' A' ' 394' ' ' PHE . 35.7 mt -89.22 -9.36 51.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.26 1.024 . . . . 0.0 112.885 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -49.45 -49.04 73.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.705 1.602 . . . . 0.0 114.828 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.05 -6.24 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.089 1.859 . . . . 0.0 113.202 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -100.73 -33.91 10.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.45 1.5 . . . . 0.0 112.983 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.88 168.08 3.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 113.946 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 113.03 20.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.838 1.255 . . . . 0.0 110.81 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.63 121.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.65 . . . . 0.0 109.547 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -92.81 -37.05 12.52 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.412 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.71 158.66 43.69 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.085 -1.01 . . . . 0.0 112.094 -174.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.4 p -166.05 136.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.688 0.795 . . . . 0.0 111.378 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.51 97.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.137 1.375 . . . . 0.0 107.578 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.5 tt -89.96 126.87 35.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.615 0.366 . . . . 0.0 110.07 174.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 83.16 1.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.035 1.334 . . . . 0.0 109.02 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.3 -30.35 71.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.864 0.865 . . . . 0.0 112.694 -173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 9.0 t -48.08 -39.06 19.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.658 1.983 . . . . 0.0 113.596 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -103.87 8.61 36.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.548 1.539 . . . . 0.0 113.682 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 56.68 36.6 27.9 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.98 1.312 . . . . 0.0 112.221 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -133.29 165.33 25.07 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.53 163.0 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.736 1.214 . . . . 0.0 111.699 165.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.48 141.73 47.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 108.543 162.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.9 t -138.43 118.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.026 0.53 . . . . 0.0 111.775 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -99.4 126.06 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 112.836 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.63 179.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.395 1.078 . . . . 0.0 111.296 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -65.35 -35.47 81.06 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 383' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 57.5 p -149.01 168.62 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.054 1.297 . . . . 0.0 114.384 -168.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.62 98.1 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.734 169.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -58.1 -45.01 87.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.063 0.847 . . . . 0.0 111.953 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.74 -47.06 79.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.375 0.67 . . . . 0.0 110.519 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.91 96.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 111.759 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.81 -40.96 97.87 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.005 0.922 . . . . 0.0 111.169 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.65 -33.49 75.15 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.792 1.633 . . . . 0.0 112.239 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.91 -64.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 118.883 -0.579 . . . . 0.0 110.512 165.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.45 -29.33 49.29 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -67.89 -34.49 76.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.651 1.98 . . . . 0.0 112.998 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -123.49 -27.25 4.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.441 ' CE1' HD23 ' A' ' 359' ' ' LEU . 35.3 t80 -69.34 121.41 16.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.954 0.902 . . . . 0.0 111.06 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 38.0 t30 57.97 27.91 15.44 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.435 1.494 . . . . 0.0 114.398 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -62.62 -32.78 73.86 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.362 -1.461 . . . . 0.0 113.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.86 -19.02 62.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 113.076 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.02 80.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.014 1.292 . . . . 0.0 113.563 -171.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.94 34.69 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.392 1.477 . . . . 0.0 114.052 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.21 149.44 55.53 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.512 1.125 . . . . 0.0 109.672 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.79 -23.73 13.98 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.593 2.195 . . . . 0.0 113.417 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.81 150.72 27.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.101 2.161 . . . . 0.0 113.101 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.7 91.36 3.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.543 1.137 . . . . 0.0 110.683 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 25.8 m -85.27 127.73 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.199 1.4 . . . . 0.0 111.14 -170.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -137.77 172.83 12.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.908 2.083 . . . . 0.0 109.622 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -70.98 120.39 16.48 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.04 -1.037 . . . . 0.0 111.005 164.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.36 -161.73 32.71 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 162.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 16.9 t -143.22 122.54 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.566 1.146 . . . . 0.0 108.903 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -86.15 -40.79 7.32 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 164.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -142.4 125.13 15.93 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.181 0.992 . . . . 0.0 111.265 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.99 132.17 1.66 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.676 -1.069 . . . . 0.0 114.37 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.415 ' HG3' HG23 ' A' ' 425' ' ' ILE . 97.1 Cg_endo -70.53 123.83 10.21 Favored 'Trans proline' 0 C--N 1.349 0.566 1 C-N-CA 125.316 4.011 . . . . 0.0 109.698 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.43 -39.49 79.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.141 0.496 . . . . 0.0 112.104 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.78 -24.03 66.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.511 1.924 . . . . 0.0 113.501 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 6.4 m -119.96 20.9 12.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.542 1.537 . . . . 0.0 111.896 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.95 139.62 30.42 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.291 1.436 . . . . 0.0 111.973 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.85 90.65 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.954 1.302 . . . . 0.0 109.43 166.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -67.71 -21.73 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -69.52 -51.14 38.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.643 0.656 . . . . 0.0 110.489 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -78.57 -19.8 51.98 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.12 38.32 19.15 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.88 1.228 . . . . 0.0 113.12 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.64 167.06 26.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.185 0.993 . . . . 0.0 113.4 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.2 m -132.24 149.86 52.28 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.331 1.053 . . . . 0.0 111.035 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 10.0 mm -107.55 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.714 HG21 HD21 ' A' ' 430' ' ' LEU . 1.3 mt -97.55 122.56 55.04 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 121.007 -1.058 . . . . 0.0 111.056 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.43 131.94 21.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.44 2.093 . . . . 0.0 111.25 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -27.7 68.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.522 1.129 . . . . 0.0 113.446 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.24 -20.99 63.94 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.426 1.012 . . . . 0.0 113.568 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.15 8.79 28.2 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.323 1.849 . . . . 0.0 112.699 -176.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.714 HD21 HG21 ' A' ' 425' ' ' ILE . 38.4 mt -92.6 147.69 22.68 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.991 1.716 . . . . 0.0 110.81 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 21.9 p -83.61 175.15 9.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.595 1.158 . . . . 0.0 111.155 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.92 -41.65 97.59 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.757 -0.589 . . . . 0.0 111.42 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.97 -40.55 95.16 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.952 0.901 . . . . 0.0 112.028 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.64 -53.16 61.43 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.593 1.157 . . . . 0.0 112.279 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.05 -40.66 96.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.812 0.845 . . . . 0.0 111.001 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -58.01 -41.78 83.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.243 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -69.93 -44.82 68.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.824 1.647 . . . . 0.0 111.758 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.4 m -52.7 -35.43 55.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.423 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.15 -43.74 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.6 t -96.68 -11.19 25.49 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.573 -1.329 . . . . 0.0 114.429 -166.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.49 139.39 53.45 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.048 -1.032 . . . . 0.0 111.943 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -77.08 -25.24 52.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.456 0.703 . . . . 0.0 112.02 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -125.97 140.12 52.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.294 1.838 . . . . 0.0 110.293 166.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.86 -179.81 40.77 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.051 0.834 . . . . 0.0 113.266 -174.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.79 -152.72 47.86 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 122.282 -0.54 . . . . 0.0 113.401 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.0 p -102.64 0.29 33.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -161.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.3 t 71.14 22.83 4.31 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 120.364 1.438 . . . . 0.0 113.556 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 85.77 3.63 85.74 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 120.594 -1.316 . . . . 0.0 113.406 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.92 151.51 89.3 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 118.74 1.27 . . . . 0.0 110.119 166.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -61.96 142.88 94.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.27 1.98 . . . . 0.0 109.865 169.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.66 109.2 3.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 32.1 m -105.72 154.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.225 1.41 . . . . 0.0 110.091 174.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -59.72 131.73 51.82 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.64 -13.0 67.09 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.22 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.493 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.9 OUTLIER -56.08 130.67 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.119 1.96 . . . . 0.0 111.558 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.4 t -116.54 130.72 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.515 1.926 . . . . 0.0 108.81 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.31 -175.69 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.0 111.372 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.32 149.36 26.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.484 1.914 . . . . 0.0 111.134 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 4.5 pt-20 -44.79 129.47 5.19 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.789 1.636 . . . . 0.0 114.274 -165.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 162.75 41.53 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.43 2.087 . . . . 0.0 111.949 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -68.34 138.72 55.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.7 mm -103.67 47.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 123.404 1.573 . . . . 0.0 109.739 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.549 0.937 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.865 141.044 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.0 m80 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -67.54 133.66 49.86 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.908 0.883 . . . . 0.0 110.493 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 368' ' ' VAL . 4.0 mp -68.49 -43.94 75.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.207 0.527 . . . . 0.0 112.181 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.786 1.234 . . . . 0.0 112.858 -179.036 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.922 0.868 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 121.791 0.805 . . . . 0.0 110.901 -179.517 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -52.43 129.72 29.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.226 1.376 . . . . 0.0 111.233 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.401 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 62.4 mmt-85 -156.36 146.02 15.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.961 1.305 . . . . 0.0 111.025 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.67 176.9 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.523 2.149 . . . . 0.0 111.432 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -121.02 76.4 30.24 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.535 1.134 . . . . 0.0 109.798 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.01 142.31 38.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.137 2.558 . . . . 0.0 110.517 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.7 t -148.28 145.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.927 1.291 . . . . 0.0 109.351 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 172.88 12.14 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.946 1.298 . . . . 0.0 110.766 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.42 ' CE2' HD12 ' A' ' 455' ' ' ILE . 43.9 m-85 -137.52 127.48 25.76 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.3 1.04 . . . . 0.0 110.042 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.48 104.53 10.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 109.861 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.5 p -70.29 -9.07 54.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 32.8 p -68.96 -19.33 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.169 1.388 . . . . 0.0 112.429 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.39 153.21 96.05 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.996 0.918 . . . . 0.0 112.383 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.39 162.45 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.925 3.083 . . . . 0.0 112.607 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.33 130.47 17.48 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.91 3.074 . . . . 0.0 112.345 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 66.66 39.25 3.71 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 111.833 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -123.42 152.18 41.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 457' ' ' PHE . 15.4 pt -120.84 147.24 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.901 1.68 . . . . 0.0 110.944 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 123.2 45.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.024 1.33 . . . . 0.0 110.289 177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 50.1 t -120.85 104.28 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.02 0.528 . . . . 0.0 110.911 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -72.76 132.86 44.16 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 111.864 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 31.2 t -74.31 141.87 45.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.814 0.816 . . . . 0.0 112.846 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -121.47 16.24 11.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.837 2.455 . . . . 0.0 110.724 166.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 22.3 m -108.7 126.03 52.55 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.156 1.383 . . . . 0.0 108.63 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.1 mt -92.76 140.08 29.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.443 1.497 . . . . 0.0 109.166 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -100.42 144.72 29.08 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 158.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 14.1 mm -128.87 112.16 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 108.574 -172.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -90.96 173.52 38.06 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.02 0.819 . . . . 0.0 112.064 166.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.54 16.45 75.81 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.4 t -73.04 126.33 90.49 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 118.723 1.261 . . . . 0.0 111.335 -165.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.01 132.86 36.01 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.477 2.785 . . . . 0.0 110.233 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.3 mp -67.84 -6.32 20.92 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -92.48 -25.23 18.52 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.69 1.196 . . . . 0.0 113.691 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.6 mtm -77.22 146.12 37.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.41 1.005 . . . . 0.0 112.506 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -122.1 -179.9 4.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.652 1.581 . . . . 0.0 111.841 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -41.68 -44.73 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.829 2.051 . . . . 0.0 114.075 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -77.96 -21.6 50.76 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -73.56 -39.61 64.55 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.349 0.977 . . . . 0.0 110.435 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.85 -46.39 89.43 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.716 168.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.8 76.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.44 1.018 . . . . 0.0 111.698 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.13 -44.09 96.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.108 1.322 . . . . 0.0 114.283 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.7 m -71.23 -34.74 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.388 0.994 . . . . 0.0 111.287 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 394' ' ' PHE . 50.0 mt -87.54 -7.51 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.923 0.889 . . . . 0.0 112.887 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -47.59 96.77 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.346 1.458 . . . . 0.0 114.399 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.59 -7.54 20.37 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.296 1.998 . . . . 0.0 113.31 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -98.45 -38.78 9.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.09 1.356 . . . . 0.0 112.705 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.71 172.75 2.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.145 1.778 . . . . 0.0 113.712 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 123.29 32.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.256 1.422 . . . . 0.0 111.442 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.71 120.25 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.591 0.756 . . . . 0.0 110.314 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -94.77 -41.73 9.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.668 1.187 . . . . 0.0 112.083 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.31 161.99 35.5 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.376 -0.828 . . . . 0.0 112.3 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 305' ' ' LEU . 0.2 OUTLIER -162.69 138.01 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.887 0.875 . . . . 0.0 111.101 176.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.69 88.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.112 1.365 . . . . 0.0 108.018 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.08 137.99 31.94 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.834 -0.541 . . . . 0.0 110.94 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.47 85.85 2.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.824 1.25 . . . . 0.0 110.243 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -57.65 -38.24 74.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.844 0.857 . . . . 0.0 112.562 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 t -56.2 -33.02 64.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.968 1.307 . . . . 0.0 112.571 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -95.75 2.17 53.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.755 1.222 . . . . 0.0 113.87 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 27.57 17.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 113.612 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -133.83 169.26 17.34 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.47 43.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.707 1.203 . . . . 0.0 111.506 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.08 141.55 47.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.757 1.223 . . . . 0.0 108.089 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.8 118.09 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.782 0.719 . . . . 0.0 110.615 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -104.1 120.33 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.666 0.786 . . . . 0.0 112.059 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 19.8 m -95.24 -172.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.975 0.91 . . . . 0.0 110.113 174.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.401 ' CG ' ' HG3' ' A' ' 319' ' ' ARG . 0.2 OUTLIER -68.75 -40.46 79.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.945 1.248 . . . . 0.0 113.949 177.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 60.6 p -148.66 167.45 25.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.192 -0.943 . . . . 0.0 112.717 -164.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.88 91.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.358 167.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -42.07 85.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.004 0.82 . . . . 0.0 112.59 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.21 -51.22 64.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.905 1.282 . . . . 0.0 110.254 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.36 97.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.475 -0.766 . . . . 0.0 112.439 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -62.77 -42.44 99.69 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.929 0.892 . . . . 0.0 111.373 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.39 -34.18 76.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.196 1.362 . . . . 0.0 112.064 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.0 -65.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.717 166.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -50.65 -34.32 25.93 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.596 1.558 . . . . 0.0 114.152 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.51 -40.81 93.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.51 1.524 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -109.2 -27.3 9.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.437 ' CE2' HD23 ' A' ' 359' ' ' LEU . 19.8 t80 -70.41 123.95 22.99 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.463 0.705 . . . . 0.0 111.112 -169.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.86 29.16 18.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.131 1.372 . . . . 0.0 114.047 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -59.85 -36.33 76.62 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.201 -0.937 . . . . 0.0 113.16 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.79 -20.55 60.44 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.764 1.226 . . . . 0.0 112.893 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.54 23.22 65.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.819 1.2 . . . . 0.0 113.663 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -89.97 -33.78 16.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.15 1.38 . . . . 0.0 114.343 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.17 148.38 77.99 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.039 0.936 . . . . 0.0 109.445 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.37 -19.91 24.78 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.502 2.135 . . . . 0.0 112.732 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.75 144.0 35.62 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.62 1.168 . . . . 0.0 112.58 -170.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -119.28 93.38 4.06 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.638 1.175 . . . . 0.0 109.562 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 85.3 m -81.08 125.0 29.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.738 1.215 . . . . 0.0 111.178 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 175.15 9.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.97 2.508 . . . . 0.0 109.852 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -74.5 121.59 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.224 -0.923 . . . . 0.0 111.206 163.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.86 -164.83 30.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.116 1.817 . . . . 0.0 110.581 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.17 137.4 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.343 0.592 . . . . 0.0 111.107 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -99.95 -46.63 1.87 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.751 2.119 . . . . 0.0 109.945 163.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.65 110.26 8.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.375 1.07 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.04 140.83 5.66 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.682 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.62 123.24 9.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.931 3.754 . . . . 0.0 109.393 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -57.48 -45.46 84.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.883 0.473 . . . . 0.0 111.878 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.37 -18.67 63.81 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.1 m -120.99 27.96 8.17 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.086 1.755 . . . . 0.0 112.276 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.22 138.12 32.11 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.233 1.013 . . . . 0.0 111.546 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -121.66 79.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.117 1.367 . . . . 0.0 109.503 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -64.24 -22.3 66.89 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -67.47 -53.5 28.26 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.689 0.677 . . . . 0.0 110.357 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -77.41 -18.37 57.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.92 40.97 8.98 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 124.756 1.17 . . . . 0.0 112.851 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.57 172.45 16.01 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.309 1.055 . . . . 0.0 112.831 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.0 p -143.26 151.37 40.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.362 1.065 . . . . 0.0 110.673 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -110.2 125.61 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.09 123.77 28.66 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.667 -1.158 . . . . 0.0 110.364 -172.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 142.91 43.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.64 1.56 . . . . 0.0 110.457 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 20.6 mtt -58.01 -35.4 71.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.378 1.071 . . . . 0.0 112.973 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -63.51 -18.67 64.05 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 17.4 mmm-85 -97.24 3.2 51.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.589 1.956 . . . . 0.0 113.821 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.28 121.28 35.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.896 0.878 . . . . 0.0 109.747 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.6 p -72.21 -179.28 2.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.488 1.515 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -41.82 99.14 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.635 -0.665 . . . . 0.0 111.217 170.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.66 92.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.395 1.078 . . . . 0.0 111.968 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.54 -52.4 65.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.941 1.296 . . . . 0.0 112.381 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -38.56 85.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.679 -0.638 . . . . 0.0 112.225 173.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -56.11 -41.71 75.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.385 -0.816 . . . . 0.0 111.848 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -70.99 -45.63 63.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.494 1.497 . . . . 0.0 111.733 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 50.2 m -51.16 -35.55 36.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.956 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 5.7 m -90.81 -58.06 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 14.5 m -86.08 -7.38 58.64 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -166.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.46 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -52.86 145.49 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.76 1.163 . . . . 0.0 111.301 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -83.98 -27.24 28.59 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.843 -0.536 . . . . 0.0 111.204 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -125.67 136.88 53.71 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.237 2.215 . . . . 0.0 110.708 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.65 -179.92 32.97 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.001 0.81 . . . . 0.0 113.204 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.38 -150.43 48.45 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.263 -1.14 . . . . 0.0 112.29 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 43.0 p -116.07 17.18 15.91 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -153.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 t 65.26 17.88 11.18 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.947 -1.096 . . . . 0.0 113.25 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.05 59.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.498 1.047 . . . . 0.0 113.788 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -84.73 145.93 45.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.84 1.32 . . . . 0.0 111.338 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.89 107.33 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.057 2.505 . . . . 0.0 109.198 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 131.1 38.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.37 0.605 . . . . 0.0 111.595 -176.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.68 168.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.629 1.572 . . . . 0.0 110.733 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -47.25 127.0 10.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.986 0.915 . . . . 0.0 110.747 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.92 65.86 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.251 -1.305 . . . . 0.0 115.306 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 325' ' ' TYR . 1.7 tp -50.48 133.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 120.239 2.02 . . . . 0.0 111.719 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.23 127.78 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.274 1.829 . . . . 0.0 108.345 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 334' ' ' ILE . 10.5 p90 -152.03 179.52 8.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.174 1.39 . . . . 0.0 111.715 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -102.34 153.09 20.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.706 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -38.11 121.0 1.04 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.606 1.562 . . . . 0.0 114.529 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 160.35 50.18 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.224 1.95 . . . . 0.0 111.728 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.46 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 70.8 m-20 -67.86 127.54 33.19 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.846 1.258 . . . . 0.0 113.907 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.16 46.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 123.415 1.579 . . . . 0.0 110.215 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 N--CA 1.477 0.918 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.681 140.559 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 30.2 m80 . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -72.73 141.02 48.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.54 -31.1 71.6 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.419 1.088 . . . . 0.0 111.661 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 124.898 1.279 . . . . 0.0 109.637 -176.126 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.935 0.874 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 124.145 0.978 . . . . 0.0 111.098 176.384 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.0 m80 . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -53.63 129.72 33.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.788 -1.195 . . . . 0.0 111.72 170.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -156.04 143.54 13.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.194 1.398 . . . . 0.0 110.847 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.84 172.36 14.69 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.672 2.248 . . . . 0.0 111.102 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 83.59 9.36 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 109.867 168.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.47 150.48 63.97 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.296 2.664 . . . . 0.0 110.534 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 10.8 t -144.33 133.41 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 109.662 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.09 167.75 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 110.845 174.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -143.88 121.79 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.971 0.908 . . . . 0.0 110.289 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.72 108.76 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.447 0.699 . . . . 0.0 111.156 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.9 p -69.35 -8.55 47.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -25.19 67.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.651 1.181 . . . . 0.0 112.235 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.53 150.49 95.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.794 0.838 . . . . 0.0 112.068 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.06 161.27 34.17 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.18 3.253 . . . . 0.0 112.539 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.17 134.65 32.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.059 3.173 . . . . 0.0 112.029 -173.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.99 44.53 4.65 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.633 1.573 . . . . 0.0 112.046 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -126.75 153.68 45.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.818 1.247 . . . . 0.0 114.141 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.37 145.74 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.615 1.966 . . . . 0.0 110.697 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -106.77 111.16 23.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.018 1.727 . . . . 0.0 109.863 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.81 97.08 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.194 0.598 . . . . 0.0 110.295 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.45 138.92 57.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.935 0.874 . . . . 0.0 111.706 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 41.4 t -75.48 136.84 40.63 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.191 -0.943 . . . . 0.0 112.577 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 18.82 14.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.51 2.324 . . . . 0.0 111.305 163.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 62.4 m -119.34 133.44 55.72 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.146 1.378 . . . . 0.0 110.293 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.36 134.87 42.66 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.34 1.056 . . . . 0.0 108.817 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.11 120.82 32.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 161.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.9 106.53 20.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -84.24 -178.23 51.49 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 168.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.12 11.78 59.32 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.377 -1.072 . . . . 0.0 115.067 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.01 130.12 91.7 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.965 1.383 . . . . 0.0 110.153 -166.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.94 128.01 18.9 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.923 2.415 . . . . 0.0 109.062 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.1 pp -59.17 -18.7 38.6 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.1 -25.95 31.5 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 9.1 mtm -73.52 146.48 44.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 0.0 112.293 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -118.13 178.97 4.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.115 1.766 . . . . 0.0 111.715 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.83 -36.47 67.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.617 1.167 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -73.88 -30.9 62.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.47 -35.85 81.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.547 1.067 . . . . 0.0 110.93 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 379' ' ' VAL . 1.2 mm? -58.33 -51.27 70.49 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.285 0.493 . . . . 0.0 110.438 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.75 69.65 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.38 -40.09 64.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.46 1.482 . . . . 0.0 112.883 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.0 -36.72 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 111.249 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.519 ' CD1' HG11 ' A' ' 379' ' ' VAL . 36.1 mt -85.99 -8.08 58.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -50.44 75.17 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.08 -7.12 19.49 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.609 2.206 . . . . 0.0 113.128 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -98.69 -37.5 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.107 1.363 . . . . 0.0 112.867 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.16 168.82 3.37 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.541 1.937 . . . . 0.0 114.05 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.08 116.08 22.7 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.787 1.635 . . . . 0.0 112.051 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 97.5 t -87.88 113.48 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.133 0.973 . . . . 0.0 109.853 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.32 -37.84 15.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.502 1.121 . . . . 0.0 111.675 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.36 150.13 35.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 0.0 111.656 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.06 141.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.899 0.88 . . . . 0.0 110.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.91 105.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.355 1.062 . . . . 0.0 108.303 167.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.57 124.52 41.86 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.275 0.559 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -112.91 84.11 1.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.972 1.709 . . . . 0.0 109.258 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.71 -28.59 65.94 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.795 1.238 . . . . 0.0 111.648 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 97.2 p -61.01 -31.83 71.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.962 1.705 . . . . 0.0 113.853 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -110.28 6.82 22.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.113 1.765 . . . . 0.0 113.099 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? 56.98 40.33 28.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.995 1.318 . . . . 0.0 111.314 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -123.7 151.61 42.96 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.28 1.832 . . . . 0.0 113.464 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.25 128.28 25.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.13 1.372 . . . . 0.0 111.289 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -81.75 131.62 35.27 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.989 -1.069 . . . . 0.0 108.853 161.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 359' ' ' LEU . 70.3 t -129.84 117.24 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.915 0.886 . . . . 0.0 109.707 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -104.24 116.13 31.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.928 1.291 . . . . 0.0 110.273 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.92 -179.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.529 0.732 . . . . 0.0 109.557 167.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 383' ' ' SER . 0.3 OUTLIER -64.02 -49.55 71.98 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 383' ' ' SER . . . . . 0.409 ' HB3' ' CE2' ' A' ' 382' ' ' TYR . 82.2 p -139.15 165.95 25.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.216 1.008 . . . . 0.0 112.941 -163.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -42.77 93.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.838 167.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -43.02 91.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.909 0.777 . . . . 0.0 112.277 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.5 -48.18 70.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.079 0.551 . . . . 0.0 111.763 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.2 95.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.162 0.892 . . . . 0.0 112.917 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -64.37 -40.8 96.53 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.784 0.834 . . . . 0.0 111.747 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.44 -35.33 77.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.473 1.033 . . . . 0.0 111.654 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.2 -65.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 119.043 -0.503 . . . . 0.0 110.524 166.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.3 mt -49.46 -35.78 20.6 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.323 1.449 . . . . 0.0 114.624 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.14 -33.55 71.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.275 1.43 . . . . 0.0 113.794 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -112.18 -28.28 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.215 1.006 . . . . 0.0 113.121 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.14 123.5 21.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.52 0.728 . . . . 0.0 111.202 -170.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.02 30.7 18.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.414 1.486 . . . . 0.0 114.121 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -33.98 76.76 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.47 -19.68 55.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.536 1.134 . . . . 0.0 112.883 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.2 22.69 60.35 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.817 1.199 . . . . 0.0 113.686 -173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.9 -32.93 17.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.13 1.372 . . . . 0.0 114.495 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.61 148.4 73.12 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.118 0.967 . . . . 0.0 109.586 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.83 -32.2 7.57 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.684 2.256 . . . . 0.0 112.249 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.36 149.61 50.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.852 1.261 . . . . 0.0 112.066 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.07 102.14 7.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.581 1.153 . . . . 0.0 110.718 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.6 m -80.18 124.58 28.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.817 1.247 . . . . 0.0 110.776 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -132.64 172.21 12.82 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.633 1.973 . . . . 0.0 109.939 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.55 121.67 20.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.062 -1.023 . . . . 0.0 111.295 166.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.15 -166.84 19.62 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.626 1.584 . . . . 0.0 110.052 167.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.5 p -165.53 136.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.323 0.649 . . . . 0.0 111.628 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.63 -47.09 3.29 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.34 1.924 . . . . 0.0 111.249 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -111.19 93.07 4.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.082 0.941 . . . . 0.0 112.254 173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.91 121.05 1.12 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.319 -1.267 . . . . 0.0 113.901 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 125.37 10.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.019 3.146 . . . . 0.0 109.5 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.33 -44.07 88.52 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.83 -12.44 59.97 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 53.5 m -117.71 12.67 14.02 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.881 1.672 . . . . 0.0 112.901 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 140.82 31.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.348 1.459 . . . . 0.0 111.926 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -123.5 86.35 2.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.65 1.58 . . . . 0.0 109.137 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.62 -20.93 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -69.72 -52.52 24.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.507 0.594 . . . . 0.0 110.368 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -79.53 -16.17 56.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.94 43.33 14.36 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.693 1.139 . . . . 0.0 112.772 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.23 167.08 31.11 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.573 1.187 . . . . 0.0 113.529 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.05 146.09 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.891 -1.131 . . . . 0.0 110.82 171.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -109.67 94.25 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.43 124.15 56.28 Favored Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.094 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.31 147.67 42.28 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.826 1.684 . . . . 0.0 110.998 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.5 mmt -57.82 -36.58 72.44 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.264 1.426 . . . . 0.0 112.363 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -68.24 -11.94 60.18 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -107.11 12.21 28.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.297 1.839 . . . . 0.0 113.312 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.84 135.49 49.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.544 1.138 . . . . 0.0 109.87 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.3 p -79.85 175.1 10.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 110.974 171.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.31 -45.9 87.16 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.523 -0.736 . . . . 0.0 110.763 171.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.15 90.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.648 1.179 . . . . 0.0 112.829 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.24 -51.22 70.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.147 0.979 . . . . 0.0 111.984 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.39 -37.61 80.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.33 0.652 . . . . 0.0 110.953 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -51.68 -52.41 48.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.861 1.264 . . . . 0.0 110.828 173.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -67.19 -41.98 84.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.22 1.373 . . . . 0.0 111.821 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 63.4 m -55.65 -28.63 56.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.768 -1.11 . . . . 0.0 112.802 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.05 -44.5 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.901 1.228 . . . . 0.0 113.945 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 31.2 m -94.68 -11.29 29.47 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.15 143.93 51.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.898 1.226 . . . . 0.0 111.839 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -72.35 -42.73 64.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.675 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -112.12 140.61 46.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.698 1.599 . . . . 0.0 110.98 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.4 176.8 25.35 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.128 -171.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.01 -164.6 51.62 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 122.023 -0.692 . . . . 0.0 113.252 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.7 p -106.87 18.96 21.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -157.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 p 69.69 13.54 8.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.563 1.145 . . . . 0.0 114.027 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 92.39 2.0 68.48 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.063 1.316 . . . . 0.0 113.504 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -67.11 150.52 97.87 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.86 1.33 . . . . 0.0 110.426 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.33 142.3 90.62 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.4 2.066 . . . . 0.0 110.215 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.7 114.87 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.04 159.23 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.614 1.566 . . . . 0.0 110.184 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 97.9 m -56.41 130.74 46.07 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.849 0.46 . . . . 0.0 109.905 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.42 84.4 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.351 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.24 137.19 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.021 1.41 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.03 132.68 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.262 1.825 . . . . 0.0 109.342 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -158.07 171.3 20.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.469 1.507 . . . . 0.0 110.79 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.07 142.06 27.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.809 0.444 . . . . 0.0 111.302 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.68 126.12 2.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.212 1.405 . . . . 0.0 114.499 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.76 166.22 30.57 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.603 3.535 . . . . 0.0 112.442 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -66.65 142.84 57.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.789 1.236 . . . . 0.0 113.897 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.76 52.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.244 1.497 . . . . 0.0 109.753 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.791 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.713 138.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.7 m80 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -75.92 142.6 42.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.733 1.213 . . . . 0.0 112.462 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.533 0.733 . . . . 0.0 112.023 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 CA--C 1.556 1.206 0 C-N-CA 125.152 1.381 . . . . 0.0 111.95 179.624 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.383 0.611 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.842 0.857 . . . . 0.0 110.779 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.358 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -55.02 130.99 43.86 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.875 1.671 . . . . 0.0 112.439 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -156.3 153.84 26.02 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.111 1.765 . . . . 0.0 111.352 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.55 168.06 24.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.174 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 81.07 4.2 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.513 1.125 . . . . 0.0 109.604 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.05 147.34 33.6 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.192 2.595 . . . . 0.0 111.035 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.6 t -147.28 137.88 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.351 1.46 . . . . 0.0 108.444 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.05 167.79 19.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.585 1.554 . . . . 0.0 110.746 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -141.57 122.82 14.8 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.036 -1.04 . . . . 0.0 111.064 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -114.4 101.16 8.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.427 1.491 . . . . 0.0 109.921 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.4 p -67.04 -14.12 62.59 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.358 1.063 . . . . 0.0 113.731 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -10.52 59.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.11 1.764 . . . . 0.0 113.908 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.39 156.99 80.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 119.88 1.218 . . . . 0.0 113.312 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.57 163.47 32.58 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.224 3.283 . . . . 0.0 113.293 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.68 134.67 24.49 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.212 3.275 . . . . 0.0 112.627 -172.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.68 34.24 12.41 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.148 1.379 . . . . 0.0 112.476 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -121.3 154.31 36.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.935 1.294 . . . . 0.0 114.401 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 pt -124.61 157.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.869 1.668 . . . . 0.0 111.891 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.58 118.9 37.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.865 1.266 . . . . 0.0 110.613 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 457' ' ' PHE . 48.7 t -112.74 107.42 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.604 0.638 . . . . 0.0 110.451 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.1 132.27 45.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 111.148 167.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.6 t -67.18 138.9 57.34 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.897 0.856 . . . . 0.0 112.064 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.17 21.13 8.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.44 2.696 . . . . 0.0 109.805 168.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 48.3 m -125.67 132.87 52.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.3 1.44 . . . . 0.0 109.014 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.51 133.41 46.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.66 1.584 . . . . 0.0 109.443 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -86.24 126.31 34.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 163.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 17.4 mm -114.67 107.46 22.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.81 170.08 47.45 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 123.168 0.414 . . . . 0.0 112.496 167.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.96 19.56 79.76 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.35 118.36 71.65 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.115 -171.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.39 147.87 47.69 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.291 2.661 . . . . 0.0 110.565 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.405 ' H ' HD12 ' A' ' 348' ' ' LEU . 2.8 mp -65.23 -18.61 65.45 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.28 -26.63 62.05 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.509 1.124 . . . . 0.0 113.381 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 12.4 mtm -75.46 152.55 37.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.6 1.091 . . . . 0.0 112.286 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -133.34 -177.67 4.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.231 2.212 . . . . 0.0 111.127 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -55.59 -39.9 71.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 112.144 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -79.14 -14.91 58.82 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.31 -40.0 52.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.161 1.346 . . . . 0.0 110.515 168.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 355' ' ' LEU . 4.1 mm? -61.33 -51.16 70.0 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.454 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.31 66.94 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.814 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -70.16 -47.4 61.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.013 1.278 . . . . 0.0 114.172 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.22 -32.37 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.583 1.538 . . . . 0.0 111.524 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 390' ' ' VAL . 39.5 mt -87.09 -11.51 49.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.072 0.949 . . . . 0.0 113.102 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -47.16 -49.1 53.16 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 126.224 1.809 . . . . 0.0 115.076 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.45 -3.31 13.51 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.199 1.933 . . . . 0.0 113.515 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.56 -36.15 7.61 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.611 1.565 . . . . 0.0 112.747 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.17 165.94 7.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.718 2.007 . . . . 0.0 112.741 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.52 100.34 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.866 1.666 . . . . 0.0 110.466 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.23 126.42 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.583 0.753 . . . . 0.0 109.835 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -95.71 -32.07 12.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.125 1.37 . . . . 0.0 112.419 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 42.3 t -152.83 155.72 37.64 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.747 1.158 . . . . 0.0 110.997 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 55.3 t -146.68 131.32 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.233 1.013 . . . . 0.0 109.324 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.09 107.93 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.35 117.08 33.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.193 0.597 . . . . 0.0 110.339 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -100.68 84.24 2.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 109.523 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.49 -38.81 69.62 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.405 1.482 . . . . 0.0 111.07 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 11.9 m -62.25 -21.82 65.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.826 2.05 . . . . 0.0 114.736 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -113.0 6.88 17.92 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.678 1.591 . . . . 0.0 112.484 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.2 mttt 52.61 35.06 17.15 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 126.562 1.945 . . . . 0.0 113.744 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -127.96 153.52 46.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.105 1.362 . . . . 0.0 113.008 -169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -134.92 131.89 37.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.814 0.846 . . . . 0.0 111.986 162.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -83.25 121.65 27.39 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.49 125.83 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.392 1.477 . . . . 0.0 108.692 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -114.61 115.51 27.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.136 1.374 . . . . 0.0 110.199 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.67 -166.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.877 0.871 . . . . 0.0 110.155 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -48.83 66.38 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.196 1.362 . . . . 0.0 113.197 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.9 p -152.15 173.04 15.43 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -160.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -45.82 80.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.057 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -53.85 -42.17 68.26 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.239 0.927 . . . . 0.0 112.674 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.28 -43.74 49.58 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.01 92.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.038 1.29 . . . . 0.0 113.011 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.52 -40.96 96.6 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.259 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.97 -31.63 72.0 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.81 1.186 . . . . 0.0 112.253 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 359' ' ' LEU . 9.7 t -63.62 -64.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.324 164.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.81 -32.12 42.49 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -74.54 -23.86 58.86 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.764 1.626 . . . . 0.0 113.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -120.91 -28.49 4.8 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.3 t80 -72.35 122.45 21.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.959 0.904 . . . . 0.0 111.378 -169.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 24.5 t30 59.5 29.11 18.64 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.531 1.933 . . . . 0.0 114.861 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -55.88 -34.34 65.42 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.746 -1.221 . . . . 0.0 113.646 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -79.29 -17.13 55.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 113.603 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 11.35 83.33 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.117 1.341 . . . . 0.0 113.728 -173.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -84.49 -31.97 24.21 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.087 1.755 . . . . 0.0 115.073 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.16 152.07 76.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.679 0.792 . . . . 0.0 109.929 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.86 -18.04 24.98 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.258 1.972 . . . . 0.0 113.011 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.99 150.72 23.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -123.41 83.04 2.08 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 109.907 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.3 m -72.39 122.78 21.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.066 1.746 . . . . 0.0 110.602 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 173.47 11.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.218 2.207 . . . . 0.0 109.375 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -66.87 123.69 20.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.168 -0.957 . . . . 0.0 111.205 162.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.85 -164.1 21.43 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 126.191 1.853 . . . . 0.0 109.663 163.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.11 134.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.66 0.784 . . . . 0.0 111.376 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -93.99 -38.87 5.03 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.182 1.849 . . . . 0.0 111.641 167.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -125.99 105.64 9.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.621 2.368 . . . . 0.0 113.475 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.96 137.68 3.97 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 118.472 -1.182 . . . . 0.0 114.567 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.37 132.26 16.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.878 3.719 . . . . 0.0 110.842 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -21.3 61.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.75 -21.42 37.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.807 1.185 . . . . 0.0 113.828 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 54.1 m -124.47 31.12 5.81 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.854 1.661 . . . . 0.0 111.693 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 19.4 t -84.83 138.97 32.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.786 1.234 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -125.69 86.8 2.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.621 1.569 . . . . 0.0 109.073 165.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -67.35 -14.77 63.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.74 -46.96 28.03 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.092 1.315 . . . . 0.0 110.426 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -81.26 -14.37 57.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 75.68 44.39 20.66 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.342 0.972 . . . . 0.0 112.919 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.48 174.5 12.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.526 1.163 . . . . 0.0 112.79 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 56.7 p -147.35 147.62 30.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.354 1.062 . . . . 0.0 111.114 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.12 124.71 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.575 HG21 HD21 ' A' ' 430' ' ' LEU . 1.1 mt -118.98 118.42 32.96 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 119.635 1.107 . . . . 0.0 111.743 -172.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -72.71 128.99 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 111.498 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -64.69 -23.93 67.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.859 1.263 . . . . 0.0 113.228 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.43 -24.4 67.61 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.835 1.198 . . . . 0.0 114.024 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -1.16 13.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.284 1.434 . . . . 0.0 114.562 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 425' ' ' ILE . 55.4 mt -61.73 136.48 58.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.163 0.892 . . . . 0.0 110.001 168.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 27.8 p -72.7 174.22 7.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.759 0.79 . . . . 0.0 111.293 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.97 -39.86 87.08 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.778 -0.576 . . . . 0.0 111.869 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.75 -36.62 65.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.242 0.617 . . . . 0.0 112.313 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -55.59 -60.03 4.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 111.283 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.71 -39.91 82.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.907 1.283 . . . . 0.0 112.25 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -47.92 70.67 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.088 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -66.12 -47.57 73.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.805 1.184 . . . . 0.0 110.972 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 13.1 m -52.33 -40.55 62.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.388 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.67 -44.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.7 t -97.23 -3.06 41.47 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -166.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -61.03 145.08 52.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.825 -1.172 . . . . 0.0 112.846 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.75 -28.74 36.4 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.827 1.251 . . . . 0.0 110.468 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -132.37 143.76 50.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.643 2.777 . . . . 0.0 110.75 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 175.53 18.51 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 123.704 0.669 . . . . 0.0 113.833 -171.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 73.52 -161.58 54.22 Favored Glycine 0 CA--C 1.546 1.973 0 O-C-N 121.501 -1.0 . . . . 0.0 114.424 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 21.1 p -93.36 3.07 56.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.962 2.105 . . . . 0.0 116.418 -160.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.4 m 78.05 6.31 2.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.83 1.252 . . . . 0.0 113.036 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.26 5.33 59.36 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.014 1.292 . . . . 0.0 113.438 -169.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -71.92 153.45 92.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.578 1.189 . . . . 0.0 109.834 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.58 146.97 93.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.086 2.524 . . . . 0.0 110.897 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 54.5 mt -70.66 104.32 2.8 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.65 158.21 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.045 1.338 . . . . 0.0 111.647 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.0 m -59.05 131.65 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.09 -1.15 79.82 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.85 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.718 1.759 . . . . 0.0 112.683 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.44 137.06 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.348 2.259 . . . . 0.0 109.452 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' PHE . . . . . 0.413 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.5 p90 -164.55 178.02 7.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.602 1.161 . . . . 0.0 111.715 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -97.54 151.69 19.78 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.107 . . . . 0.0 110.109 169.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -44.98 130.16 5.39 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -167.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.81 168.04 24.92 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.927 3.085 . . . . 0.0 111.175 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 67.4 m-20 -74.18 120.0 19.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.59 46.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.183 1.468 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.474 0.756 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 142.125 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.75 111.09 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.494 1.043 . . . . 0.0 110.327 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 70.06 -177.66 31.37 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.684 1.135 . . . . 0.0 113.821 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -109.25 155.99 40.12 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 111.339 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.75 -79.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.488 3.459 . . . . 0.0 111.444 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.2 -31.15 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.571 1.949 . . . . 0.0 112.513 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . 0.25 5.0 p 72.22 5.91 5.41 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 128.96 2.904 . . . . 0.0 115.191 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.99 -30.37 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 128.162 2.585 . . . . 0.0 113.003 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.252 0.0 OUTLIER 58.07 -156.03 0.33 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.474 1.91 . . . . 0.0 111.724 176.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.56 -25.53 7.25 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.802 1.192 . . . . 0.0 115.284 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 10.8 t -59.83 -40.71 89.37 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.413 1.107 . . . . 0.0 111.955 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -109.54 -73.51 0.68 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.315 1.446 . . . . 0.0 110.482 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -166.72 -178.66 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.532 1.533 . . . . 0.0 111.49 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -79.79 22.14 0.5 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -168.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -72.83 138.68 46.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.595 1.158 . . . . 0.0 111.885 171.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.25 -42.78 99.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.913 0.885 . . . . 0.0 110.35 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.6 160.65 34.08 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.941 1.296 . . . . 0.0 112.55 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.36 -158.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.486 3.457 . . . . 0.0 111.296 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -49.06 -40.25 30.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.678 1.191 . . . . 0.0 113.623 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 41.12 -150.04 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.164 2.186 . . . . 0.0 113.527 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.78 141.58 10.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 110.567 162.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -73.33 66.21 0.91 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 120.675 -1.265 . . . . 0.0 110.725 167.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 6.2 m -111.28 153.69 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 127.312 2.245 . . . . 0.0 111.783 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 61.1 p -62.27 -27.1 68.78 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.26 -20.34 60.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 173.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.74 122.27 80.19 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.379 1.072 . . . . 0.0 109.888 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.49 -16.24 42.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.448 2.099 . . . . 0.0 113.011 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -73.86 -0.52 16.2 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 167.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -50.39 135.57 21.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.097 1.317 . . . . 0.0 112.099 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -136.37 151.07 72.48 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 124.029 0.932 . . . . 0.0 110.72 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.81 165.98 21.77 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.014 2.476 . . . . 0.0 110.632 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.38 79.41 1.66 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 166.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.5 115.77 4.21 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.443 2.095 . . . . 0.0 108.451 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.01 142.06 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.761 1.224 . . . . 0.0 109.317 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.68 169.04 18.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.489 1.116 . . . . 0.0 109.92 174.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -140.6 111.18 6.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.811 0.845 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.61 126.78 53.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.796 0.838 . . . . 0.0 111.794 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.4 p -73.76 -7.63 52.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -18.58 65.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.508 2.323 . . . . 0.0 111.915 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.6 153.04 81.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.634 1.174 . . . . 0.0 113.361 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.12 165.1 29.57 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.559 3.506 . . . . 0.0 113.047 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.35 135.6 27.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.399 3.399 . . . . 0.0 112.776 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.28 42.92 14.36 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.694 1.597 . . . . 0.0 111.465 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -127.24 153.04 46.61 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.6 pt -126.2 147.75 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.476 1.91 . . . . 0.0 109.966 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 133.1 51.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.203 1.401 . . . . 0.0 111.331 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.01 102.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.185 0.594 . . . . 0.0 110.996 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -68.62 136.18 52.59 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.396 1.079 . . . . 0.0 111.626 166.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.4 t -78.37 136.37 37.66 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.354 -0.841 . . . . 0.0 111.364 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -103.03 12.3 36.17 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.968 1.707 . . . . 0.0 109.918 162.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 52.5 m -109.98 130.71 55.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.073 1.749 . . . . 0.0 110.127 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 mt -96.01 136.61 36.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 108.932 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -94.83 139.64 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 161.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.2 mm -124.95 107.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.79 1.236 . . . . 0.0 108.209 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.71 176.48 46.17 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 123.882 0.753 . . . . 0.0 111.868 168.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.18 17.4 72.0 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.016 0.766 . . . . 0.0 115.016 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.3 122.15 86.65 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 118.507 1.153 . . . . 0.0 110.525 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.12 137.6 29.22 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.871 2.38 . . . . 0.0 108.931 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.4 mp -64.73 -17.43 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.59 -25.66 57.19 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 47.8 mtm -78.46 139.76 38.68 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.861 0.838 . . . . 0.0 112.238 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -116.47 -173.75 2.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.744 2.018 . . . . 0.0 111.657 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -54.07 -48.44 70.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.196 1.798 . . . . 0.0 112.703 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -76.19 -18.4 59.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.01 -40.37 71.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.059 1.299 . . . . 0.0 110.683 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.2 mm? -60.01 -49.1 78.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.817 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.07 71.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.923 0.783 . . . . 0.0 112.95 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.52 -44.82 70.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.528 1.131 . . . . 0.0 113.964 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.97 -33.89 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.699 1.136 . . . . 0.0 110.683 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 394' ' ' PHE . 51.5 mt -87.02 -10.59 52.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.037 0.935 . . . . 0.0 113.187 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -48.31 -48.96 64.78 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.669 1.588 . . . . 0.0 114.674 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.34 -6.98 17.66 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.217 1.945 . . . . 0.0 113.375 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.68 -39.99 8.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.47 1.508 . . . . 0.0 112.38 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.39 169.89 3.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.13 1.772 . . . . 0.0 112.712 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.54 125.5 32.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.553 0.741 . . . . 0.0 109.835 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.67 128.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.621 0.768 . . . . 0.0 110.276 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -91.8 -43.38 9.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.123 1.369 . . . . 0.0 112.538 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.92 159.2 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 111.623 -172.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.0 p -160.79 133.7 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.731 -0.606 . . . . 0.0 111.609 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.7 103.31 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.73 133.11 43.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.794 0.837 . . . . 0.0 110.224 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.57 89.47 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.821 1.248 . . . . 0.0 109.565 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -60.24 -38.32 83.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.765 1.226 . . . . 0.0 111.711 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.0 t -58.9 -30.62 67.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.765 1.626 . . . . 0.0 113.23 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.74 -3.15 42.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.359 1.463 . . . . 0.0 113.13 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 58.8 30.85 20.6 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.297 1.839 . . . . 0.0 113.326 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -133.82 169.3 17.26 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.45 42.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.013 1.325 . . . . 0.0 111.159 164.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.28 136.76 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 45.1 t -134.72 113.3 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.428 0.691 . . . . 0.0 110.78 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -92.99 122.89 35.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 0.0 109.734 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.63 164.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.088 0.955 . . . . 0.0 109.97 169.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -73.76 -22.34 59.89 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 p -134.38 154.18 51.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.762 1.165 . . . . 0.0 113.445 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -59.43 -41.75 90.29 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.148 0.979 . . . . 0.0 111.493 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -37.68 88.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.401 0.68 . . . . 0.0 111.853 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.42 -50.65 72.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.752 1.221 . . . . 0.0 111.073 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.03 95.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.919 0.781 . . . . 0.0 112.027 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.98 -42.12 98.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.954 0.502 . . . . 0.0 112.138 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -63.45 -35.02 79.06 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.256 0.935 . . . . 0.0 112.26 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.23 -64.35 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.819 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -49.27 -36.77 21.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.893 1.277 . . . . 0.0 114.153 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.09 -35.88 80.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.918 1.287 . . . . 0.0 113.476 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -111.79 -25.6 9.39 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 18.1 t80 -72.0 124.17 24.36 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.537 0.735 . . . . 0.0 111.189 -169.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 61.89 30.17 18.08 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.263 1.425 . . . . 0.0 113.904 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -58.33 -36.07 72.84 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.806 -1.184 . . . . 0.0 113.385 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.569 1.148 . . . . 0.0 113.062 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.48 61.55 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.88 1.228 . . . . 0.0 113.737 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.16 -34.68 14.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.379 1.472 . . . . 0.0 114.389 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 24.8 mt -73.67 148.52 87.66 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.099 0.96 . . . . 0.0 109.457 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.71 -29.45 10.61 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.347 2.031 . . . . 0.0 112.181 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.87 139.97 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.959 1.704 . . . . 0.0 111.715 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.26 103.0 10.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.048 1.339 . . . . 0.0 110.08 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.8 m -81.75 124.27 29.48 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.883 1.273 . . . . 0.0 110.571 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -133.39 175.37 9.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.602 2.361 . . . . 0.0 109.248 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -73.51 123.47 24.0 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.25 -0.906 . . . . 0.0 110.889 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -100.66 -164.73 28.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 163.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.49 122.07 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.078 0.951 . . . . 0.0 109.234 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -84.73 -47.4 5.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 162.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.68 120.11 22.32 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.808 0.843 . . . . 0.0 111.732 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.06 131.73 1.54 Allowed Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.529 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.84 130.94 16.33 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 125.161 3.907 . . . . 0.0 110.405 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -36.19 79.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -72.32 -18.79 61.75 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.6 m -124.16 29.9 6.26 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.906 1.683 . . . . 0.0 111.982 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.7 155.55 25.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -139.71 73.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.802 1.641 . . . . 0.0 109.446 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -63.07 -18.62 63.57 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.47 -52.42 32.61 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.109 -0.994 . . . . 0.0 111.077 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -80.78 -17.19 51.68 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 84.43 38.33 9.96 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.964 1.269 . . . . 0.0 113.034 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -145.59 169.7 17.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.63 1.215 . . . . 0.0 112.374 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 46.4 m -141.13 157.13 45.7 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.941 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.53 127.68 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.67 125.51 28.02 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 117.405 -1.283 . . . . 0.0 111.229 -170.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.86 132.21 18.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.078 1.852 . . . . 0.0 110.362 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -20.47 61.64 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.635 1.174 . . . . 0.0 113.735 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -26.26 65.55 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.34 0.973 . . . . 0.0 113.208 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.0 -24.53 16.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.757 1.223 . . . . 0.0 112.802 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.5 116.83 4.62 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.4 p -65.55 176.54 1.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.738 1.215 . . . . 0.0 110.733 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.37 -41.3 93.44 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.502 -0.749 . . . . 0.0 110.99 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.41 -40.99 85.62 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 112.541 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -58.35 -52.55 65.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.889 1.276 . . . . 0.0 111.993 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -66.84 -37.54 84.69 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.771 -0.58 . . . . 0.0 111.566 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -47.91 73.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.212 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.41 -43.35 77.4 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.269 1.395 . . . . 0.0 111.533 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 66.8 m -53.52 -35.8 61.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.59 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.5 m -90.63 -43.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -99.51 -12.91 19.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.289 1.436 . . . . 0.0 114.489 -166.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.79 142.16 46.49 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.162 -0.961 . . . . 0.0 111.062 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -80.82 -45.56 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.509 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -100.31 131.4 46.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.297 1.039 . . . . 0.0 110.181 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.71 -176.57 45.58 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.381 0.991 . . . . 0.0 114.028 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.31 -156.44 52.99 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.417 -0.392 . . . . 0.0 112.265 -170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.8 p -99.43 -4.96 30.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 77.95 17.65 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.788 1.635 . . . . 0.0 113.317 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.44 56.04 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.122 1.344 . . . . 0.0 113.884 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 153.53 95.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.726 1.263 . . . . 0.0 111.593 172.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.84 143.93 81.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.863 2.376 . . . . 0.0 110.423 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 40.6 mt -70.75 110.53 5.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.279 0.562 . . . . 0.0 109.618 170.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.11 152.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 110.235 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.1 m -53.35 130.0 33.7 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.65 0.78 . . . . 0.0 109.71 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.52 -5.6 80.32 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.865 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.45 134.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.807 1.304 . . . . 0.0 111.514 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.5 t -119.99 140.41 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.752 2.021 . . . . 0.0 108.734 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.83 -179.61 7.33 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.691 1.196 . . . . 0.0 111.797 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -92.13 150.3 21.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.212 . . . . 0.0 110.842 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -51.16 132.21 31.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 124.553 1.141 . . . . 0.0 113.703 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.26 148.45 74.39 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.957 1.771 . . . . 0.0 109.253 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -52.96 148.29 7.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.174 0.99 . . . . 0.0 112.858 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -108.09 50.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 123.159 1.456 . . . . 0.0 110.103 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -179.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.6 142.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.74 -48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.943 -1.098 . . . . 0.0 110.929 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.29 -177.49 20.44 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.86 -163.62 0.27 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.775 0.83 . . . . 0.0 111.931 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.64 -126.65 5.66 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.32 1.438 . . . . 0.0 111.164 167.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 128.672 2.789 . . . . 0.0 111.898 174.408 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.99 138.03 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 119.446 1.021 . . . . 0.0 110.339 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -85.57 31.84 3.79 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.423 1.487 . . . . 0.0 114.133 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . 70.25 168.4 0.12 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 127.462 2.305 . . . . 0.0 111.974 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.23 -155.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.368 2.712 . . . . 0.0 111.503 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -57.17 -31.16 65.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.519 1.128 . . . . 0.0 113.457 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 70.9 p 46.7 27.18 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 128.731 2.812 . . . . 0.0 114.918 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -75.18 -21.28 58.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 112.918 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -48.83 -32.91 9.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.59 2.356 . . . . 0.0 115.67 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.16 73.29 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.218 0.913 . . . . 0.0 114.266 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.86 -146.65 0.26 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.438 1.895 . . . . 0.0 109.401 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -64.18 159.95 19.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.14 1.376 . . . . 0.0 112.895 168.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.3 163.47 0.24 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.95 1.7 . . . . 0.0 112.844 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -143.9 0.21 1.07 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -64.73 133.28 51.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.708 1.203 . . . . 0.0 111.622 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 356' ' ' ALA . 10.9 mp -69.6 -20.13 63.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.006 1.322 . . . . 0.0 111.355 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -115.53 162.71 23.53 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.913 2.085 . . . . 0.0 112.183 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.91 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.739 3.626 . . . . 0.0 111.686 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.16 56.05 0.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.224 1.409 . . . . 0.0 111.481 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.04 135.24 57.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.084 1.354 . . . . 0.0 110.858 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.0 133.33 34.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.333 0.653 . . . . 0.0 110.102 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -74.84 70.48 1.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 O-C-N 120.665 -1.272 . . . . 0.0 110.744 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.25 160.7 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 127.568 2.347 . . . . 0.0 111.178 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 39.8 t -51.12 -35.23 34.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.36 -27.11 67.63 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.246 -0.909 . . . . 0.0 113.327 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -80.11 124.36 82.89 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.015 1.326 . . . . 0.0 110.334 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.34 -19.48 61.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.529 2.153 . . . . 0.0 113.241 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.28 3.79 19.82 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.765 1.226 . . . . 0.0 113.757 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -53.68 117.94 3.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.181 1.392 . . . . 0.0 112.729 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 143.72 50.4 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 125.252 1.421 . . . . 0.0 110.491 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.3 164.85 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.294 2.663 . . . . 0.0 111.217 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 83.74 13.71 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.251 1.02 . . . . 0.0 109.019 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.98 116.37 4.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.531 2.154 . . . . 0.0 108.218 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.8 t -112.35 129.04 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.789 0.835 . . . . 0.0 109.276 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.1 170.26 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 111.0 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -138.47 121.81 17.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.445 1.098 . . . . 0.0 110.082 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -122.14 105.89 10.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.08 0.952 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -7.66 16.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.547 1.539 . . . . 0.0 113.723 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.87 -24.5 64.34 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.788 1.235 . . . . 0.0 112.375 172.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.99 150.14 96.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.633 0.773 . . . . 0.0 111.927 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.67 162.0 33.34 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.138 3.225 . . . . 0.0 112.945 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 133.53 27.24 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.963 3.109 . . . . 0.0 112.49 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.03 26.88 7.19 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.399 1.88 . . . . 0.0 113.015 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -112.58 153.64 27.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.48 151.23 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.019 2.128 . . . . 0.0 109.678 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -114.41 131.8 56.45 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.127 1.33 . . . . 0.0 111.727 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.9 106.57 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 110.794 -171.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.22 129.3 39.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.875 1.27 . . . . 0.0 111.34 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.5 t -69.41 135.1 49.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.776 -0.577 . . . . 0.0 111.973 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.412 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 32.9 mtm105 -105.37 15.31 27.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.659 1.584 . . . . 0.0 110.487 162.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 17.5 m -121.16 143.63 49.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.008 1.323 . . . . 0.0 112.054 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -111.1 136.55 49.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.829 2.052 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.96 137.46 32.32 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 166.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.82 117.36 52.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 108.058 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -99.64 174.61 27.08 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.709 1.147 . . . . 0.0 111.012 164.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.44 27.17 70.15 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 119.132 -0.815 . . . . 0.0 114.031 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.22 106.02 18.06 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.504 1.152 . . . . 0.0 110.567 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.97 146.52 87.81 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.798 2.332 . . . . 0.0 111.037 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.49 -19.24 64.58 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.69 -29.6 68.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.078 0.951 . . . . 0.0 112.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 17.6 mtm -85.62 151.8 23.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.037 0.935 . . . . 0.0 112.667 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -175.49 4.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 111.581 -175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -50.33 -35.56 28.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.387 1.875 . . . . 0.0 113.085 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -78.01 -21.24 51.08 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.9 -36.09 62.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.844 1.202 . . . . 0.0 110.639 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 355' ' ' LEU . 3.8 mm? -60.58 -46.94 88.36 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.725 0.693 . . . . 0.0 110.772 169.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 305' ' ' LEU . . . -53.86 -44.8 70.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.545 0.612 . . . . 0.0 112.437 169.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -69.49 -41.19 76.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.695 1.198 . . . . 0.0 113.456 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.6 m -73.75 -34.69 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.898 0.772 . . . . 0.0 111.864 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 379' ' ' VAL . 66.7 mt -86.3 -12.6 49.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.354 1.062 . . . . 0.0 113.397 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -48.3 71.87 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.087 1.755 . . . . 0.0 115.309 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.69 -7.44 17.62 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.66 2.24 . . . . 0.0 113.869 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -96.73 -39.87 9.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.281 1.432 . . . . 0.0 112.401 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.43 171.86 5.35 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.919 1.688 . . . . 0.0 112.747 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.39 130.8 34.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.366 0.666 . . . . 0.0 109.559 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.34 127.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 109.601 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.01 -46.63 10.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 111.699 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 45.2 t -154.57 152.03 29.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 -169.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.9 134.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.42 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 166.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.16 139.07 37.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.244 0.618 . . . . 0.0 110.731 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.28 90.82 3.0 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.546 1.165 . . . . 0.0 109.989 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.46 -31.03 68.95 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 111.82 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 6.7 m -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.544 1.938 . . . . 0.0 114.908 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.67 9.75 17.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.342 1.457 . . . . 0.0 112.932 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 55.5 35.82 25.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.908 1.683 . . . . 0.0 112.9 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -126.9 167.32 16.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.4 164.02 34.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.482 1.113 . . . . 0.0 112.112 165.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.98 123.04 42.52 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.516 1.526 . . . . 0.0 108.155 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 359' ' ' LEU . 94.1 t -117.62 116.02 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.257 1.023 . . . . 0.0 110.752 -175.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -91.29 121.04 32.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.922 0.889 . . . . 0.0 110.176 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.15 167.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.052 0.941 . . . . 0.0 109.465 168.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -76.38 -18.91 58.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.11 155.73 45.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.197 169.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -38.9 88.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.126 0.971 . . . . 0.0 111.99 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.2 -48.55 75.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.465 1.106 . . . . 0.0 111.314 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.23 91.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.018 0.527 . . . . 0.0 111.458 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -62.81 -42.28 99.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.25 1.02 . . . . 0.0 112.097 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -65.43 -34.14 77.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.658 1.117 . . . . 0.0 112.78 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.29 -62.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.64 -35.17 40.98 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.826 1.25 . . . . 0.0 114.109 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -67.02 -44.11 81.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.584 1.553 . . . . 0.0 113.266 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -103.58 -29.88 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -72.08 127.87 33.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.338 1.055 . . . . 0.0 111.388 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.72 25.64 15.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.466 . . . . 0.0 114.881 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -51.39 -45.87 62.63 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.09 3.53 38.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.888 2.075 . . . . 0.0 113.287 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.4 30.28 50.18 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.506 1.051 . . . . 0.0 113.81 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.36 65.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.86 162.23 30.29 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 126.335 1.854 . . . . 0.0 110.256 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.63 -22.73 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.328 2.018 . . . . 0.0 113.296 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 402' ' ' LEU . 0.2 OUTLIER -81.91 143.95 31.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.579 1.152 . . . . 0.0 111.724 -172.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -115.24 122.15 45.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.136 1.374 . . . . 0.0 108.919 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.6 m -107.12 128.62 54.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.507 1.123 . . . . 0.0 110.319 -167.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -132.51 175.64 9.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.818 2.047 . . . . 0.0 109.475 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -64.63 134.57 54.58 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.96 -1.087 . . . . 0.0 110.946 164.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.34 -152.82 9.61 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.702 1.62 . . . . 0.0 109.147 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.48 134.27 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.332 0.566 . . . . 0.0 112.262 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.97 -51.61 3.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -126.99 118.58 24.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.229 1.011 . . . . 0.0 112.119 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.96 143.13 4.7 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.857 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.26 130.22 17.19 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 125.686 4.257 . . . . 0.0 110.323 175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -35.29 80.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.646 0.378 . . . . 0.0 111.875 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -76.23 -16.61 59.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.14 1.376 . . . . 0.0 114.565 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.5 m -123.9 31.03 5.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.41 1.484 . . . . 0.0 111.952 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.36 138.26 32.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.632 1.573 . . . . 0.0 111.609 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -124.89 81.67 1.98 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.296 1.438 . . . . 0.0 109.881 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -66.4 -16.37 64.03 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.9 -51.23 23.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.964 1.256 . . . . 0.0 110.295 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -82.38 -12.28 58.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 73.83 42.68 37.57 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.607 1.099 . . . . 0.0 112.464 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -147.01 170.24 17.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.625 1.212 . . . . 0.0 112.836 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 25.5 m -132.57 152.24 51.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.035 0.934 . . . . 0.0 110.709 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.55 134.53 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.77 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.51 119.14 21.59 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 119.81 1.187 . . . . 0.0 111.409 -172.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.68 133.53 18.84 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.616 2.211 . . . . 0.0 111.492 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 9.6 mtt -59.5 -30.05 68.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.588 1.555 . . . . 0.0 113.762 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -65.17 -18.76 65.57 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -109.26 6.43 24.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.194 2.198 . . . . 0.0 113.346 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 425' ' ' ILE . 75.8 mt -94.48 138.34 32.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.409 1.084 . . . . 0.0 111.093 170.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.5 p -79.65 177.51 8.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.037 1.335 . . . . 0.0 111.356 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.64 -46.3 90.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.579 -0.7 . . . . 0.0 111.323 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.69 88.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.883 0.873 . . . . 0.0 112.059 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.78 -62.54 1.8 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.799 0.84 . . . . 0.0 111.338 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -61.47 -32.19 72.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.738 0.415 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -62.1 1.85 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.566 169.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -58.69 -40.52 83.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.477 1.49 . . . . 0.0 111.937 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 14.9 m -54.0 -29.23 42.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.832 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.14 -42.36 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.999 1.272 . . . . 0.0 114.087 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 20.0 m -93.08 -9.1 40.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.646 1.978 . . . . 0.0 115.033 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.24 145.9 41.24 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.086 1.312 . . . . 0.0 111.652 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.98 -53.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.011 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -97.95 136.65 37.93 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.325 1.05 . . . . 0.0 110.723 166.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 65.15 -170.79 25.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.232 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.35 -164.39 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 -166.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 49.9 p -100.9 14.41 31.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -164.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.5 m 62.22 19.11 10.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.783 1.174 . . . . 0.0 113.498 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.27 4.84 64.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.115 1.341 . . . . 0.0 114.201 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.34 151.57 96.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 118.785 1.292 . . . . 0.0 110.708 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.86 145.71 86.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.791 2.327 . . . . 0.0 110.894 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.66 107.03 3.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.98 157.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.574 1.55 . . . . 0.0 110.238 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 94.5 m -55.14 130.19 41.03 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.757 0.823 . . . . 0.0 110.019 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.77 -5.8 82.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.783 -1.009 . . . . 0.0 114.866 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.92 137.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.188 1.494 . . . . 0.0 111.973 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.7 137.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.422 1.889 . . . . 0.0 109.544 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -161.84 174.51 13.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.958 1.303 . . . . 0.0 112.694 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -87.74 150.32 23.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.801 1.241 . . . . 0.0 111.002 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 10.9 pt-20 -50.99 128.98 29.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.67 150.37 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.902 2.402 . . . . 0.0 110.98 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.1 141.55 58.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.726 1.21 . . . . 0.0 114.059 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.56 53.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 123.433 1.587 . . . . 0.0 110.294 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.74 -178.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.622 141.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.99 -48.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.688 -1.257 . . . . 0.0 111.971 172.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.11 78.44 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.725 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 76.23 165.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.805 2.442 . . . . 0.0 111.469 -170.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 178.91 131.0 1.51 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 121.14 -0.975 . . . . 0.0 113.057 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 111.917 178.447 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.91 93.45 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 120.433 1.47 . . . . 0.0 110.386 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 76.08 132.47 0.41 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.223 0.916 . . . . 0.0 111.52 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -130.44 159.67 69.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.628 1.171 . . . . 0.0 110.604 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.98 -164.19 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.46 2.774 . . . . 0.0 111.916 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -52.24 -40.97 62.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.459 1.104 . . . . 0.0 113.271 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p 53.91 26.65 6.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.641 2.376 . . . . 0.0 114.62 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -3.38 50.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.37 1.468 . . . . 0.0 114.348 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -50.32 121.18 5.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.143 1.377 . . . . 0.0 110.923 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 97.04 -56.79 1.26 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.18 1.371 . . . . 0.0 113.23 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 10.9 t -68.25 -41.22 81.46 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.5 1.15 . . . . 0.0 112.365 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -105.73 -73.5 0.68 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.5 0.72 . . . . 0.0 110.876 171.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.99 166.79 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 111.58 -166.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -77.57 12.37 1.65 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -70.41 140.92 52.17 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.093 -1.004 . . . . 0.0 112.77 171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.409 HD12 ' CZ2' ' A' ' 353' ' ' TRP . 3.3 mm? -65.54 -48.76 71.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 110.543 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.35 157.34 50.44 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.6 1.16 . . . . 0.0 113.013 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.96 69.2 4.7 Favored 'Trans proline' 0 C--N 1.357 0.984 1 C-N-CA 125.397 4.065 . . . . 0.0 111.983 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 71.12 -66.76 0.28 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 128.808 2.843 . . . . 0.0 111.142 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 44.5 -172.79 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.288 3.035 . . . . 0.0 113.973 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -131.35 156.41 45.55 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.889 -1.132 . . . . 0.0 110.329 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.52 63.84 6.87 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.872 1.269 . . . . 0.0 109.064 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 m -111.19 154.86 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.526 2.331 . . . . 0.0 110.881 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 23.6 t -60.35 -30.06 69.3 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -70.39 -19.07 63.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -77.51 123.54 86.76 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.247 1.019 . . . . 0.0 110.56 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.36 -21.08 54.54 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.436 2.091 . . . . 0.0 112.71 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -82.72 6.94 16.34 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 113.48 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -52.94 131.52 36.0 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.835 -1.166 . . . . 0.0 111.797 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -138.65 147.77 55.99 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.792 1.237 . . . . 0.0 110.083 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.78 159.92 49.06 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.791 2.327 . . . . 0.0 111.116 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 81.82 0.54 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.78 0.832 . . . . 0.0 109.01 162.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.8 121.57 7.75 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 108.539 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 13.8 t -121.54 128.92 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.806 0.842 . . . . 0.0 109.382 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.14 171.72 8.49 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.019 1.727 . . . . 0.0 110.989 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -139.88 120.48 14.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.007 . . . . 0.0 109.928 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -120.04 109.74 15.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.301 1.04 . . . . 0.0 110.609 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 99.1 p -69.06 -7.66 37.82 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.1 t -64.4 -24.91 67.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.278 1.031 . . . . 0.0 112.223 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.37 150.72 95.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.931 0.892 . . . . 0.0 112.237 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.81 161.6 35.49 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.903 3.069 . . . . 0.0 112.64 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.64 134.44 28.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.942 3.094 . . . . 0.0 112.109 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . 0.25 7.0 m-20 68.4 26.03 6.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.675 1.99 . . . . 0.0 113.362 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -111.14 153.3 25.93 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.94 148.77 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.25 1.82 . . . . 0.0 109.872 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.15 132.85 53.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.502 -1.373 . . . . 0.0 110.617 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.93 106.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.341 0.656 . . . . 0.0 111.461 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -68.49 131.59 45.54 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.579 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 32.7 t -73.1 136.57 44.91 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.723 -0.611 . . . . 0.0 111.841 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -106.89 18.64 21.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.187 1.795 . . . . 0.0 109.724 163.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 16.2 m -126.29 141.95 51.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.967 1.307 . . . . 0.0 111.763 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.5 mt -104.16 134.88 46.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 109.351 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -87.27 123.39 32.22 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 163.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.58 107.13 22.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.23 -174.84 50.67 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 166.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.61 70.02 Favored Glycine 0 N--CA 1.475 1.275 0 O-C-N 121.43 -1.041 . . . . 0.0 114.955 170.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 14.9 t -84.71 112.81 45.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 118.78 1.29 . . . . 0.0 110.295 -168.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.95 143.96 62.47 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.984 2.456 . . . . 0.0 109.919 170.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.04 -21.18 63.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.9 -27.49 63.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.859 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 33.9 mtm -80.58 145.86 31.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.59 0.709 . . . . 0.0 112.293 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -129.46 -179.4 5.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.145 2.178 . . . . 0.0 110.976 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -47.68 -40.31 19.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 114.216 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.409 ' CZ2' HD12 ' A' ' 305' ' ' LEU . 78.4 m95 -81.43 -18.63 44.7 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.76 -39.27 66.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.663 1.12 . . . . 0.0 110.185 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.24 -51.26 70.75 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.833 0.453 . . . . 0.0 110.719 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.82 71.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.662 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -68.18 -44.31 76.2 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.135 1.334 . . . . 0.0 113.996 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.82 -35.72 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.507 1.049 . . . . 0.0 110.954 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.524 HD23 ' CE1' ' A' ' 394' ' ' PHE . 30.6 mt -83.7 -11.57 57.01 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.459 1.104 . . . . 0.0 113.138 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -48.66 -48.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.849 1.66 . . . . 0.0 114.758 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.12 -6.74 17.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.133 1.889 . . . . 0.0 113.586 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -98.46 -40.93 8.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.5 1.52 . . . . 0.0 112.431 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.68 171.55 3.79 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.915 1.686 . . . . 0.0 113.461 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -85.99 138.35 32.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.661 0.784 . . . . 0.0 110.538 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.1 t -103.7 129.86 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.616 1.166 . . . . 0.0 110.169 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLN . . . . . 0.415 ' HG3' ' CE1' ' A' ' 382' ' ' TYR . 45.7 tt0 -93.64 -40.23 10.37 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.355 1.862 . . . . 0.0 112.782 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.1 t -152.82 152.04 31.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.404 1.082 . . . . 0.0 110.61 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 70.9 t -146.22 131.99 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.248 0.477 . . . . 0.0 110.417 171.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.24 107.88 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.61 122.06 40.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.066 0.546 . . . . 0.0 110.337 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -106.48 84.9 2.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.822 1.649 . . . . 0.0 109.478 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.72 -33.91 66.96 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.485 1.514 . . . . 0.0 111.354 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 65.6 m -55.72 -32.51 63.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.155 1.782 . . . . 0.0 114.27 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -110.21 9.17 23.86 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 113.191 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt 53.94 37.85 27.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.382 1.473 . . . . 0.0 112.072 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -125.5 153.39 43.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.971 1.708 . . . . 0.0 113.24 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -136.8 132.75 35.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 112.228 164.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.96 117.63 24.92 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 162.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 359' ' ' LEU . 54.8 t -118.56 114.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.706 0.803 . . . . 0.0 110.249 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -98.37 121.96 40.95 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 110.299 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.11 164.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.437 1.095 . . . . 0.0 109.553 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 366' ' ' GLN . 70.7 m-85 -74.53 -21.22 59.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.4 p -141.74 159.63 41.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.09 1.314 . . . . 0.0 114.234 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -61.54 -45.34 94.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.214 1.006 . . . . 0.0 112.079 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -58.8 -38.22 78.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.239 0.616 . . . . 0.0 112.231 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.47 -54.8 34.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.956 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.0 85.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.888 0.767 . . . . 0.0 112.307 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.69 -44.79 95.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 111.633 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -65.24 -33.79 76.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.204 -0.935 . . . . 0.0 112.654 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 359' ' ' LEU . 49.3 t -60.16 -63.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.55 166.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -51.13 -35.81 37.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.877 1.271 . . . . 0.0 114.314 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -63.83 -37.51 87.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.99 1.316 . . . . 0.0 113.085 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -112.83 -26.94 8.32 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.524 ' CE1' HD23 ' A' ' 359' ' ' LEU . 11.2 t80 -74.3 123.81 25.28 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 111.308 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.93 27.4 13.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.736 1.614 . . . . 0.0 114.168 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -24.56 66.77 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -100.56 -14.48 18.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.615 1.966 . . . . 0.0 114.524 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.26 24.28 29.55 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.548 1.07 . . . . 0.0 115.291 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.88 -42.01 22.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.562 1.681 . . . . 0.0 115.028 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.8 149.25 90.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.859 0.863 . . . . 0.0 110.57 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.84 -32.89 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.588 2.192 . . . . 0.0 111.71 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.76 163.4 25.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.203 1.801 . . . . 0.0 112.67 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -126.3 101.28 6.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.549 1.54 . . . . 0.0 109.915 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 113.06 21.2 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.115 1.366 . . . . 0.0 109.804 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.42 171.11 11.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.938 1.695 . . . . 0.0 109.178 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -67.29 130.84 44.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.097 -1.002 . . . . 0.0 110.838 163.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -115.66 -148.96 9.39 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 125.865 1.698 . . . . 0.0 109.102 167.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.96 132.17 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.29 -46.71 5.47 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 167.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -132.82 121.47 23.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 111.978 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.86 145.79 5.84 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 119.274 -0.736 . . . . 0.0 114.659 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.13 133.61 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 125.048 3.832 . . . . 0.0 109.739 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -37.73 80.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.835 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.21 -20.12 63.11 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.658 -1.276 . . . . 0.0 113.896 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.0 m -123.71 30.19 6.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.817 1.647 . . . . 0.0 112.041 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.1 p -75.65 154.06 36.83 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.969 0.89 . . . . 0.0 112.688 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.07 73.23 1.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.596 1.558 . . . . 0.0 108.837 166.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.62 -19.96 65.29 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.257 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.65 -49.67 65.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.688 -1.258 . . . . 0.0 111.19 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -83.34 -13.79 54.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.7 40.15 12.9 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.844 1.211 . . . . 0.0 112.713 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -146.52 172.19 13.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.76 1.28 . . . . 0.0 112.38 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 50.6 m -139.35 153.31 47.67 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.881 0.872 . . . . 0.0 109.805 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.5 mt -110.73 133.93 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.839 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -125.1 119.16 25.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.517 1.053 . . . . 0.0 111.915 -170.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.05 127.99 14.28 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.915 2.41 . . . . 0.0 110.96 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 42.4 mtm -61.14 -30.38 70.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.576 1.15 . . . . 0.0 113.451 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -65.82 -20.34 66.21 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 11.57 22.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.049 2.14 . . . . 0.0 113.184 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 425' ' ' ILE . 45.0 mt -92.83 145.44 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.223 1.009 . . . . 0.0 111.316 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.1 p -79.76 177.33 8.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.22 -44.39 88.45 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.554 -0.717 . . . . 0.0 111.492 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.05 93.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.948 0.899 . . . . 0.0 112.05 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.449 ' HB3' HD22 ' A' ' 430' ' ' LEU . 96.7 m-20 -56.42 -63.24 1.26 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.668 1.187 . . . . 0.0 111.405 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.16 -35.0 72.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.128 0.971 . . . . 0.0 111.027 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -56.89 -51.61 68.4 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.197 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -64.56 -41.01 96.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.726 1.603 . . . . 0.0 111.854 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 15.5 m -51.51 -32.6 28.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.016 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.24 -37.93 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.7 t -101.47 -6.68 23.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.649 1.58 . . . . 0.0 114.031 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.442 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.51 146.52 29.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.169 0.985 . . . . 0.0 112.41 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.88 -50.07 11.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.657 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -98.52 140.3 32.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.603 0.761 . . . . 0.0 111.481 159.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.54 -159.03 48.64 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.695 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 68.5 -168.51 42.51 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 47.4 p -96.14 10.05 38.93 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t 65.83 23.99 11.37 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.877 -1.14 . . . . 0.0 113.495 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.66 65.27 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.672 1.606 . . . . 0.0 114.145 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.73 150.76 96.59 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 118.926 1.363 . . . . 0.0 110.948 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 144.32 79.66 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.861 2.374 . . . . 0.0 110.689 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.7 112.3 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.556 . . . . 0.0 109.568 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.42 157.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.741 1.616 . . . . 0.0 110.279 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 92.3 m -53.59 127.14 24.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 109.81 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 92.08 -5.7 78.66 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.77 -1.017 . . . . 0.0 115.293 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.83 137.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.265 1.532 . . . . 0.0 111.676 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 137.0 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.435 1.894 . . . . 0.0 109.454 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.34 172.93 17.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.341 1.056 . . . . 0.0 112.187 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.51 148.87 25.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.74 1.216 . . . . 0.0 111.525 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.81 129.93 20.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.25 147.72 48.21 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.878 2.385 . . . . 0.0 110.417 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.442 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.1 m-20 -61.78 147.57 45.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 0.0 114.039 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.8 mm -107.37 48.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.734 1.613 . . . . 0.0 109.671 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp -57.32 169.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.58 137.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.7 t -139.57 -47.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.886 -1.134 . . . . 0.0 111.085 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.21 -53.82 4.65 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.478 1.037 . . . . 0.0 111.942 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.43 151.2 7.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.266 1.426 . . . . 0.0 111.217 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -132.19 161.92 23.91 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.598 1.57 . . . . 0.0 113.264 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.297 1.439 . . . . 0.0 111.665 -179.41 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.4 pt -130.07 43.51 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 125.456 1.503 . . . . 0.0 112.358 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.02 -165.77 53.64 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.562 -0.711 . . . . 0.0 111.825 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -165.2 158.97 14.24 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.205 1.402 . . . . 0.0 111.372 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -69.26 170.77 15.21 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.146 3.231 . . . . 0.0 112.666 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -74.94 -0.8 19.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.546 1.139 . . . . 0.0 114.065 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 72.16 5.84 5.4 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.021 2.128 . . . . 0.0 113.027 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -172.82 -35.2 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.412 2.285 . . . . 0.0 112.705 -175.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 48.58 67.56 0.84 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.921 1.688 . . . . 0.0 112.222 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.36 -11.22 52.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.781 1.181 . . . . 0.0 115.126 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 18.8 m -62.54 -46.12 89.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.603 1.561 . . . . 0.0 112.404 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 176.55 -38.53 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.808 2.043 . . . . 0.0 112.612 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.92 168.58 19.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.982 0.913 . . . . 0.0 112.026 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -143.29 15.05 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -167.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -81.69 136.52 35.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.358 1.063 . . . . 0.0 113.446 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 368' ' ' VAL . 1.1 mt -76.79 2.42 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.984 1.714 . . . . 0.0 113.026 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -141.07 162.32 48.75 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.25 1.42 . . . . 0.0 111.815 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -68.82 -169.87 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.638 3.559 . . . . 0.0 112.037 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -72.6 60.65 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.003 1.321 . . . . 0.0 111.509 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.38 150.59 46.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.388 . . . . 0.0 112.438 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 142.2 38.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.84 1.656 . . . . 0.0 109.426 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -79.35 66.67 4.87 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.842 -1.161 . . . . 0.0 110.23 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.78 152.88 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.357 2.263 . . . . 0.0 111.105 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 85.6 p -62.05 -25.67 67.81 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -71.3 -25.18 62.32 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.76 0.824 . . . . 0.0 112.834 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -76.31 122.54 86.96 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.389 1.076 . . . . 0.0 109.956 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.86 -19.4 52.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.386 2.057 . . . . 0.0 112.825 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.65 3.37 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 170.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.72 132.66 31.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.881 1.219 . . . . 0.0 111.894 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.28 146.94 60.11 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 124.502 1.121 . . . . 0.0 109.949 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.26 161.97 40.67 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.773 2.316 . . . . 0.0 110.621 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.17 79.4 1.58 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 165.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.79 126.64 13.52 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.492 2.128 . . . . 0.0 108.606 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.49 116.33 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.206 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.75 167.37 10.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 0.0 110.868 172.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -141.57 124.55 16.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.256 1.023 . . . . 0.0 109.619 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -122.73 114.01 19.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.645 0.778 . . . . 0.0 110.403 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -69.48 -8.64 48.71 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -22.77 66.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.452 171.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.62 150.99 93.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.655 0.782 . . . . 0.0 111.862 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.46 161.66 33.99 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.874 3.049 . . . . 0.0 112.77 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.59 131.62 17.65 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.945 3.097 . . . . 0.0 112.461 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 64.5 45.83 3.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.873 2.069 . . . . 0.0 111.659 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -125.8 152.51 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 17.1 pt -125.21 144.39 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.078 1.751 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.74 54.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.028 1.331 . . . . 0.0 110.378 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.64 105.99 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.055 0.942 . . . . 0.0 110.908 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -72.18 134.82 45.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.562 1.145 . . . . 0.0 111.847 167.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.6 t -76.9 136.49 38.83 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.213 -0.929 . . . . 0.0 111.732 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.4 mtm105 -103.43 15.88 27.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.529 1.932 . . . . 0.0 109.954 163.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 87.3 m -117.48 132.54 56.53 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.714 1.606 . . . . 0.0 110.673 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.29 136.76 38.01 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.185 1.394 . . . . 0.0 108.856 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -92.38 138.83 31.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 26.7 mm -124.26 108.31 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -171.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.69 174.29 46.23 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 165.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.75 30.07 70.78 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.844 -0.798 . . . . 0.0 114.146 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 91.4 t -90.38 109.39 33.38 Favored Pre-proline 0 N--CA 1.478 0.946 0 CA-C-N 118.25 1.025 . . . . 0.0 110.69 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.33 141.97 48.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.401 2.067 . . . . 0.0 110.107 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.04 -17.82 62.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.49 -35.04 79.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.064 0.946 . . . . 0.0 112.617 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 ptp -86.73 152.67 22.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -130.8 -174.44 3.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.229 1.812 . . . . 0.0 111.644 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -55.76 -39.14 70.78 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.176 1.39 . . . . 0.0 112.796 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.98 -23.05 58.21 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.19 -39.13 65.83 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.236 0.926 . . . . 0.0 110.571 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.18 -51.78 68.53 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.547 168.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.87 67.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.713 173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -46.95 64.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.939 1.245 . . . . 0.0 113.583 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.99 -33.56 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.12 0.873 . . . . 0.0 110.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.575 HD23 ' CE1' ' A' ' 394' ' ' PHE . 31.0 mt -87.45 -8.05 56.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.367 1.067 . . . . 0.0 113.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -48.67 -49.08 67.66 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.613 1.565 . . . . 0.0 114.988 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.36 -6.46 17.15 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.028 1.819 . . . . 0.0 113.262 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -98.14 -38.53 9.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.465 1.506 . . . . 0.0 112.54 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.8 168.42 5.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.47 1.908 . . . . 0.0 112.537 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.14 136.87 32.77 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.658 0.783 . . . . 0.0 110.051 169.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.89 134.95 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.623 1.169 . . . . 0.0 109.986 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.59 -35.19 9.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.51 150.13 30.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.528 1.058 . . . . 0.0 111.982 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 305' ' ' LEU . 88.9 t -146.32 139.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.15 102.39 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.9 tt -97.46 130.72 44.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.918 0.887 . . . . 0.0 109.635 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.68 91.03 3.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.263 1.025 . . . . 0.0 110.085 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.41 -40.23 90.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 111.513 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.7 t -65.17 -25.36 67.69 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.213 1.405 . . . . 0.0 112.938 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -0.67 41.62 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.486 1.515 . . . . 0.0 112.918 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 27.85 16.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.963 1.305 . . . . 0.0 113.772 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.84 170.41 15.89 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.3 40.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.001 1.321 . . . . 0.0 112.314 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.22 128.32 55.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.276 1.43 . . . . 0.0 108.692 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 359' ' ' LEU . 88.1 t -124.32 111.32 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 111.004 -173.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 112.92 25.0 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.552 1.541 . . . . 0.0 111.034 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.49 163.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.91 0.884 . . . . 0.0 110.357 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.51 -26.65 63.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.7 p -134.9 155.28 50.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.158 0.98 . . . . 0.0 113.165 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -41.83 92.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.009 0.923 . . . . 0.0 111.35 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -65.63 -36.68 84.4 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.906 -0.497 . . . . 0.0 111.452 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -59.51 -51.26 70.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.517 0.727 . . . . 0.0 111.116 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.77 94.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.635 0.652 . . . . 0.0 111.945 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.81 -43.26 98.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.219 0.608 . . . . 0.0 112.053 171.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -64.38 -34.22 77.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.398 0.999 . . . . 0.0 112.358 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 359' ' ' LEU . 34.5 t -61.48 -63.18 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.083 167.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.38 -36.39 43.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.717 1.207 . . . . 0.0 114.036 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.75 -35.34 80.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.99 1.316 . . . . 0.0 113.034 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.23 -25.45 9.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -174.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.575 ' CE1' HD23 ' A' ' 359' ' ' LEU . 13.6 t80 -72.77 122.89 22.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.361 0.664 . . . . 0.0 111.528 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 62.44 29.32 17.14 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 114.022 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.62 -31.33 68.0 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -84.8 -16.81 40.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.794 1.638 . . . . 0.0 114.076 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.42 73.74 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.794 1.188 . . . . 0.0 114.114 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.62 -34.2 35.23 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.112 1.456 . . . . 0.0 114.853 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.405 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 15.6 mt -76.55 148.56 80.14 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.156 0.982 . . . . 0.0 109.871 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.45 -29.1 13.97 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.717 2.278 . . . . 0.0 112.408 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.61 151.27 42.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.966 1.307 . . . . 0.0 111.778 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 104.74 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.767 0.827 . . . . 0.0 110.681 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.2 m -85.58 121.52 28.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.189 1.396 . . . . 0.0 109.746 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -129.13 178.04 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.628 1.971 . . . . 0.0 108.862 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -72.25 126.3 29.46 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.19 -0.943 . . . . 0.0 111.305 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.01 -156.95 19.37 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 165.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.97 136.72 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 117.117 0.459 . . . . 0.0 111.887 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.99 -44.79 3.75 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.683 1.611 . . . . 0.0 110.464 163.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.48 113.96 18.17 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.018 0.909 . . . . 0.0 113.053 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.82 139.59 4.31 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.92 129.25 15.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.006 3.804 . . . . 0.0 109.974 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -63.49 -38.25 90.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.319 0.648 . . . . 0.0 112.294 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.1 -24.9 66.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.078 1.751 . . . . 0.0 113.345 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 71.8 m -127.35 31.19 5.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.158 1.783 . . . . 0.0 111.277 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.4 t -85.01 140.76 30.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.031 1.333 . . . . 0.0 111.685 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.4 75.82 1.5 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.716 1.606 . . . . 0.0 109.124 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -63.08 -16.49 60.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -70.35 -49.1 52.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.672 1.124 . . . . 0.0 111.023 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -83.81 -16.07 45.98 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.48 38.09 11.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.841 1.21 . . . . 0.0 113.163 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -143.09 174.65 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.338 1.069 . . . . 0.0 112.49 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.3 p -146.27 153.85 41.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.536 1.134 . . . . 0.0 109.964 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.2 mt -114.32 131.14 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -120.83 123.12 28.1 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 119.433 1.015 . . . . 0.0 111.479 -171.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -69.55 132.03 22.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.69 2.26 . . . . 0.0 111.003 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.53 -32.03 72.9 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 113.236 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.87 -22.44 66.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.7 7.3 37.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.31 1.844 . . . . 0.0 112.636 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 425' ' ' ILE . 74.6 mt -92.29 142.15 27.78 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.293 1.437 . . . . 0.0 110.969 169.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.8 p -80.05 174.97 11.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.9 1.28 . . . . 0.0 111.048 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.47 -38.99 91.99 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.639 -0.663 . . . . 0.0 111.747 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.53 80.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.026 0.93 . . . . 0.0 112.205 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.82 -54.57 45.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.414 1.086 . . . . 0.0 112.141 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -68.44 -34.31 75.74 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -52.94 -51.78 60.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.243 1.017 . . . . 0.0 111.202 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -68.26 -42.2 79.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.437 1.472 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.2 m -55.52 -30.02 59.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.067 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.7 m -97.84 -40.85 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.4 t -103.13 -9.81 19.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -165.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.62 146.03 37.56 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.906 -1.121 . . . . 0.0 111.581 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -74.79 -52.41 11.53 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.795 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -96.11 133.81 39.92 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.003 0.906 . . . . 0.0 110.984 166.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 -171.26 44.31 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.828 -174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.67 -163.5 54.28 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 115.242 -0.479 . . . . 0.0 112.295 -169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 44.4 p -103.55 11.7 35.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -162.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.62 21.2 5.48 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.792 -1.192 . . . . 0.0 113.064 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.23 4.63 77.41 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 120.768 -1.208 . . . . 0.0 113.874 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -66.42 154.18 91.3 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.591 1.195 . . . . 0.0 110.373 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.1 142.45 80.78 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.151 1.901 . . . . 0.0 110.199 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 50.2 mt -67.67 120.33 13.87 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.53 155.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.304 1.441 . . . . 0.0 109.802 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -59.69 131.82 52.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.067 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.64 -5.78 83.47 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.422 -1.21 . . . . 0.0 115.186 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.8 tt -61.39 143.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.598 1.699 . . . . 0.0 112.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.21 137.0 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.542 1.937 . . . . 0.0 109.33 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -160.63 177.27 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 0.0 112.149 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -95.89 149.47 21.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.714 1.206 . . . . 0.0 111.06 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.91 135.85 56.71 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -162.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.25 153.38 40.56 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.858 2.372 . . . . 0.0 110.786 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.66 142.03 58.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.453 1.101 . . . . 0.0 113.577 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.97 48.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.335 1.54 . . . . 0.0 110.334 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.93 168.82 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.84 138.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.29 -54.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 121.028 -1.045 . . . . 0.0 110.382 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.6 -71.78 2.88 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.526 1.06 . . . . 0.0 111.706 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -163.25 162.18 25.17 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.135 1.774 . . . . 0.0 111.531 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.39 175.52 47.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.418 1.485 . . . . 0.0 112.878 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.876 1.67 . . . . 0.0 112.162 177.746 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.396 0.141 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.09 123.56 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.735 1.214 . . . . 0.0 108.651 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 95.96 146.37 20.77 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.873 1.225 . . . . 0.0 113.372 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -91.15 165.56 21.23 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.845 1.658 . . . . 0.0 111.314 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.5 -157.57 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 123.574 2.85 . . . . 0.0 111.744 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.99 -28.06 67.38 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.645 -1.284 . . . . 0.0 113.883 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 82.5 p 48.66 26.65 1.28 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.386 2.675 . . . . 0.0 114.225 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -76.67 -24.2 53.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.29 1.036 . . . . 0.0 112.668 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -47.91 128.94 14.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.421 1.489 . . . . 0.0 113.634 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 110.88 151.93 12.57 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.437 1.018 . . . . 0.0 112.1 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 3.5 m 61.91 53.81 2.99 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.665 1.586 . . . . 0.0 111.233 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 57.72 52.77 7.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.503 1.521 . . . . 0.0 112.392 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -152.42 138.43 18.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.912 . . . . 0.0 111.9 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -151.68 9.88 0.54 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -78.11 140.81 39.06 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.005 -1.06 . . . . 0.0 112.19 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 7.1 mp -83.42 -10.91 58.12 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 112.154 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.72 155.37 52.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 126.255 1.822 . . . . 0.0 111.57 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.47 160.36 36.06 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.575 2.85 . . . . 0.0 112.141 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -76.86 66.22 2.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.502 1.144 . . . . 0.0 110.413 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.93 -173.11 1.16 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.376 2.67 . . . . 0.0 113.108 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.85 129.2 55.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.214 -0.928 . . . . 0.0 111.034 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -78.74 69.28 4.89 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.32 -0.863 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 32.8 t -119.95 147.5 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 127.058 2.143 . . . . 0.0 110.273 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.3 p -58.14 -25.83 61.94 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.033 0.833 . . . . 0.0 112.604 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -81.23 122.77 81.68 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.776 1.23 . . . . 0.0 109.83 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 -17.26 52.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.589 2.193 . . . . 0.0 113.204 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -74.04 -0.96 18.03 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -51.92 127.69 21.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.618 1.099 . . . . 0.0 111.447 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.81 145.01 48.43 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 110.24 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.02 144.3 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.459 2.772 . . . . 0.0 111.004 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 83.67 0.77 Allowed Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 165.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.89 113.61 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.296 1.997 . . . . 0.0 108.624 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.3 116.44 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.5 168.45 12.11 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.273 1.429 . . . . 0.0 110.757 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.72 127.27 21.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 110.089 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -122.67 106.62 11.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.926 0.869 . . . . 0.0 111.291 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -10.45 40.39 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.341 1.456 . . . . 0.0 113.674 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 73.0 p -70.82 -22.98 62.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.68 1.592 . . . . 0.0 112.183 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.06 150.29 92.42 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.157 0.983 . . . . 0.0 111.792 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.84 161.5 36.05 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.182 3.254 . . . . 0.0 112.971 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.99 137.11 36.87 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.065 3.176 . . . . 0.0 112.692 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 67.82 24.17 8.26 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.157 1.783 . . . . 0.0 113.134 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -107.94 152.57 24.27 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.818 -1.177 . . . . 0.0 113.825 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.85 144.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 126.238 1.815 . . . . 0.0 110.389 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 128.55 54.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 0.0 111.084 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 457' ' ' PHE . 47.2 t -125.11 106.7 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.567 0.747 . . . . 0.0 111.097 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.78 130.12 42.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.42 1.088 . . . . 0.0 111.228 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.6 t -69.69 135.91 50.41 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.852 -0.53 . . . . 0.0 111.594 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.425 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 33.2 mtm105 -104.48 16.14 26.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.576 1.55 . . . . 0.0 110.858 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 21.8 m -123.66 136.19 54.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.286 1.434 . . . . 0.0 112.122 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.61 139.37 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.19 1.396 . . . . 0.0 109.951 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -92.29 139.65 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.79 108.83 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.589 1.156 . . . . 0.0 107.916 -171.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -92.4 -175.9 41.83 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.67 15.9 69.25 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.707 -0.878 . . . . 0.0 114.256 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.4 120.01 79.33 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 118.744 1.272 . . . . 0.0 110.187 -167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 139.42 38.36 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.144 1.896 . . . . 0.0 109.923 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.9 pp -61.82 -18.84 61.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.7 -23.82 49.38 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.3 ptp -87.24 148.47 25.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -125.61 -177.22 3.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.978 1.711 . . . . 0.0 111.908 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -47.15 -42.46 19.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.593 1.957 . . . . 0.0 114.243 174.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.69 -22.05 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.76 -37.06 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.149 0.886 . . . . 0.0 110.852 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.4 mm? -56.84 -51.24 69.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.387 0.54 . . . . 0.0 110.011 168.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -58.24 -39.94 80.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.015 0.825 . . . . 0.0 112.806 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -66.76 -39.88 88.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.296 1.407 . . . . 0.0 113.097 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.02 -32.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.733 1.151 . . . . 0.0 111.702 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.406 ' CD1' HG11 ' A' ' 379' ' ' VAL . 56.5 mt -86.88 -12.32 48.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.559 1.144 . . . . 0.0 113.88 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -48.89 -47.91 72.56 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.57 -6.22 17.42 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.145 1.897 . . . . 0.0 113.199 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -100.27 -39.12 8.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.397 1.479 . . . . 0.0 112.693 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.48 170.75 4.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.623 . . . . 0.0 114.161 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -81.28 135.16 35.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.556 1.143 . . . . 0.0 110.965 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 88.6 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.744 1.218 . . . . 0.0 110.19 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -91.34 -45.02 8.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.841 1.256 . . . . 0.0 112.46 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.01 149.26 29.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.848 0.859 . . . . 0.0 110.86 -171.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.02 131.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.909 0.777 . . . . 0.0 110.858 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.33 99.39 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.57 145.76 24.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.881 0.872 . . . . 0.0 110.486 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -137.1 89.57 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.556 1.142 . . . . 0.0 110.214 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.41 -32.03 71.97 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.238 -0.914 . . . . 0.0 112.061 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.8 t -60.94 -31.64 71.18 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.807 1.243 . . . . 0.0 112.694 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -96.14 -3.81 43.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 113.525 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 60.03 31.31 20.57 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.671 1.589 . . . . 0.0 113.107 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -136.29 170.27 16.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.2 162.99 36.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.963 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -118.33 128.69 54.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.559 1.544 . . . . 0.0 108.268 165.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.406 HG11 ' CD1' ' A' ' 359' ' ' LEU . 61.2 t -123.15 109.8 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.974 0.909 . . . . 0.0 110.423 -176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -85.59 117.46 24.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 109.934 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.62 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 165.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.89 -19.1 57.85 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.98 154.78 46.19 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.115 0.871 . . . . 0.0 113.174 -176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -62.99 -41.52 99.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.731 0.812 . . . . 0.0 111.577 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -63.12 -38.64 92.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.859 0.464 . . . . 0.0 110.848 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.22 -49.51 75.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.542 1.137 . . . . 0.0 111.431 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.93 97.91 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.864 -0.523 . . . . 0.0 112.139 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -64.88 -42.66 94.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.655 0.782 . . . . 0.0 111.899 171.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.29 -34.8 78.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.188 0.904 . . . . 0.0 112.045 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.3 -63.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.894 165.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.85 -32.63 53.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -65.07 -31.78 73.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.996 1.319 . . . . 0.0 113.466 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -120.18 -28.97 4.97 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -74.33 125.47 28.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.64 20.15 11.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.308 1.443 . . . . 0.0 114.164 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.34 65.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -111.13 4.26 19.19 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.577 2.351 . . . . 0.0 112.796 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 75.21 32.59 55.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.315 0.959 . . . . 0.0 113.368 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.69 59.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.77 161.68 36.73 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.061 1.345 . . . . 0.0 110.172 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.97 -7.09 18.04 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.574 2.849 . . . . 0.0 113.901 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.96 166.04 8.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.139 2.176 . . . . 0.0 112.441 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 90.1 2.49 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.0 110.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 127.98 34.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.425 1.49 . . . . 0.0 111.209 -172.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.26 170.37 15.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.257 1.823 . . . . 0.0 108.808 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -68.52 126.64 30.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.419 -0.801 . . . . 0.0 110.579 164.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.39 -152.25 17.87 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.5 136.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 117.564 0.682 . . . . 0.0 111.68 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -89.92 -48.72 3.54 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 166.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -129.26 120.29 25.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.896 0.848 . . . . 0.0 111.811 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 178.74 140.87 4.11 Favored Glycine 0 CA--C 1.542 1.746 0 CA-C-O 119.153 -0.804 . . . . 0.0 114.635 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -70.5 133.72 24.83 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.827 3.684 . . . . 0.0 110.181 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -67.12 -35.37 79.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.995 0.426 . . . . 0.0 111.904 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.07 -26.34 66.68 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.457 1.903 . . . . 0.0 113.403 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.1 m -126.78 31.82 5.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.379 1.872 . . . . 0.0 111.054 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.57 138.35 33.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.425 1.49 . . . . 0.0 111.033 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.32 77.83 1.6 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.22 1.408 . . . . 0.0 109.292 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -62.84 -19.76 64.42 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.362 -0.836 . . . . 0.0 113.133 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.96 -47.25 66.11 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.123 1.329 . . . . 0.0 111.194 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -83.23 -16.08 47.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.98 38.32 11.55 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.805 1.193 . . . . 0.0 112.919 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -146.37 169.88 17.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.931 1.366 . . . . 0.0 112.809 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.2 m -137.68 151.3 48.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.824 0.85 . . . . 0.0 110.631 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.24 130.38 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.822 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -123.28 115.78 28.63 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 119.493 1.042 . . . . 0.0 111.15 -168.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -69.71 130.33 19.21 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.065 2.51 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 30.0 mtt -59.84 -32.28 70.53 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.939 1.296 . . . . 0.0 113.243 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -65.08 -22.41 66.96 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.213 0.915 . . . . 0.0 113.039 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -105.14 8.16 34.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.87 1.668 . . . . 0.0 113.601 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 425' ' ' ILE . 53.2 mt -91.8 146.68 23.56 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.29 1.036 . . . . 0.0 111.784 169.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.7 p -83.41 174.45 10.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.727 1.211 . . . . 0.0 110.805 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.2 -41.75 99.2 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.769 -0.582 . . . . 0.0 111.391 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.54 92.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.119 0.968 . . . . 0.0 111.862 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 430' ' ' LEU . 94.3 m-20 -57.59 -61.29 2.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.471 1.109 . . . . 0.0 111.626 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -57.54 -37.84 73.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 111.45 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -57.93 -45.59 86.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.927 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -66.78 -41.49 87.6 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 120.729 1.604 . . . . 0.0 112.107 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 8.3 m -54.56 -33.2 59.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.401 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 m -98.01 -48.59 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 16.7 m -89.46 -9.32 50.54 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.13 56.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.26 1.391 . . . . 0.0 112.319 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -74.98 -48.33 24.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.968 0.907 . . . . 0.0 110.511 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -101.0 121.12 41.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.212 1.006 . . . . 0.0 110.75 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 84.87 -173.88 49.32 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.426 1.489 . . . . 0.0 112.987 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.48 -159.44 53.67 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 57.0 p -100.22 8.03 44.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.103 1.361 . . . . 0.0 114.646 -163.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.02 22.4 4.55 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.934 -1.104 . . . . 0.0 112.499 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.56 3.59 71.42 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.892 1.235 . . . . 0.0 113.859 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.68 153.24 96.09 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 118.355 1.078 . . . . 0.0 110.796 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -63.87 145.95 91.02 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.551 2.167 . . . . 0.0 110.588 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.16 121.27 19.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.378 0.609 . . . . 0.0 110.005 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.4 t -110.88 152.2 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.604 1.962 . . . . 0.0 108.715 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 74.2 m -49.41 122.6 6.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.281 0.632 . . . . 0.0 110.055 165.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 86.68 1.25 85.55 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.935 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.79 131.59 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.588 1.694 . . . . 0.0 111.532 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.02 138.7 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.045 2.138 . . . . 0.0 109.302 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.407 ' CE1' HG22 ' A' ' 336' ' ' VAL . 32.8 p90 -161.97 179.99 7.59 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.474 1.509 . . . . 0.0 112.604 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -95.77 145.6 25.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.241 1.416 . . . . 0.0 110.421 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 9.2 pt-20 -47.68 128.42 10.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.63 152.07 64.56 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 111.249 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.43 147.97 34.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.443 1.097 . . . . 0.0 113.498 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.1 mm -110.79 49.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 123.251 1.501 . . . . 0.0 110.01 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.62 171.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.927 137.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.27 -58.46 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.66 -1.275 . . . . 0.0 110.762 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.64 -55.37 3.44 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.917 1.246 . . . . 0.0 111.666 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -165.03 143.26 6.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 112.138 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -96.69 -154.89 30.39 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.187 1.375 . . . . 0.0 113.447 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.258 1.503 0 C-N-CA 125.572 1.549 . . . . 0.0 113.965 176.907 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 45.2 mt 69.1 75.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 126.826 2.051 . . . . 0.0 109.333 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 70.59 -154.89 52.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.386 0.993 . . . . 0.0 112.818 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -113.5 158.5 38.4 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.052 1.741 . . . . 0.0 110.926 172.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.55 -158.31 0.08 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.517 3.478 . . . . 0.0 110.656 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -71.87 98.93 2.1 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.717 -1.239 . . . . 0.0 111.52 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 11.1 p -81.01 48.5 1.11 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.303 1.841 . . . . 0.0 112.487 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 6.4 t -89.05 -21.58 23.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.802 1.641 . . . . 0.0 113.536 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -55.91 -36.07 67.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.648 1.579 . . . . 0.0 113.612 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.84 3.82 86.73 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.871 1.701 . . . . 0.0 114.334 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 54.7 m -117.02 -76.23 0.57 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.817 1.647 . . . . 0.0 110.891 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -164.85 -52.94 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -83.12 -177.49 6.78 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.553 0.741 . . . . 0.0 111.119 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -142.4 4.32 1.57 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -169.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -62.71 136.78 58.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.369 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.0 mp -82.13 -63.94 1.28 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -82.88 127.99 67.5 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.264 0.626 . . . . 0.0 110.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.44 172.89 13.88 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.896 3.064 . . . . 0.0 111.391 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 64.63 25.06 13.07 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.697 1.599 . . . . 0.0 113.094 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.5 110.96 9.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.967 0.907 . . . . 0.0 112.438 -160.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 126.02 15.22 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.533 1.533 . . . . 0.0 110.719 -172.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -78.84 65.81 4.15 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 121.386 -0.821 . . . . 0.0 111.96 -170.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.37 151.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.901 2.481 . . . . 0.0 111.053 -170.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 48.3 t -53.36 -36.78 61.73 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.791 1.236 . . . . 0.0 114.138 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -78.2 -0.17 27.45 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.65 124.73 38.05 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.552 1.541 . . . . 0.0 111.009 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.74 -21.56 58.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.458 2.772 . . . . 0.0 113.556 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -75.53 -4.49 40.15 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.74 131.6 25.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.725 1.21 . . . . 0.0 111.863 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.85 154.11 68.29 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.278 1.031 . . . . 0.0 109.722 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -65.27 168.42 14.33 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 110.91 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 83.37 60.72 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.21 1.404 . . . . 0.0 107.325 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 137.61 30.94 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.176 2.584 . . . . 0.0 109.052 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.8 t -138.72 136.14 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.389 1.076 . . . . 0.0 108.751 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 172.01 13.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.956 0.902 . . . . 0.0 110.806 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.12 120.1 22.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.596 1.158 . . . . 0.0 109.667 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -117.83 108.54 15.46 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.808 1.643 . . . . 0.0 110.633 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 62.7 p -70.77 -3.57 19.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.926 1.291 . . . . 0.0 114.169 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -69.86 -19.85 63.42 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.266 1.026 . . . . 0.0 112.786 173.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.43 151.57 94.04 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.043 0.937 . . . . 0.0 112.361 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.31 160.79 33.46 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.9 3.067 . . . . 0.0 112.529 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.83 133.83 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 112.376 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 64.4 36.0 9.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.759 2.024 . . . . 0.0 112.511 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.93 152.49 38.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 455' ' ' ILE . 18.8 pt -125.04 149.53 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.596 1.958 . . . . 0.0 112.111 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 111.19 23.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.445 1.498 . . . . 0.0 110.54 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.401 HG22 ' CE2' ' A' ' 457' ' ' PHE . 21.8 t -114.92 108.78 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.147 0.885 . . . . 0.0 111.884 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -72.03 135.02 46.21 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.856 1.262 . . . . 0.0 111.437 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.7 t -71.48 137.83 48.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.607 -0.683 . . . . 0.0 112.036 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -105.37 17.48 23.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.934 1.694 . . . . 0.0 110.447 160.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 57.3 m -120.8 138.95 53.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.727 1.611 . . . . 0.0 111.487 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 21.5 mt -105.71 132.14 52.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.046 2.138 . . . . 0.0 108.556 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -89.89 123.85 34.19 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 30.4 mm -114.38 109.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.841 0.857 . . . . 0.0 109.088 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.47 175.58 49.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.815 0.722 . . . . 0.0 112.07 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.14 13.57 70.21 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.29 0.948 . . . . 0.0 115.086 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.28 121.8 84.36 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-N 118.459 1.129 . . . . 0.0 110.452 -167.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.5 134.7 22.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.794 2.33 . . . . 0.0 109.633 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.16 -18.82 63.88 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.21 -33.29 75.47 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.592 1.157 . . . . 0.0 112.948 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -86.62 157.97 19.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -133.89 -177.7 4.68 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.064 1.746 . . . . 0.0 111.761 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -55.81 -35.73 66.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.36 1.464 . . . . 0.0 112.856 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -74.96 -25.21 58.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.53 -34.99 65.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.371 0.987 . . . . 0.0 110.616 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.2 mm? -60.02 -48.86 79.97 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.232 169.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.5 78.15 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.437 1.017 . . . . 0.0 112.466 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.42 -40.66 85.56 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.848 1.204 . . . . 0.0 112.92 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.37 -36.59 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.176 0.898 . . . . 0.0 112.192 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.471 HD23 ' CE2' ' A' ' 394' ' ' PHE . 67.7 mt -84.42 -13.15 52.95 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -46.05 -49.51 40.0 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 126.529 1.932 . . . . 0.0 115.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.2 -8.19 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.137 1.891 . . . . 0.0 113.705 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -97.24 -41.22 8.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.547 1.539 . . . . 0.0 112.155 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.65 172.52 4.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.672 1.589 . . . . 0.0 113.312 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -91.17 135.11 34.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.495 1.118 . . . . 0.0 111.074 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.6 131.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.146 1.378 . . . . 0.0 110.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -93.74 -42.89 8.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.081 1.352 . . . . 0.0 112.609 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 30.6 t -156.79 150.86 25.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 109.948 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -149.25 134.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.466 0.707 . . . . 0.0 109.823 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.44 107.79 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 166.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.9 tt -102.37 118.11 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 0.0 110.865 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -106.33 81.64 1.64 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.004 1.722 . . . . 0.0 109.223 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.66 -34.16 61.79 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.605 1.562 . . . . 0.0 111.411 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -60.66 -30.83 70.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.489 1.916 . . . . 0.0 113.632 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 3.32 20.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.239 1.416 . . . . 0.0 113.196 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 61.65 36.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.099 1.759 . . . . 0.0 111.57 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -124.1 154.25 40.26 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.857 2.063 . . . . 0.0 113.3 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.72 135.39 34.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.618 1.167 . . . . 0.0 111.772 161.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.64 121.19 29.75 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 160.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.71 119.46 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.127 0.971 . . . . 0.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -96.96 128.8 44.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.364 1.065 . . . . 0.0 111.213 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.83 165.7 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.452 1.101 . . . . 0.0 110.196 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -69.95 -14.58 62.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -170.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.98 159.16 40.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.546 -1.346 . . . . 0.0 113.256 -176.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -41.58 99.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.986 0.914 . . . . 0.0 109.87 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -64.97 -36.71 85.28 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.493 -0.754 . . . . 0.0 112.203 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -56.19 -53.18 60.22 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.932 0.787 . . . . 0.0 109.409 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.71 97.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.524 0.73 . . . . 0.0 112.819 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.57 -42.73 99.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.115 0.566 . . . . 0.0 111.352 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -67.86 -31.56 71.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.581 1.082 . . . . 0.0 112.368 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.9 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.918 164.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.2 -33.67 63.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.716 1.206 . . . . 0.0 114.145 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.36 -23.77 65.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.577 1.551 . . . . 0.0 113.995 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -122.14 -26.62 4.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 359' ' ' LEU . 13.3 t80 -73.67 121.93 21.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.817 0.818 . . . . 0.0 112.276 -166.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 28.8 t30 59.25 28.79 18.21 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.349 1.86 . . . . 0.0 115.089 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -56.71 -32.5 65.57 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.34 -8.79 31.66 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 114.698 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 6.78 65.45 Favored Glycine 0 CA--C 1.548 2.142 0 C-N-CA 125.195 1.379 . . . . 0.0 114.899 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -70.44 -36.52 74.01 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.75 151.64 71.29 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.849 0.859 . . . . 0.0 110.608 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.69 -26.77 9.53 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.643 2.229 . . . . 0.0 112.204 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.71 150.4 41.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.751 1.22 . . . . 0.0 111.723 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -120.59 92.14 3.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.841 1.256 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -74.43 119.99 19.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.104 0.961 . . . . 0.0 110.527 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 170.28 12.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.2 2.2 . . . . 0.0 108.882 172.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -65.77 131.67 46.87 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.169 -0.957 . . . . 0.0 111.013 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.7 -154.99 12.95 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 164.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 132.75 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.057 0.429 . . . . 0.0 112.1 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.14 -50.72 3.56 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -124.17 114.79 20.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.918 0.887 . . . . 0.0 113.036 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.26 143.72 3.97 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 118.704 -1.053 . . . . 0.0 114.846 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.85 144.54 30.95 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.856 3.704 . . . . 0.0 110.032 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -69.24 -30.57 68.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.636 0.774 . . . . 0.0 112.071 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.67 -33.5 72.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.459 2.303 . . . . 0.0 113.309 -175.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.8 m -123.89 34.86 4.96 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.041 2.136 . . . . 0.0 111.211 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.2 139.75 34.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.876 1.671 . . . . 0.0 111.74 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.75 77.8 1.81 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.757 1.623 . . . . 0.0 109.047 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -65.4 -10.53 34.4 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -75.03 -48.25 24.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.249 0.931 . . . . 0.0 110.056 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -84.0 -11.11 57.29 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.62 42.36 21.96 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.045 1.307 . . . . 0.0 112.936 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.36 169.55 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 113.291 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.2 m -137.96 152.37 48.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.897 0.879 . . . . 0.0 111.09 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.1 mm -105.43 119.1 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.42 120.42 42.82 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 120.388 1.449 . . . . 0.0 110.331 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.77 146.87 26.97 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.16 -26.98 68.63 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -65.45 -21.46 66.65 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.985 1.266 . . . . 0.0 113.302 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -97.83 0.2 46.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.095 1.758 . . . . 0.0 113.394 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.63 122.66 34.4 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.147 0.979 . . . . 0.0 110.082 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 33.7 p -76.32 179.46 5.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.14 1.376 . . . . 0.0 111.667 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -39.55 91.42 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.651 -0.655 . . . . 0.0 111.601 170.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.092 0.957 . . . . 0.0 111.975 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.27 -52.18 65.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.775 1.63 . . . . 0.0 112.172 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -61.66 -40.89 96.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.928 0.891 . . . . 0.0 111.318 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.86 -36.21 83.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.201 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -68.21 -44.9 74.74 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.574 1.534 . . . . 0.0 110.837 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.3 m -54.08 -37.51 64.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.516 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.13 -46.4 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.9 t -96.0 -8.99 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -162.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.547 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -58.77 147.98 31.36 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.187 -0.945 . . . . 0.0 111.951 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.78 -38.55 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.33 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -103.55 135.58 44.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.83 1.252 . . . . 0.0 110.209 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 60.61 -159.02 27.03 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.387 -170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 63.64 -154.15 46.08 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.44 HG21 ' HB3' ' A' ' 451' ' ' LEU . 24.9 p -106.63 1.02 24.87 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -164.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.8 t 69.42 24.68 5.68 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.932 1.293 . . . . 0.0 112.095 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.74 9.86 63.82 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.058 1.313 . . . . 0.0 114.132 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -81.14 141.34 50.05 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.185 0.992 . . . . 0.0 110.822 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.24 112.23 2.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.966 2.444 . . . . 0.0 109.0 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -78.82 133.76 37.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.451 0.643 . . . . 0.0 112.012 -174.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.5 m -122.98 171.29 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.004 1.722 . . . . 0.0 111.578 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 87.3 m -49.7 123.08 7.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.33 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 103.2 -14.6 55.12 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.725 -1.042 . . . . 0.0 115.096 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 334' ' ' ILE . 2.5 tp -52.79 130.76 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.484 1.642 . . . . 0.0 111.532 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.87 131.38 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.145 2.178 . . . . 0.0 108.326 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.401 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.1 p90 -156.2 177.65 11.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.805 1.242 . . . . 0.0 112.605 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -99.74 154.01 18.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.709 1.604 . . . . 0.0 110.0 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.85 132.56 28.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -164.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.05 154.11 71.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.12 1.88 . . . . 0.0 110.631 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.547 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 73.2 m-20 -59.14 129.23 41.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.56 1.544 . . . . 0.0 113.348 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.65 55.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 123.308 1.528 . . . . 0.0 110.593 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.81 -176.6 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.53 146.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.61 -49.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.025 -1.047 . . . . 0.0 112.652 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.5 18.12 73.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 119.108 0.867 . . . . 0.0 114.088 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -172.02 177.5 3.22 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.424 1.89 . . . . 0.0 110.948 -161.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 172.36 148.06 6.05 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.347 1.451 . . . . 0.0 112.542 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.252 1.192 0 C-N-CA 125.834 1.653 . . . . 0.0 110.972 -176.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.713 0.292 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.18 -24.04 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.268 -0.895 . . . . 0.0 113.396 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -171.17 -167.22 31.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 126.434 1.969 . . . . 0.0 111.326 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -153.82 157.42 32.58 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.426 1.09 . . . . 0.0 111.604 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.52 166.21 29.3 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.925 3.083 . . . . 0.0 112.544 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.92 -1.43 28.48 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.1 m 72.87 4.45 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.983 2.113 . . . . 0.0 113.108 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.23 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 128.669 2.787 . . . . 0.0 112.337 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 62.8 -148.99 0.36 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.615 1.566 . . . . 0.0 111.637 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.48 -41.59 2.1 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.225 1.393 . . . . 0.0 114.26 167.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 12.1 t -67.48 -37.26 82.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.268 1.027 . . . . 0.0 112.251 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -97.32 -78.84 0.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.261 1.424 . . . . 0.0 110.87 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.119 1.768 . . . . 0.0 110.281 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -87.65 27.13 1.17 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -159.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -70.25 138.33 51.56 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.308 1.043 . . . . 0.0 112.781 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mp -79.75 0.73 29.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.589 1.155 . . . . 0.0 113.232 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.76 161.08 65.84 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.468 1.507 . . . . 0.0 111.321 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -68.85 -172.27 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.883 3.056 . . . . 0.0 111.324 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -74.0 64.76 1.04 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.866 1.266 . . . . 0.0 111.325 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.5 169.28 17.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.609 1.964 . . . . 0.0 113.271 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.46 136.52 53.74 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.632 1.573 . . . . 0.0 111.492 -172.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -81.36 63.41 5.67 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.377 -0.827 . . . . 0.0 110.276 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 16.5 m -108.28 149.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.041 2.136 . . . . 0.0 110.669 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 78.7 p -62.22 -25.33 67.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -74.56 -20.49 59.93 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.8 0.84 . . . . 0.0 113.115 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -82.59 122.9 78.91 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.043 1.337 . . . . 0.0 109.683 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.93 -16.79 46.06 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.523 2.149 . . . . 0.0 113.112 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -72.72 1.34 8.62 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 166.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -52.87 127.11 22.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.412 1.46 . . . . 0.0 111.498 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -125.6 152.99 72.75 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.035 1.334 . . . . 0.0 110.606 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.42 158.92 55.6 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.296 2.664 . . . . 0.0 110.891 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.26 70.29 5.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 110.179 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.98 121.92 8.79 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.292 1.994 . . . . 0.0 108.994 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.37 127.69 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 109.316 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.93 163.95 28.38 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.151 1.38 . . . . 0.0 109.991 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -144.01 116.36 8.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.167 0.987 . . . . 0.0 109.34 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -121.54 107.79 12.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.069 0.938 . . . . 0.0 111.108 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -8.54 12.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.109 1.764 . . . . 0.0 113.923 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -68.31 -25.07 64.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.394 1.078 . . . . 0.0 112.651 172.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.03 150.55 96.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.63 0.772 . . . . 0.0 112.06 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.02 160.85 35.82 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.087 3.191 . . . . 0.0 112.934 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.46 134.14 27.87 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.958 3.105 . . . . 0.0 112.33 -171.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.55 40.02 11.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.698 1.599 . . . . 0.0 112.298 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -121.35 151.8 39.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 172.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.3 pt -123.12 151.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.744 2.018 . . . . 0.0 110.492 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.69 126.76 55.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.494 1.518 . . . . 0.0 110.184 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.95 109.64 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.715 0.689 . . . . 0.0 111.495 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -72.97 131.7 42.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.156 1.382 . . . . 0.0 112.079 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.9 m -70.26 138.18 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.532 -0.73 . . . . 0.0 112.482 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.54 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.8 mtm105 -109.3 13.46 24.26 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.539 1.936 . . . . 0.0 110.944 164.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 32.7 m -118.97 141.89 48.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.671 1.588 . . . . 0.0 110.974 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.69 133.2 49.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.579 1.952 . . . . 0.0 108.754 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -92.59 112.86 24.96 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 165.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.4 mm -97.87 120.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 179.41 37.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.618 1.104 . . . . 0.0 111.32 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.77 60.77 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 114.751 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.3 125.64 90.65 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 118.417 1.109 . . . . 0.0 109.951 -168.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 135.53 31.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.798 2.332 . . . . 0.0 109.671 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.9 mp -67.96 -10.83 56.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 -25.06 22.55 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.516 1.126 . . . . 0.0 112.985 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 19.4 mtm -79.91 149.02 31.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.885 0.85 . . . . 0.0 112.651 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -125.8 -176.01 3.5 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.504 1.921 . . . . 0.0 111.473 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 2.4 mp0 -49.88 -44.86 50.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.485 2.314 . . . . 0.0 113.062 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -77.34 -20.53 54.72 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.67 -37.33 59.68 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.048 0.84 . . . . 0.0 110.54 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.2 -49.55 77.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.524 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.77 -39.26 73.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.228 0.922 . . . . 0.0 112.732 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.02 -44.36 76.66 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.701 1.137 . . . . 0.0 113.587 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.09 -32.44 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 119.837 1.199 . . . . 0.0 111.725 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.478 HD23 ' CE2' ' A' ' 394' ' ' PHE . 62.0 mt -89.76 -10.58 45.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -46.89 -47.47 52.91 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.021 1.728 . . . . 0.0 115.37 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -6.98 16.77 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.203 1.935 . . . . 0.0 113.585 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -98.11 -39.2 9.02 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.609 1.563 . . . . 0.0 112.486 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.89 168.58 4.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.09 1.756 . . . . 0.0 113.31 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.36 129.47 34.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.856 0.862 . . . . 0.0 110.095 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.66 130.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.77 0.828 . . . . 0.0 110.206 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -95.0 -44.4 7.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.803 1.241 . . . . 0.0 112.536 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.3 m -144.13 152.63 41.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.474 1.109 . . . . 0.0 111.363 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 59.9 t -143.67 114.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.243 0.928 . . . . 0.0 110.936 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.6 93.46 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.14 129.27 45.38 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.513 0.725 . . . . 0.0 110.585 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -123.43 90.96 3.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.424 1.09 . . . . 0.0 109.932 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -58.57 -28.23 65.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.38 1.072 . . . . 0.0 112.266 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 22.7 t -56.44 -38.11 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.382 1.873 . . . . 0.0 114.178 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -107.04 6.98 29.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.867 1.267 . . . . 0.0 113.058 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 59.28 36.43 23.61 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.627 1.571 . . . . 0.0 111.412 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -124.18 164.06 20.27 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.28 33.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.759 1.224 . . . . 0.0 112.544 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.93 104.81 14.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.3 1.04 . . . . 0.0 108.654 164.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.87 100.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.111 1.364 . . . . 0.0 109.837 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -80.74 123.47 28.24 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.204 0.602 . . . . 0.0 110.277 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.53 168.01 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.346 166.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.73 -22.16 54.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.39 156.52 48.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 120.064 1.302 . . . . 0.0 113.704 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.49 -44.67 96.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.65 0.78 . . . . 0.0 112.322 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -66.46 -31.14 71.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.045 -0.41 . . . . 0.0 111.674 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.08 -53.89 42.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.755 1.222 . . . . 0.0 111.06 167.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.03 84.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.867 0.758 . . . . 0.0 112.133 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.77 -42.68 97.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.26 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -66.72 -30.69 70.98 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 120.126 1.33 . . . . 0.0 112.738 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.68 -63.56 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.736 0.698 . . . . 0.0 109.497 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.5 mt -52.25 -36.12 51.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.02 -42.95 88.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.046 1.338 . . . . 0.0 112.474 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -105.32 -23.5 12.85 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 359' ' ' LEU . 20.4 t80 -74.11 123.55 24.64 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.484 -0.76 . . . . 0.0 111.489 -168.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 61.79 29.27 17.94 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.807 1.643 . . . . 0.0 114.48 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.95 -34.69 65.91 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.804 -1.185 . . . . 0.0 113.396 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.37 -19.53 53.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.324 1.05 . . . . 0.0 113.525 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.03 70.18 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.65 1.119 . . . . 0.0 114.046 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.08 -31.53 20.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.6 1.56 . . . . 0.0 114.802 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 19.7 mt -80.62 150.78 70.53 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.351 1.06 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.93 -32.47 7.13 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.405 2.07 . . . . 0.0 112.169 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.32 151.65 45.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.286 1.434 . . . . 0.0 111.756 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -127.94 96.38 4.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.768 1.227 . . . . 0.0 109.739 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 32.8 m -73.28 123.78 24.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.357 1.063 . . . . 0.0 110.634 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -126.52 173.63 9.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.703 2.001 . . . . 0.0 108.817 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -72.11 133.48 45.23 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.94 -1.1 . . . . 0.0 111.574 164.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.94 -153.09 9.54 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 125.777 1.656 . . . . 0.0 109.295 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.35 137.06 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.13 -52.98 2.93 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.723 1.63 . . . . 0.0 109.784 167.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.89 117.85 25.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.37 142.79 4.65 Favored Glycine 0 CA--C 1.543 1.836 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.96 130.28 15.34 Favored 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 125.746 4.297 . . . . 0.0 110.849 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -67.23 -32.09 72.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.42 -18.66 54.65 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.93 1.692 . . . . 0.0 113.83 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 77.8 m -122.9 28.73 7.11 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.586 1.555 . . . . 0.0 111.881 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.5 t -84.4 141.81 30.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.073 1.349 . . . . 0.0 111.429 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.37 80.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.779 1.631 . . . . 0.0 108.915 167.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -63.95 -20.51 65.93 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.547 -0.721 . . . . 0.0 112.904 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.32 -47.62 69.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.529 1.513 . . . . 0.0 111.266 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -83.2 -13.59 55.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.4 42.54 18.11 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.809 1.195 . . . . 0.0 112.374 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -147.27 168.74 20.97 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.026 1.413 . . . . 0.0 113.151 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.5 m -131.17 152.35 50.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.285 1.034 . . . . 0.0 110.704 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.2 mm -106.29 133.06 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.531 HG21 HD21 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -126.55 118.96 22.94 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 120.116 1.326 . . . . 0.0 110.981 -173.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -73.96 139.01 26.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.44 2.093 . . . . 0.0 111.121 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 10.9 mtt -63.02 -28.81 70.35 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.41 -19.29 65.88 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -104.85 3.81 31.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.562 1.945 . . . . 0.0 113.642 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.531 HD21 HG21 ' A' ' 425' ' ' ILE . 97.9 mt -92.05 136.32 33.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 110.395 170.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.2 p -79.94 178.77 7.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.514 1.126 . . . . 0.0 111.51 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.595 -0.691 . . . . 0.0 111.633 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.59 88.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.889 0.875 . . . . 0.0 112.025 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.69 -52.76 63.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.517 1.127 . . . . 0.0 112.284 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -65.56 -37.5 86.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.859 -0.526 . . . . 0.0 111.102 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -60.16 -42.17 94.39 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.78 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -66.59 -44.3 82.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.041 1.746 . . . . 0.0 111.271 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.2 m -56.59 -32.38 65.17 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.332 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.68 -39.75 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.8 m -103.26 -7.75 20.89 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -168.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.82 147.06 39.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.211 1.368 . . . . 0.0 111.604 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -77.11 -55.29 5.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.33 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -92.78 132.45 36.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.346 0.975 . . . . 0.0 110.533 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.81 179.34 10.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.015 0.817 . . . . 0.0 113.459 -173.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.67 -163.88 34.02 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 122.242 -0.563 . . . . 0.0 113.114 -168.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.1 p -109.78 7.44 24.17 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -163.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 37.4 p 76.74 15.81 1.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.972 2.109 . . . . 0.0 113.901 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.49 4.08 64.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.988 1.28 . . . . 0.0 113.352 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -66.01 138.34 96.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.901 1.28 . . . . 0.0 109.446 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -60.19 140.91 94.57 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.177 1.918 . . . . 0.0 110.176 169.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.04 130.24 43.22 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.29 159.69 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.473 1.509 . . . . 0.0 110.089 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 78.2 m -56.61 124.92 19.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.75 -2.05 76.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.593 -1.115 . . . . 0.0 115.541 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.4 tt -62.96 140.42 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.494 1.647 . . . . 0.0 112.127 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.56 136.78 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.829 2.052 . . . . 0.0 109.61 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -162.47 175.46 11.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.097 1.359 . . . . 0.0 113.104 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.72 148.69 21.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 111.397 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -51.47 126.25 29.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -168.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.78 152.84 64.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.073 2.515 . . . . 0.0 110.539 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -63.55 144.5 56.94 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.34 52.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.337 1.541 . . . . 0.0 110.133 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.37 -178.16 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.79 141.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.63 -39.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.636 -1.29 . . . . 0.0 112.904 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 83.16 -54.64 4.99 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.202 0.906 . . . . 0.0 112.063 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.68 141.93 3.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -162.72 161.72 33.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.199 1.38 . . . . 0.0 113.323 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.001 1.32 . . . . 0.0 113.377 -172.752 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.799 -0.074 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.5 pp -118.2 161.85 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.363 1.465 . . . . 0.0 110.94 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.48 110.26 0.45 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.57 1.081 . . . . 0.0 110.796 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -147.51 153.79 44.13 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.882 1.273 . . . . 0.0 110.537 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.03 173.81 8.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.898 3.065 . . . . 0.0 111.39 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -55.1 127.63 30.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 111.71 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.169 1.388 . . . . 0.0 112.949 173.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.76 60.15 1.13 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 0.0 109.391 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -32.86 -64.36 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.139 2.176 . . . . 0.0 112.671 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.89 -146.11 3.8 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.158 1.361 . . . . 0.0 113.126 169.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 24.0 m 69.64 -74.98 0.08 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.266 1.827 . . . . 0.0 110.479 170.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -150.63 17.08 0.8 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 127.467 2.307 . . . . 0.0 113.246 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -153.65 156.61 38.22 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.668 -1.27 . . . . 0.0 113.259 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.1 8.74 3.22 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -166.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.0 133.32 46.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.16 0.984 . . . . 0.0 112.258 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.1 mp -81.53 -41.74 21.21 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.968 1.307 . . . . 0.0 111.116 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -116.14 65.99 2.96 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.962 0.905 . . . . 0.0 110.876 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.17 -172.99 0.97 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.2 3.267 . . . . 0.0 110.887 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 77.27 36.91 0.28 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.294 1.838 . . . . 0.0 112.5 170.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.0 159.41 39.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 112.504 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.75 162.67 18.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.665 1.186 . . . . 0.0 111.606 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -77.94 62.68 2.79 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.938 0.895 . . . . 0.0 110.386 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.79 149.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.359 2.263 . . . . 0.0 110.671 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 18.2 t -61.47 -26.79 68.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -67.41 -27.95 67.51 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.224 -0.923 . . . . 0.0 112.869 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -78.93 123.35 85.15 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.766 1.226 . . . . 0.0 110.191 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.1 -18.0 51.08 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.663 2.242 . . . . 0.0 113.305 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -77.8 1.07 21.41 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 169.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -49.31 134.02 18.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.593 1.542 . . . . 0.0 111.919 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 81.4 mmt-85 -136.82 144.88 48.53 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.242 1.017 . . . . 0.0 110.054 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.98 161.87 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 110.827 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -117.04 66.78 4.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.629 1.171 . . . . 0.0 109.729 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.31 115.08 4.01 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.906 2.404 . . . . 0.0 109.487 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.3 m -92.84 139.99 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.912 0.885 . . . . 0.0 110.083 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.43 164.07 29.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.022 1.329 . . . . 0.0 110.301 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -143.77 120.57 11.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.132 0.973 . . . . 0.0 109.426 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.33 110.53 17.08 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.581 0.705 . . . . 0.0 110.656 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -8.49 44.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.952 0.901 . . . . 0.0 113.299 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 64.2 p -70.54 -24.44 62.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.479 1.512 . . . . 0.0 112.174 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.0 150.53 88.1 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.958 0.903 . . . . 0.0 111.576 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 161.32 38.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.055 3.17 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.48 136.63 37.18 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.157 3.238 . . . . 0.0 112.038 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.71 33.64 10.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.428 1.491 . . . . 0.0 113.024 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.23 151.52 32.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.634 -1.291 . . . . 0.0 114.353 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 451' ' ' LEU . 12.0 pt -120.62 142.1 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.159 1.784 . . . . 0.0 110.485 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -107.75 111.54 23.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.672 -1.267 . . . . 0.0 110.63 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 25.4 t -105.69 101.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.865 0.866 . . . . 0.0 110.29 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -67.32 123.08 19.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.194 0.997 . . . . 0.0 111.477 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.2 t -69.74 134.66 48.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.625 -0.672 . . . . 0.0 111.425 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.5 mtm105 -101.93 9.98 40.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.891 1.677 . . . . 0.0 109.986 164.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 54.2 m -112.97 138.45 49.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.449 1.499 . . . . 0.0 111.041 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 40.1 mt -100.51 139.69 35.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.848 1.659 . . . . 0.0 109.503 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -95.27 138.44 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 164.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.45 114.57 44.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 166.28 26.34 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.484 1.04 . . . . 0.0 110.6 163.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.24 43.39 32.27 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 121.972 -0.722 . . . . 0.0 112.929 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.17 84.54 2.86 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.132 1.373 . . . . 0.0 110.875 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.31 173.28 11.69 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.287 2.658 . . . . 0.0 112.044 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.28 -21.75 50.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -18.9 61.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.19 0.996 . . . . 0.0 112.915 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.7 mtp -100.67 131.73 46.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.107 1.763 . . . . 0.0 109.921 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -141.23 170.07 16.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.082 1.753 . . . . 0.0 111.286 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.7 -42.66 62.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.631 1.172 . . . . 0.0 113.843 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -76.87 -27.65 55.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -38.59 84.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.663 167.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 355' ' ' LEU . 2.1 mm? -59.82 -47.96 83.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.747 0.703 . . . . 0.0 110.974 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -57.59 -42.51 83.3 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.163 0.892 . . . . 0.0 112.884 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.38 -39.69 89.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.929 1.241 . . . . 0.0 113.226 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.3 -35.35 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.539 1.063 . . . . 0.0 111.528 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.697 HD22 HG11 ' A' ' 390' ' ' VAL . 25.9 mt -85.65 -11.27 54.23 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.187 0.903 . . . . 0.0 112.819 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -48.3 82.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 126.187 1.795 . . . . 0.0 115.166 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.52 -7.35 18.62 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.023 1.815 . . . . 0.0 112.985 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -96.86 -40.14 9.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.297 1.439 . . . . 0.0 112.369 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.41 172.86 3.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.116 1.766 . . . . 0.0 113.484 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 116.88 24.93 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.868 . . . . 0.0 110.506 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 75.3 t -77.82 133.55 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.148 0.979 . . . . 0.0 110.184 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -94.05 -54.17 3.69 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.372 1.469 . . . . 0.0 112.269 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.5 m -140.07 155.11 47.18 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.823 1.249 . . . . 0.0 111.28 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.411 HG22 HG13 ' A' ' 379' ' ' VAL . 57.8 t -144.56 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.059 0.544 . . . . 0.0 110.514 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.56 105.64 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.873 1.269 . . . . 0.0 107.666 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.44 125.8 43.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.396 0.678 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 83.45 2.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.945 1.355 . . . . 0.0 109.706 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -21.61 66.29 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.595 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.5 t -57.26 -31.75 65.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.848 1.659 . . . . 0.0 113.718 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -112.3 10.89 20.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.931 1.692 . . . . 0.0 113.179 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.3 mttt 58.74 32.81 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.159 1.384 . . . . 0.0 113.171 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -126.19 169.5 12.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.23 158.63 43.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 163.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -114.05 128.9 56.59 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.267 1.427 . . . . 0.0 108.641 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 359' ' ' LEU . 63.9 t -128.08 105.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.896 0.878 . . . . 0.0 111.079 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.71 119.03 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.335 1.054 . . . . 0.0 109.791 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.65 152.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.723 1.609 . . . . 0.0 107.517 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -66.33 -19.89 65.93 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.66 156.94 43.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.586 1.085 . . . . 0.0 112.427 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -44.55 96.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.215 1.006 . . . . 0.0 109.975 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -38.84 90.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.877 0.871 . . . . 0.0 111.566 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -63.92 -53.02 56.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.526 1.13 . . . . 0.0 111.361 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.34 73.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.841 0.746 . . . . 0.0 112.284 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.21 -45.4 91.18 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.175 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -61.55 -36.01 79.4 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.257 0.935 . . . . 0.0 112.187 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.697 HG11 HD22 ' A' ' 359' ' ' LEU . 19.1 t -62.74 -61.04 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.469 169.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.05 -37.9 35.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.041 1.337 . . . . 0.0 113.73 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -69.67 -29.43 66.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.869 1.268 . . . . 0.0 113.666 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -111.79 -26.28 9.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.556 1.071 . . . . 0.0 113.709 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 359' ' ' LEU . 15.7 t80 -69.98 119.3 13.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.545 0.688 . . . . 0.0 111.698 -167.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 60.29 35.77 20.74 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.349 1.46 . . . . 0.0 113.532 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -62.72 -36.08 81.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.58 -14.85 31.68 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.444 1.498 . . . . 0.0 113.93 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.76 29.57 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.519 1.057 . . . . 0.0 114.666 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.5 -41.75 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.181 1.491 . . . . 0.0 114.581 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.2 mt -75.38 150.46 84.92 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.11 0.964 . . . . 0.0 109.802 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.18 -28.04 13.1 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.459 2.106 . . . . 0.0 112.436 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.8 141.76 28.35 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.448 0.699 . . . . 0.0 111.287 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.6 126.12 54.12 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 109.92 172.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 m -106.41 129.82 54.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.55 1.14 . . . . 0.0 109.922 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.72 175.17 9.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.46 1.904 . . . . 0.0 109.257 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -65.55 125.03 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.593 163.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -109.41 -157.21 17.37 Favored Glycine 0 N--CA 1.463 0.483 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.77 136.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.75 -51.23 2.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.736 1.636 . . . . 0.0 109.952 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -119.85 109.39 15.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.417 0.687 . . . . 0.0 112.753 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.95 136.29 3.53 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.049 -0.862 . . . . 0.0 115.222 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.444 ' HG3' HG23 ' A' ' 425' ' ' ILE . 95.8 Cg_endo -71.02 132.08 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.589 4.193 . . . . 0.0 109.89 171.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -65.37 -36.86 85.27 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.626 -0.671 . . . . 0.0 112.74 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -73.33 -20.62 60.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 46.2 m -117.36 19.06 14.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.122 1.769 . . . . 0.0 112.599 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.82 153.15 35.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.945 0.879 . . . . 0.0 112.429 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.26 78.97 1.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.91 1.684 . . . . 0.0 108.704 166.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.67 -19.22 64.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 113.275 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -70.81 -50.75 32.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.024 0.829 . . . . 0.0 110.774 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -81.27 -15.91 54.11 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.83 21.36 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.016 1.293 . . . . 0.0 113.254 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -146.78 172.81 13.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.603 1.202 . . . . 0.0 113.35 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 30.0 m -133.83 146.05 50.28 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.173 0.989 . . . . 0.0 110.74 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 14.6 mm -107.0 95.86 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.542 0.737 . . . . 0.0 109.487 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.554 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -94.57 123.54 57.92 Favored Pre-proline 0 N--CA 1.474 0.726 0 O-C-N 121.029 -1.045 . . . . 0.0 111.193 -168.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.59 132.85 22.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.526 2.15 . . . . 0.0 111.109 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 17.6 mtt -60.71 -30.8 70.18 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.026 1.331 . . . . 0.0 113.363 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.49 -16.8 64.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 8.15 24.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.845 2.058 . . . . 0.0 113.554 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 425' ' ' ILE . 96.0 mt -89.35 140.12 29.82 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.233 0.924 . . . . 0.0 110.211 169.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 20.7 p -75.88 178.33 6.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.57 1.148 . . . . 0.0 111.232 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.47 -46.17 87.46 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.42 -0.8 . . . . 0.0 111.073 169.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.876 0.87 . . . . 0.0 112.234 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.78 -55.41 35.47 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.286 1.434 . . . . 0.0 112.475 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -65.88 -36.67 84.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.845 -0.534 . . . . 0.0 110.791 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -59.12 -41.43 88.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.499 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -68.28 -45.97 71.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.423 1.465 . . . . 0.0 111.232 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 49.6 m -53.48 -36.13 61.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.612 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.62 -42.92 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.0 t -101.13 -9.06 21.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.739 1.216 . . . . 0.0 114.141 -167.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.21 146.68 27.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.427 1.108 . . . . 0.0 112.079 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.1 -57.9 3.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.734 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -91.46 132.69 36.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.273 1.029 . . . . 0.0 110.934 163.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 63.93 176.28 4.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.803 1.192 . . . . 0.0 114.094 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.1 -165.95 36.48 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.515 1.055 . . . . 0.0 112.748 -167.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 58.4 p -106.71 16.29 24.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -158.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.1 p 60.4 26.86 16.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.95 1.3 . . . . 0.0 113.441 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.0 77.03 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.506 1.527 . . . . 0.0 114.207 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -66.84 135.67 94.3 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.795 1.297 . . . . 0.0 110.13 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -59.51 144.04 99.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.534 2.156 . . . . 0.0 110.077 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 334' ' ' ILE . 80.7 mt -65.38 123.88 20.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.113 0.483 . . . . 0.0 110.493 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.06 157.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.002 2.121 . . . . 0.0 109.422 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.7 m -52.28 117.71 3.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 110.064 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 75.56 17.94 79.97 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.531 -1.15 . . . . 0.0 115.01 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 20.6 tt -62.5 126.91 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.231 1.516 . . . . 0.0 111.003 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.36 141.2 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.948 2.099 . . . . 0.0 109.501 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -166.29 171.93 11.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.36 1.464 . . . . 0.0 113.118 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.77 145.14 26.75 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.653 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -56.05 136.61 73.79 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -165.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.39 150.42 46.54 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.156 2.571 . . . . 0.0 110.992 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.414 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 85.9 m-20 -59.82 142.04 54.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.964 1.305 . . . . 0.0 113.881 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.35 52.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.635 1.683 . . . . 0.0 110.144 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -178.6 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.003 141.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.97 -44.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.759 -1.213 . . . . 0.0 111.886 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 79.07 -76.92 1.87 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.43 174.29 6.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.511 1.524 . . . . 0.0 111.72 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -176.25 164.61 34.59 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.949 1.261 . . . . 0.0 113.528 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 125.557 1.543 . . . . 0.0 111.879 -179.305 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.908 0.385 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 74.2 mt -138.81 -62.79 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.516 1.127 . . . . 0.0 109.987 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.48 175.17 23.63 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.756 1.646 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.91 32.83 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.998 1.319 . . . . 0.0 111.344 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 170.01 20.31 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 124.312 3.342 . . . . 0.0 112.195 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.16 14.0 1.3 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.146 1.378 . . . . 0.0 114.24 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 21.7 p 55.84 11.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 128.84 2.856 . . . . 0.0 115.574 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.88 -35.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.318 2.647 . . . . 0.0 111.748 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER 47.86 -103.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.514 1.525 . . . . 0.0 110.447 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 68.27 179.14 16.95 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.878 0.751 . . . . 0.0 111.767 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 87.1 m 66.66 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.971 1.708 . . . . 0.0 110.761 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -103.9 108.14 19.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.969 1.707 . . . . 0.0 110.238 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 68.37 171.92 0.28 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.792 1.637 . . . . 0.0 113.334 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -146.17 16.74 1.36 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -72.37 140.34 48.38 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.059 0.943 . . . . 0.0 113.072 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.56 8.22 10.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.955 1.302 . . . . 0.0 113.089 171.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.28 160.42 59.88 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.803 1.241 . . . . 0.0 111.585 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.14 -171.56 0.52 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.917 3.078 . . . . 0.0 111.412 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -76.32 55.4 0.98 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.378 1.071 . . . . 0.0 111.641 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.48 143.17 48.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.197 1.399 . . . . 0.0 111.964 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.0 mt -89.82 144.62 25.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.48 0.712 . . . . 0.0 111.46 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -79.8 64.3 4.61 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.897 -1.127 . . . . 0.0 110.202 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.63 154.86 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.979 2.112 . . . . 0.0 110.681 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 83.6 p -62.98 -23.26 67.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -69.17 -28.25 66.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.961 0.905 . . . . 0.0 113.201 171.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -74.92 123.15 88.8 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.867 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.04 -17.6 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.467 2.111 . . . . 0.0 113.051 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -81.82 7.17 13.43 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.828 1.251 . . . . 0.0 113.978 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -53.42 124.38 14.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.731 -1.231 . . . . 0.0 110.937 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -128.81 139.21 34.98 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 124.932 1.293 . . . . 0.0 109.223 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.9 156.93 59.47 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.884 2.389 . . . . 0.0 110.415 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 74.17 3.03 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.35 1.06 . . . . 0.0 109.962 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.6 111.59 3.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.613 2.209 . . . . 0.0 109.098 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.89 131.42 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.436 0.695 . . . . 0.0 110.042 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.41 169.57 15.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.635 1.574 . . . . 0.0 110.552 173.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -139.99 125.35 18.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.427 1.091 . . . . 0.0 110.108 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -121.23 107.38 12.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.877 0.871 . . . . 0.0 110.839 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.7 m -68.81 -5.58 21.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 55.7 p -71.33 -22.25 61.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.499 1.12 . . . . 0.0 112.188 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.1 mt -71.27 152.73 94.37 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.962 0.905 . . . . 0.0 112.247 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.81 162.17 33.06 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.113 3.208 . . . . 0.0 112.899 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.43 136.84 32.18 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.139 3.226 . . . . 0.0 112.389 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.72 47.35 10.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 111.798 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -126.12 152.91 45.28 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.337 1.055 . . . . 0.0 113.568 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.02 144.16 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.346 1.858 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -117.29 133.27 56.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.569 -1.332 . . . . 0.0 111.613 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.72 101.86 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.957 0.903 . . . . 0.0 110.582 -169.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -68.72 127.07 31.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.63 1.172 . . . . 0.0 112.024 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.3 m -70.22 135.49 49.07 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.523 -0.736 . . . . 0.0 112.275 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.4 mtm105 -102.42 10.24 39.14 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.881 1.673 . . . . 0.0 110.608 164.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 19.4 m -117.42 145.52 44.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.319 1.448 . . . . 0.0 112.141 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 52.9 mt -105.9 136.26 45.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.181 1.792 . . . . 0.0 109.552 172.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -88.98 140.95 28.91 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 162.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 18.3 mm -125.93 116.41 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 108.484 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -98.55 -177.11 32.67 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.313 0.959 . . . . 0.0 111.943 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.22 64.73 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 121.826 -0.808 . . . . 0.0 114.979 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.69 116.41 53.3 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-O 117.665 -1.16 . . . . 0.0 110.061 -166.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.23 135.29 33.87 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.305 2.003 . . . . 0.0 109.596 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.09 -20.26 63.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.38 -33.46 75.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.146 0.979 . . . . 0.0 111.949 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 3.8 ptp -82.6 151.58 26.29 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.527 0.68 . . . . 0.0 112.81 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -129.76 -175.71 3.68 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.169 1.788 . . . . 0.0 111.555 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.26 -39.79 57.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.753 1.221 . . . . 0.0 113.791 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -75.93 -21.64 56.85 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -74.52 -39.15 62.56 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.841 . . . . 0.0 110.568 169.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.8 mm? -58.07 -50.4 73.59 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.353 0.524 . . . . 0.0 110.569 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.89 80.24 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.596 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -68.46 -40.65 80.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.945 1.248 . . . . 0.0 113.512 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.51 -37.33 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.083 0.856 . . . . 0.0 111.493 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.653 HD23 ' CE1' ' A' ' 394' ' ' PHE . 27.3 mt -83.83 -9.25 58.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.056 0.942 . . . . 0.0 112.75 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.66 -49.43 65.58 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 126.152 1.781 . . . . 0.0 114.889 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -7.32 18.61 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.076 1.851 . . . . 0.0 113.185 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.83 -41.32 8.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.274 1.43 . . . . 0.0 112.3 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.73 172.85 3.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 113.743 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.27 111.87 23.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 111.43 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.82 131.25 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.983 0.913 . . . . 0.0 110.991 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.85 -46.16 8.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.106 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -151.22 152.52 33.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.604 1.162 . . . . 0.0 111.482 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.84 137.21 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.646 . . . . 0.0 110.963 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.81 106.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.638 1.175 . . . . 0.0 107.846 166.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.19 133.0 45.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.003 0.921 . . . . 0.0 110.254 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.55 91.47 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.727 1.211 . . . . 0.0 110.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.0 -27.32 68.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.489 1.116 . . . . 0.0 111.89 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 71.4 m -57.62 -32.05 66.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.025 1.73 . . . . 0.0 114.269 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 8.9 17.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.0 112.729 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.4 mttt 51.99 40.84 29.12 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.704 1.602 . . . . 0.0 112.754 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -127.33 166.7 17.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.27 161.0 41.24 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.44 130.93 57.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.985 1.314 . . . . 0.0 108.379 164.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 359' ' ' LEU . 57.3 t -123.24 102.25 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.945 0.898 . . . . 0.0 110.191 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -74.74 111.02 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.699 1.2 . . . . 0.0 110.127 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.86 153.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.68 1.592 . . . . 0.0 107.85 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.38 -17.88 64.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.81 159.24 44.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.135 1.334 . . . . 0.0 113.004 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.98 77.62 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.741 0.816 . . . . 0.0 110.305 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.7 -36.0 79.66 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.682 0.793 . . . . 0.0 111.64 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.91 -55.55 21.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 111.543 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.4 72.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.061 0.846 . . . . 0.0 112.954 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -60.53 -47.69 85.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.385 1.074 . . . . 0.0 111.878 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.03 -34.51 76.37 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.569 -0.707 . . . . 0.0 112.053 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 359' ' ' LEU . 21.7 t -61.63 -62.03 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.502 167.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -51.31 -35.28 37.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.789 1.236 . . . . 0.0 114.291 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.87 -33.11 75.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.938 1.295 . . . . 0.0 113.532 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -117.2 -27.68 6.4 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 359' ' ' LEU . 20.3 t80 -74.93 123.18 24.64 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.627 0.771 . . . . 0.0 110.919 -169.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.61 23.96 12.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -30.92 63.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.535 1.134 . . . . 0.0 113.766 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.16 -14.43 15.15 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.729 2.012 . . . . 0.0 114.229 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.29 35.48 7.0 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.716 1.15 . . . . 0.0 114.385 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.73 83.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.66 156.37 38.95 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.626 1.57 . . . . 0.0 110.497 -174.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.84 -19.13 24.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.723 2.282 . . . . 0.0 113.908 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.2 mt -62.82 166.76 5.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.903 2.081 . . . . 0.0 113.072 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -137.16 95.0 3.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.46 1.104 . . . . 0.0 110.313 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.5 122.51 28.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.283 1.833 . . . . 0.0 111.063 -172.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 170.44 14.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.596 1.958 . . . . 0.0 109.28 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -64.22 120.17 11.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.336 -0.853 . . . . 0.0 110.424 161.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.1 -155.52 25.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 411' ' ' GLY . 11.0 p -167.35 136.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.441 1.096 . . . . 0.0 110.167 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -80.14 -49.67 5.84 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.423 1.011 . . . . 0.0 110.96 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -115.2 96.65 5.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 111.08 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 408' ' ' VAL . . . -158.65 122.58 1.16 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.768 -1.018 . . . . 0.0 114.772 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.85 125.23 9.27 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.531 3.487 . . . . 0.0 110.24 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -56.37 -40.45 74.58 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.91 -15.04 61.15 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.26 16.48 13.14 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 112.224 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 138.47 31.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.406 1.482 . . . . 0.0 111.776 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -118.63 86.52 2.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.997 1.719 . . . . 0.0 108.708 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -69.36 -15.57 63.34 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.66 -48.79 58.57 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.947 -1.095 . . . . 0.0 110.602 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -84.65 -16.92 40.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.22 44.83 10.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.575 1.083 . . . . 0.0 112.431 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.61 158.17 42.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.059 0.93 . . . . 0.0 113.491 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.81 151.62 28.83 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.967 -1.083 . . . . 0.0 110.69 168.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.89 104.03 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 0.0 109.015 172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.27 131.17 22.16 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.846 -167.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.73 138.66 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.172 1.914 . . . . 0.0 110.748 168.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 4.9 mtm -61.66 -32.92 73.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.344 1.058 . . . . 0.0 112.601 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -68.81 -11.01 59.95 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -110.11 8.12 23.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.309 1.443 . . . . 0.0 113.488 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 76.2 mt -91.33 135.88 33.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.409 0.684 . . . . 0.0 110.35 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 26.3 p -72.73 175.94 6.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.424 1.09 . . . . 0.0 110.749 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -42.67 98.16 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.633 -0.667 . . . . 0.0 111.046 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.18 82.67 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 112.365 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.47 -53.82 53.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.563 1.145 . . . . 0.0 111.677 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -67.77 -35.83 79.39 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.864 -0.522 . . . . 0.0 111.615 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -54.26 -51.93 62.98 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.587 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -68.5 -40.97 80.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.472 1.487 . . . . 0.0 111.683 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -54.68 -29.62 53.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.083 -0.96 . . . . 0.0 113.138 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.48 -40.9 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 171.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.0 t -104.23 -4.76 22.64 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.136 1.374 . . . . 0.0 114.458 -165.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.72 145.88 32.96 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.995 -1.066 . . . . 0.0 111.761 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -53.13 9.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.734 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -95.23 136.52 35.46 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.808 0.843 . . . . 0.0 111.326 162.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.29 -164.07 53.92 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.392 0.996 . . . . 0.0 113.053 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.17 -168.08 52.51 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.183 0.42 . . . . 0.0 112.202 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 73.3 p -98.51 7.79 45.71 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 74.7 25.72 1.49 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.797 1.239 . . . . 0.0 112.808 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.93 82.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.07 1.319 . . . . 0.0 114.007 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -68.31 149.05 98.21 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.3 1.05 . . . . 0.0 110.219 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.28 147.57 93.68 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.341 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.17 122.88 20.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.64 153.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.557 1.943 . . . . 0.0 109.025 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 63.9 m -51.91 125.38 15.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.74 0.416 . . . . 0.0 110.096 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.31 89.1 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.503 -1.165 . . . . 0.0 114.848 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.2 tt -60.03 139.48 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.487 1.644 . . . . 0.0 111.414 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.62 139.55 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.245 1.818 . . . . 0.0 109.457 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -159.89 172.88 16.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.421 1.488 . . . . 0.0 112.193 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.34 150.56 22.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.264 1.026 . . . . 0.0 110.826 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.34 127.79 23.45 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.84 150.29 55.36 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.544 2.163 . . . . 0.0 111.115 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -61.76 146.21 50.09 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.0 113.819 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.3 50.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 123.194 1.473 . . . . 0.0 110.32 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.21 171.15 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.954 139.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 34.9 t -139.5 -43.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.0 -1.063 . . . . 0.0 111.446 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.79 -111.73 3.92 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -152.26 134.32 14.97 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.19 -175.08 21.33 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.135 1.35 . . . . 0.0 113.604 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.255 1.37 0 C-N-CA 127.184 2.194 . . . . 0.0 111.448 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.594 0.235 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.2 pt -84.96 -179.74 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.702 1.201 . . . . 0.0 112.191 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 100.54 52.06 1.16 Allowed Glycine 0 N--CA 1.472 1.059 0 C-N-CA 124.68 1.133 . . . . 0.0 112.994 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -157.95 157.03 29.19 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.47 1.908 . . . . 0.0 110.069 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.14 -74.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.45 2.766 . . . . 0.0 111.692 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 31.9 t30 42.49 88.87 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.378 1.871 . . . . 0.0 114.548 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -48.62 66.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.401 1.081 . . . . 0.0 111.89 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 15.0 t -171.07 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.768 1.627 . . . . 0.0 113.62 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -67.67 144.12 55.65 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.519 -1.363 . . . . 0.0 112.536 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.23 0.38 Allowed Glycine 0 N--CA 1.474 1.233 0 C-N-CA 123.922 0.772 . . . . 0.0 114.698 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 7.6 t -131.12 -42.06 1.1 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.352 1.461 . . . . 0.0 112.542 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -150.77 155.38 39.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.414 1.885 . . . . 0.0 110.386 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 72.65 145.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.7 2.0 . . . . 0.0 111.714 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -148.4 16.54 1.03 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -158.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -79.68 142.43 35.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.709 1.203 . . . . 0.0 111.901 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.542 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 5.2 mp -90.81 7.01 41.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.603 1.561 . . . . 0.0 112.68 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -152.37 157.44 33.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.948 1.299 . . . . 0.0 111.542 -169.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.59 176.91 3.75 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.947 3.098 . . . . 0.0 112.078 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.41 62.19 1.81 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.651 1.215 . . . . 0.0 110.892 172.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.55 164.85 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.197 1.799 . . . . 0.0 112.704 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.71 147.22 36.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.031 1.332 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -80.23 68.84 6.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.384 1.073 . . . . 0.0 110.23 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 19.2 t -113.44 148.89 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 127.183 2.193 . . . . 0.0 110.122 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 88.4 p -60.22 -25.5 65.67 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -69.8 -27.1 64.61 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.346 -0.846 . . . . 0.0 112.829 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -75.83 122.22 86.6 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.271 1.028 . . . . 0.0 109.964 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.99 -17.09 51.08 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.403 2.069 . . . . 0.0 112.99 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -78.41 2.0 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.33 133.8 34.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.391 1.451 . . . . 0.0 111.988 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -136.29 149.79 68.9 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 124.058 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -68.71 153.17 73.73 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.705 2.27 . . . . 0.0 110.318 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 78.35 8.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.383 1.073 . . . . 0.0 108.673 168.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.44 118.49 5.62 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.731 2.288 . . . . 0.0 108.798 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.52 136.44 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.911 0.884 . . . . 0.0 109.529 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.64 175.0 9.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.563 1.145 . . . . 0.0 110.496 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.505 ' CE2' HD12 ' A' ' 455' ' ' ILE . 54.5 m-85 -135.63 121.72 20.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.969 0.908 . . . . 0.0 110.102 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -115.68 108.93 17.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.011 0.91 . . . . 0.0 111.096 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.1 p -65.76 -7.49 16.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.495 1.518 . . . . 0.0 114.038 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.49 -23.04 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.699 0.799 . . . . 0.0 112.324 169.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.96 151.02 86.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 112.182 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.88 161.36 36.77 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.882 3.054 . . . . 0.0 112.574 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.06 135.13 28.97 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.132 3.222 . . . . 0.0 112.552 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.8 34.64 9.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.8 1.64 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -119.49 158.86 25.4 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.78 150.72 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.545 1.938 . . . . 0.0 110.263 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.98 127.67 54.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.895 1.678 . . . . 0.0 110.672 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 457' ' ' PHE . 38.1 t -127.26 104.19 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.571 0.749 . . . . 0.0 111.414 -174.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -70.09 137.72 51.41 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.452 1.101 . . . . 0.0 112.323 169.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 m -78.39 129.92 35.51 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.442 -0.786 . . . . 0.0 112.095 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -95.65 18.06 13.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.263 1.425 . . . . 0.0 110.958 162.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 97.4 m -130.96 142.68 50.37 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 111.412 -168.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 25.6 mt -107.11 133.29 51.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.684 1.994 . . . . 0.0 108.669 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -84.65 118.74 24.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.48 108.55 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.22 -175.96 49.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.51 0.576 . . . . 0.0 111.786 167.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.84 9.43 59.41 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.439 -1.036 . . . . 0.0 114.97 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.38 118.52 68.25 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.724 1.262 . . . . 0.0 110.2 -165.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.32 136.19 33.5 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.535 2.157 . . . . 0.0 109.017 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -18.96 50.0 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -73.9 -33.99 64.22 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.699 -0.626 . . . . 0.0 112.662 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 41.3 mtm -72.98 146.19 46.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.12 0.962 . . . . 0.0 112.424 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -126.9 179.86 5.18 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 127.406 2.282 . . . . 0.0 110.911 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.69 -46.24 29.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.645 1.578 . . . . 0.0 113.483 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -76.09 -18.89 58.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.743 1.156 . . . . 0.0 110.391 168.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.86 -42.35 84.32 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.244 0.618 . . . . 0.0 110.832 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -55.89 -52.09 65.3 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 119.1 0.864 . . . . 0.0 112.369 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.5 -38.65 91.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 26.4 m -72.11 -35.94 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.758 0.708 . . . . 0.0 111.533 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' A' ' 379' ' ' VAL . 76.8 mt -85.43 -12.88 50.94 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -46.68 87.17 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.259 1.824 . . . . 0.0 114.649 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.38 -7.03 17.67 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.011 1.807 . . . . 0.0 113.434 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.79 -39.44 9.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.499 1.52 . . . . 0.0 112.614 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.0 167.0 3.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.856 1.662 . . . . 0.0 113.916 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.29 107.49 17.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.792 0.837 . . . . 0.0 110.647 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.56 144.21 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.027 0.931 . . . . 0.0 111.257 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -111.46 -38.57 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.093 1.357 . . . . 0.0 112.092 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.4 ' HA ' HD12 ' A' ' 305' ' ' LEU . 0.0 OUTLIER -150.5 155.33 39.29 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.821 1.191 . . . . 0.0 111.757 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 379' ' ' VAL . 84.0 t -147.1 127.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.844 0.858 . . . . 0.0 110.056 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.65 105.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.29 112.51 25.03 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.732 0.813 . . . . 0.0 110.41 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.56 86.06 3.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 109.851 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.02 -32.63 66.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.941 1.296 . . . . 0.0 111.629 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 34.9 m -59.06 -27.2 65.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.915 1.686 . . . . 0.0 114.378 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -114.56 10.58 16.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.112 1.365 . . . . 0.0 112.406 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 51.29 37.8 19.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.094 1.758 . . . . 0.0 113.042 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -125.27 153.79 42.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.046 1.338 . . . . 0.0 113.661 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -139.53 131.75 28.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.641 1.176 . . . . 0.0 112.168 164.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -83.75 115.48 22.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 162.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 359' ' ' LEU . 99.2 t -122.76 107.42 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.607 . . . . 0.0 110.986 -173.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 125.77 51.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.13 0.972 . . . . 0.0 111.979 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.75 168.72 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.458 1.503 . . . . 0.0 110.018 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -70.39 -24.13 62.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 2.8 p -137.18 156.05 48.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.351 1.432 . . . . 0.0 113.515 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -43.5 98.7 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.613 -0.679 . . . . 0.0 109.895 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -58.41 -37.37 75.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.602 0.761 . . . . 0.0 112.933 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.41 -49.68 72.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.941 0.897 . . . . 0.0 111.168 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.44 93.34 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.806 0.73 . . . . 0.0 112.383 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -61.07 -48.64 80.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.047 0.939 . . . . 0.0 111.15 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -62.81 -34.12 76.62 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.492 -0.755 . . . . 0.0 112.812 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.27 -64.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.656 -0.688 . . . . 0.0 109.582 166.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.38 -35.59 28.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.531 1.132 . . . . 0.0 113.646 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.35 -30.8 71.27 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.682 1.193 . . . . 0.0 113.469 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -117.22 -27.68 6.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 14.7 t80 -73.48 125.41 27.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.673 0.749 . . . . 0.0 111.28 -167.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.4 30.05 19.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.762 1.625 . . . . 0.0 113.937 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -56.23 -36.07 68.08 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.18 -0.95 . . . . 0.0 113.457 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.18 -21.35 46.51 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.566 1.146 . . . . 0.0 113.103 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.18 27.28 49.73 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.941 1.258 . . . . 0.0 113.712 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.93 -34.93 14.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.559 1.544 . . . . 0.0 114.768 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.407 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 22.3 mt -72.95 149.57 89.97 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.12 0.968 . . . . 0.0 109.698 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.54 -30.01 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.657 2.238 . . . . 0.0 112.532 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.22 149.84 47.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.752 2.021 . . . . 0.0 112.399 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -119.37 98.34 6.1 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.572 1.149 . . . . 0.0 110.421 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.85 107.65 16.38 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.197 1.799 . . . . 0.0 109.542 -169.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -117.91 166.91 11.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 108.89 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -65.59 132.53 49.09 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.203 -0.935 . . . . 0.0 111.217 163.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.49 -146.56 8.29 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.416 1.484 . . . . 0.0 109.527 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.81 143.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.398 1.479 . . . . 0.0 108.594 167.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -75.47 -82.11 0.48 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 165.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -94.74 105.75 17.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.559 0.744 . . . . 0.0 111.074 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -169.56 140.67 6.22 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.304 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.4 125.84 11.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 125.16 3.906 . . . . 0.0 109.985 174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 -65.31 -36.68 84.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.08 -18.4 62.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.501 1.921 . . . . 0.0 114.029 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.29 30.16 6.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 111.995 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.9 t -89.62 135.87 33.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.558 1.143 . . . . 0.0 111.806 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -116.96 89.38 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.249 1.82 . . . . 0.0 108.762 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -69.7 -20.87 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.33 -46.39 80.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.594 1.543 . . . . 0.0 111.187 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -86.45 -17.54 33.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.61 48.05 8.29 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.532 1.063 . . . . 0.0 112.401 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -150.08 169.74 20.55 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.284 1.042 . . . . 0.0 112.834 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 15.9 p -137.96 151.96 48.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.71 1.204 . . . . 0.0 110.802 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 22.0 mt -110.23 130.62 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.96 127.16 25.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 119.701 1.137 . . . . 0.0 111.634 -172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.31 132.79 21.51 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.875 2.383 . . . . 0.0 111.635 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 14.5 mtm -64.32 -28.22 69.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.34 1.456 . . . . 0.0 114.048 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -68.37 -23.72 64.7 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.747 0.703 . . . . 0.0 112.893 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.07 -36.55 15.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.588 1.555 . . . . 0.0 111.923 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.2 mt -53.0 117.98 3.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.987 0.812 . . . . 0.0 109.139 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.0 p -64.62 176.17 1.21 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.758 1.223 . . . . 0.0 110.753 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -62.1 -38.85 90.43 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.693 -0.63 . . . . 0.0 111.571 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.53 -40.67 80.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.822 0.849 . . . . 0.0 112.141 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.68 -58.79 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.369 1.067 . . . . 0.0 111.608 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -61.43 -36.04 79.24 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.705 0.402 . . . . 0.0 111.927 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.14 -40.3 89.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.996 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -67.45 -45.47 75.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.539 1.518 . . . . 0.0 111.456 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -52.89 -37.63 60.81 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.496 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.76 -43.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -97.45 -12.55 22.56 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.37 142.5 43.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.183 -0.948 . . . . 0.0 111.989 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -76.34 -53.49 8.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.782 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -92.97 128.32 38.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.285 1.034 . . . . 0.0 110.415 166.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.13 -173.36 45.7 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.479 1.038 . . . . 0.0 114.324 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.19 -158.96 53.8 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.469 -0.365 . . . . 0.0 112.617 -170.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.0 p -97.64 7.52 46.3 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -164.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 p 68.93 7.06 5.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.766 1.626 . . . . 0.0 114.422 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.53 1.78 32.82 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.941 1.734 . . . . 0.0 113.973 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -66.46 153.61 92.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 118.603 1.201 . . . . 0.0 110.823 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.12 147.64 94.03 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.404 2.07 . . . . 0.0 110.038 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 27.2 mt -68.74 124.52 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.865 -0.522 . . . . 0.0 109.761 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.8 t -117.53 148.89 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.292 1.837 . . . . 0.0 108.552 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 99.7 m -50.17 122.96 7.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.18 0.592 . . . . 0.0 109.806 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.57 -2.68 77.75 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.204 -1.331 . . . . 0.0 115.265 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.505 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.8 OUTLIER -54.89 123.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.708 1.754 . . . . 0.0 111.592 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.68 138.22 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 109.243 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 336' ' ' VAL . 6.3 p90 -164.6 -178.36 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.5 1.52 . . . . 0.0 112.25 175.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -93.57 153.26 18.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.626 1.17 . . . . 0.0 111.791 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -49.14 130.32 16.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.542 1.137 . . . . 0.0 113.206 -168.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.68 150.58 68.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.116 1.878 . . . . 0.0 109.689 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -55.66 156.42 4.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.227 1.011 . . . . 0.0 113.72 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mt -121.52 46.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 123.58 1.657 . . . . 0.0 109.56 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -54.25 171.22 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.527 135.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.29 -54.8 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 120.976 -1.078 . . . . 0.0 110.557 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.18 68.89 1.45 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 75.64 -55.11 0.62 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.991 2.516 . . . . 0.0 112.917 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.12 -135.23 12.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.898 1.237 . . . . 0.0 112.191 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.252 1.203 0 C-N-CA 125.783 1.633 . . . . 0.0 112.178 -177.358 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.7 mp 53.59 81.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.796 2.039 . . . . 0.0 112.006 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -177.58 43.76 0.1 OUTLIER Glycine 0 N--CA 1.473 1.155 0 O-C-N 121.538 -0.726 . . . . 0.0 114.131 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -147.94 160.21 38.38 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.289 1.436 . . . . 0.0 111.059 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.29 -159.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.815 3.677 . . . . 0.0 111.955 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -57.7 -35.36 70.52 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.915 -1.115 . . . . 0.0 113.031 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 58.3 p 50.81 27.03 2.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 127.685 2.394 . . . . 0.0 114.387 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 6.1 t -69.73 -18.69 63.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 113.742 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -46.53 124.95 6.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 0.0 111.895 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 100.87 24.21 9.32 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.343 -1.254 . . . . 0.0 114.916 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.3 m -131.57 -68.57 0.65 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.947 1.373 . . . . 0.0 111.943 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.06 -42.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.345 1.458 . . . . 0.0 112.727 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -80.25 155.56 27.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.92 0.888 . . . . 0.0 110.042 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -143.51 12.17 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -164.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -79.64 142.24 35.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.257 1.023 . . . . 0.0 111.938 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.65 -42.53 97.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.705 1.202 . . . . 0.0 111.325 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.63 61.98 1.61 Allowed Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 125.252 1.421 . . . . 0.0 113.129 -169.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.22 76.33 3.52 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.342 4.028 . . . . 0.0 111.431 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -147.92 22.92 1.1 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.68 1.592 . . . . 0.0 112.213 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.67 146.32 51.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.132 1.773 . . . . 0.0 111.464 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.88 152.68 24.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.676 1.19 . . . . 0.0 110.877 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -79.63 67.93 5.54 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 120.989 -1.07 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.2 147.9 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 127.476 2.311 . . . . 0.0 109.612 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 85.1 p -58.66 -27.55 64.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -66.02 -33.77 76.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.251 1.02 . . . . 0.0 112.683 172.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -71.4 121.96 85.77 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.899 0.88 . . . . 0.0 110.266 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.31 -17.08 49.5 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.608 2.205 . . . . 0.0 113.085 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -79.07 2.84 19.25 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -50.57 131.7 25.28 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.149 1.341 . . . . 0.0 111.209 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.37 140.81 26.9 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 123.861 0.864 . . . . 0.0 109.951 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.9 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.217 2.612 . . . . 0.0 111.026 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 66.28 49.92 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.985 1.314 . . . . 0.0 110.442 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.38 113.15 2.79 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.113 2.542 . . . . 0.0 109.734 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.02 127.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.787 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.68 167.3 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.284 1.434 . . . . 0.0 110.367 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -139.38 122.84 17.24 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.879 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.93 115.02 23.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.803 0.841 . . . . 0.0 110.373 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.4 p -70.4 -11.14 60.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 70.5 p -67.32 -22.38 65.61 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 112.365 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -69.34 147.61 97.13 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.364 0.666 . . . . 0.0 111.478 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.84 164.26 27.71 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.821 3.014 . . . . 0.0 112.65 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.47 133.75 21.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.775 2.983 . . . . 0.0 112.07 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 69.17 30.47 4.32 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.992 2.117 . . . . 0.0 112.123 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -119.97 142.28 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 451' ' ' LEU . 16.9 pt -115.31 149.15 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.458 1.503 . . . . 0.0 110.294 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 128.46 53.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.491 1.116 . . . . 0.0 110.645 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.06 104.73 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.185 0.448 . . . . 0.0 111.618 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -67.13 138.88 57.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.96 167.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 t -81.66 136.17 35.51 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.353 -0.842 . . . . 0.0 112.432 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -105.43 18.89 21.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.944 1.697 . . . . 0.0 110.42 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 92.5 m -125.26 140.69 52.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 111.523 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.18 136.06 47.66 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.143 1.777 . . . . 0.0 108.891 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.69 122.08 33.92 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.37 109.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.29 50.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.646 0.641 . . . . 0.0 111.746 168.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.25 16.02 68.51 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.697 -0.884 . . . . 0.0 114.9 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 28.7 t -78.55 116.58 60.56 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.634 1.217 . . . . 0.0 110.021 -168.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 135.86 31.08 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.325 2.016 . . . . 0.0 108.699 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.2 -15.88 38.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.01 -27.07 61.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.788 0.835 . . . . 0.0 113.106 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.5 ' SD ' HD21 ' A' ' 402' ' ' LEU . 5.4 ptp -84.55 147.46 27.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.542 0.737 . . . . 0.0 111.753 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -124.96 -167.77 1.72 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.824 1.65 . . . . 0.0 111.741 -173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -60.24 -41.71 93.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.592 1.157 . . . . 0.0 111.957 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -73.8 -24.24 59.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.0 -41.85 70.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.882 1.219 . . . . 0.0 110.757 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.1 mm? -56.14 -53.24 59.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 122.977 0.511 . . . . 0.0 110.486 170.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.35 -32.9 67.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.238 -0.887 . . . . 0.0 113.086 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -70.28 -46.16 64.9 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.996 1.271 . . . . 0.0 113.032 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.56 -36.18 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.164 0.893 . . . . 0.0 111.077 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 11.3 mp -78.65 -6.55 56.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.078 0.951 . . . . 0.0 113.342 173.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -49.93 -50.94 65.45 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-N 120.719 1.6 . . . . 0.0 114.843 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.7 -6.34 17.47 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.088 1.859 . . . . 0.0 113.207 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -97.13 -43.04 7.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.547 1.539 . . . . 0.0 112.398 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.26 169.36 2.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 113.868 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.79 119.52 32.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.443 1.097 . . . . 0.0 111.057 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.39 129.18 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.911 1.284 . . . . 0.0 109.411 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.7 -28.63 14.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 t -153.8 149.89 27.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.752 1.221 . . . . 0.0 110.828 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.32 139.45 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.614 0.765 . . . . 0.0 109.836 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.09 104.85 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 166.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.25 118.3 30.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.105 0.478 . . . . 0.0 109.913 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -102.63 79.45 1.81 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.222 1.409 . . . . 0.0 109.058 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.66 -33.49 64.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.167 1.387 . . . . 0.0 111.4 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -32.29 66.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.953 1.701 . . . . 0.0 113.443 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.29 6.79 24.85 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.397 1.479 . . . . 0.0 113.832 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.7 mttt 56.09 38.3 29.75 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.751 1.621 . . . . 0.0 112.436 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -121.66 154.31 37.0 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.03 1.732 . . . . 0.0 113.144 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.46 130.58 28.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.577 1.151 . . . . 0.0 111.698 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -84.36 123.13 29.86 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 162.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 53.0 t -122.96 118.22 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.013 0.925 . . . . 0.0 110.059 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.45 121.1 42.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 109.68 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.96 163.34 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 110.114 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -73.71 -17.71 61.09 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 6.3 p -140.8 156.69 46.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.297 . . . . 0.0 113.154 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -43.43 96.74 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.764 -0.585 . . . . 0.0 110.6 171.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -59.15 -42.08 89.87 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.887 -0.508 . . . . 0.0 111.132 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.0 -50.0 74.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.097 0.959 . . . . 0.0 112.022 171.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.12 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.624 0.647 . . . . 0.0 111.568 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -60.94 -41.31 95.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.423 0.689 . . . . 0.0 112.356 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -66.64 -33.48 75.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.309 0.959 . . . . 0.0 112.134 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.0 -64.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.351 164.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -49.82 -35.57 23.42 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -63.99 -42.19 97.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.909 1.684 . . . . 0.0 113.369 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -110.55 -26.91 9.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -171.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -70.58 122.66 20.15 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.944 0.897 . . . . 0.0 111.095 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.07 31.77 17.77 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.843 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -34.29 73.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.1 -21.18 54.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.826 1.251 . . . . 0.0 113.073 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.99 28.04 55.11 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.933 1.254 . . . . 0.0 113.685 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -92.64 -35.12 13.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.473 1.509 . . . . 0.0 114.566 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.4 mt -72.0 150.38 92.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.431 1.092 . . . . 0.0 109.789 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.93 -34.35 8.69 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.476 2.117 . . . . 0.0 112.045 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.5 HD21 ' SD ' ' A' ' 350' ' ' MET . 1.1 mp -65.76 151.61 46.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 112.575 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -127.19 94.64 4.06 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.068 1.347 . . . . 0.0 108.946 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -77.94 116.9 18.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.027 0.931 . . . . 0.0 110.389 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -120.37 171.27 8.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.933 2.093 . . . . 0.0 108.941 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -69.63 127.46 33.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.046 -1.034 . . . . 0.0 111.273 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.23 -155.68 15.1 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 125.532 1.539 . . . . 0.0 109.27 166.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.64 134.3 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.111 0.456 . . . . 0.0 111.953 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.54 -51.06 3.79 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 166.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -123.64 112.66 17.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 112.454 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.65 2.93 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.131 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.71 128.81 14.71 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 125.195 3.93 . . . . 0.0 110.48 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -34.32 76.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.04 -19.07 60.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.297 1.039 . . . . 0.0 113.756 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.76 29.47 6.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.158 1.783 . . . . 0.0 111.654 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.4 t -83.74 136.01 34.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.886 1.274 . . . . 0.0 111.301 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -121.41 76.89 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.39 1.476 . . . . 0.0 109.087 167.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -61.71 -26.68 68.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.562 -0.711 . . . . 0.0 112.553 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.6 -49.92 74.66 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.235 1.379 . . . . 0.0 111.684 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -82.44 -13.41 56.81 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.98 39.92 18.53 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 124.803 1.192 . . . . 0.0 112.749 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.87 167.02 24.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.621 1.211 . . . . 0.0 112.946 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.9 m -130.25 153.82 48.22 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.397 -0.814 . . . . 0.0 110.465 167.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 mm -106.09 133.8 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -123.58 115.61 28.26 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 120.228 1.376 . . . . 0.0 112.014 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -71.45 133.08 21.79 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.195 2.596 . . . . 0.0 111.492 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.9 mtt -61.81 -28.94 69.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.459 1.104 . . . . 0.0 113.316 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -65.59 -19.07 65.77 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.43 16.43 16.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 112.908 176.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 425' ' ' ILE . 10.4 mt -89.96 173.55 8.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.863 1.265 . . . . 0.0 112.513 170.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.4 p -127.12 169.1 13.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.039 1.336 . . . . 0.0 110.632 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.31 -33.25 69.52 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.748 -1.22 . . . . 0.0 111.166 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.83 84.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.458 1.103 . . . . 0.0 112.014 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.499 ' CG ' HD22 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -65.55 -45.14 84.51 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.656 0.662 . . . . 0.0 112.478 179.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -62.33 -41.74 98.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -59.84 -32.36 70.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.339 1.056 . . . . 0.0 113.106 171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -72.05 -50.45 28.27 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.007 1.731 . . . . 0.0 111.877 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.7 m -51.58 -39.55 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.314 0.961 . . . . 0.0 111.715 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.3 m -82.64 -50.52 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.5 t -91.07 -13.78 32.52 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.612 -1.305 . . . . 0.0 114.27 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.4 137.69 47.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.027 0.917 . . . . 0.0 111.702 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -78.05 -44.97 24.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.883 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -102.82 140.0 37.66 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.968 1.307 . . . . 0.0 111.617 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.02 -167.5 34.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.056 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.92 -146.21 47.83 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -171.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 451' ' ' LEU . 18.7 p -117.21 1.18 12.45 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -153.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.77 18.01 1.3 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.29 1.836 . . . . 0.0 112.849 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.19 12.4 61.72 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.602 1.096 . . . . 0.0 113.659 -172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -78.56 136.93 59.3 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.032 1.333 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.18 99.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.069 2.513 . . . . 0.0 109.059 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.7 OUTLIER -67.61 147.68 52.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.625 0.77 . . . . 0.0 112.189 -176.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.3 163.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.785 1.234 . . . . 0.0 111.235 -173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.8 t -51.43 127.35 19.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.916 0.886 . . . . 0.0 110.641 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 97.03 -14.39 63.9 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.938 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.26 147.33 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.077 1.939 . . . . 0.0 112.164 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.94 132.93 69.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.759 2.024 . . . . 0.0 109.052 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 446' ' ' THR . 16.4 p90 -153.36 178.05 10.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.415 1.486 . . . . 0.0 111.752 174.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.99 151.26 19.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.163 1.385 . . . . 0.0 109.631 171.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.31 129.26 5.98 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.888 1.275 . . . . 0.0 112.371 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.57 150.54 80.0 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.293 1.328 . . . . 0.0 110.077 168.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.451 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.4 m-20 -54.24 142.87 24.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 51.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.632 1.682 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.2 173.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.499 138.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.92 -60.35 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.106 -0.996 . . . . 0.0 110.507 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.86 -71.37 2.97 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -169.81 160.73 8.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.115 1.366 . . . . 0.0 111.751 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -142.89 -162.64 9.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.636 1.589 . . . . 0.0 113.136 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.412 1.485 . . . . 0.0 110.902 179.376 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.362 0.125 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.65 -53.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.52 1.128 . . . . 0.0 110.536 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 115.75 -167.34 12.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.794 1.664 . . . . 0.0 112.19 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.74 28.85 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.745 1.618 . . . . 0.0 110.984 -175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.04 -156.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.55 3.5 . . . . 0.0 111.688 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -54.15 -41.5 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.036 -1.04 . . . . 0.0 113.061 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 72.3 p 50.9 26.72 2.78 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 127.837 2.455 . . . . 0.0 114.378 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.6 t -74.22 -11.92 60.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.884 1.674 . . . . 0.0 113.545 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -51.26 129.64 25.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.49 1.516 . . . . 0.0 111.616 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.34 78.92 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.5 -1.167 . . . . 0.0 114.799 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 6.5 m -122.2 -65.11 1.14 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.86 1.264 . . . . 0.0 110.866 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -172.4 137.47 0.86 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.366 1.867 . . . . 0.0 110.754 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.42 165.8 0.15 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.526 1.53 . . . . 0.0 113.176 -174.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -136.56 9.74 3.15 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.15 143.23 52.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.384 1.074 . . . . 0.0 112.322 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.4 mm? -62.91 -46.29 88.51 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.034 0.934 . . . . 0.0 112.183 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.01 155.75 37.92 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.193 1.397 . . . . 0.0 112.522 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.08 79.71 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.886 3.058 . . . . 0.0 111.402 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 t70 74.76 -62.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.882 2.873 . . . . 0.0 111.222 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . 0.25 21.2 pt-20 44.58 -173.33 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.114 2.966 . . . . 0.0 114.801 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mp -143.74 165.85 26.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.653 1.181 . . . . 0.0 110.245 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.06 62.8 3.56 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.734 1.214 . . . . 0.0 111.307 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.22 152.37 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 127.166 2.186 . . . . 0.0 111.415 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 60.0 p -67.06 -22.68 65.85 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.81 -23.89 61.63 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.181 0.992 . . . . 0.0 112.9 172.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -78.87 126.12 82.86 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.155 0.982 . . . . 0.0 110.309 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.26 -17.45 49.94 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.782 2.322 . . . . 0.0 113.589 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -79.02 7.1 7.86 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.743 1.217 . . . . 0.0 114.083 166.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -55.12 125.17 19.41 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.253 -1.529 . . . . 0.0 111.471 171.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.7 mmt-85 -160.24 148.33 13.11 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.758 1.623 . . . . 0.0 110.693 -170.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.06 173.47 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.644 2.229 . . . . 0.0 111.611 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -114.84 99.32 51.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.192 0.597 . . . . 0.0 109.504 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.03 154.79 25.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.522 2.815 . . . . 0.0 110.821 171.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.08 142.06 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.329 1.452 . . . . 0.0 108.967 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.74 168.09 17.77 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.388 1.075 . . . . 0.0 111.166 171.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.12 121.98 15.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.766 1.226 . . . . 0.0 109.996 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.23 107.18 12.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.822 1.249 . . . . 0.0 110.164 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 50.3 p -71.55 -4.13 25.19 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -24.59 66.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.94 1.296 . . . . 0.0 112.175 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.16 151.21 97.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.064 0.946 . . . . 0.0 112.001 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.26 161.74 32.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.826 3.017 . . . . 0.0 112.659 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.56 131.19 18.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.746 2.964 . . . . 0.0 112.057 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.05 36.21 4.28 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.074 2.15 . . . . 0.0 111.807 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -122.57 155.26 36.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.649 1.18 . . . . 0.0 113.74 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 455' ' ' ILE . 16.6 pt -123.61 154.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.652 1.981 . . . . 0.0 110.546 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -110.55 125.17 53.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.118 0.967 . . . . 0.0 110.946 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.11 105.1 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.505 1.122 . . . . 0.0 109.785 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.93 136.28 52.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.627 1.171 . . . . 0.0 111.218 168.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.7 t -73.96 138.84 44.46 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 121.325 -0.859 . . . . 0.0 112.203 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.5 mtm180 -107.37 -1.27 21.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.889 1.676 . . . . 0.0 111.815 164.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 23.1 m -100.54 123.62 45.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.072 1.349 . . . . 0.0 109.093 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.45 141.46 28.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.568 1.547 . . . . 0.0 108.751 168.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -93.93 142.99 26.75 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.47 111.93 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.169 1.388 . . . . 0.0 108.441 -172.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -91.01 172.75 37.14 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.197 0.904 . . . . 0.0 111.768 168.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.6 23.36 78.04 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.316 -0.713 . . . . 0.0 114.736 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.0 t -84.26 115.72 61.55 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 118.491 1.146 . . . . 0.0 110.405 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.87 142.24 61.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.924 2.416 . . . . 0.0 110.032 170.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.08 -20.12 50.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -21.34 52.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 22.9 mtm -83.94 144.06 29.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.949 0.881 . . . . 0.0 112.165 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -128.31 -177.16 4.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.832 2.053 . . . . 0.0 110.624 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -49.41 -39.26 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.73 1.612 . . . . 0.0 114.713 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 305' ' ' LEU . 98.5 m95 -79.36 -17.77 53.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -75.75 -38.54 58.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.549 1.068 . . . . 0.0 110.519 168.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.8 mm? -59.87 -49.07 79.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.582 168.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.36 -33.56 69.7 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.102 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -73.97 -42.45 60.45 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.923 1.238 . . . . 0.0 114.314 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.29 -35.19 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.029 1.286 . . . . 0.0 111.459 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.546 HD23 ' CE1' ' A' ' 394' ' ' PHE . 37.8 mt -87.97 -5.63 58.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.455 1.102 . . . . 0.0 113.081 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -52.53 -49.0 88.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.88 -6.17 17.77 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.616 2.21 . . . . 0.0 113.379 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -98.5 -35.91 10.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.332 1.453 . . . . 0.0 112.871 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.55 3.5 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.214 1.805 . . . . 0.0 113.936 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 122.23 30.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.184 1.394 . . . . 0.0 110.61 169.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.46 122.74 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.693 0.797 . . . . 0.0 109.592 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -96.72 -35.5 10.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.588 1.555 . . . . 0.0 112.459 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.95 155.57 44.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.36 1.064 . . . . 0.0 111.907 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 27.0 t -149.22 140.18 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 0.0 110.621 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.26 101.48 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.392 1.477 . . . . 0.0 108.254 168.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.63 131.11 49.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.174 0.59 . . . . 0.0 110.823 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 87.49 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.394 1.092 . . . . 0.0 109.96 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.42 -29.54 67.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.273 1.429 . . . . 0.0 112.237 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.3 t -59.27 -28.28 66.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.888 1.675 . . . . 0.0 114.092 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.22 1.38 16.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.083 1.753 . . . . 0.0 112.727 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 59.51 37.46 22.84 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.318 1.447 . . . . 0.0 112.26 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -125.51 167.0 15.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.42 164.76 29.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.501 1.12 . . . . 0.0 112.315 163.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.94 135.38 54.92 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.331 1.453 . . . . 0.0 108.396 162.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 359' ' ' LEU . 73.0 t -128.44 118.03 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.116 0.966 . . . . 0.0 110.92 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -101.67 120.3 40.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.786 1.234 . . . . 0.0 112.059 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.9 m -100.99 -179.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.136 0.974 . . . . 0.0 111.429 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -64.93 -37.4 87.53 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.928 1.24 . . . . 0.0 114.155 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 383' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 60.3 p -149.06 166.42 28.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -167.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -39.25 89.62 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.175 169.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -62.39 -40.36 96.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.917 0.78 . . . . 0.0 112.352 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.62 -47.76 71.61 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.37 0.668 . . . . 0.0 110.488 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.92 98.65 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.383 -0.823 . . . . 0.0 112.107 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -65.5 -40.52 93.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.935 171.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.99 -33.38 75.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.946 1.248 . . . . 0.0 112.333 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.99 -65.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 118.461 0.573 . . . . 0.0 109.886 164.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.48 -33.22 43.76 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -69.29 -35.3 75.87 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 113.454 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -111.49 -26.04 9.28 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.7 t80 -72.6 124.25 24.87 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.415 0.686 . . . . 0.0 111.872 -168.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 60.67 28.77 18.48 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.712 1.605 . . . . 0.0 114.134 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -31.03 70.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.791 -1.193 . . . . 0.0 113.737 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.16 -18.3 50.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.601 1.16 . . . . 0.0 113.382 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.72 17.69 69.92 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.848 1.213 . . . . 0.0 114.001 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.55 -31.27 19.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.54 1.536 . . . . 0.0 114.845 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 42.8 mt -79.22 149.18 72.37 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.195 0.998 . . . . 0.0 109.895 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.33 -27.84 11.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.689 2.26 . . . . 0.0 112.394 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.17 147.04 45.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.806 1.242 . . . . 0.0 111.863 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.89 103.25 8.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.564 1.146 . . . . 0.0 110.592 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -86.84 122.4 30.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 111.401 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -129.35 177.09 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.304 2.642 . . . . 0.0 109.146 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -76.05 130.84 38.98 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.777 -1.202 . . . . 0.0 111.651 162.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.0 -160.56 21.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.274 1.892 . . . . 0.0 109.594 162.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.61 125.94 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.892 1.277 . . . . 0.0 109.47 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -90.21 -43.49 4.97 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 162.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -137.66 124.4 21.11 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.168 0.987 . . . . 0.0 110.866 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 174.09 129.92 1.23 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.068 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.27 123.51 10.0 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.78 3.654 . . . . 0.0 109.797 172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.7 -37.89 74.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.279 0.561 . . . . 0.0 112.476 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.79 -18.6 62.09 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.026 2.13 . . . . 0.0 114.545 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.66 24.21 8.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.844 1.658 . . . . 0.0 112.084 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.65 140.99 29.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.309 1.444 . . . . 0.0 111.776 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.81 88.8 3.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.376 1.471 . . . . 0.0 109.199 166.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -65.78 -20.76 66.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.42 -51.51 23.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.637 0.775 . . . . 0.0 110.347 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.87 -17.67 55.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.42 36.18 27.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 124.967 1.27 . . . . 0.0 113.294 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -144.33 164.89 29.47 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.165 0.986 . . . . 0.0 112.893 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.6 m -129.73 150.52 51.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.296 1.038 . . . . 0.0 110.521 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.48 139.38 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.99 126.65 19.77 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 120.017 1.28 . . . . 0.0 111.608 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.25 135.74 27.61 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.565 2.176 . . . . 0.0 111.097 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 5.3 mtm -61.7 -33.78 74.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.498 1.119 . . . . 0.0 113.096 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -68.04 -21.91 64.99 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 119.249 0.931 . . . . 0.0 113.506 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -83.48 -38.84 21.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.184 1.393 . . . . 0.0 111.543 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.97 124.04 13.18 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.728 0.695 . . . . 0.0 109.224 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.5 p -70.77 174.7 5.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.652 1.181 . . . . 0.0 110.942 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -44.0 76.03 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.759 -0.588 . . . . 0.0 111.012 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.66 82.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.291 1.036 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.0 -51.29 70.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.7 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -63.24 -42.94 99.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -52.68 -49.74 64.67 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -69.14 -44.78 71.64 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.494 1.043 . . . . 0.0 111.55 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 64.3 m -52.63 -35.74 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.637 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.38 -42.67 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.2 t -97.63 -9.95 25.95 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -165.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.42 141.02 48.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.975 -1.078 . . . . 0.0 112.279 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -75.67 -22.78 56.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.707 0.803 . . . . 0.0 111.693 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -131.34 144.77 51.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.086 2.155 . . . . 0.0 110.566 167.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.41 -176.89 41.0 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.978 0.799 . . . . 0.0 113.014 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.13 -153.3 49.54 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 122.25 -0.559 . . . . 0.0 113.941 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.6 p -102.76 7.64 39.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.769 1.627 . . . . 0.0 115.173 -163.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.1 m 73.58 8.31 5.04 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.83 2.85 59.51 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.326 1.441 . . . . 0.0 113.58 -170.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -68.33 154.97 93.45 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.754 1.277 . . . . 0.0 110.454 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.01 141.41 83.72 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.062 1.842 . . . . 0.0 110.198 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 118.47 10.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 166.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.83 154.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.189 1.396 . . . . 0.0 109.671 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -57.27 133.63 55.26 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.806 0.442 . . . . 0.0 110.049 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.45 -8.79 79.09 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.449 -1.195 . . . . 0.0 115.181 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 334' ' ' ILE . 15.6 tt -62.41 138.82 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.985 1.892 . . . . 0.0 111.749 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.12 137.93 55.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 108.875 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.63 -179.27 7.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.149 1.38 . . . . 0.0 110.858 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -99.87 146.01 27.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.513 1.925 . . . . 0.0 110.68 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -44.32 131.87 4.6 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.451 1.5 . . . . 0.0 114.313 -166.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.36 163.99 36.74 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.143 1.895 . . . . 0.0 111.804 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.53 137.04 56.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 112.613 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.52 54.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 123.581 1.658 . . . . 0.0 109.531 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.86 178.87 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.245 140.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.05 -45.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.282 -0.886 . . . . 0.0 112.099 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.09 -59.42 4.54 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.688 1.137 . . . . 0.0 111.832 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.44 159.78 17.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.122 1.769 . . . . 0.0 110.901 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -134.31 -179.84 16.84 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.766 1.65 . . . . 0.0 113.016 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.445 1.498 . . . . 0.0 111.32 177.212 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.448 0.642 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 46.8 pt -87.94 153.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.662 -1.274 . . . . 0.0 111.535 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 75.99 120.15 0.14 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.863 1.221 . . . . 0.0 111.943 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -158.7 156.1 26.34 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.141 0.976 . . . . 0.0 111.551 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.95 178.27 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.081 3.188 . . . . 0.0 111.373 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.85 -4.67 7.17 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.4 p 64.48 6.99 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 129.697 3.199 . . . . 0.0 115.071 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.57 -33.98 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.737 2.815 . . . . 0.0 111.849 -172.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.256 0.1 OUTLIER 55.32 -154.28 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.344 1.458 . . . . 0.0 111.817 176.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 125.74 121.55 2.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 125.303 1.43 . . . . 0.0 112.693 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.5 m 74.99 -46.6 0.6 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 128.023 2.529 . . . . 0.0 112.603 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.25 -25.1 63.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.462 1.505 . . . . 0.0 113.165 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -176.47 -41.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 113.813 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 8.4 m80 56.41 17.42 2.92 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.743 1.217 . . . . 0.0 113.349 -160.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 367' ' ' SER . 31.5 m80 -89.11 147.94 23.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.971 1.709 . . . . 0.0 113.026 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.8 18.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.062 2.145 . . . . 0.0 113.029 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.58 162.29 23.51 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.915 1.686 . . . . 0.0 112.275 -168.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.48 -157.92 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.828 3.686 . . . . 0.0 111.58 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -49.44 -51.81 33.08 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.419 -1.425 . . . . 0.0 112.799 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 37.94 -151.26 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.293 2.237 . . . . 0.0 114.17 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.75 156.51 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.462 1.505 . . . . 0.0 111.236 173.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -79.47 65.22 4.58 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.34 -0.85 . . . . 0.0 110.302 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.04 149.49 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 126.775 2.03 . . . . 0.0 111.827 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 87.6 p -61.21 -26.88 68.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -70.89 -25.28 62.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.968 0.907 . . . . 0.0 113.016 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -79.26 122.08 83.75 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.078 0.951 . . . . 0.0 110.067 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.67 -16.14 45.99 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.657 2.238 . . . . 0.0 113.175 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -73.02 -6.2 43.9 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -48.42 131.08 17.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.761 1.164 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 134.45 11.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.77 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.73 168.49 22.68 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.235 2.623 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.87 70.59 10.27 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.602 1.561 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.77 115.15 3.43 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.099 2.533 . . . . 0.0 110.004 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.79 144.45 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.552 1.141 . . . . 0.0 109.362 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.7 173.17 11.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.265 1.026 . . . . 0.0 110.899 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 455' ' ' ILE . 44.4 m-85 -136.4 121.11 18.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.472 1.109 . . . . 0.0 109.634 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -115.55 108.02 15.9 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.826 1.251 . . . . 0.0 110.444 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.7 p -66.67 -8.93 31.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -25.07 67.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.088 1.355 . . . . 0.0 112.439 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.26 151.94 96.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.636 0.774 . . . . 0.0 111.927 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.54 162.41 31.16 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.891 3.061 . . . . 0.0 112.722 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 131.95 19.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.813 3.009 . . . . 0.0 112.176 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 68.38 33.7 4.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.744 2.018 . . . . 0.0 112.162 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -121.47 151.14 40.58 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.43 146.11 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.128 1.771 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -110.25 128.72 55.66 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.5 1.046 . . . . 0.0 111.529 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.3 t -125.01 104.47 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.5 0.72 . . . . 0.0 111.112 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.72 134.54 54.42 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.644 1.177 . . . . 0.0 111.589 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 33.3 t -76.34 138.99 40.81 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.193 -0.942 . . . . 0.0 111.651 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.5 mtm105 -109.63 13.96 23.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.102 1.761 . . . . 0.0 110.835 163.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.0 m -113.95 136.23 53.12 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.125 1.77 . . . . 0.0 111.052 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.7 mt -102.61 137.41 40.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.057 1.743 . . . . 0.0 110.131 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -84.12 138.84 32.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 158.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 22.9 mm -127.67 105.16 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.168 1.387 . . . . 0.0 108.346 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -81.35 178.8 53.77 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 121.366 -0.834 . . . . 0.0 111.506 165.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.33 37.28 86.03 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.72 -0.871 . . . . 0.0 113.822 173.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.08 85.14 6.34 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 125.553 1.541 . . . . 0.0 110.358 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.43 161.18 42.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.547 . . . . 0.0 111.012 171.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.8 -20.31 48.96 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -28.52 69.72 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.211 1.005 . . . . 0.0 113.058 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.5 ptm -110.9 135.93 50.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.221 1.01 . . . . 0.0 112.097 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -116.97 -176.05 2.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.257 1.823 . . . . 0.0 111.24 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.92 -34.6 68.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.535 1.134 . . . . 0.0 113.238 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -78.43 -24.18 46.28 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.11 -43.34 71.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.052 0.842 . . . . 0.0 109.851 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 37.3 mt -57.74 -52.89 63.58 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.997 0.519 . . . . 0.0 109.927 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.96 -37.25 63.72 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -72.04 -39.55 69.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.13 -30.98 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.974 1.261 . . . . 0.0 111.653 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.8 mt -81.21 -13.75 58.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.29 1.436 . . . . 0.0 112.916 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -48.09 -48.93 62.69 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.41 -4.64 15.59 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.351 2.034 . . . . 0.0 113.533 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -101.89 -41.28 6.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.62 1.568 . . . . 0.0 112.643 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.75 168.05 4.38 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 111.704 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 132.94 34.7 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.852 -0.53 . . . . 0.0 109.624 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.76 136.28 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.835 0.854 . . . . 0.0 110.133 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -41.54 6.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.339 1.456 . . . . 0.0 112.531 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 304' ' ' HIS . 0.1 OUTLIER -149.28 157.6 43.48 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.827 1.251 . . . . 0.0 109.743 -176.239 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.92 133.41 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.81 99.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 165.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 137.7 37.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.7 64.77 1.6 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.388 1.075 . . . . 0.0 110.785 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -56.48 -34.4 66.88 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 0.0 112.249 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 m -61.34 -31.41 71.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.799 1.239 . . . . 0.0 113.737 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -96.77 6.99 47.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.366 1.466 . . . . 0.0 113.239 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 63.02 21.2 12.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.247 1.819 . . . . 0.0 113.463 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -135.85 175.52 9.52 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.87 167.01 24.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.104 1.762 . . . . 0.0 111.44 166.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.81 131.69 54.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.015 1.326 . . . . 0.0 108.393 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 60.4 t -122.98 132.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.628 1.171 . . . . 0.0 109.642 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -111.87 126.84 55.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.618 1.567 . . . . 0.0 110.68 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 166.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 0.0 109.812 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -78.7 -23.2 45.72 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -167.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.53 149.46 50.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.781 1.232 . . . . 0.0 111.948 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -55.3 -41.73 72.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.288 1.035 . . . . 0.0 111.777 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -66.24 -36.65 83.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.736 -0.602 . . . . 0.0 112.058 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.72 -49.28 78.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.609 0.764 . . . . 0.0 110.771 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.73 98.23 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.638 -0.664 . . . . 0.0 111.962 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.23 -42.14 98.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.282 1.033 . . . . 0.0 111.556 170.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -67.06 -32.29 73.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.553 1.069 . . . . 0.0 112.757 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.31 -63.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 118.69 -0.671 . . . . 0.0 109.956 165.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.11 -32.99 50.26 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.92 -34.52 74.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.55 1.54 . . . . 0.0 113.377 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -124.39 -31.19 3.31 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -71.77 119.38 15.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.313 1.045 . . . . 0.0 111.159 -167.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 32.4 t30 58.07 25.48 12.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.535 1.534 . . . . 0.0 114.39 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -34.12 77.41 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.66 -1.275 . . . . 0.0 113.251 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.75 -18.32 61.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 112.775 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.19 22.29 63.38 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.067 1.318 . . . . 0.0 113.689 -172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -85.25 -31.5 23.09 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.096 1.359 . . . . 0.0 114.506 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.47 151.94 59.86 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.402 1.081 . . . . 0.0 110.017 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.0 -22.95 22.33 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.722 2.281 . . . . 0.0 113.54 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 402' ' ' LEU . 1.6 mm? -63.95 168.43 5.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.789 1.636 . . . . 0.0 112.957 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 84.97 2.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.401 1.08 . . . . 0.0 110.797 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 117.07 20.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.873 1.669 . . . . 0.0 110.372 -171.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -135.18 169.11 17.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.144 1.378 . . . . 0.0 109.791 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -63.94 119.74 10.65 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.494 -0.754 . . . . 0.0 110.654 165.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.55 -155.44 29.28 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 163.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.7 137.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.869 0.468 . . . . 0.0 111.742 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.91 -52.93 2.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -122.82 111.53 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 111.362 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.7 140.34 4.23 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.126 -0.819 . . . . 0.0 114.861 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.65 131.96 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 125.178 3.919 . . . . 0.0 110.264 174.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -65.24 -34.24 77.89 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.47 -18.64 58.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 89.8 m -123.3 29.75 6.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.141 1.776 . . . . 0.0 112.137 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 14.4 p -76.55 149.5 36.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.867 0.841 . . . . 0.0 112.138 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -132.82 72.6 1.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.475 1.51 . . . . 0.0 108.798 166.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.47 -19.63 63.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.34 -51.85 53.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.899 1.227 . . . . 0.0 110.975 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -80.36 -16.2 55.1 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.01 37.59 12.57 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.054 1.312 . . . . 0.0 112.98 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -145.98 170.31 16.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.01 1.405 . . . . 0.0 112.525 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 37.9 m -136.21 151.39 49.65 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 121.649 -0.657 . . . . 0.0 110.243 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.54 128.65 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.01 121.29 28.86 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.178 -171.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.03 141.65 36.92 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.99 1.793 . . . . 0.0 110.269 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 7.3 mtt -59.04 -31.22 68.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.356 1.062 . . . . 0.0 113.411 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.7 -21.92 66.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.05 0.841 . . . . 0.0 113.265 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.44 5.63 50.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.561 1.944 . . . . 0.0 113.741 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.1 126.38 39.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.323 171.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.8 p -77.47 -179.93 6.09 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.309 1.444 . . . . 0.0 111.343 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -62.5 -42.09 99.26 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.518 -0.739 . . . . 0.0 111.527 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.67 -40.7 92.67 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.137 0.975 . . . . 0.0 112.031 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.99 -51.94 67.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -66.42 -40.45 89.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.921 0.888 . . . . 0.0 111.339 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -58.34 -38.93 78.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.212 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -72.29 -44.77 62.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.818 1.644 . . . . 0.0 111.63 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 62.6 m -50.91 -38.43 49.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.815 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.6 m -87.31 -51.95 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.2 t -92.79 -9.33 40.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.48 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.82 141.29 39.33 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.218 -0.926 . . . . 0.0 111.653 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -73.72 -57.6 3.88 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.622 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -93.81 137.03 33.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.051 . . . . 0.0 111.367 167.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 67.44 -169.09 37.56 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.277 0.942 . . . . 0.0 113.755 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 67.01 -150.03 51.67 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 451' ' ' LEU . 23.4 p -112.26 9.85 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.6 m 69.82 14.38 8.02 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.12 1.368 . . . . 0.0 113.238 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.59 41.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.805 1.193 . . . . 0.0 113.829 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.7 144.86 37.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.906 1.353 . . . . 0.0 111.353 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.5 104.39 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.457 2.772 . . . . 0.0 108.883 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -77.63 142.22 39.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.8 m -130.42 168.15 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.165 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 10.7 t -48.66 127.34 13.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.306 1.042 . . . . 0.0 111.296 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 96.51 -14.36 64.34 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.264 -1.298 . . . . 0.0 115.204 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.6 OUTLIER -53.83 136.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.921 1.86 . . . . 0.0 112.252 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.32 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 126.624 1.97 . . . . 0.0 108.787 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -152.36 179.31 8.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.453 1.501 . . . . 0.0 111.086 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -99.21 154.29 18.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.846 1.258 . . . . 0.0 110.569 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -46.58 129.5 8.23 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.971 1.308 . . . . 0.0 112.446 -166.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.54 152.87 70.51 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.822 1.681 . . . . 0.0 110.019 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.48 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 82.7 m-20 -57.96 135.35 56.91 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.467 1.107 . . . . 0.0 113.29 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.47 50.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 123.306 1.527 . . . . 0.0 109.923 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.8 pt -54.92 170.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.932 137.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 42.2 t -138.36 -38.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.109 -0.995 . . . . 0.0 111.296 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -117.54 5.76 Favored Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -167.52 176.06 6.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.705 1.202 . . . . 0.0 111.052 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.65 -129.82 1.34 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.458 1.028 . . . . 0.0 112.064 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.437 1.495 . . . . 0.0 110.224 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.484 0.183 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.69 27.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.88 1.672 . . . . 0.0 112.214 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.32 162.05 32.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.312 0.958 . . . . 0.0 111.784 -167.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -148.61 162.37 30.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.496 1.518 . . . . 0.0 109.802 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -72.1 -157.64 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.324 2.683 . . . . 0.0 111.021 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -52.37 -36.44 53.81 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 57.8 p 45.47 28.06 0.45 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.721 2.808 . . . . 0.0 115.709 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 24.9 p -74.24 -16.02 60.97 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.498 1.519 . . . . 0.0 113.192 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -55.79 163.35 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.032 1.733 . . . . 0.0 113.474 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.04 -12.93 68.28 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.642 1.115 . . . . 0.0 113.567 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.94 -164.23 0.97 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.331 1.853 . . . . 0.0 109.972 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -63.84 -26.12 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -79.43 143.53 34.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.987 0.915 . . . . 0.0 111.95 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -154.82 16.97 0.44 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -162.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -76.52 149.33 36.72 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.065 1.346 . . . . 0.0 112.583 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.4 mp -98.07 -39.85 8.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.232 1.013 . . . . 0.0 111.596 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -127.91 65.59 68.92 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.137 0.975 . . . . 0.0 110.142 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.9 -175.74 1.54 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.825 3.016 . . . . 0.0 110.948 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.9 t0 66.52 54.64 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.643 1.577 . . . . 0.0 111.709 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -158.33 157.41 32.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.778 1.631 . . . . 0.0 112.033 -173.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.07 163.73 17.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.771 1.228 . . . . 0.0 110.832 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.0 64.34 3.18 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.408 1.083 . . . . 0.0 110.616 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.89 150.09 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 127.336 2.254 . . . . 0.0 111.425 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 78.4 p -63.42 -26.2 68.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -70.76 -25.94 63.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -79.26 122.83 84.61 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.069 0.948 . . . . 0.0 110.185 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.23 -16.75 49.26 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.53 2.153 . . . . 0.0 113.164 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -76.11 0.51 18.59 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 168.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.41 135.47 17.61 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.559 1.527 . . . . 0.0 112.044 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -140.73 149.96 58.43 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 124.273 1.029 . . . . 0.0 111.04 174.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.38 169.34 21.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.834 3.023 . . . . 0.0 111.639 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -124.17 71.32 54.05 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.435 1.094 . . . . 0.0 110.5 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.03 108.21 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.617 2.211 . . . . 0.0 109.288 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.0 139.29 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.349 1.06 . . . . 0.0 109.527 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.44 172.61 12.67 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.651 1.581 . . . . 0.0 109.878 174.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.97 124.09 13.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.026 -1.047 . . . . 0.0 109.103 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -121.69 110.42 15.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.9 t -70.16 -6.14 32.17 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -24.99 67.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.08 . . . . 0.0 112.13 170.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 150.47 90.72 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 111.669 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.31 164.09 26.97 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.974 3.116 . . . . 0.0 113.3 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.64 136.83 28.97 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 112.375 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.13 38.55 16.87 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.596 1.559 . . . . 0.0 112.786 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -124.25 158.17 33.13 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.971 1.308 . . . . 0.0 113.834 171.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 455' ' ' ILE . 2.7 pt -128.53 152.64 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.785 2.034 . . . . 0.0 110.69 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.32 132.05 54.49 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.575 -1.328 . . . . 0.0 111.449 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.499 HG22 ' CE2' ' A' ' 457' ' ' PHE . 61.4 t -126.59 105.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 -171.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -68.74 129.72 40.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 111.915 168.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 2.4 m -71.43 134.62 46.74 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.802 -0.561 . . . . 0.0 111.65 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.4 mtm105 -102.98 16.3 27.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.696 1.999 . . . . 0.0 110.614 162.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 93.6 m -123.91 133.94 53.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.66 1.584 . . . . 0.0 110.623 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 46.5 mt -101.11 138.36 38.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.755 2.422 . . . . 0.0 109.785 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -86.31 124.16 32.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 162.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.38 103.05 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.061 0.944 . . . . 0.0 108.466 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -82.17 -175.89 50.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 164.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.0 30.1 75.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.665 -0.903 . . . . 0.0 113.854 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.73 103.68 12.15 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.446 1.098 . . . . 0.0 110.045 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 144.73 64.88 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.277 1.985 . . . . 0.0 109.918 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.8 mp -65.24 -19.67 66.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -63.76 -32.54 74.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.764 1.226 . . . . 0.0 112.858 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -87.84 154.79 20.26 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -134.13 -175.99 4.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.499 1.519 . . . . 0.0 111.312 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 352' ' ' GLU . 1.7 mp0 -52.93 -38.4 61.9 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.167 2.187 . . . . 0.0 112.441 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -75.98 -26.61 56.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.58 -43.25 81.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.633 1.106 . . . . 0.0 109.679 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.72 -48.41 81.27 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.669 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -53.0 -46.2 68.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.397 0.999 . . . . 0.0 113.023 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.56 -37.64 80.08 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.45 -33.09 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.095 0.861 . . . . 0.0 111.887 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.58 -14.13 55.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -49.86 -48.92 76.69 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.943 1.697 . . . . 0.0 115.426 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.71 -6.39 18.14 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.008 1.806 . . . . 0.0 112.955 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.33 -46.49 5.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.281 1.433 . . . . 0.0 112.12 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.24 1.69 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.062 1.745 . . . . 0.0 113.469 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.74 133.8 34.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.001 . . . . 0.0 110.913 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.05 130.02 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.707 1.203 . . . . 0.0 109.579 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -91.52 -44.39 9.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.087 0.955 . . . . 0.0 111.69 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.5 p -161.26 163.47 30.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.822 1.249 . . . . 0.0 111.25 -171.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 305' ' ' LEU . 0.6 OUTLIER -165.44 132.52 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.57 0.748 . . . . 0.0 111.767 174.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.93 105.42 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 377' ' ' ALA . 0.9 OUTLIER -99.43 115.52 29.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.103 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.88 83.64 2.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.617 1.567 . . . . 0.0 109.205 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -55.5 -37.93 68.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.174 0.99 . . . . 0.0 111.418 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 m -61.38 -28.89 69.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.872 2.069 . . . . 0.0 113.877 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.95 4.5 34.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.991 1.716 . . . . 0.0 112.817 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 79.9 mttt 55.38 34.6 23.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.178 1.791 . . . . 0.0 112.897 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -131.82 156.48 45.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.66 1.584 . . . . 0.0 113.59 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.439 ' HB2' ' HG ' ' A' ' 370' ' ' LEU . . . -141.76 134.25 28.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.125 1.37 . . . . 0.0 112.637 166.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -88.74 102.43 14.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 166.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 38.8 t -99.38 120.52 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.983 0.913 . . . . 0.0 110.964 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -106.19 126.33 52.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.078 0.951 . . . . 0.0 111.898 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.7 169.13 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.934 1.294 . . . . 0.0 110.168 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -75.48 -15.63 60.39 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -168.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.0 160.9 43.05 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.258 -0.901 . . . . 0.0 112.421 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.36 -41.99 98.85 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.594 0.758 . . . . 0.0 111.456 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.92 -41.64 87.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.346 0.521 . . . . 0.0 111.299 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.66 -51.84 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.08 0.952 . . . . 0.0 109.692 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.27 95.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.557 0.743 . . . . 0.0 112.633 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.3 -43.07 99.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.173 0.989 . . . . 0.0 111.267 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -66.52 -34.19 77.37 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.407 -0.808 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 66.2 t -60.37 -65.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.766 164.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.1 mt -51.95 -35.23 45.35 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -60.16 -37.48 80.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.837 1.255 . . . . 0.0 112.906 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.23 -27.41 7.64 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.56 125.87 28.2 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.78 23.06 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -53.83 -48.04 70.32 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.064 -1.023 . . . . 0.0 113.607 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.45 5.55 49.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.555 1.942 . . . . 0.0 112.806 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 72.62 38.71 57.16 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.566 1.079 . . . . 0.0 112.922 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -57.48 -29.52 64.32 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.232 1.013 . . . . 0.0 113.569 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.12 162.98 25.06 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.763 1.625 . . . . 0.0 110.045 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 -15.73 21.43 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.98 2.453 . . . . 0.0 113.408 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.68 161.01 21.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.342 2.257 . . . . 0.0 112.455 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -128.46 97.08 4.6 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.845 1.258 . . . . 0.0 109.995 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.98 21.24 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.46 1.904 . . . . 0.0 111.739 -177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.18 173.2 11.27 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.295 1.838 . . . . 0.0 108.999 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -70.18 125.44 26.78 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.154 -0.966 . . . . 0.0 110.902 163.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.46 -154.38 14.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.606 1.574 . . . . 0.0 109.174 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -163.49 136.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.646 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -94.42 -45.21 3.29 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.114 1.34 . . . . 0.0 110.296 163.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -124.29 109.99 14.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.148 0.979 . . . . 0.0 113.401 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -176.52 136.4 3.21 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.487 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.57 126.56 12.91 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.094 3.862 . . . . 0.0 110.194 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -36.6 80.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 112.404 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.07 -18.23 60.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.63 1.572 . . . . 0.0 114.285 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.2 27.18 8.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.753 1.621 . . . . 0.0 111.885 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.5 t -84.83 135.42 34.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.59 1.156 . . . . 0.0 111.69 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.05 79.6 1.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.349 1.46 . . . . 0.0 109.34 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -62.83 -24.05 67.58 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.517 -0.74 . . . . 0.0 112.926 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -64.22 -49.36 72.25 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.827 1.194 . . . . 0.0 111.321 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -81.72 -17.38 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 81.77 41.02 10.05 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 124.844 1.212 . . . . 0.0 112.624 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -147.54 165.79 29.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.62 1.21 . . . . 0.0 112.978 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 22.4 m -129.49 152.48 48.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.556 0.742 . . . . 0.0 110.368 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.76 136.24 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.795 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.43 120.04 21.97 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 120.331 1.423 . . . . 0.0 112.004 -173.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -69.31 126.64 13.86 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.981 2.454 . . . . 0.0 111.341 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -33.65 74.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.03 0.932 . . . . 0.0 113.069 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -65.65 -17.87 64.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -109.39 11.04 25.32 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 113.691 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 425' ' ' ILE . 47.9 mt -90.37 145.28 25.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.885 0.874 . . . . 0.0 111.052 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 16.7 p -77.0 179.06 6.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.577 1.151 . . . . 0.0 111.175 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.11 -41.77 76.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.598 -0.689 . . . . 0.0 111.364 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.16 94.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.89 1.276 . . . . 0.0 111.901 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.92 -64.32 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.257 1.423 . . . . 0.0 111.923 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -63.29 -35.23 79.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.63 0.772 . . . . 0.0 111.472 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -53.1 -56.82 13.32 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.504 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -59.59 -39.77 85.28 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.742 1.61 . . . . 0.0 112.734 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.1 m -50.1 -43.48 51.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.426 1.012 . . . . 0.0 112.149 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.12 -21.22 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.6 t -117.68 -17.44 9.91 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.713 1.605 . . . . 0.0 113.905 -165.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.08 139.73 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.179 -0.951 . . . . 0.0 111.186 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -65.27 -49.39 69.75 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.901 0.48 . . . . 0.0 110.667 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -103.66 110.17 22.14 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.592 1.187 . . . . 0.0 108.92 163.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -175.7 -171.49 39.65 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.422 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -74.95 -64.69 2.27 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.101 -1.049 . . . . 0.0 113.642 -164.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 17.4 p -113.65 41.94 2.09 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.107 0.963 . . . . 0.0 110.005 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.8 m -55.74 100.75 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.271 -0.893 . . . . 0.0 111.986 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.97 -8.04 59.22 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 125.817 1.675 . . . . 0.0 115.895 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -110.14 146.39 34.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.264 2.225 . . . . 0.0 111.029 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.76 168.08 25.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.69 2.927 . . . . 0.0 112.21 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.32 121.52 30.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.652 0.781 . . . . 0.0 110.967 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.28 160.46 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.299 1.44 . . . . 0.0 110.602 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.6 m -58.31 125.75 24.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.558 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 83.85 6.34 87.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.846 1.212 . . . . 0.0 114.847 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 334' ' ' ILE . 14.9 tt -62.32 137.67 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.371 1.586 . . . . 0.0 111.115 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.55 138.52 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.164 2.185 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.499 ' CE2' HG22 ' A' ' 336' ' ' VAL . 9.4 p90 -165.45 -176.96 4.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.012 0.925 . . . . 0.0 113.169 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -100.2 146.54 26.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.575 1.55 . . . . 0.0 111.091 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.19 138.24 27.11 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -167.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.32 156.54 50.62 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.685 2.257 . . . . 0.0 112.419 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.84 142.66 58.35 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.917 0.887 . . . . 0.0 112.363 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.44 45.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 123.639 1.685 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 2.7 pt -49.75 149.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.249 143.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 5.5 t 64.5 12.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 120.052 1.296 . . . . 0.0 111.523 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -57.68 121.03 24.27 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.348 1.452 . . . . 0.0 113.316 -170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -166.95 165.67 15.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.066 0.947 . . . . 0.0 111.446 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -153.59 -158.88 8.81 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.152 1.358 . . . . 0.0 112.997 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.42 1.488 . . . . 0.0 111.514 178.606 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 19.0 tt -57.08 -31.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 120.449 1.477 . . . . 0.0 113.505 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 98.31 149.73 25.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.053 1.311 . . . . 0.0 111.986 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -153.53 158.02 32.7 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.248 1.419 . . . . 0.0 110.659 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.38 -178.74 3.12 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.187 2.591 . . . . 0.0 110.939 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -62.67 -14.58 45.3 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . 0.271 1.8 p 71.42 1.18 3.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.572 3.149 . . . . 0.0 114.378 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.13 -31.65 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 10.6 p90 48.17 -150.61 0.14 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.358 1.863 . . . . 0.0 113.663 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.77 -17.85 23.83 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.788 1.185 . . . . 0.0 115.217 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.8 m -66.47 -42.49 87.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.728 1.611 . . . . 0.0 111.48 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -107.74 -48.27 3.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.501 1.12 . . . . 0.0 112.046 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.51 171.57 16.83 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.303 1.441 . . . . 0.0 110.765 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -102.4 18.27 21.49 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -165.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -74.87 137.49 41.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.437 1.095 . . . . 0.0 113.282 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.2 -35.19 23.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.978 1.311 . . . . 0.0 111.564 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -120.19 73.58 20.35 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.951 0.9 . . . . 0.0 110.698 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.05 177.08 8.66 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.587 2.858 . . . . 0.0 111.591 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 61.61 59.32 1.85 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.446 1.498 . . . . 0.0 111.452 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -153.62 168.4 26.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.492 1.117 . . . . 0.0 113.158 -175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 92.4 mt -140.57 158.93 43.26 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.153 1.781 . . . . 0.0 110.497 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -79.16 71.68 5.67 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.101 0.961 . . . . 0.0 110.507 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.84 146.01 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.151 2.181 . . . . 0.0 110.724 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 72.1 p -60.97 -24.2 65.92 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.46 -26.48 62.73 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.253 -0.904 . . . . 0.0 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -79.47 124.34 83.99 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.788 1.235 . . . . 0.0 110.394 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.74 -18.78 63.6 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.941 1.761 . . . . 0.0 113.141 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -77.36 -2.51 35.41 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.711 1.204 . . . . 0.0 113.79 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.5 134.87 56.35 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.268 -1.52 . . . . 0.0 112.676 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -149.38 151.27 33.31 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.197 1.399 . . . . 0.0 110.013 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 159.86 50.59 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.07 2.514 . . . . 0.0 111.593 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -112.71 83.25 5.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.74 109.36 2.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.195 1.93 . . . . 0.0 109.799 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.42 132.6 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.479 1.112 . . . . 0.0 108.592 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 79.6 p -129.26 176.25 8.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.716 0.806 . . . . 0.0 111.06 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.16 124.18 18.85 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.533 1.133 . . . . 0.0 110.29 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -126.46 106.66 9.62 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.087 0.946 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.5 m -67.12 -2.9 6.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 114.118 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 -20.39 61.26 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.493 1.042 . . . . 0.0 112.391 170.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.09 151.09 90.32 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.72 0.691 . . . . 0.0 112.071 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.8 162.66 30.93 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.805 3.003 . . . . 0.0 113.04 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.6 133.55 28.1 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.539 2.826 . . . . 0.0 112.699 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.12 20.07 6.52 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 126.275 1.83 . . . . 0.0 112.808 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -106.47 155.49 19.53 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 455' ' ' ILE . 16.1 pt -126.78 154.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.94 2.096 . . . . 0.0 110.478 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -117.59 126.26 52.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.497 1.499 . . . . 0.0 111.855 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.86 107.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.748 0.819 . . . . 0.0 110.498 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -73.59 134.49 43.74 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.07 1.348 . . . . 0.0 111.658 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 38.3 t -70.44 144.29 51.52 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.557 -0.714 . . . . 0.0 111.322 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -123.88 28.91 6.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.816 1.646 . . . . 0.0 110.213 162.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.1 m -127.43 143.14 51.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.393 1.877 . . . . 0.0 109.556 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.57 126.4 55.3 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.239 1.816 . . . . 0.0 108.708 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.09 119.45 27.33 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.6 110.04 30.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.86 37.07 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.494 0.568 . . . . 0.0 112.441 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.38 21.19 70.24 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 169.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.97 128.63 93.2 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.383 1.073 . . . . 0.0 109.928 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.29 130.49 18.77 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.333 2.022 . . . . 0.0 109.396 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 pp -61.13 -20.18 62.37 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -166.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 -21.55 59.28 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.29 147.43 22.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.277 0.944 . . . . 0.0 113.23 -173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -120.47 -179.77 4.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 112.441 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -49.67 -39.17 35.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.613 1.565 . . . . 0.0 114.467 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.92 -14.95 57.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -79.39 -36.56 39.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.264 0.938 . . . . 0.0 110.791 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.48 -51.05 69.94 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.17 -39.14 69.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.21 -42.59 75.53 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.48 -32.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.182 1.356 . . . . 0.0 111.686 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 44.1 mt -81.81 -14.5 56.27 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.196 0.999 . . . . 0.0 112.824 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -43.23 -50.27 15.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.523 1.929 . . . . 0.0 116.193 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.45 -8.34 17.19 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.29 1.994 . . . . 0.0 114.12 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.64 -38.73 9.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.071 1.748 . . . . 0.0 112.236 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.04 160.46 2.77 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.442 1.897 . . . . 0.0 112.776 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.15 106.76 18.7 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.655 0.74 . . . . 0.0 109.033 162.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.77 137.65 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.67 1.188 . . . . 0.0 111.133 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -89.59 -41.84 11.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.436 1.094 . . . . 0.0 111.602 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.59 148.7 28.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.768 1.227 . . . . 0.0 111.031 -170.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.0 t -144.96 137.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 119.171 0.896 . . . . 0.0 110.877 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.86 104.32 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 165.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.85 98.96 11.72 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.588 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -83.25 75.07 9.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.433 1.111 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -56.39 -32.25 64.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.1 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -59.51 -23.44 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.445 1.498 . . . . 0.0 113.786 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.08 13.23 12.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 112.912 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.86 34.05 23.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.328 1.451 . . . . 0.0 112.222 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -117.27 156.55 27.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.415 1.886 . . . . 0.0 112.741 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.5 135.39 28.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 112.112 161.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.11 124.31 31.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 162.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.5 101.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 108.846 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -90.21 116.47 28.22 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.116 1.366 . . . . 0.0 110.019 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.69 149.22 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.313 1.045 . . . . 0.0 108.347 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -74.97 3.57 8.09 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 t -160.32 147.15 15.82 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.25 -1.531 . . . . 0.0 112.903 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -59.89 -39.69 86.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.213 1.405 . . . . 0.0 111.085 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.85 -35.05 79.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.932 0.493 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -68.26 -53.36 25.06 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.796 0.838 . . . . 0.0 110.696 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.14 87.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -64.9 -44.09 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.484 168.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -65.34 -29.03 69.73 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.058 1.299 . . . . 0.0 112.555 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.2 -67.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 118.872 0.76 . . . . 0.0 109.672 161.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.98 -30.87 62.44 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.1 -35.7 81.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.049 1.74 . . . . 0.0 112.756 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.95 -25.76 7.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -75.17 124.57 27.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.327 1.051 . . . . 0.0 111.26 -167.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 59.76 28.35 17.79 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.253 1.821 . . . . 0.0 114.067 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -62.43 -25.88 68.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.716 -1.24 . . . . 0.0 114.186 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.56 -15.12 46.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.447 1.099 . . . . 0.0 113.42 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.01 83.69 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.703 1.144 . . . . 0.0 114.098 -173.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.0 29.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.815 1.646 . . . . 0.0 115.375 -171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.18 151.09 59.37 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.215 0.916 . . . . 0.0 110.39 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.65 -23.75 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.832 2.355 . . . . 0.0 112.736 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.71 142.36 51.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.594 1.958 . . . . 0.0 112.423 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -115.92 90.28 3.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.047 0.939 . . . . 0.0 109.836 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.1 m -79.04 116.28 19.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.542 1.137 . . . . 0.0 109.867 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -116.38 165.88 12.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.681 1.993 . . . . 0.0 108.846 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -63.43 131.19 47.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.741 -1.225 . . . . 0.0 109.992 158.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -112.41 -155.19 12.4 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 125.555 1.55 . . . . 0.0 109.799 164.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.0 p -165.6 141.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 117.798 0.799 . . . . 0.0 111.365 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.31 -45.34 4.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.009 163.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -118.42 102.52 8.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.742 1.217 . . . . 0.0 112.916 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.33 123.73 1.13 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 118.789 -1.006 . . . . 0.0 115.284 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.84 128.92 10.36 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.473 3.449 . . . . 0.0 111.302 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -61.19 -32.6 72.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.34 -24.56 66.54 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.762 1.625 . . . . 0.0 113.205 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 23.1 m -134.84 32.42 3.25 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 112.255 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.72 140.97 49.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.999 1.319 . . . . 0.0 111.476 171.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -131.75 78.69 1.83 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.023 1.729 . . . . 0.0 109.338 163.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -64.41 -12.88 47.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 113.375 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.85 -47.49 18.68 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.685 1.129 . . . . 0.0 111.152 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -80.59 -17.13 52.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.305 0.642 . . . . 0.0 112.623 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.72 47.53 9.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.082 1.325 . . . . 0.0 112.083 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -147.65 171.81 15.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.771 1.286 . . . . 0.0 112.376 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 20.3 m -141.24 150.35 42.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.993 1.317 . . . . 0.0 110.591 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.49 132.37 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.11 124.41 25.34 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 119.537 1.062 . . . . 0.0 111.768 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.05 140.05 17.65 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.549 2.833 . . . . 0.0 112.636 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.81 -19.85 66.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.767 1.627 . . . . 0.0 113.985 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -74.58 -21.66 59.38 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.93 0.786 . . . . 0.0 112.911 172.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -95.51 -26.43 15.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.38 112.62 2.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.684 1.129 . . . . 0.0 109.506 169.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 36.6 p -66.93 177.33 1.73 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.29 1.436 . . . . 0.0 111.491 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -59.97 -38.9 83.85 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.056 -1.028 . . . . 0.0 111.905 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.39 -37.9 65.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.624 0.77 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.31 -51.43 69.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.746 1.218 . . . . 0.0 111.286 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -65.93 -36.27 82.91 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.621 -0.674 . . . . 0.0 111.535 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -51.94 67.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.076 0.853 . . . . 0.0 111.515 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.17 -44.61 94.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.226 1.375 . . . . 0.0 110.667 175.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 m -56.37 -32.84 65.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.249 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.41 -34.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 47.6 m -102.3 -9.27 20.52 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -168.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.63 152.19 27.03 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.952 1.251 . . . . 0.0 112.768 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -81.35 -38.77 26.14 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.135 0.574 . . . . 0.0 110.922 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -116.48 137.3 52.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.247 1.019 . . . . 0.0 110.749 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.43 -169.9 51.2 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.361 -168.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 69.54 -162.11 52.27 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.293 0.949 . . . . 0.0 113.266 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 29.3 p -95.11 1.76 54.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.549 1.54 . . . . 0.0 114.373 -168.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 19.7 m 66.89 11.93 8.62 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.46 1.027 . . . . 0.0 113.655 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.22 48.23 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.303 1.43 . . . . 0.0 114.33 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.7 154.23 93.09 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.469 1.135 . . . . 0.0 110.725 169.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.12 148.7 81.54 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.901 2.4 . . . . 0.0 111.051 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.1 105.53 5.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.547 -0.721 . . . . 0.0 110.011 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.39 158.91 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.653 1.581 . . . . 0.0 110.73 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 76.2 m -60.15 133.13 55.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.02 84.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.491 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 334' ' ' ILE . 15.8 tt -63.99 135.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.937 1.868 . . . . 0.0 111.78 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 36.3 t -120.01 139.45 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 126.376 1.87 . . . . 0.0 109.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -163.52 -176.1 4.53 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.237 1.015 . . . . 0.0 112.743 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.54 148.2 22.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.341 1.457 . . . . 0.0 109.434 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -49.16 131.03 16.35 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.44 157.25 56.91 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.729 2.286 . . . . 0.0 111.612 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -58.38 134.78 56.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.582 1.153 . . . . 0.0 112.757 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.32 58.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 123.572 1.653 . . . . 0.0 109.966 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.96 174.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.068 140.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.51 -66.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 O-C-N 121.06 -1.025 . . . . 0.0 110.195 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.09 -66.7 3.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.195 0.902 . . . . 0.0 112.117 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -166.17 153.39 9.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.879 1.672 . . . . 0.0 110.387 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -172.82 160.62 31.65 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.483 1.039 . . . . 0.0 113.248 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.211 1.404 . . . . 0.0 112.16 177.255 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 26.2 mm 71.42 145.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 127.475 2.31 . . . . 0.0 111.595 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -100.27 51.2 1.04 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.152 1.358 . . . . 0.0 112.895 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 294' ' ' PRO . . . 69.52 169.32 0.11 Allowed Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 126.789 2.036 . . . . 0.0 111.759 -173.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 293' ' ' ALA . 55.4 Cg_endo -70.78 -157.6 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.478 2.786 . . . . 0.0 112.246 173.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -53.34 -41.06 65.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.247 1.019 . . . . 0.0 113.047 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.4 p 48.25 29.53 1.92 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.014 2.526 . . . . 0.0 113.989 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -77.22 -13.69 59.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.824 1.65 . . . . 0.0 113.391 -174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -50.05 138.34 15.86 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 112.485 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 133.41 -67.32 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.7 1.143 . . . . 0.0 112.148 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.0 t -153.06 8.81 0.42 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -106.9 -66.91 0.98 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.013 -1.054 . . . . 0.0 112.074 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.7 177.37 11.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.663 1.185 . . . . 0.0 112.216 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -122.93 -10.51 8.2 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -63.73 138.1 58.35 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.57 0.748 . . . . 0.0 111.414 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.9 mm? -59.55 -43.75 93.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.154 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.86 156.87 35.51 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.835 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.46 89.66 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.271 3.314 . . . . 0.0 112.156 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 50.7 41.09 25.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.166 1.387 . . . . 0.0 111.106 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -55.15 150.44 10.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.377 1.471 . . . . 0.0 113.031 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.89 161.23 17.87 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.513 1.125 . . . . 0.0 110.417 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -79.02 68.7 5.04 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.865 0.866 . . . . 0.0 111.596 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 146.9 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 127.132 2.173 . . . . 0.0 110.237 -170.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 87.8 p -63.17 -25.4 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -69.9 -23.34 63.22 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.269 -0.894 . . . . 0.0 112.705 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -83.28 122.78 77.45 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.915 1.286 . . . . 0.0 110.564 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.27 -17.89 50.13 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.398 2.066 . . . . 0.0 113.125 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -74.52 1.44 11.95 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -51.08 127.42 18.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.682 1.583 . . . . 0.0 111.645 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -157.19 147.35 15.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.56 1.544 . . . . 0.0 110.85 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.7 173.76 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.67 2.247 . . . . 0.0 111.541 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -108.55 83.3 1.95 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.941 0.896 . . . . 0.0 110.194 167.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.55 141.08 30.73 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.26 2.64 . . . . 0.0 110.303 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.72 145.19 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.208 1.403 . . . . 0.0 108.524 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 75.9 p -140.39 179.78 6.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.178 0.991 . . . . 0.0 111.084 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -143.92 130.77 20.36 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.093 -1.005 . . . . 0.0 110.085 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -107.64 102.93 12.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.274 1.03 . . . . 0.0 109.643 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -12.77 17.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.002 1.321 . . . . 0.0 113.667 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.88 0.92 54.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.691 1.597 . . . . 0.0 113.018 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.6 154.61 50.86 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.644 1.111 . . . . 0.0 113.688 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 162.73 40.98 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.948 3.766 . . . . 0.0 113.191 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.03 138.98 34.9 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.445 3.43 . . . . 0.0 112.937 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.04 37.33 18.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.921 1.288 . . . . 0.0 111.744 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -115.61 140.24 49.36 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.62 -1.3 . . . . 0.0 112.763 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 425' ' ' ILE . 25.6 pt -106.81 146.15 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.387 1.475 . . . . 0.0 109.591 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 117.96 33.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.504 1.121 . . . . 0.0 109.494 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.7 106.93 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 O-C-N 122.096 -0.377 . . . . 0.0 110.568 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.08 128.84 36.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.811 1.244 . . . . 0.0 111.793 170.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 66.1 m -69.16 144.7 53.73 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -131.72 16.02 4.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.484 2.714 . . . . 0.0 110.843 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 13.3 m -110.27 129.68 55.69 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.117 1.767 . . . . 0.0 108.786 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.08 136.44 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.615 1.566 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -93.63 142.87 26.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 159.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.79 106.32 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.98 1.312 . . . . 0.0 108.709 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.41 41.81 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.831 0.729 . . . . 0.0 111.966 168.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.6 78.65 Favored Glycine 0 N--CA 1.475 1.234 0 O-C-N 122.054 -0.674 . . . . 0.0 114.651 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.4 t -78.79 119.97 79.19 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.532 1.166 . . . . 0.0 110.358 -171.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 138.53 34.42 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.721 2.28 . . . . 0.0 109.609 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -16.81 54.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -29.48 63.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.139 0.976 . . . . 0.0 112.557 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.406 ' CE ' HD21 ' A' ' 402' ' ' LEU . 5.9 mtm -78.79 149.33 32.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.63 0.728 . . . . 0.0 112.735 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -127.83 -178.33 4.46 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.878 2.071 . . . . 0.0 111.222 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.466 ' HA ' HG11 ' A' ' 368' ' ' VAL . 10.6 pm0 -51.08 -41.55 60.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.844 1.658 . . . . 0.0 114.449 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.499 ' CE2' HD12 ' A' ' 305' ' ' LEU . 96.1 m95 -77.12 -17.63 58.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.69 -40.31 61.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.272 0.942 . . . . 0.0 110.545 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.7 mm? -60.26 -47.35 86.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.497 0.59 . . . . 0.0 110.939 170.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.33 -34.16 72.01 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.717 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.72 -42.42 64.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.954 1.252 . . . . 0.0 114.376 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.27 -37.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.964 0.802 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 394' ' ' PHE . 32.6 mt -85.75 -5.32 59.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.893 0.877 . . . . 0.0 112.479 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -52.85 -49.83 84.72 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.966 1.707 . . . . 0.0 115.161 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.67 -5.01 16.39 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.457 2.105 . . . . 0.0 113.431 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -101.23 -39.56 7.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.191 1.396 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.5 167.28 5.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.643 1.977 . . . . 0.0 113.111 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -92.67 102.1 14.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.67 1.188 . . . . 0.0 111.642 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 379' ' ' VAL . 59.4 t -70.51 118.58 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.883 0.873 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -91.95 -36.13 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.897 1.679 . . . . 0.0 112.778 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.7 t -144.16 153.16 41.83 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.318 0.963 . . . . 0.0 112.169 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 352' ' ' GLU . 49.0 t -144.81 140.35 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.855 0.862 . . . . 0.0 111.259 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.61 97.79 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.313 1.445 . . . . 0.0 108.019 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -97.3 132.99 42.5 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.858 0.463 . . . . 0.0 110.734 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.05 89.09 2.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.976 1.31 . . . . 0.0 109.769 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.46 -37.45 83.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.087 1.355 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.1 t -58.47 -32.43 68.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.055 1.742 . . . . 0.0 113.064 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -98.45 -1.0 42.39 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.151 1.38 . . . . 0.0 113.197 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 59.03 30.95 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.399 1.88 . . . . 0.0 113.408 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.29 170.5 15.62 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.66 24.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 111.68 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.14 140.12 53.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.377 1.471 . . . . 0.0 108.895 164.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 365' ' ' VAL . 95.1 t -132.77 111.96 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.493 1.117 . . . . 0.0 109.705 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -92.45 119.97 32.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.565 0.746 . . . . 0.0 110.239 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.27 176.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.907 0.883 . . . . 0.0 108.918 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 147.4 46.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.601 -0.687 . . . . 0.0 111.268 -164.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.65 81.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.759 0.824 . . . . 0.0 110.652 166.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -39.93 80.53 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.053 0.842 . . . . 0.0 112.435 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -65.63 -52.38 52.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.674 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.56 80.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.411 1.085 . . . . 0.0 113.037 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.47 -41.57 98.88 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -61.72 -32.61 72.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.645 1.111 . . . . 0.0 111.916 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 359' ' ' LEU . 3.7 t -63.73 -62.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.858 166.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.61 -36.98 26.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.208 1.403 . . . . 0.0 114.111 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.56 -38.59 70.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.377 1.471 . . . . 0.0 112.885 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -106.73 -26.31 11.36 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.56 ' CE1' HD23 ' A' ' 359' ' ' LEU . 25.4 t80 -70.89 127.7 33.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -171.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 29.0 t30 60.66 28.42 18.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.39 1.476 . . . . 0.0 113.9 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -59.64 -34.75 73.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.853 -1.154 . . . . 0.0 113.325 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.32 -20.14 60.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.883 1.273 . . . . 0.0 113.063 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.86 19.61 75.06 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.929 1.252 . . . . 0.0 113.725 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.78 -32.67 17.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.242 1.417 . . . . 0.0 114.291 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.49 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 20.0 mt -77.48 146.77 74.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.859 0.864 . . . . 0.0 109.093 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.79 -18.9 28.0 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.17 1.913 . . . . 0.0 112.718 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.406 HD21 ' CE ' ' A' ' 350' ' ' MET . 3.8 mt -82.27 144.43 30.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.048 0.939 . . . . 0.0 112.524 -169.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.14 9.71 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 110.245 174.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 33.3 m -83.11 125.12 31.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.237 1.415 . . . . 0.0 110.628 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.83 174.98 9.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.022 2.129 . . . . 0.0 109.661 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -72.53 122.87 22.06 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.207 -0.933 . . . . 0.0 111.398 163.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.83 -177.72 35.08 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.281 1.419 . . . . 0.0 110.551 163.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.64 119.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.679 0.791 . . . . 0.0 109.619 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.49 -36.78 10.26 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.759 1.647 . . . . 0.0 110.943 161.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -145.99 109.19 4.65 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.921 0.861 . . . . 0.0 112.149 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.34 133.74 2.13 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.821 -0.988 . . . . 0.0 115.467 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.25 122.17 7.79 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 125.268 3.978 . . . . 0.0 110.83 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -55.27 -37.18 66.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -74.99 -16.41 60.62 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.694 1.598 . . . . 0.0 114.16 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.7 m -127.21 27.82 5.84 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.916 1.686 . . . . 0.0 111.93 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.65 140.48 29.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.201 1.401 . . . . 0.0 111.669 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -126.12 87.78 2.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.444 1.116 . . . . 0.0 109.567 167.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.25 -22.0 65.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.835 0.854 . . . . 0.0 113.181 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -68.77 -51.97 35.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.077 0.853 . . . . 0.0 110.232 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.09 -18.72 59.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.11 45.55 8.86 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.415 1.007 . . . . 0.0 112.459 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -154.6 175.33 13.79 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.306 1.05 . . . . 0.0 112.99 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 35.2 p -147.22 153.32 39.67 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.414 1.086 . . . . 0.0 110.967 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mm -108.33 135.34 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -129.42 109.73 17.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 119.843 1.201 . . . . 0.0 110.523 -172.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.65 131.94 27.43 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.595 2.197 . . . . 0.0 110.917 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 45.7 mtt -64.7 -15.72 61.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.687 1.195 . . . . 0.0 113.132 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -65.35 -25.16 67.47 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 113.038 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 13.08 14.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.426 2.29 . . . . 0.0 113.243 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 425' ' ' ILE . 9.4 mt -85.0 176.41 8.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.521 1.528 . . . . 0.0 111.706 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 2.3 p -127.87 165.06 20.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 110.759 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -65.92 -37.28 85.67 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.041 -1.037 . . . . 0.0 111.41 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.83 -42.21 90.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.771 0.829 . . . . 0.0 112.071 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -48.48 70.0 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.022 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.45 -38.12 86.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.017 0.826 . . . . 0.0 110.107 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.06 -33.05 71.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.659 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -72.56 -45.32 59.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.266 1.394 . . . . 0.0 111.858 168.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 m -53.21 -39.7 63.9 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.767 1.167 . . . . 0.0 111.402 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.24 -48.12 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.2 m -93.49 -5.95 47.97 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.22 138.19 45.55 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.896 1.225 . . . . 0.0 112.533 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -78.02 -27.36 48.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.569 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -124.89 138.46 54.25 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.611 1.564 . . . . 0.0 111.221 164.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.02 -168.64 47.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.396 -172.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.18 -156.91 53.5 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.23 0.443 . . . . 0.0 112.556 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.6 p -107.27 11.77 28.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.24 1.416 . . . . 0.0 114.746 -159.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.5 t 66.19 14.87 9.86 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.911 -1.118 . . . . 0.0 113.21 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.08 61.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.281 1.42 . . . . 0.0 114.233 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -68.19 145.37 97.51 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 119.309 1.555 . . . . 0.0 111.126 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.32 148.27 90.94 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.981 2.454 . . . . 0.0 110.976 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.1 109.4 8.55 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.047 0.451 . . . . 0.0 110.448 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.75 170.87 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.966 1.706 . . . . 0.0 111.471 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.9 m -57.23 119.36 6.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.29 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.19 79.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.283 0.945 . . . . 0.0 115.123 172.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.6 tt -58.27 125.01 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.176 1.488 . . . . 0.0 111.184 172.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.08 132.93 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.707 1.603 . . . . 0.0 109.003 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.79 170.52 21.44 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.154 0.982 . . . . 0.0 112.071 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.91 147.59 25.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.593 1.157 . . . . 0.0 108.982 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -40.0 125.17 1.63 Allowed Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.529 1.132 . . . . 0.0 113.966 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.07 150.6 85.15 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.489 1.459 . . . . 0.0 110.111 172.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -56.7 161.4 2.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.504 1.145 . . . . 0.0 113.52 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 1.4 mt -118.94 47.49 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 123.231 1.491 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.58 140.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.24 -47.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.673 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.68 -99.68 1.38 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.19 134.97 7.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.972 1.309 . . . . 0.0 110.431 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -127.05 -160.82 10.66 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.779 1.657 . . . . 0.0 112.997 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.177 1.391 . . . . 0.0 110.833 178.209 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.22 145.25 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.085 1.354 . . . . 0.0 110.473 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -74.76 165.07 54.73 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.746 0.689 . . . . 0.0 111.867 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -131.96 154.93 81.88 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.583 1.153 . . . . 0.0 111.764 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.72 178.56 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 124.481 3.454 . . . . 0.0 112.326 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -24.3 67.72 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.748 0.819 . . . . 0.0 112.851 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.3 m 76.93 9.0 2.88 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 127.482 2.313 . . . . 0.0 112.399 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.47 -32.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.173 2.189 . . . . 0.0 114.101 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 50.42 63.73 2.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.324 1.85 . . . . 0.0 112.877 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -100.42 17.97 56.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.469 1.509 . . . . 0.0 115.482 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 9.6 t -118.53 -52.73 2.35 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.089 1.356 . . . . 0.0 113.203 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.2 -64.44 1.15 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.843 0.857 . . . . 0.0 112.384 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -159.82 -102.77 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.218 1.407 . . . . 0.0 110.526 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -160.13 18.65 0.15 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 113.681 -164.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -79.54 140.12 37.32 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.361 1.064 . . . . 0.0 111.388 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.74 -47.03 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.182 0.593 . . . . 0.0 110.609 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -119.53 81.3 23.6 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.139 1.376 . . . . 0.0 110.231 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.71 -28.3 14.08 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.711 2.274 . . . . 0.0 112.028 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.92 56.39 3.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.104 1.362 . . . . 0.0 110.844 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.39 144.02 28.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.818 1.247 . . . . 0.0 111.225 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.16 165.84 18.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.47 1.508 . . . . 0.0 110.096 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -77.06 73.74 3.64 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.524 -0.735 . . . . 0.0 110.805 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 38.8 t -133.19 145.68 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.432 2.293 . . . . 0.0 110.196 -171.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.6 t -53.94 -31.19 49.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -66.49 -27.12 67.54 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.937 -1.102 . . . . 0.0 112.781 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -81.7 126.74 74.94 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.681 1.193 . . . . 0.0 110.685 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.84 -17.17 55.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.715 2.277 . . . . 0.0 113.677 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.35 6.94 5.93 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.57 125.63 23.03 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 120.685 -1.259 . . . . 0.0 111.654 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.5 mmt-85 -156.09 147.16 16.52 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 111.358 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.01 174.28 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.916 2.411 . . . . 0.0 111.145 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -115.98 77.72 7.04 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.999 0.92 . . . . 0.0 110.084 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.39 135.84 23.01 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.485 2.79 . . . . 0.0 110.306 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 t -147.46 140.64 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.055 1.342 . . . . 0.0 108.866 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.04 173.4 10.76 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.984 1.314 . . . . 0.0 111.043 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.493 ' CE2' HD12 ' A' ' 455' ' ' ILE . 42.5 m-85 -137.17 124.64 22.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.31 1.044 . . . . 0.0 109.988 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -119.36 103.07 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.216 1.008 . . . . 0.0 110.589 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.0 p -66.8 -5.03 10.61 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.499 1.519 . . . . 0.0 113.972 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -22.4 64.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.802 0.841 . . . . 0.0 112.509 168.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.92 153.04 95.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.875 0.87 . . . . 0.0 112.179 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.13 161.99 31.49 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.799 2.999 . . . . 0.0 112.557 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.78 131.54 18.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.894 3.062 . . . . 0.0 112.122 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.88 44.89 3.42 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.254 1.822 . . . . 0.0 111.558 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -130.33 155.26 46.64 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.5 pt -128.25 144.77 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.101 1.761 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -100.43 115.86 31.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.232 1.413 . . . . 0.0 109.659 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.6 102.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.475 0.71 . . . . 0.0 110.384 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -71.17 136.2 47.98 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.401 1.08 . . . . 0.0 111.776 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.2 t -75.48 140.23 42.71 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.16 -0.962 . . . . 0.0 112.173 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.436 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 4.7 mtm180 -110.32 2.34 19.07 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.896 1.678 . . . . 0.0 111.288 165.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 35.9 m -104.65 129.32 52.82 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.084 1.353 . . . . 0.0 109.567 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.33 137.43 34.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.064 1.746 . . . . 0.0 108.604 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -91.79 137.82 32.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 159.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 19.8 mm -127.69 108.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 108.398 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.82 -177.55 38.09 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.328 0.966 . . . . 0.0 112.229 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.01 16.58 64.39 Favored Glycine 0 N--CA 1.477 1.402 0 C-N-CA 124.189 0.9 . . . . 0.0 114.87 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.2 t -71.85 129.16 88.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 118.141 0.971 . . . . 0.0 110.262 -164.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.94 130.21 22.53 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.366 2.044 . . . . 0.0 109.278 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.41 -19.09 54.87 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.24 -29.56 64.05 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.517 -0.739 . . . . 0.0 112.906 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.4 ptp -84.5 145.93 27.86 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -120.25 -177.83 3.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.231 1.812 . . . . 0.0 112.494 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.86 -41.04 44.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.288 1.435 . . . . 0.0 113.559 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -76.47 -22.55 54.41 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.49 -35.27 65.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.76 0.709 . . . . 0.0 110.79 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 355' ' ' LEU . 1.4 mm? -59.55 -51.18 70.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.987 0.812 . . . . 0.0 110.437 168.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.11 -38.23 67.89 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.464 0.574 . . . . 0.0 112.416 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -72.53 -42.96 64.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.115 1.366 . . . . 0.0 114.474 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.32 -31.94 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 120.462 1.483 . . . . 0.0 111.049 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.441 HD23 ' CE1' ' A' ' 394' ' ' PHE . 35.7 mt -89.22 -9.36 51.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.26 1.024 . . . . 0.0 112.885 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -49.45 -49.04 73.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.705 1.602 . . . . 0.0 114.828 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.05 -6.24 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.089 1.859 . . . . 0.0 113.202 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -100.73 -33.91 10.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.45 1.5 . . . . 0.0 112.983 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.88 168.08 3.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 113.946 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 113.03 20.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.838 1.255 . . . . 0.0 110.81 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.63 121.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.65 . . . . 0.0 109.547 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -92.81 -37.05 12.52 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.412 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.71 158.66 43.69 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.085 -1.01 . . . . 0.0 112.094 -174.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.4 p -166.05 136.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.688 0.795 . . . . 0.0 111.378 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.51 97.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.137 1.375 . . . . 0.0 107.578 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.5 tt -89.96 126.87 35.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.615 0.366 . . . . 0.0 110.07 174.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 83.16 1.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.035 1.334 . . . . 0.0 109.02 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.3 -30.35 71.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.864 0.865 . . . . 0.0 112.694 -173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 9.0 t -48.08 -39.06 19.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.658 1.983 . . . . 0.0 113.596 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -103.87 8.61 36.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.548 1.539 . . . . 0.0 113.682 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 56.68 36.6 27.9 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.98 1.312 . . . . 0.0 112.221 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -133.29 165.33 25.07 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.53 163.0 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.736 1.214 . . . . 0.0 111.699 165.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.48 141.73 47.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 108.543 162.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.9 t -138.43 118.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.026 0.53 . . . . 0.0 111.775 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -99.4 126.06 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 112.836 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.63 179.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.395 1.078 . . . . 0.0 111.296 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -65.35 -35.47 81.06 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 57.5 p -149.01 168.62 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.054 1.297 . . . . 0.0 114.384 -168.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.62 98.1 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.734 169.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -58.1 -45.01 87.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.063 0.847 . . . . 0.0 111.953 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.74 -47.06 79.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.375 0.67 . . . . 0.0 110.519 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.91 96.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 111.759 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.81 -40.96 97.87 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.005 0.922 . . . . 0.0 111.169 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.65 -33.49 75.15 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.792 1.633 . . . . 0.0 112.239 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.91 -64.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 118.883 -0.579 . . . . 0.0 110.512 165.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.45 -29.33 49.29 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -67.89 -34.49 76.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.651 1.98 . . . . 0.0 112.998 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -123.49 -27.25 4.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.441 ' CE1' HD23 ' A' ' 359' ' ' LEU . 35.3 t80 -69.34 121.41 16.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.954 0.902 . . . . 0.0 111.06 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 38.0 t30 57.97 27.91 15.44 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.435 1.494 . . . . 0.0 114.398 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -62.62 -32.78 73.86 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.362 -1.461 . . . . 0.0 113.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.86 -19.02 62.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 113.076 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.02 80.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.014 1.292 . . . . 0.0 113.563 -171.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.94 34.69 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.392 1.477 . . . . 0.0 114.052 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.21 149.44 55.53 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.512 1.125 . . . . 0.0 109.672 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.79 -23.73 13.98 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.593 2.195 . . . . 0.0 113.417 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.81 150.72 27.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.101 2.161 . . . . 0.0 113.101 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.7 91.36 3.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.543 1.137 . . . . 0.0 110.683 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 25.8 m -85.27 127.73 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.199 1.4 . . . . 0.0 111.14 -170.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -137.77 172.83 12.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.908 2.083 . . . . 0.0 109.622 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -70.98 120.39 16.48 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.04 -1.037 . . . . 0.0 111.005 164.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.36 -161.73 32.71 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 162.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 16.9 t -143.22 122.54 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.566 1.146 . . . . 0.0 108.903 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -86.15 -40.79 7.32 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 164.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -142.4 125.13 15.93 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.181 0.992 . . . . 0.0 111.265 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.99 132.17 1.66 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.676 -1.069 . . . . 0.0 114.37 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.415 ' HG3' HG23 ' A' ' 425' ' ' ILE . 97.1 Cg_endo -70.53 123.83 10.21 Favored 'Trans proline' 0 C--N 1.349 0.566 1 C-N-CA 125.316 4.011 . . . . 0.0 109.698 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.43 -39.49 79.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.141 0.496 . . . . 0.0 112.104 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.78 -24.03 66.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.511 1.924 . . . . 0.0 113.501 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 6.4 m -119.96 20.9 12.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.542 1.537 . . . . 0.0 111.896 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.95 139.62 30.42 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.291 1.436 . . . . 0.0 111.973 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.85 90.65 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.954 1.302 . . . . 0.0 109.43 166.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -67.71 -21.73 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -69.52 -51.14 38.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.643 0.656 . . . . 0.0 110.489 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -78.57 -19.8 51.98 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.12 38.32 19.15 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.88 1.228 . . . . 0.0 113.12 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.64 167.06 26.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.185 0.993 . . . . 0.0 113.4 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.2 m -132.24 149.86 52.28 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.331 1.053 . . . . 0.0 111.035 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 10.0 mm -107.55 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.714 HG21 HD21 ' A' ' 430' ' ' LEU . 1.3 mt -97.55 122.56 55.04 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 121.007 -1.058 . . . . 0.0 111.056 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.43 131.94 21.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.44 2.093 . . . . 0.0 111.25 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -27.7 68.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.522 1.129 . . . . 0.0 113.446 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.24 -20.99 63.94 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.426 1.012 . . . . 0.0 113.568 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.15 8.79 28.2 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.323 1.849 . . . . 0.0 112.699 -176.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.714 HD21 HG21 ' A' ' 425' ' ' ILE . 38.4 mt -92.6 147.69 22.68 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.991 1.716 . . . . 0.0 110.81 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 21.9 p -83.61 175.15 9.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.595 1.158 . . . . 0.0 111.155 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.92 -41.65 97.59 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.757 -0.589 . . . . 0.0 111.42 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.97 -40.55 95.16 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.952 0.901 . . . . 0.0 112.028 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.64 -53.16 61.43 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.593 1.157 . . . . 0.0 112.279 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.05 -40.66 96.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.812 0.845 . . . . 0.0 111.001 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -58.01 -41.78 83.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.243 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -69.93 -44.82 68.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.824 1.647 . . . . 0.0 111.758 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.4 m -52.7 -35.43 55.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.423 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.15 -43.74 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.6 t -96.68 -11.19 25.49 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.573 -1.329 . . . . 0.0 114.429 -166.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.49 139.39 53.45 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.048 -1.032 . . . . 0.0 111.943 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -77.08 -25.24 52.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.456 0.703 . . . . 0.0 112.02 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -125.97 140.12 52.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.294 1.838 . . . . 0.0 110.293 166.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.86 -179.81 40.77 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.051 0.834 . . . . 0.0 113.266 -174.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.79 -152.72 47.86 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 122.282 -0.54 . . . . 0.0 113.401 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.0 p -102.64 0.29 33.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -161.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.3 t 71.14 22.83 4.31 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 120.364 1.438 . . . . 0.0 113.556 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 85.77 3.63 85.74 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 120.594 -1.316 . . . . 0.0 113.406 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.92 151.51 89.3 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 118.74 1.27 . . . . 0.0 110.119 166.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -61.96 142.88 94.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.27 1.98 . . . . 0.0 109.865 169.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.66 109.2 3.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 32.1 m -105.72 154.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.225 1.41 . . . . 0.0 110.091 174.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -59.72 131.73 51.82 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.64 -13.0 67.09 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.22 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.493 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.9 OUTLIER -56.08 130.67 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.119 1.96 . . . . 0.0 111.558 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.4 t -116.54 130.72 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.515 1.926 . . . . 0.0 108.81 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.31 -175.69 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.0 111.372 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.32 149.36 26.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.484 1.914 . . . . 0.0 111.134 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 4.5 pt-20 -44.79 129.47 5.19 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.789 1.636 . . . . 0.0 114.274 -165.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 162.75 41.53 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.43 2.087 . . . . 0.0 111.949 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -68.34 138.72 55.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.7 mm -103.67 47.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 123.404 1.573 . . . . 0.0 109.739 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pt -54.37 179.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.865 141.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.18 -41.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 120.206 -1.559 . . . . 0.0 112.687 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.92 -45.58 2.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.687 1.137 . . . . 0.0 112.895 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -153.25 -67.24 0.15 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.692 1.597 . . . . 0.0 111.141 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.47 17.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.949 1.261 . . . . 0.0 112.835 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.279 1.431 . . . . 0.0 112.799 177.764 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 40.4 mt 55.99 73.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 126.021 1.729 . . . . 0.0 110.716 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 168.85 151.06 6.99 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.059 0.837 . . . . 0.0 112.824 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -138.12 161.4 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.893 1.677 . . . . 0.0 109.947 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.25 -155.41 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.061 3.174 . . . . 0.0 111.807 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.44 -33.49 67.97 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.947 -1.096 . . . . 0.0 113.468 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 77.2 p 50.0 30.03 3.82 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 127.857 2.463 . . . . 0.0 114.027 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.26 -7.63 59.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.13 1.772 . . . . 0.0 113.976 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -57.97 127.1 30.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.351 1.46 . . . . 0.0 111.286 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 73.68 13.07 80.61 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.987 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.4 m -128.88 -46.5 1.26 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.382 1.473 . . . . 0.0 111.42 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -130.48 -70.96 0.6 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.816 0.846 . . . . 0.0 111.914 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -134.29 -167.73 2.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.231 1.412 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -117.63 -1.43 11.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -67.54 133.66 49.86 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.908 0.883 . . . . 0.0 110.493 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 368' ' ' VAL . 4.0 mp -68.49 -43.94 75.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.207 0.527 . . . . 0.0 112.181 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 159.19 86.21 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.786 1.234 . . . . 0.0 112.858 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.73 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.754 3.636 . . . . 0.0 111.897 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -132.64 46.82 2.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.95 1.7 . . . . 0.0 108.317 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.65 147.68 21.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.225 1.012 . . . . 0.0 111.697 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 160.86 30.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.701 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -79.49 64.68 4.44 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.791 0.805 . . . . 0.0 110.901 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 16.4 m -117.54 146.38 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 127.138 2.175 . . . . 0.0 111.343 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 86.6 p -61.47 -25.34 67.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -71.36 -26.23 62.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.227 1.011 . . . . 0.0 112.48 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -78.81 123.34 85.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.333 1.053 . . . . 0.0 109.997 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.19 -16.43 48.69 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.464 2.109 . . . . 0.0 112.902 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 4.23 10.79 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 167.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -52.43 129.72 29.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.226 1.376 . . . . 0.0 111.233 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.401 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 62.4 mmt-85 -156.36 146.02 15.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.961 1.305 . . . . 0.0 111.025 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.67 176.9 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.523 2.149 . . . . 0.0 111.432 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -121.02 76.4 30.24 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.535 1.134 . . . . 0.0 109.798 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.01 142.31 38.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.137 2.558 . . . . 0.0 110.517 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.7 t -148.28 145.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.927 1.291 . . . . 0.0 109.351 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 172.88 12.14 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.946 1.298 . . . . 0.0 110.766 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.42 ' CE2' HD12 ' A' ' 455' ' ' ILE . 43.9 m-85 -137.52 127.48 25.76 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.3 1.04 . . . . 0.0 110.042 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.48 104.53 10.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 109.861 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.5 p -70.29 -9.07 54.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 32.8 p -68.96 -19.33 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.169 1.388 . . . . 0.0 112.429 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.39 153.21 96.05 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.996 0.918 . . . . 0.0 112.383 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.39 162.45 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.925 3.083 . . . . 0.0 112.607 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.33 130.47 17.48 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.91 3.074 . . . . 0.0 112.345 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 66.66 39.25 3.71 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 111.833 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -123.42 152.18 41.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 457' ' ' PHE . 15.4 pt -120.84 147.24 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.901 1.68 . . . . 0.0 110.944 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 123.2 45.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.024 1.33 . . . . 0.0 110.289 177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 50.1 t -120.85 104.28 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.02 0.528 . . . . 0.0 110.911 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -72.76 132.86 44.16 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 111.864 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 31.2 t -74.31 141.87 45.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.814 0.816 . . . . 0.0 112.846 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -121.47 16.24 11.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.837 2.455 . . . . 0.0 110.724 166.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 22.3 m -108.7 126.03 52.55 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.156 1.383 . . . . 0.0 108.63 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.1 mt -92.76 140.08 29.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.443 1.497 . . . . 0.0 109.166 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -100.42 144.72 29.08 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 158.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 14.1 mm -128.87 112.16 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 108.574 -172.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -90.96 173.52 38.06 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.02 0.819 . . . . 0.0 112.064 166.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.54 16.45 75.81 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.4 t -73.04 126.33 90.49 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 118.723 1.261 . . . . 0.0 111.335 -165.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.01 132.86 36.01 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.477 2.785 . . . . 0.0 110.233 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 348' ' ' LEU . 1.3 mp -67.84 -6.32 20.92 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -92.48 -25.23 18.52 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.69 1.196 . . . . 0.0 113.691 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.6 mtm -77.22 146.12 37.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.41 1.005 . . . . 0.0 112.506 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -122.1 -179.9 4.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.652 1.581 . . . . 0.0 111.841 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -41.68 -44.73 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.829 2.051 . . . . 0.0 114.075 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -77.96 -21.6 50.76 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -73.56 -39.61 64.55 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.349 0.977 . . . . 0.0 110.435 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.85 -46.39 89.43 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.716 168.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.8 76.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.44 1.018 . . . . 0.0 111.698 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.13 -44.09 96.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.108 1.322 . . . . 0.0 114.283 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.7 m -71.23 -34.74 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.388 0.994 . . . . 0.0 111.287 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 394' ' ' PHE . 50.0 mt -87.54 -7.51 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.923 0.889 . . . . 0.0 112.887 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -47.59 96.77 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.346 1.458 . . . . 0.0 114.399 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.59 -7.54 20.37 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.296 1.998 . . . . 0.0 113.31 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -98.45 -38.78 9.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.09 1.356 . . . . 0.0 112.705 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.71 172.75 2.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.145 1.778 . . . . 0.0 113.712 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 123.29 32.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.256 1.422 . . . . 0.0 111.442 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.71 120.25 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.591 0.756 . . . . 0.0 110.314 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -94.77 -41.73 9.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.668 1.187 . . . . 0.0 112.083 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.31 161.99 35.5 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.376 -0.828 . . . . 0.0 112.3 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 305' ' ' LEU . 0.2 OUTLIER -162.69 138.01 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.887 0.875 . . . . 0.0 111.101 176.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.69 88.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.112 1.365 . . . . 0.0 108.018 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.08 137.99 31.94 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.834 -0.541 . . . . 0.0 110.94 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.47 85.85 2.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.824 1.25 . . . . 0.0 110.243 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -57.65 -38.24 74.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.844 0.857 . . . . 0.0 112.562 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 t -56.2 -33.02 64.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.968 1.307 . . . . 0.0 112.571 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -95.75 2.17 53.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.755 1.222 . . . . 0.0 113.87 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 27.57 17.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 113.612 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -133.83 169.26 17.34 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.47 43.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.707 1.203 . . . . 0.0 111.506 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.08 141.55 47.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.757 1.223 . . . . 0.0 108.089 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.8 118.09 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.782 0.719 . . . . 0.0 110.615 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -104.1 120.33 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.666 0.786 . . . . 0.0 112.059 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 19.8 m -95.24 -172.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.975 0.91 . . . . 0.0 110.113 174.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.401 ' CG ' ' HG3' ' A' ' 319' ' ' ARG . 0.2 OUTLIER -68.75 -40.46 79.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.945 1.248 . . . . 0.0 113.949 177.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 60.6 p -148.66 167.45 25.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.192 -0.943 . . . . 0.0 112.717 -164.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.88 91.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.358 167.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -42.07 85.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.004 0.82 . . . . 0.0 112.59 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.21 -51.22 64.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.905 1.282 . . . . 0.0 110.254 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.36 97.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.475 -0.766 . . . . 0.0 112.439 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -62.77 -42.44 99.69 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.929 0.892 . . . . 0.0 111.373 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.39 -34.18 76.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.196 1.362 . . . . 0.0 112.064 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.0 -65.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.717 166.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -50.65 -34.32 25.93 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.596 1.558 . . . . 0.0 114.152 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.51 -40.81 93.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.51 1.524 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -109.2 -27.3 9.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.437 ' CE2' HD23 ' A' ' 359' ' ' LEU . 19.8 t80 -70.41 123.95 22.99 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.463 0.705 . . . . 0.0 111.112 -169.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.86 29.16 18.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.131 1.372 . . . . 0.0 114.047 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -59.85 -36.33 76.62 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.201 -0.937 . . . . 0.0 113.16 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.79 -20.55 60.44 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.764 1.226 . . . . 0.0 112.893 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.54 23.22 65.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.819 1.2 . . . . 0.0 113.663 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -89.97 -33.78 16.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.15 1.38 . . . . 0.0 114.343 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.17 148.38 77.99 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.039 0.936 . . . . 0.0 109.445 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.37 -19.91 24.78 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.502 2.135 . . . . 0.0 112.732 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.75 144.0 35.62 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.62 1.168 . . . . 0.0 112.58 -170.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -119.28 93.38 4.06 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.638 1.175 . . . . 0.0 109.562 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 85.3 m -81.08 125.0 29.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.738 1.215 . . . . 0.0 111.178 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 175.15 9.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.97 2.508 . . . . 0.0 109.852 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -74.5 121.59 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.224 -0.923 . . . . 0.0 111.206 163.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.86 -164.83 30.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.116 1.817 . . . . 0.0 110.581 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.17 137.4 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.343 0.592 . . . . 0.0 111.107 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -99.95 -46.63 1.87 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.751 2.119 . . . . 0.0 109.945 163.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.65 110.26 8.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.375 1.07 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.04 140.83 5.66 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.682 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.62 123.24 9.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.931 3.754 . . . . 0.0 109.393 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -57.48 -45.46 84.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.883 0.473 . . . . 0.0 111.878 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.37 -18.67 63.81 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.1 m -120.99 27.96 8.17 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.086 1.755 . . . . 0.0 112.276 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.22 138.12 32.11 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.233 1.013 . . . . 0.0 111.546 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -121.66 79.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.117 1.367 . . . . 0.0 109.503 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -64.24 -22.3 66.89 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -67.47 -53.5 28.26 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.689 0.677 . . . . 0.0 110.357 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -77.41 -18.37 57.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.92 40.97 8.98 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 124.756 1.17 . . . . 0.0 112.851 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.57 172.45 16.01 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.309 1.055 . . . . 0.0 112.831 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.0 p -143.26 151.37 40.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.362 1.065 . . . . 0.0 110.673 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -110.2 125.61 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.09 123.77 28.66 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.667 -1.158 . . . . 0.0 110.364 -172.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 142.91 43.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.64 1.56 . . . . 0.0 110.457 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 20.6 mtt -58.01 -35.4 71.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.378 1.071 . . . . 0.0 112.973 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -63.51 -18.67 64.05 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 17.4 mmm-85 -97.24 3.2 51.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.589 1.956 . . . . 0.0 113.821 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.28 121.28 35.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.896 0.878 . . . . 0.0 109.747 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.6 p -72.21 -179.28 2.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.488 1.515 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -41.82 99.14 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.635 -0.665 . . . . 0.0 111.217 170.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.66 92.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.395 1.078 . . . . 0.0 111.968 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.54 -52.4 65.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.941 1.296 . . . . 0.0 112.381 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -38.56 85.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.679 -0.638 . . . . 0.0 112.225 173.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -56.11 -41.71 75.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.385 -0.816 . . . . 0.0 111.848 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -70.99 -45.63 63.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.494 1.497 . . . . 0.0 111.733 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 50.2 m -51.16 -35.55 36.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.956 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 5.7 m -90.81 -58.06 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 14.5 m -86.08 -7.38 58.64 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -166.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.46 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -52.86 145.49 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.76 1.163 . . . . 0.0 111.301 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -83.98 -27.24 28.59 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.843 -0.536 . . . . 0.0 111.204 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -125.67 136.88 53.71 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.237 2.215 . . . . 0.0 110.708 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.65 -179.92 32.97 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.001 0.81 . . . . 0.0 113.204 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.38 -150.43 48.45 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.263 -1.14 . . . . 0.0 112.29 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 43.0 p -116.07 17.18 15.91 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -153.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 t 65.26 17.88 11.18 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.947 -1.096 . . . . 0.0 113.25 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.05 59.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.498 1.047 . . . . 0.0 113.788 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -84.73 145.93 45.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.84 1.32 . . . . 0.0 111.338 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.89 107.33 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.057 2.505 . . . . 0.0 109.198 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 131.1 38.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.37 0.605 . . . . 0.0 111.595 -176.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.68 168.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.629 1.572 . . . . 0.0 110.733 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -47.25 127.0 10.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.986 0.915 . . . . 0.0 110.747 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.92 65.86 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.251 -1.305 . . . . 0.0 115.306 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 325' ' ' TYR . 1.7 tp -50.48 133.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 120.239 2.02 . . . . 0.0 111.719 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.23 127.78 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.274 1.829 . . . . 0.0 108.345 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 334' ' ' ILE . 10.5 p90 -152.03 179.52 8.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.174 1.39 . . . . 0.0 111.715 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -102.34 153.09 20.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.706 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -38.11 121.0 1.04 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.606 1.562 . . . . 0.0 114.529 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 160.35 50.18 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.224 1.95 . . . . 0.0 111.728 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.46 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 70.8 m-20 -67.86 127.54 33.19 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.846 1.258 . . . . 0.0 113.907 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.16 46.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 123.415 1.579 . . . . 0.0 110.215 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.5 pt -52.03 157.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.681 140.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 3.3 t 68.03 7.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.443 -1.411 . . . . 0.0 111.222 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.42 157.04 53.01 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.331 1.443 . . . . 0.0 112.985 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -164.79 -59.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.761 1.224 . . . . 0.0 110.83 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.61 113.95 0.79 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.814 1.197 . . . . 0.0 111.795 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . 0.312 29.7 m . . . . . 0 N--CA 1.49 1.573 0 C-N-CA 130.663 3.585 . . . . 0.0 117.21 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 119.915 -0.088 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 31.3 pt -115.72 -26.13 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 71.33 27.19 72.01 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.063 0.847 . . . . 0.0 114.682 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.11 79.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.87 -172.02 1.13 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.613 2.875 . . . . 0.0 111.569 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -59.72 -22.9 62.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.878 0.871 . . . . 0.0 113.299 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.0 p 78.99 -1.64 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 129.764 3.226 . . . . 0.0 113.709 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.02 -34.39 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.623 1.969 . . . . 0.0 113.393 -176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 305' ' ' LEU . 6.4 p90 46.2 75.74 0.11 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.768 2.027 . . . . 0.0 112.231 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -77.68 -100.58 0.19 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.857 1.218 . . . . 0.0 112.573 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 74.7 p -73.37 -22.35 60.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.59 1.156 . . . . 0.0 112.985 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -80.08 51.52 1.38 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.538 1.935 . . . . 0.0 112.892 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 64.93 -175.51 0.17 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.276 1.831 . . . . 0.0 111.487 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -124.41 12.64 8.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -168.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -72.73 141.02 48.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.474 ' HA ' ' CE2' ' A' ' 298' ' ' PHE . 9.1 mp -66.54 -31.1 71.6 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.419 1.088 . . . . 0.0 111.661 172.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.72 73.98 65.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.898 1.279 . . . . 0.0 109.637 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 -27.83 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.773 2.316 . . . . 0.0 111.551 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -82.35 46.64 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.032 1.733 . . . . 0.0 111.497 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.24 160.83 39.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.022 1.729 . . . . 0.0 110.578 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 95.0 mt -136.83 171.6 14.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.885 1.274 . . . . 0.0 110.331 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -78.23 63.33 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.145 0.978 . . . . 0.0 111.098 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 14.4 m -125.04 149.11 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.313 2.245 . . . . 0.0 111.199 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.3 p -63.01 -23.98 67.71 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.34 -22.89 65.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.528 0.731 . . . . 0.0 112.865 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -84.66 125.45 71.27 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.801 1.24 . . . . 0.0 110.493 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.22 -17.84 50.38 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.552 2.168 . . . . 0.0 113.123 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -78.38 5.28 10.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.911 1.284 . . . . 0.0 114.431 168.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -53.63 129.72 33.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.788 -1.195 . . . . 0.0 111.72 170.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -156.04 143.54 13.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.194 1.398 . . . . 0.0 110.847 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.84 172.36 14.69 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.672 2.248 . . . . 0.0 111.102 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 83.59 9.36 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 109.867 168.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.47 150.48 63.97 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.296 2.664 . . . . 0.0 110.534 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 10.8 t -144.33 133.41 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 109.662 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.09 167.75 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 110.845 174.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -143.88 121.79 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.971 0.908 . . . . 0.0 110.289 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.72 108.76 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.447 0.699 . . . . 0.0 111.156 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.9 p -69.35 -8.55 47.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -25.19 67.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.651 1.181 . . . . 0.0 112.235 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.53 150.49 95.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.794 0.838 . . . . 0.0 112.068 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.06 161.27 34.17 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.18 3.253 . . . . 0.0 112.539 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.17 134.65 32.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.059 3.173 . . . . 0.0 112.029 -173.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.99 44.53 4.65 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.633 1.573 . . . . 0.0 112.046 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -126.75 153.68 45.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.818 1.247 . . . . 0.0 114.141 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.37 145.74 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.615 1.966 . . . . 0.0 110.697 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -106.77 111.16 23.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.018 1.727 . . . . 0.0 109.863 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.81 97.08 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.194 0.598 . . . . 0.0 110.295 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.45 138.92 57.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.935 0.874 . . . . 0.0 111.706 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 41.4 t -75.48 136.84 40.63 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.191 -0.943 . . . . 0.0 112.577 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 18.82 14.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.51 2.324 . . . . 0.0 111.305 163.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 62.4 m -119.34 133.44 55.72 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.146 1.378 . . . . 0.0 110.293 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.36 134.87 42.66 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.34 1.056 . . . . 0.0 108.817 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.11 120.82 32.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 161.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.9 106.53 20.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -84.24 -178.23 51.49 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 168.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.12 11.78 59.32 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.377 -1.072 . . . . 0.0 115.067 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.01 130.12 91.7 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.965 1.383 . . . . 0.0 110.153 -166.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.94 128.01 18.9 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.923 2.415 . . . . 0.0 109.062 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.1 pp -59.17 -18.7 38.6 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.1 -25.95 31.5 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 9.1 mtm -73.52 146.48 44.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 0.0 112.293 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -118.13 178.97 4.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.115 1.766 . . . . 0.0 111.715 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.83 -36.47 67.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.617 1.167 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -73.88 -30.9 62.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.47 -35.85 81.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.547 1.067 . . . . 0.0 110.93 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 379' ' ' VAL . 1.2 mm? -58.33 -51.27 70.49 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.285 0.493 . . . . 0.0 110.438 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.75 69.65 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.38 -40.09 64.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.46 1.482 . . . . 0.0 112.883 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.0 -36.72 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 111.249 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.519 ' CD1' HG11 ' A' ' 379' ' ' VAL . 36.1 mt -85.99 -8.08 58.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -50.44 75.17 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.08 -7.12 19.49 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.609 2.206 . . . . 0.0 113.128 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -98.69 -37.5 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.107 1.363 . . . . 0.0 112.867 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.16 168.82 3.37 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.541 1.937 . . . . 0.0 114.05 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.08 116.08 22.7 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.787 1.635 . . . . 0.0 112.051 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 97.5 t -87.88 113.48 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.133 0.973 . . . . 0.0 109.853 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.32 -37.84 15.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.502 1.121 . . . . 0.0 111.675 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.36 150.13 35.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 0.0 111.656 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.06 141.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.899 0.88 . . . . 0.0 110.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.91 105.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.355 1.062 . . . . 0.0 108.303 167.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.57 124.52 41.86 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.275 0.559 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -112.91 84.11 1.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.972 1.709 . . . . 0.0 109.258 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.71 -28.59 65.94 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.795 1.238 . . . . 0.0 111.648 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 97.2 p -61.01 -31.83 71.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.962 1.705 . . . . 0.0 113.853 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -110.28 6.82 22.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.113 1.765 . . . . 0.0 113.099 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? 56.98 40.33 28.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.995 1.318 . . . . 0.0 111.314 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -123.7 151.61 42.96 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.28 1.832 . . . . 0.0 113.464 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.25 128.28 25.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.13 1.372 . . . . 0.0 111.289 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -81.75 131.62 35.27 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.989 -1.069 . . . . 0.0 108.853 161.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 359' ' ' LEU . 70.3 t -129.84 117.24 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.915 0.886 . . . . 0.0 109.707 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -104.24 116.13 31.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.928 1.291 . . . . 0.0 110.273 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.92 -179.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.529 0.732 . . . . 0.0 109.557 167.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 383' ' ' SER . 0.3 OUTLIER -64.02 -49.55 71.98 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' SER . . . . . 0.409 ' HB3' ' CE2' ' A' ' 382' ' ' TYR . 82.2 p -139.15 165.95 25.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.216 1.008 . . . . 0.0 112.941 -163.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -42.77 93.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.838 167.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -43.02 91.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.909 0.777 . . . . 0.0 112.277 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.5 -48.18 70.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.079 0.551 . . . . 0.0 111.763 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.2 95.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.162 0.892 . . . . 0.0 112.917 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -64.37 -40.8 96.53 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.784 0.834 . . . . 0.0 111.747 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.44 -35.33 77.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.473 1.033 . . . . 0.0 111.654 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.2 -65.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 119.043 -0.503 . . . . 0.0 110.524 166.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.3 mt -49.46 -35.78 20.6 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.323 1.449 . . . . 0.0 114.624 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.14 -33.55 71.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.275 1.43 . . . . 0.0 113.794 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -112.18 -28.28 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.215 1.006 . . . . 0.0 113.121 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.14 123.5 21.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.52 0.728 . . . . 0.0 111.202 -170.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.02 30.7 18.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.414 1.486 . . . . 0.0 114.121 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -33.98 76.76 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.47 -19.68 55.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.536 1.134 . . . . 0.0 112.883 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.2 22.69 60.35 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.817 1.199 . . . . 0.0 113.686 -173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.9 -32.93 17.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.13 1.372 . . . . 0.0 114.495 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.61 148.4 73.12 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.118 0.967 . . . . 0.0 109.586 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.83 -32.2 7.57 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.684 2.256 . . . . 0.0 112.249 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.36 149.61 50.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.852 1.261 . . . . 0.0 112.066 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.07 102.14 7.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.581 1.153 . . . . 0.0 110.718 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.6 m -80.18 124.58 28.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.817 1.247 . . . . 0.0 110.776 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -132.64 172.21 12.82 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.633 1.973 . . . . 0.0 109.939 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.55 121.67 20.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.062 -1.023 . . . . 0.0 111.295 166.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.15 -166.84 19.62 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.626 1.584 . . . . 0.0 110.052 167.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.5 p -165.53 136.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.323 0.649 . . . . 0.0 111.628 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.63 -47.09 3.29 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.34 1.924 . . . . 0.0 111.249 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -111.19 93.07 4.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.082 0.941 . . . . 0.0 112.254 173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.91 121.05 1.12 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.319 -1.267 . . . . 0.0 113.901 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 125.37 10.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.019 3.146 . . . . 0.0 109.5 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.33 -44.07 88.52 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.83 -12.44 59.97 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 53.5 m -117.71 12.67 14.02 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.881 1.672 . . . . 0.0 112.901 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 140.82 31.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.348 1.459 . . . . 0.0 111.926 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -123.5 86.35 2.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.65 1.58 . . . . 0.0 109.137 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.62 -20.93 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -69.72 -52.52 24.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.507 0.594 . . . . 0.0 110.368 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -79.53 -16.17 56.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.94 43.33 14.36 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.693 1.139 . . . . 0.0 112.772 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.23 167.08 31.11 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.573 1.187 . . . . 0.0 113.529 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.05 146.09 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.891 -1.131 . . . . 0.0 110.82 171.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -109.67 94.25 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.43 124.15 56.28 Favored Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.094 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.31 147.67 42.28 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.826 1.684 . . . . 0.0 110.998 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.5 mmt -57.82 -36.58 72.44 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.264 1.426 . . . . 0.0 112.363 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -68.24 -11.94 60.18 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -107.11 12.21 28.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.297 1.839 . . . . 0.0 113.312 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.84 135.49 49.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.544 1.138 . . . . 0.0 109.87 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.3 p -79.85 175.1 10.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 110.974 171.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.31 -45.9 87.16 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.523 -0.736 . . . . 0.0 110.763 171.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.15 90.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.648 1.179 . . . . 0.0 112.829 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.24 -51.22 70.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.147 0.979 . . . . 0.0 111.984 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.39 -37.61 80.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.33 0.652 . . . . 0.0 110.953 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -51.68 -52.41 48.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.861 1.264 . . . . 0.0 110.828 173.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -67.19 -41.98 84.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.22 1.373 . . . . 0.0 111.821 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 63.4 m -55.65 -28.63 56.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.768 -1.11 . . . . 0.0 112.802 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.05 -44.5 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.901 1.228 . . . . 0.0 113.945 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 31.2 m -94.68 -11.29 29.47 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.15 143.93 51.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.898 1.226 . . . . 0.0 111.839 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -72.35 -42.73 64.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.675 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -112.12 140.61 46.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.698 1.599 . . . . 0.0 110.98 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.4 176.8 25.35 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.128 -171.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.01 -164.6 51.62 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 122.023 -0.692 . . . . 0.0 113.252 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.7 p -106.87 18.96 21.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -157.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 p 69.69 13.54 8.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.563 1.145 . . . . 0.0 114.027 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 92.39 2.0 68.48 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.063 1.316 . . . . 0.0 113.504 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -67.11 150.52 97.87 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.86 1.33 . . . . 0.0 110.426 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.33 142.3 90.62 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.4 2.066 . . . . 0.0 110.215 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.7 114.87 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.04 159.23 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.614 1.566 . . . . 0.0 110.184 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 97.9 m -56.41 130.74 46.07 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.849 0.46 . . . . 0.0 109.905 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.42 84.4 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.351 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.24 137.19 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.021 1.41 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.03 132.68 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.262 1.825 . . . . 0.0 109.342 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -158.07 171.3 20.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.469 1.507 . . . . 0.0 110.79 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.07 142.06 27.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.809 0.444 . . . . 0.0 111.302 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.68 126.12 2.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.212 1.405 . . . . 0.0 114.499 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.76 166.22 30.57 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.603 3.535 . . . . 0.0 112.442 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -66.65 142.84 57.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.789 1.236 . . . . 0.0 113.897 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.76 52.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.244 1.497 . . . . 0.0 109.753 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.55 172.81 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.713 138.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.19 -48.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 120.984 -1.073 . . . . 0.0 110.98 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.41 -51.75 4.4 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.745 1.165 . . . . 0.0 112.171 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.31 156.74 2.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.598 1.959 . . . . 0.0 111.202 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 171.84 162.24 23.75 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.305 1.431 . . . . 0.0 113.676 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.862 1.665 . . . . 0.0 112.198 -177.57 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.605 0.24 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 28.0 pt -136.7 159.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.189 1.395 . . . . 0.0 111.859 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.72 140.72 4.38 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.229 1.395 . . . . 0.0 112.22 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -116.83 152.53 48.67 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.464 1.506 . . . . 0.0 111.232 173.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.96 -62.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.24 2.627 . . . . 0.0 112.831 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 52.6 t30 34.37 77.22 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.479 2.312 . . . . 0.0 114.657 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.6 m -63.41 -52.14 62.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.684 1.594 . . . . 0.0 112.45 -170.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.6 t -170.15 13.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.356 1.862 . . . . 0.0 113.673 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -62.35 119.63 9.45 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.909 -1.119 . . . . 0.0 111.141 -174.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 133.05 -13.53 4.97 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 117.711 -1.605 . . . . 0.0 116.631 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 13.4 t -160.63 67.43 0.33 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.972 1.886 . . . . 0.0 112.053 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 70.54 161.51 0.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.789 2.436 . . . . 0.0 112.401 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 6.6 m120 64.54 147.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.841 2.057 . . . . 0.0 113.418 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -144.96 11.51 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -75.92 142.6 42.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.733 1.213 . . . . 0.0 112.462 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.533 0.733 . . . . 0.0 112.023 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.84 159.51 50.89 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.152 1.381 . . . . 0.0 111.95 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.57 -156.64 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.818 3.679 . . . . 0.0 111.617 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.18 62.1 0.9 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.384 1.474 . . . . 0.0 110.534 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -74.56 159.65 31.91 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 128.478 2.711 . . . . 0.0 113.279 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.25 155.4 33.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.791 1.636 . . . . 0.0 111.041 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -80.22 69.31 6.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.842 0.857 . . . . 0.0 110.779 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.02 147.5 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.262 2.225 . . . . 0.0 109.22 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.1 p -60.37 -25.06 65.59 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -68.85 -25.23 64.54 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.41 127.24 76.68 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.986 1.314 . . . . 0.0 110.563 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.29 -18.58 55.72 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.833 1.689 . . . . 0.0 113.323 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.26 9.68 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 168.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -55.02 130.99 43.86 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.875 1.671 . . . . 0.0 112.439 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -156.3 153.84 26.02 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.111 1.765 . . . . 0.0 111.352 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.55 168.06 24.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.174 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 81.07 4.2 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.513 1.125 . . . . 0.0 109.604 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.05 147.34 33.6 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.192 2.595 . . . . 0.0 111.035 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.6 t -147.28 137.88 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.351 1.46 . . . . 0.0 108.444 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.05 167.79 19.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.585 1.554 . . . . 0.0 110.746 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -141.57 122.82 14.8 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.036 -1.04 . . . . 0.0 111.064 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -114.4 101.16 8.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.427 1.491 . . . . 0.0 109.921 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.4 p -67.04 -14.12 62.59 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.358 1.063 . . . . 0.0 113.731 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -10.52 59.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.11 1.764 . . . . 0.0 113.908 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.39 156.99 80.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 119.88 1.218 . . . . 0.0 113.312 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.57 163.47 32.58 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.224 3.283 . . . . 0.0 113.293 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.68 134.67 24.49 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.212 3.275 . . . . 0.0 112.627 -172.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.68 34.24 12.41 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.148 1.379 . . . . 0.0 112.476 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -121.3 154.31 36.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.935 1.294 . . . . 0.0 114.401 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 pt -124.61 157.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.869 1.668 . . . . 0.0 111.891 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.58 118.9 37.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.865 1.266 . . . . 0.0 110.613 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 457' ' ' PHE . 48.7 t -112.74 107.42 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.604 0.638 . . . . 0.0 110.451 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.1 132.27 45.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 111.148 167.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.6 t -67.18 138.9 57.34 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.897 0.856 . . . . 0.0 112.064 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.17 21.13 8.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.44 2.696 . . . . 0.0 109.805 168.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 48.3 m -125.67 132.87 52.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.3 1.44 . . . . 0.0 109.014 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.51 133.41 46.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.66 1.584 . . . . 0.0 109.443 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -86.24 126.31 34.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 163.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 17.4 mm -114.67 107.46 22.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.81 170.08 47.45 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 123.168 0.414 . . . . 0.0 112.496 167.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.96 19.56 79.76 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.35 118.36 71.65 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.115 -171.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.39 147.87 47.69 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.291 2.661 . . . . 0.0 110.565 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.405 ' H ' HD12 ' A' ' 348' ' ' LEU . 2.8 mp -65.23 -18.61 65.45 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.28 -26.63 62.05 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.509 1.124 . . . . 0.0 113.381 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 12.4 mtm -75.46 152.55 37.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.6 1.091 . . . . 0.0 112.286 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -133.34 -177.67 4.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.231 2.212 . . . . 0.0 111.127 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -55.59 -39.9 71.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 112.144 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -79.14 -14.91 58.82 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.31 -40.0 52.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.161 1.346 . . . . 0.0 110.515 168.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 355' ' ' LEU . 4.1 mm? -61.33 -51.16 70.0 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.454 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.31 66.94 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.814 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -70.16 -47.4 61.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.013 1.278 . . . . 0.0 114.172 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.22 -32.37 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.583 1.538 . . . . 0.0 111.524 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 390' ' ' VAL . 39.5 mt -87.09 -11.51 49.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.072 0.949 . . . . 0.0 113.102 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -47.16 -49.1 53.16 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 126.224 1.809 . . . . 0.0 115.076 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.45 -3.31 13.51 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.199 1.933 . . . . 0.0 113.515 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.56 -36.15 7.61 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.611 1.565 . . . . 0.0 112.747 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.17 165.94 7.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.718 2.007 . . . . 0.0 112.741 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.52 100.34 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.866 1.666 . . . . 0.0 110.466 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.23 126.42 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.583 0.753 . . . . 0.0 109.835 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -95.71 -32.07 12.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.125 1.37 . . . . 0.0 112.419 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 42.3 t -152.83 155.72 37.64 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.747 1.158 . . . . 0.0 110.997 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 55.3 t -146.68 131.32 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.233 1.013 . . . . 0.0 109.324 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.09 107.93 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.35 117.08 33.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.193 0.597 . . . . 0.0 110.339 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -100.68 84.24 2.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 109.523 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.49 -38.81 69.62 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.405 1.482 . . . . 0.0 111.07 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 11.9 m -62.25 -21.82 65.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.826 2.05 . . . . 0.0 114.736 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -113.0 6.88 17.92 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.678 1.591 . . . . 0.0 112.484 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.2 mttt 52.61 35.06 17.15 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 126.562 1.945 . . . . 0.0 113.744 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -127.96 153.52 46.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.105 1.362 . . . . 0.0 113.008 -169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -134.92 131.89 37.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.814 0.846 . . . . 0.0 111.986 162.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -83.25 121.65 27.39 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.49 125.83 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.392 1.477 . . . . 0.0 108.692 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -114.61 115.51 27.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.136 1.374 . . . . 0.0 110.199 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.67 -166.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.877 0.871 . . . . 0.0 110.155 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -48.83 66.38 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.196 1.362 . . . . 0.0 113.197 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.9 p -152.15 173.04 15.43 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -160.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -45.82 80.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.057 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -53.85 -42.17 68.26 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.239 0.927 . . . . 0.0 112.674 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.28 -43.74 49.58 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.01 92.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.038 1.29 . . . . 0.0 113.011 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.52 -40.96 96.6 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.259 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.97 -31.63 72.0 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.81 1.186 . . . . 0.0 112.253 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 359' ' ' LEU . 9.7 t -63.62 -64.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.324 164.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.81 -32.12 42.49 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -74.54 -23.86 58.86 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.764 1.626 . . . . 0.0 113.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -120.91 -28.49 4.8 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.3 t80 -72.35 122.45 21.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.959 0.904 . . . . 0.0 111.378 -169.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 24.5 t30 59.5 29.11 18.64 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.531 1.933 . . . . 0.0 114.861 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -55.88 -34.34 65.42 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.746 -1.221 . . . . 0.0 113.646 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -79.29 -17.13 55.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 113.603 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 11.35 83.33 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.117 1.341 . . . . 0.0 113.728 -173.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -84.49 -31.97 24.21 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.087 1.755 . . . . 0.0 115.073 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.16 152.07 76.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.679 0.792 . . . . 0.0 109.929 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.86 -18.04 24.98 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.258 1.972 . . . . 0.0 113.011 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.99 150.72 23.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -123.41 83.04 2.08 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 109.907 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.3 m -72.39 122.78 21.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.066 1.746 . . . . 0.0 110.602 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 173.47 11.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.218 2.207 . . . . 0.0 109.375 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -66.87 123.69 20.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.168 -0.957 . . . . 0.0 111.205 162.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.85 -164.1 21.43 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 126.191 1.853 . . . . 0.0 109.663 163.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.11 134.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.66 0.784 . . . . 0.0 111.376 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -93.99 -38.87 5.03 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.182 1.849 . . . . 0.0 111.641 167.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -125.99 105.64 9.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.621 2.368 . . . . 0.0 113.475 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.96 137.68 3.97 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 118.472 -1.182 . . . . 0.0 114.567 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.37 132.26 16.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.878 3.719 . . . . 0.0 110.842 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -21.3 61.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.75 -21.42 37.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.807 1.185 . . . . 0.0 113.828 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 54.1 m -124.47 31.12 5.81 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.854 1.661 . . . . 0.0 111.693 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 19.4 t -84.83 138.97 32.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.786 1.234 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -125.69 86.8 2.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.621 1.569 . . . . 0.0 109.073 165.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -67.35 -14.77 63.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.74 -46.96 28.03 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.092 1.315 . . . . 0.0 110.426 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -81.26 -14.37 57.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 75.68 44.39 20.66 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.342 0.972 . . . . 0.0 112.919 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.48 174.5 12.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.526 1.163 . . . . 0.0 112.79 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 56.7 p -147.35 147.62 30.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.354 1.062 . . . . 0.0 111.114 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.12 124.71 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.575 HG21 HD21 ' A' ' 430' ' ' LEU . 1.1 mt -118.98 118.42 32.96 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 119.635 1.107 . . . . 0.0 111.743 -172.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -72.71 128.99 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 111.498 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -64.69 -23.93 67.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.859 1.263 . . . . 0.0 113.228 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.43 -24.4 67.61 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.835 1.198 . . . . 0.0 114.024 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -1.16 13.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.284 1.434 . . . . 0.0 114.562 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 425' ' ' ILE . 55.4 mt -61.73 136.48 58.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.163 0.892 . . . . 0.0 110.001 168.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 27.8 p -72.7 174.22 7.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.759 0.79 . . . . 0.0 111.293 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.97 -39.86 87.08 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.778 -0.576 . . . . 0.0 111.869 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.75 -36.62 65.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.242 0.617 . . . . 0.0 112.313 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -55.59 -60.03 4.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 111.283 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.71 -39.91 82.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.907 1.283 . . . . 0.0 112.25 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -47.92 70.67 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.088 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -66.12 -47.57 73.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.805 1.184 . . . . 0.0 110.972 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 13.1 m -52.33 -40.55 62.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.388 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.67 -44.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.7 t -97.23 -3.06 41.47 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -166.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -61.03 145.08 52.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.825 -1.172 . . . . 0.0 112.846 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.75 -28.74 36.4 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.827 1.251 . . . . 0.0 110.468 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -132.37 143.76 50.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.643 2.777 . . . . 0.0 110.75 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 175.53 18.51 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 123.704 0.669 . . . . 0.0 113.833 -171.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 73.52 -161.58 54.22 Favored Glycine 0 CA--C 1.546 1.973 0 O-C-N 121.501 -1.0 . . . . 0.0 114.424 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 21.1 p -93.36 3.07 56.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.962 2.105 . . . . 0.0 116.418 -160.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.4 m 78.05 6.31 2.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.83 1.252 . . . . 0.0 113.036 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.26 5.33 59.36 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.014 1.292 . . . . 0.0 113.438 -169.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -71.92 153.45 92.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.578 1.189 . . . . 0.0 109.834 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.58 146.97 93.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.086 2.524 . . . . 0.0 110.897 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 54.5 mt -70.66 104.32 2.8 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.65 158.21 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.045 1.338 . . . . 0.0 111.647 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.0 m -59.05 131.65 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.09 -1.15 79.82 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.85 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.718 1.759 . . . . 0.0 112.683 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.44 137.06 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.348 2.259 . . . . 0.0 109.452 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' PHE . . . . . 0.413 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.5 p90 -164.55 178.02 7.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.602 1.161 . . . . 0.0 111.715 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -97.54 151.69 19.78 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.107 . . . . 0.0 110.109 169.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -44.98 130.16 5.39 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -167.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.81 168.04 24.92 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.927 3.085 . . . . 0.0 111.175 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 67.4 m-20 -74.18 120.0 19.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.59 46.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.183 1.468 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 6.2 pt -54.03 156.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 142.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 3.5 t 67.16 9.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.917 -1.114 . . . . 0.0 111.48 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -57.5 138.95 47.43 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.339 -1.476 . . . . 0.0 113.88 -168.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -158.24 157.44 32.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.057 0.943 . . . . 0.0 112.198 -166.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -91.21 -174.93 43.68 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.602 1.572 . . . . 0.0 113.907 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 125.579 1.551 . . . . 0.0 111.298 177.799 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 42.0 m80 . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -72.83 138.68 46.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.595 1.158 . . . . 0.0 111.885 171.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.25 -42.78 99.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.913 0.885 . . . . 0.0 110.35 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 124.941 1.296 . . . . 0.0 112.55 -178.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 CA--C 1.553 1.076 0 O-C-N 120.675 -1.265 . . . . 0.0 110.725 167.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.1 m80 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -50.39 135.57 21.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.097 1.317 . . . . 0.0 112.099 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -136.37 151.07 72.48 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 124.029 0.932 . . . . 0.0 110.72 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.81 165.98 21.77 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.014 2.476 . . . . 0.0 110.632 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.38 79.41 1.66 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 166.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.5 115.77 4.21 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.443 2.095 . . . . 0.0 108.451 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.01 142.06 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.761 1.224 . . . . 0.0 109.317 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.68 169.04 18.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.489 1.116 . . . . 0.0 109.92 174.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -140.6 111.18 6.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.811 0.845 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.61 126.78 53.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.796 0.838 . . . . 0.0 111.794 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.4 p -73.76 -7.63 52.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -18.58 65.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.508 2.323 . . . . 0.0 111.915 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.6 153.04 81.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.634 1.174 . . . . 0.0 113.361 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.12 165.1 29.57 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.559 3.506 . . . . 0.0 113.047 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.35 135.6 27.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.399 3.399 . . . . 0.0 112.776 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.28 42.92 14.36 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.694 1.597 . . . . 0.0 111.465 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -127.24 153.04 46.61 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.6 pt -126.2 147.75 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.476 1.91 . . . . 0.0 109.966 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 133.1 51.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.203 1.401 . . . . 0.0 111.331 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.01 102.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.185 0.594 . . . . 0.0 110.996 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -68.62 136.18 52.59 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.396 1.079 . . . . 0.0 111.626 166.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.4 t -78.37 136.37 37.66 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.354 -0.841 . . . . 0.0 111.364 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -103.03 12.3 36.17 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.968 1.707 . . . . 0.0 109.918 162.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 52.5 m -109.98 130.71 55.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.073 1.749 . . . . 0.0 110.127 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 mt -96.01 136.61 36.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 108.932 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -94.83 139.64 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 161.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.2 mm -124.95 107.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.79 1.236 . . . . 0.0 108.209 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.71 176.48 46.17 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 123.882 0.753 . . . . 0.0 111.868 168.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.18 17.4 72.0 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.016 0.766 . . . . 0.0 115.016 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.3 122.15 86.65 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 118.507 1.153 . . . . 0.0 110.525 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.12 137.6 29.22 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.871 2.38 . . . . 0.0 108.931 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.4 mp -64.73 -17.43 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.59 -25.66 57.19 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 47.8 mtm -78.46 139.76 38.68 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.861 0.838 . . . . 0.0 112.238 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -116.47 -173.75 2.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.744 2.018 . . . . 0.0 111.657 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -54.07 -48.44 70.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.196 1.798 . . . . 0.0 112.703 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -76.19 -18.4 59.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.01 -40.37 71.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.059 1.299 . . . . 0.0 110.683 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.2 mm? -60.01 -49.1 78.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.817 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.07 71.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.923 0.783 . . . . 0.0 112.95 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.52 -44.82 70.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.528 1.131 . . . . 0.0 113.964 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.97 -33.89 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.699 1.136 . . . . 0.0 110.683 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 394' ' ' PHE . 51.5 mt -87.02 -10.59 52.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.037 0.935 . . . . 0.0 113.187 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -48.31 -48.96 64.78 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.669 1.588 . . . . 0.0 114.674 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.34 -6.98 17.66 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.217 1.945 . . . . 0.0 113.375 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.68 -39.99 8.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.47 1.508 . . . . 0.0 112.38 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.39 169.89 3.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.13 1.772 . . . . 0.0 112.712 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.54 125.5 32.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.553 0.741 . . . . 0.0 109.835 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.67 128.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.621 0.768 . . . . 0.0 110.276 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -91.8 -43.38 9.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.123 1.369 . . . . 0.0 112.538 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.92 159.2 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 111.623 -172.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.0 p -160.79 133.7 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.731 -0.606 . . . . 0.0 111.609 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.7 103.31 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.73 133.11 43.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.794 0.837 . . . . 0.0 110.224 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.57 89.47 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.821 1.248 . . . . 0.0 109.565 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -60.24 -38.32 83.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.765 1.226 . . . . 0.0 111.711 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.0 t -58.9 -30.62 67.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.765 1.626 . . . . 0.0 113.23 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.74 -3.15 42.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.359 1.463 . . . . 0.0 113.13 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 58.8 30.85 20.6 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.297 1.839 . . . . 0.0 113.326 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -133.82 169.3 17.26 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.45 42.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.013 1.325 . . . . 0.0 111.159 164.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.28 136.76 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 45.1 t -134.72 113.3 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.428 0.691 . . . . 0.0 110.78 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -92.99 122.89 35.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 0.0 109.734 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.63 164.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.088 0.955 . . . . 0.0 109.97 169.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -73.76 -22.34 59.89 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 p -134.38 154.18 51.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.762 1.165 . . . . 0.0 113.445 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -59.43 -41.75 90.29 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.148 0.979 . . . . 0.0 111.493 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -37.68 88.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.401 0.68 . . . . 0.0 111.853 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.42 -50.65 72.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.752 1.221 . . . . 0.0 111.073 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.03 95.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.919 0.781 . . . . 0.0 112.027 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.98 -42.12 98.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.954 0.502 . . . . 0.0 112.138 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -63.45 -35.02 79.06 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.256 0.935 . . . . 0.0 112.26 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.23 -64.35 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.819 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -49.27 -36.77 21.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.893 1.277 . . . . 0.0 114.153 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.09 -35.88 80.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.918 1.287 . . . . 0.0 113.476 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -111.79 -25.6 9.39 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 18.1 t80 -72.0 124.17 24.36 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.537 0.735 . . . . 0.0 111.189 -169.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 61.89 30.17 18.08 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.263 1.425 . . . . 0.0 113.904 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -58.33 -36.07 72.84 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.806 -1.184 . . . . 0.0 113.385 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.569 1.148 . . . . 0.0 113.062 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.48 61.55 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.88 1.228 . . . . 0.0 113.737 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.16 -34.68 14.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.379 1.472 . . . . 0.0 114.389 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 24.8 mt -73.67 148.52 87.66 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.099 0.96 . . . . 0.0 109.457 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.71 -29.45 10.61 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.347 2.031 . . . . 0.0 112.181 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.87 139.97 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.959 1.704 . . . . 0.0 111.715 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.26 103.0 10.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.048 1.339 . . . . 0.0 110.08 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.8 m -81.75 124.27 29.48 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.883 1.273 . . . . 0.0 110.571 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -133.39 175.37 9.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.602 2.361 . . . . 0.0 109.248 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -73.51 123.47 24.0 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.25 -0.906 . . . . 0.0 110.889 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -100.66 -164.73 28.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 163.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.49 122.07 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.078 0.951 . . . . 0.0 109.234 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -84.73 -47.4 5.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 162.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.68 120.11 22.32 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.808 0.843 . . . . 0.0 111.732 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.06 131.73 1.54 Allowed Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.529 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.84 130.94 16.33 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 125.161 3.907 . . . . 0.0 110.405 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -36.19 79.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -72.32 -18.79 61.75 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.6 m -124.16 29.9 6.26 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.906 1.683 . . . . 0.0 111.982 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.7 155.55 25.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -139.71 73.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.802 1.641 . . . . 0.0 109.446 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -63.07 -18.62 63.57 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.47 -52.42 32.61 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.109 -0.994 . . . . 0.0 111.077 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -80.78 -17.19 51.68 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 84.43 38.33 9.96 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.964 1.269 . . . . 0.0 113.034 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -145.59 169.7 17.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.63 1.215 . . . . 0.0 112.374 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 46.4 m -141.13 157.13 45.7 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.941 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.53 127.68 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.67 125.51 28.02 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 117.405 -1.283 . . . . 0.0 111.229 -170.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.86 132.21 18.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.078 1.852 . . . . 0.0 110.362 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -20.47 61.64 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.635 1.174 . . . . 0.0 113.735 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -26.26 65.55 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.34 0.973 . . . . 0.0 113.208 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.0 -24.53 16.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.757 1.223 . . . . 0.0 112.802 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.5 116.83 4.62 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.4 p -65.55 176.54 1.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.738 1.215 . . . . 0.0 110.733 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.37 -41.3 93.44 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.502 -0.749 . . . . 0.0 110.99 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.41 -40.99 85.62 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 112.541 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -58.35 -52.55 65.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.889 1.276 . . . . 0.0 111.993 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -66.84 -37.54 84.69 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.771 -0.58 . . . . 0.0 111.566 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -47.91 73.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.212 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.41 -43.35 77.4 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.269 1.395 . . . . 0.0 111.533 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 66.8 m -53.52 -35.8 61.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.59 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.5 m -90.63 -43.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -99.51 -12.91 19.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.289 1.436 . . . . 0.0 114.489 -166.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.79 142.16 46.49 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.162 -0.961 . . . . 0.0 111.062 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -80.82 -45.56 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.509 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -100.31 131.4 46.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.297 1.039 . . . . 0.0 110.181 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.71 -176.57 45.58 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.381 0.991 . . . . 0.0 114.028 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.31 -156.44 52.99 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.417 -0.392 . . . . 0.0 112.265 -170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.8 p -99.43 -4.96 30.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 77.95 17.65 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.788 1.635 . . . . 0.0 113.317 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.44 56.04 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.122 1.344 . . . . 0.0 113.884 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 153.53 95.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.726 1.263 . . . . 0.0 111.593 172.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.84 143.93 81.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.863 2.376 . . . . 0.0 110.423 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 40.6 mt -70.75 110.53 5.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.279 0.562 . . . . 0.0 109.618 170.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.11 152.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 110.235 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.1 m -53.35 130.0 33.7 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.65 0.78 . . . . 0.0 109.71 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.52 -5.6 80.32 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.865 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.45 134.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.807 1.304 . . . . 0.0 111.514 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.5 t -119.99 140.41 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.752 2.021 . . . . 0.0 108.734 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.83 -179.61 7.33 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.691 1.196 . . . . 0.0 111.797 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -92.13 150.3 21.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.212 . . . . 0.0 110.842 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -51.16 132.21 31.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 124.553 1.141 . . . . 0.0 113.703 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.26 148.45 74.39 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.957 1.771 . . . . 0.0 109.253 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -52.96 148.29 7.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.174 0.99 . . . . 0.0 112.858 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -108.09 50.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 123.159 1.456 . . . . 0.0 110.103 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.6 142.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 29.7 m80 . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -64.73 133.28 51.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.708 1.203 . . . . 0.0 111.622 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 356' ' ' ALA . 10.9 mp -69.6 -20.13 63.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.006 1.322 . . . . 0.0 111.355 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 126.913 2.085 . . . . 0.0 112.183 -172.709 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 CA--C 1.551 0.991 0 O-C-N 120.665 -1.272 . . . . 0.0 110.744 173.712 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -53.68 117.94 3.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.181 1.392 . . . . 0.0 112.729 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 143.72 50.4 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 125.252 1.421 . . . . 0.0 110.491 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.3 164.85 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.294 2.663 . . . . 0.0 111.217 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 83.74 13.71 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.251 1.02 . . . . 0.0 109.019 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.98 116.37 4.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.531 2.154 . . . . 0.0 108.218 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.8 t -112.35 129.04 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.789 0.835 . . . . 0.0 109.276 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.1 170.26 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 111.0 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -138.47 121.81 17.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.445 1.098 . . . . 0.0 110.082 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -122.14 105.89 10.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.08 0.952 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -7.66 16.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.547 1.539 . . . . 0.0 113.723 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.87 -24.5 64.34 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.788 1.235 . . . . 0.0 112.375 172.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.99 150.14 96.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.633 0.773 . . . . 0.0 111.927 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.67 162.0 33.34 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.138 3.225 . . . . 0.0 112.945 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 133.53 27.24 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.963 3.109 . . . . 0.0 112.49 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.03 26.88 7.19 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.399 1.88 . . . . 0.0 113.015 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -112.58 153.64 27.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.48 151.23 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.019 2.128 . . . . 0.0 109.678 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -114.41 131.8 56.45 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.127 1.33 . . . . 0.0 111.727 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.9 106.57 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 110.794 -171.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.22 129.3 39.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.875 1.27 . . . . 0.0 111.34 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.5 t -69.41 135.1 49.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.776 -0.577 . . . . 0.0 111.973 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.412 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 32.9 mtm105 -105.37 15.31 27.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.659 1.584 . . . . 0.0 110.487 162.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 17.5 m -121.16 143.63 49.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.008 1.323 . . . . 0.0 112.054 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -111.1 136.55 49.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.829 2.052 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.96 137.46 32.32 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 166.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.82 117.36 52.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 108.058 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -99.64 174.61 27.08 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.709 1.147 . . . . 0.0 111.012 164.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.44 27.17 70.15 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 119.132 -0.815 . . . . 0.0 114.031 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.22 106.02 18.06 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.504 1.152 . . . . 0.0 110.567 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.97 146.52 87.81 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.798 2.332 . . . . 0.0 111.037 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.49 -19.24 64.58 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.69 -29.6 68.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.078 0.951 . . . . 0.0 112.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 17.6 mtm -85.62 151.8 23.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.037 0.935 . . . . 0.0 112.667 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -175.49 4.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 111.581 -175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -50.33 -35.56 28.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.387 1.875 . . . . 0.0 113.085 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -78.01 -21.24 51.08 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.9 -36.09 62.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.844 1.202 . . . . 0.0 110.639 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 355' ' ' LEU . 3.8 mm? -60.58 -46.94 88.36 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.725 0.693 . . . . 0.0 110.772 169.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 305' ' ' LEU . . . -53.86 -44.8 70.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.545 0.612 . . . . 0.0 112.437 169.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -69.49 -41.19 76.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.695 1.198 . . . . 0.0 113.456 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.6 m -73.75 -34.69 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.898 0.772 . . . . 0.0 111.864 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 379' ' ' VAL . 66.7 mt -86.3 -12.6 49.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.354 1.062 . . . . 0.0 113.397 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -48.3 71.87 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.087 1.755 . . . . 0.0 115.309 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.69 -7.44 17.62 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.66 2.24 . . . . 0.0 113.869 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -96.73 -39.87 9.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.281 1.432 . . . . 0.0 112.401 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.43 171.86 5.35 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.919 1.688 . . . . 0.0 112.747 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.39 130.8 34.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.366 0.666 . . . . 0.0 109.559 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.34 127.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 109.601 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.01 -46.63 10.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 111.699 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 45.2 t -154.57 152.03 29.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 -169.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.9 134.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.42 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 166.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.16 139.07 37.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.244 0.618 . . . . 0.0 110.731 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.28 90.82 3.0 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.546 1.165 . . . . 0.0 109.989 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.46 -31.03 68.95 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 111.82 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 6.7 m -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.544 1.938 . . . . 0.0 114.908 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.67 9.75 17.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.342 1.457 . . . . 0.0 112.932 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 55.5 35.82 25.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.908 1.683 . . . . 0.0 112.9 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -126.9 167.32 16.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.4 164.02 34.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.482 1.113 . . . . 0.0 112.112 165.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.98 123.04 42.52 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.516 1.526 . . . . 0.0 108.155 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 359' ' ' LEU . 94.1 t -117.62 116.02 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.257 1.023 . . . . 0.0 110.752 -175.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -91.29 121.04 32.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.922 0.889 . . . . 0.0 110.176 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.15 167.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.052 0.941 . . . . 0.0 109.465 168.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -76.38 -18.91 58.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.11 155.73 45.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.197 169.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -38.9 88.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.126 0.971 . . . . 0.0 111.99 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.2 -48.55 75.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.465 1.106 . . . . 0.0 111.314 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.23 91.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.018 0.527 . . . . 0.0 111.458 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -62.81 -42.28 99.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.25 1.02 . . . . 0.0 112.097 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -65.43 -34.14 77.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.658 1.117 . . . . 0.0 112.78 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.29 -62.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.64 -35.17 40.98 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.826 1.25 . . . . 0.0 114.109 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -67.02 -44.11 81.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.584 1.553 . . . . 0.0 113.266 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -103.58 -29.88 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -72.08 127.87 33.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.338 1.055 . . . . 0.0 111.388 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.72 25.64 15.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.466 . . . . 0.0 114.881 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -51.39 -45.87 62.63 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.09 3.53 38.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.888 2.075 . . . . 0.0 113.287 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.4 30.28 50.18 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.506 1.051 . . . . 0.0 113.81 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.36 65.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.86 162.23 30.29 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 126.335 1.854 . . . . 0.0 110.256 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.63 -22.73 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.328 2.018 . . . . 0.0 113.296 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 402' ' ' LEU . 0.2 OUTLIER -81.91 143.95 31.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.579 1.152 . . . . 0.0 111.724 -172.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -115.24 122.15 45.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.136 1.374 . . . . 0.0 108.919 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.6 m -107.12 128.62 54.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.507 1.123 . . . . 0.0 110.319 -167.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -132.51 175.64 9.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.818 2.047 . . . . 0.0 109.475 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -64.63 134.57 54.58 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.96 -1.087 . . . . 0.0 110.946 164.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.34 -152.82 9.61 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.702 1.62 . . . . 0.0 109.147 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.48 134.27 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.332 0.566 . . . . 0.0 112.262 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.97 -51.61 3.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -126.99 118.58 24.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.229 1.011 . . . . 0.0 112.119 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.96 143.13 4.7 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.857 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.26 130.22 17.19 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 125.686 4.257 . . . . 0.0 110.323 175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -35.29 80.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.646 0.378 . . . . 0.0 111.875 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -76.23 -16.61 59.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.14 1.376 . . . . 0.0 114.565 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.5 m -123.9 31.03 5.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.41 1.484 . . . . 0.0 111.952 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.36 138.26 32.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.632 1.573 . . . . 0.0 111.609 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -124.89 81.67 1.98 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.296 1.438 . . . . 0.0 109.881 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -66.4 -16.37 64.03 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.9 -51.23 23.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.964 1.256 . . . . 0.0 110.295 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -82.38 -12.28 58.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 73.83 42.68 37.57 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.607 1.099 . . . . 0.0 112.464 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -147.01 170.24 17.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.625 1.212 . . . . 0.0 112.836 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 25.5 m -132.57 152.24 51.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.035 0.934 . . . . 0.0 110.709 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.55 134.53 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.77 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.51 119.14 21.59 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 119.81 1.187 . . . . 0.0 111.409 -172.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.68 133.53 18.84 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.616 2.211 . . . . 0.0 111.492 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 9.6 mtt -59.5 -30.05 68.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.588 1.555 . . . . 0.0 113.762 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -65.17 -18.76 65.57 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -109.26 6.43 24.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.194 2.198 . . . . 0.0 113.346 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 425' ' ' ILE . 75.8 mt -94.48 138.34 32.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.409 1.084 . . . . 0.0 111.093 170.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.5 p -79.65 177.51 8.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.037 1.335 . . . . 0.0 111.356 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.64 -46.3 90.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.579 -0.7 . . . . 0.0 111.323 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.69 88.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.883 0.873 . . . . 0.0 112.059 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.78 -62.54 1.8 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.799 0.84 . . . . 0.0 111.338 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -61.47 -32.19 72.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.738 0.415 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -62.1 1.85 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.566 169.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -58.69 -40.52 83.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.477 1.49 . . . . 0.0 111.937 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 14.9 m -54.0 -29.23 42.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.832 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.14 -42.36 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.999 1.272 . . . . 0.0 114.087 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 20.0 m -93.08 -9.1 40.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.646 1.978 . . . . 0.0 115.033 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.24 145.9 41.24 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.086 1.312 . . . . 0.0 111.652 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.98 -53.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.011 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -97.95 136.65 37.93 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.325 1.05 . . . . 0.0 110.723 166.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 65.15 -170.79 25.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.232 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.35 -164.39 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 -166.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 49.9 p -100.9 14.41 31.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -164.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.5 m 62.22 19.11 10.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.783 1.174 . . . . 0.0 113.498 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.27 4.84 64.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.115 1.341 . . . . 0.0 114.201 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.34 151.57 96.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 118.785 1.292 . . . . 0.0 110.708 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.86 145.71 86.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.791 2.327 . . . . 0.0 110.894 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.66 107.03 3.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.98 157.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.574 1.55 . . . . 0.0 110.238 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 94.5 m -55.14 130.19 41.03 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.757 0.823 . . . . 0.0 110.019 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.77 -5.8 82.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.783 -1.009 . . . . 0.0 114.866 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.92 137.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.188 1.494 . . . . 0.0 111.973 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.7 137.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.422 1.889 . . . . 0.0 109.544 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -161.84 174.51 13.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.958 1.303 . . . . 0.0 112.694 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -87.74 150.32 23.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.801 1.241 . . . . 0.0 111.002 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 10.9 pt-20 -50.99 128.98 29.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.67 150.37 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.902 2.402 . . . . 0.0 110.98 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.1 141.55 58.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.726 1.21 . . . . 0.0 114.059 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.56 53.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 123.433 1.587 . . . . 0.0 110.294 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.549 0.916 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.622 141.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -70.41 140.92 52.17 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.093 -1.004 . . . . 0.0 112.77 171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.409 HD12 ' CZ2' ' A' ' 353' ' ' TRP . 3.3 mm? -65.54 -48.76 71.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 110.543 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 CA--C 1.551 0.989 0 C-N-CA 124.6 1.16 . . . . 0.0 113.013 -176.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 122.07 0.938 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 124.872 1.269 . . . . 0.0 109.064 175.19 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 29.9 m80 . . . . . 0 CA--C 1.549 0.919 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -52.94 131.52 36.0 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.835 -1.166 . . . . 0.0 111.797 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -138.65 147.77 55.99 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.792 1.237 . . . . 0.0 110.083 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.78 159.92 49.06 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.791 2.327 . . . . 0.0 111.116 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 81.82 0.54 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.78 0.832 . . . . 0.0 109.01 162.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.8 121.57 7.75 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 108.539 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 13.8 t -121.54 128.92 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.806 0.842 . . . . 0.0 109.382 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.14 171.72 8.49 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.019 1.727 . . . . 0.0 110.989 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -139.88 120.48 14.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.007 . . . . 0.0 109.928 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -120.04 109.74 15.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.301 1.04 . . . . 0.0 110.609 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 99.1 p -69.06 -7.66 37.82 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.1 t -64.4 -24.91 67.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.278 1.031 . . . . 0.0 112.223 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.37 150.72 95.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.931 0.892 . . . . 0.0 112.237 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.81 161.6 35.49 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.903 3.069 . . . . 0.0 112.64 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.64 134.44 28.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.942 3.094 . . . . 0.0 112.109 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . 0.25 7.0 m-20 68.4 26.03 6.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.675 1.99 . . . . 0.0 113.362 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -111.14 153.3 25.93 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.94 148.77 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.25 1.82 . . . . 0.0 109.872 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.15 132.85 53.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.502 -1.373 . . . . 0.0 110.617 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.93 106.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.341 0.656 . . . . 0.0 111.461 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -68.49 131.59 45.54 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.579 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 32.7 t -73.1 136.57 44.91 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.723 -0.611 . . . . 0.0 111.841 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -106.89 18.64 21.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.187 1.795 . . . . 0.0 109.724 163.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 16.2 m -126.29 141.95 51.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.967 1.307 . . . . 0.0 111.763 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.5 mt -104.16 134.88 46.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 109.351 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -87.27 123.39 32.22 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 163.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.58 107.13 22.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.23 -174.84 50.67 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 166.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.61 70.02 Favored Glycine 0 N--CA 1.475 1.275 0 O-C-N 121.43 -1.041 . . . . 0.0 114.955 170.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 14.9 t -84.71 112.81 45.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 118.78 1.29 . . . . 0.0 110.295 -168.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.95 143.96 62.47 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.984 2.456 . . . . 0.0 109.919 170.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.04 -21.18 63.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.9 -27.49 63.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.859 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 33.9 mtm -80.58 145.86 31.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.59 0.709 . . . . 0.0 112.293 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -129.46 -179.4 5.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.145 2.178 . . . . 0.0 110.976 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -47.68 -40.31 19.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 114.216 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.409 ' CZ2' HD12 ' A' ' 305' ' ' LEU . 78.4 m95 -81.43 -18.63 44.7 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.76 -39.27 66.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.663 1.12 . . . . 0.0 110.185 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.24 -51.26 70.75 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.833 0.453 . . . . 0.0 110.719 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.82 71.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.662 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -68.18 -44.31 76.2 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.135 1.334 . . . . 0.0 113.996 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.82 -35.72 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.507 1.049 . . . . 0.0 110.954 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.524 HD23 ' CE1' ' A' ' 394' ' ' PHE . 30.6 mt -83.7 -11.57 57.01 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.459 1.104 . . . . 0.0 113.138 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -48.66 -48.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.849 1.66 . . . . 0.0 114.758 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.12 -6.74 17.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.133 1.889 . . . . 0.0 113.586 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -98.46 -40.93 8.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.5 1.52 . . . . 0.0 112.431 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.68 171.55 3.79 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.915 1.686 . . . . 0.0 113.461 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -85.99 138.35 32.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.661 0.784 . . . . 0.0 110.538 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.1 t -103.7 129.86 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.616 1.166 . . . . 0.0 110.169 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . 0.415 ' HG3' ' CE1' ' A' ' 382' ' ' TYR . 45.7 tt0 -93.64 -40.23 10.37 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.355 1.862 . . . . 0.0 112.782 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.1 t -152.82 152.04 31.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.404 1.082 . . . . 0.0 110.61 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 70.9 t -146.22 131.99 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.248 0.477 . . . . 0.0 110.417 171.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.24 107.88 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.61 122.06 40.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.066 0.546 . . . . 0.0 110.337 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -106.48 84.9 2.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.822 1.649 . . . . 0.0 109.478 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.72 -33.91 66.96 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.485 1.514 . . . . 0.0 111.354 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 65.6 m -55.72 -32.51 63.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.155 1.782 . . . . 0.0 114.27 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -110.21 9.17 23.86 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 113.191 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt 53.94 37.85 27.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.382 1.473 . . . . 0.0 112.072 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -125.5 153.39 43.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.971 1.708 . . . . 0.0 113.24 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -136.8 132.75 35.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 112.228 164.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.96 117.63 24.92 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 162.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 359' ' ' LEU . 54.8 t -118.56 114.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.706 0.803 . . . . 0.0 110.249 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -98.37 121.96 40.95 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 110.299 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.11 164.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.437 1.095 . . . . 0.0 109.553 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 366' ' ' GLN . 70.7 m-85 -74.53 -21.22 59.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.4 p -141.74 159.63 41.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.09 1.314 . . . . 0.0 114.234 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -61.54 -45.34 94.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.214 1.006 . . . . 0.0 112.079 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -58.8 -38.22 78.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.239 0.616 . . . . 0.0 112.231 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.47 -54.8 34.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.956 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.0 85.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.888 0.767 . . . . 0.0 112.307 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.69 -44.79 95.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 111.633 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -65.24 -33.79 76.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.204 -0.935 . . . . 0.0 112.654 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 359' ' ' LEU . 49.3 t -60.16 -63.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.55 166.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -51.13 -35.81 37.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.877 1.271 . . . . 0.0 114.314 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -63.83 -37.51 87.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.99 1.316 . . . . 0.0 113.085 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -112.83 -26.94 8.32 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.524 ' CE1' HD23 ' A' ' 359' ' ' LEU . 11.2 t80 -74.3 123.81 25.28 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 111.308 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.93 27.4 13.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.736 1.614 . . . . 0.0 114.168 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -24.56 66.77 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -100.56 -14.48 18.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.615 1.966 . . . . 0.0 114.524 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.26 24.28 29.55 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.548 1.07 . . . . 0.0 115.291 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.88 -42.01 22.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.562 1.681 . . . . 0.0 115.028 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.8 149.25 90.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.859 0.863 . . . . 0.0 110.57 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.84 -32.89 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.588 2.192 . . . . 0.0 111.71 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.76 163.4 25.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.203 1.801 . . . . 0.0 112.67 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -126.3 101.28 6.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.549 1.54 . . . . 0.0 109.915 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 113.06 21.2 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.115 1.366 . . . . 0.0 109.804 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.42 171.11 11.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.938 1.695 . . . . 0.0 109.178 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -67.29 130.84 44.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.097 -1.002 . . . . 0.0 110.838 163.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -115.66 -148.96 9.39 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 125.865 1.698 . . . . 0.0 109.102 167.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.96 132.17 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.29 -46.71 5.47 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 167.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -132.82 121.47 23.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 111.978 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.86 145.79 5.84 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 119.274 -0.736 . . . . 0.0 114.659 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.13 133.61 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 125.048 3.832 . . . . 0.0 109.739 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -37.73 80.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.835 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.21 -20.12 63.11 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.658 -1.276 . . . . 0.0 113.896 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.0 m -123.71 30.19 6.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.817 1.647 . . . . 0.0 112.041 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.1 p -75.65 154.06 36.83 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.969 0.89 . . . . 0.0 112.688 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.07 73.23 1.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.596 1.558 . . . . 0.0 108.837 166.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.62 -19.96 65.29 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.257 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.65 -49.67 65.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.688 -1.258 . . . . 0.0 111.19 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -83.34 -13.79 54.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.7 40.15 12.9 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.844 1.211 . . . . 0.0 112.713 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -146.52 172.19 13.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.76 1.28 . . . . 0.0 112.38 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 50.6 m -139.35 153.31 47.67 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.881 0.872 . . . . 0.0 109.805 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.5 mt -110.73 133.93 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.839 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -125.1 119.16 25.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.517 1.053 . . . . 0.0 111.915 -170.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.05 127.99 14.28 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.915 2.41 . . . . 0.0 110.96 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 42.4 mtm -61.14 -30.38 70.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.576 1.15 . . . . 0.0 113.451 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -65.82 -20.34 66.21 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 11.57 22.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.049 2.14 . . . . 0.0 113.184 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 425' ' ' ILE . 45.0 mt -92.83 145.44 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.223 1.009 . . . . 0.0 111.316 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.1 p -79.76 177.33 8.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.22 -44.39 88.45 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.554 -0.717 . . . . 0.0 111.492 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.05 93.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.948 0.899 . . . . 0.0 112.05 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.449 ' HB3' HD22 ' A' ' 430' ' ' LEU . 96.7 m-20 -56.42 -63.24 1.26 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.668 1.187 . . . . 0.0 111.405 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.16 -35.0 72.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.128 0.971 . . . . 0.0 111.027 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -56.89 -51.61 68.4 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.197 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -64.56 -41.01 96.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.726 1.603 . . . . 0.0 111.854 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 15.5 m -51.51 -32.6 28.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.016 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.24 -37.93 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.7 t -101.47 -6.68 23.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.649 1.58 . . . . 0.0 114.031 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.442 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.51 146.52 29.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.169 0.985 . . . . 0.0 112.41 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.88 -50.07 11.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.657 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -98.52 140.3 32.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.603 0.761 . . . . 0.0 111.481 159.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.54 -159.03 48.64 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.695 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 68.5 -168.51 42.51 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 47.4 p -96.14 10.05 38.93 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t 65.83 23.99 11.37 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.877 -1.14 . . . . 0.0 113.495 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.66 65.27 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.672 1.606 . . . . 0.0 114.145 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.73 150.76 96.59 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 118.926 1.363 . . . . 0.0 110.948 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 144.32 79.66 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.861 2.374 . . . . 0.0 110.689 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.7 112.3 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.556 . . . . 0.0 109.568 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.42 157.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.741 1.616 . . . . 0.0 110.279 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 92.3 m -53.59 127.14 24.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 109.81 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 92.08 -5.7 78.66 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.77 -1.017 . . . . 0.0 115.293 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.83 137.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.265 1.532 . . . . 0.0 111.676 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 137.0 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.435 1.894 . . . . 0.0 109.454 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.34 172.93 17.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.341 1.056 . . . . 0.0 112.187 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.51 148.87 25.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.74 1.216 . . . . 0.0 111.525 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.81 129.93 20.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.25 147.72 48.21 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.878 2.385 . . . . 0.0 110.417 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.442 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.1 m-20 -61.78 147.57 45.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 0.0 114.039 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.8 mm -107.37 48.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.734 1.613 . . . . 0.0 109.671 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.474 0.771 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.58 137.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 27.7 m80 . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -81.69 136.52 35.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.358 1.063 . . . . 0.0 113.446 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 368' ' ' VAL . 1.1 mt -76.79 2.42 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.984 1.714 . . . . 0.0 113.026 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 125.25 1.42 . . . . 0.0 111.815 -173.39 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 CA--C 1.549 0.941 0 O-C-N 120.842 -1.161 . . . . 0.0 110.23 175.379 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.72 132.66 31.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.881 1.219 . . . . 0.0 111.894 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.28 146.94 60.11 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 124.502 1.121 . . . . 0.0 109.949 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.26 161.97 40.67 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.773 2.316 . . . . 0.0 110.621 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.17 79.4 1.58 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 165.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.79 126.64 13.52 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.492 2.128 . . . . 0.0 108.606 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.49 116.33 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.206 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.75 167.37 10.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 0.0 110.868 172.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -141.57 124.55 16.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.256 1.023 . . . . 0.0 109.619 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -122.73 114.01 19.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.645 0.778 . . . . 0.0 110.403 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -69.48 -8.64 48.71 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -22.77 66.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.452 171.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.62 150.99 93.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.655 0.782 . . . . 0.0 111.862 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.46 161.66 33.99 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.874 3.049 . . . . 0.0 112.77 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.59 131.62 17.65 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.945 3.097 . . . . 0.0 112.461 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 64.5 45.83 3.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.873 2.069 . . . . 0.0 111.659 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -125.8 152.51 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 17.1 pt -125.21 144.39 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.078 1.751 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.74 54.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.028 1.331 . . . . 0.0 110.378 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.64 105.99 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.055 0.942 . . . . 0.0 110.908 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -72.18 134.82 45.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.562 1.145 . . . . 0.0 111.847 167.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.6 t -76.9 136.49 38.83 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.213 -0.929 . . . . 0.0 111.732 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.4 mtm105 -103.43 15.88 27.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.529 1.932 . . . . 0.0 109.954 163.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 87.3 m -117.48 132.54 56.53 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.714 1.606 . . . . 0.0 110.673 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.29 136.76 38.01 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.185 1.394 . . . . 0.0 108.856 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -92.38 138.83 31.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 26.7 mm -124.26 108.31 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -171.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.69 174.29 46.23 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 165.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.75 30.07 70.78 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.844 -0.798 . . . . 0.0 114.146 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 91.4 t -90.38 109.39 33.38 Favored Pre-proline 0 N--CA 1.478 0.946 0 CA-C-N 118.25 1.025 . . . . 0.0 110.69 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.33 141.97 48.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.401 2.067 . . . . 0.0 110.107 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.04 -17.82 62.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.49 -35.04 79.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.064 0.946 . . . . 0.0 112.617 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 ptp -86.73 152.67 22.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -130.8 -174.44 3.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.229 1.812 . . . . 0.0 111.644 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -55.76 -39.14 70.78 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.176 1.39 . . . . 0.0 112.796 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.98 -23.05 58.21 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.19 -39.13 65.83 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.236 0.926 . . . . 0.0 110.571 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.18 -51.78 68.53 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.547 168.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.87 67.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.713 173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -46.95 64.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.939 1.245 . . . . 0.0 113.583 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.99 -33.56 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.12 0.873 . . . . 0.0 110.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.575 HD23 ' CE1' ' A' ' 394' ' ' PHE . 31.0 mt -87.45 -8.05 56.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.367 1.067 . . . . 0.0 113.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -48.67 -49.08 67.66 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.613 1.565 . . . . 0.0 114.988 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.36 -6.46 17.15 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.028 1.819 . . . . 0.0 113.262 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -98.14 -38.53 9.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.465 1.506 . . . . 0.0 112.54 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.8 168.42 5.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.47 1.908 . . . . 0.0 112.537 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.14 136.87 32.77 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.658 0.783 . . . . 0.0 110.051 169.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.89 134.95 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.623 1.169 . . . . 0.0 109.986 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.59 -35.19 9.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.51 150.13 30.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.528 1.058 . . . . 0.0 111.982 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 305' ' ' LEU . 88.9 t -146.32 139.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.15 102.39 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.9 tt -97.46 130.72 44.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.918 0.887 . . . . 0.0 109.635 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.68 91.03 3.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.263 1.025 . . . . 0.0 110.085 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.41 -40.23 90.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 111.513 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.7 t -65.17 -25.36 67.69 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.213 1.405 . . . . 0.0 112.938 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -0.67 41.62 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.486 1.515 . . . . 0.0 112.918 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 27.85 16.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.963 1.305 . . . . 0.0 113.772 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.84 170.41 15.89 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.3 40.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.001 1.321 . . . . 0.0 112.314 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.22 128.32 55.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.276 1.43 . . . . 0.0 108.692 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 359' ' ' LEU . 88.1 t -124.32 111.32 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 111.004 -173.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 112.92 25.0 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.552 1.541 . . . . 0.0 111.034 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.49 163.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.91 0.884 . . . . 0.0 110.357 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.51 -26.65 63.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.7 p -134.9 155.28 50.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.158 0.98 . . . . 0.0 113.165 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -41.83 92.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.009 0.923 . . . . 0.0 111.35 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -65.63 -36.68 84.4 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.906 -0.497 . . . . 0.0 111.452 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -59.51 -51.26 70.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.517 0.727 . . . . 0.0 111.116 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.77 94.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.635 0.652 . . . . 0.0 111.945 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.81 -43.26 98.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.219 0.608 . . . . 0.0 112.053 171.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -64.38 -34.22 77.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.398 0.999 . . . . 0.0 112.358 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 359' ' ' LEU . 34.5 t -61.48 -63.18 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.083 167.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.38 -36.39 43.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.717 1.207 . . . . 0.0 114.036 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.75 -35.34 80.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.99 1.316 . . . . 0.0 113.034 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.23 -25.45 9.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -174.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.575 ' CE1' HD23 ' A' ' 359' ' ' LEU . 13.6 t80 -72.77 122.89 22.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.361 0.664 . . . . 0.0 111.528 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 62.44 29.32 17.14 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 114.022 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.62 -31.33 68.0 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -84.8 -16.81 40.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.794 1.638 . . . . 0.0 114.076 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.42 73.74 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.794 1.188 . . . . 0.0 114.114 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.62 -34.2 35.23 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.112 1.456 . . . . 0.0 114.853 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.405 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 15.6 mt -76.55 148.56 80.14 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.156 0.982 . . . . 0.0 109.871 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.45 -29.1 13.97 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.717 2.278 . . . . 0.0 112.408 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.61 151.27 42.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.966 1.307 . . . . 0.0 111.778 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 104.74 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.767 0.827 . . . . 0.0 110.681 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.2 m -85.58 121.52 28.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.189 1.396 . . . . 0.0 109.746 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -129.13 178.04 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.628 1.971 . . . . 0.0 108.862 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -72.25 126.3 29.46 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.19 -0.943 . . . . 0.0 111.305 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.01 -156.95 19.37 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 165.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.97 136.72 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 117.117 0.459 . . . . 0.0 111.887 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.99 -44.79 3.75 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.683 1.611 . . . . 0.0 110.464 163.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.48 113.96 18.17 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.018 0.909 . . . . 0.0 113.053 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.82 139.59 4.31 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.92 129.25 15.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.006 3.804 . . . . 0.0 109.974 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -63.49 -38.25 90.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.319 0.648 . . . . 0.0 112.294 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.1 -24.9 66.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.078 1.751 . . . . 0.0 113.345 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 71.8 m -127.35 31.19 5.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.158 1.783 . . . . 0.0 111.277 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.4 t -85.01 140.76 30.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.031 1.333 . . . . 0.0 111.685 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.4 75.82 1.5 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.716 1.606 . . . . 0.0 109.124 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -63.08 -16.49 60.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -70.35 -49.1 52.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.672 1.124 . . . . 0.0 111.023 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -83.81 -16.07 45.98 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.48 38.09 11.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.841 1.21 . . . . 0.0 113.163 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -143.09 174.65 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.338 1.069 . . . . 0.0 112.49 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.3 p -146.27 153.85 41.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.536 1.134 . . . . 0.0 109.964 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.2 mt -114.32 131.14 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -120.83 123.12 28.1 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 119.433 1.015 . . . . 0.0 111.479 -171.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -69.55 132.03 22.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.69 2.26 . . . . 0.0 111.003 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.53 -32.03 72.9 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 113.236 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.87 -22.44 66.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.7 7.3 37.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.31 1.844 . . . . 0.0 112.636 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 425' ' ' ILE . 74.6 mt -92.29 142.15 27.78 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.293 1.437 . . . . 0.0 110.969 169.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.8 p -80.05 174.97 11.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.9 1.28 . . . . 0.0 111.048 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.47 -38.99 91.99 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.639 -0.663 . . . . 0.0 111.747 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.53 80.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.026 0.93 . . . . 0.0 112.205 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.82 -54.57 45.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.414 1.086 . . . . 0.0 112.141 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -68.44 -34.31 75.74 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -52.94 -51.78 60.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.243 1.017 . . . . 0.0 111.202 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -68.26 -42.2 79.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.437 1.472 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.2 m -55.52 -30.02 59.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.067 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.7 m -97.84 -40.85 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.4 t -103.13 -9.81 19.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -165.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.62 146.03 37.56 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.906 -1.121 . . . . 0.0 111.581 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -74.79 -52.41 11.53 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.795 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -96.11 133.81 39.92 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.003 0.906 . . . . 0.0 110.984 166.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 -171.26 44.31 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.828 -174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.67 -163.5 54.28 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 115.242 -0.479 . . . . 0.0 112.295 -169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 44.4 p -103.55 11.7 35.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -162.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.62 21.2 5.48 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.792 -1.192 . . . . 0.0 113.064 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.23 4.63 77.41 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 120.768 -1.208 . . . . 0.0 113.874 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -66.42 154.18 91.3 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.591 1.195 . . . . 0.0 110.373 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.1 142.45 80.78 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.151 1.901 . . . . 0.0 110.199 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 50.2 mt -67.67 120.33 13.87 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.53 155.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.304 1.441 . . . . 0.0 109.802 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -59.69 131.82 52.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.067 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.64 -5.78 83.47 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.422 -1.21 . . . . 0.0 115.186 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.8 tt -61.39 143.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.598 1.699 . . . . 0.0 112.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.21 137.0 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.542 1.937 . . . . 0.0 109.33 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -160.63 177.27 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 0.0 112.149 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -95.89 149.47 21.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.714 1.206 . . . . 0.0 111.06 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.91 135.85 56.71 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -162.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.25 153.38 40.56 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.858 2.372 . . . . 0.0 110.786 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.66 142.03 58.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.453 1.101 . . . . 0.0 113.577 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.97 48.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.335 1.54 . . . . 0.0 110.334 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 CA--C 1.547 0.847 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.84 138.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 26.7 m80 . . . . . 0 CA--C 1.552 1.028 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -78.11 140.81 39.06 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.005 -1.06 . . . . 0.0 112.19 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 7.1 mp -83.42 -10.91 58.12 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 112.154 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 126.255 1.822 . . . . 0.0 111.57 -170.316 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.039 0.447 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.7 t30 . . . . . 0 CA--C 1.547 0.838 0 O-C-N 121.32 -0.863 . . . . 0.0 111.07 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.9 m80 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -51.92 127.69 21.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.618 1.099 . . . . 0.0 111.447 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.81 145.01 48.43 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 110.24 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.02 144.3 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.459 2.772 . . . . 0.0 111.004 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 83.67 0.77 Allowed Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 165.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.89 113.61 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.296 1.997 . . . . 0.0 108.624 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.3 116.44 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.5 168.45 12.11 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.273 1.429 . . . . 0.0 110.757 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.72 127.27 21.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 110.089 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -122.67 106.62 11.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.926 0.869 . . . . 0.0 111.291 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -10.45 40.39 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.341 1.456 . . . . 0.0 113.674 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 73.0 p -70.82 -22.98 62.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.68 1.592 . . . . 0.0 112.183 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.06 150.29 92.42 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.157 0.983 . . . . 0.0 111.792 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.84 161.5 36.05 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.182 3.254 . . . . 0.0 112.971 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.99 137.11 36.87 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.065 3.176 . . . . 0.0 112.692 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 67.82 24.17 8.26 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.157 1.783 . . . . 0.0 113.134 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -107.94 152.57 24.27 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.818 -1.177 . . . . 0.0 113.825 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.85 144.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 126.238 1.815 . . . . 0.0 110.389 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 128.55 54.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 0.0 111.084 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 457' ' ' PHE . 47.2 t -125.11 106.7 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.567 0.747 . . . . 0.0 111.097 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.78 130.12 42.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.42 1.088 . . . . 0.0 111.228 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.6 t -69.69 135.91 50.41 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.852 -0.53 . . . . 0.0 111.594 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.425 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 33.2 mtm105 -104.48 16.14 26.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.576 1.55 . . . . 0.0 110.858 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 21.8 m -123.66 136.19 54.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.286 1.434 . . . . 0.0 112.122 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.61 139.37 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.19 1.396 . . . . 0.0 109.951 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -92.29 139.65 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.79 108.83 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.589 1.156 . . . . 0.0 107.916 -171.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -92.4 -175.9 41.83 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.67 15.9 69.25 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.707 -0.878 . . . . 0.0 114.256 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.4 120.01 79.33 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 118.744 1.272 . . . . 0.0 110.187 -167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 139.42 38.36 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.144 1.896 . . . . 0.0 109.923 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.9 pp -61.82 -18.84 61.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.7 -23.82 49.38 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.3 ptp -87.24 148.47 25.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -125.61 -177.22 3.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.978 1.711 . . . . 0.0 111.908 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -47.15 -42.46 19.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.593 1.957 . . . . 0.0 114.243 174.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.69 -22.05 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.76 -37.06 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.149 0.886 . . . . 0.0 110.852 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.4 mm? -56.84 -51.24 69.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.387 0.54 . . . . 0.0 110.011 168.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -58.24 -39.94 80.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.015 0.825 . . . . 0.0 112.806 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -66.76 -39.88 88.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.296 1.407 . . . . 0.0 113.097 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.02 -32.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.733 1.151 . . . . 0.0 111.702 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.406 ' CD1' HG11 ' A' ' 379' ' ' VAL . 56.5 mt -86.88 -12.32 48.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.559 1.144 . . . . 0.0 113.88 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -48.89 -47.91 72.56 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.57 -6.22 17.42 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.145 1.897 . . . . 0.0 113.199 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -100.27 -39.12 8.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.397 1.479 . . . . 0.0 112.693 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.48 170.75 4.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.623 . . . . 0.0 114.161 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -81.28 135.16 35.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.556 1.143 . . . . 0.0 110.965 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 88.6 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.744 1.218 . . . . 0.0 110.19 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -91.34 -45.02 8.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.841 1.256 . . . . 0.0 112.46 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.01 149.26 29.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.848 0.859 . . . . 0.0 110.86 -171.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.02 131.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.909 0.777 . . . . 0.0 110.858 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.33 99.39 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.453 HD21 ' ND2' ' A' ' 372' ' ' ASN . 9.6 tt -95.57 145.76 24.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.881 0.872 . . . . 0.0 110.486 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -137.1 89.57 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.556 1.142 . . . . 0.0 110.214 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . 0.453 ' ND2' HD21 ' A' ' 370' ' ' LEU . 30.1 m120 -61.41 -32.03 71.97 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.238 -0.914 . . . . 0.0 112.061 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.8 t -60.94 -31.64 71.18 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.807 1.243 . . . . 0.0 112.694 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -96.14 -3.81 43.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 113.525 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 60.03 31.31 20.57 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.671 1.589 . . . . 0.0 113.107 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -136.29 170.27 16.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.2 162.99 36.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.963 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -118.33 128.69 54.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.559 1.544 . . . . 0.0 108.268 165.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.406 HG11 ' CD1' ' A' ' 359' ' ' LEU . 61.2 t -123.15 109.8 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.974 0.909 . . . . 0.0 110.423 -176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -85.59 117.46 24.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 109.934 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.62 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 165.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.89 -19.1 57.85 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.98 154.78 46.19 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.115 0.871 . . . . 0.0 113.174 -176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -62.99 -41.52 99.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.731 0.812 . . . . 0.0 111.577 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -63.12 -38.64 92.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.859 0.464 . . . . 0.0 110.848 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.22 -49.51 75.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.542 1.137 . . . . 0.0 111.431 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.93 97.91 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.864 -0.523 . . . . 0.0 112.139 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -64.88 -42.66 94.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.655 0.782 . . . . 0.0 111.899 171.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.29 -34.8 78.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.188 0.904 . . . . 0.0 112.045 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.3 -63.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.894 165.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.85 -32.63 53.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -65.07 -31.78 73.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.996 1.319 . . . . 0.0 113.466 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -120.18 -28.97 4.97 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -74.33 125.47 28.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.64 20.15 11.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.308 1.443 . . . . 0.0 114.164 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.34 65.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -111.13 4.26 19.19 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.577 2.351 . . . . 0.0 112.796 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 75.21 32.59 55.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.315 0.959 . . . . 0.0 113.368 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.69 59.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.77 161.68 36.73 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.061 1.345 . . . . 0.0 110.172 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.97 -7.09 18.04 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.574 2.849 . . . . 0.0 113.901 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.96 166.04 8.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.139 2.176 . . . . 0.0 112.441 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 90.1 2.49 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.0 110.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 127.98 34.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.425 1.49 . . . . 0.0 111.209 -172.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.26 170.37 15.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.257 1.823 . . . . 0.0 108.808 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -68.52 126.64 30.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.419 -0.801 . . . . 0.0 110.579 164.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.39 -152.25 17.87 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.5 136.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 117.564 0.682 . . . . 0.0 111.68 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -89.92 -48.72 3.54 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 166.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -129.26 120.29 25.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.896 0.848 . . . . 0.0 111.811 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 178.74 140.87 4.11 Favored Glycine 0 CA--C 1.542 1.746 0 CA-C-O 119.153 -0.804 . . . . 0.0 114.635 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -70.5 133.72 24.83 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.827 3.684 . . . . 0.0 110.181 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -67.12 -35.37 79.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.995 0.426 . . . . 0.0 111.904 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.07 -26.34 66.68 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.457 1.903 . . . . 0.0 113.403 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.1 m -126.78 31.82 5.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.379 1.872 . . . . 0.0 111.054 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.57 138.35 33.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.425 1.49 . . . . 0.0 111.033 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.32 77.83 1.6 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.22 1.408 . . . . 0.0 109.292 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -62.84 -19.76 64.42 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.362 -0.836 . . . . 0.0 113.133 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.96 -47.25 66.11 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.123 1.329 . . . . 0.0 111.194 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -83.23 -16.08 47.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.98 38.32 11.55 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.805 1.193 . . . . 0.0 112.919 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -146.37 169.88 17.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.931 1.366 . . . . 0.0 112.809 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.2 m -137.68 151.3 48.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.824 0.85 . . . . 0.0 110.631 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.24 130.38 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.822 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -123.28 115.78 28.63 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 119.493 1.042 . . . . 0.0 111.15 -168.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -69.71 130.33 19.21 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.065 2.51 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 30.0 mtt -59.84 -32.28 70.53 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.939 1.296 . . . . 0.0 113.243 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -65.08 -22.41 66.96 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.213 0.915 . . . . 0.0 113.039 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -105.14 8.16 34.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.87 1.668 . . . . 0.0 113.601 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 425' ' ' ILE . 53.2 mt -91.8 146.68 23.56 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.29 1.036 . . . . 0.0 111.784 169.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.7 p -83.41 174.45 10.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.727 1.211 . . . . 0.0 110.805 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.2 -41.75 99.2 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.769 -0.582 . . . . 0.0 111.391 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.54 92.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.119 0.968 . . . . 0.0 111.862 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 430' ' ' LEU . 94.3 m-20 -57.59 -61.29 2.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.471 1.109 . . . . 0.0 111.626 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -57.54 -37.84 73.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 111.45 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -57.93 -45.59 86.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.927 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -66.78 -41.49 87.6 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 120.729 1.604 . . . . 0.0 112.107 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 8.3 m -54.56 -33.2 59.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.401 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 m -98.01 -48.59 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 16.7 m -89.46 -9.32 50.54 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.13 56.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.26 1.391 . . . . 0.0 112.319 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -74.98 -48.33 24.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.968 0.907 . . . . 0.0 110.511 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -101.0 121.12 41.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.212 1.006 . . . . 0.0 110.75 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 84.87 -173.88 49.32 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.426 1.489 . . . . 0.0 112.987 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.48 -159.44 53.67 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 57.0 p -100.22 8.03 44.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.103 1.361 . . . . 0.0 114.646 -163.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.02 22.4 4.55 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.934 -1.104 . . . . 0.0 112.499 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.56 3.59 71.42 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.892 1.235 . . . . 0.0 113.859 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.68 153.24 96.09 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 118.355 1.078 . . . . 0.0 110.796 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -63.87 145.95 91.02 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.551 2.167 . . . . 0.0 110.588 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.16 121.27 19.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.378 0.609 . . . . 0.0 110.005 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.4 t -110.88 152.2 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.604 1.962 . . . . 0.0 108.715 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 74.2 m -49.41 122.6 6.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.281 0.632 . . . . 0.0 110.055 165.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 86.68 1.25 85.55 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.935 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.79 131.59 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.588 1.694 . . . . 0.0 111.532 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.02 138.7 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.045 2.138 . . . . 0.0 109.302 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.407 ' CE1' HG22 ' A' ' 336' ' ' VAL . 32.8 p90 -161.97 179.99 7.59 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.474 1.509 . . . . 0.0 112.604 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -95.77 145.6 25.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.241 1.416 . . . . 0.0 110.421 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 9.2 pt-20 -47.68 128.42 10.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.63 152.07 64.56 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 111.249 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.43 147.97 34.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.443 1.097 . . . . 0.0 113.498 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.1 mm -110.79 49.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 123.251 1.501 . . . . 0.0 110.01 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.548 0.87 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.927 137.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.3 m80 . . . . . 0 CA--C 1.552 1.036 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -62.71 136.78 58.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.369 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.0 mp -82.13 -63.94 1.28 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.264 0.626 . . . . 0.0 110.679 -177.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 . . . . . 0 CA--C 1.555 1.157 0 O-C-N 121.386 -0.821 . . . . 0.0 111.96 -170.304 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.74 131.6 25.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.725 1.21 . . . . 0.0 111.863 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.85 154.11 68.29 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.278 1.031 . . . . 0.0 109.722 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -65.27 168.42 14.33 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 110.91 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 83.37 60.72 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.21 1.404 . . . . 0.0 107.325 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 137.61 30.94 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.176 2.584 . . . . 0.0 109.052 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.8 t -138.72 136.14 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.389 1.076 . . . . 0.0 108.751 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 172.01 13.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.956 0.902 . . . . 0.0 110.806 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.12 120.1 22.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.596 1.158 . . . . 0.0 109.667 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -117.83 108.54 15.46 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.808 1.643 . . . . 0.0 110.633 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 62.7 p -70.77 -3.57 19.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.926 1.291 . . . . 0.0 114.169 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -69.86 -19.85 63.42 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.266 1.026 . . . . 0.0 112.786 173.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.43 151.57 94.04 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.043 0.937 . . . . 0.0 112.361 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.31 160.79 33.46 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.9 3.067 . . . . 0.0 112.529 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.83 133.83 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 112.376 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 64.4 36.0 9.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.759 2.024 . . . . 0.0 112.511 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.93 152.49 38.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 455' ' ' ILE . 18.8 pt -125.04 149.53 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.596 1.958 . . . . 0.0 112.111 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 111.19 23.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.445 1.498 . . . . 0.0 110.54 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.401 HG22 ' CE2' ' A' ' 457' ' ' PHE . 21.8 t -114.92 108.78 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.147 0.885 . . . . 0.0 111.884 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -72.03 135.02 46.21 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.856 1.262 . . . . 0.0 111.437 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.7 t -71.48 137.83 48.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.607 -0.683 . . . . 0.0 112.036 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -105.37 17.48 23.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.934 1.694 . . . . 0.0 110.447 160.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 57.3 m -120.8 138.95 53.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.727 1.611 . . . . 0.0 111.487 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 21.5 mt -105.71 132.14 52.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.046 2.138 . . . . 0.0 108.556 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -89.89 123.85 34.19 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 30.4 mm -114.38 109.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.841 0.857 . . . . 0.0 109.088 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.47 175.58 49.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.815 0.722 . . . . 0.0 112.07 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.14 13.57 70.21 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.29 0.948 . . . . 0.0 115.086 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.28 121.8 84.36 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-N 118.459 1.129 . . . . 0.0 110.452 -167.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.5 134.7 22.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.794 2.33 . . . . 0.0 109.633 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.16 -18.82 63.88 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.21 -33.29 75.47 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.592 1.157 . . . . 0.0 112.948 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -86.62 157.97 19.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -133.89 -177.7 4.68 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.064 1.746 . . . . 0.0 111.761 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -55.81 -35.73 66.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.36 1.464 . . . . 0.0 112.856 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -74.96 -25.21 58.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.53 -34.99 65.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.371 0.987 . . . . 0.0 110.616 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.2 mm? -60.02 -48.86 79.97 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.232 169.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.5 78.15 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.437 1.017 . . . . 0.0 112.466 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.42 -40.66 85.56 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.848 1.204 . . . . 0.0 112.92 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.37 -36.59 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.176 0.898 . . . . 0.0 112.192 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.471 HD23 ' CE2' ' A' ' 394' ' ' PHE . 67.7 mt -84.42 -13.15 52.95 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -46.05 -49.51 40.0 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 126.529 1.932 . . . . 0.0 115.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.2 -8.19 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.137 1.891 . . . . 0.0 113.705 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -97.24 -41.22 8.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.547 1.539 . . . . 0.0 112.155 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.65 172.52 4.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.672 1.589 . . . . 0.0 113.312 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -91.17 135.11 34.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.495 1.118 . . . . 0.0 111.074 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.6 131.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.146 1.378 . . . . 0.0 110.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -93.74 -42.89 8.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.081 1.352 . . . . 0.0 112.609 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 30.6 t -156.79 150.86 25.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 109.948 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -149.25 134.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.466 0.707 . . . . 0.0 109.823 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.44 107.79 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 166.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.9 tt -102.37 118.11 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 0.0 110.865 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -106.33 81.64 1.64 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.004 1.722 . . . . 0.0 109.223 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.66 -34.16 61.79 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.605 1.562 . . . . 0.0 111.411 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -60.66 -30.83 70.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.489 1.916 . . . . 0.0 113.632 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 3.32 20.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.239 1.416 . . . . 0.0 113.196 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 61.65 36.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.099 1.759 . . . . 0.0 111.57 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -124.1 154.25 40.26 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.857 2.063 . . . . 0.0 113.3 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.72 135.39 34.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.618 1.167 . . . . 0.0 111.772 161.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.64 121.19 29.75 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 160.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.71 119.46 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.127 0.971 . . . . 0.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -96.96 128.8 44.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.364 1.065 . . . . 0.0 111.213 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.83 165.7 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.452 1.101 . . . . 0.0 110.196 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -69.95 -14.58 62.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -170.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.98 159.16 40.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.546 -1.346 . . . . 0.0 113.256 -176.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -41.58 99.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.986 0.914 . . . . 0.0 109.87 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -64.97 -36.71 85.28 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.493 -0.754 . . . . 0.0 112.203 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -56.19 -53.18 60.22 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.932 0.787 . . . . 0.0 109.409 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.71 97.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.524 0.73 . . . . 0.0 112.819 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.57 -42.73 99.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.115 0.566 . . . . 0.0 111.352 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -67.86 -31.56 71.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.581 1.082 . . . . 0.0 112.368 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.9 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.918 164.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.2 -33.67 63.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.716 1.206 . . . . 0.0 114.145 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.36 -23.77 65.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.577 1.551 . . . . 0.0 113.995 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -122.14 -26.62 4.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 359' ' ' LEU . 13.3 t80 -73.67 121.93 21.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.817 0.818 . . . . 0.0 112.276 -166.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 28.8 t30 59.25 28.79 18.21 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.349 1.86 . . . . 0.0 115.089 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -56.71 -32.5 65.57 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.34 -8.79 31.66 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 114.698 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 6.78 65.45 Favored Glycine 0 CA--C 1.548 2.142 0 C-N-CA 125.195 1.379 . . . . 0.0 114.899 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -70.44 -36.52 74.01 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.75 151.64 71.29 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.849 0.859 . . . . 0.0 110.608 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.69 -26.77 9.53 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.643 2.229 . . . . 0.0 112.204 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.71 150.4 41.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.751 1.22 . . . . 0.0 111.723 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -120.59 92.14 3.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.841 1.256 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -74.43 119.99 19.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.104 0.961 . . . . 0.0 110.527 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 170.28 12.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.2 2.2 . . . . 0.0 108.882 172.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -65.77 131.67 46.87 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.169 -0.957 . . . . 0.0 111.013 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.7 -154.99 12.95 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 164.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 132.75 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.057 0.429 . . . . 0.0 112.1 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.14 -50.72 3.56 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -124.17 114.79 20.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.918 0.887 . . . . 0.0 113.036 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.26 143.72 3.97 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 118.704 -1.053 . . . . 0.0 114.846 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.85 144.54 30.95 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.856 3.704 . . . . 0.0 110.032 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -69.24 -30.57 68.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.636 0.774 . . . . 0.0 112.071 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.67 -33.5 72.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.459 2.303 . . . . 0.0 113.309 -175.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.8 m -123.89 34.86 4.96 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.041 2.136 . . . . 0.0 111.211 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.2 139.75 34.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.876 1.671 . . . . 0.0 111.74 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.75 77.8 1.81 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.757 1.623 . . . . 0.0 109.047 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -65.4 -10.53 34.4 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -75.03 -48.25 24.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.249 0.931 . . . . 0.0 110.056 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -84.0 -11.11 57.29 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.62 42.36 21.96 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.045 1.307 . . . . 0.0 112.936 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.36 169.55 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 113.291 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.2 m -137.96 152.37 48.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.897 0.879 . . . . 0.0 111.09 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.1 mm -105.43 119.1 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.42 120.42 42.82 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 120.388 1.449 . . . . 0.0 110.331 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.77 146.87 26.97 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.16 -26.98 68.63 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -65.45 -21.46 66.65 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.985 1.266 . . . . 0.0 113.302 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -97.83 0.2 46.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.095 1.758 . . . . 0.0 113.394 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.63 122.66 34.4 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.147 0.979 . . . . 0.0 110.082 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 33.7 p -76.32 179.46 5.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.14 1.376 . . . . 0.0 111.667 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -39.55 91.42 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.651 -0.655 . . . . 0.0 111.601 170.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.092 0.957 . . . . 0.0 111.975 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.27 -52.18 65.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.775 1.63 . . . . 0.0 112.172 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -61.66 -40.89 96.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.928 0.891 . . . . 0.0 111.318 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.86 -36.21 83.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.201 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -68.21 -44.9 74.74 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.574 1.534 . . . . 0.0 110.837 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.3 m -54.08 -37.51 64.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.516 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.13 -46.4 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.9 t -96.0 -8.99 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -162.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.547 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -58.77 147.98 31.36 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.187 -0.945 . . . . 0.0 111.951 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.78 -38.55 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.33 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -103.55 135.58 44.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.83 1.252 . . . . 0.0 110.209 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 60.61 -159.02 27.03 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.387 -170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 63.64 -154.15 46.08 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.44 HG21 ' HB3' ' A' ' 451' ' ' LEU . 24.9 p -106.63 1.02 24.87 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -164.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.8 t 69.42 24.68 5.68 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.932 1.293 . . . . 0.0 112.095 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.74 9.86 63.82 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.058 1.313 . . . . 0.0 114.132 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -81.14 141.34 50.05 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.185 0.992 . . . . 0.0 110.822 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.24 112.23 2.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.966 2.444 . . . . 0.0 109.0 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -78.82 133.76 37.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.451 0.643 . . . . 0.0 112.012 -174.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.5 m -122.98 171.29 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.004 1.722 . . . . 0.0 111.578 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 87.3 m -49.7 123.08 7.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.33 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 103.2 -14.6 55.12 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.725 -1.042 . . . . 0.0 115.096 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 334' ' ' ILE . 2.5 tp -52.79 130.76 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.484 1.642 . . . . 0.0 111.532 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.87 131.38 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.145 2.178 . . . . 0.0 108.326 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.401 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.1 p90 -156.2 177.65 11.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.805 1.242 . . . . 0.0 112.605 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -99.74 154.01 18.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.709 1.604 . . . . 0.0 110.0 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.85 132.56 28.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -164.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.05 154.11 71.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.12 1.88 . . . . 0.0 110.631 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.547 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 73.2 m-20 -59.14 129.23 41.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.56 1.544 . . . . 0.0 113.348 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.65 55.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 123.308 1.528 . . . . 0.0 110.593 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.0 pt . . . . . 0 CA--C 1.551 0.984 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.53 146.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -70.25 138.33 51.56 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.308 1.043 . . . . 0.0 112.781 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mp -79.75 0.73 29.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.589 1.155 . . . . 0.0 113.232 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 125.468 1.507 . . . . 0.0 111.321 -176.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 CA--C 1.547 0.833 0 O-C-N 121.377 -0.827 . . . . 0.0 110.276 176.523 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 24.0 m80 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -52.87 127.11 22.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.412 1.46 . . . . 0.0 111.498 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -125.6 152.99 72.75 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.035 1.334 . . . . 0.0 110.606 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.42 158.92 55.6 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.296 2.664 . . . . 0.0 110.891 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.26 70.29 5.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 110.179 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.98 121.92 8.79 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.292 1.994 . . . . 0.0 108.994 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.37 127.69 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 109.316 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.93 163.95 28.38 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.151 1.38 . . . . 0.0 109.991 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -144.01 116.36 8.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.167 0.987 . . . . 0.0 109.34 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -121.54 107.79 12.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.069 0.938 . . . . 0.0 111.108 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -8.54 12.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.109 1.764 . . . . 0.0 113.923 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -68.31 -25.07 64.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.394 1.078 . . . . 0.0 112.651 172.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.03 150.55 96.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.63 0.772 . . . . 0.0 112.06 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.02 160.85 35.82 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.087 3.191 . . . . 0.0 112.934 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.46 134.14 27.87 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.958 3.105 . . . . 0.0 112.33 -171.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.55 40.02 11.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.698 1.599 . . . . 0.0 112.298 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -121.35 151.8 39.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 172.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.3 pt -123.12 151.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.744 2.018 . . . . 0.0 110.492 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.69 126.76 55.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.494 1.518 . . . . 0.0 110.184 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.95 109.64 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.715 0.689 . . . . 0.0 111.495 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -72.97 131.7 42.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.156 1.382 . . . . 0.0 112.079 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.9 m -70.26 138.18 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.532 -0.73 . . . . 0.0 112.482 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.54 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.8 mtm105 -109.3 13.46 24.26 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.539 1.936 . . . . 0.0 110.944 164.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 32.7 m -118.97 141.89 48.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.671 1.588 . . . . 0.0 110.974 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.69 133.2 49.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.579 1.952 . . . . 0.0 108.754 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -92.59 112.86 24.96 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 165.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.4 mm -97.87 120.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 179.41 37.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.618 1.104 . . . . 0.0 111.32 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.77 60.77 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 114.751 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.3 125.64 90.65 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 118.417 1.109 . . . . 0.0 109.951 -168.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 135.53 31.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.798 2.332 . . . . 0.0 109.671 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.9 mp -67.96 -10.83 56.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 -25.06 22.55 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.516 1.126 . . . . 0.0 112.985 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 19.4 mtm -79.91 149.02 31.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.885 0.85 . . . . 0.0 112.651 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -125.8 -176.01 3.5 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.504 1.921 . . . . 0.0 111.473 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 352' ' ' GLU . 2.4 mp0 -49.88 -44.86 50.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.485 2.314 . . . . 0.0 113.062 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -77.34 -20.53 54.72 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.67 -37.33 59.68 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.048 0.84 . . . . 0.0 110.54 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.2 -49.55 77.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.524 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.77 -39.26 73.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.228 0.922 . . . . 0.0 112.732 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.02 -44.36 76.66 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.701 1.137 . . . . 0.0 113.587 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.09 -32.44 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 119.837 1.199 . . . . 0.0 111.725 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.478 HD23 ' CE2' ' A' ' 394' ' ' PHE . 62.0 mt -89.76 -10.58 45.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -46.89 -47.47 52.91 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.021 1.728 . . . . 0.0 115.37 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -6.98 16.77 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.203 1.935 . . . . 0.0 113.585 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -98.11 -39.2 9.02 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.609 1.563 . . . . 0.0 112.486 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.89 168.58 4.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.09 1.756 . . . . 0.0 113.31 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.36 129.47 34.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.856 0.862 . . . . 0.0 110.095 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.66 130.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.77 0.828 . . . . 0.0 110.206 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -95.0 -44.4 7.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.803 1.241 . . . . 0.0 112.536 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.3 m -144.13 152.63 41.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.474 1.109 . . . . 0.0 111.363 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 59.9 t -143.67 114.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.243 0.928 . . . . 0.0 110.936 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.6 93.46 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.14 129.27 45.38 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.513 0.725 . . . . 0.0 110.585 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -123.43 90.96 3.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.424 1.09 . . . . 0.0 109.932 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -58.57 -28.23 65.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.38 1.072 . . . . 0.0 112.266 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 22.7 t -56.44 -38.11 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.382 1.873 . . . . 0.0 114.178 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -107.04 6.98 29.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.867 1.267 . . . . 0.0 113.058 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 59.28 36.43 23.61 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.627 1.571 . . . . 0.0 111.412 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -124.18 164.06 20.27 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.28 33.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.759 1.224 . . . . 0.0 112.544 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.93 104.81 14.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.3 1.04 . . . . 0.0 108.654 164.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.87 100.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.111 1.364 . . . . 0.0 109.837 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -80.74 123.47 28.24 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.204 0.602 . . . . 0.0 110.277 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.53 168.01 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.346 166.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.73 -22.16 54.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.39 156.52 48.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 120.064 1.302 . . . . 0.0 113.704 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.49 -44.67 96.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.65 0.78 . . . . 0.0 112.322 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -66.46 -31.14 71.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.045 -0.41 . . . . 0.0 111.674 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.08 -53.89 42.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.755 1.222 . . . . 0.0 111.06 167.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.03 84.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.867 0.758 . . . . 0.0 112.133 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.77 -42.68 97.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.26 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -66.72 -30.69 70.98 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 120.126 1.33 . . . . 0.0 112.738 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.68 -63.56 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.736 0.698 . . . . 0.0 109.497 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.5 mt -52.25 -36.12 51.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.02 -42.95 88.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.046 1.338 . . . . 0.0 112.474 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -105.32 -23.5 12.85 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 359' ' ' LEU . 20.4 t80 -74.11 123.55 24.64 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.484 -0.76 . . . . 0.0 111.489 -168.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 61.79 29.27 17.94 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.807 1.643 . . . . 0.0 114.48 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.95 -34.69 65.91 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.804 -1.185 . . . . 0.0 113.396 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.37 -19.53 53.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.324 1.05 . . . . 0.0 113.525 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.03 70.18 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.65 1.119 . . . . 0.0 114.046 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.08 -31.53 20.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.6 1.56 . . . . 0.0 114.802 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 19.7 mt -80.62 150.78 70.53 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.351 1.06 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.93 -32.47 7.13 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.405 2.07 . . . . 0.0 112.169 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.32 151.65 45.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.286 1.434 . . . . 0.0 111.756 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -127.94 96.38 4.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.768 1.227 . . . . 0.0 109.739 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 32.8 m -73.28 123.78 24.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.357 1.063 . . . . 0.0 110.634 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -126.52 173.63 9.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.703 2.001 . . . . 0.0 108.817 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -72.11 133.48 45.23 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.94 -1.1 . . . . 0.0 111.574 164.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.94 -153.09 9.54 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 125.777 1.656 . . . . 0.0 109.295 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.35 137.06 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.13 -52.98 2.93 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.723 1.63 . . . . 0.0 109.784 167.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.89 117.85 25.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.37 142.79 4.65 Favored Glycine 0 CA--C 1.543 1.836 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.96 130.28 15.34 Favored 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 125.746 4.297 . . . . 0.0 110.849 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -67.23 -32.09 72.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.42 -18.66 54.65 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.93 1.692 . . . . 0.0 113.83 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 77.8 m -122.9 28.73 7.11 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.586 1.555 . . . . 0.0 111.881 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.5 t -84.4 141.81 30.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.073 1.349 . . . . 0.0 111.429 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.37 80.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.779 1.631 . . . . 0.0 108.915 167.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -63.95 -20.51 65.93 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.547 -0.721 . . . . 0.0 112.904 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.32 -47.62 69.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.529 1.513 . . . . 0.0 111.266 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -83.2 -13.59 55.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.4 42.54 18.11 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.809 1.195 . . . . 0.0 112.374 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -147.27 168.74 20.97 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.026 1.413 . . . . 0.0 113.151 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.5 m -131.17 152.35 50.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.285 1.034 . . . . 0.0 110.704 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.2 mm -106.29 133.06 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.531 HG21 HD21 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -126.55 118.96 22.94 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 120.116 1.326 . . . . 0.0 110.981 -173.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -73.96 139.01 26.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.44 2.093 . . . . 0.0 111.121 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 10.9 mtt -63.02 -28.81 70.35 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.41 -19.29 65.88 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -104.85 3.81 31.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.562 1.945 . . . . 0.0 113.642 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.531 HD21 HG21 ' A' ' 425' ' ' ILE . 97.9 mt -92.05 136.32 33.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 110.395 170.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.2 p -79.94 178.77 7.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.514 1.126 . . . . 0.0 111.51 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.595 -0.691 . . . . 0.0 111.633 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.59 88.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.889 0.875 . . . . 0.0 112.025 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.69 -52.76 63.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.517 1.127 . . . . 0.0 112.284 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -65.56 -37.5 86.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.859 -0.526 . . . . 0.0 111.102 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -60.16 -42.17 94.39 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.78 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -66.59 -44.3 82.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.041 1.746 . . . . 0.0 111.271 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.2 m -56.59 -32.38 65.17 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.332 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.68 -39.75 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.8 m -103.26 -7.75 20.89 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -168.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.82 147.06 39.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.211 1.368 . . . . 0.0 111.604 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -77.11 -55.29 5.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.33 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -92.78 132.45 36.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.346 0.975 . . . . 0.0 110.533 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.81 179.34 10.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.015 0.817 . . . . 0.0 113.459 -173.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.67 -163.88 34.02 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 122.242 -0.563 . . . . 0.0 113.114 -168.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.1 p -109.78 7.44 24.17 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -163.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 37.4 p 76.74 15.81 1.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.972 2.109 . . . . 0.0 113.901 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.49 4.08 64.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.988 1.28 . . . . 0.0 113.352 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -66.01 138.34 96.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.901 1.28 . . . . 0.0 109.446 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -60.19 140.91 94.57 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.177 1.918 . . . . 0.0 110.176 169.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.04 130.24 43.22 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.29 159.69 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.473 1.509 . . . . 0.0 110.089 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 78.2 m -56.61 124.92 19.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.75 -2.05 76.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.593 -1.115 . . . . 0.0 115.541 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.4 tt -62.96 140.42 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.494 1.647 . . . . 0.0 112.127 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.56 136.78 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.829 2.052 . . . . 0.0 109.61 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -162.47 175.46 11.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.097 1.359 . . . . 0.0 113.104 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.72 148.69 21.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 111.397 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -51.47 126.25 29.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -168.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.78 152.84 64.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.073 2.515 . . . . 0.0 110.539 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -63.55 144.5 56.94 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.34 52.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.337 1.541 . . . . 0.0 110.133 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.549 0.938 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.79 141.469 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.1 m80 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.0 133.32 46.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.16 0.984 . . . . 0.0 112.258 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.1 mp -81.53 -41.74 21.21 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.968 1.307 . . . . 0.0 111.116 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 123.962 0.905 . . . . 0.0 110.876 -179.275 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.591 0.71 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 . . . . . 0 CA--C 1.551 1.002 0 C-N-CA 123.938 0.895 . . . . 0.0 110.386 174.304 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.2 m80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -49.31 134.02 18.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.593 1.542 . . . . 0.0 111.919 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 81.4 mmt-85 -136.82 144.88 48.53 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.242 1.017 . . . . 0.0 110.054 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.98 161.87 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 110.827 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -117.04 66.78 4.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.629 1.171 . . . . 0.0 109.729 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.31 115.08 4.01 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.906 2.404 . . . . 0.0 109.487 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.3 m -92.84 139.99 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.912 0.885 . . . . 0.0 110.083 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.43 164.07 29.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.022 1.329 . . . . 0.0 110.301 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -143.77 120.57 11.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.132 0.973 . . . . 0.0 109.426 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.33 110.53 17.08 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.581 0.705 . . . . 0.0 110.656 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -8.49 44.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.952 0.901 . . . . 0.0 113.299 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 64.2 p -70.54 -24.44 62.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.479 1.512 . . . . 0.0 112.174 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.0 150.53 88.1 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.958 0.903 . . . . 0.0 111.576 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 161.32 38.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.055 3.17 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.48 136.63 37.18 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.157 3.238 . . . . 0.0 112.038 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.71 33.64 10.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.428 1.491 . . . . 0.0 113.024 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.23 151.52 32.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.634 -1.291 . . . . 0.0 114.353 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 451' ' ' LEU . 12.0 pt -120.62 142.1 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.159 1.784 . . . . 0.0 110.485 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -107.75 111.54 23.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.672 -1.267 . . . . 0.0 110.63 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 25.4 t -105.69 101.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.865 0.866 . . . . 0.0 110.29 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -67.32 123.08 19.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.194 0.997 . . . . 0.0 111.477 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.2 t -69.74 134.66 48.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.625 -0.672 . . . . 0.0 111.425 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.5 mtm105 -101.93 9.98 40.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.891 1.677 . . . . 0.0 109.986 164.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 54.2 m -112.97 138.45 49.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.449 1.499 . . . . 0.0 111.041 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 40.1 mt -100.51 139.69 35.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.848 1.659 . . . . 0.0 109.503 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -95.27 138.44 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 164.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.45 114.57 44.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 166.28 26.34 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.484 1.04 . . . . 0.0 110.6 163.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.24 43.39 32.27 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 121.972 -0.722 . . . . 0.0 112.929 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.17 84.54 2.86 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.132 1.373 . . . . 0.0 110.875 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.31 173.28 11.69 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.287 2.658 . . . . 0.0 112.044 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.28 -21.75 50.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -18.9 61.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.19 0.996 . . . . 0.0 112.915 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.7 mtp -100.67 131.73 46.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.107 1.763 . . . . 0.0 109.921 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -141.23 170.07 16.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.082 1.753 . . . . 0.0 111.286 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.7 -42.66 62.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.631 1.172 . . . . 0.0 113.843 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -76.87 -27.65 55.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -38.59 84.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.663 167.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 355' ' ' LEU . 2.1 mm? -59.82 -47.96 83.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.747 0.703 . . . . 0.0 110.974 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -57.59 -42.51 83.3 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.163 0.892 . . . . 0.0 112.884 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.38 -39.69 89.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.929 1.241 . . . . 0.0 113.226 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.3 -35.35 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.539 1.063 . . . . 0.0 111.528 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.697 HD22 HG11 ' A' ' 390' ' ' VAL . 25.9 mt -85.65 -11.27 54.23 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.187 0.903 . . . . 0.0 112.819 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -48.3 82.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 126.187 1.795 . . . . 0.0 115.166 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.52 -7.35 18.62 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.023 1.815 . . . . 0.0 112.985 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -96.86 -40.14 9.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.297 1.439 . . . . 0.0 112.369 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.41 172.86 3.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.116 1.766 . . . . 0.0 113.484 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 116.88 24.93 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.868 . . . . 0.0 110.506 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 75.3 t -77.82 133.55 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.148 0.979 . . . . 0.0 110.184 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -94.05 -54.17 3.69 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.372 1.469 . . . . 0.0 112.269 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.5 m -140.07 155.11 47.18 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.823 1.249 . . . . 0.0 111.28 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.411 HG22 HG13 ' A' ' 379' ' ' VAL . 57.8 t -144.56 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.059 0.544 . . . . 0.0 110.514 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.56 105.64 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.873 1.269 . . . . 0.0 107.666 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.44 125.8 43.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.396 0.678 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 83.45 2.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.945 1.355 . . . . 0.0 109.706 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -21.61 66.29 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.595 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.5 t -57.26 -31.75 65.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.848 1.659 . . . . 0.0 113.718 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -112.3 10.89 20.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.931 1.692 . . . . 0.0 113.179 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.3 mttt 58.74 32.81 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.159 1.384 . . . . 0.0 113.171 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -126.19 169.5 12.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.23 158.63 43.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 163.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -114.05 128.9 56.59 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.267 1.427 . . . . 0.0 108.641 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 359' ' ' LEU . 63.9 t -128.08 105.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.896 0.878 . . . . 0.0 111.079 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.71 119.03 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.335 1.054 . . . . 0.0 109.791 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.65 152.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.723 1.609 . . . . 0.0 107.517 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -66.33 -19.89 65.93 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.66 156.94 43.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.586 1.085 . . . . 0.0 112.427 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -44.55 96.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.215 1.006 . . . . 0.0 109.975 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -38.84 90.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.877 0.871 . . . . 0.0 111.566 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -63.92 -53.02 56.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.526 1.13 . . . . 0.0 111.361 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.34 73.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.841 0.746 . . . . 0.0 112.284 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.21 -45.4 91.18 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.175 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -61.55 -36.01 79.4 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.257 0.935 . . . . 0.0 112.187 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.697 HG11 HD22 ' A' ' 359' ' ' LEU . 19.1 t -62.74 -61.04 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.469 169.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.05 -37.9 35.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.041 1.337 . . . . 0.0 113.73 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -69.67 -29.43 66.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.869 1.268 . . . . 0.0 113.666 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -111.79 -26.28 9.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.556 1.071 . . . . 0.0 113.709 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 359' ' ' LEU . 15.7 t80 -69.98 119.3 13.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.545 0.688 . . . . 0.0 111.698 -167.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 60.29 35.77 20.74 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.349 1.46 . . . . 0.0 113.532 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -62.72 -36.08 81.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.58 -14.85 31.68 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.444 1.498 . . . . 0.0 113.93 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.76 29.57 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.519 1.057 . . . . 0.0 114.666 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.5 -41.75 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.181 1.491 . . . . 0.0 114.581 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.2 mt -75.38 150.46 84.92 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.11 0.964 . . . . 0.0 109.802 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.18 -28.04 13.1 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.459 2.106 . . . . 0.0 112.436 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.8 141.76 28.35 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.448 0.699 . . . . 0.0 111.287 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.6 126.12 54.12 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 109.92 172.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 m -106.41 129.82 54.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.55 1.14 . . . . 0.0 109.922 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.72 175.17 9.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.46 1.904 . . . . 0.0 109.257 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -65.55 125.03 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.593 163.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -109.41 -157.21 17.37 Favored Glycine 0 N--CA 1.463 0.483 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.77 136.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.75 -51.23 2.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.736 1.636 . . . . 0.0 109.952 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -119.85 109.39 15.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.417 0.687 . . . . 0.0 112.753 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.95 136.29 3.53 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.049 -0.862 . . . . 0.0 115.222 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.444 ' HG3' HG23 ' A' ' 425' ' ' ILE . 95.8 Cg_endo -71.02 132.08 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.589 4.193 . . . . 0.0 109.89 171.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -65.37 -36.86 85.27 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.626 -0.671 . . . . 0.0 112.74 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -73.33 -20.62 60.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 46.2 m -117.36 19.06 14.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.122 1.769 . . . . 0.0 112.599 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.82 153.15 35.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.945 0.879 . . . . 0.0 112.429 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.26 78.97 1.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.91 1.684 . . . . 0.0 108.704 166.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.67 -19.22 64.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 113.275 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -70.81 -50.75 32.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.024 0.829 . . . . 0.0 110.774 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -81.27 -15.91 54.11 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.83 21.36 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.016 1.293 . . . . 0.0 113.254 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -146.78 172.81 13.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.603 1.202 . . . . 0.0 113.35 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 30.0 m -133.83 146.05 50.28 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.173 0.989 . . . . 0.0 110.74 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 14.6 mm -107.0 95.86 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.542 0.737 . . . . 0.0 109.487 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.554 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -94.57 123.54 57.92 Favored Pre-proline 0 N--CA 1.474 0.726 0 O-C-N 121.029 -1.045 . . . . 0.0 111.193 -168.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.59 132.85 22.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.526 2.15 . . . . 0.0 111.109 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 17.6 mtt -60.71 -30.8 70.18 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.026 1.331 . . . . 0.0 113.363 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.49 -16.8 64.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 8.15 24.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.845 2.058 . . . . 0.0 113.554 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 425' ' ' ILE . 96.0 mt -89.35 140.12 29.82 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.233 0.924 . . . . 0.0 110.211 169.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 20.7 p -75.88 178.33 6.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.57 1.148 . . . . 0.0 111.232 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.47 -46.17 87.46 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.42 -0.8 . . . . 0.0 111.073 169.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.876 0.87 . . . . 0.0 112.234 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.78 -55.41 35.47 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.286 1.434 . . . . 0.0 112.475 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -65.88 -36.67 84.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.845 -0.534 . . . . 0.0 110.791 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -59.12 -41.43 88.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.499 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -68.28 -45.97 71.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.423 1.465 . . . . 0.0 111.232 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 49.6 m -53.48 -36.13 61.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.612 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.62 -42.92 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.0 t -101.13 -9.06 21.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.739 1.216 . . . . 0.0 114.141 -167.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.21 146.68 27.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.427 1.108 . . . . 0.0 112.079 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.1 -57.9 3.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.734 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -91.46 132.69 36.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.273 1.029 . . . . 0.0 110.934 163.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 63.93 176.28 4.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.803 1.192 . . . . 0.0 114.094 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.1 -165.95 36.48 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.515 1.055 . . . . 0.0 112.748 -167.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 58.4 p -106.71 16.29 24.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -158.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.1 p 60.4 26.86 16.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.95 1.3 . . . . 0.0 113.441 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.0 77.03 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.506 1.527 . . . . 0.0 114.207 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -66.84 135.67 94.3 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.795 1.297 . . . . 0.0 110.13 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -59.51 144.04 99.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.534 2.156 . . . . 0.0 110.077 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 334' ' ' ILE . 80.7 mt -65.38 123.88 20.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.113 0.483 . . . . 0.0 110.493 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.06 157.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.002 2.121 . . . . 0.0 109.422 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.7 m -52.28 117.71 3.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 110.064 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 75.56 17.94 79.97 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.531 -1.15 . . . . 0.0 115.01 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 20.6 tt -62.5 126.91 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.231 1.516 . . . . 0.0 111.003 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.36 141.2 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.948 2.099 . . . . 0.0 109.501 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -166.29 171.93 11.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.36 1.464 . . . . 0.0 113.118 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.77 145.14 26.75 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.653 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -56.05 136.61 73.79 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -165.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.39 150.42 46.54 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.156 2.571 . . . . 0.0 110.992 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.414 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 85.9 m-20 -59.82 142.04 54.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.964 1.305 . . . . 0.0 113.881 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.35 52.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.635 1.683 . . . . 0.0 110.144 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.549 0.914 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.003 141.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.2 m80 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -72.37 140.34 48.38 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.059 0.943 . . . . 0.0 113.072 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.56 8.22 10.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.955 1.302 . . . . 0.0 113.089 171.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 124.803 1.241 . . . . 0.0 111.585 -170.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.549 0.905 0 O-C-N 120.897 -1.127 . . . . 0.0 110.202 172.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -53.42 124.38 14.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.731 -1.231 . . . . 0.0 110.937 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -128.81 139.21 34.98 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 124.932 1.293 . . . . 0.0 109.223 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.9 156.93 59.47 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.884 2.389 . . . . 0.0 110.415 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 74.17 3.03 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.35 1.06 . . . . 0.0 109.962 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.6 111.59 3.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.613 2.209 . . . . 0.0 109.098 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.89 131.42 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.436 0.695 . . . . 0.0 110.042 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.41 169.57 15.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.635 1.574 . . . . 0.0 110.552 173.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -139.99 125.35 18.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.427 1.091 . . . . 0.0 110.108 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -121.23 107.38 12.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.877 0.871 . . . . 0.0 110.839 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.7 m -68.81 -5.58 21.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 55.7 p -71.33 -22.25 61.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.499 1.12 . . . . 0.0 112.188 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.1 mt -71.27 152.73 94.37 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.962 0.905 . . . . 0.0 112.247 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.81 162.17 33.06 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.113 3.208 . . . . 0.0 112.899 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.43 136.84 32.18 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.139 3.226 . . . . 0.0 112.389 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.72 47.35 10.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 111.798 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -126.12 152.91 45.28 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.337 1.055 . . . . 0.0 113.568 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.02 144.16 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.346 1.858 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -117.29 133.27 56.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.569 -1.332 . . . . 0.0 111.613 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.72 101.86 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.957 0.903 . . . . 0.0 110.582 -169.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -68.72 127.07 31.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.63 1.172 . . . . 0.0 112.024 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.3 m -70.22 135.49 49.07 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.523 -0.736 . . . . 0.0 112.275 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.4 mtm105 -102.42 10.24 39.14 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.881 1.673 . . . . 0.0 110.608 164.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 19.4 m -117.42 145.52 44.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.319 1.448 . . . . 0.0 112.141 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 52.9 mt -105.9 136.26 45.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.181 1.792 . . . . 0.0 109.552 172.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -88.98 140.95 28.91 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 162.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 18.3 mm -125.93 116.41 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 108.484 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -98.55 -177.11 32.67 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.313 0.959 . . . . 0.0 111.943 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.22 64.73 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 121.826 -0.808 . . . . 0.0 114.979 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.69 116.41 53.3 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-O 117.665 -1.16 . . . . 0.0 110.061 -166.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.23 135.29 33.87 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.305 2.003 . . . . 0.0 109.596 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.09 -20.26 63.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.38 -33.46 75.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.146 0.979 . . . . 0.0 111.949 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 3.8 ptp -82.6 151.58 26.29 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.527 0.68 . . . . 0.0 112.81 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -129.76 -175.71 3.68 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.169 1.788 . . . . 0.0 111.555 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.26 -39.79 57.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.753 1.221 . . . . 0.0 113.791 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -75.93 -21.64 56.85 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -74.52 -39.15 62.56 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.841 . . . . 0.0 110.568 169.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.8 mm? -58.07 -50.4 73.59 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.353 0.524 . . . . 0.0 110.569 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.89 80.24 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.596 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -68.46 -40.65 80.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.945 1.248 . . . . 0.0 113.512 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.51 -37.33 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.083 0.856 . . . . 0.0 111.493 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.653 HD23 ' CE1' ' A' ' 394' ' ' PHE . 27.3 mt -83.83 -9.25 58.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.056 0.942 . . . . 0.0 112.75 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.66 -49.43 65.58 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 126.152 1.781 . . . . 0.0 114.889 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -7.32 18.61 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.076 1.851 . . . . 0.0 113.185 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.83 -41.32 8.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.274 1.43 . . . . 0.0 112.3 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.73 172.85 3.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 113.743 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.27 111.87 23.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 111.43 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.82 131.25 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.983 0.913 . . . . 0.0 110.991 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.85 -46.16 8.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.106 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -151.22 152.52 33.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.604 1.162 . . . . 0.0 111.482 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.84 137.21 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.646 . . . . 0.0 110.963 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.81 106.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.638 1.175 . . . . 0.0 107.846 166.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.19 133.0 45.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.003 0.921 . . . . 0.0 110.254 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.55 91.47 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.727 1.211 . . . . 0.0 110.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.0 -27.32 68.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.489 1.116 . . . . 0.0 111.89 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 71.4 m -57.62 -32.05 66.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.025 1.73 . . . . 0.0 114.269 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 8.9 17.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.0 112.729 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.4 mttt 51.99 40.84 29.12 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.704 1.602 . . . . 0.0 112.754 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -127.33 166.7 17.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.27 161.0 41.24 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.44 130.93 57.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.985 1.314 . . . . 0.0 108.379 164.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 359' ' ' LEU . 57.3 t -123.24 102.25 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.945 0.898 . . . . 0.0 110.191 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -74.74 111.02 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.699 1.2 . . . . 0.0 110.127 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.86 153.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.68 1.592 . . . . 0.0 107.85 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.38 -17.88 64.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.81 159.24 44.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.135 1.334 . . . . 0.0 113.004 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.98 77.62 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.741 0.816 . . . . 0.0 110.305 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.7 -36.0 79.66 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.682 0.793 . . . . 0.0 111.64 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.91 -55.55 21.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 111.543 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.4 72.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.061 0.846 . . . . 0.0 112.954 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -60.53 -47.69 85.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.385 1.074 . . . . 0.0 111.878 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.03 -34.51 76.37 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.569 -0.707 . . . . 0.0 112.053 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 359' ' ' LEU . 21.7 t -61.63 -62.03 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.502 167.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -51.31 -35.28 37.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.789 1.236 . . . . 0.0 114.291 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.87 -33.11 75.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.938 1.295 . . . . 0.0 113.532 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -117.2 -27.68 6.4 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 359' ' ' LEU . 20.3 t80 -74.93 123.18 24.64 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.627 0.771 . . . . 0.0 110.919 -169.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.61 23.96 12.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -30.92 63.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.535 1.134 . . . . 0.0 113.766 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.16 -14.43 15.15 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.729 2.012 . . . . 0.0 114.229 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.29 35.48 7.0 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.716 1.15 . . . . 0.0 114.385 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.73 83.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.66 156.37 38.95 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.626 1.57 . . . . 0.0 110.497 -174.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.84 -19.13 24.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.723 2.282 . . . . 0.0 113.908 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.2 mt -62.82 166.76 5.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.903 2.081 . . . . 0.0 113.072 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -137.16 95.0 3.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.46 1.104 . . . . 0.0 110.313 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.5 122.51 28.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.283 1.833 . . . . 0.0 111.063 -172.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 170.44 14.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.596 1.958 . . . . 0.0 109.28 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -64.22 120.17 11.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.336 -0.853 . . . . 0.0 110.424 161.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.1 -155.52 25.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 411' ' ' GLY . 11.0 p -167.35 136.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.441 1.096 . . . . 0.0 110.167 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -80.14 -49.67 5.84 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.423 1.011 . . . . 0.0 110.96 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -115.2 96.65 5.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 111.08 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 408' ' ' VAL . . . -158.65 122.58 1.16 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.768 -1.018 . . . . 0.0 114.772 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.85 125.23 9.27 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.531 3.487 . . . . 0.0 110.24 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -56.37 -40.45 74.58 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.91 -15.04 61.15 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.26 16.48 13.14 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 112.224 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 138.47 31.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.406 1.482 . . . . 0.0 111.776 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -118.63 86.52 2.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.997 1.719 . . . . 0.0 108.708 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -69.36 -15.57 63.34 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.66 -48.79 58.57 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.947 -1.095 . . . . 0.0 110.602 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -84.65 -16.92 40.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.22 44.83 10.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.575 1.083 . . . . 0.0 112.431 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.61 158.17 42.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.059 0.93 . . . . 0.0 113.491 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.81 151.62 28.83 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.967 -1.083 . . . . 0.0 110.69 168.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.89 104.03 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 0.0 109.015 172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.27 131.17 22.16 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.846 -167.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.73 138.66 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.172 1.914 . . . . 0.0 110.748 168.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 4.9 mtm -61.66 -32.92 73.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.344 1.058 . . . . 0.0 112.601 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -68.81 -11.01 59.95 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -110.11 8.12 23.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.309 1.443 . . . . 0.0 113.488 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 76.2 mt -91.33 135.88 33.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.409 0.684 . . . . 0.0 110.35 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 26.3 p -72.73 175.94 6.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.424 1.09 . . . . 0.0 110.749 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -42.67 98.16 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.633 -0.667 . . . . 0.0 111.046 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.18 82.67 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 112.365 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.47 -53.82 53.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.563 1.145 . . . . 0.0 111.677 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -67.77 -35.83 79.39 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.864 -0.522 . . . . 0.0 111.615 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -54.26 -51.93 62.98 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.587 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -68.5 -40.97 80.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.472 1.487 . . . . 0.0 111.683 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -54.68 -29.62 53.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.083 -0.96 . . . . 0.0 113.138 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.48 -40.9 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 171.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.0 t -104.23 -4.76 22.64 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.136 1.374 . . . . 0.0 114.458 -165.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.72 145.88 32.96 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.995 -1.066 . . . . 0.0 111.761 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -53.13 9.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.734 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -95.23 136.52 35.46 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.808 0.843 . . . . 0.0 111.326 162.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.29 -164.07 53.92 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.392 0.996 . . . . 0.0 113.053 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.17 -168.08 52.51 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.183 0.42 . . . . 0.0 112.202 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 73.3 p -98.51 7.79 45.71 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 74.7 25.72 1.49 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.797 1.239 . . . . 0.0 112.808 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.93 82.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.07 1.319 . . . . 0.0 114.007 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -68.31 149.05 98.21 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.3 1.05 . . . . 0.0 110.219 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.28 147.57 93.68 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.341 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.17 122.88 20.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.64 153.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.557 1.943 . . . . 0.0 109.025 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 63.9 m -51.91 125.38 15.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.74 0.416 . . . . 0.0 110.096 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.31 89.1 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.503 -1.165 . . . . 0.0 114.848 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.2 tt -60.03 139.48 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.487 1.644 . . . . 0.0 111.414 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.62 139.55 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.245 1.818 . . . . 0.0 109.457 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -159.89 172.88 16.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.421 1.488 . . . . 0.0 112.193 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.34 150.56 22.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.264 1.026 . . . . 0.0 110.826 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.34 127.79 23.45 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.84 150.29 55.36 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.544 2.163 . . . . 0.0 111.115 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -61.76 146.21 50.09 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.0 113.819 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.3 50.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 123.194 1.473 . . . . 0.0 110.32 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.954 139.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.2 m80 . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -79.68 142.43 35.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.709 1.203 . . . . 0.0 111.901 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.542 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 5.2 mp -90.81 7.01 41.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.603 1.561 . . . . 0.0 112.68 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.948 1.299 . . . . 0.0 111.542 -169.42 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.538 0.685 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.5 t30 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.384 1.073 . . . . 0.0 110.23 177.657 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.6 m80 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.33 133.8 34.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.391 1.451 . . . . 0.0 111.988 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -136.29 149.79 68.9 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 124.058 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -68.71 153.17 73.73 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.705 2.27 . . . . 0.0 110.318 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 78.35 8.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.383 1.073 . . . . 0.0 108.673 168.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.44 118.49 5.62 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.731 2.288 . . . . 0.0 108.798 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.52 136.44 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.911 0.884 . . . . 0.0 109.529 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.64 175.0 9.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.563 1.145 . . . . 0.0 110.496 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.505 ' CE2' HD12 ' A' ' 455' ' ' ILE . 54.5 m-85 -135.63 121.72 20.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.969 0.908 . . . . 0.0 110.102 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -115.68 108.93 17.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.011 0.91 . . . . 0.0 111.096 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.1 p -65.76 -7.49 16.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.495 1.518 . . . . 0.0 114.038 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.49 -23.04 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.699 0.799 . . . . 0.0 112.324 169.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.96 151.02 86.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 112.182 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.88 161.36 36.77 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.882 3.054 . . . . 0.0 112.574 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.06 135.13 28.97 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.132 3.222 . . . . 0.0 112.552 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.8 34.64 9.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.8 1.64 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -119.49 158.86 25.4 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.78 150.72 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.545 1.938 . . . . 0.0 110.263 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.98 127.67 54.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.895 1.678 . . . . 0.0 110.672 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 457' ' ' PHE . 38.1 t -127.26 104.19 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.571 0.749 . . . . 0.0 111.414 -174.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -70.09 137.72 51.41 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.452 1.101 . . . . 0.0 112.323 169.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 m -78.39 129.92 35.51 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.442 -0.786 . . . . 0.0 112.095 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -95.65 18.06 13.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.263 1.425 . . . . 0.0 110.958 162.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 97.4 m -130.96 142.68 50.37 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 111.412 -168.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 25.6 mt -107.11 133.29 51.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.684 1.994 . . . . 0.0 108.669 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -84.65 118.74 24.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.48 108.55 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.22 -175.96 49.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.51 0.576 . . . . 0.0 111.786 167.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.84 9.43 59.41 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.439 -1.036 . . . . 0.0 114.97 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.38 118.52 68.25 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.724 1.262 . . . . 0.0 110.2 -165.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.32 136.19 33.5 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.535 2.157 . . . . 0.0 109.017 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -18.96 50.0 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -73.9 -33.99 64.22 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.699 -0.626 . . . . 0.0 112.662 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 41.3 mtm -72.98 146.19 46.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.12 0.962 . . . . 0.0 112.424 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -126.9 179.86 5.18 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 127.406 2.282 . . . . 0.0 110.911 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.69 -46.24 29.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.645 1.578 . . . . 0.0 113.483 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -76.09 -18.89 58.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.743 1.156 . . . . 0.0 110.391 168.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.86 -42.35 84.32 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.244 0.618 . . . . 0.0 110.832 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -55.89 -52.09 65.3 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 119.1 0.864 . . . . 0.0 112.369 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.5 -38.65 91.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 26.4 m -72.11 -35.94 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.758 0.708 . . . . 0.0 111.533 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' A' ' 379' ' ' VAL . 76.8 mt -85.43 -12.88 50.94 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -46.68 87.17 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.259 1.824 . . . . 0.0 114.649 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.38 -7.03 17.67 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.011 1.807 . . . . 0.0 113.434 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.79 -39.44 9.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.499 1.52 . . . . 0.0 112.614 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.0 167.0 3.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.856 1.662 . . . . 0.0 113.916 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.29 107.49 17.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.792 0.837 . . . . 0.0 110.647 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.56 144.21 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.027 0.931 . . . . 0.0 111.257 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -111.46 -38.57 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.093 1.357 . . . . 0.0 112.092 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . 0.4 ' HA ' HD12 ' A' ' 305' ' ' LEU . 0.0 OUTLIER -150.5 155.33 39.29 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.821 1.191 . . . . 0.0 111.757 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 379' ' ' VAL . 84.0 t -147.1 127.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.844 0.858 . . . . 0.0 110.056 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.65 105.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.29 112.51 25.03 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.732 0.813 . . . . 0.0 110.41 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.56 86.06 3.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 109.851 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.02 -32.63 66.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.941 1.296 . . . . 0.0 111.629 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 34.9 m -59.06 -27.2 65.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.915 1.686 . . . . 0.0 114.378 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -114.56 10.58 16.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.112 1.365 . . . . 0.0 112.406 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 51.29 37.8 19.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.094 1.758 . . . . 0.0 113.042 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -125.27 153.79 42.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.046 1.338 . . . . 0.0 113.661 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -139.53 131.75 28.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.641 1.176 . . . . 0.0 112.168 164.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -83.75 115.48 22.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 162.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 359' ' ' LEU . 99.2 t -122.76 107.42 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.607 . . . . 0.0 110.986 -173.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 125.77 51.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.13 0.972 . . . . 0.0 111.979 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.75 168.72 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.458 1.503 . . . . 0.0 110.018 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -70.39 -24.13 62.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 2.8 p -137.18 156.05 48.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.351 1.432 . . . . 0.0 113.515 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -43.5 98.7 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.613 -0.679 . . . . 0.0 109.895 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -58.41 -37.37 75.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.602 0.761 . . . . 0.0 112.933 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.41 -49.68 72.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.941 0.897 . . . . 0.0 111.168 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.44 93.34 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.806 0.73 . . . . 0.0 112.383 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -61.07 -48.64 80.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.047 0.939 . . . . 0.0 111.15 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -62.81 -34.12 76.62 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.492 -0.755 . . . . 0.0 112.812 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.27 -64.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.656 -0.688 . . . . 0.0 109.582 166.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.38 -35.59 28.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.531 1.132 . . . . 0.0 113.646 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.35 -30.8 71.27 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.682 1.193 . . . . 0.0 113.469 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -117.22 -27.68 6.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 14.7 t80 -73.48 125.41 27.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.673 0.749 . . . . 0.0 111.28 -167.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.4 30.05 19.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.762 1.625 . . . . 0.0 113.937 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -56.23 -36.07 68.08 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.18 -0.95 . . . . 0.0 113.457 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.18 -21.35 46.51 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.566 1.146 . . . . 0.0 113.103 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.18 27.28 49.73 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.941 1.258 . . . . 0.0 113.712 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.93 -34.93 14.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.559 1.544 . . . . 0.0 114.768 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.407 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 22.3 mt -72.95 149.57 89.97 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.12 0.968 . . . . 0.0 109.698 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.54 -30.01 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.657 2.238 . . . . 0.0 112.532 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.22 149.84 47.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.752 2.021 . . . . 0.0 112.399 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -119.37 98.34 6.1 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.572 1.149 . . . . 0.0 110.421 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.85 107.65 16.38 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.197 1.799 . . . . 0.0 109.542 -169.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -117.91 166.91 11.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 108.89 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -65.59 132.53 49.09 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.203 -0.935 . . . . 0.0 111.217 163.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.49 -146.56 8.29 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.416 1.484 . . . . 0.0 109.527 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.81 143.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.398 1.479 . . . . 0.0 108.594 167.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -75.47 -82.11 0.48 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 165.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -94.74 105.75 17.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.559 0.744 . . . . 0.0 111.074 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -169.56 140.67 6.22 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.304 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.4 125.84 11.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 125.16 3.906 . . . . 0.0 109.985 174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 -65.31 -36.68 84.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.08 -18.4 62.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.501 1.921 . . . . 0.0 114.029 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.29 30.16 6.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 111.995 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.9 t -89.62 135.87 33.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.558 1.143 . . . . 0.0 111.806 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -116.96 89.38 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.249 1.82 . . . . 0.0 108.762 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -69.7 -20.87 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.33 -46.39 80.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.594 1.543 . . . . 0.0 111.187 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -86.45 -17.54 33.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.61 48.05 8.29 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.532 1.063 . . . . 0.0 112.401 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -150.08 169.74 20.55 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.284 1.042 . . . . 0.0 112.834 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 15.9 p -137.96 151.96 48.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.71 1.204 . . . . 0.0 110.802 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 22.0 mt -110.23 130.62 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.96 127.16 25.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 119.701 1.137 . . . . 0.0 111.634 -172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.31 132.79 21.51 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.875 2.383 . . . . 0.0 111.635 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 14.5 mtm -64.32 -28.22 69.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.34 1.456 . . . . 0.0 114.048 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -68.37 -23.72 64.7 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.747 0.703 . . . . 0.0 112.893 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.07 -36.55 15.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.588 1.555 . . . . 0.0 111.923 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.2 mt -53.0 117.98 3.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.987 0.812 . . . . 0.0 109.139 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.0 p -64.62 176.17 1.21 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.758 1.223 . . . . 0.0 110.753 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -62.1 -38.85 90.43 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.693 -0.63 . . . . 0.0 111.571 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.53 -40.67 80.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.822 0.849 . . . . 0.0 112.141 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.68 -58.79 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.369 1.067 . . . . 0.0 111.608 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -61.43 -36.04 79.24 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.705 0.402 . . . . 0.0 111.927 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.14 -40.3 89.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.996 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -67.45 -45.47 75.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.539 1.518 . . . . 0.0 111.456 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -52.89 -37.63 60.81 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.496 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.76 -43.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -97.45 -12.55 22.56 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.37 142.5 43.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.183 -0.948 . . . . 0.0 111.989 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -76.34 -53.49 8.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.782 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -92.97 128.32 38.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.285 1.034 . . . . 0.0 110.415 166.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.13 -173.36 45.7 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.479 1.038 . . . . 0.0 114.324 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.19 -158.96 53.8 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.469 -0.365 . . . . 0.0 112.617 -170.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.0 p -97.64 7.52 46.3 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -164.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 p 68.93 7.06 5.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.766 1.626 . . . . 0.0 114.422 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.53 1.78 32.82 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.941 1.734 . . . . 0.0 113.973 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -66.46 153.61 92.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 118.603 1.201 . . . . 0.0 110.823 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.12 147.64 94.03 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.404 2.07 . . . . 0.0 110.038 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 27.2 mt -68.74 124.52 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.865 -0.522 . . . . 0.0 109.761 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.8 t -117.53 148.89 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.292 1.837 . . . . 0.0 108.552 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 99.7 m -50.17 122.96 7.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.18 0.592 . . . . 0.0 109.806 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.57 -2.68 77.75 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.204 -1.331 . . . . 0.0 115.265 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.505 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.8 OUTLIER -54.89 123.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.708 1.754 . . . . 0.0 111.592 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.68 138.22 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 109.243 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 336' ' ' VAL . 6.3 p90 -164.6 -178.36 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.5 1.52 . . . . 0.0 112.25 175.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -93.57 153.26 18.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.626 1.17 . . . . 0.0 111.791 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -49.14 130.32 16.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.542 1.137 . . . . 0.0 113.206 -168.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.68 150.58 68.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.116 1.878 . . . . 0.0 109.689 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -55.66 156.42 4.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.227 1.011 . . . . 0.0 113.72 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mt -121.52 46.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 123.58 1.657 . . . . 0.0 109.56 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.527 135.257 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -79.64 142.24 35.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.257 1.023 . . . . 0.0 111.938 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.65 -42.53 97.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.705 1.202 . . . . 0.0 111.325 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.559 1.3 0 C-N-CA 125.252 1.421 . . . . 0.0 113.129 -169.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 . . . . . 0 CA--C 1.55 0.949 0 O-C-N 120.989 -1.07 . . . . 0.0 110.346 177.777 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.8 m80 . . . . . 0 CA--C 1.548 0.901 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -50.57 131.7 25.28 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.149 1.341 . . . . 0.0 111.209 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.37 140.81 26.9 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 123.861 0.864 . . . . 0.0 109.951 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.9 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.217 2.612 . . . . 0.0 111.026 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 66.28 49.92 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.985 1.314 . . . . 0.0 110.442 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.38 113.15 2.79 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.113 2.542 . . . . 0.0 109.734 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.02 127.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.787 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.68 167.3 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.284 1.434 . . . . 0.0 110.367 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -139.38 122.84 17.24 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.879 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.93 115.02 23.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.803 0.841 . . . . 0.0 110.373 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.4 p -70.4 -11.14 60.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 70.5 p -67.32 -22.38 65.61 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 112.365 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -69.34 147.61 97.13 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.364 0.666 . . . . 0.0 111.478 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.84 164.26 27.71 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.821 3.014 . . . . 0.0 112.65 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.47 133.75 21.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.775 2.983 . . . . 0.0 112.07 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 69.17 30.47 4.32 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.992 2.117 . . . . 0.0 112.123 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -119.97 142.28 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 451' ' ' LEU . 16.9 pt -115.31 149.15 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.458 1.503 . . . . 0.0 110.294 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 128.46 53.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.491 1.116 . . . . 0.0 110.645 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.06 104.73 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.185 0.448 . . . . 0.0 111.618 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -67.13 138.88 57.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.96 167.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 t -81.66 136.17 35.51 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.353 -0.842 . . . . 0.0 112.432 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -105.43 18.89 21.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.944 1.697 . . . . 0.0 110.42 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 92.5 m -125.26 140.69 52.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 111.523 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.18 136.06 47.66 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.143 1.777 . . . . 0.0 108.891 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.69 122.08 33.92 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.37 109.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.29 50.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.646 0.641 . . . . 0.0 111.746 168.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.25 16.02 68.51 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.697 -0.884 . . . . 0.0 114.9 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 28.7 t -78.55 116.58 60.56 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.634 1.217 . . . . 0.0 110.021 -168.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 135.86 31.08 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.325 2.016 . . . . 0.0 108.699 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.2 -15.88 38.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.01 -27.07 61.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.788 0.835 . . . . 0.0 113.106 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.5 ' SD ' HD21 ' A' ' 402' ' ' LEU . 5.4 ptp -84.55 147.46 27.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.542 0.737 . . . . 0.0 111.753 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -124.96 -167.77 1.72 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.824 1.65 . . . . 0.0 111.741 -173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -60.24 -41.71 93.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.592 1.157 . . . . 0.0 111.957 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -73.8 -24.24 59.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.0 -41.85 70.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.882 1.219 . . . . 0.0 110.757 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.1 mm? -56.14 -53.24 59.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 122.977 0.511 . . . . 0.0 110.486 170.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.35 -32.9 67.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.238 -0.887 . . . . 0.0 113.086 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -70.28 -46.16 64.9 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.996 1.271 . . . . 0.0 113.032 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.56 -36.18 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.164 0.893 . . . . 0.0 111.077 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 11.3 mp -78.65 -6.55 56.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.078 0.951 . . . . 0.0 113.342 173.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -49.93 -50.94 65.45 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-N 120.719 1.6 . . . . 0.0 114.843 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.7 -6.34 17.47 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.088 1.859 . . . . 0.0 113.207 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -97.13 -43.04 7.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.547 1.539 . . . . 0.0 112.398 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.26 169.36 2.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 113.868 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.79 119.52 32.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.443 1.097 . . . . 0.0 111.057 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.39 129.18 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.911 1.284 . . . . 0.0 109.411 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.7 -28.63 14.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 t -153.8 149.89 27.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.752 1.221 . . . . 0.0 110.828 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.32 139.45 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.614 0.765 . . . . 0.0 109.836 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.09 104.85 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 166.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.25 118.3 30.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.105 0.478 . . . . 0.0 109.913 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -102.63 79.45 1.81 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.222 1.409 . . . . 0.0 109.058 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.66 -33.49 64.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.167 1.387 . . . . 0.0 111.4 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -32.29 66.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.953 1.701 . . . . 0.0 113.443 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.29 6.79 24.85 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.397 1.479 . . . . 0.0 113.832 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.7 mttt 56.09 38.3 29.75 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.751 1.621 . . . . 0.0 112.436 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -121.66 154.31 37.0 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.03 1.732 . . . . 0.0 113.144 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.46 130.58 28.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.577 1.151 . . . . 0.0 111.698 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -84.36 123.13 29.86 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 162.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 53.0 t -122.96 118.22 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.013 0.925 . . . . 0.0 110.059 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.45 121.1 42.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 109.68 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.96 163.34 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 110.114 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -73.71 -17.71 61.09 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 6.3 p -140.8 156.69 46.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.297 . . . . 0.0 113.154 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -43.43 96.74 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.764 -0.585 . . . . 0.0 110.6 171.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -59.15 -42.08 89.87 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.887 -0.508 . . . . 0.0 111.132 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.0 -50.0 74.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.097 0.959 . . . . 0.0 112.022 171.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.12 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.624 0.647 . . . . 0.0 111.568 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -60.94 -41.31 95.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.423 0.689 . . . . 0.0 112.356 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -66.64 -33.48 75.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.309 0.959 . . . . 0.0 112.134 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.0 -64.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.351 164.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -49.82 -35.57 23.42 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -63.99 -42.19 97.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.909 1.684 . . . . 0.0 113.369 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -110.55 -26.91 9.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -171.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -70.58 122.66 20.15 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.944 0.897 . . . . 0.0 111.095 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.07 31.77 17.77 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.843 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -34.29 73.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.1 -21.18 54.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.826 1.251 . . . . 0.0 113.073 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.99 28.04 55.11 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.933 1.254 . . . . 0.0 113.685 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -92.64 -35.12 13.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.473 1.509 . . . . 0.0 114.566 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.4 mt -72.0 150.38 92.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.431 1.092 . . . . 0.0 109.789 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.93 -34.35 8.69 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.476 2.117 . . . . 0.0 112.045 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.5 HD21 ' SD ' ' A' ' 350' ' ' MET . 1.1 mp -65.76 151.61 46.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 112.575 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -127.19 94.64 4.06 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.068 1.347 . . . . 0.0 108.946 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -77.94 116.9 18.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.027 0.931 . . . . 0.0 110.389 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -120.37 171.27 8.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.933 2.093 . . . . 0.0 108.941 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -69.63 127.46 33.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.046 -1.034 . . . . 0.0 111.273 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.23 -155.68 15.1 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 125.532 1.539 . . . . 0.0 109.27 166.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.64 134.3 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.111 0.456 . . . . 0.0 111.953 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.54 -51.06 3.79 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 166.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -123.64 112.66 17.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 112.454 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.65 2.93 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.131 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.71 128.81 14.71 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 125.195 3.93 . . . . 0.0 110.48 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -34.32 76.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.04 -19.07 60.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.297 1.039 . . . . 0.0 113.756 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.76 29.47 6.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.158 1.783 . . . . 0.0 111.654 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.4 t -83.74 136.01 34.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.886 1.274 . . . . 0.0 111.301 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -121.41 76.89 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.39 1.476 . . . . 0.0 109.087 167.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -61.71 -26.68 68.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.562 -0.711 . . . . 0.0 112.553 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.6 -49.92 74.66 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.235 1.379 . . . . 0.0 111.684 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -82.44 -13.41 56.81 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.98 39.92 18.53 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 124.803 1.192 . . . . 0.0 112.749 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.87 167.02 24.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.621 1.211 . . . . 0.0 112.946 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.9 m -130.25 153.82 48.22 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.397 -0.814 . . . . 0.0 110.465 167.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 mm -106.09 133.8 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -123.58 115.61 28.26 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 120.228 1.376 . . . . 0.0 112.014 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -71.45 133.08 21.79 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.195 2.596 . . . . 0.0 111.492 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.9 mtt -61.81 -28.94 69.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.459 1.104 . . . . 0.0 113.316 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -65.59 -19.07 65.77 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.43 16.43 16.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 112.908 176.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 425' ' ' ILE . 10.4 mt -89.96 173.55 8.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.863 1.265 . . . . 0.0 112.513 170.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.4 p -127.12 169.1 13.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.039 1.336 . . . . 0.0 110.632 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.31 -33.25 69.52 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.748 -1.22 . . . . 0.0 111.166 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.83 84.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.458 1.103 . . . . 0.0 112.014 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.499 ' CG ' HD22 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -65.55 -45.14 84.51 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.656 0.662 . . . . 0.0 112.478 179.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -62.33 -41.74 98.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -59.84 -32.36 70.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.339 1.056 . . . . 0.0 113.106 171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -72.05 -50.45 28.27 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.007 1.731 . . . . 0.0 111.877 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.7 m -51.58 -39.55 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.314 0.961 . . . . 0.0 111.715 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.3 m -82.64 -50.52 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.5 t -91.07 -13.78 32.52 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.612 -1.305 . . . . 0.0 114.27 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.4 137.69 47.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.027 0.917 . . . . 0.0 111.702 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -78.05 -44.97 24.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.883 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -102.82 140.0 37.66 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.968 1.307 . . . . 0.0 111.617 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.02 -167.5 34.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.056 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.92 -146.21 47.83 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -171.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 451' ' ' LEU . 18.7 p -117.21 1.18 12.45 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -153.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.77 18.01 1.3 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.29 1.836 . . . . 0.0 112.849 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.19 12.4 61.72 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.602 1.096 . . . . 0.0 113.659 -172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -78.56 136.93 59.3 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.032 1.333 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.18 99.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.069 2.513 . . . . 0.0 109.059 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.7 OUTLIER -67.61 147.68 52.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.625 0.77 . . . . 0.0 112.189 -176.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.3 163.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.785 1.234 . . . . 0.0 111.235 -173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.8 t -51.43 127.35 19.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.916 0.886 . . . . 0.0 110.641 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 97.03 -14.39 63.9 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.938 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.26 147.33 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.077 1.939 . . . . 0.0 112.164 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.94 132.93 69.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.759 2.024 . . . . 0.0 109.052 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 446' ' ' THR . 16.4 p90 -153.36 178.05 10.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.415 1.486 . . . . 0.0 111.752 174.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.99 151.26 19.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.163 1.385 . . . . 0.0 109.631 171.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.31 129.26 5.98 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.888 1.275 . . . . 0.0 112.371 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.57 150.54 80.0 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.293 1.328 . . . . 0.0 110.077 168.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.451 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.4 m-20 -54.24 142.87 24.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 51.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.632 1.682 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.549 0.911 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.499 138.688 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.9 m80 . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.15 143.23 52.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.384 1.074 . . . . 0.0 112.322 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.4 mm? -62.91 -46.29 88.51 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.034 0.934 . . . . 0.0 112.183 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 CA--C 1.549 0.938 0 C-N-CA 125.193 1.397 . . . . 0.0 112.522 -175.11 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 122.301 1.048 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 124.734 1.214 . . . . 0.0 111.307 179.027 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -55.12 125.17 19.41 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.253 -1.529 . . . . 0.0 111.471 171.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.7 mmt-85 -160.24 148.33 13.11 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.758 1.623 . . . . 0.0 110.693 -170.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.06 173.47 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.644 2.229 . . . . 0.0 111.611 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -114.84 99.32 51.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.192 0.597 . . . . 0.0 109.504 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.03 154.79 25.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.522 2.815 . . . . 0.0 110.821 171.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.08 142.06 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.329 1.452 . . . . 0.0 108.967 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.74 168.09 17.77 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.388 1.075 . . . . 0.0 111.166 171.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.12 121.98 15.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.766 1.226 . . . . 0.0 109.996 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.23 107.18 12.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.822 1.249 . . . . 0.0 110.164 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 50.3 p -71.55 -4.13 25.19 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -24.59 66.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.94 1.296 . . . . 0.0 112.175 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.16 151.21 97.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.064 0.946 . . . . 0.0 112.001 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.26 161.74 32.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.826 3.017 . . . . 0.0 112.659 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.56 131.19 18.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.746 2.964 . . . . 0.0 112.057 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.05 36.21 4.28 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.074 2.15 . . . . 0.0 111.807 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -122.57 155.26 36.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.649 1.18 . . . . 0.0 113.74 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 455' ' ' ILE . 16.6 pt -123.61 154.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.652 1.981 . . . . 0.0 110.546 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -110.55 125.17 53.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.118 0.967 . . . . 0.0 110.946 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.11 105.1 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.505 1.122 . . . . 0.0 109.785 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.93 136.28 52.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.627 1.171 . . . . 0.0 111.218 168.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.7 t -73.96 138.84 44.46 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 121.325 -0.859 . . . . 0.0 112.203 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.5 mtm180 -107.37 -1.27 21.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.889 1.676 . . . . 0.0 111.815 164.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 23.1 m -100.54 123.62 45.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.072 1.349 . . . . 0.0 109.093 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.45 141.46 28.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.568 1.547 . . . . 0.0 108.751 168.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -93.93 142.99 26.75 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.47 111.93 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.169 1.388 . . . . 0.0 108.441 -172.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -91.01 172.75 37.14 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.197 0.904 . . . . 0.0 111.768 168.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.6 23.36 78.04 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.316 -0.713 . . . . 0.0 114.736 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.0 t -84.26 115.72 61.55 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 118.491 1.146 . . . . 0.0 110.405 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.87 142.24 61.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.924 2.416 . . . . 0.0 110.032 170.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.08 -20.12 50.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -21.34 52.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 22.9 mtm -83.94 144.06 29.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.949 0.881 . . . . 0.0 112.165 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -128.31 -177.16 4.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.832 2.053 . . . . 0.0 110.624 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -49.41 -39.26 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.73 1.612 . . . . 0.0 114.713 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 305' ' ' LEU . 98.5 m95 -79.36 -17.77 53.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -75.75 -38.54 58.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.549 1.068 . . . . 0.0 110.519 168.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.8 mm? -59.87 -49.07 79.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.582 168.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.36 -33.56 69.7 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.102 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -73.97 -42.45 60.45 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.923 1.238 . . . . 0.0 114.314 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.29 -35.19 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.029 1.286 . . . . 0.0 111.459 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.546 HD23 ' CE1' ' A' ' 394' ' ' PHE . 37.8 mt -87.97 -5.63 58.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.455 1.102 . . . . 0.0 113.081 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -52.53 -49.0 88.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.88 -6.17 17.77 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.616 2.21 . . . . 0.0 113.379 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -98.5 -35.91 10.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.332 1.453 . . . . 0.0 112.871 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.55 3.5 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.214 1.805 . . . . 0.0 113.936 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 122.23 30.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.184 1.394 . . . . 0.0 110.61 169.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.46 122.74 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.693 0.797 . . . . 0.0 109.592 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -96.72 -35.5 10.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.588 1.555 . . . . 0.0 112.459 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.95 155.57 44.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.36 1.064 . . . . 0.0 111.907 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 27.0 t -149.22 140.18 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 0.0 110.621 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.26 101.48 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.392 1.477 . . . . 0.0 108.254 168.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.63 131.11 49.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.174 0.59 . . . . 0.0 110.823 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 87.49 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.394 1.092 . . . . 0.0 109.96 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.42 -29.54 67.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.273 1.429 . . . . 0.0 112.237 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.3 t -59.27 -28.28 66.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.888 1.675 . . . . 0.0 114.092 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.22 1.38 16.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.083 1.753 . . . . 0.0 112.727 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 59.51 37.46 22.84 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.318 1.447 . . . . 0.0 112.26 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -125.51 167.0 15.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.42 164.76 29.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.501 1.12 . . . . 0.0 112.315 163.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.94 135.38 54.92 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.331 1.453 . . . . 0.0 108.396 162.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 359' ' ' LEU . 73.0 t -128.44 118.03 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.116 0.966 . . . . 0.0 110.92 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -101.67 120.3 40.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.786 1.234 . . . . 0.0 112.059 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.9 m -100.99 -179.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.136 0.974 . . . . 0.0 111.429 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -64.93 -37.4 87.53 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.928 1.24 . . . . 0.0 114.155 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 60.3 p -149.06 166.42 28.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -167.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -39.25 89.62 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.175 169.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -62.39 -40.36 96.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.917 0.78 . . . . 0.0 112.352 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.62 -47.76 71.61 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.37 0.668 . . . . 0.0 110.488 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.92 98.65 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.383 -0.823 . . . . 0.0 112.107 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -65.5 -40.52 93.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.935 171.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.99 -33.38 75.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.946 1.248 . . . . 0.0 112.333 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.99 -65.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 118.461 0.573 . . . . 0.0 109.886 164.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.48 -33.22 43.76 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -69.29 -35.3 75.87 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 113.454 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -111.49 -26.04 9.28 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.7 t80 -72.6 124.25 24.87 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.415 0.686 . . . . 0.0 111.872 -168.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 60.67 28.77 18.48 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.712 1.605 . . . . 0.0 114.134 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -31.03 70.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.791 -1.193 . . . . 0.0 113.737 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.16 -18.3 50.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.601 1.16 . . . . 0.0 113.382 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.72 17.69 69.92 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.848 1.213 . . . . 0.0 114.001 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.55 -31.27 19.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.54 1.536 . . . . 0.0 114.845 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 42.8 mt -79.22 149.18 72.37 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.195 0.998 . . . . 0.0 109.895 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.33 -27.84 11.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.689 2.26 . . . . 0.0 112.394 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.17 147.04 45.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.806 1.242 . . . . 0.0 111.863 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.89 103.25 8.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.564 1.146 . . . . 0.0 110.592 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -86.84 122.4 30.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 111.401 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -129.35 177.09 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.304 2.642 . . . . 0.0 109.146 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -76.05 130.84 38.98 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.777 -1.202 . . . . 0.0 111.651 162.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.0 -160.56 21.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.274 1.892 . . . . 0.0 109.594 162.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.61 125.94 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.892 1.277 . . . . 0.0 109.47 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -90.21 -43.49 4.97 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 162.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -137.66 124.4 21.11 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.168 0.987 . . . . 0.0 110.866 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 174.09 129.92 1.23 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.068 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.27 123.51 10.0 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.78 3.654 . . . . 0.0 109.797 172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.7 -37.89 74.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.279 0.561 . . . . 0.0 112.476 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.79 -18.6 62.09 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.026 2.13 . . . . 0.0 114.545 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.66 24.21 8.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.844 1.658 . . . . 0.0 112.084 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.65 140.99 29.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.309 1.444 . . . . 0.0 111.776 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.81 88.8 3.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.376 1.471 . . . . 0.0 109.199 166.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -65.78 -20.76 66.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.42 -51.51 23.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.637 0.775 . . . . 0.0 110.347 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.87 -17.67 55.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.42 36.18 27.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 124.967 1.27 . . . . 0.0 113.294 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -144.33 164.89 29.47 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.165 0.986 . . . . 0.0 112.893 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.6 m -129.73 150.52 51.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.296 1.038 . . . . 0.0 110.521 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.48 139.38 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.99 126.65 19.77 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 120.017 1.28 . . . . 0.0 111.608 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.25 135.74 27.61 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.565 2.176 . . . . 0.0 111.097 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 5.3 mtm -61.7 -33.78 74.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.498 1.119 . . . . 0.0 113.096 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -68.04 -21.91 64.99 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 119.249 0.931 . . . . 0.0 113.506 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -83.48 -38.84 21.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.184 1.393 . . . . 0.0 111.543 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.97 124.04 13.18 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.728 0.695 . . . . 0.0 109.224 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.5 p -70.77 174.7 5.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.652 1.181 . . . . 0.0 110.942 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -44.0 76.03 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.759 -0.588 . . . . 0.0 111.012 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.66 82.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.291 1.036 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.0 -51.29 70.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.7 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -63.24 -42.94 99.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -52.68 -49.74 64.67 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -69.14 -44.78 71.64 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.494 1.043 . . . . 0.0 111.55 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 64.3 m -52.63 -35.74 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.637 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.38 -42.67 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.2 t -97.63 -9.95 25.95 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -165.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.42 141.02 48.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.975 -1.078 . . . . 0.0 112.279 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -75.67 -22.78 56.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.707 0.803 . . . . 0.0 111.693 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -131.34 144.77 51.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.086 2.155 . . . . 0.0 110.566 167.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.41 -176.89 41.0 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.978 0.799 . . . . 0.0 113.014 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.13 -153.3 49.54 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 122.25 -0.559 . . . . 0.0 113.941 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.6 p -102.76 7.64 39.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.769 1.627 . . . . 0.0 115.173 -163.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.1 m 73.58 8.31 5.04 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.83 2.85 59.51 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.326 1.441 . . . . 0.0 113.58 -170.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -68.33 154.97 93.45 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.754 1.277 . . . . 0.0 110.454 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.01 141.41 83.72 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.062 1.842 . . . . 0.0 110.198 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 118.47 10.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 166.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.83 154.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.189 1.396 . . . . 0.0 109.671 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -57.27 133.63 55.26 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.806 0.442 . . . . 0.0 110.049 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.45 -8.79 79.09 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.449 -1.195 . . . . 0.0 115.181 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 334' ' ' ILE . 15.6 tt -62.41 138.82 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.985 1.892 . . . . 0.0 111.749 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.12 137.93 55.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 108.875 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.63 -179.27 7.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.149 1.38 . . . . 0.0 110.858 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -99.87 146.01 27.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.513 1.925 . . . . 0.0 110.68 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -44.32 131.87 4.6 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.451 1.5 . . . . 0.0 114.313 -166.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.36 163.99 36.74 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.143 1.895 . . . . 0.0 111.804 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.53 137.04 56.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 112.613 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.52 54.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 123.581 1.658 . . . . 0.0 109.531 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.544 0.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.245 140.624 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 8.4 m80 . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 367' ' ' SER . 31.5 m80 -89.11 147.94 23.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.971 1.709 . . . . 0.0 113.026 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.8 18.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.062 2.145 . . . . 0.0 113.029 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 4.1 p90 . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 125.915 1.686 . . . . 0.0 112.275 -168.013 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 CA--C 1.548 0.886 0 O-C-N 121.34 -0.85 . . . . 0.0 110.302 173.776 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 61.1 m170 . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -48.42 131.08 17.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.761 1.164 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 134.45 11.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.77 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.73 168.49 22.68 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.235 2.623 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.87 70.59 10.27 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.602 1.561 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.77 115.15 3.43 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.099 2.533 . . . . 0.0 110.004 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.79 144.45 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.552 1.141 . . . . 0.0 109.362 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.7 173.17 11.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.265 1.026 . . . . 0.0 110.899 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 455' ' ' ILE . 44.4 m-85 -136.4 121.11 18.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.472 1.109 . . . . 0.0 109.634 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -115.55 108.02 15.9 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.826 1.251 . . . . 0.0 110.444 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.7 p -66.67 -8.93 31.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -25.07 67.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.088 1.355 . . . . 0.0 112.439 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.26 151.94 96.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.636 0.774 . . . . 0.0 111.927 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.54 162.41 31.16 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.891 3.061 . . . . 0.0 112.722 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 131.95 19.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.813 3.009 . . . . 0.0 112.176 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 68.38 33.7 4.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.744 2.018 . . . . 0.0 112.162 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -121.47 151.14 40.58 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.43 146.11 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.128 1.771 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -110.25 128.72 55.66 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.5 1.046 . . . . 0.0 111.529 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.3 t -125.01 104.47 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.5 0.72 . . . . 0.0 111.112 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.72 134.54 54.42 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.644 1.177 . . . . 0.0 111.589 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 33.3 t -76.34 138.99 40.81 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.193 -0.942 . . . . 0.0 111.651 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.5 mtm105 -109.63 13.96 23.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.102 1.761 . . . . 0.0 110.835 163.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.0 m -113.95 136.23 53.12 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.125 1.77 . . . . 0.0 111.052 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.7 mt -102.61 137.41 40.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.057 1.743 . . . . 0.0 110.131 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -84.12 138.84 32.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 158.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 22.9 mm -127.67 105.16 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.168 1.387 . . . . 0.0 108.346 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -81.35 178.8 53.77 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 121.366 -0.834 . . . . 0.0 111.506 165.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.33 37.28 86.03 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.72 -0.871 . . . . 0.0 113.822 173.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.08 85.14 6.34 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 125.553 1.541 . . . . 0.0 110.358 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.43 161.18 42.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.547 . . . . 0.0 111.012 171.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.8 -20.31 48.96 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -28.52 69.72 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.211 1.005 . . . . 0.0 113.058 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.5 ptm -110.9 135.93 50.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.221 1.01 . . . . 0.0 112.097 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -116.97 -176.05 2.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.257 1.823 . . . . 0.0 111.24 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.92 -34.6 68.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.535 1.134 . . . . 0.0 113.238 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -78.43 -24.18 46.28 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.11 -43.34 71.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.052 0.842 . . . . 0.0 109.851 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 37.3 mt -57.74 -52.89 63.58 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.997 0.519 . . . . 0.0 109.927 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.96 -37.25 63.72 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -72.04 -39.55 69.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.13 -30.98 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.974 1.261 . . . . 0.0 111.653 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.8 mt -81.21 -13.75 58.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.29 1.436 . . . . 0.0 112.916 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -48.09 -48.93 62.69 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.41 -4.64 15.59 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.351 2.034 . . . . 0.0 113.533 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -101.89 -41.28 6.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.62 1.568 . . . . 0.0 112.643 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.75 168.05 4.38 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 111.704 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 132.94 34.7 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.852 -0.53 . . . . 0.0 109.624 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.76 136.28 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.835 0.854 . . . . 0.0 110.133 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -41.54 6.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.339 1.456 . . . . 0.0 112.531 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 304' ' ' HIS . 0.1 OUTLIER -149.28 157.6 43.48 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.827 1.251 . . . . 0.0 109.743 -176.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.92 133.41 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.81 99.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 165.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 137.7 37.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.7 64.77 1.6 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.388 1.075 . . . . 0.0 110.785 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -56.48 -34.4 66.88 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 0.0 112.249 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 m -61.34 -31.41 71.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.799 1.239 . . . . 0.0 113.737 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -96.77 6.99 47.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.366 1.466 . . . . 0.0 113.239 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 63.02 21.2 12.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.247 1.819 . . . . 0.0 113.463 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -135.85 175.52 9.52 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.87 167.01 24.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.104 1.762 . . . . 0.0 111.44 166.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.81 131.69 54.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.015 1.326 . . . . 0.0 108.393 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 60.4 t -122.98 132.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.628 1.171 . . . . 0.0 109.642 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -111.87 126.84 55.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.618 1.567 . . . . 0.0 110.68 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 166.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 0.0 109.812 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -78.7 -23.2 45.72 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -167.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.53 149.46 50.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.781 1.232 . . . . 0.0 111.948 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -55.3 -41.73 72.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.288 1.035 . . . . 0.0 111.777 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -66.24 -36.65 83.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.736 -0.602 . . . . 0.0 112.058 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.72 -49.28 78.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.609 0.764 . . . . 0.0 110.771 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.73 98.23 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.638 -0.664 . . . . 0.0 111.962 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.23 -42.14 98.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.282 1.033 . . . . 0.0 111.556 170.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -67.06 -32.29 73.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.553 1.069 . . . . 0.0 112.757 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.31 -63.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 118.69 -0.671 . . . . 0.0 109.956 165.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.11 -32.99 50.26 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.92 -34.52 74.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.55 1.54 . . . . 0.0 113.377 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -124.39 -31.19 3.31 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -71.77 119.38 15.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.313 1.045 . . . . 0.0 111.159 -167.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 32.4 t30 58.07 25.48 12.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.535 1.534 . . . . 0.0 114.39 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -34.12 77.41 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.66 -1.275 . . . . 0.0 113.251 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.75 -18.32 61.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 112.775 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.19 22.29 63.38 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.067 1.318 . . . . 0.0 113.689 -172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -85.25 -31.5 23.09 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.096 1.359 . . . . 0.0 114.506 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.47 151.94 59.86 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.402 1.081 . . . . 0.0 110.017 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.0 -22.95 22.33 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.722 2.281 . . . . 0.0 113.54 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 402' ' ' LEU . 1.6 mm? -63.95 168.43 5.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.789 1.636 . . . . 0.0 112.957 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 84.97 2.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.401 1.08 . . . . 0.0 110.797 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 117.07 20.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.873 1.669 . . . . 0.0 110.372 -171.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -135.18 169.11 17.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.144 1.378 . . . . 0.0 109.791 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -63.94 119.74 10.65 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.494 -0.754 . . . . 0.0 110.654 165.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.55 -155.44 29.28 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 163.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.7 137.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.869 0.468 . . . . 0.0 111.742 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.91 -52.93 2.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -122.82 111.53 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 111.362 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.7 140.34 4.23 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.126 -0.819 . . . . 0.0 114.861 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.65 131.96 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 125.178 3.919 . . . . 0.0 110.264 174.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -65.24 -34.24 77.89 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.47 -18.64 58.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 89.8 m -123.3 29.75 6.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.141 1.776 . . . . 0.0 112.137 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 14.4 p -76.55 149.5 36.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.867 0.841 . . . . 0.0 112.138 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -132.82 72.6 1.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.475 1.51 . . . . 0.0 108.798 166.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.47 -19.63 63.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.34 -51.85 53.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.899 1.227 . . . . 0.0 110.975 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -80.36 -16.2 55.1 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.01 37.59 12.57 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.054 1.312 . . . . 0.0 112.98 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -145.98 170.31 16.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.01 1.405 . . . . 0.0 112.525 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 37.9 m -136.21 151.39 49.65 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 121.649 -0.657 . . . . 0.0 110.243 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.54 128.65 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.01 121.29 28.86 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.178 -171.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.03 141.65 36.92 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.99 1.793 . . . . 0.0 110.269 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 7.3 mtt -59.04 -31.22 68.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.356 1.062 . . . . 0.0 113.411 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.7 -21.92 66.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.05 0.841 . . . . 0.0 113.265 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.44 5.63 50.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.561 1.944 . . . . 0.0 113.741 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.1 126.38 39.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.323 171.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.8 p -77.47 -179.93 6.09 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.309 1.444 . . . . 0.0 111.343 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -62.5 -42.09 99.26 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.518 -0.739 . . . . 0.0 111.527 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.67 -40.7 92.67 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.137 0.975 . . . . 0.0 112.031 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.99 -51.94 67.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -66.42 -40.45 89.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.921 0.888 . . . . 0.0 111.339 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -58.34 -38.93 78.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.212 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -72.29 -44.77 62.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.818 1.644 . . . . 0.0 111.63 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 62.6 m -50.91 -38.43 49.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.815 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.6 m -87.31 -51.95 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.2 t -92.79 -9.33 40.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.48 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.82 141.29 39.33 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.218 -0.926 . . . . 0.0 111.653 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -73.72 -57.6 3.88 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.622 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -93.81 137.03 33.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.051 . . . . 0.0 111.367 167.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 67.44 -169.09 37.56 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.277 0.942 . . . . 0.0 113.755 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 67.01 -150.03 51.67 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 451' ' ' LEU . 23.4 p -112.26 9.85 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.6 m 69.82 14.38 8.02 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.12 1.368 . . . . 0.0 113.238 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.59 41.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.805 1.193 . . . . 0.0 113.829 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.7 144.86 37.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.906 1.353 . . . . 0.0 111.353 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.5 104.39 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.457 2.772 . . . . 0.0 108.883 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -77.63 142.22 39.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.8 m -130.42 168.15 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.165 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 10.7 t -48.66 127.34 13.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.306 1.042 . . . . 0.0 111.296 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 96.51 -14.36 64.34 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.264 -1.298 . . . . 0.0 115.204 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.6 OUTLIER -53.83 136.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.921 1.86 . . . . 0.0 112.252 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.32 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 126.624 1.97 . . . . 0.0 108.787 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -152.36 179.31 8.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.453 1.501 . . . . 0.0 111.086 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -99.21 154.29 18.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.846 1.258 . . . . 0.0 110.569 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -46.58 129.5 8.23 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.971 1.308 . . . . 0.0 112.446 -166.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.54 152.87 70.51 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.822 1.681 . . . . 0.0 110.019 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.48 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 82.7 m-20 -57.96 135.35 56.91 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.467 1.107 . . . . 0.0 113.29 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.47 50.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 123.306 1.527 . . . . 0.0 109.923 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.546 0.8 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.932 137.736 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 7.4 m80 . . . . . 0 CA--C 1.55 0.978 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -76.52 149.33 36.72 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.065 1.346 . . . . 0.0 112.583 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.4 mp -98.07 -39.85 8.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.232 1.013 . . . . 0.0 111.596 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 124.137 0.975 . . . . 0.0 110.142 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.235 0.313 0 CA-C-O 122.22 1.01 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 CA--C 1.552 1.024 0 C-N-CA 124.408 1.083 . . . . 0.0 110.616 174.125 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 22.7 m80 . . . . . 0 CA--C 1.548 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.41 135.47 17.61 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.559 1.527 . . . . 0.0 112.044 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -140.73 149.96 58.43 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 124.273 1.029 . . . . 0.0 111.04 174.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.38 169.34 21.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.834 3.023 . . . . 0.0 111.639 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -124.17 71.32 54.05 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.435 1.094 . . . . 0.0 110.5 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.03 108.21 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.617 2.211 . . . . 0.0 109.288 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.0 139.29 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.349 1.06 . . . . 0.0 109.527 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.44 172.61 12.67 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.651 1.581 . . . . 0.0 109.878 174.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.97 124.09 13.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.026 -1.047 . . . . 0.0 109.103 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -121.69 110.42 15.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.9 t -70.16 -6.14 32.17 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -24.99 67.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.08 . . . . 0.0 112.13 170.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 150.47 90.72 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 111.669 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.31 164.09 26.97 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.974 3.116 . . . . 0.0 113.3 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.64 136.83 28.97 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 112.375 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.13 38.55 16.87 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.596 1.559 . . . . 0.0 112.786 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -124.25 158.17 33.13 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.971 1.308 . . . . 0.0 113.834 171.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 455' ' ' ILE . 2.7 pt -128.53 152.64 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.785 2.034 . . . . 0.0 110.69 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.32 132.05 54.49 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.575 -1.328 . . . . 0.0 111.449 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.499 HG22 ' CE2' ' A' ' 457' ' ' PHE . 61.4 t -126.59 105.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 -171.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -68.74 129.72 40.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 111.915 168.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 2.4 m -71.43 134.62 46.74 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.802 -0.561 . . . . 0.0 111.65 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.4 mtm105 -102.98 16.3 27.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.696 1.999 . . . . 0.0 110.614 162.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 93.6 m -123.91 133.94 53.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.66 1.584 . . . . 0.0 110.623 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 46.5 mt -101.11 138.36 38.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.755 2.422 . . . . 0.0 109.785 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -86.31 124.16 32.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 162.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.38 103.05 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.061 0.944 . . . . 0.0 108.466 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -82.17 -175.89 50.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 164.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.0 30.1 75.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.665 -0.903 . . . . 0.0 113.854 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.73 103.68 12.15 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.446 1.098 . . . . 0.0 110.045 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 144.73 64.88 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.277 1.985 . . . . 0.0 109.918 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.8 mp -65.24 -19.67 66.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -63.76 -32.54 74.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.764 1.226 . . . . 0.0 112.858 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -87.84 154.79 20.26 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -134.13 -175.99 4.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.499 1.519 . . . . 0.0 111.312 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 352' ' ' GLU . 1.7 mp0 -52.93 -38.4 61.9 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.167 2.187 . . . . 0.0 112.441 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -75.98 -26.61 56.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.58 -43.25 81.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.633 1.106 . . . . 0.0 109.679 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.72 -48.41 81.27 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.669 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -53.0 -46.2 68.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.397 0.999 . . . . 0.0 113.023 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.56 -37.64 80.08 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.45 -33.09 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.095 0.861 . . . . 0.0 111.887 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.58 -14.13 55.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -49.86 -48.92 76.69 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.943 1.697 . . . . 0.0 115.426 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.71 -6.39 18.14 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.008 1.806 . . . . 0.0 112.955 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.33 -46.49 5.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.281 1.433 . . . . 0.0 112.12 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.24 1.69 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.062 1.745 . . . . 0.0 113.469 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.74 133.8 34.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.001 . . . . 0.0 110.913 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.05 130.02 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.707 1.203 . . . . 0.0 109.579 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -91.52 -44.39 9.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.087 0.955 . . . . 0.0 111.69 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.5 p -161.26 163.47 30.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.822 1.249 . . . . 0.0 111.25 -171.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 305' ' ' LEU . 0.6 OUTLIER -165.44 132.52 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.57 0.748 . . . . 0.0 111.767 174.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.93 105.42 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 377' ' ' ALA . 0.9 OUTLIER -99.43 115.52 29.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.103 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.88 83.64 2.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.617 1.567 . . . . 0.0 109.205 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -55.5 -37.93 68.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.174 0.99 . . . . 0.0 111.418 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 m -61.38 -28.89 69.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.872 2.069 . . . . 0.0 113.877 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.95 4.5 34.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.991 1.716 . . . . 0.0 112.817 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 79.9 mttt 55.38 34.6 23.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.178 1.791 . . . . 0.0 112.897 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -131.82 156.48 45.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.66 1.584 . . . . 0.0 113.59 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.439 ' HB2' ' HG ' ' A' ' 370' ' ' LEU . . . -141.76 134.25 28.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.125 1.37 . . . . 0.0 112.637 166.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -88.74 102.43 14.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 166.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 38.8 t -99.38 120.52 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.983 0.913 . . . . 0.0 110.964 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -106.19 126.33 52.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.078 0.951 . . . . 0.0 111.898 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.7 169.13 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.934 1.294 . . . . 0.0 110.168 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -75.48 -15.63 60.39 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -168.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.0 160.9 43.05 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.258 -0.901 . . . . 0.0 112.421 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.36 -41.99 98.85 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.594 0.758 . . . . 0.0 111.456 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.92 -41.64 87.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.346 0.521 . . . . 0.0 111.299 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.66 -51.84 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.08 0.952 . . . . 0.0 109.692 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.27 95.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.557 0.743 . . . . 0.0 112.633 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.3 -43.07 99.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.173 0.989 . . . . 0.0 111.267 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -66.52 -34.19 77.37 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.407 -0.808 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 66.2 t -60.37 -65.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.766 164.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.1 mt -51.95 -35.23 45.35 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -60.16 -37.48 80.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.837 1.255 . . . . 0.0 112.906 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.23 -27.41 7.64 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.56 125.87 28.2 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.78 23.06 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -53.83 -48.04 70.32 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.064 -1.023 . . . . 0.0 113.607 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.45 5.55 49.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.555 1.942 . . . . 0.0 112.806 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 72.62 38.71 57.16 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.566 1.079 . . . . 0.0 112.922 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -57.48 -29.52 64.32 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.232 1.013 . . . . 0.0 113.569 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.12 162.98 25.06 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.763 1.625 . . . . 0.0 110.045 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 -15.73 21.43 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.98 2.453 . . . . 0.0 113.408 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.68 161.01 21.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.342 2.257 . . . . 0.0 112.455 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -128.46 97.08 4.6 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.845 1.258 . . . . 0.0 109.995 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.98 21.24 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.46 1.904 . . . . 0.0 111.739 -177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.18 173.2 11.27 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.295 1.838 . . . . 0.0 108.999 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -70.18 125.44 26.78 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.154 -0.966 . . . . 0.0 110.902 163.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.46 -154.38 14.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.606 1.574 . . . . 0.0 109.174 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -163.49 136.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.646 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -94.42 -45.21 3.29 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.114 1.34 . . . . 0.0 110.296 163.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -124.29 109.99 14.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.148 0.979 . . . . 0.0 113.401 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -176.52 136.4 3.21 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.487 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.57 126.56 12.91 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.094 3.862 . . . . 0.0 110.194 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -36.6 80.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 112.404 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.07 -18.23 60.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.63 1.572 . . . . 0.0 114.285 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.2 27.18 8.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.753 1.621 . . . . 0.0 111.885 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.5 t -84.83 135.42 34.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.59 1.156 . . . . 0.0 111.69 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.05 79.6 1.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.349 1.46 . . . . 0.0 109.34 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -62.83 -24.05 67.58 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.517 -0.74 . . . . 0.0 112.926 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -64.22 -49.36 72.25 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.827 1.194 . . . . 0.0 111.321 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -81.72 -17.38 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 81.77 41.02 10.05 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 124.844 1.212 . . . . 0.0 112.624 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -147.54 165.79 29.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.62 1.21 . . . . 0.0 112.978 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 22.4 m -129.49 152.48 48.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.556 0.742 . . . . 0.0 110.368 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.76 136.24 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.795 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.43 120.04 21.97 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 120.331 1.423 . . . . 0.0 112.004 -173.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -69.31 126.64 13.86 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.981 2.454 . . . . 0.0 111.341 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -33.65 74.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.03 0.932 . . . . 0.0 113.069 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -65.65 -17.87 64.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -109.39 11.04 25.32 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 113.691 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 425' ' ' ILE . 47.9 mt -90.37 145.28 25.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.885 0.874 . . . . 0.0 111.052 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 16.7 p -77.0 179.06 6.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.577 1.151 . . . . 0.0 111.175 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.11 -41.77 76.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.598 -0.689 . . . . 0.0 111.364 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.16 94.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.89 1.276 . . . . 0.0 111.901 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.92 -64.32 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.257 1.423 . . . . 0.0 111.923 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -63.29 -35.23 79.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.63 0.772 . . . . 0.0 111.472 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -53.1 -56.82 13.32 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.504 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -59.59 -39.77 85.28 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.742 1.61 . . . . 0.0 112.734 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.1 m -50.1 -43.48 51.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.426 1.012 . . . . 0.0 112.149 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.12 -21.22 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.6 t -117.68 -17.44 9.91 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.713 1.605 . . . . 0.0 113.905 -165.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.08 139.73 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.179 -0.951 . . . . 0.0 111.186 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -65.27 -49.39 69.75 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.901 0.48 . . . . 0.0 110.667 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -103.66 110.17 22.14 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.592 1.187 . . . . 0.0 108.92 163.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -175.7 -171.49 39.65 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.422 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -74.95 -64.69 2.27 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.101 -1.049 . . . . 0.0 113.642 -164.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 17.4 p -113.65 41.94 2.09 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.107 0.963 . . . . 0.0 110.005 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.8 m -55.74 100.75 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.271 -0.893 . . . . 0.0 111.986 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.97 -8.04 59.22 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 125.817 1.675 . . . . 0.0 115.895 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -110.14 146.39 34.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.264 2.225 . . . . 0.0 111.029 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.76 168.08 25.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.69 2.927 . . . . 0.0 112.21 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.32 121.52 30.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.652 0.781 . . . . 0.0 110.967 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.28 160.46 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.299 1.44 . . . . 0.0 110.602 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.6 m -58.31 125.75 24.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.558 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 83.85 6.34 87.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.846 1.212 . . . . 0.0 114.847 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 334' ' ' ILE . 14.9 tt -62.32 137.67 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.371 1.586 . . . . 0.0 111.115 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.55 138.52 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.164 2.185 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.499 ' CE2' HG22 ' A' ' 336' ' ' VAL . 9.4 p90 -165.45 -176.96 4.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.012 0.925 . . . . 0.0 113.169 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -100.2 146.54 26.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.575 1.55 . . . . 0.0 111.091 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.19 138.24 27.11 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -167.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.32 156.54 50.62 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.685 2.257 . . . . 0.0 112.419 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.84 142.66 58.35 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.917 0.887 . . . . 0.0 112.363 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.44 45.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 123.639 1.685 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.475 0.789 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.249 143.13 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.4 m80 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.87 137.49 41.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.437 1.095 . . . . 0.0 113.282 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.2 -35.19 23.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.978 1.311 . . . . 0.0 111.564 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 123.951 0.9 . . . . 0.0 110.698 -178.668 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.533 0.682 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.101 0.961 . . . . 0.0 110.507 177.152 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m80 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.5 134.87 56.35 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.268 -1.52 . . . . 0.0 112.676 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -149.38 151.27 33.31 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.197 1.399 . . . . 0.0 110.013 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 159.86 50.59 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.07 2.514 . . . . 0.0 111.593 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -112.71 83.25 5.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.74 109.36 2.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.195 1.93 . . . . 0.0 109.799 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.42 132.6 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.479 1.112 . . . . 0.0 108.592 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 79.6 p -129.26 176.25 8.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.716 0.806 . . . . 0.0 111.06 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.16 124.18 18.85 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.533 1.133 . . . . 0.0 110.29 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -126.46 106.66 9.62 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.087 0.946 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.5 m -67.12 -2.9 6.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 114.118 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 -20.39 61.26 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.493 1.042 . . . . 0.0 112.391 170.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.09 151.09 90.32 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.72 0.691 . . . . 0.0 112.071 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.8 162.66 30.93 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.805 3.003 . . . . 0.0 113.04 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.6 133.55 28.1 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.539 2.826 . . . . 0.0 112.699 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.12 20.07 6.52 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 126.275 1.83 . . . . 0.0 112.808 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -106.47 155.49 19.53 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 455' ' ' ILE . 16.1 pt -126.78 154.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.94 2.096 . . . . 0.0 110.478 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -117.59 126.26 52.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.497 1.499 . . . . 0.0 111.855 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.86 107.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.748 0.819 . . . . 0.0 110.498 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -73.59 134.49 43.74 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.07 1.348 . . . . 0.0 111.658 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 38.3 t -70.44 144.29 51.52 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.557 -0.714 . . . . 0.0 111.322 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -123.88 28.91 6.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.816 1.646 . . . . 0.0 110.213 162.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.1 m -127.43 143.14 51.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.393 1.877 . . . . 0.0 109.556 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.57 126.4 55.3 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.239 1.816 . . . . 0.0 108.708 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.09 119.45 27.33 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.6 110.04 30.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.86 37.07 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.494 0.568 . . . . 0.0 112.441 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.38 21.19 70.24 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 169.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.97 128.63 93.2 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.383 1.073 . . . . 0.0 109.928 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.29 130.49 18.77 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.333 2.022 . . . . 0.0 109.396 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 pp -61.13 -20.18 62.37 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -166.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 -21.55 59.28 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.29 147.43 22.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.277 0.944 . . . . 0.0 113.23 -173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -120.47 -179.77 4.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 112.441 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -49.67 -39.17 35.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.613 1.565 . . . . 0.0 114.467 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.92 -14.95 57.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -79.39 -36.56 39.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.264 0.938 . . . . 0.0 110.791 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.48 -51.05 69.94 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.17 -39.14 69.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.21 -42.59 75.53 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.48 -32.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.182 1.356 . . . . 0.0 111.686 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 44.1 mt -81.81 -14.5 56.27 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.196 0.999 . . . . 0.0 112.824 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -43.23 -50.27 15.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.523 1.929 . . . . 0.0 116.193 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.45 -8.34 17.19 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.29 1.994 . . . . 0.0 114.12 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.64 -38.73 9.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.071 1.748 . . . . 0.0 112.236 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.04 160.46 2.77 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.442 1.897 . . . . 0.0 112.776 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.15 106.76 18.7 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.655 0.74 . . . . 0.0 109.033 162.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.77 137.65 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.67 1.188 . . . . 0.0 111.133 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -89.59 -41.84 11.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.436 1.094 . . . . 0.0 111.602 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.59 148.7 28.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.768 1.227 . . . . 0.0 111.031 -170.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.0 t -144.96 137.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 119.171 0.896 . . . . 0.0 110.877 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.86 104.32 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 165.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.85 98.96 11.72 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.588 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -83.25 75.07 9.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.433 1.111 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -56.39 -32.25 64.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.1 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -59.51 -23.44 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.445 1.498 . . . . 0.0 113.786 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.08 13.23 12.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 112.912 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.86 34.05 23.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.328 1.451 . . . . 0.0 112.222 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -117.27 156.55 27.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.415 1.886 . . . . 0.0 112.741 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.5 135.39 28.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 112.112 161.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.11 124.31 31.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 162.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.5 101.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 108.846 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -90.21 116.47 28.22 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.116 1.366 . . . . 0.0 110.019 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.69 149.22 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.313 1.045 . . . . 0.0 108.347 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -74.97 3.57 8.09 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 t -160.32 147.15 15.82 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.25 -1.531 . . . . 0.0 112.903 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -59.89 -39.69 86.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.213 1.405 . . . . 0.0 111.085 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.85 -35.05 79.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.932 0.493 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -68.26 -53.36 25.06 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.796 0.838 . . . . 0.0 110.696 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.14 87.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -64.9 -44.09 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.484 168.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -65.34 -29.03 69.73 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.058 1.299 . . . . 0.0 112.555 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.2 -67.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 118.872 0.76 . . . . 0.0 109.672 161.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.98 -30.87 62.44 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.1 -35.7 81.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.049 1.74 . . . . 0.0 112.756 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.95 -25.76 7.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -75.17 124.57 27.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.327 1.051 . . . . 0.0 111.26 -167.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 59.76 28.35 17.79 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.253 1.821 . . . . 0.0 114.067 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -62.43 -25.88 68.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.716 -1.24 . . . . 0.0 114.186 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.56 -15.12 46.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.447 1.099 . . . . 0.0 113.42 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.01 83.69 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.703 1.144 . . . . 0.0 114.098 -173.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.0 29.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.815 1.646 . . . . 0.0 115.375 -171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.18 151.09 59.37 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.215 0.916 . . . . 0.0 110.39 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.65 -23.75 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.832 2.355 . . . . 0.0 112.736 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.71 142.36 51.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.594 1.958 . . . . 0.0 112.423 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -115.92 90.28 3.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.047 0.939 . . . . 0.0 109.836 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.1 m -79.04 116.28 19.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.542 1.137 . . . . 0.0 109.867 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -116.38 165.88 12.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.681 1.993 . . . . 0.0 108.846 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -63.43 131.19 47.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.741 -1.225 . . . . 0.0 109.992 158.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -112.41 -155.19 12.4 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 125.555 1.55 . . . . 0.0 109.799 164.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.0 p -165.6 141.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 117.798 0.799 . . . . 0.0 111.365 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.31 -45.34 4.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.009 163.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -118.42 102.52 8.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.742 1.217 . . . . 0.0 112.916 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.33 123.73 1.13 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 118.789 -1.006 . . . . 0.0 115.284 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.84 128.92 10.36 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.473 3.449 . . . . 0.0 111.302 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -61.19 -32.6 72.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.34 -24.56 66.54 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.762 1.625 . . . . 0.0 113.205 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 23.1 m -134.84 32.42 3.25 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 112.255 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.72 140.97 49.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.999 1.319 . . . . 0.0 111.476 171.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -131.75 78.69 1.83 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.023 1.729 . . . . 0.0 109.338 163.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -64.41 -12.88 47.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 113.375 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.85 -47.49 18.68 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.685 1.129 . . . . 0.0 111.152 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -80.59 -17.13 52.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.305 0.642 . . . . 0.0 112.623 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.72 47.53 9.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.082 1.325 . . . . 0.0 112.083 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -147.65 171.81 15.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.771 1.286 . . . . 0.0 112.376 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 20.3 m -141.24 150.35 42.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.993 1.317 . . . . 0.0 110.591 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.49 132.37 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.11 124.41 25.34 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 119.537 1.062 . . . . 0.0 111.768 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.05 140.05 17.65 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.549 2.833 . . . . 0.0 112.636 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.81 -19.85 66.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.767 1.627 . . . . 0.0 113.985 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -74.58 -21.66 59.38 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.93 0.786 . . . . 0.0 112.911 172.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -95.51 -26.43 15.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.38 112.62 2.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.684 1.129 . . . . 0.0 109.506 169.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 36.6 p -66.93 177.33 1.73 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.29 1.436 . . . . 0.0 111.491 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -59.97 -38.9 83.85 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.056 -1.028 . . . . 0.0 111.905 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.39 -37.9 65.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.624 0.77 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.31 -51.43 69.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.746 1.218 . . . . 0.0 111.286 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -65.93 -36.27 82.91 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.621 -0.674 . . . . 0.0 111.535 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -51.94 67.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.076 0.853 . . . . 0.0 111.515 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.17 -44.61 94.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.226 1.375 . . . . 0.0 110.667 175.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 m -56.37 -32.84 65.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.249 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.41 -34.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 47.6 m -102.3 -9.27 20.52 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -168.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.63 152.19 27.03 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.952 1.251 . . . . 0.0 112.768 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -81.35 -38.77 26.14 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.135 0.574 . . . . 0.0 110.922 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -116.48 137.3 52.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.247 1.019 . . . . 0.0 110.749 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.43 -169.9 51.2 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.361 -168.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 69.54 -162.11 52.27 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.293 0.949 . . . . 0.0 113.266 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 29.3 p -95.11 1.76 54.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.549 1.54 . . . . 0.0 114.373 -168.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 19.7 m 66.89 11.93 8.62 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.46 1.027 . . . . 0.0 113.655 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.22 48.23 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.303 1.43 . . . . 0.0 114.33 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.7 154.23 93.09 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.469 1.135 . . . . 0.0 110.725 169.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.12 148.7 81.54 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.901 2.4 . . . . 0.0 111.051 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.1 105.53 5.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.547 -0.721 . . . . 0.0 110.011 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.39 158.91 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.653 1.581 . . . . 0.0 110.73 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 76.2 m -60.15 133.13 55.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.02 84.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.491 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 334' ' ' ILE . 15.8 tt -63.99 135.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.937 1.868 . . . . 0.0 111.78 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 36.3 t -120.01 139.45 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 126.376 1.87 . . . . 0.0 109.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -163.52 -176.1 4.53 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.237 1.015 . . . . 0.0 112.743 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.54 148.2 22.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.341 1.457 . . . . 0.0 109.434 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -49.16 131.03 16.35 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.44 157.25 56.91 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.729 2.286 . . . . 0.0 111.612 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -58.38 134.78 56.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.582 1.153 . . . . 0.0 112.757 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.32 58.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 123.572 1.653 . . . . 0.0 109.966 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.068 140.412 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.5 m170 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -63.73 138.1 58.35 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.57 0.748 . . . . 0.0 111.414 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.9 mm? -59.55 -43.75 93.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.154 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.835 -175.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.238 0.461 0 CA-C-O 122.319 1.057 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.865 0.866 . . . . 0.0 111.596 -178.438 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 7.8 m80 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -51.08 127.42 18.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.682 1.583 . . . . 0.0 111.645 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -157.19 147.35 15.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.56 1.544 . . . . 0.0 110.85 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.7 173.76 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.67 2.247 . . . . 0.0 111.541 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -108.55 83.3 1.95 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.941 0.896 . . . . 0.0 110.194 167.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.55 141.08 30.73 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.26 2.64 . . . . 0.0 110.303 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.72 145.19 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.208 1.403 . . . . 0.0 108.524 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 75.9 p -140.39 179.78 6.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.178 0.991 . . . . 0.0 111.084 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -143.92 130.77 20.36 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.093 -1.005 . . . . 0.0 110.085 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -107.64 102.93 12.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.274 1.03 . . . . 0.0 109.643 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -12.77 17.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.002 1.321 . . . . 0.0 113.667 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.88 0.92 54.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.691 1.597 . . . . 0.0 113.018 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.6 154.61 50.86 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.644 1.111 . . . . 0.0 113.688 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 162.73 40.98 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.948 3.766 . . . . 0.0 113.191 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.03 138.98 34.9 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.445 3.43 . . . . 0.0 112.937 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.04 37.33 18.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.921 1.288 . . . . 0.0 111.744 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -115.61 140.24 49.36 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.62 -1.3 . . . . 0.0 112.763 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 425' ' ' ILE . 25.6 pt -106.81 146.15 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.387 1.475 . . . . 0.0 109.591 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 117.96 33.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.504 1.121 . . . . 0.0 109.494 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.7 106.93 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 O-C-N 122.096 -0.377 . . . . 0.0 110.568 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.08 128.84 36.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.811 1.244 . . . . 0.0 111.793 170.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 66.1 m -69.16 144.7 53.73 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -131.72 16.02 4.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.484 2.714 . . . . 0.0 110.843 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 13.3 m -110.27 129.68 55.69 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.117 1.767 . . . . 0.0 108.786 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.08 136.44 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.615 1.566 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -93.63 142.87 26.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 159.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.79 106.32 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.98 1.312 . . . . 0.0 108.709 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.41 41.81 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.831 0.729 . . . . 0.0 111.966 168.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.6 78.65 Favored Glycine 0 N--CA 1.475 1.234 0 O-C-N 122.054 -0.674 . . . . 0.0 114.651 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.4 t -78.79 119.97 79.19 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.532 1.166 . . . . 0.0 110.358 -171.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 138.53 34.42 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.721 2.28 . . . . 0.0 109.609 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -16.81 54.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -29.48 63.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.139 0.976 . . . . 0.0 112.557 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.406 ' CE ' HD21 ' A' ' 402' ' ' LEU . 5.9 mtm -78.79 149.33 32.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.63 0.728 . . . . 0.0 112.735 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -127.83 -178.33 4.46 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.878 2.071 . . . . 0.0 111.222 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.466 ' HA ' HG11 ' A' ' 368' ' ' VAL . 10.6 pm0 -51.08 -41.55 60.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.844 1.658 . . . . 0.0 114.449 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.499 ' CE2' HD12 ' A' ' 305' ' ' LEU . 96.1 m95 -77.12 -17.63 58.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.69 -40.31 61.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.272 0.942 . . . . 0.0 110.545 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.7 mm? -60.26 -47.35 86.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.497 0.59 . . . . 0.0 110.939 170.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.33 -34.16 72.01 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.717 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.72 -42.42 64.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.954 1.252 . . . . 0.0 114.376 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.27 -37.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.964 0.802 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 394' ' ' PHE . 32.6 mt -85.75 -5.32 59.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.893 0.877 . . . . 0.0 112.479 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -52.85 -49.83 84.72 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.966 1.707 . . . . 0.0 115.161 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.67 -5.01 16.39 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.457 2.105 . . . . 0.0 113.431 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -101.23 -39.56 7.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.191 1.396 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.5 167.28 5.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.643 1.977 . . . . 0.0 113.111 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -92.67 102.1 14.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.67 1.188 . . . . 0.0 111.642 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 379' ' ' VAL . 59.4 t -70.51 118.58 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.883 0.873 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -91.95 -36.13 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.897 1.679 . . . . 0.0 112.778 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.7 t -144.16 153.16 41.83 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.318 0.963 . . . . 0.0 112.169 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 352' ' ' GLU . 49.0 t -144.81 140.35 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.855 0.862 . . . . 0.0 111.259 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.61 97.79 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.313 1.445 . . . . 0.0 108.019 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -97.3 132.99 42.5 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.858 0.463 . . . . 0.0 110.734 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.05 89.09 2.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.976 1.31 . . . . 0.0 109.769 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.46 -37.45 83.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.087 1.355 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.1 t -58.47 -32.43 68.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.055 1.742 . . . . 0.0 113.064 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -98.45 -1.0 42.39 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.151 1.38 . . . . 0.0 113.197 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 59.03 30.95 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.399 1.88 . . . . 0.0 113.408 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.29 170.5 15.62 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.66 24.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 111.68 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.14 140.12 53.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.377 1.471 . . . . 0.0 108.895 164.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 365' ' ' VAL . 95.1 t -132.77 111.96 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.493 1.117 . . . . 0.0 109.705 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -92.45 119.97 32.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.565 0.746 . . . . 0.0 110.239 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.27 176.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.907 0.883 . . . . 0.0 108.918 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 147.4 46.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.601 -0.687 . . . . 0.0 111.268 -164.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.65 81.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.759 0.824 . . . . 0.0 110.652 166.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -39.93 80.53 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.053 0.842 . . . . 0.0 112.435 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -65.63 -52.38 52.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.674 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.56 80.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.411 1.085 . . . . 0.0 113.037 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.47 -41.57 98.88 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -61.72 -32.61 72.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.645 1.111 . . . . 0.0 111.916 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 359' ' ' LEU . 3.7 t -63.73 -62.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.858 166.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.61 -36.98 26.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.208 1.403 . . . . 0.0 114.111 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.56 -38.59 70.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.377 1.471 . . . . 0.0 112.885 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -106.73 -26.31 11.36 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.56 ' CE1' HD23 ' A' ' 359' ' ' LEU . 25.4 t80 -70.89 127.7 33.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -171.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 29.0 t30 60.66 28.42 18.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.39 1.476 . . . . 0.0 113.9 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -59.64 -34.75 73.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.853 -1.154 . . . . 0.0 113.325 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.32 -20.14 60.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.883 1.273 . . . . 0.0 113.063 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.86 19.61 75.06 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.929 1.252 . . . . 0.0 113.725 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.78 -32.67 17.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.242 1.417 . . . . 0.0 114.291 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.49 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 20.0 mt -77.48 146.77 74.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.859 0.864 . . . . 0.0 109.093 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.79 -18.9 28.0 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.17 1.913 . . . . 0.0 112.718 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.406 HD21 ' CE ' ' A' ' 350' ' ' MET . 3.8 mt -82.27 144.43 30.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.048 0.939 . . . . 0.0 112.524 -169.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.14 9.71 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 110.245 174.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 33.3 m -83.11 125.12 31.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.237 1.415 . . . . 0.0 110.628 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.83 174.98 9.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.022 2.129 . . . . 0.0 109.661 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -72.53 122.87 22.06 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.207 -0.933 . . . . 0.0 111.398 163.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.83 -177.72 35.08 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.281 1.419 . . . . 0.0 110.551 163.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.64 119.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.679 0.791 . . . . 0.0 109.619 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.49 -36.78 10.26 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.759 1.647 . . . . 0.0 110.943 161.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -145.99 109.19 4.65 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.921 0.861 . . . . 0.0 112.149 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.34 133.74 2.13 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.821 -0.988 . . . . 0.0 115.467 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.25 122.17 7.79 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 125.268 3.978 . . . . 0.0 110.83 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -55.27 -37.18 66.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -74.99 -16.41 60.62 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.694 1.598 . . . . 0.0 114.16 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.7 m -127.21 27.82 5.84 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.916 1.686 . . . . 0.0 111.93 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.65 140.48 29.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.201 1.401 . . . . 0.0 111.669 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -126.12 87.78 2.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.444 1.116 . . . . 0.0 109.567 167.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.25 -22.0 65.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.835 0.854 . . . . 0.0 113.181 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -68.77 -51.97 35.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.077 0.853 . . . . 0.0 110.232 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.09 -18.72 59.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.11 45.55 8.86 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.415 1.007 . . . . 0.0 112.459 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -154.6 175.33 13.79 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.306 1.05 . . . . 0.0 112.99 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 35.2 p -147.22 153.32 39.67 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.414 1.086 . . . . 0.0 110.967 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mm -108.33 135.34 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -129.42 109.73 17.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 119.843 1.201 . . . . 0.0 110.523 -172.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.65 131.94 27.43 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.595 2.197 . . . . 0.0 110.917 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 45.7 mtt -64.7 -15.72 61.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.687 1.195 . . . . 0.0 113.132 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -65.35 -25.16 67.47 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 113.038 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 13.08 14.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.426 2.29 . . . . 0.0 113.243 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 425' ' ' ILE . 9.4 mt -85.0 176.41 8.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.521 1.528 . . . . 0.0 111.706 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 2.3 p -127.87 165.06 20.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 110.759 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -65.92 -37.28 85.67 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.041 -1.037 . . . . 0.0 111.41 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.83 -42.21 90.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.771 0.829 . . . . 0.0 112.071 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -48.48 70.0 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.022 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.45 -38.12 86.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.017 0.826 . . . . 0.0 110.107 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.06 -33.05 71.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.659 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -72.56 -45.32 59.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.266 1.394 . . . . 0.0 111.858 168.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 m -53.21 -39.7 63.9 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.767 1.167 . . . . 0.0 111.402 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.24 -48.12 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.2 m -93.49 -5.95 47.97 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.22 138.19 45.55 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.896 1.225 . . . . 0.0 112.533 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -78.02 -27.36 48.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.569 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -124.89 138.46 54.25 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.611 1.564 . . . . 0.0 111.221 164.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.02 -168.64 47.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.396 -172.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.18 -156.91 53.5 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.23 0.443 . . . . 0.0 112.556 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.6 p -107.27 11.77 28.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.24 1.416 . . . . 0.0 114.746 -159.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.5 t 66.19 14.87 9.86 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.911 -1.118 . . . . 0.0 113.21 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.08 61.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.281 1.42 . . . . 0.0 114.233 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -68.19 145.37 97.51 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 119.309 1.555 . . . . 0.0 111.126 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.32 148.27 90.94 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.981 2.454 . . . . 0.0 110.976 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.1 109.4 8.55 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.047 0.451 . . . . 0.0 110.448 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.75 170.87 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.966 1.706 . . . . 0.0 111.471 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.9 m -57.23 119.36 6.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.29 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.19 79.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.283 0.945 . . . . 0.0 115.123 172.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.6 tt -58.27 125.01 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.176 1.488 . . . . 0.0 111.184 172.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.08 132.93 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.707 1.603 . . . . 0.0 109.003 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.79 170.52 21.44 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.154 0.982 . . . . 0.0 112.071 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.91 147.59 25.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.593 1.157 . . . . 0.0 108.982 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -40.0 125.17 1.63 Allowed Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.529 1.132 . . . . 0.0 113.966 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.07 150.6 85.15 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.489 1.459 . . . . 0.0 110.111 172.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -56.7 161.4 2.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.504 1.145 . . . . 0.0 113.52 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 1.4 mt -118.94 47.49 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 123.231 1.491 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.7 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.58 140.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 18.7 m80 . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -79.54 140.12 37.32 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.361 1.064 . . . . 0.0 111.388 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.74 -47.03 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.182 0.593 . . . . 0.0 110.609 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 CA--C 1.548 0.904 0 C-N-CA 125.139 1.376 . . . . 0.0 110.231 -176.332 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.238 0.451 0 CA-C-O 121.549 0.69 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 CA--C 1.552 1.039 0 O-C-N 121.524 -0.735 . . . . 0.0 110.805 -178.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.57 125.63 23.03 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 120.685 -1.259 . . . . 0.0 111.654 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.5 mmt-85 -156.09 147.16 16.52 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 111.358 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.01 174.28 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.916 2.411 . . . . 0.0 111.145 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -115.98 77.72 7.04 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.999 0.92 . . . . 0.0 110.084 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.39 135.84 23.01 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.485 2.79 . . . . 0.0 110.306 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 t -147.46 140.64 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.055 1.342 . . . . 0.0 108.866 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.04 173.4 10.76 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.984 1.314 . . . . 0.0 111.043 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.493 ' CE2' HD12 ' A' ' 455' ' ' ILE . 42.5 m-85 -137.17 124.64 22.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.31 1.044 . . . . 0.0 109.988 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -119.36 103.07 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.216 1.008 . . . . 0.0 110.589 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.0 p -66.8 -5.03 10.61 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.499 1.519 . . . . 0.0 113.972 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -22.4 64.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.802 0.841 . . . . 0.0 112.509 168.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.92 153.04 95.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.875 0.87 . . . . 0.0 112.179 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.13 161.99 31.49 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.799 2.999 . . . . 0.0 112.557 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.78 131.54 18.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.894 3.062 . . . . 0.0 112.122 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.88 44.89 3.42 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.254 1.822 . . . . 0.0 111.558 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -130.33 155.26 46.64 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.5 pt -128.25 144.77 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.101 1.761 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -100.43 115.86 31.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.232 1.413 . . . . 0.0 109.659 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.6 102.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.475 0.71 . . . . 0.0 110.384 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -71.17 136.2 47.98 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.401 1.08 . . . . 0.0 111.776 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.2 t -75.48 140.23 42.71 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.16 -0.962 . . . . 0.0 112.173 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.436 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 4.7 mtm180 -110.32 2.34 19.07 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.896 1.678 . . . . 0.0 111.288 165.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 35.9 m -104.65 129.32 52.82 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.084 1.353 . . . . 0.0 109.567 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.33 137.43 34.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.064 1.746 . . . . 0.0 108.604 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -91.79 137.82 32.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 159.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 19.8 mm -127.69 108.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 108.398 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.82 -177.55 38.09 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.328 0.966 . . . . 0.0 112.229 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.01 16.58 64.39 Favored Glycine 0 N--CA 1.477 1.402 0 C-N-CA 124.189 0.9 . . . . 0.0 114.87 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.2 t -71.85 129.16 88.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 118.141 0.971 . . . . 0.0 110.262 -164.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.94 130.21 22.53 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.366 2.044 . . . . 0.0 109.278 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.41 -19.09 54.87 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.24 -29.56 64.05 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.517 -0.739 . . . . 0.0 112.906 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.4 ptp -84.5 145.93 27.86 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -120.25 -177.83 3.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.231 1.812 . . . . 0.0 112.494 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.86 -41.04 44.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.288 1.435 . . . . 0.0 113.559 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -76.47 -22.55 54.41 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.49 -35.27 65.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.76 0.709 . . . . 0.0 110.79 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 355' ' ' LEU . 1.4 mm? -59.55 -51.18 70.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.987 0.812 . . . . 0.0 110.437 168.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.11 -38.23 67.89 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.464 0.574 . . . . 0.0 112.416 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -72.53 -42.96 64.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.115 1.366 . . . . 0.0 114.474 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.32 -31.94 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 120.462 1.483 . . . . 0.0 111.049 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.441 HD23 ' CE1' ' A' ' 394' ' ' PHE . 35.7 mt -89.22 -9.36 51.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.26 1.024 . . . . 0.0 112.885 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -49.45 -49.04 73.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.705 1.602 . . . . 0.0 114.828 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.05 -6.24 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.089 1.859 . . . . 0.0 113.202 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -100.73 -33.91 10.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.45 1.5 . . . . 0.0 112.983 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.88 168.08 3.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 113.946 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 113.03 20.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.838 1.255 . . . . 0.0 110.81 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.63 121.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.65 . . . . 0.0 109.547 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -92.81 -37.05 12.52 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.412 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.71 158.66 43.69 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.085 -1.01 . . . . 0.0 112.094 -174.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.4 p -166.05 136.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.688 0.795 . . . . 0.0 111.378 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.51 97.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.137 1.375 . . . . 0.0 107.578 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 372' ' ' ASN . 5.5 tt -89.96 126.87 35.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.615 0.366 . . . . 0.0 110.07 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 83.16 1.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.035 1.334 . . . . 0.0 109.02 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . 0.44 HD22 HD21 ' A' ' 370' ' ' LEU . 3.8 t-20 -63.3 -30.35 71.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.864 0.865 . . . . 0.0 112.694 -173.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 9.0 t -48.08 -39.06 19.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.658 1.983 . . . . 0.0 113.596 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -103.87 8.61 36.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.548 1.539 . . . . 0.0 113.682 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 56.68 36.6 27.9 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.98 1.312 . . . . 0.0 112.221 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -133.29 165.33 25.07 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.53 163.0 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.736 1.214 . . . . 0.0 111.699 165.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.48 141.73 47.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 108.543 162.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.9 t -138.43 118.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.026 0.53 . . . . 0.0 111.775 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -99.4 126.06 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 112.836 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.63 179.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.395 1.078 . . . . 0.0 111.296 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -65.35 -35.47 81.06 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 57.5 p -149.01 168.62 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.054 1.297 . . . . 0.0 114.384 -168.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.62 98.1 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.734 169.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -58.1 -45.01 87.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.063 0.847 . . . . 0.0 111.953 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.74 -47.06 79.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.375 0.67 . . . . 0.0 110.519 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.91 96.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 111.759 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.81 -40.96 97.87 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.005 0.922 . . . . 0.0 111.169 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.65 -33.49 75.15 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.792 1.633 . . . . 0.0 112.239 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.91 -64.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 118.883 -0.579 . . . . 0.0 110.512 165.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.45 -29.33 49.29 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -67.89 -34.49 76.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.651 1.98 . . . . 0.0 112.998 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -123.49 -27.25 4.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.441 ' CE1' HD23 ' A' ' 359' ' ' LEU . 35.3 t80 -69.34 121.41 16.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.954 0.902 . . . . 0.0 111.06 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 38.0 t30 57.97 27.91 15.44 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.435 1.494 . . . . 0.0 114.398 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -62.62 -32.78 73.86 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.362 -1.461 . . . . 0.0 113.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.86 -19.02 62.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 113.076 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.02 80.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.014 1.292 . . . . 0.0 113.563 -171.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.94 34.69 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.392 1.477 . . . . 0.0 114.052 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.21 149.44 55.53 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.512 1.125 . . . . 0.0 109.672 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.79 -23.73 13.98 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.593 2.195 . . . . 0.0 113.417 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.81 150.72 27.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.101 2.161 . . . . 0.0 113.101 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.7 91.36 3.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.543 1.137 . . . . 0.0 110.683 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 25.8 m -85.27 127.73 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.199 1.4 . . . . 0.0 111.14 -170.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -137.77 172.83 12.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.908 2.083 . . . . 0.0 109.622 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -70.98 120.39 16.48 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.04 -1.037 . . . . 0.0 111.005 164.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.36 -161.73 32.71 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 162.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 16.9 t -143.22 122.54 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.566 1.146 . . . . 0.0 108.903 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -86.15 -40.79 7.32 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 164.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -142.4 125.13 15.93 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.181 0.992 . . . . 0.0 111.265 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.99 132.17 1.66 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.676 -1.069 . . . . 0.0 114.37 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.415 ' HG3' HG23 ' A' ' 425' ' ' ILE . 97.1 Cg_endo -70.53 123.83 10.21 Favored 'Trans proline' 0 C--N 1.349 0.566 1 C-N-CA 125.316 4.011 . . . . 0.0 109.698 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.43 -39.49 79.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.141 0.496 . . . . 0.0 112.104 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.78 -24.03 66.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.511 1.924 . . . . 0.0 113.501 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 6.4 m -119.96 20.9 12.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.542 1.537 . . . . 0.0 111.896 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.95 139.62 30.42 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.291 1.436 . . . . 0.0 111.973 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.85 90.65 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.954 1.302 . . . . 0.0 109.43 166.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -67.71 -21.73 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -69.52 -51.14 38.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.643 0.656 . . . . 0.0 110.489 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -78.57 -19.8 51.98 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.12 38.32 19.15 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.88 1.228 . . . . 0.0 113.12 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.64 167.06 26.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.185 0.993 . . . . 0.0 113.4 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.2 m -132.24 149.86 52.28 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.331 1.053 . . . . 0.0 111.035 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 10.0 mm -107.55 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.714 HG21 HD21 ' A' ' 430' ' ' LEU . 1.3 mt -97.55 122.56 55.04 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 121.007 -1.058 . . . . 0.0 111.056 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.43 131.94 21.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.44 2.093 . . . . 0.0 111.25 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -27.7 68.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.522 1.129 . . . . 0.0 113.446 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.24 -20.99 63.94 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.426 1.012 . . . . 0.0 113.568 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.15 8.79 28.2 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.323 1.849 . . . . 0.0 112.699 -176.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.714 HD21 HG21 ' A' ' 425' ' ' ILE . 38.4 mt -92.6 147.69 22.68 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.991 1.716 . . . . 0.0 110.81 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 21.9 p -83.61 175.15 9.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.595 1.158 . . . . 0.0 111.155 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.92 -41.65 97.59 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.757 -0.589 . . . . 0.0 111.42 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.97 -40.55 95.16 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.952 0.901 . . . . 0.0 112.028 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.64 -53.16 61.43 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.593 1.157 . . . . 0.0 112.279 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.05 -40.66 96.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.812 0.845 . . . . 0.0 111.001 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -58.01 -41.78 83.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.243 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -69.93 -44.82 68.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.824 1.647 . . . . 0.0 111.758 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.4 m -52.7 -35.43 55.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.423 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.15 -43.74 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.6 t -96.68 -11.19 25.49 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.573 -1.329 . . . . 0.0 114.429 -166.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.49 139.39 53.45 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.048 -1.032 . . . . 0.0 111.943 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -77.08 -25.24 52.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.456 0.703 . . . . 0.0 112.02 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -125.97 140.12 52.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.294 1.838 . . . . 0.0 110.293 166.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.86 -179.81 40.77 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.051 0.834 . . . . 0.0 113.266 -174.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.79 -152.72 47.86 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 122.282 -0.54 . . . . 0.0 113.401 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.0 p -102.64 0.29 33.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -161.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.3 t 71.14 22.83 4.31 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 120.364 1.438 . . . . 0.0 113.556 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 85.77 3.63 85.74 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 120.594 -1.316 . . . . 0.0 113.406 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.92 151.51 89.3 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 118.74 1.27 . . . . 0.0 110.119 166.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -61.96 142.88 94.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.27 1.98 . . . . 0.0 109.865 169.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.66 109.2 3.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 32.1 m -105.72 154.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.225 1.41 . . . . 0.0 110.091 174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -59.72 131.73 51.82 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.64 -13.0 67.09 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.22 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.493 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.9 OUTLIER -56.08 130.67 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.119 1.96 . . . . 0.0 111.558 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.4 t -116.54 130.72 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.515 1.926 . . . . 0.0 108.81 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.31 -175.69 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.0 111.372 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.32 149.36 26.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.484 1.914 . . . . 0.0 111.134 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 4.5 pt-20 -44.79 129.47 5.19 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.789 1.636 . . . . 0.0 114.274 -165.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 162.75 41.53 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.43 2.087 . . . . 0.0 111.949 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -68.34 138.72 55.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.7 mm -103.67 47.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 123.404 1.573 . . . . 0.0 109.739 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.549 0.937 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.865 141.044 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.0 m80 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -67.54 133.66 49.86 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.908 0.883 . . . . 0.0 110.493 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 368' ' ' VAL . 4.0 mp -68.49 -43.94 75.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.207 0.527 . . . . 0.0 112.181 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.786 1.234 . . . . 0.0 112.858 -179.036 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.922 0.868 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 121.791 0.805 . . . . 0.0 110.901 -179.517 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -52.43 129.72 29.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.226 1.376 . . . . 0.0 111.233 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.401 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 62.4 mmt-85 -156.36 146.02 15.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.961 1.305 . . . . 0.0 111.025 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.67 176.9 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.523 2.149 . . . . 0.0 111.432 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -121.02 76.4 30.24 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.535 1.134 . . . . 0.0 109.798 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.01 142.31 38.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.137 2.558 . . . . 0.0 110.517 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.7 t -148.28 145.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.927 1.291 . . . . 0.0 109.351 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 172.88 12.14 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.946 1.298 . . . . 0.0 110.766 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.42 ' CE2' HD12 ' A' ' 455' ' ' ILE . 43.9 m-85 -137.52 127.48 25.76 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.3 1.04 . . . . 0.0 110.042 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.48 104.53 10.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 109.861 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.5 p -70.29 -9.07 54.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 32.8 p -68.96 -19.33 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.169 1.388 . . . . 0.0 112.429 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.39 153.21 96.05 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.996 0.918 . . . . 0.0 112.383 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.39 162.45 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.925 3.083 . . . . 0.0 112.607 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.33 130.47 17.48 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.91 3.074 . . . . 0.0 112.345 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 66.66 39.25 3.71 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 111.833 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -123.42 152.18 41.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 457' ' ' PHE . 15.4 pt -120.84 147.24 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.901 1.68 . . . . 0.0 110.944 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 123.2 45.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.024 1.33 . . . . 0.0 110.289 177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 50.1 t -120.85 104.28 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.02 0.528 . . . . 0.0 110.911 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -72.76 132.86 44.16 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 111.864 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 31.2 t -74.31 141.87 45.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.814 0.816 . . . . 0.0 112.846 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -121.47 16.24 11.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.837 2.455 . . . . 0.0 110.724 166.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 22.3 m -108.7 126.03 52.55 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.156 1.383 . . . . 0.0 108.63 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.1 mt -92.76 140.08 29.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.443 1.497 . . . . 0.0 109.166 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -100.42 144.72 29.08 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 158.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 14.1 mm -128.87 112.16 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 108.574 -172.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -90.96 173.52 38.06 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.02 0.819 . . . . 0.0 112.064 166.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.54 16.45 75.81 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.4 t -73.04 126.33 90.49 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 118.723 1.261 . . . . 0.0 111.335 -165.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.01 132.86 36.01 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.477 2.785 . . . . 0.0 110.233 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.3 mp -67.84 -6.32 20.92 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -92.48 -25.23 18.52 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.69 1.196 . . . . 0.0 113.691 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.6 mtm -77.22 146.12 37.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.41 1.005 . . . . 0.0 112.506 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -122.1 -179.9 4.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.652 1.581 . . . . 0.0 111.841 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -41.68 -44.73 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.829 2.051 . . . . 0.0 114.075 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -77.96 -21.6 50.76 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -73.56 -39.61 64.55 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.349 0.977 . . . . 0.0 110.435 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.85 -46.39 89.43 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.716 168.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.8 76.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.44 1.018 . . . . 0.0 111.698 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.13 -44.09 96.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.108 1.322 . . . . 0.0 114.283 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.7 m -71.23 -34.74 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.388 0.994 . . . . 0.0 111.287 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 394' ' ' PHE . 50.0 mt -87.54 -7.51 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.923 0.889 . . . . 0.0 112.887 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -47.59 96.77 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.346 1.458 . . . . 0.0 114.399 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.59 -7.54 20.37 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.296 1.998 . . . . 0.0 113.31 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -98.45 -38.78 9.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.09 1.356 . . . . 0.0 112.705 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.71 172.75 2.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.145 1.778 . . . . 0.0 113.712 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 123.29 32.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.256 1.422 . . . . 0.0 111.442 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.71 120.25 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.591 0.756 . . . . 0.0 110.314 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -94.77 -41.73 9.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.668 1.187 . . . . 0.0 112.083 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.31 161.99 35.5 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.376 -0.828 . . . . 0.0 112.3 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 305' ' ' LEU . 0.2 OUTLIER -162.69 138.01 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.887 0.875 . . . . 0.0 111.101 176.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.69 88.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.112 1.365 . . . . 0.0 108.018 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.08 137.99 31.94 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.834 -0.541 . . . . 0.0 110.94 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.47 85.85 2.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.824 1.25 . . . . 0.0 110.243 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -57.65 -38.24 74.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.844 0.857 . . . . 0.0 112.562 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 t -56.2 -33.02 64.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.968 1.307 . . . . 0.0 112.571 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -95.75 2.17 53.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.755 1.222 . . . . 0.0 113.87 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 27.57 17.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 113.612 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -133.83 169.26 17.34 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.47 43.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.707 1.203 . . . . 0.0 111.506 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.08 141.55 47.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.757 1.223 . . . . 0.0 108.089 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.8 118.09 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.782 0.719 . . . . 0.0 110.615 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -104.1 120.33 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.666 0.786 . . . . 0.0 112.059 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 19.8 m -95.24 -172.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.975 0.91 . . . . 0.0 110.113 174.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.401 ' CG ' ' HG3' ' A' ' 319' ' ' ARG . 0.2 OUTLIER -68.75 -40.46 79.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.945 1.248 . . . . 0.0 113.949 177.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 60.6 p -148.66 167.45 25.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.192 -0.943 . . . . 0.0 112.717 -164.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.88 91.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.358 167.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -42.07 85.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.004 0.82 . . . . 0.0 112.59 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.21 -51.22 64.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.905 1.282 . . . . 0.0 110.254 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.36 97.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.475 -0.766 . . . . 0.0 112.439 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -62.77 -42.44 99.69 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.929 0.892 . . . . 0.0 111.373 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.39 -34.18 76.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.196 1.362 . . . . 0.0 112.064 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.0 -65.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.717 166.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -50.65 -34.32 25.93 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.596 1.558 . . . . 0.0 114.152 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.51 -40.81 93.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.51 1.524 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -109.2 -27.3 9.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.437 ' CE2' HD23 ' A' ' 359' ' ' LEU . 19.8 t80 -70.41 123.95 22.99 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.463 0.705 . . . . 0.0 111.112 -169.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.86 29.16 18.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.131 1.372 . . . . 0.0 114.047 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -59.85 -36.33 76.62 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.201 -0.937 . . . . 0.0 113.16 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.79 -20.55 60.44 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.764 1.226 . . . . 0.0 112.893 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.54 23.22 65.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.819 1.2 . . . . 0.0 113.663 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -89.97 -33.78 16.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.15 1.38 . . . . 0.0 114.343 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.17 148.38 77.99 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.039 0.936 . . . . 0.0 109.445 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.37 -19.91 24.78 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.502 2.135 . . . . 0.0 112.732 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.75 144.0 35.62 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.62 1.168 . . . . 0.0 112.58 -170.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -119.28 93.38 4.06 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.638 1.175 . . . . 0.0 109.562 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 85.3 m -81.08 125.0 29.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.738 1.215 . . . . 0.0 111.178 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 175.15 9.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.97 2.508 . . . . 0.0 109.852 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -74.5 121.59 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.224 -0.923 . . . . 0.0 111.206 163.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.86 -164.83 30.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.116 1.817 . . . . 0.0 110.581 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.17 137.4 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.343 0.592 . . . . 0.0 111.107 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -99.95 -46.63 1.87 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.751 2.119 . . . . 0.0 109.945 163.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.65 110.26 8.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.375 1.07 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.04 140.83 5.66 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.682 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.62 123.24 9.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.931 3.754 . . . . 0.0 109.393 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -57.48 -45.46 84.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.883 0.473 . . . . 0.0 111.878 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.37 -18.67 63.81 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.1 m -120.99 27.96 8.17 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.086 1.755 . . . . 0.0 112.276 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.22 138.12 32.11 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.233 1.013 . . . . 0.0 111.546 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -121.66 79.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.117 1.367 . . . . 0.0 109.503 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -64.24 -22.3 66.89 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -67.47 -53.5 28.26 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.689 0.677 . . . . 0.0 110.357 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -77.41 -18.37 57.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.92 40.97 8.98 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 124.756 1.17 . . . . 0.0 112.851 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.57 172.45 16.01 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.309 1.055 . . . . 0.0 112.831 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.0 p -143.26 151.37 40.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.362 1.065 . . . . 0.0 110.673 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -110.2 125.61 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.09 123.77 28.66 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.667 -1.158 . . . . 0.0 110.364 -172.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 142.91 43.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.64 1.56 . . . . 0.0 110.457 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 20.6 mtt -58.01 -35.4 71.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.378 1.071 . . . . 0.0 112.973 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -63.51 -18.67 64.05 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 17.4 mmm-85 -97.24 3.2 51.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.589 1.956 . . . . 0.0 113.821 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.28 121.28 35.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.896 0.878 . . . . 0.0 109.747 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.6 p -72.21 -179.28 2.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.488 1.515 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -41.82 99.14 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.635 -0.665 . . . . 0.0 111.217 170.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.66 92.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.395 1.078 . . . . 0.0 111.968 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.54 -52.4 65.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.941 1.296 . . . . 0.0 112.381 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -38.56 85.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.679 -0.638 . . . . 0.0 112.225 173.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -56.11 -41.71 75.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.385 -0.816 . . . . 0.0 111.848 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -70.99 -45.63 63.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.494 1.497 . . . . 0.0 111.733 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 50.2 m -51.16 -35.55 36.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.956 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 5.7 m -90.81 -58.06 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 14.5 m -86.08 -7.38 58.64 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -166.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.46 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -52.86 145.49 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.76 1.163 . . . . 0.0 111.301 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -83.98 -27.24 28.59 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.843 -0.536 . . . . 0.0 111.204 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -125.67 136.88 53.71 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.237 2.215 . . . . 0.0 110.708 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.65 -179.92 32.97 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.001 0.81 . . . . 0.0 113.204 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.38 -150.43 48.45 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.263 -1.14 . . . . 0.0 112.29 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 43.0 p -116.07 17.18 15.91 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -153.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 t 65.26 17.88 11.18 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.947 -1.096 . . . . 0.0 113.25 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.05 59.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.498 1.047 . . . . 0.0 113.788 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -84.73 145.93 45.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.84 1.32 . . . . 0.0 111.338 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.89 107.33 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.057 2.505 . . . . 0.0 109.198 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 131.1 38.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.37 0.605 . . . . 0.0 111.595 -176.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.68 168.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.629 1.572 . . . . 0.0 110.733 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -47.25 127.0 10.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.986 0.915 . . . . 0.0 110.747 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.92 65.86 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.251 -1.305 . . . . 0.0 115.306 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 325' ' ' TYR . 1.7 tp -50.48 133.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 120.239 2.02 . . . . 0.0 111.719 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.23 127.78 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.274 1.829 . . . . 0.0 108.345 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 334' ' ' ILE . 10.5 p90 -152.03 179.52 8.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.174 1.39 . . . . 0.0 111.715 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -102.34 153.09 20.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.706 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -38.11 121.0 1.04 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.606 1.562 . . . . 0.0 114.529 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 160.35 50.18 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.224 1.95 . . . . 0.0 111.728 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.46 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 70.8 m-20 -67.86 127.54 33.19 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.846 1.258 . . . . 0.0 113.907 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.16 46.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 123.415 1.579 . . . . 0.0 110.215 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 N--CA 1.477 0.918 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.681 140.559 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 30.2 m80 . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -72.73 141.02 48.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.54 -31.1 71.6 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.419 1.088 . . . . 0.0 111.661 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 124.898 1.279 . . . . 0.0 109.637 -176.126 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.935 0.874 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 124.145 0.978 . . . . 0.0 111.098 176.384 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.0 m80 . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -53.63 129.72 33.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.788 -1.195 . . . . 0.0 111.72 170.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -156.04 143.54 13.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.194 1.398 . . . . 0.0 110.847 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.84 172.36 14.69 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.672 2.248 . . . . 0.0 111.102 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 83.59 9.36 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 109.867 168.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.47 150.48 63.97 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.296 2.664 . . . . 0.0 110.534 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 10.8 t -144.33 133.41 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 109.662 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.09 167.75 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 110.845 174.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -143.88 121.79 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.971 0.908 . . . . 0.0 110.289 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.72 108.76 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.447 0.699 . . . . 0.0 111.156 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.9 p -69.35 -8.55 47.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -25.19 67.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.651 1.181 . . . . 0.0 112.235 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.53 150.49 95.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.794 0.838 . . . . 0.0 112.068 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.06 161.27 34.17 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.18 3.253 . . . . 0.0 112.539 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.17 134.65 32.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.059 3.173 . . . . 0.0 112.029 -173.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.99 44.53 4.65 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.633 1.573 . . . . 0.0 112.046 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -126.75 153.68 45.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.818 1.247 . . . . 0.0 114.141 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.37 145.74 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.615 1.966 . . . . 0.0 110.697 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -106.77 111.16 23.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.018 1.727 . . . . 0.0 109.863 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.81 97.08 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.194 0.598 . . . . 0.0 110.295 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.45 138.92 57.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.935 0.874 . . . . 0.0 111.706 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 41.4 t -75.48 136.84 40.63 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.191 -0.943 . . . . 0.0 112.577 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 18.82 14.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.51 2.324 . . . . 0.0 111.305 163.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 62.4 m -119.34 133.44 55.72 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.146 1.378 . . . . 0.0 110.293 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.36 134.87 42.66 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.34 1.056 . . . . 0.0 108.817 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.11 120.82 32.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 161.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.9 106.53 20.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -84.24 -178.23 51.49 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 168.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.12 11.78 59.32 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.377 -1.072 . . . . 0.0 115.067 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.01 130.12 91.7 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.965 1.383 . . . . 0.0 110.153 -166.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.94 128.01 18.9 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.923 2.415 . . . . 0.0 109.062 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.1 pp -59.17 -18.7 38.6 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.1 -25.95 31.5 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 9.1 mtm -73.52 146.48 44.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 0.0 112.293 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -118.13 178.97 4.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.115 1.766 . . . . 0.0 111.715 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.83 -36.47 67.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.617 1.167 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -73.88 -30.9 62.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.47 -35.85 81.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.547 1.067 . . . . 0.0 110.93 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 379' ' ' VAL . 1.2 mm? -58.33 -51.27 70.49 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.285 0.493 . . . . 0.0 110.438 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.75 69.65 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.38 -40.09 64.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.46 1.482 . . . . 0.0 112.883 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.0 -36.72 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 111.249 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.519 ' CD1' HG11 ' A' ' 379' ' ' VAL . 36.1 mt -85.99 -8.08 58.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -50.44 75.17 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.08 -7.12 19.49 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.609 2.206 . . . . 0.0 113.128 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -98.69 -37.5 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.107 1.363 . . . . 0.0 112.867 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.16 168.82 3.37 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.541 1.937 . . . . 0.0 114.05 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.08 116.08 22.7 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.787 1.635 . . . . 0.0 112.051 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 97.5 t -87.88 113.48 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.133 0.973 . . . . 0.0 109.853 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.32 -37.84 15.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.502 1.121 . . . . 0.0 111.675 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.36 150.13 35.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 0.0 111.656 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.06 141.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.899 0.88 . . . . 0.0 110.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.91 105.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.355 1.062 . . . . 0.0 108.303 167.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.57 124.52 41.86 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.275 0.559 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -112.91 84.11 1.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.972 1.709 . . . . 0.0 109.258 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.71 -28.59 65.94 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.795 1.238 . . . . 0.0 111.648 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 97.2 p -61.01 -31.83 71.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.962 1.705 . . . . 0.0 113.853 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -110.28 6.82 22.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.113 1.765 . . . . 0.0 113.099 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? 56.98 40.33 28.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.995 1.318 . . . . 0.0 111.314 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -123.7 151.61 42.96 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.28 1.832 . . . . 0.0 113.464 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.25 128.28 25.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.13 1.372 . . . . 0.0 111.289 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -81.75 131.62 35.27 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.989 -1.069 . . . . 0.0 108.853 161.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 359' ' ' LEU . 70.3 t -129.84 117.24 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.915 0.886 . . . . 0.0 109.707 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -104.24 116.13 31.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.928 1.291 . . . . 0.0 110.273 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.92 -179.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.529 0.732 . . . . 0.0 109.557 167.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 383' ' ' SER . 0.3 OUTLIER -64.02 -49.55 71.98 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . 0.409 ' HB3' ' CE2' ' A' ' 382' ' ' TYR . 82.2 p -139.15 165.95 25.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.216 1.008 . . . . 0.0 112.941 -163.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -42.77 93.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.838 167.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -43.02 91.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.909 0.777 . . . . 0.0 112.277 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.5 -48.18 70.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.079 0.551 . . . . 0.0 111.763 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.2 95.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.162 0.892 . . . . 0.0 112.917 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -64.37 -40.8 96.53 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.784 0.834 . . . . 0.0 111.747 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.44 -35.33 77.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.473 1.033 . . . . 0.0 111.654 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.2 -65.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 119.043 -0.503 . . . . 0.0 110.524 166.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.3 mt -49.46 -35.78 20.6 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.323 1.449 . . . . 0.0 114.624 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.14 -33.55 71.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.275 1.43 . . . . 0.0 113.794 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -112.18 -28.28 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.215 1.006 . . . . 0.0 113.121 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.14 123.5 21.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.52 0.728 . . . . 0.0 111.202 -170.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.02 30.7 18.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.414 1.486 . . . . 0.0 114.121 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -33.98 76.76 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.47 -19.68 55.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.536 1.134 . . . . 0.0 112.883 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.2 22.69 60.35 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.817 1.199 . . . . 0.0 113.686 -173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.9 -32.93 17.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.13 1.372 . . . . 0.0 114.495 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.61 148.4 73.12 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.118 0.967 . . . . 0.0 109.586 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.83 -32.2 7.57 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.684 2.256 . . . . 0.0 112.249 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.36 149.61 50.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.852 1.261 . . . . 0.0 112.066 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.07 102.14 7.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.581 1.153 . . . . 0.0 110.718 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.6 m -80.18 124.58 28.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.817 1.247 . . . . 0.0 110.776 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -132.64 172.21 12.82 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.633 1.973 . . . . 0.0 109.939 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.55 121.67 20.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.062 -1.023 . . . . 0.0 111.295 166.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.15 -166.84 19.62 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.626 1.584 . . . . 0.0 110.052 167.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.5 p -165.53 136.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.323 0.649 . . . . 0.0 111.628 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.63 -47.09 3.29 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.34 1.924 . . . . 0.0 111.249 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -111.19 93.07 4.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.082 0.941 . . . . 0.0 112.254 173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.91 121.05 1.12 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.319 -1.267 . . . . 0.0 113.901 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 125.37 10.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.019 3.146 . . . . 0.0 109.5 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.33 -44.07 88.52 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.83 -12.44 59.97 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 53.5 m -117.71 12.67 14.02 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.881 1.672 . . . . 0.0 112.901 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 140.82 31.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.348 1.459 . . . . 0.0 111.926 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -123.5 86.35 2.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.65 1.58 . . . . 0.0 109.137 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.62 -20.93 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -69.72 -52.52 24.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.507 0.594 . . . . 0.0 110.368 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -79.53 -16.17 56.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.94 43.33 14.36 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.693 1.139 . . . . 0.0 112.772 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.23 167.08 31.11 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.573 1.187 . . . . 0.0 113.529 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.05 146.09 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.891 -1.131 . . . . 0.0 110.82 171.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -109.67 94.25 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.43 124.15 56.28 Favored Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.094 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.31 147.67 42.28 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.826 1.684 . . . . 0.0 110.998 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.5 mmt -57.82 -36.58 72.44 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.264 1.426 . . . . 0.0 112.363 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -68.24 -11.94 60.18 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -107.11 12.21 28.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.297 1.839 . . . . 0.0 113.312 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.84 135.49 49.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.544 1.138 . . . . 0.0 109.87 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.3 p -79.85 175.1 10.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 110.974 171.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.31 -45.9 87.16 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.523 -0.736 . . . . 0.0 110.763 171.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.15 90.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.648 1.179 . . . . 0.0 112.829 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.24 -51.22 70.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.147 0.979 . . . . 0.0 111.984 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.39 -37.61 80.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.33 0.652 . . . . 0.0 110.953 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -51.68 -52.41 48.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.861 1.264 . . . . 0.0 110.828 173.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -67.19 -41.98 84.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.22 1.373 . . . . 0.0 111.821 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 63.4 m -55.65 -28.63 56.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.768 -1.11 . . . . 0.0 112.802 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.05 -44.5 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.901 1.228 . . . . 0.0 113.945 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 31.2 m -94.68 -11.29 29.47 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.15 143.93 51.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.898 1.226 . . . . 0.0 111.839 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -72.35 -42.73 64.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.675 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -112.12 140.61 46.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.698 1.599 . . . . 0.0 110.98 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.4 176.8 25.35 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.128 -171.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.01 -164.6 51.62 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 122.023 -0.692 . . . . 0.0 113.252 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.7 p -106.87 18.96 21.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -157.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 p 69.69 13.54 8.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.563 1.145 . . . . 0.0 114.027 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 92.39 2.0 68.48 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.063 1.316 . . . . 0.0 113.504 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -67.11 150.52 97.87 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.86 1.33 . . . . 0.0 110.426 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.33 142.3 90.62 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.4 2.066 . . . . 0.0 110.215 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.7 114.87 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.04 159.23 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.614 1.566 . . . . 0.0 110.184 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 97.9 m -56.41 130.74 46.07 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.849 0.46 . . . . 0.0 109.905 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.42 84.4 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.351 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.24 137.19 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.021 1.41 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.03 132.68 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.262 1.825 . . . . 0.0 109.342 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -158.07 171.3 20.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.469 1.507 . . . . 0.0 110.79 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.07 142.06 27.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.809 0.444 . . . . 0.0 111.302 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.68 126.12 2.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.212 1.405 . . . . 0.0 114.499 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.76 166.22 30.57 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.603 3.535 . . . . 0.0 112.442 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -66.65 142.84 57.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.789 1.236 . . . . 0.0 113.897 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.76 52.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.244 1.497 . . . . 0.0 109.753 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.791 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.713 138.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.7 m80 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -75.92 142.6 42.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.733 1.213 . . . . 0.0 112.462 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.533 0.733 . . . . 0.0 112.023 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 CA--C 1.556 1.206 0 C-N-CA 125.152 1.381 . . . . 0.0 111.95 179.624 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.383 0.611 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.842 0.857 . . . . 0.0 110.779 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.358 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -55.02 130.99 43.86 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.875 1.671 . . . . 0.0 112.439 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -156.3 153.84 26.02 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.111 1.765 . . . . 0.0 111.352 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.55 168.06 24.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.174 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 81.07 4.2 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.513 1.125 . . . . 0.0 109.604 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.05 147.34 33.6 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.192 2.595 . . . . 0.0 111.035 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.6 t -147.28 137.88 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.351 1.46 . . . . 0.0 108.444 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.05 167.79 19.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.585 1.554 . . . . 0.0 110.746 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -141.57 122.82 14.8 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.036 -1.04 . . . . 0.0 111.064 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -114.4 101.16 8.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.427 1.491 . . . . 0.0 109.921 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.4 p -67.04 -14.12 62.59 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.358 1.063 . . . . 0.0 113.731 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -10.52 59.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.11 1.764 . . . . 0.0 113.908 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.39 156.99 80.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 119.88 1.218 . . . . 0.0 113.312 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.57 163.47 32.58 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.224 3.283 . . . . 0.0 113.293 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.68 134.67 24.49 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.212 3.275 . . . . 0.0 112.627 -172.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.68 34.24 12.41 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.148 1.379 . . . . 0.0 112.476 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -121.3 154.31 36.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.935 1.294 . . . . 0.0 114.401 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 pt -124.61 157.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.869 1.668 . . . . 0.0 111.891 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.58 118.9 37.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.865 1.266 . . . . 0.0 110.613 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 457' ' ' PHE . 48.7 t -112.74 107.42 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.604 0.638 . . . . 0.0 110.451 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.1 132.27 45.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 111.148 167.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.6 t -67.18 138.9 57.34 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.897 0.856 . . . . 0.0 112.064 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.17 21.13 8.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.44 2.696 . . . . 0.0 109.805 168.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 48.3 m -125.67 132.87 52.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.3 1.44 . . . . 0.0 109.014 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.51 133.41 46.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.66 1.584 . . . . 0.0 109.443 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -86.24 126.31 34.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 163.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 17.4 mm -114.67 107.46 22.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.81 170.08 47.45 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 123.168 0.414 . . . . 0.0 112.496 167.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.96 19.56 79.76 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.35 118.36 71.65 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.115 -171.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.39 147.87 47.69 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.291 2.661 . . . . 0.0 110.565 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 348' ' ' LEU . 2.8 mp -65.23 -18.61 65.45 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.28 -26.63 62.05 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.509 1.124 . . . . 0.0 113.381 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 12.4 mtm -75.46 152.55 37.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.6 1.091 . . . . 0.0 112.286 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -133.34 -177.67 4.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.231 2.212 . . . . 0.0 111.127 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -55.59 -39.9 71.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 112.144 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -79.14 -14.91 58.82 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.31 -40.0 52.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.161 1.346 . . . . 0.0 110.515 168.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 355' ' ' LEU . 4.1 mm? -61.33 -51.16 70.0 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.454 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.31 66.94 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.814 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -70.16 -47.4 61.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.013 1.278 . . . . 0.0 114.172 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.22 -32.37 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.583 1.538 . . . . 0.0 111.524 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 390' ' ' VAL . 39.5 mt -87.09 -11.51 49.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.072 0.949 . . . . 0.0 113.102 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -47.16 -49.1 53.16 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 126.224 1.809 . . . . 0.0 115.076 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.45 -3.31 13.51 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.199 1.933 . . . . 0.0 113.515 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.56 -36.15 7.61 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.611 1.565 . . . . 0.0 112.747 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.17 165.94 7.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.718 2.007 . . . . 0.0 112.741 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.52 100.34 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.866 1.666 . . . . 0.0 110.466 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.23 126.42 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.583 0.753 . . . . 0.0 109.835 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -95.71 -32.07 12.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.125 1.37 . . . . 0.0 112.419 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 42.3 t -152.83 155.72 37.64 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.747 1.158 . . . . 0.0 110.997 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 55.3 t -146.68 131.32 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.233 1.013 . . . . 0.0 109.324 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.09 107.93 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.35 117.08 33.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.193 0.597 . . . . 0.0 110.339 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -100.68 84.24 2.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 109.523 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.49 -38.81 69.62 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.405 1.482 . . . . 0.0 111.07 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 11.9 m -62.25 -21.82 65.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.826 2.05 . . . . 0.0 114.736 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -113.0 6.88 17.92 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.678 1.591 . . . . 0.0 112.484 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.2 mttt 52.61 35.06 17.15 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 126.562 1.945 . . . . 0.0 113.744 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -127.96 153.52 46.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.105 1.362 . . . . 0.0 113.008 -169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -134.92 131.89 37.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.814 0.846 . . . . 0.0 111.986 162.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -83.25 121.65 27.39 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.49 125.83 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.392 1.477 . . . . 0.0 108.692 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -114.61 115.51 27.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.136 1.374 . . . . 0.0 110.199 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.67 -166.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.877 0.871 . . . . 0.0 110.155 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -48.83 66.38 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.196 1.362 . . . . 0.0 113.197 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.9 p -152.15 173.04 15.43 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -160.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -45.82 80.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.057 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -53.85 -42.17 68.26 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.239 0.927 . . . . 0.0 112.674 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.28 -43.74 49.58 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.01 92.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.038 1.29 . . . . 0.0 113.011 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.52 -40.96 96.6 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.259 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.97 -31.63 72.0 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.81 1.186 . . . . 0.0 112.253 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 359' ' ' LEU . 9.7 t -63.62 -64.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.324 164.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.81 -32.12 42.49 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -74.54 -23.86 58.86 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.764 1.626 . . . . 0.0 113.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -120.91 -28.49 4.8 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.3 t80 -72.35 122.45 21.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.959 0.904 . . . . 0.0 111.378 -169.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 24.5 t30 59.5 29.11 18.64 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.531 1.933 . . . . 0.0 114.861 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -55.88 -34.34 65.42 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.746 -1.221 . . . . 0.0 113.646 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -79.29 -17.13 55.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 113.603 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 11.35 83.33 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.117 1.341 . . . . 0.0 113.728 -173.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -84.49 -31.97 24.21 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.087 1.755 . . . . 0.0 115.073 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.16 152.07 76.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.679 0.792 . . . . 0.0 109.929 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.86 -18.04 24.98 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.258 1.972 . . . . 0.0 113.011 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.99 150.72 23.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -123.41 83.04 2.08 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 109.907 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.3 m -72.39 122.78 21.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.066 1.746 . . . . 0.0 110.602 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 173.47 11.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.218 2.207 . . . . 0.0 109.375 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -66.87 123.69 20.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.168 -0.957 . . . . 0.0 111.205 162.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.85 -164.1 21.43 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 126.191 1.853 . . . . 0.0 109.663 163.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.11 134.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.66 0.784 . . . . 0.0 111.376 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -93.99 -38.87 5.03 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.182 1.849 . . . . 0.0 111.641 167.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -125.99 105.64 9.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.621 2.368 . . . . 0.0 113.475 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.96 137.68 3.97 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 118.472 -1.182 . . . . 0.0 114.567 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.37 132.26 16.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.878 3.719 . . . . 0.0 110.842 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -21.3 61.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.75 -21.42 37.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.807 1.185 . . . . 0.0 113.828 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 54.1 m -124.47 31.12 5.81 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.854 1.661 . . . . 0.0 111.693 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 19.4 t -84.83 138.97 32.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.786 1.234 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -125.69 86.8 2.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.621 1.569 . . . . 0.0 109.073 165.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -67.35 -14.77 63.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.74 -46.96 28.03 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.092 1.315 . . . . 0.0 110.426 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -81.26 -14.37 57.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 75.68 44.39 20.66 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.342 0.972 . . . . 0.0 112.919 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.48 174.5 12.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.526 1.163 . . . . 0.0 112.79 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 56.7 p -147.35 147.62 30.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.354 1.062 . . . . 0.0 111.114 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.12 124.71 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.575 HG21 HD21 ' A' ' 430' ' ' LEU . 1.1 mt -118.98 118.42 32.96 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 119.635 1.107 . . . . 0.0 111.743 -172.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -72.71 128.99 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 111.498 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -64.69 -23.93 67.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.859 1.263 . . . . 0.0 113.228 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.43 -24.4 67.61 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.835 1.198 . . . . 0.0 114.024 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -1.16 13.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.284 1.434 . . . . 0.0 114.562 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 425' ' ' ILE . 55.4 mt -61.73 136.48 58.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.163 0.892 . . . . 0.0 110.001 168.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 27.8 p -72.7 174.22 7.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.759 0.79 . . . . 0.0 111.293 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.97 -39.86 87.08 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.778 -0.576 . . . . 0.0 111.869 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.75 -36.62 65.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.242 0.617 . . . . 0.0 112.313 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -55.59 -60.03 4.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 111.283 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.71 -39.91 82.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.907 1.283 . . . . 0.0 112.25 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -47.92 70.67 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.088 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -66.12 -47.57 73.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.805 1.184 . . . . 0.0 110.972 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 13.1 m -52.33 -40.55 62.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.388 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.67 -44.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.7 t -97.23 -3.06 41.47 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -166.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -61.03 145.08 52.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.825 -1.172 . . . . 0.0 112.846 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.75 -28.74 36.4 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.827 1.251 . . . . 0.0 110.468 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -132.37 143.76 50.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.643 2.777 . . . . 0.0 110.75 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 175.53 18.51 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 123.704 0.669 . . . . 0.0 113.833 -171.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 73.52 -161.58 54.22 Favored Glycine 0 CA--C 1.546 1.973 0 O-C-N 121.501 -1.0 . . . . 0.0 114.424 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 21.1 p -93.36 3.07 56.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.962 2.105 . . . . 0.0 116.418 -160.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.4 m 78.05 6.31 2.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.83 1.252 . . . . 0.0 113.036 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.26 5.33 59.36 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.014 1.292 . . . . 0.0 113.438 -169.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -71.92 153.45 92.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.578 1.189 . . . . 0.0 109.834 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.58 146.97 93.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.086 2.524 . . . . 0.0 110.897 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 54.5 mt -70.66 104.32 2.8 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.65 158.21 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.045 1.338 . . . . 0.0 111.647 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.0 m -59.05 131.65 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.09 -1.15 79.82 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.85 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.718 1.759 . . . . 0.0 112.683 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.44 137.06 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.348 2.259 . . . . 0.0 109.452 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' PHE . . . . . 0.413 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.5 p90 -164.55 178.02 7.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.602 1.161 . . . . 0.0 111.715 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -97.54 151.69 19.78 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.107 . . . . 0.0 110.109 169.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -44.98 130.16 5.39 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -167.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.81 168.04 24.92 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.927 3.085 . . . . 0.0 111.175 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 67.4 m-20 -74.18 120.0 19.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.59 46.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.183 1.468 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.474 0.756 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 142.125 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.75 111.09 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.494 1.043 . . . . 0.0 110.327 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 70.06 -177.66 31.37 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.684 1.135 . . . . 0.0 113.821 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -109.25 155.99 40.12 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 111.339 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.75 -79.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.488 3.459 . . . . 0.0 111.444 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.2 -31.15 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.571 1.949 . . . . 0.0 112.513 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . 0.25 5.0 p 72.22 5.91 5.41 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 128.96 2.904 . . . . 0.0 115.191 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.99 -30.37 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 128.162 2.585 . . . . 0.0 113.003 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.252 0.0 OUTLIER 58.07 -156.03 0.33 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.474 1.91 . . . . 0.0 111.724 176.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.56 -25.53 7.25 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 124.802 1.192 . . . . 0.0 115.284 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 10.8 t -59.83 -40.71 89.37 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.413 1.107 . . . . 0.0 111.955 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -109.54 -73.51 0.68 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.315 1.446 . . . . 0.0 110.482 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.72 -178.66 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.532 1.533 . . . . 0.0 111.49 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -79.79 22.14 0.5 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -168.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -72.83 138.68 46.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.595 1.158 . . . . 0.0 111.885 171.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.25 -42.78 99.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.913 0.885 . . . . 0.0 110.35 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.6 160.65 34.08 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.941 1.296 . . . . 0.0 112.55 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.36 -158.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.486 3.457 . . . . 0.0 111.296 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -49.06 -40.25 30.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.678 1.191 . . . . 0.0 113.623 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 41.12 -150.04 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.164 2.186 . . . . 0.0 113.527 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.78 141.58 10.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 110.567 162.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -73.33 66.21 0.91 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 120.675 -1.265 . . . . 0.0 110.725 167.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 6.2 m -111.28 153.69 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 127.312 2.245 . . . . 0.0 111.783 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 61.1 p -62.27 -27.1 68.78 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.26 -20.34 60.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 173.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.74 122.27 80.19 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.379 1.072 . . . . 0.0 109.888 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.49 -16.24 42.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.448 2.099 . . . . 0.0 113.011 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -73.86 -0.52 16.2 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 167.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -50.39 135.57 21.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.097 1.317 . . . . 0.0 112.099 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -136.37 151.07 72.48 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 124.029 0.932 . . . . 0.0 110.72 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.81 165.98 21.77 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.014 2.476 . . . . 0.0 110.632 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.38 79.41 1.66 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 166.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.5 115.77 4.21 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.443 2.095 . . . . 0.0 108.451 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.01 142.06 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.761 1.224 . . . . 0.0 109.317 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.68 169.04 18.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.489 1.116 . . . . 0.0 109.92 174.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -140.6 111.18 6.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.811 0.845 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.61 126.78 53.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.796 0.838 . . . . 0.0 111.794 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.4 p -73.76 -7.63 52.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -18.58 65.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.508 2.323 . . . . 0.0 111.915 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.6 153.04 81.11 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.634 1.174 . . . . 0.0 113.361 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.12 165.1 29.57 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.559 3.506 . . . . 0.0 113.047 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.35 135.6 27.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.399 3.399 . . . . 0.0 112.776 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.28 42.92 14.36 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.694 1.597 . . . . 0.0 111.465 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -127.24 153.04 46.61 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.6 pt -126.2 147.75 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.476 1.91 . . . . 0.0 109.966 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 133.1 51.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.203 1.401 . . . . 0.0 111.331 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.01 102.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.185 0.594 . . . . 0.0 110.996 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -68.62 136.18 52.59 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.396 1.079 . . . . 0.0 111.626 166.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.4 t -78.37 136.37 37.66 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.354 -0.841 . . . . 0.0 111.364 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -103.03 12.3 36.17 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.968 1.707 . . . . 0.0 109.918 162.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 52.5 m -109.98 130.71 55.49 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 126.073 1.749 . . . . 0.0 110.127 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 mt -96.01 136.61 36.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.593 1.557 . . . . 0.0 108.932 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -94.83 139.64 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 161.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.2 mm -124.95 107.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.79 1.236 . . . . 0.0 108.209 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.71 176.48 46.17 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 123.882 0.753 . . . . 0.0 111.868 168.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.18 17.4 72.0 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.016 0.766 . . . . 0.0 115.016 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.3 122.15 86.65 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 118.507 1.153 . . . . 0.0 110.525 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -72.12 137.6 29.22 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.871 2.38 . . . . 0.0 108.931 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.4 mp -64.73 -17.43 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.59 -25.66 57.19 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 47.8 mtm -78.46 139.76 38.68 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.861 0.838 . . . . 0.0 112.238 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -116.47 -173.75 2.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.744 2.018 . . . . 0.0 111.657 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -54.07 -48.44 70.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.196 1.798 . . . . 0.0 112.703 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -76.19 -18.4 59.09 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.01 -40.37 71.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.059 1.299 . . . . 0.0 110.683 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.2 mm? -60.01 -49.1 78.99 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.817 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.07 71.3 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.923 0.783 . . . . 0.0 112.95 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.52 -44.82 70.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.528 1.131 . . . . 0.0 113.964 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.97 -33.89 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.699 1.136 . . . . 0.0 110.683 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 394' ' ' PHE . 51.5 mt -87.02 -10.59 52.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.037 0.935 . . . . 0.0 113.187 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -48.31 -48.96 64.78 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.669 1.588 . . . . 0.0 114.674 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.34 -6.98 17.66 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.217 1.945 . . . . 0.0 113.375 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.68 -39.99 8.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.47 1.508 . . . . 0.0 112.38 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.39 169.89 3.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.13 1.772 . . . . 0.0 112.712 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.54 125.5 32.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.553 0.741 . . . . 0.0 109.835 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.67 128.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.621 0.768 . . . . 0.0 110.276 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -91.8 -43.38 9.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.123 1.369 . . . . 0.0 112.538 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.92 159.2 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 111.623 -172.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.0 p -160.79 133.7 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.731 -0.606 . . . . 0.0 111.609 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.7 103.31 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.73 133.11 43.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.794 0.837 . . . . 0.0 110.224 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.57 89.47 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.821 1.248 . . . . 0.0 109.565 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -60.24 -38.32 83.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.765 1.226 . . . . 0.0 111.711 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.0 t -58.9 -30.62 67.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.765 1.626 . . . . 0.0 113.23 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.74 -3.15 42.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.359 1.463 . . . . 0.0 113.13 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 58.8 30.85 20.6 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.297 1.839 . . . . 0.0 113.326 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -133.82 169.3 17.26 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.45 42.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.013 1.325 . . . . 0.0 111.159 164.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.28 136.76 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 45.1 t -134.72 113.3 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.428 0.691 . . . . 0.0 110.78 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -92.99 122.89 35.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 0.0 109.734 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.63 164.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.088 0.955 . . . . 0.0 109.97 169.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -73.76 -22.34 59.89 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 p -134.38 154.18 51.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.762 1.165 . . . . 0.0 113.445 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -59.43 -41.75 90.29 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.148 0.979 . . . . 0.0 111.493 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -37.68 88.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.401 0.68 . . . . 0.0 111.853 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.42 -50.65 72.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.752 1.221 . . . . 0.0 111.073 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.03 95.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.919 0.781 . . . . 0.0 112.027 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.98 -42.12 98.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.954 0.502 . . . . 0.0 112.138 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -63.45 -35.02 79.06 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.256 0.935 . . . . 0.0 112.26 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.23 -64.35 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.819 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -49.27 -36.77 21.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.893 1.277 . . . . 0.0 114.153 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.09 -35.88 80.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.918 1.287 . . . . 0.0 113.476 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -111.79 -25.6 9.39 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 18.1 t80 -72.0 124.17 24.36 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.537 0.735 . . . . 0.0 111.189 -169.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 61.89 30.17 18.08 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.263 1.425 . . . . 0.0 113.904 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -58.33 -36.07 72.84 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.806 -1.184 . . . . 0.0 113.385 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.569 1.148 . . . . 0.0 113.062 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.48 61.55 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.88 1.228 . . . . 0.0 113.737 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.16 -34.68 14.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.379 1.472 . . . . 0.0 114.389 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 24.8 mt -73.67 148.52 87.66 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.099 0.96 . . . . 0.0 109.457 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.71 -29.45 10.61 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.347 2.031 . . . . 0.0 112.181 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.87 139.97 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.959 1.704 . . . . 0.0 111.715 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.26 103.0 10.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.048 1.339 . . . . 0.0 110.08 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.8 m -81.75 124.27 29.48 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.883 1.273 . . . . 0.0 110.571 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -133.39 175.37 9.47 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.602 2.361 . . . . 0.0 109.248 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -73.51 123.47 24.0 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.25 -0.906 . . . . 0.0 110.889 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -100.66 -164.73 28.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 163.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.49 122.07 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.078 0.951 . . . . 0.0 109.234 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -84.73 -47.4 5.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 162.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.68 120.11 22.32 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.808 0.843 . . . . 0.0 111.732 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.06 131.73 1.54 Allowed Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.529 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.84 130.94 16.33 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 125.161 3.907 . . . . 0.0 110.405 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -36.19 79.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -72.32 -18.79 61.75 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.6 m -124.16 29.9 6.26 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.906 1.683 . . . . 0.0 111.982 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.7 155.55 25.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -139.71 73.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.802 1.641 . . . . 0.0 109.446 167.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -63.07 -18.62 63.57 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.47 -52.42 32.61 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.109 -0.994 . . . . 0.0 111.077 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -80.78 -17.19 51.68 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 84.43 38.33 9.96 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.964 1.269 . . . . 0.0 113.034 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -145.59 169.7 17.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.63 1.215 . . . . 0.0 112.374 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 46.4 m -141.13 157.13 45.7 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.941 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.53 127.68 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.67 125.51 28.02 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 117.405 -1.283 . . . . 0.0 111.229 -170.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.86 132.21 18.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.078 1.852 . . . . 0.0 110.362 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -20.47 61.64 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.635 1.174 . . . . 0.0 113.735 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -26.26 65.55 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 119.34 0.973 . . . . 0.0 113.208 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.0 -24.53 16.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.757 1.223 . . . . 0.0 112.802 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.5 116.83 4.62 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.4 p -65.55 176.54 1.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.738 1.215 . . . . 0.0 110.733 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.37 -41.3 93.44 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.502 -0.749 . . . . 0.0 110.99 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.41 -40.99 85.62 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 112.541 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -58.35 -52.55 65.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.889 1.276 . . . . 0.0 111.993 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -66.84 -37.54 84.69 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.771 -0.58 . . . . 0.0 111.566 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -47.91 73.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.212 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.41 -43.35 77.4 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.269 1.395 . . . . 0.0 111.533 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 66.8 m -53.52 -35.8 61.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.59 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.5 m -90.63 -43.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -99.51 -12.91 19.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.289 1.436 . . . . 0.0 114.489 -166.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.79 142.16 46.49 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.162 -0.961 . . . . 0.0 111.062 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -80.82 -45.56 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.509 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -100.31 131.4 46.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.297 1.039 . . . . 0.0 110.181 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.71 -176.57 45.58 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.381 0.991 . . . . 0.0 114.028 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.31 -156.44 52.99 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.417 -0.392 . . . . 0.0 112.265 -170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.8 p -99.43 -4.96 30.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 77.95 17.65 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.788 1.635 . . . . 0.0 113.317 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.44 56.04 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.122 1.344 . . . . 0.0 113.884 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 153.53 95.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.726 1.263 . . . . 0.0 111.593 172.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.84 143.93 81.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.863 2.376 . . . . 0.0 110.423 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 40.6 mt -70.75 110.53 5.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.279 0.562 . . . . 0.0 109.618 170.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.11 152.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 110.235 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.1 m -53.35 130.0 33.7 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.65 0.78 . . . . 0.0 109.71 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.52 -5.6 80.32 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.865 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.45 134.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.807 1.304 . . . . 0.0 111.514 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.5 t -119.99 140.41 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.752 2.021 . . . . 0.0 108.734 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -161.83 -179.61 7.33 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.691 1.196 . . . . 0.0 111.797 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -92.13 150.3 21.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.212 . . . . 0.0 110.842 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -51.16 132.21 31.69 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 124.553 1.141 . . . . 0.0 113.703 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.26 148.45 74.39 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.957 1.771 . . . . 0.0 109.253 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -52.96 148.29 7.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.174 0.99 . . . . 0.0 112.858 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -108.09 50.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 123.159 1.456 . . . . 0.0 110.103 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -179.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.6 142.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.74 -48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.943 -1.098 . . . . 0.0 110.929 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.29 -177.49 20.44 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.86 -163.62 0.27 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.775 0.83 . . . . 0.0 111.931 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.64 -126.65 5.66 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.32 1.438 . . . . 0.0 111.164 167.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.489 1.506 0 C-N-CA 128.672 2.789 . . . . 0.0 111.898 174.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.99 138.03 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 119.446 1.021 . . . . 0.0 110.339 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -85.57 31.84 3.79 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.423 1.487 . . . . 0.0 114.133 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . 70.25 168.4 0.12 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 127.462 2.305 . . . . 0.0 111.974 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.23 -155.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.368 2.712 . . . . 0.0 111.503 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -57.17 -31.16 65.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.519 1.128 . . . . 0.0 113.457 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 70.9 p 46.7 27.18 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 128.731 2.812 . . . . 0.0 114.918 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -75.18 -21.28 58.85 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 112.918 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -48.83 -32.91 9.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.59 2.356 . . . . 0.0 115.67 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.16 73.29 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.218 0.913 . . . . 0.0 114.266 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.86 -146.65 0.26 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.438 1.895 . . . . 0.0 109.401 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -64.18 159.95 19.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.14 1.376 . . . . 0.0 112.895 168.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.3 163.47 0.24 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.95 1.7 . . . . 0.0 112.844 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -143.9 0.21 1.07 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -64.73 133.28 51.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.708 1.203 . . . . 0.0 111.622 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 356' ' ' ALA . 10.9 mp -69.6 -20.13 63.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.006 1.322 . . . . 0.0 111.355 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -115.53 162.71 23.53 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.913 2.085 . . . . 0.0 112.183 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.91 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.739 3.626 . . . . 0.0 111.686 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.16 56.05 0.45 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.224 1.409 . . . . 0.0 111.481 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.04 135.24 57.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.084 1.354 . . . . 0.0 110.858 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.0 133.33 34.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.333 0.653 . . . . 0.0 110.102 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -74.84 70.48 1.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 O-C-N 120.665 -1.272 . . . . 0.0 110.744 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.25 160.7 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 127.568 2.347 . . . . 0.0 111.178 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 39.8 t -51.12 -35.23 34.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.36 -27.11 67.63 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.246 -0.909 . . . . 0.0 113.327 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -80.11 124.36 82.89 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.015 1.326 . . . . 0.0 110.334 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.34 -19.48 61.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.529 2.153 . . . . 0.0 113.241 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.28 3.79 19.82 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.765 1.226 . . . . 0.0 113.757 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -53.68 117.94 3.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.181 1.392 . . . . 0.0 112.729 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.49 143.72 50.4 Favored Pre-proline 0 N--CA 1.473 0.683 0 C-N-CA 125.252 1.421 . . . . 0.0 110.491 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.3 164.85 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.294 2.663 . . . . 0.0 111.217 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 83.74 13.71 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.251 1.02 . . . . 0.0 109.019 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.98 116.37 4.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.531 2.154 . . . . 0.0 108.218 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.8 t -112.35 129.04 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.789 0.835 . . . . 0.0 109.276 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.1 170.26 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 111.0 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -138.47 121.81 17.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.445 1.098 . . . . 0.0 110.082 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -122.14 105.89 10.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.08 0.952 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -7.66 16.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.547 1.539 . . . . 0.0 113.723 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.87 -24.5 64.34 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.788 1.235 . . . . 0.0 112.375 172.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.99 150.14 96.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.633 0.773 . . . . 0.0 111.927 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.67 162.0 33.34 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.138 3.225 . . . . 0.0 112.945 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 133.53 27.24 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.963 3.109 . . . . 0.0 112.49 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.03 26.88 7.19 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.399 1.88 . . . . 0.0 113.015 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -112.58 153.64 27.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.48 151.23 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.019 2.128 . . . . 0.0 109.678 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -114.41 131.8 56.45 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.127 1.33 . . . . 0.0 111.727 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.9 106.57 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 110.794 -171.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.22 129.3 39.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.875 1.27 . . . . 0.0 111.34 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.5 t -69.41 135.1 49.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.776 -0.577 . . . . 0.0 111.973 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.412 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 32.9 mtm105 -105.37 15.31 27.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.659 1.584 . . . . 0.0 110.487 162.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 17.5 m -121.16 143.63 49.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.008 1.323 . . . . 0.0 112.054 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -111.1 136.55 49.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.829 2.052 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -89.96 137.46 32.32 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 166.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.82 117.36 52.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 108.058 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -99.64 174.61 27.08 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.709 1.147 . . . . 0.0 111.012 164.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.44 27.17 70.15 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 119.132 -0.815 . . . . 0.0 114.031 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.22 106.02 18.06 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.504 1.152 . . . . 0.0 110.567 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.97 146.52 87.81 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.798 2.332 . . . . 0.0 111.037 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.49 -19.24 64.58 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.69 -29.6 68.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.078 0.951 . . . . 0.0 112.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 17.6 mtm -85.62 151.8 23.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.037 0.935 . . . . 0.0 112.667 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -175.49 4.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.208 1.403 . . . . 0.0 111.581 -175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -50.33 -35.56 28.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.387 1.875 . . . . 0.0 113.085 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -78.01 -21.24 51.08 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.9 -36.09 62.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.844 1.202 . . . . 0.0 110.639 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 355' ' ' LEU . 3.8 mm? -60.58 -46.94 88.36 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.725 0.693 . . . . 0.0 110.772 169.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 305' ' ' LEU . . . -53.86 -44.8 70.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.545 0.612 . . . . 0.0 112.437 169.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -69.49 -41.19 76.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.695 1.198 . . . . 0.0 113.456 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.6 m -73.75 -34.69 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.898 0.772 . . . . 0.0 111.864 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 379' ' ' VAL . 66.7 mt -86.3 -12.6 49.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.354 1.062 . . . . 0.0 113.397 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -48.3 71.87 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.087 1.755 . . . . 0.0 115.309 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.69 -7.44 17.62 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.66 2.24 . . . . 0.0 113.869 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -96.73 -39.87 9.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.281 1.432 . . . . 0.0 112.401 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.43 171.86 5.35 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.919 1.688 . . . . 0.0 112.747 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.39 130.8 34.38 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.366 0.666 . . . . 0.0 109.559 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.34 127.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 109.601 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.01 -46.63 10.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 111.699 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 45.2 t -154.57 152.03 29.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 -169.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.9 134.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.42 104.11 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 166.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.16 139.07 37.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.244 0.618 . . . . 0.0 110.731 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.28 90.82 3.0 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.546 1.165 . . . . 0.0 109.989 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.46 -31.03 68.95 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 111.82 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 6.7 m -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.544 1.938 . . . . 0.0 114.908 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.67 9.75 17.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.342 1.457 . . . . 0.0 112.932 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 55.5 35.82 25.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.908 1.683 . . . . 0.0 112.9 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -126.9 167.32 16.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.4 164.02 34.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.482 1.113 . . . . 0.0 112.112 165.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.98 123.04 42.52 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.516 1.526 . . . . 0.0 108.155 164.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 359' ' ' LEU . 94.1 t -117.62 116.02 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.257 1.023 . . . . 0.0 110.752 -175.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -91.29 121.04 32.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.922 0.889 . . . . 0.0 110.176 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.15 167.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.052 0.941 . . . . 0.0 109.465 168.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -76.38 -18.91 58.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.11 155.73 45.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.197 169.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -38.9 88.59 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.126 0.971 . . . . 0.0 111.99 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.2 -48.55 75.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.465 1.106 . . . . 0.0 111.314 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.23 91.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.018 0.527 . . . . 0.0 111.458 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -62.81 -42.28 99.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.25 1.02 . . . . 0.0 112.097 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -65.43 -34.14 77.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.658 1.117 . . . . 0.0 112.78 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.29 -62.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.64 -35.17 40.98 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.826 1.25 . . . . 0.0 114.109 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -67.02 -44.11 81.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.584 1.553 . . . . 0.0 113.266 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -103.58 -29.88 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -72.08 127.87 33.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.338 1.055 . . . . 0.0 111.388 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.72 25.64 15.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.466 . . . . 0.0 114.881 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -51.39 -45.87 62.63 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.09 3.53 38.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.888 2.075 . . . . 0.0 113.287 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.4 30.28 50.18 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.506 1.051 . . . . 0.0 113.81 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.36 65.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.86 162.23 30.29 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 126.335 1.854 . . . . 0.0 110.256 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.63 -22.73 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.328 2.018 . . . . 0.0 113.296 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 402' ' ' LEU . 0.2 OUTLIER -81.91 143.95 31.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.579 1.152 . . . . 0.0 111.724 -172.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -115.24 122.15 45.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.136 1.374 . . . . 0.0 108.919 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.6 m -107.12 128.62 54.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.507 1.123 . . . . 0.0 110.319 -167.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -132.51 175.64 9.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.818 2.047 . . . . 0.0 109.475 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -64.63 134.57 54.58 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.96 -1.087 . . . . 0.0 110.946 164.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.34 -152.82 9.61 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.702 1.62 . . . . 0.0 109.147 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.48 134.27 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.332 0.566 . . . . 0.0 112.262 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.97 -51.61 3.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -126.99 118.58 24.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.229 1.011 . . . . 0.0 112.119 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.96 143.13 4.7 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.857 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.26 130.22 17.19 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 125.686 4.257 . . . . 0.0 110.323 175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -35.29 80.7 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.646 0.378 . . . . 0.0 111.875 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -76.23 -16.61 59.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.14 1.376 . . . . 0.0 114.565 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.5 m -123.9 31.03 5.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.41 1.484 . . . . 0.0 111.952 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.36 138.26 32.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.632 1.573 . . . . 0.0 111.609 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -124.89 81.67 1.98 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.296 1.438 . . . . 0.0 109.881 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -66.4 -16.37 64.03 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.9 -51.23 23.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.964 1.256 . . . . 0.0 110.295 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -82.38 -12.28 58.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 73.83 42.68 37.57 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.607 1.099 . . . . 0.0 112.464 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -147.01 170.24 17.53 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.625 1.212 . . . . 0.0 112.836 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 25.5 m -132.57 152.24 51.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.035 0.934 . . . . 0.0 110.709 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.55 134.53 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.77 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.51 119.14 21.59 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 119.81 1.187 . . . . 0.0 111.409 -172.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.68 133.53 18.84 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.616 2.211 . . . . 0.0 111.492 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 9.6 mtt -59.5 -30.05 68.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.588 1.555 . . . . 0.0 113.762 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -65.17 -18.76 65.57 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -109.26 6.43 24.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.194 2.198 . . . . 0.0 113.346 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 425' ' ' ILE . 75.8 mt -94.48 138.34 32.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.409 1.084 . . . . 0.0 111.093 170.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.5 p -79.65 177.51 8.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.037 1.335 . . . . 0.0 111.356 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.64 -46.3 90.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.579 -0.7 . . . . 0.0 111.323 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.69 88.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.883 0.873 . . . . 0.0 112.059 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.78 -62.54 1.8 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.799 0.84 . . . . 0.0 111.338 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -61.47 -32.19 72.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.738 0.415 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -62.1 1.85 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.566 169.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -58.69 -40.52 83.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.477 1.49 . . . . 0.0 111.937 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 14.9 m -54.0 -29.23 42.46 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.832 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.14 -42.36 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.999 1.272 . . . . 0.0 114.087 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 20.0 m -93.08 -9.1 40.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.646 1.978 . . . . 0.0 115.033 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.24 145.9 41.24 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.086 1.312 . . . . 0.0 111.652 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.98 -53.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.011 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -97.95 136.65 37.93 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.325 1.05 . . . . 0.0 110.723 166.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 65.15 -170.79 25.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.232 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.35 -164.39 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 111.821 -0.511 . . . . 0.0 111.821 -166.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 49.9 p -100.9 14.41 31.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -164.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.5 m 62.22 19.11 10.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.783 1.174 . . . . 0.0 113.498 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.27 4.84 64.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.115 1.341 . . . . 0.0 114.201 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.34 151.57 96.83 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 118.785 1.292 . . . . 0.0 110.708 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.86 145.71 86.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.791 2.327 . . . . 0.0 110.894 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.66 107.03 3.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.98 157.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.574 1.55 . . . . 0.0 110.238 171.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 94.5 m -55.14 130.19 41.03 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.757 0.823 . . . . 0.0 110.019 169.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.77 -5.8 82.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.783 -1.009 . . . . 0.0 114.866 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 15.3 tt -61.92 137.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.188 1.494 . . . . 0.0 111.973 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.7 137.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.422 1.889 . . . . 0.0 109.544 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -161.84 174.51 13.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.958 1.303 . . . . 0.0 112.694 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -87.74 150.32 23.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.801 1.241 . . . . 0.0 111.002 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 10.9 pt-20 -50.99 128.98 29.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.67 150.37 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.902 2.402 . . . . 0.0 110.98 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -63.1 141.55 58.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.726 1.21 . . . . 0.0 114.059 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.56 53.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 123.433 1.587 . . . . 0.0 110.294 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.74 -178.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.622 141.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.99 -48.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.688 -1.257 . . . . 0.0 111.971 172.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.11 78.44 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.725 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 76.23 165.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.805 2.442 . . . . 0.0 111.469 -170.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 178.91 131.0 1.51 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 121.14 -0.975 . . . . 0.0 113.057 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 111.917 178.447 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.91 93.45 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 120.433 1.47 . . . . 0.0 110.386 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 76.08 132.47 0.41 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.223 0.916 . . . . 0.0 111.52 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -130.44 159.67 69.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.628 1.171 . . . . 0.0 110.604 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.98 -164.19 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.46 2.774 . . . . 0.0 111.916 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -52.24 -40.97 62.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.459 1.104 . . . . 0.0 113.271 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p 53.91 26.65 6.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.641 2.376 . . . . 0.0 114.62 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -3.38 50.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.37 1.468 . . . . 0.0 114.348 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -50.32 121.18 5.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.143 1.377 . . . . 0.0 110.923 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 97.04 -56.79 1.26 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.18 1.371 . . . . 0.0 113.23 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 10.9 t -68.25 -41.22 81.46 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.5 1.15 . . . . 0.0 112.365 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -105.73 -73.5 0.68 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.5 0.72 . . . . 0.0 110.876 171.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.99 166.79 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 111.58 -166.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -77.57 12.37 1.65 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -70.41 140.92 52.17 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.093 -1.004 . . . . 0.0 112.77 171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.409 HD12 ' CZ2' ' A' ' 353' ' ' TRP . 3.3 mm? -65.54 -48.76 71.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 110.543 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -88.35 157.34 50.44 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.6 1.16 . . . . 0.0 113.013 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.96 69.2 4.7 Favored 'Trans proline' 0 C--N 1.357 0.984 1 C-N-CA 125.397 4.065 . . . . 0.0 111.983 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 71.12 -66.76 0.28 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 128.808 2.843 . . . . 0.0 111.142 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 44.5 -172.79 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.288 3.035 . . . . 0.0 113.973 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -131.35 156.41 45.55 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.889 -1.132 . . . . 0.0 110.329 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.52 63.84 6.87 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.872 1.269 . . . . 0.0 109.064 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 m -111.19 154.86 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.526 2.331 . . . . 0.0 110.881 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 23.6 t -60.35 -30.06 69.3 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -70.39 -19.07 63.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -77.51 123.54 86.76 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.247 1.019 . . . . 0.0 110.56 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.36 -21.08 54.54 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.436 2.091 . . . . 0.0 112.71 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -82.72 6.94 16.34 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 113.48 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -52.94 131.52 36.0 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.835 -1.166 . . . . 0.0 111.797 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -138.65 147.77 55.99 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.792 1.237 . . . . 0.0 110.083 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.78 159.92 49.06 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.791 2.327 . . . . 0.0 111.116 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 81.82 0.54 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.78 0.832 . . . . 0.0 109.01 162.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.8 121.57 7.75 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.104 1.869 . . . . 0.0 108.539 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 13.8 t -121.54 128.92 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.806 0.842 . . . . 0.0 109.382 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.14 171.72 8.49 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.019 1.727 . . . . 0.0 110.989 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -139.88 120.48 14.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.007 . . . . 0.0 109.928 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -120.04 109.74 15.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.301 1.04 . . . . 0.0 110.609 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 99.1 p -69.06 -7.66 37.82 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.1 t -64.4 -24.91 67.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.278 1.031 . . . . 0.0 112.223 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.8 mt -70.37 150.72 95.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.931 0.892 . . . . 0.0 112.237 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.81 161.6 35.49 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.903 3.069 . . . . 0.0 112.64 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.64 134.44 28.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.942 3.094 . . . . 0.0 112.109 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . 0.25 7.0 m-20 68.4 26.03 6.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.675 1.99 . . . . 0.0 113.362 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -111.14 153.3 25.93 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.94 148.77 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.25 1.82 . . . . 0.0 109.872 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.15 132.85 53.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.502 -1.373 . . . . 0.0 110.617 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.93 106.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.341 0.656 . . . . 0.0 111.461 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -68.49 131.59 45.54 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.579 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 32.7 t -73.1 136.57 44.91 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.723 -0.611 . . . . 0.0 111.841 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -106.89 18.64 21.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.187 1.795 . . . . 0.0 109.724 163.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 16.2 m -126.29 141.95 51.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.967 1.307 . . . . 0.0 111.763 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.5 mt -104.16 134.88 46.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 109.351 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -87.27 123.39 32.22 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 163.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.58 107.13 22.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.23 -174.84 50.67 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 166.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.61 70.02 Favored Glycine 0 N--CA 1.475 1.275 0 O-C-N 121.43 -1.041 . . . . 0.0 114.955 170.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 14.9 t -84.71 112.81 45.29 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 118.78 1.29 . . . . 0.0 110.295 -168.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.95 143.96 62.47 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.984 2.456 . . . . 0.0 109.919 170.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.04 -21.18 63.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.9 -27.49 63.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.859 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 33.9 mtm -80.58 145.86 31.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.59 0.709 . . . . 0.0 112.293 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -129.46 -179.4 5.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.145 2.178 . . . . 0.0 110.976 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -47.68 -40.31 19.65 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 114.216 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.409 ' CZ2' HD12 ' A' ' 305' ' ' LEU . 78.4 m95 -81.43 -18.63 44.7 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -72.76 -39.27 66.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.663 1.12 . . . . 0.0 110.185 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.24 -51.26 70.75 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.833 0.453 . . . . 0.0 110.719 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.05 -38.82 71.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.386 -0.816 . . . . 0.0 112.662 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -68.18 -44.31 76.2 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.135 1.334 . . . . 0.0 113.996 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.82 -35.72 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.507 1.049 . . . . 0.0 110.954 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.524 HD23 ' CE1' ' A' ' 394' ' ' PHE . 30.6 mt -83.7 -11.57 57.01 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.459 1.104 . . . . 0.0 113.138 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -48.66 -48.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.849 1.66 . . . . 0.0 114.758 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.12 -6.74 17.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.133 1.889 . . . . 0.0 113.586 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -98.46 -40.93 8.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.5 1.52 . . . . 0.0 112.431 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.68 171.55 3.79 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.915 1.686 . . . . 0.0 113.461 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -85.99 138.35 32.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.661 0.784 . . . . 0.0 110.538 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.1 t -103.7 129.86 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.616 1.166 . . . . 0.0 110.169 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . 0.415 ' HG3' ' CE1' ' A' ' 382' ' ' TYR . 45.7 tt0 -93.64 -40.23 10.37 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.355 1.862 . . . . 0.0 112.782 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.1 t -152.82 152.04 31.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.404 1.082 . . . . 0.0 110.61 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 70.9 t -146.22 131.99 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.248 0.477 . . . . 0.0 110.417 171.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.24 107.88 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.61 122.06 40.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.066 0.546 . . . . 0.0 110.337 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -106.48 84.9 2.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.822 1.649 . . . . 0.0 109.478 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.72 -33.91 66.96 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.485 1.514 . . . . 0.0 111.354 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 65.6 m -55.72 -32.51 63.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.155 1.782 . . . . 0.0 114.27 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -110.21 9.17 23.86 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 113.191 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt 53.94 37.85 27.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.382 1.473 . . . . 0.0 112.072 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -125.5 153.39 43.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.971 1.708 . . . . 0.0 113.24 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -136.8 132.75 35.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.536 1.134 . . . . 0.0 112.228 164.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.96 117.63 24.92 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 162.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 359' ' ' LEU . 54.8 t -118.56 114.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.706 0.803 . . . . 0.0 110.249 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -98.37 121.96 40.95 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 110.299 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.11 164.11 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.437 1.095 . . . . 0.0 109.553 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 366' ' ' GLN . 70.7 m-85 -74.53 -21.22 59.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.4 p -141.74 159.63 41.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.09 1.314 . . . . 0.0 114.234 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -61.54 -45.34 94.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.214 1.006 . . . . 0.0 112.079 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -58.8 -38.22 78.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.239 0.616 . . . . 0.0 112.231 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.47 -54.8 34.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.68 0.792 . . . . 0.0 110.956 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.0 85.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.888 0.767 . . . . 0.0 112.307 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.69 -44.79 95.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 111.633 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -65.24 -33.79 76.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.204 -0.935 . . . . 0.0 112.654 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 359' ' ' LEU . 49.3 t -60.16 -63.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.55 166.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -51.13 -35.81 37.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.877 1.271 . . . . 0.0 114.314 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -63.83 -37.51 87.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.99 1.316 . . . . 0.0 113.085 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -112.83 -26.94 8.32 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.524 ' CE1' HD23 ' A' ' 359' ' ' LEU . 11.2 t80 -74.3 123.81 25.28 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 111.308 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.93 27.4 13.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.736 1.614 . . . . 0.0 114.168 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -24.56 66.77 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -100.56 -14.48 18.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.615 1.966 . . . . 0.0 114.524 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.26 24.28 29.55 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.548 1.07 . . . . 0.0 115.291 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.88 -42.01 22.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.562 1.681 . . . . 0.0 115.028 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.8 149.25 90.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.859 0.863 . . . . 0.0 110.57 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.84 -32.89 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.588 2.192 . . . . 0.0 111.71 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.76 163.4 25.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.203 1.801 . . . . 0.0 112.67 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -126.3 101.28 6.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.549 1.54 . . . . 0.0 109.915 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 113.06 21.2 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.115 1.366 . . . . 0.0 109.804 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.42 171.11 11.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.938 1.695 . . . . 0.0 109.178 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -67.29 130.84 44.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.097 -1.002 . . . . 0.0 110.838 163.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -115.66 -148.96 9.39 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 125.865 1.698 . . . . 0.0 109.102 167.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -160.96 132.17 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.29 -46.71 5.47 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 167.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -132.82 121.47 23.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 111.978 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 176.86 145.79 5.84 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 119.274 -0.736 . . . . 0.0 114.659 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.13 133.61 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 125.048 3.832 . . . . 0.0 109.739 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -37.73 80.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.835 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.21 -20.12 63.11 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.658 -1.276 . . . . 0.0 113.896 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 99.0 m -123.71 30.19 6.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.817 1.647 . . . . 0.0 112.041 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.1 p -75.65 154.06 36.83 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.969 0.89 . . . . 0.0 112.688 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.07 73.23 1.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.596 1.558 . . . . 0.0 108.837 166.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.62 -19.96 65.29 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.257 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.65 -49.67 65.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.688 -1.258 . . . . 0.0 111.19 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -83.34 -13.79 54.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.7 40.15 12.9 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.844 1.211 . . . . 0.0 112.713 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -146.52 172.19 13.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.76 1.28 . . . . 0.0 112.38 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 50.6 m -139.35 153.31 47.67 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.881 0.872 . . . . 0.0 109.805 170.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.5 mt -110.73 133.93 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.839 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -125.1 119.16 25.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.517 1.053 . . . . 0.0 111.915 -170.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.05 127.99 14.28 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.915 2.41 . . . . 0.0 110.96 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 42.4 mtm -61.14 -30.38 70.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.576 1.15 . . . . 0.0 113.451 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -65.82 -20.34 66.21 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 11.57 22.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.049 2.14 . . . . 0.0 113.184 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 425' ' ' ILE . 45.0 mt -92.83 145.44 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.223 1.009 . . . . 0.0 111.316 167.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.1 p -79.76 177.33 8.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.22 -44.39 88.45 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.554 -0.717 . . . . 0.0 111.492 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.05 93.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.948 0.899 . . . . 0.0 112.05 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.449 ' HB3' HD22 ' A' ' 430' ' ' LEU . 96.7 m-20 -56.42 -63.24 1.26 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.668 1.187 . . . . 0.0 111.405 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.16 -35.0 72.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.128 0.971 . . . . 0.0 111.027 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -56.89 -51.61 68.4 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.197 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -64.56 -41.01 96.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.726 1.603 . . . . 0.0 111.854 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 15.5 m -51.51 -32.6 28.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.016 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.24 -37.93 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.7 t -101.47 -6.68 23.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.649 1.58 . . . . 0.0 114.031 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.442 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.51 146.52 29.62 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.169 0.985 . . . . 0.0 112.41 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.88 -50.07 11.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.657 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -98.52 140.3 32.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.603 0.761 . . . . 0.0 111.481 159.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.54 -159.03 48.64 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.695 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 68.5 -168.51 42.51 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 47.4 p -96.14 10.05 38.93 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 t 65.83 23.99 11.37 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.877 -1.14 . . . . 0.0 113.495 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.66 65.27 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.672 1.606 . . . . 0.0 114.145 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.73 150.76 96.59 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 118.926 1.363 . . . . 0.0 110.948 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 144.32 79.66 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.861 2.374 . . . . 0.0 110.689 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.7 112.3 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.269 0.556 . . . . 0.0 109.568 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.42 157.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.741 1.616 . . . . 0.0 110.279 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 92.3 m -53.59 127.14 24.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 109.81 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 92.08 -5.7 78.66 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.77 -1.017 . . . . 0.0 115.293 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.83 137.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.265 1.532 . . . . 0.0 111.676 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 137.0 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.435 1.894 . . . . 0.0 109.454 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.34 172.93 17.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.341 1.056 . . . . 0.0 112.187 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.51 148.87 25.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.74 1.216 . . . . 0.0 111.525 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.81 129.93 20.99 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.25 147.72 48.21 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.878 2.385 . . . . 0.0 110.417 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.442 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.1 m-20 -61.78 147.57 45.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 0.0 114.039 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.8 mm -107.37 48.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.734 1.613 . . . . 0.0 109.671 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.6 pp -57.32 169.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.58 137.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.7 t -139.57 -47.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.886 -1.134 . . . . 0.0 111.085 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.21 -53.82 4.65 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.478 1.037 . . . . 0.0 111.942 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.43 151.2 7.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.266 1.426 . . . . 0.0 111.217 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -132.19 161.92 23.91 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.598 1.57 . . . . 0.0 113.264 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.297 1.439 . . . . 0.0 111.665 -179.41 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.4 pt -130.07 43.51 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 125.456 1.503 . . . . 0.0 112.358 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.02 -165.77 53.64 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.562 -0.711 . . . . 0.0 111.825 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -165.2 158.97 14.24 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.205 1.402 . . . . 0.0 111.372 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -69.26 170.77 15.21 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.146 3.231 . . . . 0.0 112.666 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -74.94 -0.8 19.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.546 1.139 . . . . 0.0 114.065 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 72.16 5.84 5.4 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.021 2.128 . . . . 0.0 113.027 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -172.82 -35.2 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.412 2.285 . . . . 0.0 112.705 -175.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 48.58 67.56 0.84 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.921 1.688 . . . . 0.0 112.222 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.36 -11.22 52.49 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.781 1.181 . . . . 0.0 115.126 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 18.8 m -62.54 -46.12 89.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.603 1.561 . . . . 0.0 112.404 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 176.55 -38.53 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.808 2.043 . . . . 0.0 112.612 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.92 168.58 19.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.982 0.913 . . . . 0.0 112.026 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -143.29 15.05 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -167.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -81.69 136.52 35.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.358 1.063 . . . . 0.0 113.446 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 368' ' ' VAL . 1.1 mt -76.79 2.42 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.984 1.714 . . . . 0.0 113.026 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -141.07 162.32 48.75 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.25 1.42 . . . . 0.0 111.815 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -68.82 -169.87 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.638 3.559 . . . . 0.0 112.037 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -72.6 60.65 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.003 1.321 . . . . 0.0 111.509 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.38 150.59 46.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.388 . . . . 0.0 112.438 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 142.2 38.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.84 1.656 . . . . 0.0 109.426 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -79.35 66.67 4.87 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.842 -1.161 . . . . 0.0 110.23 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.78 152.88 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.357 2.263 . . . . 0.0 111.105 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 85.6 p -62.05 -25.67 67.81 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -71.3 -25.18 62.32 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.76 0.824 . . . . 0.0 112.834 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -76.31 122.54 86.96 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.389 1.076 . . . . 0.0 109.956 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.86 -19.4 52.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.386 2.057 . . . . 0.0 112.825 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -76.65 3.37 11.73 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 170.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.72 132.66 31.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.881 1.219 . . . . 0.0 111.894 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.28 146.94 60.11 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 124.502 1.121 . . . . 0.0 109.949 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.26 161.97 40.67 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.773 2.316 . . . . 0.0 110.621 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.17 79.4 1.58 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 165.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.79 126.64 13.52 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.492 2.128 . . . . 0.0 108.606 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.49 116.33 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.206 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.75 167.37 10.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 0.0 110.868 172.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -141.57 124.55 16.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.256 1.023 . . . . 0.0 109.619 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -122.73 114.01 19.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.645 0.778 . . . . 0.0 110.403 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -69.48 -8.64 48.71 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.12 -22.77 66.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.452 171.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.62 150.99 93.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.655 0.782 . . . . 0.0 111.862 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.46 161.66 33.99 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.874 3.049 . . . . 0.0 112.77 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.59 131.62 17.65 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.945 3.097 . . . . 0.0 112.461 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 64.5 45.83 3.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.873 2.069 . . . . 0.0 111.659 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -125.8 152.51 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 17.1 pt -125.21 144.39 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.078 1.751 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.74 54.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.028 1.331 . . . . 0.0 110.378 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.64 105.99 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.055 0.942 . . . . 0.0 110.908 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -72.18 134.82 45.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.562 1.145 . . . . 0.0 111.847 167.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.6 t -76.9 136.49 38.83 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.213 -0.929 . . . . 0.0 111.732 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.4 mtm105 -103.43 15.88 27.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.529 1.932 . . . . 0.0 109.954 163.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 87.3 m -117.48 132.54 56.53 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.714 1.606 . . . . 0.0 110.673 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.29 136.76 38.01 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.185 1.394 . . . . 0.0 108.856 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -92.38 138.83 31.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 26.7 mm -124.26 108.31 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -171.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.69 174.29 46.23 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 165.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 69.75 30.07 70.78 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.844 -0.798 . . . . 0.0 114.146 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 91.4 t -90.38 109.39 33.38 Favored Pre-proline 0 N--CA 1.478 0.946 0 CA-C-N 118.25 1.025 . . . . 0.0 110.69 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.33 141.97 48.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.401 2.067 . . . . 0.0 110.107 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.04 -17.82 62.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.49 -35.04 79.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.064 0.946 . . . . 0.0 112.617 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 ptp -86.73 152.67 22.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -130.8 -174.44 3.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.229 1.812 . . . . 0.0 111.644 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -55.76 -39.14 70.78 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.176 1.39 . . . . 0.0 112.796 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -74.98 -23.05 58.21 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.19 -39.13 65.83 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.236 0.926 . . . . 0.0 110.571 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.18 -51.78 68.53 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.547 168.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.87 67.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.713 173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -46.95 64.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.939 1.245 . . . . 0.0 113.583 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.99 -33.56 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.12 0.873 . . . . 0.0 110.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.575 HD23 ' CE1' ' A' ' 394' ' ' PHE . 31.0 mt -87.45 -8.05 56.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.367 1.067 . . . . 0.0 113.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -48.67 -49.08 67.66 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.613 1.565 . . . . 0.0 114.988 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.36 -6.46 17.15 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.028 1.819 . . . . 0.0 113.262 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -98.14 -38.53 9.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.465 1.506 . . . . 0.0 112.54 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.8 168.42 5.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.47 1.908 . . . . 0.0 112.537 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.14 136.87 32.77 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.658 0.783 . . . . 0.0 110.051 169.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.89 134.95 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.623 1.169 . . . . 0.0 109.986 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.59 -35.19 9.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.51 150.13 30.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.528 1.058 . . . . 0.0 111.982 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 305' ' ' LEU . 88.9 t -146.32 139.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.669 0.787 . . . . 0.0 109.763 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.15 102.39 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.9 tt -97.46 130.72 44.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.918 0.887 . . . . 0.0 109.635 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.68 91.03 3.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.263 1.025 . . . . 0.0 110.085 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.41 -40.23 90.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.042 1.337 . . . . 0.0 111.513 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.7 t -65.17 -25.36 67.69 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.213 1.405 . . . . 0.0 112.938 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -0.67 41.62 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.486 1.515 . . . . 0.0 112.918 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 27.85 16.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.963 1.305 . . . . 0.0 113.772 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.84 170.41 15.89 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.3 40.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.001 1.321 . . . . 0.0 112.314 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.22 128.32 55.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.276 1.43 . . . . 0.0 108.692 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 359' ' ' LEU . 88.1 t -124.32 111.32 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 111.004 -173.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 112.92 25.0 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.552 1.541 . . . . 0.0 111.034 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.49 163.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.91 0.884 . . . . 0.0 110.357 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.51 -26.65 63.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.7 p -134.9 155.28 50.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.158 0.98 . . . . 0.0 113.165 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -41.83 92.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.009 0.923 . . . . 0.0 111.35 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -65.63 -36.68 84.4 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.906 -0.497 . . . . 0.0 111.452 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -59.51 -51.26 70.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.517 0.727 . . . . 0.0 111.116 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.77 94.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.635 0.652 . . . . 0.0 111.945 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.81 -43.26 98.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.219 0.608 . . . . 0.0 112.053 171.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -64.38 -34.22 77.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.398 0.999 . . . . 0.0 112.358 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 359' ' ' LEU . 34.5 t -61.48 -63.18 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.083 167.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.6 mt -51.38 -36.39 43.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.717 1.207 . . . . 0.0 114.036 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.75 -35.34 80.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.99 1.316 . . . . 0.0 113.034 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.23 -25.45 9.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -174.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.575 ' CE1' HD23 ' A' ' 359' ' ' LEU . 13.6 t80 -72.77 122.89 22.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.361 0.664 . . . . 0.0 111.528 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 62.44 29.32 17.14 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 114.022 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.62 -31.33 68.0 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -84.8 -16.81 40.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.794 1.638 . . . . 0.0 114.076 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.42 73.74 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.794 1.188 . . . . 0.0 114.114 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.62 -34.2 35.23 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.112 1.456 . . . . 0.0 114.853 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.405 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 15.6 mt -76.55 148.56 80.14 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.156 0.982 . . . . 0.0 109.871 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.45 -29.1 13.97 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.717 2.278 . . . . 0.0 112.408 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.61 151.27 42.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.966 1.307 . . . . 0.0 111.778 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 104.74 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.767 0.827 . . . . 0.0 110.681 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.2 m -85.58 121.52 28.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.189 1.396 . . . . 0.0 109.746 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -129.13 178.04 6.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.628 1.971 . . . . 0.0 108.862 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -72.25 126.3 29.46 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.19 -0.943 . . . . 0.0 111.305 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.01 -156.95 19.37 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 165.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.97 136.72 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 117.117 0.459 . . . . 0.0 111.887 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.99 -44.79 3.75 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.683 1.611 . . . . 0.0 110.464 163.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.48 113.96 18.17 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.018 0.909 . . . . 0.0 113.053 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.82 139.59 4.31 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.92 129.25 15.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.006 3.804 . . . . 0.0 109.974 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -63.49 -38.25 90.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.319 0.648 . . . . 0.0 112.294 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.1 -24.9 66.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.078 1.751 . . . . 0.0 113.345 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 71.8 m -127.35 31.19 5.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.158 1.783 . . . . 0.0 111.277 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.4 t -85.01 140.76 30.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.031 1.333 . . . . 0.0 111.685 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.4 75.82 1.5 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.716 1.606 . . . . 0.0 109.124 168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -63.08 -16.49 60.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -70.35 -49.1 52.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.672 1.124 . . . . 0.0 111.023 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -83.81 -16.07 45.98 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.48 38.09 11.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.841 1.21 . . . . 0.0 113.163 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -143.09 174.65 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.338 1.069 . . . . 0.0 112.49 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.3 p -146.27 153.85 41.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.536 1.134 . . . . 0.0 109.964 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.2 mt -114.32 131.14 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -120.83 123.12 28.1 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 119.433 1.015 . . . . 0.0 111.479 -171.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -69.55 132.03 22.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.69 2.26 . . . . 0.0 111.003 169.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.53 -32.03 72.9 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 113.236 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.87 -22.44 66.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.7 7.3 37.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.31 1.844 . . . . 0.0 112.636 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 425' ' ' ILE . 74.6 mt -92.29 142.15 27.78 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.293 1.437 . . . . 0.0 110.969 169.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.8 p -80.05 174.97 11.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.9 1.28 . . . . 0.0 111.048 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.47 -38.99 91.99 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.639 -0.663 . . . . 0.0 111.747 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.53 80.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.026 0.93 . . . . 0.0 112.205 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.82 -54.57 45.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.414 1.086 . . . . 0.0 112.141 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -68.44 -34.31 75.74 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -52.94 -51.78 60.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.243 1.017 . . . . 0.0 111.202 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -68.26 -42.2 79.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.437 1.472 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.2 m -55.52 -30.02 59.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.067 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.7 m -97.84 -40.85 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.4 t -103.13 -9.81 19.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -165.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.62 146.03 37.56 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.906 -1.121 . . . . 0.0 111.581 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -74.79 -52.41 11.53 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.795 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -96.11 133.81 39.92 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.003 0.906 . . . . 0.0 110.984 166.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 -171.26 44.31 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.828 -174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.67 -163.5 54.28 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 115.242 -0.479 . . . . 0.0 112.295 -169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 44.4 p -103.55 11.7 35.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -162.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.62 21.2 5.48 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.792 -1.192 . . . . 0.0 113.064 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.23 4.63 77.41 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 120.768 -1.208 . . . . 0.0 113.874 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -66.42 154.18 91.3 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.591 1.195 . . . . 0.0 110.373 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.1 142.45 80.78 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.151 1.901 . . . . 0.0 110.199 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 50.2 mt -67.67 120.33 13.87 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.53 155.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.304 1.441 . . . . 0.0 109.802 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -59.69 131.82 52.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.067 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.64 -5.78 83.47 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.422 -1.21 . . . . 0.0 115.186 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 14.8 tt -61.39 143.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.598 1.699 . . . . 0.0 112.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.21 137.0 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.542 1.937 . . . . 0.0 109.33 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -160.63 177.27 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 0.0 112.149 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -95.89 149.47 21.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.714 1.206 . . . . 0.0 111.06 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.91 135.85 56.71 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -162.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.25 153.38 40.56 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.858 2.372 . . . . 0.0 110.786 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.66 142.03 58.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.453 1.101 . . . . 0.0 113.577 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.97 48.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.335 1.54 . . . . 0.0 110.334 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.93 168.82 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.84 138.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.29 -54.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 121.028 -1.045 . . . . 0.0 110.382 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.6 -71.78 2.88 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.526 1.06 . . . . 0.0 111.706 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -163.25 162.18 25.17 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.135 1.774 . . . . 0.0 111.531 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.39 175.52 47.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.418 1.485 . . . . 0.0 112.878 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.876 1.67 . . . . 0.0 112.162 177.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.396 0.141 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.09 123.56 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.735 1.214 . . . . 0.0 108.651 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 95.96 146.37 20.77 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.873 1.225 . . . . 0.0 113.372 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -91.15 165.56 21.23 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.845 1.658 . . . . 0.0 111.314 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.5 -157.57 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 123.574 2.85 . . . . 0.0 111.744 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.99 -28.06 67.38 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.645 -1.284 . . . . 0.0 113.883 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 82.5 p 48.66 26.65 1.28 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.386 2.675 . . . . 0.0 114.225 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -76.67 -24.2 53.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.29 1.036 . . . . 0.0 112.668 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -47.91 128.94 14.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.421 1.489 . . . . 0.0 113.634 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 110.88 151.93 12.57 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.437 1.018 . . . . 0.0 112.1 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 3.5 m 61.91 53.81 2.99 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.665 1.586 . . . . 0.0 111.233 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 57.72 52.77 7.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.503 1.521 . . . . 0.0 112.392 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -152.42 138.43 18.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.912 . . . . 0.0 111.9 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -151.68 9.88 0.54 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -78.11 140.81 39.06 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.005 -1.06 . . . . 0.0 112.19 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 7.1 mp -83.42 -10.91 58.12 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 112.154 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.72 155.37 52.51 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 126.255 1.822 . . . . 0.0 111.57 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.47 160.36 36.06 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.575 2.85 . . . . 0.0 112.141 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -76.86 66.22 2.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.502 1.144 . . . . 0.0 110.413 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.93 -173.11 1.16 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.376 2.67 . . . . 0.0 113.108 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.85 129.2 55.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.214 -0.928 . . . . 0.0 111.034 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -78.74 69.28 4.89 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.32 -0.863 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 32.8 t -119.95 147.5 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 127.058 2.143 . . . . 0.0 110.273 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.3 p -58.14 -25.83 61.94 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -69.53 -26.98 64.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.033 0.833 . . . . 0.0 112.604 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -81.23 122.77 81.68 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.776 1.23 . . . . 0.0 109.83 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 -17.26 52.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.589 2.193 . . . . 0.0 113.204 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -74.04 -0.96 18.03 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -51.92 127.69 21.93 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.618 1.099 . . . . 0.0 111.447 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.81 145.01 48.43 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 110.24 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.02 144.3 63.41 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.459 2.772 . . . . 0.0 111.004 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 83.67 0.77 Allowed Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 165.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.89 113.61 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.296 1.997 . . . . 0.0 108.624 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.3 116.44 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.5 168.45 12.11 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.273 1.429 . . . . 0.0 110.757 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.72 127.27 21.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 110.089 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -122.67 106.62 11.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.926 0.869 . . . . 0.0 111.291 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -10.45 40.39 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.341 1.456 . . . . 0.0 113.674 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 73.0 p -70.82 -22.98 62.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.68 1.592 . . . . 0.0 112.183 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.06 150.29 92.42 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.157 0.983 . . . . 0.0 111.792 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.84 161.5 36.05 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.182 3.254 . . . . 0.0 112.971 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.99 137.11 36.87 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.065 3.176 . . . . 0.0 112.692 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 67.82 24.17 8.26 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.157 1.783 . . . . 0.0 113.134 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -107.94 152.57 24.27 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.818 -1.177 . . . . 0.0 113.825 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.85 144.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 126.238 1.815 . . . . 0.0 110.389 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 128.55 54.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 0.0 111.084 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 457' ' ' PHE . 47.2 t -125.11 106.7 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.567 0.747 . . . . 0.0 111.097 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.78 130.12 42.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.42 1.088 . . . . 0.0 111.228 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.6 t -69.69 135.91 50.41 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.852 -0.53 . . . . 0.0 111.594 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.425 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 33.2 mtm105 -104.48 16.14 26.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.576 1.55 . . . . 0.0 110.858 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 21.8 m -123.66 136.19 54.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.286 1.434 . . . . 0.0 112.122 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.61 139.37 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.19 1.396 . . . . 0.0 109.951 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -92.29 139.65 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.79 108.83 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.589 1.156 . . . . 0.0 107.916 -171.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -92.4 -175.9 41.83 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.67 15.9 69.25 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.707 -0.878 . . . . 0.0 114.256 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.4 120.01 79.33 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 118.744 1.272 . . . . 0.0 110.187 -167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 139.42 38.36 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.144 1.896 . . . . 0.0 109.923 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.9 pp -61.82 -18.84 61.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.7 -23.82 49.38 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.3 ptp -87.24 148.47 25.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -125.61 -177.22 3.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.978 1.711 . . . . 0.0 111.908 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -47.15 -42.46 19.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.593 1.957 . . . . 0.0 114.243 174.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.69 -22.05 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.76 -37.06 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.149 0.886 . . . . 0.0 110.852 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.4 mm? -56.84 -51.24 69.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.387 0.54 . . . . 0.0 110.011 168.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -58.24 -39.94 80.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.015 0.825 . . . . 0.0 112.806 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -66.76 -39.88 88.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.296 1.407 . . . . 0.0 113.097 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.02 -32.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.733 1.151 . . . . 0.0 111.702 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.406 ' CD1' HG11 ' A' ' 379' ' ' VAL . 56.5 mt -86.88 -12.32 48.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.559 1.144 . . . . 0.0 113.88 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -48.89 -47.91 72.56 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.57 -6.22 17.42 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.145 1.897 . . . . 0.0 113.199 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -100.27 -39.12 8.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.397 1.479 . . . . 0.0 112.693 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.48 170.75 4.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.623 . . . . 0.0 114.161 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -81.28 135.16 35.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.556 1.143 . . . . 0.0 110.965 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 88.6 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.744 1.218 . . . . 0.0 110.19 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -91.34 -45.02 8.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.841 1.256 . . . . 0.0 112.46 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.01 149.26 29.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.848 0.859 . . . . 0.0 110.86 -171.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.02 131.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.909 0.777 . . . . 0.0 110.858 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.33 99.39 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.453 HD21 ' ND2' ' A' ' 372' ' ' ASN . 9.6 tt -95.57 145.76 24.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.881 0.872 . . . . 0.0 110.486 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -137.1 89.57 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.556 1.142 . . . . 0.0 110.214 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.453 ' ND2' HD21 ' A' ' 370' ' ' LEU . 30.1 m120 -61.41 -32.03 71.97 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.238 -0.914 . . . . 0.0 112.061 -177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 39.8 t -60.94 -31.64 71.18 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.807 1.243 . . . . 0.0 112.694 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -96.14 -3.81 43.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 113.525 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 60.03 31.31 20.57 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.671 1.589 . . . . 0.0 113.107 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -136.29 170.27 16.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.2 162.99 36.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.963 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -118.33 128.69 54.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.559 1.544 . . . . 0.0 108.268 165.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.406 HG11 ' CD1' ' A' ' 359' ' ' LEU . 61.2 t -123.15 109.8 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.974 0.909 . . . . 0.0 110.423 -176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -85.59 117.46 24.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 109.934 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.62 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 165.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.89 -19.1 57.85 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.98 154.78 46.19 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.115 0.871 . . . . 0.0 113.174 -176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -62.99 -41.52 99.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.731 0.812 . . . . 0.0 111.577 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -63.12 -38.64 92.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.859 0.464 . . . . 0.0 110.848 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.22 -49.51 75.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.542 1.137 . . . . 0.0 111.431 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.93 97.91 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.864 -0.523 . . . . 0.0 112.139 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -64.88 -42.66 94.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.655 0.782 . . . . 0.0 111.899 171.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.29 -34.8 78.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.188 0.904 . . . . 0.0 112.045 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.3 -63.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.894 165.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.85 -32.63 53.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -65.07 -31.78 73.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.996 1.319 . . . . 0.0 113.466 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -120.18 -28.97 4.97 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -74.33 125.47 28.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -171.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.64 20.15 11.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.308 1.443 . . . . 0.0 114.164 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.34 65.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -111.13 4.26 19.19 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.577 2.351 . . . . 0.0 112.796 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 75.21 32.59 55.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.315 0.959 . . . . 0.0 113.368 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -55.71 -29.69 59.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.77 161.68 36.73 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.061 1.345 . . . . 0.0 110.172 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.97 -7.09 18.04 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.574 2.849 . . . . 0.0 113.901 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.96 166.04 8.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.139 2.176 . . . . 0.0 112.441 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 90.1 2.49 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.0 110.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 127.98 34.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.425 1.49 . . . . 0.0 111.209 -172.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.26 170.37 15.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.257 1.823 . . . . 0.0 108.808 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -68.52 126.64 30.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.419 -0.801 . . . . 0.0 110.579 164.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.39 -152.25 17.87 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.5 136.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 117.564 0.682 . . . . 0.0 111.68 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -89.92 -48.72 3.54 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 166.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -129.26 120.29 25.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.896 0.848 . . . . 0.0 111.811 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 178.74 140.87 4.11 Favored Glycine 0 CA--C 1.542 1.746 0 CA-C-O 119.153 -0.804 . . . . 0.0 114.635 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -70.5 133.72 24.83 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.827 3.684 . . . . 0.0 110.181 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -67.12 -35.37 79.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.995 0.426 . . . . 0.0 111.904 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.07 -26.34 66.68 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.457 1.903 . . . . 0.0 113.403 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.1 m -126.78 31.82 5.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.379 1.872 . . . . 0.0 111.054 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.57 138.35 33.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.425 1.49 . . . . 0.0 111.033 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.32 77.83 1.6 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.22 1.408 . . . . 0.0 109.292 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -62.84 -19.76 64.42 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.362 -0.836 . . . . 0.0 113.133 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.96 -47.25 66.11 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 120.123 1.329 . . . . 0.0 111.194 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -83.23 -16.08 47.85 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.98 38.32 11.55 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.805 1.193 . . . . 0.0 112.919 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -146.37 169.88 17.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.931 1.366 . . . . 0.0 112.809 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.2 m -137.68 151.3 48.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.824 0.85 . . . . 0.0 110.631 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.24 130.38 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.822 HG21 HD21 ' A' ' 430' ' ' LEU . 0.7 OUTLIER -123.28 115.78 28.63 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 119.493 1.042 . . . . 0.0 111.15 -168.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -69.71 130.33 19.21 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.065 2.51 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 30.0 mtt -59.84 -32.28 70.53 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.939 1.296 . . . . 0.0 113.243 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -65.08 -22.41 66.96 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.213 0.915 . . . . 0.0 113.039 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -105.14 8.16 34.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.87 1.668 . . . . 0.0 113.601 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 425' ' ' ILE . 53.2 mt -91.8 146.68 23.56 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.29 1.036 . . . . 0.0 111.784 169.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 24.7 p -83.41 174.45 10.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.727 1.211 . . . . 0.0 110.805 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.2 -41.75 99.2 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.769 -0.582 . . . . 0.0 111.391 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.54 92.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.119 0.968 . . . . 0.0 111.862 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 430' ' ' LEU . 94.3 m-20 -57.59 -61.29 2.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.471 1.109 . . . . 0.0 111.626 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -57.54 -37.84 73.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 111.45 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -57.93 -45.59 86.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.927 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -66.78 -41.49 87.6 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 120.729 1.604 . . . . 0.0 112.107 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 8.3 m -54.56 -33.2 59.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.401 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 m -98.01 -48.59 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 16.7 m -89.46 -9.32 50.54 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.13 56.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.26 1.391 . . . . 0.0 112.319 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -74.98 -48.33 24.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.968 0.907 . . . . 0.0 110.511 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -101.0 121.12 41.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.212 1.006 . . . . 0.0 110.75 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 84.87 -173.88 49.32 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.426 1.489 . . . . 0.0 112.987 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.48 -159.44 53.67 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 57.0 p -100.22 8.03 44.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.103 1.361 . . . . 0.0 114.646 -163.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.02 22.4 4.55 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.934 -1.104 . . . . 0.0 112.499 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.56 3.59 71.42 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.892 1.235 . . . . 0.0 113.859 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.68 153.24 96.09 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 118.355 1.078 . . . . 0.0 110.796 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -63.87 145.95 91.02 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.551 2.167 . . . . 0.0 110.588 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.16 121.27 19.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.378 0.609 . . . . 0.0 110.005 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.4 t -110.88 152.2 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.604 1.962 . . . . 0.0 108.715 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 74.2 m -49.41 122.6 6.36 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.281 0.632 . . . . 0.0 110.055 165.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 86.68 1.25 85.55 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.935 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.79 131.59 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.588 1.694 . . . . 0.0 111.532 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.02 138.7 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.045 2.138 . . . . 0.0 109.302 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.407 ' CE1' HG22 ' A' ' 336' ' ' VAL . 32.8 p90 -161.97 179.99 7.59 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.474 1.509 . . . . 0.0 112.604 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -95.77 145.6 25.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.241 1.416 . . . . 0.0 110.421 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 9.2 pt-20 -47.68 128.42 10.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.63 152.07 64.56 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 111.249 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.43 147.97 34.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.443 1.097 . . . . 0.0 113.498 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.1 mm -110.79 49.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 123.251 1.501 . . . . 0.0 110.01 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.62 171.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.927 137.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.27 -58.46 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 120.66 -1.275 . . . . 0.0 110.762 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.64 -55.37 3.44 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.917 1.246 . . . . 0.0 111.666 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -165.03 143.26 6.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 112.138 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -96.69 -154.89 30.39 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.187 1.375 . . . . 0.0 113.447 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.258 1.503 0 C-N-CA 125.572 1.549 . . . . 0.0 113.965 176.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 45.2 mt 69.1 75.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 126.826 2.051 . . . . 0.0 109.333 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 70.59 -154.89 52.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.386 0.993 . . . . 0.0 112.818 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -113.5 158.5 38.4 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.052 1.741 . . . . 0.0 110.926 172.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.55 -158.31 0.08 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.517 3.478 . . . . 0.0 110.656 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -71.87 98.93 2.1 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.717 -1.239 . . . . 0.0 111.52 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 11.1 p -81.01 48.5 1.11 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.303 1.841 . . . . 0.0 112.487 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 6.4 t -89.05 -21.58 23.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.802 1.641 . . . . 0.0 113.536 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -55.91 -36.07 67.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.648 1.579 . . . . 0.0 113.612 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.84 3.82 86.73 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.871 1.701 . . . . 0.0 114.334 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 54.7 m -117.02 -76.23 0.57 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.817 1.647 . . . . 0.0 110.891 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -164.85 -52.94 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -83.12 -177.49 6.78 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.553 0.741 . . . . 0.0 111.119 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -142.4 4.32 1.57 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -169.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -62.71 136.78 58.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.065 1.346 . . . . 0.0 112.369 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.0 mp -82.13 -63.94 1.28 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -82.88 127.99 67.5 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.264 0.626 . . . . 0.0 110.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.44 172.89 13.88 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.896 3.064 . . . . 0.0 111.391 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 64.63 25.06 13.07 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.697 1.599 . . . . 0.0 113.094 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.5 110.96 9.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.967 0.907 . . . . 0.0 112.438 -160.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 126.02 15.22 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.533 1.533 . . . . 0.0 110.719 -172.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -78.84 65.81 4.15 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 121.386 -0.821 . . . . 0.0 111.96 -170.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.37 151.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.901 2.481 . . . . 0.0 111.053 -170.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 48.3 t -53.36 -36.78 61.73 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.791 1.236 . . . . 0.0 114.138 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -78.2 -0.17 27.45 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.65 124.73 38.05 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.552 1.541 . . . . 0.0 111.009 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.74 -21.56 58.27 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.458 2.772 . . . . 0.0 113.556 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -75.53 -4.49 40.15 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.74 131.6 25.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.725 1.21 . . . . 0.0 111.863 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.85 154.11 68.29 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.278 1.031 . . . . 0.0 109.722 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -65.27 168.42 14.33 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 110.91 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 83.37 60.72 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.21 1.404 . . . . 0.0 107.325 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 137.61 30.94 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.176 2.584 . . . . 0.0 109.052 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.8 t -138.72 136.14 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.389 1.076 . . . . 0.0 108.751 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 172.01 13.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.956 0.902 . . . . 0.0 110.806 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.12 120.1 22.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.596 1.158 . . . . 0.0 109.667 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -117.83 108.54 15.46 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.808 1.643 . . . . 0.0 110.633 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 62.7 p -70.77 -3.57 19.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.926 1.291 . . . . 0.0 114.169 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -69.86 -19.85 63.42 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.266 1.026 . . . . 0.0 112.786 173.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.43 151.57 94.04 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.043 0.937 . . . . 0.0 112.361 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.31 160.79 33.46 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.9 3.067 . . . . 0.0 112.529 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.83 133.83 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 112.376 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 64.4 36.0 9.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.759 2.024 . . . . 0.0 112.511 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.93 152.49 38.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 455' ' ' ILE . 18.8 pt -125.04 149.53 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.596 1.958 . . . . 0.0 112.111 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 111.19 23.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.445 1.498 . . . . 0.0 110.54 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.401 HG22 ' CE2' ' A' ' 457' ' ' PHE . 21.8 t -114.92 108.78 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.147 0.885 . . . . 0.0 111.884 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -72.03 135.02 46.21 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.856 1.262 . . . . 0.0 111.437 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.7 t -71.48 137.83 48.51 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.607 -0.683 . . . . 0.0 112.036 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -105.37 17.48 23.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.934 1.694 . . . . 0.0 110.447 160.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 57.3 m -120.8 138.95 53.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.727 1.611 . . . . 0.0 111.487 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 21.5 mt -105.71 132.14 52.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.046 2.138 . . . . 0.0 108.556 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -89.89 123.85 34.19 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 30.4 mm -114.38 109.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.841 0.857 . . . . 0.0 109.088 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.47 175.58 49.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.815 0.722 . . . . 0.0 112.07 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.14 13.57 70.21 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.29 0.948 . . . . 0.0 115.086 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.28 121.8 84.36 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-N 118.459 1.129 . . . . 0.0 110.452 -167.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.5 134.7 22.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.794 2.33 . . . . 0.0 109.633 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.16 -18.82 63.88 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.21 -33.29 75.47 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.592 1.157 . . . . 0.0 112.948 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -86.62 157.97 19.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -133.89 -177.7 4.68 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.064 1.746 . . . . 0.0 111.761 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -55.81 -35.73 66.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.36 1.464 . . . . 0.0 112.856 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -74.96 -25.21 58.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.53 -34.99 65.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.371 0.987 . . . . 0.0 110.616 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.2 mm? -60.02 -48.86 79.97 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.232 169.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.5 78.15 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.437 1.017 . . . . 0.0 112.466 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -67.42 -40.66 85.56 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.848 1.204 . . . . 0.0 112.92 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.37 -36.59 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 119.176 0.898 . . . . 0.0 112.192 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.471 HD23 ' CE2' ' A' ' 394' ' ' PHE . 67.7 mt -84.42 -13.15 52.95 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -46.05 -49.51 40.0 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 126.529 1.932 . . . . 0.0 115.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.2 -8.19 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.137 1.891 . . . . 0.0 113.705 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -97.24 -41.22 8.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.547 1.539 . . . . 0.0 112.155 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.65 172.52 4.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.672 1.589 . . . . 0.0 113.312 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -91.17 135.11 34.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.495 1.118 . . . . 0.0 111.074 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.6 131.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.146 1.378 . . . . 0.0 110.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -93.74 -42.89 8.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.081 1.352 . . . . 0.0 112.609 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 30.6 t -156.79 150.86 25.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 109.948 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 49.0 t -149.25 134.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.466 0.707 . . . . 0.0 109.823 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.44 107.79 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 166.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.9 tt -102.37 118.11 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 0.0 110.865 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -106.33 81.64 1.64 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.004 1.722 . . . . 0.0 109.223 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.66 -34.16 61.79 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.605 1.562 . . . . 0.0 111.411 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -60.66 -30.83 70.14 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.489 1.916 . . . . 0.0 113.632 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 3.32 20.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.239 1.416 . . . . 0.0 113.196 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 61.65 36.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.099 1.759 . . . . 0.0 111.57 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -124.1 154.25 40.26 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.857 2.063 . . . . 0.0 113.3 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.72 135.39 34.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.618 1.167 . . . . 0.0 111.772 161.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.64 121.19 29.75 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 160.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.71 119.46 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.127 0.971 . . . . 0.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -96.96 128.8 44.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.364 1.065 . . . . 0.0 111.213 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.83 165.7 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.452 1.101 . . . . 0.0 110.196 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -69.95 -14.58 62.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -170.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.98 159.16 40.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.546 -1.346 . . . . 0.0 113.256 -176.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -41.58 99.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.986 0.914 . . . . 0.0 109.87 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -64.97 -36.71 85.28 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.493 -0.754 . . . . 0.0 112.203 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -56.19 -53.18 60.22 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.932 0.787 . . . . 0.0 109.409 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.71 97.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.524 0.73 . . . . 0.0 112.819 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.57 -42.73 99.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.115 0.566 . . . . 0.0 111.352 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -67.86 -31.56 71.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.581 1.082 . . . . 0.0 112.368 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 86.1 t -60.9 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.918 164.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.2 -33.67 63.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.716 1.206 . . . . 0.0 114.145 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.36 -23.77 65.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.577 1.551 . . . . 0.0 113.995 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -122.14 -26.62 4.68 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 359' ' ' LEU . 13.3 t80 -73.67 121.93 21.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.817 0.818 . . . . 0.0 112.276 -166.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 28.8 t30 59.25 28.79 18.21 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.349 1.86 . . . . 0.0 115.089 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -56.71 -32.5 65.57 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.34 -8.79 31.66 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 114.698 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 6.78 65.45 Favored Glycine 0 CA--C 1.548 2.142 0 C-N-CA 125.195 1.379 . . . . 0.0 114.899 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -70.44 -36.52 74.01 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.75 151.64 71.29 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.849 0.859 . . . . 0.0 110.608 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.69 -26.77 9.53 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.643 2.229 . . . . 0.0 112.204 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.71 150.4 41.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.751 1.22 . . . . 0.0 111.723 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -120.59 92.14 3.7 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.841 1.256 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -74.43 119.99 19.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.104 0.961 . . . . 0.0 110.527 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 170.28 12.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.2 2.2 . . . . 0.0 108.882 172.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -65.77 131.67 46.87 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.169 -0.957 . . . . 0.0 111.013 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.7 -154.99 12.95 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 164.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 132.75 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.057 0.429 . . . . 0.0 112.1 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.14 -50.72 3.56 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -124.17 114.79 20.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.918 0.887 . . . . 0.0 113.036 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.26 143.72 3.97 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 118.704 -1.053 . . . . 0.0 114.846 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.85 144.54 30.95 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.856 3.704 . . . . 0.0 110.032 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -69.24 -30.57 68.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.636 0.774 . . . . 0.0 112.071 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.67 -33.5 72.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.459 2.303 . . . . 0.0 113.309 -175.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.8 m -123.89 34.86 4.96 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.041 2.136 . . . . 0.0 111.211 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.2 139.75 34.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.876 1.671 . . . . 0.0 111.74 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.75 77.8 1.81 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.757 1.623 . . . . 0.0 109.047 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -65.4 -10.53 34.4 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -75.03 -48.25 24.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.249 0.931 . . . . 0.0 110.056 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -84.0 -11.11 57.29 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.62 42.36 21.96 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.045 1.307 . . . . 0.0 112.936 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -151.36 169.55 21.72 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.07 0.948 . . . . 0.0 113.291 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.2 m -137.96 152.37 48.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.897 0.879 . . . . 0.0 111.09 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.1 mm -105.43 119.1 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.42 120.42 42.82 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 120.388 1.449 . . . . 0.0 110.331 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.77 146.87 26.97 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.16 -26.98 68.63 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -65.45 -21.46 66.65 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 119.985 1.266 . . . . 0.0 113.302 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -97.83 0.2 46.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.095 1.758 . . . . 0.0 113.394 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.63 122.66 34.4 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.147 0.979 . . . . 0.0 110.082 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 33.7 p -76.32 179.46 5.79 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.14 1.376 . . . . 0.0 111.667 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -39.55 91.42 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.651 -0.655 . . . . 0.0 111.601 170.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.092 0.957 . . . . 0.0 111.975 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.27 -52.18 65.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.775 1.63 . . . . 0.0 112.172 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -61.66 -40.89 96.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.928 0.891 . . . . 0.0 111.318 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.86 -36.21 83.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.201 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -68.21 -44.9 74.74 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.574 1.534 . . . . 0.0 110.837 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.3 m -54.08 -37.51 64.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.516 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.13 -46.4 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 3.9 t -96.0 -8.99 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -162.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.547 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -58.77 147.98 31.36 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.187 -0.945 . . . . 0.0 111.951 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.78 -38.55 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.33 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -103.55 135.58 44.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.83 1.252 . . . . 0.0 110.209 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 60.61 -159.02 27.03 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.387 -170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 63.64 -154.15 46.08 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.44 HG21 ' HB3' ' A' ' 451' ' ' LEU . 24.9 p -106.63 1.02 24.87 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -164.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.8 t 69.42 24.68 5.68 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.932 1.293 . . . . 0.0 112.095 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.74 9.86 63.82 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.058 1.313 . . . . 0.0 114.132 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -81.14 141.34 50.05 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.185 0.992 . . . . 0.0 110.822 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.24 112.23 2.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.966 2.444 . . . . 0.0 109.0 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -78.82 133.76 37.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.451 0.643 . . . . 0.0 112.012 -174.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.5 m -122.98 171.29 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.004 1.722 . . . . 0.0 111.578 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 87.3 m -49.7 123.08 7.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.33 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 103.2 -14.6 55.12 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.725 -1.042 . . . . 0.0 115.096 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 334' ' ' ILE . 2.5 tp -52.79 130.76 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.484 1.642 . . . . 0.0 111.532 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.87 131.38 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.145 2.178 . . . . 0.0 108.326 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.401 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.1 p90 -156.2 177.65 11.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.805 1.242 . . . . 0.0 112.605 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -99.74 154.01 18.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.709 1.604 . . . . 0.0 110.0 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.85 132.56 28.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -164.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.05 154.11 71.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.12 1.88 . . . . 0.0 110.631 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.547 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 73.2 m-20 -59.14 129.23 41.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.56 1.544 . . . . 0.0 113.348 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.65 55.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 123.308 1.528 . . . . 0.0 110.593 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.81 -176.6 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.53 146.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.61 -49.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.025 -1.047 . . . . 0.0 112.652 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.5 18.12 73.33 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 119.108 0.867 . . . . 0.0 114.088 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -172.02 177.5 3.22 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.424 1.89 . . . . 0.0 110.948 -161.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 172.36 148.06 6.05 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.347 1.451 . . . . 0.0 112.542 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.252 1.192 0 C-N-CA 125.834 1.653 . . . . 0.0 110.972 -176.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.713 0.292 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.18 -24.04 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.268 -0.895 . . . . 0.0 113.396 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -171.17 -167.22 31.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 126.434 1.969 . . . . 0.0 111.326 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -153.82 157.42 32.58 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.426 1.09 . . . . 0.0 111.604 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.52 166.21 29.3 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.925 3.083 . . . . 0.0 112.544 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.92 -1.43 28.48 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.1 m 72.87 4.45 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.983 2.113 . . . . 0.0 113.108 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.23 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 128.669 2.787 . . . . 0.0 112.337 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 62.8 -148.99 0.36 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.615 1.566 . . . . 0.0 111.637 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.48 -41.59 2.1 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.225 1.393 . . . . 0.0 114.26 167.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 12.1 t -67.48 -37.26 82.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.268 1.027 . . . . 0.0 112.251 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -97.32 -78.84 0.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.261 1.424 . . . . 0.0 110.87 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.119 1.768 . . . . 0.0 110.281 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -87.65 27.13 1.17 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -159.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -70.25 138.33 51.56 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.308 1.043 . . . . 0.0 112.781 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 2.9 mp -79.75 0.73 29.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.589 1.155 . . . . 0.0 113.232 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -134.76 161.08 65.84 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.468 1.507 . . . . 0.0 111.321 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -68.85 -172.27 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.883 3.056 . . . . 0.0 111.324 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -74.0 64.76 1.04 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.866 1.266 . . . . 0.0 111.325 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.5 169.28 17.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.609 1.964 . . . . 0.0 113.271 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.46 136.52 53.74 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.632 1.573 . . . . 0.0 111.492 -172.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -81.36 63.41 5.67 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.377 -0.827 . . . . 0.0 110.276 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 16.5 m -108.28 149.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.041 2.136 . . . . 0.0 110.669 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 78.7 p -62.22 -25.33 67.75 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -74.56 -20.49 59.93 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.8 0.84 . . . . 0.0 113.115 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -82.59 122.9 78.91 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.043 1.337 . . . . 0.0 109.683 172.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.93 -16.79 46.06 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.523 2.149 . . . . 0.0 113.112 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -72.72 1.34 8.62 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 166.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -52.87 127.11 22.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.412 1.46 . . . . 0.0 111.498 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -125.6 152.99 72.75 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.035 1.334 . . . . 0.0 110.606 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.42 158.92 55.6 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.296 2.664 . . . . 0.0 110.891 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.26 70.29 5.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 110.179 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.98 121.92 8.79 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.292 1.994 . . . . 0.0 108.994 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.37 127.69 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 109.316 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.93 163.95 28.38 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.151 1.38 . . . . 0.0 109.991 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -144.01 116.36 8.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.167 0.987 . . . . 0.0 109.34 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -121.54 107.79 12.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.069 0.938 . . . . 0.0 111.108 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -8.54 12.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.109 1.764 . . . . 0.0 113.923 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.2 t -68.31 -25.07 64.94 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.394 1.078 . . . . 0.0 112.651 172.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.03 150.55 96.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.63 0.772 . . . . 0.0 112.06 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.02 160.85 35.82 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.087 3.191 . . . . 0.0 112.934 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.46 134.14 27.87 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.958 3.105 . . . . 0.0 112.33 -171.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.55 40.02 11.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.698 1.599 . . . . 0.0 112.298 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -121.35 151.8 39.71 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 172.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 18.3 pt -123.12 151.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.744 2.018 . . . . 0.0 110.492 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.69 126.76 55.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.494 1.518 . . . . 0.0 110.184 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.95 109.64 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 118.715 0.689 . . . . 0.0 111.495 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -72.97 131.7 42.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.156 1.382 . . . . 0.0 112.079 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.9 m -70.26 138.18 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.532 -0.73 . . . . 0.0 112.482 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.54 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.8 mtm105 -109.3 13.46 24.26 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.539 1.936 . . . . 0.0 110.944 164.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 32.7 m -118.97 141.89 48.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.671 1.588 . . . . 0.0 110.974 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.69 133.2 49.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.579 1.952 . . . . 0.0 108.754 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -92.59 112.86 24.96 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 165.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 24.4 mm -97.87 120.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 179.41 37.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.618 1.104 . . . . 0.0 111.32 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.77 60.77 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 114.751 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.3 125.64 90.65 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 118.417 1.109 . . . . 0.0 109.951 -168.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 135.53 31.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.798 2.332 . . . . 0.0 109.671 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.9 mp -67.96 -10.83 56.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 -25.06 22.55 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.516 1.126 . . . . 0.0 112.985 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 19.4 mtm -79.91 149.02 31.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.885 0.85 . . . . 0.0 112.651 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -125.8 -176.01 3.5 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.504 1.921 . . . . 0.0 111.473 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 352' ' ' GLU . 2.4 mp0 -49.88 -44.86 50.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.485 2.314 . . . . 0.0 113.062 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -77.34 -20.53 54.72 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.67 -37.33 59.68 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.048 0.84 . . . . 0.0 110.54 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.2 -49.55 77.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.524 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -56.77 -39.26 73.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.228 0.922 . . . . 0.0 112.732 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.02 -44.36 76.66 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.701 1.137 . . . . 0.0 113.587 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.09 -32.44 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 119.837 1.199 . . . . 0.0 111.725 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.478 HD23 ' CE2' ' A' ' 394' ' ' PHE . 62.0 mt -89.76 -10.58 45.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -46.89 -47.47 52.91 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.021 1.728 . . . . 0.0 115.37 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -6.98 16.77 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.203 1.935 . . . . 0.0 113.585 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -98.11 -39.2 9.02 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.609 1.563 . . . . 0.0 112.486 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.89 168.58 4.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.09 1.756 . . . . 0.0 113.31 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.36 129.47 34.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.856 0.862 . . . . 0.0 110.095 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.66 130.6 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.77 0.828 . . . . 0.0 110.206 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -95.0 -44.4 7.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.803 1.241 . . . . 0.0 112.536 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.3 m -144.13 152.63 41.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.474 1.109 . . . . 0.0 111.363 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 59.9 t -143.67 114.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.243 0.928 . . . . 0.0 110.936 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.6 93.46 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.6 tt -99.14 129.27 45.38 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.513 0.725 . . . . 0.0 110.585 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -123.43 90.96 3.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.424 1.09 . . . . 0.0 109.932 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -58.57 -28.23 65.34 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.38 1.072 . . . . 0.0 112.266 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 22.7 t -56.44 -38.11 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.382 1.873 . . . . 0.0 114.178 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -107.04 6.98 29.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.867 1.267 . . . . 0.0 113.058 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 59.28 36.43 23.61 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.627 1.571 . . . . 0.0 111.412 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -124.18 164.06 20.27 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.28 33.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.759 1.224 . . . . 0.0 112.544 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.93 104.81 14.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.3 1.04 . . . . 0.0 108.654 164.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.87 100.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.111 1.364 . . . . 0.0 109.837 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -80.74 123.47 28.24 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.204 0.602 . . . . 0.0 110.277 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.53 168.01 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.346 166.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.73 -22.16 54.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.39 156.52 48.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 120.064 1.302 . . . . 0.0 113.704 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.49 -44.67 96.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.65 0.78 . . . . 0.0 112.322 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -66.46 -31.14 71.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.045 -0.41 . . . . 0.0 111.674 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.08 -53.89 42.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.755 1.222 . . . . 0.0 111.06 167.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.03 84.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.867 0.758 . . . . 0.0 112.133 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.77 -42.68 97.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.26 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -66.72 -30.69 70.98 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 120.126 1.33 . . . . 0.0 112.738 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.68 -63.56 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.736 0.698 . . . . 0.0 109.497 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.5 mt -52.25 -36.12 51.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.02 -42.95 88.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.046 1.338 . . . . 0.0 112.474 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -105.32 -23.5 12.85 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 359' ' ' LEU . 20.4 t80 -74.11 123.55 24.64 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.484 -0.76 . . . . 0.0 111.489 -168.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 61.79 29.27 17.94 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.807 1.643 . . . . 0.0 114.48 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.95 -34.69 65.91 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.804 -1.185 . . . . 0.0 113.396 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.37 -19.53 53.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.324 1.05 . . . . 0.0 113.525 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.03 70.18 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.65 1.119 . . . . 0.0 114.046 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.08 -31.53 20.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.6 1.56 . . . . 0.0 114.802 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 19.7 mt -80.62 150.78 70.53 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.351 1.06 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.93 -32.47 7.13 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.405 2.07 . . . . 0.0 112.169 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.32 151.65 45.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.286 1.434 . . . . 0.0 111.756 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -127.94 96.38 4.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.768 1.227 . . . . 0.0 109.739 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 32.8 m -73.28 123.78 24.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.357 1.063 . . . . 0.0 110.634 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -126.52 173.63 9.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.703 2.001 . . . . 0.0 108.817 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -72.11 133.48 45.23 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.94 -1.1 . . . . 0.0 111.574 164.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.94 -153.09 9.54 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 125.777 1.656 . . . . 0.0 109.295 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.35 137.06 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.13 -52.98 2.93 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.723 1.63 . . . . 0.0 109.784 167.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.89 117.85 25.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.37 142.79 4.65 Favored Glycine 0 CA--C 1.543 1.836 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.96 130.28 15.34 Favored 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 125.746 4.297 . . . . 0.0 110.849 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -67.23 -32.09 72.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.42 -18.66 54.65 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.93 1.692 . . . . 0.0 113.83 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 77.8 m -122.9 28.73 7.11 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.586 1.555 . . . . 0.0 111.881 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 6.5 t -84.4 141.81 30.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.073 1.349 . . . . 0.0 111.429 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.37 80.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.779 1.631 . . . . 0.0 108.915 167.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -63.95 -20.51 65.93 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.547 -0.721 . . . . 0.0 112.904 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.32 -47.62 69.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.529 1.513 . . . . 0.0 111.266 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -83.2 -13.59 55.09 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.4 42.54 18.11 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.809 1.195 . . . . 0.0 112.374 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -147.27 168.74 20.97 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.026 1.413 . . . . 0.0 113.151 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 24.5 m -131.17 152.35 50.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.285 1.034 . . . . 0.0 110.704 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.2 mm -106.29 133.06 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.531 HG21 HD21 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -126.55 118.96 22.94 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 120.116 1.326 . . . . 0.0 110.981 -173.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -73.96 139.01 26.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.44 2.093 . . . . 0.0 111.121 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 10.9 mtt -63.02 -28.81 70.35 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.41 -19.29 65.88 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -104.85 3.81 31.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.562 1.945 . . . . 0.0 113.642 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.531 HD21 HG21 ' A' ' 425' ' ' ILE . 97.9 mt -92.05 136.32 33.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 110.395 170.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.2 p -79.94 178.77 7.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.514 1.126 . . . . 0.0 111.51 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.595 -0.691 . . . . 0.0 111.633 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.59 88.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.889 0.875 . . . . 0.0 112.025 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.69 -52.76 63.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.517 1.127 . . . . 0.0 112.284 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -65.56 -37.5 86.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.859 -0.526 . . . . 0.0 111.102 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -60.16 -42.17 94.39 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.78 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -66.59 -44.3 82.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.041 1.746 . . . . 0.0 111.271 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.2 m -56.59 -32.38 65.17 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.332 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.68 -39.75 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.8 m -103.26 -7.75 20.89 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -168.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.82 147.06 39.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.211 1.368 . . . . 0.0 111.604 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -77.11 -55.29 5.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.33 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -92.78 132.45 36.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.346 0.975 . . . . 0.0 110.533 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.81 179.34 10.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.015 0.817 . . . . 0.0 113.459 -173.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.67 -163.88 34.02 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 122.242 -0.563 . . . . 0.0 113.114 -168.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.1 p -109.78 7.44 24.17 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -163.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 37.4 p 76.74 15.81 1.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.972 2.109 . . . . 0.0 113.901 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.49 4.08 64.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.988 1.28 . . . . 0.0 113.352 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -66.01 138.34 96.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.901 1.28 . . . . 0.0 109.446 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -60.19 140.91 94.57 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.177 1.918 . . . . 0.0 110.176 169.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.04 130.24 43.22 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.29 159.69 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.473 1.509 . . . . 0.0 110.089 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 78.2 m -56.61 124.92 19.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.75 -2.05 76.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.593 -1.115 . . . . 0.0 115.541 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.4 tt -62.96 140.42 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.494 1.647 . . . . 0.0 112.127 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.56 136.78 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.829 2.052 . . . . 0.0 109.61 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -162.47 175.46 11.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.097 1.359 . . . . 0.0 113.104 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.72 148.69 21.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 111.397 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -51.47 126.25 29.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -168.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.78 152.84 64.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.073 2.515 . . . . 0.0 110.539 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -63.55 144.5 56.94 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.34 52.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.337 1.541 . . . . 0.0 110.133 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.37 -178.16 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.79 141.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.63 -39.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.636 -1.29 . . . . 0.0 112.904 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 83.16 -54.64 4.99 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.202 0.906 . . . . 0.0 112.063 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.68 141.93 3.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -162.72 161.72 33.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.199 1.38 . . . . 0.0 113.323 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.001 1.32 . . . . 0.0 113.377 -172.752 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.799 -0.074 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 2.5 pp -118.2 161.85 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.363 1.465 . . . . 0.0 110.94 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.48 110.26 0.45 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.57 1.081 . . . . 0.0 110.796 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -147.51 153.79 44.13 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.882 1.273 . . . . 0.0 110.537 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.03 173.81 8.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.898 3.065 . . . . 0.0 111.39 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -55.1 127.63 30.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 111.71 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.169 1.388 . . . . 0.0 112.949 173.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.76 60.15 1.13 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.275 1.03 . . . . 0.0 109.391 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -32.86 -64.36 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.139 2.176 . . . . 0.0 112.671 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.89 -146.11 3.8 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.158 1.361 . . . . 0.0 113.126 169.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 24.0 m 69.64 -74.98 0.08 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.266 1.827 . . . . 0.0 110.479 170.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -150.63 17.08 0.8 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 127.467 2.307 . . . . 0.0 113.246 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -153.65 156.61 38.22 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.668 -1.27 . . . . 0.0 113.259 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.1 8.74 3.22 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -166.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.0 133.32 46.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.16 0.984 . . . . 0.0 112.258 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.1 mp -81.53 -41.74 21.21 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.968 1.307 . . . . 0.0 111.116 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -116.14 65.99 2.96 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.962 0.905 . . . . 0.0 110.876 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.17 -172.99 0.97 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.2 3.267 . . . . 0.0 110.887 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 77.27 36.91 0.28 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.294 1.838 . . . . 0.0 112.5 170.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.0 159.41 39.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.324 1.45 . . . . 0.0 112.504 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.75 162.67 18.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.665 1.186 . . . . 0.0 111.606 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -77.94 62.68 2.79 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.938 0.895 . . . . 0.0 110.386 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.79 149.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.359 2.263 . . . . 0.0 110.671 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 18.2 t -61.47 -26.79 68.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -67.41 -27.95 67.51 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.224 -0.923 . . . . 0.0 112.869 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -78.93 123.35 85.15 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.766 1.226 . . . . 0.0 110.191 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.1 -18.0 51.08 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.663 2.242 . . . . 0.0 113.305 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -77.8 1.07 21.41 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 169.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -49.31 134.02 18.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.593 1.542 . . . . 0.0 111.919 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 81.4 mmt-85 -136.82 144.88 48.53 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.242 1.017 . . . . 0.0 110.054 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.98 161.87 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 110.827 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -117.04 66.78 4.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.629 1.171 . . . . 0.0 109.729 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.31 115.08 4.01 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.906 2.404 . . . . 0.0 109.487 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 19.3 m -92.84 139.99 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.912 0.885 . . . . 0.0 110.083 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.43 164.07 29.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.022 1.329 . . . . 0.0 110.301 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -143.77 120.57 11.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.132 0.973 . . . . 0.0 109.426 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.33 110.53 17.08 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.581 0.705 . . . . 0.0 110.656 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -8.49 44.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.952 0.901 . . . . 0.0 113.299 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 64.2 p -70.54 -24.44 62.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.479 1.512 . . . . 0.0 112.174 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.0 150.53 88.1 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.958 0.903 . . . . 0.0 111.576 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 161.32 38.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.055 3.17 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.48 136.63 37.18 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.157 3.238 . . . . 0.0 112.038 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.71 33.64 10.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.428 1.491 . . . . 0.0 113.024 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.23 151.52 32.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.634 -1.291 . . . . 0.0 114.353 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 451' ' ' LEU . 12.0 pt -120.62 142.1 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.159 1.784 . . . . 0.0 110.485 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -107.75 111.54 23.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.672 -1.267 . . . . 0.0 110.63 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 25.4 t -105.69 101.33 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.865 0.866 . . . . 0.0 110.29 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -67.32 123.08 19.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.194 0.997 . . . . 0.0 111.477 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 37.2 t -69.74 134.66 48.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.625 -0.672 . . . . 0.0 111.425 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.5 mtm105 -101.93 9.98 40.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.891 1.677 . . . . 0.0 109.986 164.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 54.2 m -112.97 138.45 49.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.449 1.499 . . . . 0.0 111.041 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 40.1 mt -100.51 139.69 35.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.848 1.659 . . . . 0.0 109.503 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -95.27 138.44 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 164.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.45 114.57 44.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.68 166.28 26.34 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.484 1.04 . . . . 0.0 110.6 163.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.24 43.39 32.27 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 121.972 -0.722 . . . . 0.0 112.929 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.17 84.54 2.86 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.132 1.373 . . . . 0.0 110.875 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.31 173.28 11.69 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.287 2.658 . . . . 0.0 112.044 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.28 -21.75 50.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -18.9 61.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.19 0.996 . . . . 0.0 112.915 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.7 mtp -100.67 131.73 46.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.107 1.763 . . . . 0.0 109.921 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -141.23 170.07 16.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.082 1.753 . . . . 0.0 111.286 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.7 -42.66 62.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.631 1.172 . . . . 0.0 113.843 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -76.87 -27.65 55.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -38.59 84.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.663 167.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 355' ' ' LEU . 2.1 mm? -59.82 -47.96 83.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.747 0.703 . . . . 0.0 110.974 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -57.59 -42.51 83.3 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.163 0.892 . . . . 0.0 112.884 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.38 -39.69 89.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.929 1.241 . . . . 0.0 113.226 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.3 -35.35 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.539 1.063 . . . . 0.0 111.528 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.697 HD22 HG11 ' A' ' 390' ' ' VAL . 25.9 mt -85.65 -11.27 54.23 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.187 0.903 . . . . 0.0 112.819 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -48.3 82.54 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 126.187 1.795 . . . . 0.0 115.166 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.52 -7.35 18.62 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.023 1.815 . . . . 0.0 112.985 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -96.86 -40.14 9.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.297 1.439 . . . . 0.0 112.369 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.41 172.86 3.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.116 1.766 . . . . 0.0 113.484 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.52 116.88 24.93 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.868 . . . . 0.0 110.506 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 75.3 t -77.82 133.55 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.148 0.979 . . . . 0.0 110.184 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -94.05 -54.17 3.69 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.372 1.469 . . . . 0.0 112.269 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.5 m -140.07 155.11 47.18 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.823 1.249 . . . . 0.0 111.28 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.411 HG22 HG13 ' A' ' 379' ' ' VAL . 57.8 t -144.56 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.059 0.544 . . . . 0.0 110.514 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.56 105.64 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.873 1.269 . . . . 0.0 107.666 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.44 125.8 43.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.396 0.678 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 83.45 2.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.945 1.355 . . . . 0.0 109.706 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.09 -21.61 66.29 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.595 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.5 t -57.26 -31.75 65.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.848 1.659 . . . . 0.0 113.718 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -112.3 10.89 20.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.931 1.692 . . . . 0.0 113.179 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.3 mttt 58.74 32.81 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.159 1.384 . . . . 0.0 113.171 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -126.19 169.5 12.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.23 158.63 43.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 163.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -114.05 128.9 56.59 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.267 1.427 . . . . 0.0 108.641 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 359' ' ' LEU . 63.9 t -128.08 105.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.896 0.878 . . . . 0.0 111.079 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.71 119.03 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.335 1.054 . . . . 0.0 109.791 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.65 152.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.723 1.609 . . . . 0.0 107.517 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -66.33 -19.89 65.93 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.66 156.94 43.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.586 1.085 . . . . 0.0 112.427 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -44.55 96.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.215 1.006 . . . . 0.0 109.975 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -38.84 90.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.877 0.871 . . . . 0.0 111.566 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -63.92 -53.02 56.92 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.526 1.13 . . . . 0.0 111.361 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.34 73.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.841 0.746 . . . . 0.0 112.284 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.21 -45.4 91.18 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.175 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -61.55 -36.01 79.4 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.257 0.935 . . . . 0.0 112.187 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.697 HG11 HD22 ' A' ' 359' ' ' LEU . 19.1 t -62.74 -61.04 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.469 169.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.05 -37.9 35.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.041 1.337 . . . . 0.0 113.73 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -69.67 -29.43 66.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.869 1.268 . . . . 0.0 113.666 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -111.79 -26.28 9.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.556 1.071 . . . . 0.0 113.709 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 359' ' ' LEU . 15.7 t80 -69.98 119.3 13.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.545 0.688 . . . . 0.0 111.698 -167.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 60.29 35.77 20.74 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.349 1.46 . . . . 0.0 113.532 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -62.72 -36.08 81.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.58 -14.85 31.68 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.444 1.498 . . . . 0.0 113.93 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.76 29.57 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.519 1.057 . . . . 0.0 114.666 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -80.5 -41.75 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.181 1.491 . . . . 0.0 114.581 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.2 mt -75.38 150.46 84.92 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.11 0.964 . . . . 0.0 109.802 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.18 -28.04 13.1 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.459 2.106 . . . . 0.0 112.436 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.8 141.76 28.35 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.448 0.699 . . . . 0.0 111.287 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.6 126.12 54.12 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.001 0.92 . . . . 0.0 109.92 172.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 m -106.41 129.82 54.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.55 1.14 . . . . 0.0 109.922 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.72 175.17 9.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.46 1.904 . . . . 0.0 109.257 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -65.55 125.03 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.593 163.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -109.41 -157.21 17.37 Favored Glycine 0 N--CA 1.463 0.483 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.77 136.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.75 -51.23 2.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.736 1.636 . . . . 0.0 109.952 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -119.85 109.39 15.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.417 0.687 . . . . 0.0 112.753 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.95 136.29 3.53 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.049 -0.862 . . . . 0.0 115.222 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.444 ' HG3' HG23 ' A' ' 425' ' ' ILE . 95.8 Cg_endo -71.02 132.08 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.589 4.193 . . . . 0.0 109.89 171.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -65.37 -36.86 85.27 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.626 -0.671 . . . . 0.0 112.74 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -73.33 -20.62 60.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 46.2 m -117.36 19.06 14.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.122 1.769 . . . . 0.0 112.599 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.82 153.15 35.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.945 0.879 . . . . 0.0 112.429 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.26 78.97 1.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.91 1.684 . . . . 0.0 108.704 166.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.67 -19.22 64.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 113.275 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -70.81 -50.75 32.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.024 0.829 . . . . 0.0 110.774 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -81.27 -15.91 54.11 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.83 21.36 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.016 1.293 . . . . 0.0 113.254 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -146.78 172.81 13.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.603 1.202 . . . . 0.0 113.35 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 30.0 m -133.83 146.05 50.28 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.173 0.989 . . . . 0.0 110.74 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 14.6 mm -107.0 95.86 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.542 0.737 . . . . 0.0 109.487 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.554 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -94.57 123.54 57.92 Favored Pre-proline 0 N--CA 1.474 0.726 0 O-C-N 121.029 -1.045 . . . . 0.0 111.193 -168.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.59 132.85 22.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.526 2.15 . . . . 0.0 111.109 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 17.6 mtt -60.71 -30.8 70.18 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.026 1.331 . . . . 0.0 113.363 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -65.49 -16.8 64.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 8.15 24.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.845 2.058 . . . . 0.0 113.554 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 425' ' ' ILE . 96.0 mt -89.35 140.12 29.82 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.233 0.924 . . . . 0.0 110.211 169.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 20.7 p -75.88 178.33 6.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.57 1.148 . . . . 0.0 111.232 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.47 -46.17 87.46 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.42 -0.8 . . . . 0.0 111.073 169.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.876 0.87 . . . . 0.0 112.234 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.78 -55.41 35.47 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.286 1.434 . . . . 0.0 112.475 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -65.88 -36.67 84.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.845 -0.534 . . . . 0.0 110.791 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -59.12 -41.43 88.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.499 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -68.28 -45.97 71.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.423 1.465 . . . . 0.0 111.232 170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 49.6 m -53.48 -36.13 61.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.612 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.62 -42.92 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.0 t -101.13 -9.06 21.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.739 1.216 . . . . 0.0 114.141 -167.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -57.21 146.68 27.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.427 1.108 . . . . 0.0 112.079 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.1 -57.9 3.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.734 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -91.46 132.69 36.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.273 1.029 . . . . 0.0 110.934 163.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 63.93 176.28 4.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.803 1.192 . . . . 0.0 114.094 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 87.1 -165.95 36.48 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.515 1.055 . . . . 0.0 112.748 -167.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 58.4 p -106.71 16.29 24.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -158.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.1 p 60.4 26.86 16.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.95 1.3 . . . . 0.0 113.441 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.44 -0.0 77.03 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.506 1.527 . . . . 0.0 114.207 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -66.84 135.67 94.3 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.795 1.297 . . . . 0.0 110.13 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -59.51 144.04 99.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.534 2.156 . . . . 0.0 110.077 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 334' ' ' ILE . 80.7 mt -65.38 123.88 20.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.113 0.483 . . . . 0.0 110.493 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.06 157.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.002 2.121 . . . . 0.0 109.422 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.7 m -52.28 117.71 3.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.309 0.644 . . . . 0.0 110.064 167.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 75.56 17.94 79.97 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.531 -1.15 . . . . 0.0 115.01 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 20.6 tt -62.5 126.91 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.231 1.516 . . . . 0.0 111.003 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.36 141.2 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.948 2.099 . . . . 0.0 109.501 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -166.29 171.93 11.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.36 1.464 . . . . 0.0 113.118 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.77 145.14 26.75 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.653 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -56.05 136.61 73.79 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -165.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.39 150.42 46.54 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.156 2.571 . . . . 0.0 110.992 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.414 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 85.9 m-20 -59.82 142.04 54.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.964 1.305 . . . . 0.0 113.881 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.35 52.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.635 1.683 . . . . 0.0 110.144 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -178.6 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.003 141.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.97 -44.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.759 -1.213 . . . . 0.0 111.886 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 79.07 -76.92 1.87 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.43 174.29 6.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.511 1.524 . . . . 0.0 111.72 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -176.25 164.61 34.59 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.949 1.261 . . . . 0.0 113.528 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 125.557 1.543 . . . . 0.0 111.879 -179.305 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.908 0.385 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 74.2 mt -138.81 -62.79 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.516 1.127 . . . . 0.0 109.987 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.48 175.17 23.63 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.756 1.646 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.91 32.83 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.998 1.319 . . . . 0.0 111.344 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 170.01 20.31 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 124.312 3.342 . . . . 0.0 112.195 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.16 14.0 1.3 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.146 1.378 . . . . 0.0 114.24 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 21.7 p 55.84 11.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 128.84 2.856 . . . . 0.0 115.574 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.88 -35.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.318 2.647 . . . . 0.0 111.748 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER 47.86 -103.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.514 1.525 . . . . 0.0 110.447 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 68.27 179.14 16.95 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.878 0.751 . . . . 0.0 111.767 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 87.1 m 66.66 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.971 1.708 . . . . 0.0 110.761 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -103.9 108.14 19.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.969 1.707 . . . . 0.0 110.238 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 68.37 171.92 0.28 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.792 1.637 . . . . 0.0 113.334 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -146.17 16.74 1.36 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -72.37 140.34 48.38 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.059 0.943 . . . . 0.0 113.072 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.56 8.22 10.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.955 1.302 . . . . 0.0 113.089 171.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.28 160.42 59.88 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.803 1.241 . . . . 0.0 111.585 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.14 -171.56 0.52 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.917 3.078 . . . . 0.0 111.412 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -76.32 55.4 0.98 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.378 1.071 . . . . 0.0 111.641 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.48 143.17 48.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.197 1.399 . . . . 0.0 111.964 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.0 mt -89.82 144.62 25.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.48 0.712 . . . . 0.0 111.46 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -79.8 64.3 4.61 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.897 -1.127 . . . . 0.0 110.202 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.63 154.86 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.979 2.112 . . . . 0.0 110.681 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 83.6 p -62.98 -23.26 67.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -69.17 -28.25 66.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.961 0.905 . . . . 0.0 113.201 171.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -74.92 123.15 88.8 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.867 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.04 -17.6 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.467 2.111 . . . . 0.0 113.051 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -81.82 7.17 13.43 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.828 1.251 . . . . 0.0 113.978 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -53.42 124.38 14.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.731 -1.231 . . . . 0.0 110.937 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -128.81 139.21 34.98 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 124.932 1.293 . . . . 0.0 109.223 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.9 156.93 59.47 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.884 2.389 . . . . 0.0 110.415 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 74.17 3.03 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.35 1.06 . . . . 0.0 109.962 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.6 111.59 3.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.613 2.209 . . . . 0.0 109.098 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.89 131.42 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.436 0.695 . . . . 0.0 110.042 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.41 169.57 15.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.635 1.574 . . . . 0.0 110.552 173.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -139.99 125.35 18.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.427 1.091 . . . . 0.0 110.108 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -121.23 107.38 12.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.877 0.871 . . . . 0.0 110.839 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.7 m -68.81 -5.58 21.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 55.7 p -71.33 -22.25 61.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.499 1.12 . . . . 0.0 112.188 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.1 mt -71.27 152.73 94.37 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.962 0.905 . . . . 0.0 112.247 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.81 162.17 33.06 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.113 3.208 . . . . 0.0 112.899 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.43 136.84 32.18 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.139 3.226 . . . . 0.0 112.389 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.72 47.35 10.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 111.798 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -126.12 152.91 45.28 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.337 1.055 . . . . 0.0 113.568 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.02 144.16 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.346 1.858 . . . . 0.0 109.791 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -117.29 133.27 56.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.569 -1.332 . . . . 0.0 111.613 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.72 101.86 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.957 0.903 . . . . 0.0 110.582 -169.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -68.72 127.07 31.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.63 1.172 . . . . 0.0 112.024 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.3 m -70.22 135.49 49.07 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.523 -0.736 . . . . 0.0 112.275 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.4 mtm105 -102.42 10.24 39.14 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.881 1.673 . . . . 0.0 110.608 164.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 19.4 m -117.42 145.52 44.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.319 1.448 . . . . 0.0 112.141 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 52.9 mt -105.9 136.26 45.87 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.181 1.792 . . . . 0.0 109.552 172.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -88.98 140.95 28.91 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 162.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 18.3 mm -125.93 116.41 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.722 1.209 . . . . 0.0 108.484 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -98.55 -177.11 32.67 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.313 0.959 . . . . 0.0 111.943 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.22 64.73 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 121.826 -0.808 . . . . 0.0 114.979 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.69 116.41 53.3 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-O 117.665 -1.16 . . . . 0.0 110.061 -166.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.23 135.29 33.87 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.305 2.003 . . . . 0.0 109.596 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.09 -20.26 63.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.38 -33.46 75.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.146 0.979 . . . . 0.0 111.949 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 3.8 ptp -82.6 151.58 26.29 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.527 0.68 . . . . 0.0 112.81 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -129.76 -175.71 3.68 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.169 1.788 . . . . 0.0 111.555 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.26 -39.79 57.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.753 1.221 . . . . 0.0 113.791 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -75.93 -21.64 56.85 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -74.52 -39.15 62.56 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.841 . . . . 0.0 110.568 169.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.8 mm? -58.07 -50.4 73.59 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.353 0.524 . . . . 0.0 110.569 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.89 80.24 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.596 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -68.46 -40.65 80.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.945 1.248 . . . . 0.0 113.512 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.51 -37.33 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.083 0.856 . . . . 0.0 111.493 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.653 HD23 ' CE1' ' A' ' 394' ' ' PHE . 27.3 mt -83.83 -9.25 58.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.056 0.942 . . . . 0.0 112.75 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.66 -49.43 65.58 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 126.152 1.781 . . . . 0.0 114.889 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.51 -7.32 18.61 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.076 1.851 . . . . 0.0 113.185 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.83 -41.32 8.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.274 1.43 . . . . 0.0 112.3 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.73 172.85 3.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 113.743 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.27 111.87 23.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 111.43 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.82 131.25 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.983 0.913 . . . . 0.0 110.991 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.85 -46.16 8.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.106 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -151.22 152.52 33.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.604 1.162 . . . . 0.0 111.482 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.84 137.21 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.646 . . . . 0.0 110.963 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.81 106.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.638 1.175 . . . . 0.0 107.846 166.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.19 133.0 45.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.003 0.921 . . . . 0.0 110.254 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.55 91.47 3.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.727 1.211 . . . . 0.0 110.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.0 -27.32 68.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.489 1.116 . . . . 0.0 111.89 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 71.4 m -57.62 -32.05 66.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.025 1.73 . . . . 0.0 114.269 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 8.9 17.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.0 112.729 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.4 mttt 51.99 40.84 29.12 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.704 1.602 . . . . 0.0 112.754 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -127.33 166.7 17.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -146.27 161.0 41.24 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -115.44 130.93 57.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.985 1.314 . . . . 0.0 108.379 164.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 359' ' ' LEU . 57.3 t -123.24 102.25 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.945 0.898 . . . . 0.0 110.191 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -74.74 111.02 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.699 1.2 . . . . 0.0 110.127 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.86 153.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.68 1.592 . . . . 0.0 107.85 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.38 -17.88 64.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.81 159.24 44.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.135 1.334 . . . . 0.0 113.004 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -48.98 77.62 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.741 0.816 . . . . 0.0 110.305 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.7 -36.0 79.66 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.682 0.793 . . . . 0.0 111.64 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.91 -55.55 21.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 111.543 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.4 72.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.061 0.846 . . . . 0.0 112.954 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -60.53 -47.69 85.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.385 1.074 . . . . 0.0 111.878 170.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.03 -34.51 76.37 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.569 -0.707 . . . . 0.0 112.053 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 359' ' ' LEU . 21.7 t -61.63 -62.03 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.502 167.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.0 mt -51.31 -35.28 37.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.789 1.236 . . . . 0.0 114.291 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.87 -33.11 75.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.938 1.295 . . . . 0.0 113.532 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -117.2 -27.68 6.4 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 359' ' ' LEU . 20.3 t80 -74.93 123.18 24.64 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.627 0.771 . . . . 0.0 110.919 -169.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.61 23.96 12.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -30.92 63.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.535 1.134 . . . . 0.0 113.766 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.16 -14.43 15.15 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.729 2.012 . . . . 0.0 114.229 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.29 35.48 7.0 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.716 1.15 . . . . 0.0 114.385 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.73 83.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.66 156.37 38.95 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.626 1.57 . . . . 0.0 110.497 -174.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.84 -19.13 24.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.723 2.282 . . . . 0.0 113.908 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.2 mt -62.82 166.76 5.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.903 2.081 . . . . 0.0 113.072 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -137.16 95.0 3.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.46 1.104 . . . . 0.0 110.313 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.5 122.51 28.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.283 1.833 . . . . 0.0 111.063 -172.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 170.44 14.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.596 1.958 . . . . 0.0 109.28 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -64.22 120.17 11.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.336 -0.853 . . . . 0.0 110.424 161.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.1 -155.52 25.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 411' ' ' GLY . 11.0 p -167.35 136.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.441 1.096 . . . . 0.0 110.167 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -80.14 -49.67 5.84 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.423 1.011 . . . . 0.0 110.96 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -115.2 96.65 5.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 111.08 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 408' ' ' VAL . . . -158.65 122.58 1.16 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.768 -1.018 . . . . 0.0 114.772 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.85 125.23 9.27 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.531 3.487 . . . . 0.0 110.24 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -56.37 -40.45 74.58 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.91 -15.04 61.15 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.26 16.48 13.14 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 112.224 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 138.47 31.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.406 1.482 . . . . 0.0 111.776 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -118.63 86.52 2.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.997 1.719 . . . . 0.0 108.708 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -69.36 -15.57 63.34 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.66 -48.79 58.57 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.947 -1.095 . . . . 0.0 110.602 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -84.65 -16.92 40.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.22 44.83 10.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.575 1.083 . . . . 0.0 112.431 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.61 158.17 42.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.059 0.93 . . . . 0.0 113.491 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.81 151.62 28.83 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.967 -1.083 . . . . 0.0 110.69 168.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.89 104.03 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 0.0 109.015 172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.27 131.17 22.16 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.846 -167.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.73 138.66 41.89 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.172 1.914 . . . . 0.0 110.748 168.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 4.9 mtm -61.66 -32.92 73.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.344 1.058 . . . . 0.0 112.601 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -68.81 -11.01 59.95 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -110.11 8.12 23.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.309 1.443 . . . . 0.0 113.488 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 76.2 mt -91.33 135.88 33.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.409 0.684 . . . . 0.0 110.35 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 26.3 p -72.73 175.94 6.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.424 1.09 . . . . 0.0 110.749 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -42.67 98.16 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.633 -0.667 . . . . 0.0 111.046 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.18 82.67 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 112.365 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.47 -53.82 53.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.563 1.145 . . . . 0.0 111.677 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -67.77 -35.83 79.39 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.864 -0.522 . . . . 0.0 111.615 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -54.26 -51.93 62.98 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.587 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -68.5 -40.97 80.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.472 1.487 . . . . 0.0 111.683 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -54.68 -29.62 53.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.083 -0.96 . . . . 0.0 113.138 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.48 -40.9 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 171.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.0 t -104.23 -4.76 22.64 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.136 1.374 . . . . 0.0 114.458 -165.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.72 145.88 32.96 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.995 -1.066 . . . . 0.0 111.761 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -53.13 9.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.734 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -95.23 136.52 35.46 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.808 0.843 . . . . 0.0 111.326 162.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.29 -164.07 53.92 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.392 0.996 . . . . 0.0 113.053 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.17 -168.08 52.51 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.183 0.42 . . . . 0.0 112.202 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 73.3 p -98.51 7.79 45.71 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 74.7 25.72 1.49 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.797 1.239 . . . . 0.0 112.808 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.93 82.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.07 1.319 . . . . 0.0 114.007 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -68.31 149.05 98.21 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.3 1.05 . . . . 0.0 110.219 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.28 147.57 93.68 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.341 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.17 122.88 20.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 172.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.64 153.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.557 1.943 . . . . 0.0 109.025 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 63.9 m -51.91 125.38 15.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.74 0.416 . . . . 0.0 110.096 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.31 89.1 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.503 -1.165 . . . . 0.0 114.848 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 17.2 tt -60.03 139.48 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.487 1.644 . . . . 0.0 111.414 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.62 139.55 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.245 1.818 . . . . 0.0 109.457 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -159.89 172.88 16.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.421 1.488 . . . . 0.0 112.193 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.34 150.56 22.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.264 1.026 . . . . 0.0 110.826 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.34 127.79 23.45 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.84 150.29 55.36 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.544 2.163 . . . . 0.0 111.115 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -61.76 146.21 50.09 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.0 113.819 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.3 50.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 123.194 1.473 . . . . 0.0 110.32 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.21 171.15 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.954 139.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 34.9 t -139.5 -43.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.0 -1.063 . . . . 0.0 111.446 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.79 -111.73 3.92 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -152.26 134.32 14.97 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.19 -175.08 21.33 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.135 1.35 . . . . 0.0 113.604 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.255 1.37 0 C-N-CA 127.184 2.194 . . . . 0.0 111.448 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.594 0.235 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.2 pt -84.96 -179.74 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.702 1.201 . . . . 0.0 112.191 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 100.54 52.06 1.16 Allowed Glycine 0 N--CA 1.472 1.059 0 C-N-CA 124.68 1.133 . . . . 0.0 112.994 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -157.95 157.03 29.19 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.47 1.908 . . . . 0.0 110.069 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.14 -74.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.45 2.766 . . . . 0.0 111.692 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 31.9 t30 42.49 88.87 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.378 1.871 . . . . 0.0 114.548 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -48.62 66.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.401 1.081 . . . . 0.0 111.89 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 15.0 t -171.07 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.768 1.627 . . . . 0.0 113.62 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -67.67 144.12 55.65 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.519 -1.363 . . . . 0.0 112.536 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.23 0.38 Allowed Glycine 0 N--CA 1.474 1.233 0 C-N-CA 123.922 0.772 . . . . 0.0 114.698 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 7.6 t -131.12 -42.06 1.1 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.352 1.461 . . . . 0.0 112.542 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -150.77 155.38 39.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.414 1.885 . . . . 0.0 110.386 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 72.65 145.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.7 2.0 . . . . 0.0 111.714 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -148.4 16.54 1.03 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -158.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -79.68 142.43 35.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.709 1.203 . . . . 0.0 111.901 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.542 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 5.2 mp -90.81 7.01 41.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.603 1.561 . . . . 0.0 112.68 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -152.37 157.44 33.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.948 1.299 . . . . 0.0 111.542 -169.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.59 176.91 3.75 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.947 3.098 . . . . 0.0 112.078 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.41 62.19 1.81 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.651 1.215 . . . . 0.0 110.892 172.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.55 164.85 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.197 1.799 . . . . 0.0 112.704 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.71 147.22 36.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.031 1.332 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -80.23 68.84 6.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.384 1.073 . . . . 0.0 110.23 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 19.2 t -113.44 148.89 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 127.183 2.193 . . . . 0.0 110.122 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 88.4 p -60.22 -25.5 65.67 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -69.8 -27.1 64.61 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.346 -0.846 . . . . 0.0 112.829 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -75.83 122.22 86.6 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.271 1.028 . . . . 0.0 109.964 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.99 -17.09 51.08 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.403 2.069 . . . . 0.0 112.99 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -78.41 2.0 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.33 133.8 34.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.391 1.451 . . . . 0.0 111.988 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -136.29 149.79 68.9 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 124.058 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -68.71 153.17 73.73 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.705 2.27 . . . . 0.0 110.318 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 78.35 8.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.383 1.073 . . . . 0.0 108.673 168.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.44 118.49 5.62 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.731 2.288 . . . . 0.0 108.798 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.52 136.44 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.911 0.884 . . . . 0.0 109.529 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.64 175.0 9.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.563 1.145 . . . . 0.0 110.496 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.505 ' CE2' HD12 ' A' ' 455' ' ' ILE . 54.5 m-85 -135.63 121.72 20.14 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.969 0.908 . . . . 0.0 110.102 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -115.68 108.93 17.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.011 0.91 . . . . 0.0 111.096 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 10.1 p -65.76 -7.49 16.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.495 1.518 . . . . 0.0 114.038 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.49 -23.04 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.699 0.799 . . . . 0.0 112.324 169.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.96 151.02 86.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 112.182 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.88 161.36 36.77 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.882 3.054 . . . . 0.0 112.574 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.06 135.13 28.97 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.132 3.222 . . . . 0.0 112.552 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.8 34.64 9.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.8 1.64 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -119.49 158.86 25.4 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.78 150.72 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.545 1.938 . . . . 0.0 110.263 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.98 127.67 54.93 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.895 1.678 . . . . 0.0 110.672 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 457' ' ' PHE . 38.1 t -127.26 104.19 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.571 0.749 . . . . 0.0 111.414 -174.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -70.09 137.72 51.41 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.452 1.101 . . . . 0.0 112.323 169.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 m -78.39 129.92 35.51 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.442 -0.786 . . . . 0.0 112.095 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -95.65 18.06 13.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.263 1.425 . . . . 0.0 110.958 162.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 97.4 m -130.96 142.68 50.37 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 111.412 -168.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 25.6 mt -107.11 133.29 51.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.684 1.994 . . . . 0.0 108.669 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -84.65 118.74 24.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.48 108.55 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.22 -175.96 49.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.51 0.576 . . . . 0.0 111.786 167.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.84 9.43 59.41 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.439 -1.036 . . . . 0.0 114.97 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.38 118.52 68.25 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.724 1.262 . . . . 0.0 110.2 -165.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.32 136.19 33.5 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.535 2.157 . . . . 0.0 109.017 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -18.96 50.0 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -73.9 -33.99 64.22 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.699 -0.626 . . . . 0.0 112.662 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 41.3 mtm -72.98 146.19 46.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.12 0.962 . . . . 0.0 112.424 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -126.9 179.86 5.18 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 127.406 2.282 . . . . 0.0 110.911 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.69 -46.24 29.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.645 1.578 . . . . 0.0 113.483 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -76.09 -18.89 58.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.743 1.156 . . . . 0.0 110.391 168.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.86 -42.35 84.32 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.244 0.618 . . . . 0.0 110.832 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -55.89 -52.09 65.3 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 119.1 0.864 . . . . 0.0 112.369 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.5 -38.65 91.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 26.4 m -72.11 -35.94 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.758 0.708 . . . . 0.0 111.533 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' A' ' 379' ' ' VAL . 76.8 mt -85.43 -12.88 50.94 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -46.68 87.17 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.259 1.824 . . . . 0.0 114.649 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.38 -7.03 17.67 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.011 1.807 . . . . 0.0 113.434 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.79 -39.44 9.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.499 1.52 . . . . 0.0 112.614 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.0 167.0 3.02 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.856 1.662 . . . . 0.0 113.916 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.29 107.49 17.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.792 0.837 . . . . 0.0 110.647 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.56 144.21 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.027 0.931 . . . . 0.0 111.257 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -111.46 -38.57 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.093 1.357 . . . . 0.0 112.092 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.4 ' HA ' HD12 ' A' ' 305' ' ' LEU . 0.0 OUTLIER -150.5 155.33 39.29 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.821 1.191 . . . . 0.0 111.757 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 379' ' ' VAL . 84.0 t -147.1 127.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.844 0.858 . . . . 0.0 110.056 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.65 105.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.29 112.51 25.03 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.732 0.813 . . . . 0.0 110.41 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.56 86.06 3.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.77 1.628 . . . . 0.0 109.851 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.02 -32.63 66.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.941 1.296 . . . . 0.0 111.629 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 34.9 m -59.06 -27.2 65.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.915 1.686 . . . . 0.0 114.378 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -114.56 10.58 16.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.112 1.365 . . . . 0.0 112.406 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 51.29 37.8 19.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.094 1.758 . . . . 0.0 113.042 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -125.27 153.79 42.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.046 1.338 . . . . 0.0 113.661 -173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -139.53 131.75 28.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.641 1.176 . . . . 0.0 112.168 164.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -83.75 115.48 22.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 162.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 359' ' ' LEU . 99.2 t -122.76 107.42 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.607 . . . . 0.0 110.986 -173.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 125.77 51.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.13 0.972 . . . . 0.0 111.979 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.75 168.72 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.458 1.503 . . . . 0.0 110.018 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -70.39 -24.13 62.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 2.8 p -137.18 156.05 48.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.351 1.432 . . . . 0.0 113.515 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -43.5 98.7 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.613 -0.679 . . . . 0.0 109.895 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -58.41 -37.37 75.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.602 0.761 . . . . 0.0 112.933 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.41 -49.68 72.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.941 0.897 . . . . 0.0 111.168 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.44 93.34 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.806 0.73 . . . . 0.0 112.383 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -61.07 -48.64 80.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.047 0.939 . . . . 0.0 111.15 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -62.81 -34.12 76.62 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.492 -0.755 . . . . 0.0 112.812 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.27 -64.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.656 -0.688 . . . . 0.0 109.582 166.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.38 -35.59 28.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.531 1.132 . . . . 0.0 113.646 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.35 -30.8 71.27 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.682 1.193 . . . . 0.0 113.469 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -117.22 -27.68 6.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 400' ' ' LEU . 14.7 t80 -73.48 125.41 27.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.673 0.749 . . . . 0.0 111.28 -167.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.4 30.05 19.69 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.762 1.625 . . . . 0.0 113.937 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -56.23 -36.07 68.08 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.18 -0.95 . . . . 0.0 113.457 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.18 -21.35 46.51 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.566 1.146 . . . . 0.0 113.103 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.18 27.28 49.73 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.941 1.258 . . . . 0.0 113.712 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -91.93 -34.93 14.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.559 1.544 . . . . 0.0 114.768 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.407 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 22.3 mt -72.95 149.57 89.97 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.12 0.968 . . . . 0.0 109.698 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.54 -30.01 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.657 2.238 . . . . 0.0 112.532 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.22 149.84 47.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.752 2.021 . . . . 0.0 112.399 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -119.37 98.34 6.1 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.572 1.149 . . . . 0.0 110.421 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.85 107.65 16.38 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.197 1.799 . . . . 0.0 109.542 -169.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -117.91 166.91 11.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 108.89 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -65.59 132.53 49.09 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.203 -0.935 . . . . 0.0 111.217 163.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -117.49 -146.56 8.29 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.416 1.484 . . . . 0.0 109.527 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.81 143.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.398 1.479 . . . . 0.0 108.594 167.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -75.47 -82.11 0.48 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 165.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -94.74 105.75 17.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.559 0.744 . . . . 0.0 111.074 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -169.56 140.67 6.22 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.662 -1.077 . . . . 0.0 115.304 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.4 125.84 11.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 125.16 3.906 . . . . 0.0 109.985 174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 -65.31 -36.68 84.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.08 -18.4 62.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.501 1.921 . . . . 0.0 114.029 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.29 30.16 6.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 111.995 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 3.9 t -89.62 135.87 33.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.558 1.143 . . . . 0.0 111.806 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -116.96 89.38 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.249 1.82 . . . . 0.0 108.762 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -69.7 -20.87 63.53 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.33 -46.39 80.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.594 1.543 . . . . 0.0 111.187 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -86.45 -17.54 33.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.61 48.05 8.29 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.532 1.063 . . . . 0.0 112.401 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -150.08 169.74 20.55 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.284 1.042 . . . . 0.0 112.834 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 15.9 p -137.96 151.96 48.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.71 1.204 . . . . 0.0 110.802 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 22.0 mt -110.23 130.62 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -123.96 127.16 25.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 119.701 1.137 . . . . 0.0 111.634 -172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.31 132.79 21.51 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.875 2.383 . . . . 0.0 111.635 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 14.5 mtm -64.32 -28.22 69.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.34 1.456 . . . . 0.0 114.048 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -68.37 -23.72 64.7 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.747 0.703 . . . . 0.0 112.893 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.07 -36.55 15.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.588 1.555 . . . . 0.0 111.923 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.2 mt -53.0 117.98 3.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.987 0.812 . . . . 0.0 109.139 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 23.0 p -64.62 176.17 1.21 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.758 1.223 . . . . 0.0 110.753 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -62.1 -38.85 90.43 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.693 -0.63 . . . . 0.0 111.571 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.53 -40.67 80.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.822 0.849 . . . . 0.0 112.141 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.68 -58.79 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.369 1.067 . . . . 0.0 111.608 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -61.43 -36.04 79.24 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.705 0.402 . . . . 0.0 111.927 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.14 -40.3 89.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.996 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -67.45 -45.47 75.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.539 1.518 . . . . 0.0 111.456 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -52.89 -37.63 60.81 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.496 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.76 -43.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.1 t -97.45 -12.55 22.56 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.37 142.5 43.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.183 -0.948 . . . . 0.0 111.989 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -76.34 -53.49 8.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.782 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -92.97 128.32 38.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.285 1.034 . . . . 0.0 110.415 166.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.13 -173.36 45.7 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.479 1.038 . . . . 0.0 114.324 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 71.19 -158.96 53.8 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.469 -0.365 . . . . 0.0 112.617 -170.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 24.0 p -97.64 7.52 46.3 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -164.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 p 68.93 7.06 5.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.766 1.626 . . . . 0.0 114.422 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.53 1.78 32.82 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.941 1.734 . . . . 0.0 113.973 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -66.46 153.61 92.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 118.603 1.201 . . . . 0.0 110.823 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.12 147.64 94.03 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.404 2.07 . . . . 0.0 110.038 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 27.2 mt -68.74 124.52 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.865 -0.522 . . . . 0.0 109.761 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.8 t -117.53 148.89 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.292 1.837 . . . . 0.0 108.552 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 99.7 m -50.17 122.96 7.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.18 0.592 . . . . 0.0 109.806 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 91.57 -2.68 77.75 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.204 -1.331 . . . . 0.0 115.265 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.505 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.8 OUTLIER -54.89 123.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.708 1.754 . . . . 0.0 111.592 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.68 138.22 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 109.243 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 336' ' ' VAL . 6.3 p90 -164.6 -178.36 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.5 1.52 . . . . 0.0 112.25 175.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -93.57 153.26 18.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.626 1.17 . . . . 0.0 111.791 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -49.14 130.32 16.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.542 1.137 . . . . 0.0 113.206 -168.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.68 150.58 68.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.116 1.878 . . . . 0.0 109.689 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -55.66 156.42 4.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.227 1.011 . . . . 0.0 113.72 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mt -121.52 46.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 123.58 1.657 . . . . 0.0 109.56 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -54.25 171.22 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.527 135.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.29 -54.8 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 120.976 -1.078 . . . . 0.0 110.557 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.18 68.89 1.45 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 75.64 -55.11 0.62 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.991 2.516 . . . . 0.0 112.917 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.12 -135.23 12.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.898 1.237 . . . . 0.0 112.191 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.252 1.203 0 C-N-CA 125.783 1.633 . . . . 0.0 112.178 -177.358 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.7 mp 53.59 81.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.796 2.039 . . . . 0.0 112.006 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -177.58 43.76 0.1 OUTLIER Glycine 0 N--CA 1.473 1.155 0 O-C-N 121.538 -0.726 . . . . 0.0 114.131 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -147.94 160.21 38.38 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.289 1.436 . . . . 0.0 111.059 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.29 -159.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.815 3.677 . . . . 0.0 111.955 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -57.7 -35.36 70.52 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.915 -1.115 . . . . 0.0 113.031 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 58.3 p 50.81 27.03 2.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 127.685 2.394 . . . . 0.0 114.387 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 6.1 t -69.73 -18.69 63.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.806 1.642 . . . . 0.0 113.742 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -46.53 124.95 6.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 0.0 111.895 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 100.87 24.21 9.32 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.343 -1.254 . . . . 0.0 114.916 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.3 m -131.57 -68.57 0.65 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.947 1.373 . . . . 0.0 111.943 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.06 -42.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.345 1.458 . . . . 0.0 112.727 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -80.25 155.56 27.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.92 0.888 . . . . 0.0 110.042 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -143.51 12.17 1.71 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -164.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -79.64 142.24 35.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.257 1.023 . . . . 0.0 111.938 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.65 -42.53 97.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.705 1.202 . . . . 0.0 111.325 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.63 61.98 1.61 Allowed Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 125.252 1.421 . . . . 0.0 113.129 -169.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.22 76.33 3.52 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.342 4.028 . . . . 0.0 111.431 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -147.92 22.92 1.1 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.68 1.592 . . . . 0.0 112.213 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.67 146.32 51.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.132 1.773 . . . . 0.0 111.464 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.88 152.68 24.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.676 1.19 . . . . 0.0 110.877 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -79.63 67.93 5.54 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 120.989 -1.07 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.2 147.9 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 127.476 2.311 . . . . 0.0 109.612 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 85.1 p -58.66 -27.55 64.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -66.02 -33.77 76.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.251 1.02 . . . . 0.0 112.683 172.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -71.4 121.96 85.77 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.899 0.88 . . . . 0.0 110.266 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.31 -17.08 49.5 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.608 2.205 . . . . 0.0 113.085 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -79.07 2.84 19.25 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -50.57 131.7 25.28 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.149 1.341 . . . . 0.0 111.209 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.37 140.81 26.9 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 123.861 0.864 . . . . 0.0 109.951 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.9 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.217 2.612 . . . . 0.0 111.026 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 66.28 49.92 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.985 1.314 . . . . 0.0 110.442 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.38 113.15 2.79 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.113 2.542 . . . . 0.0 109.734 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.02 127.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.787 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.68 167.3 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.284 1.434 . . . . 0.0 110.367 170.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -139.38 122.84 17.24 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.879 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.93 115.02 23.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.803 0.841 . . . . 0.0 110.373 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.4 p -70.4 -11.14 60.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 70.5 p -67.32 -22.38 65.61 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 112.365 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -69.34 147.61 97.13 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.364 0.666 . . . . 0.0 111.478 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.84 164.26 27.71 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.821 3.014 . . . . 0.0 112.65 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.47 133.75 21.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.775 2.983 . . . . 0.0 112.07 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 69.17 30.47 4.32 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.992 2.117 . . . . 0.0 112.123 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -119.97 142.28 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 451' ' ' LEU . 16.9 pt -115.31 149.15 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.458 1.503 . . . . 0.0 110.294 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 128.46 53.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.491 1.116 . . . . 0.0 110.645 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.06 104.73 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.185 0.448 . . . . 0.0 111.618 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -67.13 138.88 57.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.96 167.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 t -81.66 136.17 35.51 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.353 -0.842 . . . . 0.0 112.432 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -105.43 18.89 21.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.944 1.697 . . . . 0.0 110.42 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 92.5 m -125.26 140.69 52.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.608 1.563 . . . . 0.0 111.523 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.18 136.06 47.66 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.143 1.777 . . . . 0.0 108.891 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -91.69 122.08 33.92 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 163.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.37 109.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.29 50.33 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.646 0.641 . . . . 0.0 111.746 168.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.25 16.02 68.51 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.697 -0.884 . . . . 0.0 114.9 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 28.7 t -78.55 116.58 60.56 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.634 1.217 . . . . 0.0 110.021 -168.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 135.86 31.08 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.325 2.016 . . . . 0.0 108.699 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.2 -15.88 38.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.01 -27.07 61.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.788 0.835 . . . . 0.0 113.106 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.5 ' SD ' HD21 ' A' ' 402' ' ' LEU . 5.4 ptp -84.55 147.46 27.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.542 0.737 . . . . 0.0 111.753 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -124.96 -167.77 1.72 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.824 1.65 . . . . 0.0 111.741 -173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -60.24 -41.71 93.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.592 1.157 . . . . 0.0 111.957 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -73.8 -24.24 59.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.0 -41.85 70.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.882 1.219 . . . . 0.0 110.757 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.1 mm? -56.14 -53.24 59.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 122.977 0.511 . . . . 0.0 110.486 170.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.35 -32.9 67.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.238 -0.887 . . . . 0.0 113.086 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -70.28 -46.16 64.9 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.996 1.271 . . . . 0.0 113.032 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.56 -36.18 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.164 0.893 . . . . 0.0 111.077 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 11.3 mp -78.65 -6.55 56.0 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.078 0.951 . . . . 0.0 113.342 173.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -49.93 -50.94 65.45 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-N 120.719 1.6 . . . . 0.0 114.843 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.7 -6.34 17.47 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.088 1.859 . . . . 0.0 113.207 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -97.13 -43.04 7.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.547 1.539 . . . . 0.0 112.398 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -176.26 169.36 2.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 113.868 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.79 119.52 32.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.443 1.097 . . . . 0.0 111.057 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.39 129.18 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.911 1.284 . . . . 0.0 109.411 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.7 -28.63 14.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 t -153.8 149.89 27.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.752 1.221 . . . . 0.0 110.828 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.32 139.45 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.614 0.765 . . . . 0.0 109.836 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.09 104.85 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 166.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.25 118.3 30.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.105 0.478 . . . . 0.0 109.913 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -102.63 79.45 1.81 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.222 1.409 . . . . 0.0 109.058 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.66 -33.49 64.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.167 1.387 . . . . 0.0 111.4 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -32.29 66.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.953 1.701 . . . . 0.0 113.443 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.29 6.79 24.85 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.397 1.479 . . . . 0.0 113.832 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.7 mttt 56.09 38.3 29.75 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.751 1.621 . . . . 0.0 112.436 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -121.66 154.31 37.0 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.03 1.732 . . . . 0.0 113.144 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.46 130.58 28.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.577 1.151 . . . . 0.0 111.698 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -84.36 123.13 29.86 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 162.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 53.0 t -122.96 118.22 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.013 0.925 . . . . 0.0 110.059 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.45 121.1 42.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 109.68 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.96 163.34 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 110.114 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -73.71 -17.71 61.09 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 6.3 p -140.8 156.69 46.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.297 . . . . 0.0 113.154 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -43.43 96.74 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.764 -0.585 . . . . 0.0 110.6 171.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -59.15 -42.08 89.87 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.887 -0.508 . . . . 0.0 111.132 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.0 -50.0 74.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.097 0.959 . . . . 0.0 112.022 171.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.12 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.624 0.647 . . . . 0.0 111.568 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -60.94 -41.31 95.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.423 0.689 . . . . 0.0 112.356 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -66.64 -33.48 75.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.309 0.959 . . . . 0.0 112.134 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.0 -64.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.351 164.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.8 mt -49.82 -35.57 23.42 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -63.99 -42.19 97.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.909 1.684 . . . . 0.0 113.369 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -110.55 -26.91 9.22 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -171.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -70.58 122.66 20.15 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.944 0.897 . . . . 0.0 111.095 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.07 31.77 17.77 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.843 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -34.29 73.53 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.1 -21.18 54.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.826 1.251 . . . . 0.0 113.073 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.99 28.04 55.11 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.933 1.254 . . . . 0.0 113.685 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -92.64 -35.12 13.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.473 1.509 . . . . 0.0 114.566 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.4 mt -72.0 150.38 92.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.431 1.092 . . . . 0.0 109.789 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.93 -34.35 8.69 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.476 2.117 . . . . 0.0 112.045 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.5 HD21 ' SD ' ' A' ' 350' ' ' MET . 1.1 mp -65.76 151.61 46.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 112.575 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -127.19 94.64 4.06 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.068 1.347 . . . . 0.0 108.946 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -77.94 116.9 18.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.027 0.931 . . . . 0.0 110.389 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -120.37 171.27 8.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.933 2.093 . . . . 0.0 108.941 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -69.63 127.46 33.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.046 -1.034 . . . . 0.0 111.273 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.23 -155.68 15.1 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 125.532 1.539 . . . . 0.0 109.27 166.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.64 134.3 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.111 0.456 . . . . 0.0 111.953 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.54 -51.06 3.79 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 166.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -123.64 112.66 17.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 112.454 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -178.96 136.65 2.93 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.131 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.71 128.81 14.71 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 125.195 3.93 . . . . 0.0 110.48 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -34.32 76.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.04 -19.07 60.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.297 1.039 . . . . 0.0 113.756 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.76 29.47 6.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.158 1.783 . . . . 0.0 111.654 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.4 t -83.74 136.01 34.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.886 1.274 . . . . 0.0 111.301 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -121.41 76.89 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.39 1.476 . . . . 0.0 109.087 167.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -61.71 -26.68 68.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.562 -0.711 . . . . 0.0 112.553 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.6 -49.92 74.66 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.235 1.379 . . . . 0.0 111.684 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -82.44 -13.41 56.81 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 78.98 39.92 18.53 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 124.803 1.192 . . . . 0.0 112.749 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -145.87 167.02 24.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.621 1.211 . . . . 0.0 112.946 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 21.9 m -130.25 153.82 48.22 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.397 -0.814 . . . . 0.0 110.465 167.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 mm -106.09 133.8 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 430' ' ' LEU . 1.2 mt -123.58 115.61 28.26 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 120.228 1.376 . . . . 0.0 112.014 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -71.45 133.08 21.79 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.195 2.596 . . . . 0.0 111.492 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.9 mtt -61.81 -28.94 69.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.459 1.104 . . . . 0.0 113.316 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -65.59 -19.07 65.77 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.43 16.43 16.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 112.908 176.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 425' ' ' ILE . 10.4 mt -89.96 173.55 8.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.863 1.265 . . . . 0.0 112.513 170.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.4 p -127.12 169.1 13.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.039 1.336 . . . . 0.0 110.632 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.31 -33.25 69.52 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.748 -1.22 . . . . 0.0 111.166 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.83 84.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.458 1.103 . . . . 0.0 112.014 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.499 ' CG ' HD22 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -65.55 -45.14 84.51 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.656 0.662 . . . . 0.0 112.478 179.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -62.33 -41.74 98.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -59.84 -32.36 70.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.339 1.056 . . . . 0.0 113.106 171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -72.05 -50.45 28.27 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.007 1.731 . . . . 0.0 111.877 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.7 m -51.58 -39.55 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.314 0.961 . . . . 0.0 111.715 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.3 m -82.64 -50.52 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.5 t -91.07 -13.78 32.52 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.612 -1.305 . . . . 0.0 114.27 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.451 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.4 137.69 47.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.027 0.917 . . . . 0.0 111.702 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -78.05 -44.97 24.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.883 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -102.82 140.0 37.66 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.968 1.307 . . . . 0.0 111.617 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 66.02 -167.5 34.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.056 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.92 -146.21 47.83 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -171.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 451' ' ' LEU . 18.7 p -117.21 1.18 12.45 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -153.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.77 18.01 1.3 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.29 1.836 . . . . 0.0 112.849 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 90.19 12.4 61.72 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.602 1.096 . . . . 0.0 113.659 -172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -78.56 136.93 59.3 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.032 1.333 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.18 99.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.069 2.513 . . . . 0.0 109.059 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.7 OUTLIER -67.61 147.68 52.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.625 0.77 . . . . 0.0 112.189 -176.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.3 163.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.785 1.234 . . . . 0.0 111.235 -173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.8 t -51.43 127.35 19.68 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.916 0.886 . . . . 0.0 110.641 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 97.03 -14.39 63.9 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.938 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.26 147.33 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.077 1.939 . . . . 0.0 112.164 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.94 132.93 69.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.759 2.024 . . . . 0.0 109.052 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 446' ' ' THR . 16.4 p90 -153.36 178.05 10.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.415 1.486 . . . . 0.0 111.752 174.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -94.99 151.26 19.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.163 1.385 . . . . 0.0 109.631 171.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.31 129.26 5.98 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.888 1.275 . . . . 0.0 112.371 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.57 150.54 80.0 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.293 1.328 . . . . 0.0 110.077 168.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.451 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 80.4 m-20 -54.24 142.87 24.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 51.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.632 1.682 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.2 173.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.499 138.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.92 -60.35 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.106 -0.996 . . . . 0.0 110.507 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.86 -71.37 2.97 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -169.81 160.73 8.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.115 1.366 . . . . 0.0 111.751 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -142.89 -162.64 9.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.636 1.589 . . . . 0.0 113.136 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.412 1.485 . . . . 0.0 110.902 179.376 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.362 0.125 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.65 -53.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.52 1.128 . . . . 0.0 110.536 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 115.75 -167.34 12.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.794 1.664 . . . . 0.0 112.19 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.74 28.85 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.745 1.618 . . . . 0.0 110.984 -175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.04 -156.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.55 3.5 . . . . 0.0 111.688 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -54.15 -41.5 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.036 -1.04 . . . . 0.0 113.061 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 72.3 p 50.9 26.72 2.78 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 127.837 2.455 . . . . 0.0 114.378 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.6 t -74.22 -11.92 60.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.884 1.674 . . . . 0.0 113.545 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -51.26 129.64 25.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.49 1.516 . . . . 0.0 111.616 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.34 78.92 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.5 -1.167 . . . . 0.0 114.799 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 6.5 m -122.2 -65.11 1.14 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.86 1.264 . . . . 0.0 110.866 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -172.4 137.47 0.86 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.366 1.867 . . . . 0.0 110.754 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.42 165.8 0.15 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.526 1.53 . . . . 0.0 113.176 -174.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -136.56 9.74 3.15 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.15 143.23 52.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.384 1.074 . . . . 0.0 112.322 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.4 mm? -62.91 -46.29 88.51 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.034 0.934 . . . . 0.0 112.183 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.01 155.75 37.92 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.193 1.397 . . . . 0.0 112.522 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.08 79.71 3.06 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.886 3.058 . . . . 0.0 111.402 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 t70 74.76 -62.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.882 2.873 . . . . 0.0 111.222 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . 0.25 21.2 pt-20 44.58 -173.33 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.114 2.966 . . . . 0.0 114.801 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.5 mp -143.74 165.85 26.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.653 1.181 . . . . 0.0 110.245 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.06 62.8 3.56 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.734 1.214 . . . . 0.0 111.307 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.22 152.37 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 127.166 2.186 . . . . 0.0 111.415 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 60.0 p -67.06 -22.68 65.85 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.81 -23.89 61.63 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.181 0.992 . . . . 0.0 112.9 172.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -78.87 126.12 82.86 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.155 0.982 . . . . 0.0 110.309 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.26 -17.45 49.94 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.782 2.322 . . . . 0.0 113.589 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -79.02 7.1 7.86 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.743 1.217 . . . . 0.0 114.083 166.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -55.12 125.17 19.41 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.253 -1.529 . . . . 0.0 111.471 171.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.7 mmt-85 -160.24 148.33 13.11 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.758 1.623 . . . . 0.0 110.693 -170.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.06 173.47 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.644 2.229 . . . . 0.0 111.611 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -114.84 99.32 51.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.192 0.597 . . . . 0.0 109.504 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.03 154.79 25.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.522 2.815 . . . . 0.0 110.821 171.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.08 142.06 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.329 1.452 . . . . 0.0 108.967 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.74 168.09 17.77 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.388 1.075 . . . . 0.0 111.166 171.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -140.12 121.98 15.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.766 1.226 . . . . 0.0 109.996 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -121.23 107.18 12.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.822 1.249 . . . . 0.0 110.164 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 50.3 p -71.55 -4.13 25.19 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -24.59 66.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.94 1.296 . . . . 0.0 112.175 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.16 151.21 97.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.064 0.946 . . . . 0.0 112.001 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.26 161.74 32.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.826 3.017 . . . . 0.0 112.659 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.56 131.19 18.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.746 2.964 . . . . 0.0 112.057 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.05 36.21 4.28 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.074 2.15 . . . . 0.0 111.807 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -122.57 155.26 36.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.649 1.18 . . . . 0.0 113.74 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 455' ' ' ILE . 16.6 pt -123.61 154.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.652 1.981 . . . . 0.0 110.546 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -110.55 125.17 53.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.118 0.967 . . . . 0.0 110.946 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.11 105.1 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.505 1.122 . . . . 0.0 109.785 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.93 136.28 52.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.627 1.171 . . . . 0.0 111.218 168.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.7 t -73.96 138.84 44.46 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 121.325 -0.859 . . . . 0.0 112.203 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 36.5 mtm180 -107.37 -1.27 21.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.889 1.676 . . . . 0.0 111.815 164.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 23.1 m -100.54 123.62 45.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.072 1.349 . . . . 0.0 109.093 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.45 141.46 28.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.568 1.547 . . . . 0.0 108.751 168.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -93.93 142.99 26.75 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 23.8 mm -128.47 111.93 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.169 1.388 . . . . 0.0 108.441 -172.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -91.01 172.75 37.14 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.197 0.904 . . . . 0.0 111.768 168.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.6 23.36 78.04 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.316 -0.713 . . . . 0.0 114.736 170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.0 t -84.26 115.72 61.55 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 118.491 1.146 . . . . 0.0 110.405 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.87 142.24 61.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.924 2.416 . . . . 0.0 110.032 170.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.08 -20.12 50.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -21.34 52.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 22.9 mtm -83.94 144.06 29.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.949 0.881 . . . . 0.0 112.165 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -128.31 -177.16 4.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.832 2.053 . . . . 0.0 110.624 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -49.41 -39.26 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.73 1.612 . . . . 0.0 114.713 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 305' ' ' LEU . 98.5 m95 -79.36 -17.77 53.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -75.75 -38.54 58.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.549 1.068 . . . . 0.0 110.519 168.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.8 mm? -59.87 -49.07 79.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.582 168.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -58.36 -33.56 69.7 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.102 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -73.97 -42.45 60.45 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.923 1.238 . . . . 0.0 114.314 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.29 -35.19 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.029 1.286 . . . . 0.0 111.459 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.546 HD23 ' CE1' ' A' ' 394' ' ' PHE . 37.8 mt -87.97 -5.63 58.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.455 1.102 . . . . 0.0 113.081 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -52.53 -49.0 88.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.88 -6.17 17.77 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.616 2.21 . . . . 0.0 113.379 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -98.5 -35.91 10.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.332 1.453 . . . . 0.0 112.871 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.55 3.5 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.214 1.805 . . . . 0.0 113.936 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 122.23 30.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.184 1.394 . . . . 0.0 110.61 169.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.46 122.74 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.693 0.797 . . . . 0.0 109.592 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -96.72 -35.5 10.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.588 1.555 . . . . 0.0 112.459 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.95 155.57 44.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.36 1.064 . . . . 0.0 111.907 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 27.0 t -149.22 140.18 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.164 0.986 . . . . 0.0 110.621 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.26 101.48 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.392 1.477 . . . . 0.0 108.254 168.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.63 131.11 49.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.174 0.59 . . . . 0.0 110.823 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 87.49 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.394 1.092 . . . . 0.0 109.96 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.42 -29.54 67.83 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.273 1.429 . . . . 0.0 112.237 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.3 t -59.27 -28.28 66.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.888 1.675 . . . . 0.0 114.092 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.22 1.38 16.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.083 1.753 . . . . 0.0 112.727 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 59.51 37.46 22.84 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.318 1.447 . . . . 0.0 112.26 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -125.51 167.0 15.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -141.42 164.76 29.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.501 1.12 . . . . 0.0 112.315 163.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.94 135.38 54.92 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.331 1.453 . . . . 0.0 108.396 162.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 359' ' ' LEU . 73.0 t -128.44 118.03 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.116 0.966 . . . . 0.0 110.92 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -101.67 120.3 40.13 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.786 1.234 . . . . 0.0 112.059 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.9 m -100.99 -179.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.136 0.974 . . . . 0.0 111.429 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -64.93 -37.4 87.53 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.928 1.24 . . . . 0.0 114.155 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 60.3 p -149.06 166.42 28.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -167.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -39.25 89.62 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.175 169.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -62.39 -40.36 96.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.917 0.78 . . . . 0.0 112.352 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.62 -47.76 71.61 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.37 0.668 . . . . 0.0 110.488 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.92 98.65 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.383 -0.823 . . . . 0.0 112.107 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -65.5 -40.52 93.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.935 171.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.99 -33.38 75.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.946 1.248 . . . . 0.0 112.333 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.99 -65.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 118.461 0.573 . . . . 0.0 109.886 164.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.48 -33.22 43.76 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -69.29 -35.3 75.87 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 113.454 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -111.49 -26.04 9.28 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.7 t80 -72.6 124.25 24.87 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.415 0.686 . . . . 0.0 111.872 -168.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 60.67 28.77 18.48 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.712 1.605 . . . . 0.0 114.134 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -31.03 70.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.791 -1.193 . . . . 0.0 113.737 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.16 -18.3 50.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.601 1.16 . . . . 0.0 113.382 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.72 17.69 69.92 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.848 1.213 . . . . 0.0 114.001 -173.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -87.55 -31.27 19.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.54 1.536 . . . . 0.0 114.845 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 42.8 mt -79.22 149.18 72.37 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.195 0.998 . . . . 0.0 109.895 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.33 -27.84 11.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.689 2.26 . . . . 0.0 112.394 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.17 147.04 45.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.806 1.242 . . . . 0.0 111.863 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.89 103.25 8.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.564 1.146 . . . . 0.0 110.592 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 54.0 m -86.84 122.4 30.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 111.401 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -129.35 177.09 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.304 2.642 . . . . 0.0 109.146 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -76.05 130.84 38.98 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.777 -1.202 . . . . 0.0 111.651 162.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.0 -160.56 21.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.274 1.892 . . . . 0.0 109.594 162.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.61 125.94 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.892 1.277 . . . . 0.0 109.47 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -90.21 -43.49 4.97 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 162.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -137.66 124.4 21.11 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.168 0.987 . . . . 0.0 110.866 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 174.09 129.92 1.23 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.068 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.27 123.51 10.0 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.78 3.654 . . . . 0.0 109.797 172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.7 -37.89 74.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.279 0.561 . . . . 0.0 112.476 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.79 -18.6 62.09 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.026 2.13 . . . . 0.0 114.545 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.66 24.21 8.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.844 1.658 . . . . 0.0 112.084 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 12.2 t -86.65 140.99 29.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.309 1.444 . . . . 0.0 111.776 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -121.81 88.8 3.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.376 1.471 . . . . 0.0 109.199 166.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -65.78 -20.76 66.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.42 -51.51 23.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.637 0.775 . . . . 0.0 110.347 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -78.87 -17.67 55.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.42 36.18 27.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 124.967 1.27 . . . . 0.0 113.294 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -144.33 164.89 29.47 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.165 0.986 . . . . 0.0 112.893 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 17.6 m -129.73 150.52 51.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.296 1.038 . . . . 0.0 110.521 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.48 139.38 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.99 126.65 19.77 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 120.017 1.28 . . . . 0.0 111.608 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.25 135.74 27.61 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.565 2.176 . . . . 0.0 111.097 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 5.3 mtm -61.7 -33.78 74.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.498 1.119 . . . . 0.0 113.096 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -68.04 -21.91 64.99 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 119.249 0.931 . . . . 0.0 113.506 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -83.48 -38.84 21.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.184 1.393 . . . . 0.0 111.543 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.97 124.04 13.18 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.728 0.695 . . . . 0.0 109.224 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 31.5 p -70.77 174.7 5.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.652 1.181 . . . . 0.0 110.942 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -44.0 76.03 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.759 -0.588 . . . . 0.0 111.012 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.66 82.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.291 1.036 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.0 -51.29 70.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.7 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -63.24 -42.94 99.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -52.68 -49.74 64.67 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -69.14 -44.78 71.64 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.494 1.043 . . . . 0.0 111.55 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 64.3 m -52.63 -35.74 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.637 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.38 -42.67 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 4.2 t -97.63 -9.95 25.95 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -165.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.42 141.02 48.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.975 -1.078 . . . . 0.0 112.279 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -75.67 -22.78 56.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.707 0.803 . . . . 0.0 111.693 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -131.34 144.77 51.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.086 2.155 . . . . 0.0 110.566 167.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.41 -176.89 41.0 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.978 0.799 . . . . 0.0 113.014 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.13 -153.3 49.54 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 122.25 -0.559 . . . . 0.0 113.941 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 26.6 p -102.76 7.64 39.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.769 1.627 . . . . 0.0 115.173 -163.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.1 m 73.58 8.31 5.04 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.83 2.85 59.51 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.326 1.441 . . . . 0.0 113.58 -170.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -68.33 154.97 93.45 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.754 1.277 . . . . 0.0 110.454 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.01 141.41 83.72 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.062 1.842 . . . . 0.0 110.198 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 118.47 10.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 166.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.83 154.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.189 1.396 . . . . 0.0 109.671 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 11.8 t -57.27 133.63 55.26 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.806 0.442 . . . . 0.0 110.049 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.45 -8.79 79.09 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.449 -1.195 . . . . 0.0 115.181 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.517 HG22 HG22 ' A' ' 334' ' ' ILE . 15.6 tt -62.41 138.82 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.985 1.892 . . . . 0.0 111.749 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.12 137.93 55.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 108.875 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.63 -179.27 7.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.149 1.38 . . . . 0.0 110.858 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -99.87 146.01 27.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.513 1.925 . . . . 0.0 110.68 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 12.0 pt-20 -44.32 131.87 4.6 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.451 1.5 . . . . 0.0 114.313 -166.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.36 163.99 36.74 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.143 1.895 . . . . 0.0 111.804 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -66.53 137.04 56.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 112.613 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.52 54.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 123.581 1.658 . . . . 0.0 109.531 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.86 178.87 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.245 140.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.05 -45.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.282 -0.886 . . . . 0.0 112.099 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 80.09 -59.42 4.54 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.688 1.137 . . . . 0.0 111.832 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.44 159.78 17.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.122 1.769 . . . . 0.0 110.901 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -134.31 -179.84 16.84 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.766 1.65 . . . . 0.0 113.016 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.445 1.498 . . . . 0.0 111.32 177.212 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.448 0.642 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 46.8 pt -87.94 153.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.662 -1.274 . . . . 0.0 111.535 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 75.99 120.15 0.14 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.863 1.221 . . . . 0.0 111.943 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -158.7 156.1 26.34 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.141 0.976 . . . . 0.0 111.551 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.95 178.27 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.081 3.188 . . . . 0.0 111.373 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.85 -4.67 7.17 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.4 p 64.48 6.99 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 129.697 3.199 . . . . 0.0 115.071 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.57 -33.98 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.737 2.815 . . . . 0.0 111.849 -172.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . 0.256 0.1 OUTLIER 55.32 -154.28 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.344 1.458 . . . . 0.0 111.817 176.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 125.74 121.55 2.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 125.303 1.43 . . . . 0.0 112.693 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.5 m 74.99 -46.6 0.6 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 128.023 2.529 . . . . 0.0 112.603 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.25 -25.1 63.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.462 1.505 . . . . 0.0 113.165 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -176.47 -41.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 113.813 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 8.4 m80 56.41 17.42 2.92 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.743 1.217 . . . . 0.0 113.349 -160.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 367' ' ' SER . 31.5 m80 -89.11 147.94 23.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.971 1.709 . . . . 0.0 113.026 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.8 18.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.062 2.145 . . . . 0.0 113.029 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.58 162.29 23.51 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.915 1.686 . . . . 0.0 112.275 -168.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.48 -157.92 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.828 3.686 . . . . 0.0 111.58 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -49.44 -51.81 33.08 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.419 -1.425 . . . . 0.0 112.799 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 37.94 -151.26 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.293 2.237 . . . . 0.0 114.17 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.75 156.51 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.462 1.505 . . . . 0.0 111.236 173.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -79.47 65.22 4.58 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.34 -0.85 . . . . 0.0 110.302 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.04 149.49 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 126.775 2.03 . . . . 0.0 111.827 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 87.6 p -61.21 -26.88 68.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -70.89 -25.28 62.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.968 0.907 . . . . 0.0 113.016 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -79.26 122.08 83.75 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.078 0.951 . . . . 0.0 110.067 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.67 -16.14 45.99 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.657 2.238 . . . . 0.0 113.175 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -73.02 -6.2 43.9 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -48.42 131.08 17.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.761 1.164 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 134.45 11.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.77 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.73 168.49 22.68 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.235 2.623 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.87 70.59 10.27 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.602 1.561 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.77 115.15 3.43 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.099 2.533 . . . . 0.0 110.004 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.79 144.45 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.552 1.141 . . . . 0.0 109.362 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.7 173.17 11.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.265 1.026 . . . . 0.0 110.899 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 455' ' ' ILE . 44.4 m-85 -136.4 121.11 18.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.472 1.109 . . . . 0.0 109.634 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -115.55 108.02 15.9 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.826 1.251 . . . . 0.0 110.444 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.7 p -66.67 -8.93 31.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -25.07 67.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.088 1.355 . . . . 0.0 112.439 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.26 151.94 96.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.636 0.774 . . . . 0.0 111.927 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.54 162.41 31.16 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.891 3.061 . . . . 0.0 112.722 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 131.95 19.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.813 3.009 . . . . 0.0 112.176 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 68.38 33.7 4.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.744 2.018 . . . . 0.0 112.162 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -121.47 151.14 40.58 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.43 146.11 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.128 1.771 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -110.25 128.72 55.66 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.5 1.046 . . . . 0.0 111.529 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.3 t -125.01 104.47 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.5 0.72 . . . . 0.0 111.112 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.72 134.54 54.42 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.644 1.177 . . . . 0.0 111.589 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 33.3 t -76.34 138.99 40.81 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.193 -0.942 . . . . 0.0 111.651 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.5 mtm105 -109.63 13.96 23.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.102 1.761 . . . . 0.0 110.835 163.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.0 m -113.95 136.23 53.12 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.125 1.77 . . . . 0.0 111.052 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.7 mt -102.61 137.41 40.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.057 1.743 . . . . 0.0 110.131 167.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -84.12 138.84 32.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 158.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 22.9 mm -127.67 105.16 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.168 1.387 . . . . 0.0 108.346 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -81.35 178.8 53.77 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 121.366 -0.834 . . . . 0.0 111.506 165.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 68.33 37.28 86.03 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.72 -0.871 . . . . 0.0 113.822 173.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.08 85.14 6.34 Favored Pre-proline 0 N--CA 1.474 0.775 0 C-N-CA 125.553 1.541 . . . . 0.0 110.358 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.43 161.18 42.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.547 . . . . 0.0 111.012 171.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 pp -58.8 -20.31 48.96 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -28.52 69.72 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.211 1.005 . . . . 0.0 113.058 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 6.5 ptm -110.9 135.93 50.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.221 1.01 . . . . 0.0 112.097 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -116.97 -176.05 2.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.257 1.823 . . . . 0.0 111.24 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.92 -34.6 68.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.535 1.134 . . . . 0.0 113.238 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -78.43 -24.18 46.28 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.11 -43.34 71.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.052 0.842 . . . . 0.0 109.851 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 37.3 mt -57.74 -52.89 63.58 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.997 0.519 . . . . 0.0 109.927 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -53.96 -37.25 63.72 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -72.04 -39.55 69.02 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.13 -30.98 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.974 1.261 . . . . 0.0 111.653 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.8 mt -81.21 -13.75 58.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.29 1.436 . . . . 0.0 112.916 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -48.09 -48.93 62.69 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.41 -4.64 15.59 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.351 2.034 . . . . 0.0 113.533 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -101.89 -41.28 6.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.62 1.568 . . . . 0.0 112.643 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.75 168.05 4.38 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.277 1.831 . . . . 0.0 111.704 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 132.94 34.7 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.852 -0.53 . . . . 0.0 109.624 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.76 136.28 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.835 0.854 . . . . 0.0 110.133 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -41.54 6.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.339 1.456 . . . . 0.0 112.531 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 304' ' ' HIS . 0.1 OUTLIER -149.28 157.6 43.48 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.827 1.251 . . . . 0.0 109.743 -176.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.92 133.41 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.81 99.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 165.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 137.7 37.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.7 64.77 1.6 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.388 1.075 . . . . 0.0 110.785 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -56.48 -34.4 66.88 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 0.0 112.249 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 m -61.34 -31.41 71.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.799 1.239 . . . . 0.0 113.737 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -96.77 6.99 47.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.366 1.466 . . . . 0.0 113.239 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 63.02 21.2 12.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.247 1.819 . . . . 0.0 113.463 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -135.85 175.52 9.52 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.87 167.01 24.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.104 1.762 . . . . 0.0 111.44 166.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.81 131.69 54.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.015 1.326 . . . . 0.0 108.393 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 60.4 t -122.98 132.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.628 1.171 . . . . 0.0 109.642 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -111.87 126.84 55.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.618 1.567 . . . . 0.0 110.68 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 166.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 0.0 109.812 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -78.7 -23.2 45.72 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -167.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.53 149.46 50.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.781 1.232 . . . . 0.0 111.948 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -55.3 -41.73 72.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.288 1.035 . . . . 0.0 111.777 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -66.24 -36.65 83.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.736 -0.602 . . . . 0.0 112.058 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.72 -49.28 78.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.609 0.764 . . . . 0.0 110.771 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.73 98.23 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.638 -0.664 . . . . 0.0 111.962 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.23 -42.14 98.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.282 1.033 . . . . 0.0 111.556 170.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -67.06 -32.29 73.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.553 1.069 . . . . 0.0 112.757 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.31 -63.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 118.69 -0.671 . . . . 0.0 109.956 165.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.11 -32.99 50.26 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.92 -34.52 74.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.55 1.54 . . . . 0.0 113.377 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -124.39 -31.19 3.31 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -71.77 119.38 15.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.313 1.045 . . . . 0.0 111.159 -167.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 32.4 t30 58.07 25.48 12.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.535 1.534 . . . . 0.0 114.39 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -34.12 77.41 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.66 -1.275 . . . . 0.0 113.251 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.75 -18.32 61.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 112.775 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.19 22.29 63.38 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.067 1.318 . . . . 0.0 113.689 -172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -85.25 -31.5 23.09 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.096 1.359 . . . . 0.0 114.506 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.47 151.94 59.86 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.402 1.081 . . . . 0.0 110.017 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.0 -22.95 22.33 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.722 2.281 . . . . 0.0 113.54 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 402' ' ' LEU . 1.6 mm? -63.95 168.43 5.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.789 1.636 . . . . 0.0 112.957 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 84.97 2.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.401 1.08 . . . . 0.0 110.797 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 117.07 20.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.873 1.669 . . . . 0.0 110.372 -171.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -135.18 169.11 17.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.144 1.378 . . . . 0.0 109.791 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -63.94 119.74 10.65 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.494 -0.754 . . . . 0.0 110.654 165.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.55 -155.44 29.28 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 163.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.7 137.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.869 0.468 . . . . 0.0 111.742 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -87.91 -52.93 2.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -122.82 111.53 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 111.362 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.7 140.34 4.23 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.126 -0.819 . . . . 0.0 114.861 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.65 131.96 18.07 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 125.178 3.919 . . . . 0.0 110.264 174.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -65.24 -34.24 77.89 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.47 -18.64 58.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 89.8 m -123.3 29.75 6.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.141 1.776 . . . . 0.0 112.137 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 14.4 p -76.55 149.5 36.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.867 0.841 . . . . 0.0 112.138 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -132.82 72.6 1.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.475 1.51 . . . . 0.0 108.798 166.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.47 -19.63 63.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.34 -51.85 53.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.899 1.227 . . . . 0.0 110.975 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -80.36 -16.2 55.1 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 83.01 37.59 12.57 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.054 1.312 . . . . 0.0 112.98 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -145.98 170.31 16.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.01 1.405 . . . . 0.0 112.525 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 37.9 m -136.21 151.39 49.65 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 121.649 -0.657 . . . . 0.0 110.243 170.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.54 128.65 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.01 121.29 28.86 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.178 -171.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.03 141.65 36.92 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.99 1.793 . . . . 0.0 110.269 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 7.3 mtt -59.04 -31.22 68.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.356 1.062 . . . . 0.0 113.411 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.7 -21.92 66.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.05 0.841 . . . . 0.0 113.265 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.44 5.63 50.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.561 1.944 . . . . 0.0 113.741 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.1 126.38 39.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.323 171.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.8 p -77.47 -179.93 6.09 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.309 1.444 . . . . 0.0 111.343 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -62.5 -42.09 99.26 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.518 -0.739 . . . . 0.0 111.527 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.67 -40.7 92.67 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.137 0.975 . . . . 0.0 112.031 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.99 -51.94 67.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -66.42 -40.45 89.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.921 0.888 . . . . 0.0 111.339 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -58.34 -38.93 78.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.212 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -72.29 -44.77 62.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.818 1.644 . . . . 0.0 111.63 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 62.6 m -50.91 -38.43 49.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.815 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.6 m -87.31 -51.95 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.2 t -92.79 -9.33 40.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.48 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -55.82 141.29 39.33 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.218 -0.926 . . . . 0.0 111.653 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -73.72 -57.6 3.88 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.622 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -93.81 137.03 33.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.051 . . . . 0.0 111.367 167.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 67.44 -169.09 37.56 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.277 0.942 . . . . 0.0 113.755 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 67.01 -150.03 51.67 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 451' ' ' LEU . 23.4 p -112.26 9.85 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -156.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.6 m 69.82 14.38 8.02 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.12 1.368 . . . . 0.0 113.238 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.59 41.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.805 1.193 . . . . 0.0 113.829 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.7 144.86 37.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.906 1.353 . . . . 0.0 111.353 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.5 104.39 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.457 2.772 . . . . 0.0 108.883 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 446' ' ' THR . 0.5 OUTLIER -77.63 142.22 39.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 21.8 m -130.42 168.15 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.165 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 10.7 t -48.66 127.34 13.39 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.306 1.042 . . . . 0.0 111.296 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 96.51 -14.36 64.34 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.264 -1.298 . . . . 0.0 115.204 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.6 OUTLIER -53.83 136.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.921 1.86 . . . . 0.0 112.252 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.32 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 126.624 1.97 . . . . 0.0 108.787 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -152.36 179.31 8.66 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.453 1.501 . . . . 0.0 111.086 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -99.21 154.29 18.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.846 1.258 . . . . 0.0 110.569 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -46.58 129.5 8.23 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.971 1.308 . . . . 0.0 112.446 -166.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.54 152.87 70.51 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.822 1.681 . . . . 0.0 110.019 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.48 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 82.7 m-20 -57.96 135.35 56.91 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.467 1.107 . . . . 0.0 113.29 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.47 50.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 123.306 1.527 . . . . 0.0 109.923 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.8 pt -54.92 170.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.932 137.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 42.2 t -138.36 -38.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.109 -0.995 . . . . 0.0 111.296 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -117.54 5.76 Favored Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -167.52 176.06 6.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.705 1.202 . . . . 0.0 111.052 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.65 -129.82 1.34 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.458 1.028 . . . . 0.0 112.064 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.437 1.495 . . . . 0.0 110.224 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.484 0.183 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.69 27.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.88 1.672 . . . . 0.0 112.214 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.32 162.05 32.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.312 0.958 . . . . 0.0 111.784 -167.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -148.61 162.37 30.15 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.496 1.518 . . . . 0.0 109.802 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -72.1 -157.64 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.324 2.683 . . . . 0.0 111.021 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -52.37 -36.44 53.81 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 57.8 p 45.47 28.06 0.45 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.721 2.808 . . . . 0.0 115.709 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 24.9 p -74.24 -16.02 60.97 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.498 1.519 . . . . 0.0 113.192 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -55.79 163.35 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.032 1.733 . . . . 0.0 113.474 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.04 -12.93 68.28 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.642 1.115 . . . . 0.0 113.567 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.94 -164.23 0.97 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.331 1.853 . . . . 0.0 109.972 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -63.84 -26.12 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -79.43 143.53 34.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.987 0.915 . . . . 0.0 111.95 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -154.82 16.97 0.44 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -162.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -76.52 149.33 36.72 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.065 1.346 . . . . 0.0 112.583 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 9.4 mp -98.07 -39.85 8.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.232 1.013 . . . . 0.0 111.596 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -127.91 65.59 68.92 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.137 0.975 . . . . 0.0 110.142 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.9 -175.74 1.54 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.825 3.016 . . . . 0.0 110.948 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 29.9 t0 66.52 54.64 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.643 1.577 . . . . 0.0 111.709 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -158.33 157.41 32.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.778 1.631 . . . . 0.0 112.033 -173.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.07 163.73 17.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.771 1.228 . . . . 0.0 110.832 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.0 64.34 3.18 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.408 1.083 . . . . 0.0 110.616 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.89 150.09 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 127.336 2.254 . . . . 0.0 111.425 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 78.4 p -63.42 -26.2 68.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -70.76 -25.94 63.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -79.26 122.83 84.61 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.069 0.948 . . . . 0.0 110.185 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.23 -16.75 49.26 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.53 2.153 . . . . 0.0 113.164 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.11 0.51 18.59 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 168.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.41 135.47 17.61 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.559 1.527 . . . . 0.0 112.044 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -140.73 149.96 58.43 Favored Pre-proline 0 N--CA 1.473 0.693 0 C-N-CA 124.273 1.029 . . . . 0.0 111.04 174.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.38 169.34 21.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.834 3.023 . . . . 0.0 111.639 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -124.17 71.32 54.05 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.435 1.094 . . . . 0.0 110.5 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.03 108.21 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.617 2.211 . . . . 0.0 109.288 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.0 139.29 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.349 1.06 . . . . 0.0 109.527 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.44 172.61 12.67 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.651 1.581 . . . . 0.0 109.878 174.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.97 124.09 13.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.026 -1.047 . . . . 0.0 109.103 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -121.69 110.42 15.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.9 t -70.16 -6.14 32.17 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -24.99 67.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.08 . . . . 0.0 112.13 170.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 150.47 90.72 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 111.669 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.31 164.09 26.97 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.974 3.116 . . . . 0.0 113.3 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.64 136.83 28.97 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 112.375 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.13 38.55 16.87 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.596 1.559 . . . . 0.0 112.786 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -124.25 158.17 33.13 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.971 1.308 . . . . 0.0 113.834 171.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 455' ' ' ILE . 2.7 pt -128.53 152.64 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.785 2.034 . . . . 0.0 110.69 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.32 132.05 54.49 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.575 -1.328 . . . . 0.0 111.449 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.499 HG22 ' CE2' ' A' ' 457' ' ' PHE . 61.4 t -126.59 105.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 -171.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -68.74 129.72 40.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 111.915 168.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 2.4 m -71.43 134.62 46.74 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.802 -0.561 . . . . 0.0 111.65 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.4 mtm105 -102.98 16.3 27.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.696 1.999 . . . . 0.0 110.614 162.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 93.6 m -123.91 133.94 53.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.66 1.584 . . . . 0.0 110.623 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 46.5 mt -101.11 138.36 38.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.755 2.422 . . . . 0.0 109.785 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -86.31 124.16 32.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 162.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.38 103.05 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.061 0.944 . . . . 0.0 108.466 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -82.17 -175.89 50.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 164.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.0 30.1 75.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.665 -0.903 . . . . 0.0 113.854 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.73 103.68 12.15 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.446 1.098 . . . . 0.0 110.045 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 144.73 64.88 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.277 1.985 . . . . 0.0 109.918 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.8 mp -65.24 -19.67 66.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -63.76 -32.54 74.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.764 1.226 . . . . 0.0 112.858 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.8 ptp -87.84 154.79 20.26 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -134.13 -175.99 4.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.499 1.519 . . . . 0.0 111.312 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 352' ' ' GLU . 1.7 mp0 -52.93 -38.4 61.9 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.167 2.187 . . . . 0.0 112.441 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -75.98 -26.61 56.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.58 -43.25 81.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.633 1.106 . . . . 0.0 109.679 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.72 -48.41 81.27 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.669 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 305' ' ' LEU . . . -53.0 -46.2 68.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.397 0.999 . . . . 0.0 113.023 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.56 -37.64 80.08 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.45 -33.09 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.095 0.861 . . . . 0.0 111.887 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.58 -14.13 55.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -49.86 -48.92 76.69 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.943 1.697 . . . . 0.0 115.426 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.71 -6.39 18.14 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.008 1.806 . . . . 0.0 112.955 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.33 -46.49 5.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.281 1.433 . . . . 0.0 112.12 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.24 1.69 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.062 1.745 . . . . 0.0 113.469 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.74 133.8 34.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.001 . . . . 0.0 110.913 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.05 130.02 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.707 1.203 . . . . 0.0 109.579 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -91.52 -44.39 9.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.087 0.955 . . . . 0.0 111.69 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.5 p -161.26 163.47 30.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.822 1.249 . . . . 0.0 111.25 -171.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 305' ' ' LEU . 0.6 OUTLIER -165.44 132.52 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.57 0.748 . . . . 0.0 111.767 174.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.93 105.42 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 377' ' ' ALA . 0.9 OUTLIER -99.43 115.52 29.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.103 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.88 83.64 2.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.617 1.567 . . . . 0.0 109.205 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -55.5 -37.93 68.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.174 0.99 . . . . 0.0 111.418 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 m -61.38 -28.89 69.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.872 2.069 . . . . 0.0 113.877 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.95 4.5 34.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.991 1.716 . . . . 0.0 112.817 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 79.9 mttt 55.38 34.6 23.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.178 1.791 . . . . 0.0 112.897 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -131.82 156.48 45.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.66 1.584 . . . . 0.0 113.59 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.439 ' HB2' ' HG ' ' A' ' 370' ' ' LEU . . . -141.76 134.25 28.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.125 1.37 . . . . 0.0 112.637 166.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -88.74 102.43 14.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 166.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 38.8 t -99.38 120.52 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.983 0.913 . . . . 0.0 110.964 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -106.19 126.33 52.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.078 0.951 . . . . 0.0 111.898 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.7 169.13 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.934 1.294 . . . . 0.0 110.168 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -75.48 -15.63 60.39 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -168.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.0 160.9 43.05 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.258 -0.901 . . . . 0.0 112.421 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -63.36 -41.99 98.85 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.594 0.758 . . . . 0.0 111.456 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -58.92 -41.64 87.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.346 0.521 . . . . 0.0 111.299 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.66 -51.84 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.08 0.952 . . . . 0.0 109.692 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.27 95.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.557 0.743 . . . . 0.0 112.633 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.3 -43.07 99.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.173 0.989 . . . . 0.0 111.267 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -66.52 -34.19 77.37 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.407 -0.808 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 66.2 t -60.37 -65.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.766 164.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.1 mt -51.95 -35.23 45.35 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -60.16 -37.48 80.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.837 1.255 . . . . 0.0 112.906 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.23 -27.41 7.64 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.56 125.87 28.2 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.78 23.06 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -53.83 -48.04 70.32 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.064 -1.023 . . . . 0.0 113.607 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.45 5.55 49.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.555 1.942 . . . . 0.0 112.806 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 72.62 38.71 57.16 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.566 1.079 . . . . 0.0 112.922 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -57.48 -29.52 64.32 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.232 1.013 . . . . 0.0 113.569 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.12 162.98 25.06 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.763 1.625 . . . . 0.0 110.045 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 -15.73 21.43 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.98 2.453 . . . . 0.0 113.408 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.68 161.01 21.51 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.342 2.257 . . . . 0.0 112.455 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -128.46 97.08 4.6 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.845 1.258 . . . . 0.0 109.995 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.98 21.24 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.46 1.904 . . . . 0.0 111.739 -177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.18 173.2 11.27 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.295 1.838 . . . . 0.0 108.999 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -70.18 125.44 26.78 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.154 -0.966 . . . . 0.0 110.902 163.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.46 -154.38 14.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.606 1.574 . . . . 0.0 109.174 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 8.1 p -163.49 136.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.646 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -94.42 -45.21 3.29 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.114 1.34 . . . . 0.0 110.296 163.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -124.29 109.99 14.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.148 0.979 . . . . 0.0 113.401 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -176.52 136.4 3.21 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.487 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.57 126.56 12.91 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.094 3.862 . . . . 0.0 110.194 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -36.6 80.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 112.404 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.07 -18.23 60.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.63 1.572 . . . . 0.0 114.285 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 69.7 m -122.2 27.18 8.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.753 1.621 . . . . 0.0 111.885 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 5.5 t -84.83 135.42 34.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.59 1.156 . . . . 0.0 111.69 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.05 79.6 1.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.349 1.46 . . . . 0.0 109.34 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -62.83 -24.05 67.58 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.517 -0.74 . . . . 0.0 112.926 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -64.22 -49.36 72.25 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.827 1.194 . . . . 0.0 111.321 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -81.72 -17.38 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 81.77 41.02 10.05 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 124.844 1.212 . . . . 0.0 112.624 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -147.54 165.79 29.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.62 1.21 . . . . 0.0 112.978 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 22.4 m -129.49 152.48 48.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.556 0.742 . . . . 0.0 110.368 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.76 136.24 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.795 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -127.43 120.04 21.97 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 120.331 1.423 . . . . 0.0 112.004 -173.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -69.31 126.64 13.86 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.981 2.454 . . . . 0.0 111.341 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -33.65 74.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.03 0.932 . . . . 0.0 113.069 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -65.65 -17.87 64.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -109.39 11.04 25.32 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 113.691 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 425' ' ' ILE . 47.9 mt -90.37 145.28 25.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.885 0.874 . . . . 0.0 111.052 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 16.7 p -77.0 179.06 6.47 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.577 1.151 . . . . 0.0 111.175 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.11 -41.77 76.99 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.598 -0.689 . . . . 0.0 111.364 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.16 94.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.89 1.276 . . . . 0.0 111.901 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.92 -64.32 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.257 1.423 . . . . 0.0 111.923 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -63.29 -35.23 79.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.63 0.772 . . . . 0.0 111.472 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -53.1 -56.82 13.32 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.504 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -59.59 -39.77 85.28 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.742 1.61 . . . . 0.0 112.734 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.1 m -50.1 -43.48 51.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.426 1.012 . . . . 0.0 112.149 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.12 -21.22 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.6 t -117.68 -17.44 9.91 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.713 1.605 . . . . 0.0 113.905 -165.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.08 139.73 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.179 -0.951 . . . . 0.0 111.186 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -65.27 -49.39 69.75 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.901 0.48 . . . . 0.0 110.667 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -103.66 110.17 22.14 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.592 1.187 . . . . 0.0 108.92 163.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -175.7 -171.49 39.65 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.422 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -74.95 -64.69 2.27 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.101 -1.049 . . . . 0.0 113.642 -164.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 17.4 p -113.65 41.94 2.09 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.107 0.963 . . . . 0.0 110.005 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.8 m -55.74 100.75 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.271 -0.893 . . . . 0.0 111.986 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 99.97 -8.04 59.22 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 125.817 1.675 . . . . 0.0 115.895 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -110.14 146.39 34.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.264 2.225 . . . . 0.0 111.029 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.76 168.08 25.64 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.69 2.927 . . . . 0.0 112.21 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.32 121.52 30.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.652 0.781 . . . . 0.0 110.967 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.28 160.46 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.299 1.44 . . . . 0.0 110.602 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.6 m -58.31 125.75 24.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.558 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 83.85 6.34 87.01 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.846 1.212 . . . . 0.0 114.847 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.498 HG22 HG22 ' A' ' 334' ' ' ILE . 14.9 tt -62.32 137.67 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.371 1.586 . . . . 0.0 111.115 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.55 138.52 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.164 2.185 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.499 ' CE2' HG22 ' A' ' 336' ' ' VAL . 9.4 p90 -165.45 -176.96 4.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.012 0.925 . . . . 0.0 113.169 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -100.2 146.54 26.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.575 1.55 . . . . 0.0 111.091 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.19 138.24 27.11 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -167.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.32 156.54 50.62 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.685 2.257 . . . . 0.0 112.419 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.84 142.66 58.35 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.917 0.887 . . . . 0.0 112.363 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.44 45.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 123.639 1.685 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 2.7 pt -49.75 149.43 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.249 143.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 5.5 t 64.5 12.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 120.052 1.296 . . . . 0.0 111.523 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -57.68 121.03 24.27 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.348 1.452 . . . . 0.0 113.316 -170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -166.95 165.67 15.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.066 0.947 . . . . 0.0 111.446 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -153.59 -158.88 8.81 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.152 1.358 . . . . 0.0 112.997 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.42 1.488 . . . . 0.0 111.514 178.606 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 19.0 tt -57.08 -31.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 120.449 1.477 . . . . 0.0 113.505 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 98.31 149.73 25.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.053 1.311 . . . . 0.0 111.986 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -153.53 158.02 32.7 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.248 1.419 . . . . 0.0 110.659 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.38 -178.74 3.12 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.187 2.591 . . . . 0.0 110.939 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -62.67 -14.58 45.3 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . 0.271 1.8 p 71.42 1.18 3.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.572 3.149 . . . . 0.0 114.378 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.13 -31.65 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 10.6 p90 48.17 -150.61 0.14 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.358 1.863 . . . . 0.0 113.663 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.77 -17.85 23.83 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.788 1.185 . . . . 0.0 115.217 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.8 m -66.47 -42.49 87.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.728 1.611 . . . . 0.0 111.48 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -107.74 -48.27 3.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.501 1.12 . . . . 0.0 112.046 172.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.51 171.57 16.83 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.303 1.441 . . . . 0.0 110.765 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -102.4 18.27 21.49 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -165.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -74.87 137.49 41.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.437 1.095 . . . . 0.0 113.282 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.2 -35.19 23.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.978 1.311 . . . . 0.0 111.564 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -120.19 73.58 20.35 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.951 0.9 . . . . 0.0 110.698 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.05 177.08 8.66 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.587 2.858 . . . . 0.0 111.591 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 61.61 59.32 1.85 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.446 1.498 . . . . 0.0 111.452 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -153.62 168.4 26.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.492 1.117 . . . . 0.0 113.158 -175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 92.4 mt -140.57 158.93 43.26 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.153 1.781 . . . . 0.0 110.497 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -79.16 71.68 5.67 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.101 0.961 . . . . 0.0 110.507 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.84 146.01 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.151 2.181 . . . . 0.0 110.724 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 72.1 p -60.97 -24.2 65.92 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.46 -26.48 62.73 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.253 -0.904 . . . . 0.0 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -79.47 124.34 83.99 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.788 1.235 . . . . 0.0 110.394 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.74 -18.78 63.6 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.941 1.761 . . . . 0.0 113.141 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -77.36 -2.51 35.41 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.711 1.204 . . . . 0.0 113.79 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.5 134.87 56.35 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.268 -1.52 . . . . 0.0 112.676 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -149.38 151.27 33.31 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.197 1.399 . . . . 0.0 110.013 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 159.86 50.59 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.07 2.514 . . . . 0.0 111.593 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -112.71 83.25 5.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.74 109.36 2.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.195 1.93 . . . . 0.0 109.799 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.42 132.6 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.479 1.112 . . . . 0.0 108.592 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 79.6 p -129.26 176.25 8.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.716 0.806 . . . . 0.0 111.06 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.16 124.18 18.85 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.533 1.133 . . . . 0.0 110.29 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -126.46 106.66 9.62 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.087 0.946 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.5 m -67.12 -2.9 6.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 114.118 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 -20.39 61.26 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.493 1.042 . . . . 0.0 112.391 170.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.09 151.09 90.32 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.72 0.691 . . . . 0.0 112.071 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.8 162.66 30.93 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.805 3.003 . . . . 0.0 113.04 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.6 133.55 28.1 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.539 2.826 . . . . 0.0 112.699 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.12 20.07 6.52 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 126.275 1.83 . . . . 0.0 112.808 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -106.47 155.49 19.53 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 455' ' ' ILE . 16.1 pt -126.78 154.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.94 2.096 . . . . 0.0 110.478 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -117.59 126.26 52.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.497 1.499 . . . . 0.0 111.855 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.86 107.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.748 0.819 . . . . 0.0 110.498 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -73.59 134.49 43.74 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.07 1.348 . . . . 0.0 111.658 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 38.3 t -70.44 144.29 51.52 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.557 -0.714 . . . . 0.0 111.322 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -123.88 28.91 6.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.816 1.646 . . . . 0.0 110.213 162.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 86.1 m -127.43 143.14 51.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.393 1.877 . . . . 0.0 109.556 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.57 126.4 55.3 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.239 1.816 . . . . 0.0 108.708 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.09 119.45 27.33 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.6 110.04 30.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.86 37.07 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.494 0.568 . . . . 0.0 112.441 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.38 21.19 70.24 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 169.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.97 128.63 93.2 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.383 1.073 . . . . 0.0 109.928 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.29 130.49 18.77 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.333 2.022 . . . . 0.0 109.396 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 pp -61.13 -20.18 62.37 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -166.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 -21.55 59.28 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.3 ptp -93.29 147.43 22.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.277 0.944 . . . . 0.0 113.23 -173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -120.47 -179.77 4.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 112.441 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -49.67 -39.17 35.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.613 1.565 . . . . 0.0 114.467 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.92 -14.95 57.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -79.39 -36.56 39.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.264 0.938 . . . . 0.0 110.791 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.48 -51.05 69.94 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.17 -39.14 69.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.21 -42.59 75.53 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.48 -32.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.182 1.356 . . . . 0.0 111.686 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 44.1 mt -81.81 -14.5 56.27 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.196 0.999 . . . . 0.0 112.824 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -43.23 -50.27 15.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.523 1.929 . . . . 0.0 116.193 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -77.45 -8.34 17.19 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.29 1.994 . . . . 0.0 114.12 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.64 -38.73 9.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.071 1.748 . . . . 0.0 112.236 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.04 160.46 2.77 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.442 1.897 . . . . 0.0 112.776 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.15 106.76 18.7 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.655 0.74 . . . . 0.0 109.033 162.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.77 137.65 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.67 1.188 . . . . 0.0 111.133 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -89.59 -41.84 11.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.436 1.094 . . . . 0.0 111.602 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.59 148.7 28.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.768 1.227 . . . . 0.0 111.031 -170.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 88.0 t -144.96 137.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 119.171 0.896 . . . . 0.0 110.877 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.86 104.32 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 165.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.85 98.96 11.72 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.588 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -83.25 75.07 9.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.433 1.111 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -56.39 -32.25 64.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.1 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.8 t -59.51 -23.44 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.445 1.498 . . . . 0.0 113.786 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.08 13.23 12.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 112.912 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.86 34.05 23.43 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.328 1.451 . . . . 0.0 112.222 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -117.27 156.55 27.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.415 1.886 . . . . 0.0 112.741 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -142.5 135.39 28.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.072 0.949 . . . . 0.0 112.112 161.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.11 124.31 31.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 162.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.5 101.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.712 1.205 . . . . 0.0 108.846 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -90.21 116.47 28.22 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.116 1.366 . . . . 0.0 110.019 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.69 149.22 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.313 1.045 . . . . 0.0 108.347 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -74.97 3.57 8.09 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 1.2 t -160.32 147.15 15.82 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.25 -1.531 . . . . 0.0 112.903 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -59.89 -39.69 86.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.213 1.405 . . . . 0.0 111.085 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.85 -35.05 79.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.932 0.493 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -68.26 -53.36 25.06 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.796 0.838 . . . . 0.0 110.696 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.14 87.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -64.9 -44.09 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.484 168.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -65.34 -29.03 69.73 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.058 1.299 . . . . 0.0 112.555 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.2 -67.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 118.872 0.76 . . . . 0.0 109.672 161.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.98 -30.87 62.44 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.1 -35.7 81.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.049 1.74 . . . . 0.0 112.756 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.95 -25.76 7.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -75.17 124.57 27.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.327 1.051 . . . . 0.0 111.26 -167.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 59.76 28.35 17.79 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.253 1.821 . . . . 0.0 114.067 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -62.43 -25.88 68.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.716 -1.24 . . . . 0.0 114.186 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.56 -15.12 46.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.447 1.099 . . . . 0.0 113.42 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.01 83.69 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.703 1.144 . . . . 0.0 114.098 -173.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.0 29.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.815 1.646 . . . . 0.0 115.375 -171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.18 151.09 59.37 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.215 0.916 . . . . 0.0 110.39 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.65 -23.75 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.832 2.355 . . . . 0.0 112.736 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.71 142.36 51.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.594 1.958 . . . . 0.0 112.423 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -115.92 90.28 3.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.047 0.939 . . . . 0.0 109.836 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.1 m -79.04 116.28 19.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.542 1.137 . . . . 0.0 109.867 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -116.38 165.88 12.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.681 1.993 . . . . 0.0 108.846 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -63.43 131.19 47.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.741 -1.225 . . . . 0.0 109.992 158.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -112.41 -155.19 12.4 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 125.555 1.55 . . . . 0.0 109.799 164.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.0 p -165.6 141.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 117.798 0.799 . . . . 0.0 111.365 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -91.31 -45.34 4.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.009 163.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -118.42 102.52 8.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.742 1.217 . . . . 0.0 112.916 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.33 123.73 1.13 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 118.789 -1.006 . . . . 0.0 115.284 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.84 128.92 10.36 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.473 3.449 . . . . 0.0 111.302 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -61.19 -32.6 72.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.34 -24.56 66.54 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.762 1.625 . . . . 0.0 113.205 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 23.1 m -134.84 32.42 3.25 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 112.255 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 1.2 m -71.72 140.97 49.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.999 1.319 . . . . 0.0 111.476 171.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -131.75 78.69 1.83 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.023 1.729 . . . . 0.0 109.338 163.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -64.41 -12.88 47.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 113.375 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.85 -47.49 18.68 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.685 1.129 . . . . 0.0 111.152 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -80.59 -17.13 52.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.305 0.642 . . . . 0.0 112.623 172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 76.72 47.53 9.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.082 1.325 . . . . 0.0 112.083 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -147.65 171.81 15.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.771 1.286 . . . . 0.0 112.376 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 20.3 m -141.24 150.35 42.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.993 1.317 . . . . 0.0 110.591 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.49 132.37 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.11 124.41 25.34 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 119.537 1.062 . . . . 0.0 111.768 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.05 140.05 17.65 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.549 2.833 . . . . 0.0 112.636 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.81 -19.85 66.04 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.767 1.627 . . . . 0.0 113.985 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -74.58 -21.66 59.38 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.93 0.786 . . . . 0.0 112.911 172.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -95.51 -26.43 15.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.38 112.62 2.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.684 1.129 . . . . 0.0 109.506 169.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 36.6 p -66.93 177.33 1.73 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.29 1.436 . . . . 0.0 111.491 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -59.97 -38.9 83.85 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.056 -1.028 . . . . 0.0 111.905 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.39 -37.9 65.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.624 0.77 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.31 -51.43 69.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.746 1.218 . . . . 0.0 111.286 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -65.93 -36.27 82.91 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.621 -0.674 . . . . 0.0 111.535 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -51.94 67.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.076 0.853 . . . . 0.0 111.515 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.17 -44.61 94.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.226 1.375 . . . . 0.0 110.667 175.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 m -56.37 -32.84 65.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.249 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.41 -34.94 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 47.6 m -102.3 -9.27 20.52 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -168.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.63 152.19 27.03 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.952 1.251 . . . . 0.0 112.768 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -81.35 -38.77 26.14 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.135 0.574 . . . . 0.0 110.922 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -116.48 137.3 52.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.247 1.019 . . . . 0.0 110.749 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 72.43 -169.9 51.2 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.361 -168.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 69.54 -162.11 52.27 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.293 0.949 . . . . 0.0 113.266 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 29.3 p -95.11 1.76 54.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.549 1.54 . . . . 0.0 114.373 -168.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 19.7 m 66.89 11.93 8.62 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.46 1.027 . . . . 0.0 113.655 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.22 48.23 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.303 1.43 . . . . 0.0 114.33 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.7 154.23 93.09 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 118.469 1.135 . . . . 0.0 110.725 169.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.12 148.7 81.54 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.901 2.4 . . . . 0.0 111.051 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.1 105.53 5.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.547 -0.721 . . . . 0.0 110.011 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.39 158.91 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.653 1.581 . . . . 0.0 110.73 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 76.2 m -60.15 133.13 55.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.02 84.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.491 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 334' ' ' ILE . 15.8 tt -63.99 135.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.937 1.868 . . . . 0.0 111.78 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 36.3 t -120.01 139.45 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 126.376 1.87 . . . . 0.0 109.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -163.52 -176.1 4.53 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.237 1.015 . . . . 0.0 112.743 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.54 148.2 22.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.341 1.457 . . . . 0.0 109.434 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -49.16 131.03 16.35 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.44 157.25 56.91 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.729 2.286 . . . . 0.0 111.612 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -58.38 134.78 56.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.582 1.153 . . . . 0.0 112.757 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.32 58.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 123.572 1.653 . . . . 0.0 109.966 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.96 174.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.068 140.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.51 -66.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 O-C-N 121.06 -1.025 . . . . 0.0 110.195 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 82.09 -66.7 3.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.195 0.902 . . . . 0.0 112.117 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -166.17 153.39 9.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.879 1.672 . . . . 0.0 110.387 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -172.82 160.62 31.65 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.483 1.039 . . . . 0.0 113.248 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.211 1.404 . . . . 0.0 112.16 177.255 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 26.2 mm 71.42 145.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 127.475 2.31 . . . . 0.0 111.595 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -100.27 51.2 1.04 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.152 1.358 . . . . 0.0 112.895 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 294' ' ' PRO . . . 69.52 169.32 0.11 Allowed Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 126.789 2.036 . . . . 0.0 111.759 -173.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 293' ' ' ALA . 55.4 Cg_endo -70.78 -157.6 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.478 2.786 . . . . 0.0 112.246 173.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -53.34 -41.06 65.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.247 1.019 . . . . 0.0 113.047 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.4 p 48.25 29.53 1.92 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.014 2.526 . . . . 0.0 113.989 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -77.22 -13.69 59.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.824 1.65 . . . . 0.0 113.391 -174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -50.05 138.34 15.86 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 112.485 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 133.41 -67.32 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.7 1.143 . . . . 0.0 112.148 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.0 t -153.06 8.81 0.42 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -106.9 -66.91 0.98 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.013 -1.054 . . . . 0.0 112.074 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.7 177.37 11.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.663 1.185 . . . . 0.0 112.216 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -122.93 -10.51 8.2 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -63.73 138.1 58.35 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.57 0.748 . . . . 0.0 111.414 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 353' ' ' TRP . 2.9 mm? -59.55 -43.75 93.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.88 0.872 . . . . 0.0 112.154 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.86 156.87 35.51 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.835 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.46 89.66 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.271 3.314 . . . . 0.0 112.156 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 50.7 41.09 25.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.166 1.387 . . . . 0.0 111.106 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -55.15 150.44 10.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.377 1.471 . . . . 0.0 113.031 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.89 161.23 17.87 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.513 1.125 . . . . 0.0 110.417 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -79.02 68.7 5.04 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.865 0.866 . . . . 0.0 111.596 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.42 146.9 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 127.132 2.173 . . . . 0.0 110.237 -170.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 87.8 p -63.17 -25.4 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -69.9 -23.34 63.22 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.269 -0.894 . . . . 0.0 112.705 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -83.28 122.78 77.45 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.915 1.286 . . . . 0.0 110.564 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.27 -17.89 50.13 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.398 2.066 . . . . 0.0 113.125 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -74.52 1.44 11.95 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -51.08 127.42 18.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.682 1.583 . . . . 0.0 111.645 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -157.19 147.35 15.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.56 1.544 . . . . 0.0 110.85 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.7 173.76 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.67 2.247 . . . . 0.0 111.541 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -108.55 83.3 1.95 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.941 0.896 . . . . 0.0 110.194 167.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.55 141.08 30.73 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.26 2.64 . . . . 0.0 110.303 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.72 145.19 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.208 1.403 . . . . 0.0 108.524 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 75.9 p -140.39 179.78 6.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.178 0.991 . . . . 0.0 111.084 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -143.92 130.77 20.36 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.093 -1.005 . . . . 0.0 110.085 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -107.64 102.93 12.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.274 1.03 . . . . 0.0 109.643 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -12.77 17.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.002 1.321 . . . . 0.0 113.667 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.88 0.92 54.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.691 1.597 . . . . 0.0 113.018 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.6 154.61 50.86 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.644 1.111 . . . . 0.0 113.688 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 162.73 40.98 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.948 3.766 . . . . 0.0 113.191 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.03 138.98 34.9 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.445 3.43 . . . . 0.0 112.937 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.04 37.33 18.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.921 1.288 . . . . 0.0 111.744 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -115.61 140.24 49.36 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.62 -1.3 . . . . 0.0 112.763 171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 425' ' ' ILE . 25.6 pt -106.81 146.15 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.387 1.475 . . . . 0.0 109.591 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 117.96 33.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.504 1.121 . . . . 0.0 109.494 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.7 106.93 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 O-C-N 122.096 -0.377 . . . . 0.0 110.568 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.08 128.84 36.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.811 1.244 . . . . 0.0 111.793 170.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 66.1 m -69.16 144.7 53.73 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -131.72 16.02 4.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.484 2.714 . . . . 0.0 110.843 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 13.3 m -110.27 129.68 55.69 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.117 1.767 . . . . 0.0 108.786 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.08 136.44 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.615 1.566 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -93.63 142.87 26.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 159.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.79 106.32 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.98 1.312 . . . . 0.0 108.709 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.41 41.81 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.831 0.729 . . . . 0.0 111.966 168.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.6 78.65 Favored Glycine 0 N--CA 1.475 1.234 0 O-C-N 122.054 -0.674 . . . . 0.0 114.651 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.4 t -78.79 119.97 79.19 Favored Pre-proline 0 N--CA 1.475 0.8 0 CA-C-N 118.532 1.166 . . . . 0.0 110.358 -171.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.89 138.53 34.42 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.721 2.28 . . . . 0.0 109.609 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -16.81 54.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -29.48 63.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.139 0.976 . . . . 0.0 112.557 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.406 ' CE ' HD21 ' A' ' 402' ' ' LEU . 5.9 mtm -78.79 149.33 32.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.63 0.728 . . . . 0.0 112.735 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -127.83 -178.33 4.46 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.878 2.071 . . . . 0.0 111.222 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.466 ' HA ' HG11 ' A' ' 368' ' ' VAL . 10.6 pm0 -51.08 -41.55 60.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.844 1.658 . . . . 0.0 114.449 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.499 ' CE2' HD12 ' A' ' 305' ' ' LEU . 96.1 m95 -77.12 -17.63 58.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.69 -40.31 61.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.272 0.942 . . . . 0.0 110.545 167.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 355' ' ' LEU . 2.7 mm? -60.26 -47.35 86.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.497 0.59 . . . . 0.0 110.939 170.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -59.33 -34.16 72.01 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.717 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.72 -42.42 64.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.954 1.252 . . . . 0.0 114.376 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.27 -37.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.964 0.802 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 394' ' ' PHE . 32.6 mt -85.75 -5.32 59.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.893 0.877 . . . . 0.0 112.479 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -52.85 -49.83 84.72 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.966 1.707 . . . . 0.0 115.161 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.67 -5.01 16.39 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.457 2.105 . . . . 0.0 113.431 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -101.23 -39.56 7.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.191 1.396 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -172.5 167.28 5.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.643 1.977 . . . . 0.0 113.111 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -92.67 102.1 14.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.67 1.188 . . . . 0.0 111.642 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 379' ' ' VAL . 59.4 t -70.51 118.58 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.883 0.873 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -91.95 -36.13 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.897 1.679 . . . . 0.0 112.778 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.7 t -144.16 153.16 41.83 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.318 0.963 . . . . 0.0 112.169 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 352' ' ' GLU . 49.0 t -144.81 140.35 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.855 0.862 . . . . 0.0 111.259 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.61 97.79 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.313 1.445 . . . . 0.0 108.019 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 1.1 tt -97.3 132.99 42.5 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.858 0.463 . . . . 0.0 110.734 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.05 89.09 2.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.976 1.31 . . . . 0.0 109.769 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.46 -37.45 83.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.087 1.355 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.1 t -58.47 -32.43 68.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.055 1.742 . . . . 0.0 113.064 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -98.45 -1.0 42.39 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.151 1.38 . . . . 0.0 113.197 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 59.03 30.95 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.399 1.88 . . . . 0.0 113.408 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.29 170.5 15.62 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.66 24.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 111.68 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.14 140.12 53.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.377 1.471 . . . . 0.0 108.895 164.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 365' ' ' VAL . 95.1 t -132.77 111.96 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.493 1.117 . . . . 0.0 109.705 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -92.45 119.97 32.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.565 0.746 . . . . 0.0 110.239 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.27 176.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.907 0.883 . . . . 0.0 108.918 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.3 60.26 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 147.4 46.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.601 -0.687 . . . . 0.0 111.268 -164.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.65 81.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.759 0.824 . . . . 0.0 110.652 166.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -39.93 80.53 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.053 0.842 . . . . 0.0 112.435 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -65.63 -52.38 52.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.674 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.56 80.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.411 1.085 . . . . 0.0 113.037 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.47 -41.57 98.88 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.857 0.863 . . . . 0.0 111.508 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -61.72 -32.61 72.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.645 1.111 . . . . 0.0 111.916 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 359' ' ' LEU . 3.7 t -63.73 -62.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.858 166.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.61 -36.98 26.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.208 1.403 . . . . 0.0 114.111 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.56 -38.59 70.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.377 1.471 . . . . 0.0 112.885 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -106.73 -26.31 11.36 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.56 ' CE1' HD23 ' A' ' 359' ' ' LEU . 25.4 t80 -70.89 127.7 33.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -171.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 29.0 t30 60.66 28.42 18.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.39 1.476 . . . . 0.0 113.9 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -59.64 -34.75 73.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.853 -1.154 . . . . 0.0 113.325 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.32 -20.14 60.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.883 1.273 . . . . 0.0 113.063 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.86 19.61 75.06 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.929 1.252 . . . . 0.0 113.725 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.78 -32.67 17.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.242 1.417 . . . . 0.0 114.291 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.49 HD13 ' CZ ' ' A' ' 394' ' ' PHE . 20.0 mt -77.48 146.77 74.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.859 0.864 . . . . 0.0 109.093 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.79 -18.9 28.0 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.17 1.913 . . . . 0.0 112.718 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.406 HD21 ' CE ' ' A' ' 350' ' ' MET . 3.8 mt -82.27 144.43 30.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.048 0.939 . . . . 0.0 112.524 -169.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.14 9.71 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 110.245 174.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 33.3 m -83.11 125.12 31.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.237 1.415 . . . . 0.0 110.628 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.83 174.98 9.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.022 2.129 . . . . 0.0 109.661 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -72.53 122.87 22.06 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.207 -0.933 . . . . 0.0 111.398 163.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.83 -177.72 35.08 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.281 1.419 . . . . 0.0 110.551 163.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.64 119.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.679 0.791 . . . . 0.0 109.619 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -85.49 -36.78 10.26 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.759 1.647 . . . . 0.0 110.943 161.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -145.99 109.19 4.65 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.921 0.861 . . . . 0.0 112.149 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -179.34 133.74 2.13 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.821 -0.988 . . . . 0.0 115.467 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.25 122.17 7.79 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 125.268 3.978 . . . . 0.0 110.83 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -55.27 -37.18 66.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -74.99 -16.41 60.62 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.694 1.598 . . . . 0.0 114.16 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 96.7 m -127.21 27.82 5.84 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.916 1.686 . . . . 0.0 111.93 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.65 140.48 29.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.201 1.401 . . . . 0.0 111.669 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -126.12 87.78 2.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.444 1.116 . . . . 0.0 109.567 167.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.25 -22.0 65.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.835 0.854 . . . . 0.0 113.181 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -68.77 -51.97 35.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.077 0.853 . . . . 0.0 110.232 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.09 -18.72 59.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 79.11 45.55 8.86 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.415 1.007 . . . . 0.0 112.459 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -154.6 175.33 13.79 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.306 1.05 . . . . 0.0 112.99 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 35.2 p -147.22 153.32 39.67 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.414 1.086 . . . . 0.0 110.967 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.5 mm -108.33 135.34 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -129.42 109.73 17.69 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 119.843 1.201 . . . . 0.0 110.523 -172.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.65 131.94 27.43 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.595 2.197 . . . . 0.0 110.917 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 45.7 mtt -64.7 -15.72 61.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.687 1.195 . . . . 0.0 113.132 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -65.35 -25.16 67.47 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 113.038 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 13.08 14.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.426 2.29 . . . . 0.0 113.243 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 425' ' ' ILE . 9.4 mt -85.0 176.41 8.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.521 1.528 . . . . 0.0 111.706 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 2.3 p -127.87 165.06 20.9 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 110.759 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -65.92 -37.28 85.67 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.041 -1.037 . . . . 0.0 111.41 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.83 -42.21 90.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.771 0.829 . . . . 0.0 112.071 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -48.48 70.0 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.022 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.45 -38.12 86.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.017 0.826 . . . . 0.0 110.107 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.06 -33.05 71.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.659 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -72.56 -45.32 59.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.266 1.394 . . . . 0.0 111.858 168.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 m -53.21 -39.7 63.9 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.767 1.167 . . . . 0.0 111.402 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.24 -48.12 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.2 m -93.49 -5.95 47.97 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -55.22 138.19 45.55 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.896 1.225 . . . . 0.0 112.533 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -78.02 -27.36 48.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.569 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 27.8 m-90 -124.89 138.46 54.25 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.611 1.564 . . . . 0.0 111.221 164.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.02 -168.64 47.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.396 -172.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.18 -156.91 53.5 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.23 0.443 . . . . 0.0 112.556 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.6 p -107.27 11.77 28.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.24 1.416 . . . . 0.0 114.746 -159.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.5 t 66.19 14.87 9.86 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.911 -1.118 . . . . 0.0 113.21 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 95.81 1.08 61.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.281 1.42 . . . . 0.0 114.233 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -68.19 145.37 97.51 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 119.309 1.555 . . . . 0.0 111.126 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.32 148.27 90.94 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.981 2.454 . . . . 0.0 110.976 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.1 109.4 8.55 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.047 0.451 . . . . 0.0 110.448 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.75 170.87 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.966 1.706 . . . . 0.0 111.471 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 16.9 m -57.23 119.36 6.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.29 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.19 79.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.283 0.945 . . . . 0.0 115.123 172.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 2.6 tt -58.27 125.01 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.176 1.488 . . . . 0.0 111.184 172.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.08 132.93 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.707 1.603 . . . . 0.0 109.003 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.79 170.52 21.44 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.154 0.982 . . . . 0.0 112.071 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.91 147.59 25.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.593 1.157 . . . . 0.0 108.982 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -40.0 125.17 1.63 Allowed Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.529 1.132 . . . . 0.0 113.966 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.07 150.6 85.15 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.489 1.459 . . . . 0.0 110.111 172.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -56.7 161.4 2.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.504 1.145 . . . . 0.0 113.52 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 1.4 mt -118.94 47.49 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 123.231 1.491 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.58 140.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.24 -47.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.673 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.68 -99.68 1.38 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.19 134.97 7.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.972 1.309 . . . . 0.0 110.431 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -127.05 -160.82 10.66 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.779 1.657 . . . . 0.0 112.997 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.177 1.391 . . . . 0.0 110.833 178.209 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.22 145.25 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.085 1.354 . . . . 0.0 110.473 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -74.76 165.07 54.73 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.746 0.689 . . . . 0.0 111.867 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -131.96 154.93 81.88 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.583 1.153 . . . . 0.0 111.764 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.72 178.56 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 124.481 3.454 . . . . 0.0 112.326 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -24.3 67.72 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.748 0.819 . . . . 0.0 112.851 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.3 m 76.93 9.0 2.88 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 127.482 2.313 . . . . 0.0 112.399 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.47 -32.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.173 2.189 . . . . 0.0 114.101 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 50.42 63.73 2.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.324 1.85 . . . . 0.0 112.877 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -100.42 17.97 56.0 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.469 1.509 . . . . 0.0 115.482 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 9.6 t -118.53 -52.73 2.35 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.089 1.356 . . . . 0.0 113.203 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.2 -64.44 1.15 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.843 0.857 . . . . 0.0 112.384 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -159.82 -102.77 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.218 1.407 . . . . 0.0 110.526 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -160.13 18.65 0.15 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 113.681 -164.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -79.54 140.12 37.32 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.361 1.064 . . . . 0.0 111.388 174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.74 -47.03 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.182 0.593 . . . . 0.0 110.609 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -119.53 81.3 23.6 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.139 1.376 . . . . 0.0 110.231 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.71 -28.3 14.08 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.711 2.274 . . . . 0.0 112.028 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.92 56.39 3.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.104 1.362 . . . . 0.0 110.844 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.39 144.02 28.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.818 1.247 . . . . 0.0 111.225 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.16 165.84 18.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.47 1.508 . . . . 0.0 110.096 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -77.06 73.74 3.64 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.524 -0.735 . . . . 0.0 110.805 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 38.8 t -133.19 145.68 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.432 2.293 . . . . 0.0 110.196 -171.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.6 t -53.94 -31.19 49.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -66.49 -27.12 67.54 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.937 -1.102 . . . . 0.0 112.781 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -81.7 126.74 74.94 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.681 1.193 . . . . 0.0 110.685 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.84 -17.17 55.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.715 2.277 . . . . 0.0 113.677 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.35 6.94 5.93 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.57 125.63 23.03 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 120.685 -1.259 . . . . 0.0 111.654 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 56.5 mmt-85 -156.09 147.16 16.52 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.764 1.226 . . . . 0.0 111.358 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.01 174.28 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.916 2.411 . . . . 0.0 111.145 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -115.98 77.72 7.04 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.999 0.92 . . . . 0.0 110.084 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.39 135.84 23.01 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.485 2.79 . . . . 0.0 110.306 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 t -147.46 140.64 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.055 1.342 . . . . 0.0 108.866 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.04 173.4 10.76 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.984 1.314 . . . . 0.0 111.043 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.493 ' CE2' HD12 ' A' ' 455' ' ' ILE . 42.5 m-85 -137.17 124.64 22.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.31 1.044 . . . . 0.0 109.988 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -119.36 103.07 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.216 1.008 . . . . 0.0 110.589 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.0 p -66.8 -5.03 10.61 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.499 1.519 . . . . 0.0 113.972 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -22.4 64.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.802 0.841 . . . . 0.0 112.509 168.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.92 153.04 95.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.875 0.87 . . . . 0.0 112.179 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.13 161.99 31.49 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.799 2.999 . . . . 0.0 112.557 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.78 131.54 18.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.894 3.062 . . . . 0.0 112.122 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.88 44.89 3.42 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.254 1.822 . . . . 0.0 111.558 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -130.33 155.26 46.64 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.5 pt -128.25 144.77 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.101 1.761 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -100.43 115.86 31.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.232 1.413 . . . . 0.0 109.659 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.6 102.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.475 0.71 . . . . 0.0 110.384 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -71.17 136.2 47.98 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.401 1.08 . . . . 0.0 111.776 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.2 t -75.48 140.23 42.71 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.16 -0.962 . . . . 0.0 112.173 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.436 ' H ' ' CD ' ' A' ' 459' ' ' GLU . 4.7 mtm180 -110.32 2.34 19.07 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.896 1.678 . . . . 0.0 111.288 165.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 35.9 m -104.65 129.32 52.82 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.084 1.353 . . . . 0.0 109.567 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.33 137.43 34.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.064 1.746 . . . . 0.0 108.604 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -91.79 137.82 32.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 159.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 19.8 mm -127.69 108.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 108.398 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -94.82 -177.55 38.09 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.328 0.966 . . . . 0.0 112.229 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.01 16.58 64.39 Favored Glycine 0 N--CA 1.477 1.402 0 C-N-CA 124.189 0.9 . . . . 0.0 114.87 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 57.2 t -71.85 129.16 88.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 118.141 0.971 . . . . 0.0 110.262 -164.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.94 130.21 22.53 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.366 2.044 . . . . 0.0 109.278 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.41 -19.09 54.87 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.24 -29.56 64.05 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.517 -0.739 . . . . 0.0 112.906 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 2.4 ptp -84.5 145.93 27.86 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -120.25 -177.83 3.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.231 1.812 . . . . 0.0 112.494 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.86 -41.04 44.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.288 1.435 . . . . 0.0 113.559 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -76.47 -22.55 54.41 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.49 -35.27 65.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.76 0.709 . . . . 0.0 110.79 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 355' ' ' LEU . 1.4 mm? -59.55 -51.18 70.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.987 0.812 . . . . 0.0 110.437 168.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.11 -38.23 67.89 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.464 0.574 . . . . 0.0 112.416 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -72.53 -42.96 64.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.115 1.366 . . . . 0.0 114.474 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.32 -31.94 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 120.462 1.483 . . . . 0.0 111.049 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.441 HD23 ' CE1' ' A' ' 394' ' ' PHE . 35.7 mt -89.22 -9.36 51.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.26 1.024 . . . . 0.0 112.885 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -49.45 -49.04 73.77 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.705 1.602 . . . . 0.0 114.828 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.05 -6.24 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.089 1.859 . . . . 0.0 113.202 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -100.73 -33.91 10.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.45 1.5 . . . . 0.0 112.983 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.88 168.08 3.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 113.946 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 113.03 20.88 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.838 1.255 . . . . 0.0 110.81 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.63 121.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.65 . . . . 0.0 109.547 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -92.81 -37.05 12.52 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.412 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.71 158.66 43.69 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.085 -1.01 . . . . 0.0 112.094 -174.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 2.4 p -166.05 136.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.688 0.795 . . . . 0.0 111.378 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.51 97.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.137 1.375 . . . . 0.0 107.578 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 372' ' ' ASN . 5.5 tt -89.96 126.87 35.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.615 0.366 . . . . 0.0 110.07 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 83.16 1.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.035 1.334 . . . . 0.0 109.02 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.44 HD22 HD21 ' A' ' 370' ' ' LEU . 3.8 t-20 -63.3 -30.35 71.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.864 0.865 . . . . 0.0 112.694 -173.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 9.0 t -48.08 -39.06 19.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.658 1.983 . . . . 0.0 113.596 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -103.87 8.61 36.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.548 1.539 . . . . 0.0 113.682 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 56.68 36.6 27.9 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.98 1.312 . . . . 0.0 112.221 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -133.29 165.33 25.07 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -143.53 163.0 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.736 1.214 . . . . 0.0 111.699 165.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.48 141.73 47.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.725 1.21 . . . . 0.0 108.543 162.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 48.9 t -138.43 118.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.026 0.53 . . . . 0.0 111.775 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -99.4 126.06 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 112.836 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.63 179.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.395 1.078 . . . . 0.0 111.296 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 383' ' ' SER . 0.0 OUTLIER -65.35 -35.47 81.06 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 382' ' ' TYR . 57.5 p -149.01 168.62 22.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.054 1.297 . . . . 0.0 114.384 -168.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.62 98.1 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.734 169.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -58.1 -45.01 87.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.063 0.847 . . . . 0.0 111.953 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.74 -47.06 79.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.375 0.67 . . . . 0.0 110.519 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.91 96.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 111.759 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.81 -40.96 97.87 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.005 0.922 . . . . 0.0 111.169 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.65 -33.49 75.15 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.792 1.633 . . . . 0.0 112.239 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.91 -64.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 118.883 -0.579 . . . . 0.0 110.512 165.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.45 -29.33 49.29 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -67.89 -34.49 76.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.651 1.98 . . . . 0.0 112.998 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -123.49 -27.25 4.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.441 ' CE1' HD23 ' A' ' 359' ' ' LEU . 35.3 t80 -69.34 121.41 16.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.954 0.902 . . . . 0.0 111.06 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 38.0 t30 57.97 27.91 15.44 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.435 1.494 . . . . 0.0 114.398 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -62.62 -32.78 73.86 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.362 -1.461 . . . . 0.0 113.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.86 -19.02 62.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 113.076 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.02 80.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.014 1.292 . . . . 0.0 113.563 -171.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.94 34.69 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.392 1.477 . . . . 0.0 114.052 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.21 149.44 55.53 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.512 1.125 . . . . 0.0 109.672 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.79 -23.73 13.98 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.593 2.195 . . . . 0.0 113.417 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.81 150.72 27.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.101 2.161 . . . . 0.0 113.101 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.7 91.36 3.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.543 1.137 . . . . 0.0 110.683 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 25.8 m -85.27 127.73 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.199 1.4 . . . . 0.0 111.14 -170.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -137.77 172.83 12.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.908 2.083 . . . . 0.0 109.622 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -70.98 120.39 16.48 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.04 -1.037 . . . . 0.0 111.005 164.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -96.36 -161.73 32.71 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 162.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 16.9 t -143.22 122.54 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.566 1.146 . . . . 0.0 108.903 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -86.15 -40.79 7.32 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 164.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -142.4 125.13 15.93 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.181 0.992 . . . . 0.0 111.265 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 177.99 132.17 1.66 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.676 -1.069 . . . . 0.0 114.37 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.415 ' HG3' HG23 ' A' ' 425' ' ' ILE . 97.1 Cg_endo -70.53 123.83 10.21 Favored 'Trans proline' 0 C--N 1.349 0.566 1 C-N-CA 125.316 4.011 . . . . 0.0 109.698 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.43 -39.49 79.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.141 0.496 . . . . 0.0 112.104 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.78 -24.03 66.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.511 1.924 . . . . 0.0 113.501 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 6.4 m -119.96 20.9 12.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.542 1.537 . . . . 0.0 111.896 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.95 139.62 30.42 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.291 1.436 . . . . 0.0 111.973 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.85 90.65 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.954 1.302 . . . . 0.0 109.43 166.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -67.71 -21.73 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -69.52 -51.14 38.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.643 0.656 . . . . 0.0 110.489 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -78.57 -19.8 51.98 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.12 38.32 19.15 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.88 1.228 . . . . 0.0 113.12 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.64 167.06 26.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.185 0.993 . . . . 0.0 113.4 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.2 m -132.24 149.86 52.28 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.331 1.053 . . . . 0.0 111.035 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 10.0 mm -107.55 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.714 HG21 HD21 ' A' ' 430' ' ' LEU . 1.3 mt -97.55 122.56 55.04 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 121.007 -1.058 . . . . 0.0 111.056 -169.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.43 131.94 21.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.44 2.093 . . . . 0.0 111.25 168.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -27.7 68.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.522 1.129 . . . . 0.0 113.446 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.24 -20.99 63.94 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.426 1.012 . . . . 0.0 113.568 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.15 8.79 28.2 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.323 1.849 . . . . 0.0 112.699 -176.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.714 HD21 HG21 ' A' ' 425' ' ' ILE . 38.4 mt -92.6 147.69 22.68 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.991 1.716 . . . . 0.0 110.81 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 21.9 p -83.61 175.15 9.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.595 1.158 . . . . 0.0 111.155 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.92 -41.65 97.59 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.757 -0.589 . . . . 0.0 111.42 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -64.97 -40.55 95.16 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.952 0.901 . . . . 0.0 112.028 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.64 -53.16 61.43 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.593 1.157 . . . . 0.0 112.279 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.05 -40.66 96.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.812 0.845 . . . . 0.0 111.001 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -58.01 -41.78 83.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.243 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -69.93 -44.82 68.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.824 1.647 . . . . 0.0 111.758 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.4 m -52.7 -35.43 55.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.423 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.15 -43.74 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 5.6 t -96.68 -11.19 25.49 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.573 -1.329 . . . . 0.0 114.429 -166.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.49 139.39 53.45 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.048 -1.032 . . . . 0.0 111.943 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -77.08 -25.24 52.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.456 0.703 . . . . 0.0 112.02 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -125.97 140.12 52.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.294 1.838 . . . . 0.0 110.293 166.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 73.86 -179.81 40.77 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.051 0.834 . . . . 0.0 113.266 -174.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 72.79 -152.72 47.86 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 122.282 -0.54 . . . . 0.0 113.401 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.0 p -102.64 0.29 33.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -161.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.3 t 71.14 22.83 4.31 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 120.364 1.438 . . . . 0.0 113.556 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 85.77 3.63 85.74 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 120.594 -1.316 . . . . 0.0 113.406 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.92 151.51 89.3 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 118.74 1.27 . . . . 0.0 110.119 166.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -61.96 142.88 94.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.27 1.98 . . . . 0.0 109.865 169.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.66 109.2 3.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 32.1 m -105.72 154.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.225 1.41 . . . . 0.0 110.091 174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -59.72 131.73 51.82 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.64 -13.0 67.09 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.22 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.493 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.9 OUTLIER -56.08 130.67 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.119 1.96 . . . . 0.0 111.558 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.4 t -116.54 130.72 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.515 1.926 . . . . 0.0 108.81 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.31 -175.69 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.0 111.372 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.32 149.36 26.12 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.484 1.914 . . . . 0.0 111.134 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 339' ' ' ARG . 4.5 pt-20 -44.79 129.47 5.19 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.789 1.636 . . . . 0.0 114.274 -165.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 162.75 41.53 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.43 2.087 . . . . 0.0 111.949 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -68.34 138.72 55.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.7 mm -103.67 47.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 123.404 1.573 . . . . 0.0 109.739 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.3 pt -54.37 179.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.865 141.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.18 -41.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 120.206 -1.559 . . . . 0.0 112.687 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.92 -45.58 2.77 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.687 1.137 . . . . 0.0 112.895 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -153.25 -67.24 0.15 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.692 1.597 . . . . 0.0 111.141 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.47 17.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.949 1.261 . . . . 0.0 112.835 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.279 1.431 . . . . 0.0 112.799 177.764 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 40.4 mt 55.99 73.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 126.021 1.729 . . . . 0.0 110.716 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 168.85 151.06 6.99 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.059 0.837 . . . . 0.0 112.824 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -138.12 161.4 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.893 1.677 . . . . 0.0 109.947 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.25 -155.41 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.061 3.174 . . . . 0.0 111.807 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -57.44 -33.49 67.97 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.947 -1.096 . . . . 0.0 113.468 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 77.2 p 50.0 30.03 3.82 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 127.857 2.463 . . . . 0.0 114.027 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.26 -7.63 59.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.13 1.772 . . . . 0.0 113.976 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -57.97 127.1 30.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.351 1.46 . . . . 0.0 111.286 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 73.68 13.07 80.61 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.987 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 5.4 m -128.88 -46.5 1.26 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.382 1.473 . . . . 0.0 111.42 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -130.48 -70.96 0.6 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.816 0.846 . . . . 0.0 111.914 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -134.29 -167.73 2.02 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.231 1.412 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -117.63 -1.43 11.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -67.54 133.66 49.86 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.908 0.883 . . . . 0.0 110.493 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 368' ' ' VAL . 4.0 mp -68.49 -43.94 75.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.207 0.527 . . . . 0.0 112.181 -178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.61 159.19 86.21 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.786 1.234 . . . . 0.0 112.858 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.73 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.754 3.636 . . . . 0.0 111.897 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -132.64 46.82 2.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.95 1.7 . . . . 0.0 108.317 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.65 147.68 21.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.225 1.012 . . . . 0.0 111.697 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 160.86 30.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.701 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -79.49 64.68 4.44 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.791 0.805 . . . . 0.0 110.901 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 16.4 m -117.54 146.38 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 127.138 2.175 . . . . 0.0 111.343 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 86.6 p -61.47 -25.34 67.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -71.36 -26.23 62.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.227 1.011 . . . . 0.0 112.48 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -78.81 123.34 85.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.333 1.053 . . . . 0.0 109.997 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.19 -16.43 48.69 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.464 2.109 . . . . 0.0 112.902 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 4.23 10.79 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 167.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -52.43 129.72 29.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.226 1.376 . . . . 0.0 111.233 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.401 ' HG3' ' CG ' ' A' ' 382' ' ' TYR . 62.4 mmt-85 -156.36 146.02 15.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.961 1.305 . . . . 0.0 111.025 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.67 176.9 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.523 2.149 . . . . 0.0 111.432 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -121.02 76.4 30.24 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.535 1.134 . . . . 0.0 109.798 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.01 142.31 38.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.137 2.558 . . . . 0.0 110.517 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.7 t -148.28 145.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.927 1.291 . . . . 0.0 109.351 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 172.88 12.14 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.946 1.298 . . . . 0.0 110.766 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.42 ' CE2' HD12 ' A' ' 455' ' ' ILE . 43.9 m-85 -137.52 127.48 25.76 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.3 1.04 . . . . 0.0 110.042 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.48 104.53 10.4 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 109.861 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.5 p -70.29 -9.07 54.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 32.8 p -68.96 -19.33 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.169 1.388 . . . . 0.0 112.429 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.39 153.21 96.05 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.996 0.918 . . . . 0.0 112.383 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.39 162.45 33.58 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.925 3.083 . . . . 0.0 112.607 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.33 130.47 17.48 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.91 3.074 . . . . 0.0 112.345 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 66.66 39.25 3.71 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 111.833 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -123.42 152.18 41.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 457' ' ' PHE . 15.4 pt -120.84 147.24 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.901 1.68 . . . . 0.0 110.944 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 123.2 45.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.024 1.33 . . . . 0.0 110.289 177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 50.1 t -120.85 104.28 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.02 0.528 . . . . 0.0 110.911 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -72.76 132.86 44.16 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 111.864 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 31.2 t -74.31 141.87 45.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.814 0.816 . . . . 0.0 112.846 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -121.47 16.24 11.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.837 2.455 . . . . 0.0 110.724 166.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 22.3 m -108.7 126.03 52.55 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.156 1.383 . . . . 0.0 108.63 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 74.1 mt -92.76 140.08 29.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.443 1.497 . . . . 0.0 109.166 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -100.42 144.72 29.08 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 158.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 14.1 mm -128.87 112.16 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.22 1.408 . . . . 0.0 108.574 -172.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -90.96 173.52 38.06 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.02 0.819 . . . . 0.0 112.064 166.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.54 16.45 75.81 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.4 t -73.04 126.33 90.49 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 118.723 1.261 . . . . 0.0 111.335 -165.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.01 132.86 36.01 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.477 2.785 . . . . 0.0 110.233 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 348' ' ' LEU . 1.3 mp -67.84 -6.32 20.92 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -92.48 -25.23 18.52 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.69 1.196 . . . . 0.0 113.691 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 5.6 mtm -77.22 146.12 37.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.41 1.005 . . . . 0.0 112.506 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -122.1 -179.9 4.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.652 1.581 . . . . 0.0 111.841 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -41.68 -44.73 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.829 2.051 . . . . 0.0 114.075 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -77.96 -21.6 50.76 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -73.56 -39.61 64.55 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.349 0.977 . . . . 0.0 110.435 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 355' ' ' LEU . 3.1 mm? -59.85 -46.39 89.43 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.716 168.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.8 76.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.44 1.018 . . . . 0.0 111.698 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.13 -44.09 96.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.108 1.322 . . . . 0.0 114.283 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.7 m -71.23 -34.74 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.388 0.994 . . . . 0.0 111.287 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.437 HD23 ' CE2' ' A' ' 394' ' ' PHE . 50.0 mt -87.54 -7.51 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.923 0.889 . . . . 0.0 112.887 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -47.59 96.77 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.346 1.458 . . . . 0.0 114.399 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.59 -7.54 20.37 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.296 1.998 . . . . 0.0 113.31 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -98.45 -38.78 9.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.09 1.356 . . . . 0.0 112.705 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -174.71 172.75 2.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.145 1.778 . . . . 0.0 113.712 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 123.29 32.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.256 1.422 . . . . 0.0 111.442 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.71 120.25 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.591 0.756 . . . . 0.0 110.314 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -94.77 -41.73 9.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.668 1.187 . . . . 0.0 112.083 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.31 161.99 35.5 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.376 -0.828 . . . . 0.0 112.3 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 305' ' ' LEU . 0.2 OUTLIER -162.69 138.01 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.887 0.875 . . . . 0.0 111.101 176.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.69 88.9 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.112 1.365 . . . . 0.0 108.018 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.08 137.99 31.94 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.834 -0.541 . . . . 0.0 110.94 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.47 85.85 2.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.824 1.25 . . . . 0.0 110.243 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -57.65 -38.24 74.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.844 0.857 . . . . 0.0 112.562 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 t -56.2 -33.02 64.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.968 1.307 . . . . 0.0 112.571 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -95.75 2.17 53.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.755 1.222 . . . . 0.0 113.87 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 27.57 17.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 113.612 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -133.83 169.26 17.34 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.47 43.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.707 1.203 . . . . 0.0 111.506 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -115.08 141.55 47.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.757 1.223 . . . . 0.0 108.089 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.8 118.09 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.782 0.719 . . . . 0.0 110.615 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -104.1 120.33 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.666 0.786 . . . . 0.0 112.059 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 19.8 m -95.24 -172.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.975 0.91 . . . . 0.0 110.113 174.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.401 ' CG ' ' HG3' ' A' ' 319' ' ' ARG . 0.2 OUTLIER -68.75 -40.46 79.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.945 1.248 . . . . 0.0 113.949 177.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 60.6 p -148.66 167.45 25.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.192 -0.943 . . . . 0.0 112.717 -164.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.88 91.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.358 167.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -42.07 85.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.004 0.82 . . . . 0.0 112.59 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.21 -51.22 64.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.905 1.282 . . . . 0.0 110.254 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.36 97.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.475 -0.766 . . . . 0.0 112.439 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -62.77 -42.44 99.69 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.929 0.892 . . . . 0.0 111.373 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.39 -34.18 76.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.196 1.362 . . . . 0.0 112.064 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.0 -65.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.717 166.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.7 mt -50.65 -34.32 25.93 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.596 1.558 . . . . 0.0 114.152 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.51 -40.81 93.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.51 1.524 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -109.2 -27.3 9.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.437 ' CE2' HD23 ' A' ' 359' ' ' LEU . 19.8 t80 -70.41 123.95 22.99 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.463 0.705 . . . . 0.0 111.112 -169.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 26.5 t30 60.86 29.16 18.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.131 1.372 . . . . 0.0 114.047 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -59.85 -36.33 76.62 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.201 -0.937 . . . . 0.0 113.16 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.79 -20.55 60.44 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.764 1.226 . . . . 0.0 112.893 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 78.54 23.22 65.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.819 1.2 . . . . 0.0 113.663 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -89.97 -33.78 16.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.15 1.38 . . . . 0.0 114.343 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.17 148.38 77.99 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.039 0.936 . . . . 0.0 109.445 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.37 -19.91 24.78 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.502 2.135 . . . . 0.0 112.732 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.75 144.0 35.62 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.62 1.168 . . . . 0.0 112.58 -170.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -119.28 93.38 4.06 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.638 1.175 . . . . 0.0 109.562 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 85.3 m -81.08 125.0 29.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.738 1.215 . . . . 0.0 111.178 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 175.15 9.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.97 2.508 . . . . 0.0 109.852 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -74.5 121.59 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.224 -0.923 . . . . 0.0 111.206 163.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.86 -164.83 30.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.116 1.817 . . . . 0.0 110.581 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.17 137.4 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.343 0.592 . . . . 0.0 111.107 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -99.95 -46.63 1.87 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.751 2.119 . . . . 0.0 109.945 163.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.65 110.26 8.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.375 1.07 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.04 140.83 5.66 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.682 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.62 123.24 9.95 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.931 3.754 . . . . 0.0 109.393 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -57.48 -45.46 84.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.883 0.473 . . . . 0.0 111.878 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.37 -18.67 63.81 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 86.1 m -120.99 27.96 8.17 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.086 1.755 . . . . 0.0 112.276 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 2.5 t -86.22 138.12 32.11 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.233 1.013 . . . . 0.0 111.546 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -121.66 79.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.117 1.367 . . . . 0.0 109.503 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -64.24 -22.3 66.89 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -67.47 -53.5 28.26 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.689 0.677 . . . . 0.0 110.357 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -77.41 -18.37 57.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 82.92 40.97 8.98 Favored Glycine 0 N--CA 1.467 0.76 0 C-N-CA 124.756 1.17 . . . . 0.0 112.851 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.57 172.45 16.01 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.309 1.055 . . . . 0.0 112.831 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.0 p -143.26 151.37 40.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.362 1.065 . . . . 0.0 110.673 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -110.2 125.61 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.09 123.77 28.66 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.667 -1.158 . . . . 0.0 110.364 -172.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 142.91 43.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.64 1.56 . . . . 0.0 110.457 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 20.6 mtt -58.01 -35.4 71.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.378 1.071 . . . . 0.0 112.973 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -63.51 -18.67 64.05 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 17.4 mmm-85 -97.24 3.2 51.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.589 1.956 . . . . 0.0 113.821 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.28 121.28 35.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.896 0.878 . . . . 0.0 109.747 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 30.6 p -72.21 -179.28 2.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.488 1.515 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -41.82 99.14 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.635 -0.665 . . . . 0.0 111.217 170.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.66 92.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.395 1.078 . . . . 0.0 111.968 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.54 -52.4 65.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.941 1.296 . . . . 0.0 112.381 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.25 -38.56 85.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.679 -0.638 . . . . 0.0 112.225 173.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -56.11 -41.71 75.68 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.385 -0.816 . . . . 0.0 111.848 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -70.99 -45.63 63.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.494 1.497 . . . . 0.0 111.733 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 50.2 m -51.16 -35.55 36.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.956 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 5.7 m -90.81 -58.06 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 14.5 m -86.08 -7.38 58.64 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -166.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.46 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -52.86 145.49 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.76 1.163 . . . . 0.0 111.301 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -83.98 -27.24 28.59 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.843 -0.536 . . . . 0.0 111.204 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -125.67 136.88 53.71 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.237 2.215 . . . . 0.0 110.708 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.65 -179.92 32.97 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.001 0.81 . . . . 0.0 113.204 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 70.38 -150.43 48.45 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.263 -1.14 . . . . 0.0 112.29 -172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 43.0 p -116.07 17.18 15.91 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -153.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.0 t 65.26 17.88 11.18 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.947 -1.096 . . . . 0.0 113.25 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.05 59.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.498 1.047 . . . . 0.0 113.788 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -84.73 145.93 45.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.84 1.32 . . . . 0.0 111.338 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.89 107.33 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.057 2.505 . . . . 0.0 109.198 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 131.1 38.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.37 0.605 . . . . 0.0 111.595 -176.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.68 168.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.629 1.572 . . . . 0.0 110.733 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.3 t -47.25 127.0 10.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.986 0.915 . . . . 0.0 110.747 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.92 65.86 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.251 -1.305 . . . . 0.0 115.306 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 325' ' ' TYR . 1.7 tp -50.48 133.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 120.239 2.02 . . . . 0.0 111.719 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.23 127.78 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.274 1.829 . . . . 0.0 108.345 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 334' ' ' ILE . 10.5 p90 -152.03 179.52 8.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.174 1.39 . . . . 0.0 111.715 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -102.34 153.09 20.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.706 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -38.11 121.0 1.04 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.606 1.562 . . . . 0.0 114.529 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 160.35 50.18 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.224 1.95 . . . . 0.0 111.728 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.46 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 70.8 m-20 -67.86 127.54 33.19 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.846 1.258 . . . . 0.0 113.907 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.16 46.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 123.415 1.579 . . . . 0.0 110.215 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 3.5 pt -52.03 157.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.681 140.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 3.3 t 68.03 7.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.443 -1.411 . . . . 0.0 111.222 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.42 157.04 53.01 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.331 1.443 . . . . 0.0 112.985 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -164.79 -59.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.761 1.224 . . . . 0.0 110.83 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.61 113.95 0.79 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.814 1.197 . . . . 0.0 111.795 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . 0.312 29.7 m . . . . . 0 N--CA 1.49 1.573 0 C-N-CA 130.663 3.585 . . . . 0.0 117.21 175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 119.915 -0.088 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 31.3 pt -115.72 -26.13 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 71.33 27.19 72.01 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.063 0.847 . . . . 0.0 114.682 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.11 79.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.87 -172.02 1.13 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.613 2.875 . . . . 0.0 111.569 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -59.72 -22.9 62.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.878 0.871 . . . . 0.0 113.299 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.0 p 78.99 -1.64 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 129.764 3.226 . . . . 0.0 113.709 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.02 -34.39 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.623 1.969 . . . . 0.0 113.393 -176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 305' ' ' LEU . 6.4 p90 46.2 75.74 0.11 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.768 2.027 . . . . 0.0 112.231 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -77.68 -100.58 0.19 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.857 1.218 . . . . 0.0 112.573 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 74.7 p -73.37 -22.35 60.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.59 1.156 . . . . 0.0 112.985 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -80.08 51.52 1.38 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.538 1.935 . . . . 0.0 112.892 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 64.93 -175.51 0.17 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.276 1.831 . . . . 0.0 111.487 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -124.41 12.64 8.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -168.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -72.73 141.02 48.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.474 ' HA ' ' CE2' ' A' ' 298' ' ' PHE . 9.1 mp -66.54 -31.1 71.6 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.419 1.088 . . . . 0.0 111.661 172.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.72 73.98 65.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.898 1.279 . . . . 0.0 109.637 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 -27.83 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.773 2.316 . . . . 0.0 111.551 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -82.35 46.64 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.032 1.733 . . . . 0.0 111.497 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -142.24 160.83 39.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.022 1.729 . . . . 0.0 110.578 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 95.0 mt -136.83 171.6 14.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.885 1.274 . . . . 0.0 110.331 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -78.23 63.33 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.145 0.978 . . . . 0.0 111.098 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 14.4 m -125.04 149.11 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.313 2.245 . . . . 0.0 111.199 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.3 p -63.01 -23.98 67.71 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.34 -22.89 65.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.528 0.731 . . . . 0.0 112.865 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -84.66 125.45 71.27 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.801 1.24 . . . . 0.0 110.493 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.22 -17.84 50.38 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.552 2.168 . . . . 0.0 113.123 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -78.38 5.28 10.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.911 1.284 . . . . 0.0 114.431 168.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -53.63 129.72 33.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.788 -1.195 . . . . 0.0 111.72 170.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -156.04 143.54 13.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.194 1.398 . . . . 0.0 110.847 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.84 172.36 14.69 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.672 2.248 . . . . 0.0 111.102 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 83.59 9.36 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 109.867 168.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.47 150.48 63.97 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.296 2.664 . . . . 0.0 110.534 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 10.8 t -144.33 133.41 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 109.662 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.09 167.75 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 110.845 174.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -143.88 121.79 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.971 0.908 . . . . 0.0 110.289 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.72 108.76 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.447 0.699 . . . . 0.0 111.156 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 24.9 p -69.35 -8.55 47.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -25.19 67.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.651 1.181 . . . . 0.0 112.235 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.53 150.49 95.59 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.794 0.838 . . . . 0.0 112.068 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.06 161.27 34.17 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 124.18 3.253 . . . . 0.0 112.539 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.17 134.65 32.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.059 3.173 . . . . 0.0 112.029 -173.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.99 44.53 4.65 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.633 1.573 . . . . 0.0 112.046 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -126.75 153.68 45.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.818 1.247 . . . . 0.0 114.141 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.37 145.74 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.615 1.966 . . . . 0.0 110.697 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -106.77 111.16 23.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.018 1.727 . . . . 0.0 109.863 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 41.7 t -110.81 97.08 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.194 0.598 . . . . 0.0 110.295 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.45 138.92 57.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.935 0.874 . . . . 0.0 111.706 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 41.4 t -75.48 136.84 40.63 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.191 -0.943 . . . . 0.0 112.577 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 18.82 14.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.51 2.324 . . . . 0.0 111.305 163.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 62.4 m -119.34 133.44 55.72 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.146 1.378 . . . . 0.0 110.293 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.36 134.87 42.66 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.34 1.056 . . . . 0.0 108.817 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.11 120.82 32.38 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 161.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.9 106.53 20.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -84.24 -178.23 51.49 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 168.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 67.12 11.78 59.32 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.377 -1.072 . . . . 0.0 115.067 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.01 130.12 91.7 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.965 1.383 . . . . 0.0 110.153 -166.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.94 128.01 18.9 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.923 2.415 . . . . 0.0 109.062 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.1 pp -59.17 -18.7 38.6 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.1 -25.95 31.5 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 9.1 mtm -73.52 146.48 44.81 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 0.0 112.293 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -118.13 178.97 4.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.115 1.766 . . . . 0.0 111.715 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.83 -36.47 67.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.617 1.167 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -73.88 -30.9 62.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.47 -35.85 81.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.547 1.067 . . . . 0.0 110.93 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 379' ' ' VAL . 1.2 mm? -58.33 -51.27 70.49 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.285 0.493 . . . . 0.0 110.438 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.75 69.65 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.38 -40.09 64.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.46 1.482 . . . . 0.0 112.883 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.0 -36.72 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 111.249 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.519 ' CD1' HG11 ' A' ' 379' ' ' VAL . 36.1 mt -85.99 -8.08 58.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -50.44 75.17 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.08 -7.12 19.49 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.609 2.206 . . . . 0.0 113.128 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -98.69 -37.5 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.107 1.363 . . . . 0.0 112.867 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -175.16 168.82 3.37 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.541 1.937 . . . . 0.0 114.05 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.08 116.08 22.7 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.787 1.635 . . . . 0.0 112.051 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 97.5 t -87.88 113.48 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.133 0.973 . . . . 0.0 109.853 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.32 -37.84 15.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.502 1.121 . . . . 0.0 111.675 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.36 150.13 35.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 0.0 111.656 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.06 141.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.899 0.88 . . . . 0.0 110.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.91 105.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.355 1.062 . . . . 0.0 108.303 167.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.57 124.52 41.86 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.275 0.559 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -112.91 84.11 1.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.972 1.709 . . . . 0.0 109.258 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.71 -28.59 65.94 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.795 1.238 . . . . 0.0 111.648 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 97.2 p -61.01 -31.83 71.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.962 1.705 . . . . 0.0 113.853 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -110.28 6.82 22.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.113 1.765 . . . . 0.0 113.099 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? 56.98 40.33 28.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.995 1.318 . . . . 0.0 111.314 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -123.7 151.61 42.96 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.28 1.832 . . . . 0.0 113.464 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -138.25 128.28 25.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.13 1.372 . . . . 0.0 111.289 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -81.75 131.62 35.27 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.989 -1.069 . . . . 0.0 108.853 161.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 359' ' ' LEU . 70.3 t -129.84 117.24 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.915 0.886 . . . . 0.0 109.707 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -104.24 116.13 31.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.928 1.291 . . . . 0.0 110.273 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.92 -179.13 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.529 0.732 . . . . 0.0 109.557 167.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 383' ' ' SER . 0.3 OUTLIER -64.02 -49.55 71.98 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . 0.409 ' HB3' ' CE2' ' A' ' 382' ' ' TYR . 82.2 p -139.15 165.95 25.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.216 1.008 . . . . 0.0 112.941 -163.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -42.77 93.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.838 167.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -43.02 91.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.909 0.777 . . . . 0.0 112.277 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.5 -48.18 70.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.079 0.551 . . . . 0.0 111.763 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.2 95.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.162 0.892 . . . . 0.0 112.917 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -64.37 -40.8 96.53 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.784 0.834 . . . . 0.0 111.747 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.44 -35.33 77.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.473 1.033 . . . . 0.0 111.654 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.2 -65.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 119.043 -0.503 . . . . 0.0 110.524 166.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 3.3 mt -49.46 -35.78 20.6 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.323 1.449 . . . . 0.0 114.624 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.14 -33.55 71.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.275 1.43 . . . . 0.0 113.794 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -112.18 -28.28 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.215 1.006 . . . . 0.0 113.121 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.14 123.5 21.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.52 0.728 . . . . 0.0 111.202 -170.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 62.02 30.7 18.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.414 1.486 . . . . 0.0 114.121 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -33.98 76.76 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.47 -19.68 55.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.536 1.134 . . . . 0.0 112.883 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.2 22.69 60.35 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.817 1.199 . . . . 0.0 113.686 -173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -88.9 -32.93 17.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.13 1.372 . . . . 0.0 114.495 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.61 148.4 73.12 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.118 0.967 . . . . 0.0 109.586 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.83 -32.2 7.57 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.684 2.256 . . . . 0.0 112.249 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.36 149.61 50.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.852 1.261 . . . . 0.0 112.066 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.07 102.14 7.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.581 1.153 . . . . 0.0 110.718 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 31.6 m -80.18 124.58 28.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.817 1.247 . . . . 0.0 110.776 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -132.64 172.21 12.82 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.633 1.973 . . . . 0.0 109.939 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.55 121.67 20.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.062 -1.023 . . . . 0.0 111.295 166.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.15 -166.84 19.62 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.626 1.584 . . . . 0.0 110.052 167.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.5 p -165.53 136.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.323 0.649 . . . . 0.0 111.628 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -92.63 -47.09 3.29 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.34 1.924 . . . . 0.0 111.249 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -111.19 93.07 4.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.082 0.941 . . . . 0.0 112.254 173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.91 121.05 1.12 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.319 -1.267 . . . . 0.0 113.901 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 125.37 10.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.019 3.146 . . . . 0.0 109.5 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.33 -44.07 88.52 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.83 -12.44 59.97 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 53.5 m -117.71 12.67 14.02 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.881 1.672 . . . . 0.0 112.901 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 140.82 31.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.348 1.459 . . . . 0.0 111.926 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -123.5 86.35 2.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.65 1.58 . . . . 0.0 109.137 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.62 -20.93 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -69.72 -52.52 24.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.507 0.594 . . . . 0.0 110.368 175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -79.53 -16.17 56.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 77.94 43.33 14.36 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.693 1.139 . . . . 0.0 112.772 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.23 167.08 31.11 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.573 1.187 . . . . 0.0 113.529 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.05 146.09 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.891 -1.131 . . . . 0.0 110.82 171.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -109.67 94.25 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.43 124.15 56.28 Favored Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.094 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.31 147.67 42.28 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.826 1.684 . . . . 0.0 110.998 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.5 mmt -57.82 -36.58 72.44 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.264 1.426 . . . . 0.0 112.363 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -68.24 -11.94 60.18 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -107.11 12.21 28.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.297 1.839 . . . . 0.0 113.312 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.84 135.49 49.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.544 1.138 . . . . 0.0 109.87 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 28.3 p -79.85 175.1 10.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 110.974 171.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.31 -45.9 87.16 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.523 -0.736 . . . . 0.0 110.763 171.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.15 90.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.648 1.179 . . . . 0.0 112.829 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.24 -51.22 70.49 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.147 0.979 . . . . 0.0 111.984 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.39 -37.61 80.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.33 0.652 . . . . 0.0 110.953 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -51.68 -52.41 48.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.861 1.264 . . . . 0.0 110.828 173.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -67.19 -41.98 84.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.22 1.373 . . . . 0.0 111.821 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 63.4 m -55.65 -28.63 56.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.768 -1.11 . . . . 0.0 112.802 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.05 -44.5 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.901 1.228 . . . . 0.0 113.945 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 31.2 m -94.68 -11.29 29.47 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.15 143.93 51.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.898 1.226 . . . . 0.0 111.839 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -72.35 -42.73 64.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.675 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -112.12 140.61 46.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.698 1.599 . . . . 0.0 110.98 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 71.4 176.8 25.35 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.128 -171.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 78.01 -164.6 51.62 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 122.023 -0.692 . . . . 0.0 113.252 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 68.7 p -106.87 18.96 21.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -157.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 p 69.69 13.54 8.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.563 1.145 . . . . 0.0 114.027 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 92.39 2.0 68.48 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.063 1.316 . . . . 0.0 113.504 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -67.11 150.52 97.87 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.86 1.33 . . . . 0.0 110.426 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.33 142.3 90.62 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.4 2.066 . . . . 0.0 110.215 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.7 114.87 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.04 159.23 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.614 1.566 . . . . 0.0 110.184 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 97.9 m -56.41 130.74 46.07 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.849 0.46 . . . . 0.0 109.905 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.42 84.4 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.351 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.24 137.19 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.021 1.41 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.03 132.68 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.262 1.825 . . . . 0.0 109.342 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -158.07 171.3 20.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.469 1.507 . . . . 0.0 110.79 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.07 142.06 27.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.809 0.444 . . . . 0.0 111.302 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.68 126.12 2.44 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.212 1.405 . . . . 0.0 114.499 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.76 166.22 30.57 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.603 3.535 . . . . 0.0 112.442 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -66.65 142.84 57.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.789 1.236 . . . . 0.0 113.897 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.76 52.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.244 1.497 . . . . 0.0 109.753 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.55 172.81 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.713 138.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.19 -48.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 O-C-N 120.984 -1.073 . . . . 0.0 110.98 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 86.41 -51.75 4.4 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.745 1.165 . . . . 0.0 112.171 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.31 156.74 2.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.598 1.959 . . . . 0.0 111.202 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 171.84 162.24 23.75 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.305 1.431 . . . . 0.0 113.676 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.862 1.665 . . . . 0.0 112.198 -177.57 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.605 0.24 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 28.0 pt -136.7 159.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.189 1.395 . . . . 0.0 111.859 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.72 140.72 4.38 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.229 1.395 . . . . 0.0 112.22 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -116.83 152.53 48.67 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.464 1.506 . . . . 0.0 111.232 173.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.96 -62.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.24 2.627 . . . . 0.0 112.831 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 52.6 t30 34.37 77.22 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.479 2.312 . . . . 0.0 114.657 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.6 m -63.41 -52.14 62.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.684 1.594 . . . . 0.0 112.45 -170.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.6 t -170.15 13.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.356 1.862 . . . . 0.0 113.673 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -62.35 119.63 9.45 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.909 -1.119 . . . . 0.0 111.141 -174.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 133.05 -13.53 4.97 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 117.711 -1.605 . . . . 0.0 116.631 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 13.4 t -160.63 67.43 0.33 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.972 1.886 . . . . 0.0 112.053 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 70.54 161.51 0.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.789 2.436 . . . . 0.0 112.401 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 6.6 m120 64.54 147.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.841 2.057 . . . . 0.0 113.418 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -144.96 11.51 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -75.92 142.6 42.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.733 1.213 . . . . 0.0 112.462 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.533 0.733 . . . . 0.0 112.023 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.84 159.51 50.89 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.152 1.381 . . . . 0.0 111.95 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.57 -156.64 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.818 3.679 . . . . 0.0 111.617 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.18 62.1 0.9 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.384 1.474 . . . . 0.0 110.534 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -74.56 159.65 31.91 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 128.478 2.711 . . . . 0.0 113.279 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.25 155.4 33.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.791 1.636 . . . . 0.0 111.041 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -80.22 69.31 6.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.842 0.857 . . . . 0.0 110.779 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.02 147.5 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.262 2.225 . . . . 0.0 109.22 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.1 p -60.37 -25.06 65.59 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -68.85 -25.23 64.54 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -80.41 127.24 76.68 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.986 1.314 . . . . 0.0 110.563 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.29 -18.58 55.72 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.833 1.689 . . . . 0.0 113.323 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.26 9.68 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 168.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -55.02 130.99 43.86 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.875 1.671 . . . . 0.0 112.439 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -156.3 153.84 26.02 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.111 1.765 . . . . 0.0 111.352 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.55 168.06 24.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.174 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 81.07 4.2 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.513 1.125 . . . . 0.0 109.604 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.05 147.34 33.6 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.192 2.595 . . . . 0.0 111.035 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 9.6 t -147.28 137.88 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.351 1.46 . . . . 0.0 108.444 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.05 167.79 19.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.585 1.554 . . . . 0.0 110.746 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -141.57 122.82 14.8 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.036 -1.04 . . . . 0.0 111.064 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -114.4 101.16 8.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.427 1.491 . . . . 0.0 109.921 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.4 p -67.04 -14.12 62.59 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.358 1.063 . . . . 0.0 113.731 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -10.52 59.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.11 1.764 . . . . 0.0 113.908 175.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.39 156.99 80.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 119.88 1.218 . . . . 0.0 113.312 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.57 163.47 32.58 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.224 3.283 . . . . 0.0 113.293 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.68 134.67 24.49 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.212 3.275 . . . . 0.0 112.627 -172.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.68 34.24 12.41 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.148 1.379 . . . . 0.0 112.476 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -121.3 154.31 36.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.935 1.294 . . . . 0.0 114.401 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 pt -124.61 157.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.869 1.668 . . . . 0.0 111.891 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.58 118.9 37.95 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.865 1.266 . . . . 0.0 110.613 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 457' ' ' PHE . 48.7 t -112.74 107.42 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.604 0.638 . . . . 0.0 110.451 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.1 132.27 45.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 111.148 167.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 30.6 t -67.18 138.9 57.34 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.897 0.856 . . . . 0.0 112.064 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.17 21.13 8.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.44 2.696 . . . . 0.0 109.805 168.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' THR . . . . . . . . . . . . . 48.3 m -125.67 132.87 52.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.3 1.44 . . . . 0.0 109.014 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 48.5 mt -101.51 133.41 46.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.66 1.584 . . . . 0.0 109.443 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -86.24 126.31 34.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 163.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 17.4 mm -114.67 107.46 22.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . -83.81 170.08 47.45 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 123.168 0.414 . . . . 0.0 112.496 167.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.96 19.56 79.76 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.35 118.36 71.65 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.115 -171.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.39 147.87 47.69 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.291 2.661 . . . . 0.0 110.565 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 348' ' ' LEU . 2.8 mp -65.23 -18.61 65.45 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.28 -26.63 62.05 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.509 1.124 . . . . 0.0 113.381 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 12.4 mtm -75.46 152.55 37.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.6 1.091 . . . . 0.0 112.286 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -133.34 -177.67 4.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.231 2.212 . . . . 0.0 111.127 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -55.59 -39.9 71.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 112.144 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -79.14 -14.91 58.82 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.31 -40.0 52.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.161 1.346 . . . . 0.0 110.515 168.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 355' ' ' LEU . 4.1 mm? -61.33 -51.16 70.0 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.454 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.31 66.94 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.179 -0.915 . . . . 0.0 112.814 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -70.16 -47.4 61.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.013 1.278 . . . . 0.0 114.172 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.22 -32.37 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.583 1.538 . . . . 0.0 111.524 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 390' ' ' VAL . 39.5 mt -87.09 -11.51 49.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.072 0.949 . . . . 0.0 113.102 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -47.16 -49.1 53.16 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 126.224 1.809 . . . . 0.0 115.076 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.45 -3.31 13.51 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.199 1.933 . . . . 0.0 113.515 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.56 -36.15 7.61 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.611 1.565 . . . . 0.0 112.747 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -171.17 165.94 7.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.718 2.007 . . . . 0.0 112.741 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.52 100.34 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.866 1.666 . . . . 0.0 110.466 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.23 126.42 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.583 0.753 . . . . 0.0 109.835 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -95.71 -32.07 12.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.125 1.37 . . . . 0.0 112.419 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 42.3 t -152.83 155.72 37.64 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.747 1.158 . . . . 0.0 110.997 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 55.3 t -146.68 131.32 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.233 1.013 . . . . 0.0 109.324 172.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.09 107.93 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.35 117.08 33.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.193 0.597 . . . . 0.0 110.339 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -100.68 84.24 2.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 109.523 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.49 -38.81 69.62 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.405 1.482 . . . . 0.0 111.07 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 11.9 m -62.25 -21.82 65.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.826 2.05 . . . . 0.0 114.736 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -113.0 6.88 17.92 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.678 1.591 . . . . 0.0 112.484 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.2 mttt 52.61 35.06 17.15 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 126.562 1.945 . . . . 0.0 113.744 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -127.96 153.52 46.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.105 1.362 . . . . 0.0 113.008 -169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -134.92 131.89 37.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.814 0.846 . . . . 0.0 111.986 162.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -83.25 121.65 27.39 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.49 125.83 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.392 1.477 . . . . 0.0 108.692 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -114.61 115.51 27.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.136 1.374 . . . . 0.0 110.199 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.67 -166.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.877 0.871 . . . . 0.0 110.155 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -48.83 66.38 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.196 1.362 . . . . 0.0 113.197 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.9 p -152.15 173.04 15.43 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -160.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -45.82 80.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.057 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -53.85 -42.17 68.26 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.239 0.927 . . . . 0.0 112.674 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.28 -43.74 49.58 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.01 92.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.038 1.29 . . . . 0.0 113.011 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.52 -40.96 96.6 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.259 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.97 -31.63 72.0 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.81 1.186 . . . . 0.0 112.253 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 359' ' ' LEU . 9.7 t -63.62 -64.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.324 164.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.81 -32.12 42.49 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -74.54 -23.86 58.86 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.764 1.626 . . . . 0.0 113.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -120.91 -28.49 4.8 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' A' ' 359' ' ' LEU . 21.3 t80 -72.35 122.45 21.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.959 0.904 . . . . 0.0 111.378 -169.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ASN . . . . . . . . . . . . . 24.5 t30 59.5 29.11 18.64 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.531 1.933 . . . . 0.0 114.861 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -55.88 -34.34 65.42 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.746 -1.221 . . . . 0.0 113.646 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -79.29 -17.13 55.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 113.603 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 81.45 11.35 83.33 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.117 1.341 . . . . 0.0 113.728 -173.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -84.49 -31.97 24.21 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.087 1.755 . . . . 0.0 115.073 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.16 152.07 76.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.679 0.792 . . . . 0.0 109.929 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.86 -18.04 24.98 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.258 1.972 . . . . 0.0 113.011 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.99 150.72 23.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -123.41 83.04 2.08 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 109.907 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.3 m -72.39 122.78 21.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.066 1.746 . . . . 0.0 110.602 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 173.47 11.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.218 2.207 . . . . 0.0 109.375 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -66.87 123.69 20.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.168 -0.957 . . . . 0.0 111.205 162.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.85 -164.1 21.43 Favored Glycine 0 N--CA 1.467 0.725 0 C-N-CA 126.191 1.853 . . . . 0.0 109.663 163.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.11 134.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.66 0.784 . . . . 0.0 111.376 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . -93.99 -38.87 5.03 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.182 1.849 . . . . 0.0 111.641 167.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -125.99 105.64 9.04 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.621 2.368 . . . . 0.0 113.475 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -174.96 137.68 3.97 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 118.472 -1.182 . . . . 0.0 114.567 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.37 132.26 16.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.878 3.719 . . . . 0.0 110.842 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -21.3 61.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.75 -21.42 37.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.807 1.185 . . . . 0.0 113.828 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' CYS . . . . . . . . . . . . . 54.1 m -124.47 31.12 5.81 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.854 1.661 . . . . 0.0 111.693 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 19.4 t -84.83 138.97 32.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.786 1.234 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -125.69 86.8 2.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.621 1.569 . . . . 0.0 109.073 165.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -67.35 -14.77 63.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.74 -46.96 28.03 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.092 1.315 . . . . 0.0 110.426 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -81.26 -14.37 57.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 75.68 44.39 20.66 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.342 0.972 . . . . 0.0 112.919 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.48 174.5 12.86 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.526 1.163 . . . . 0.0 112.79 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 56.7 p -147.35 147.62 30.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.354 1.062 . . . . 0.0 111.114 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.12 124.71 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.575 HG21 HD21 ' A' ' 430' ' ' LEU . 1.1 mt -118.98 118.42 32.96 Favored Pre-proline 0 N--CA 1.477 0.923 0 CA-C-N 119.635 1.107 . . . . 0.0 111.743 -172.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -72.71 128.99 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 111.498 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -64.69 -23.93 67.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.859 1.263 . . . . 0.0 113.228 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.43 -24.4 67.61 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.835 1.198 . . . . 0.0 114.024 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -1.16 13.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.284 1.434 . . . . 0.0 114.562 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 425' ' ' ILE . 55.4 mt -61.73 136.48 58.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.163 0.892 . . . . 0.0 110.001 168.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 27.8 p -72.7 174.22 7.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.759 0.79 . . . . 0.0 111.293 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.97 -39.86 87.08 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.778 -0.576 . . . . 0.0 111.869 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -73.75 -36.62 65.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.242 0.617 . . . . 0.0 112.313 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -55.59 -60.03 4.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 111.283 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.71 -39.91 82.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.907 1.283 . . . . 0.0 112.25 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -47.92 70.67 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.088 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -66.12 -47.57 73.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.805 1.184 . . . . 0.0 110.972 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 13.1 m -52.33 -40.55 62.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.388 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.67 -44.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 2.7 t -97.23 -3.06 41.47 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -166.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 461' ' ' ASP . . . -61.03 145.08 52.06 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.825 -1.172 . . . . 0.0 112.846 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.75 -28.74 36.4 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.827 1.251 . . . . 0.0 110.468 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -132.37 143.76 50.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.643 2.777 . . . . 0.0 110.75 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 70.52 175.53 18.51 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 123.704 0.669 . . . . 0.0 113.833 -171.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 73.52 -161.58 54.22 Favored Glycine 0 CA--C 1.546 1.973 0 O-C-N 121.501 -1.0 . . . . 0.0 114.424 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 21.1 p -93.36 3.07 56.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.962 2.105 . . . . 0.0 116.418 -160.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.4 m 78.05 6.31 2.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.83 1.252 . . . . 0.0 113.036 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 96.26 5.33 59.36 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.014 1.292 . . . . 0.0 113.438 -169.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -71.92 153.45 92.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.578 1.189 . . . . 0.0 109.834 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.58 146.97 93.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.086 2.524 . . . . 0.0 110.897 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' LEU . . . . . . . . . . . . . 54.5 mt -70.66 104.32 2.8 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.65 158.21 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.045 1.338 . . . . 0.0 111.647 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.0 m -59.05 131.65 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 90.09 -1.15 79.82 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.85 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.718 1.759 . . . . 0.0 112.683 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.44 137.06 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.348 2.259 . . . . 0.0 109.452 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . 0.413 ' CE2' HG22 ' A' ' 336' ' ' VAL . 5.5 p90 -164.55 178.02 7.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.602 1.161 . . . . 0.0 111.715 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -97.54 151.69 19.78 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.107 . . . . 0.0 110.109 169.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -44.98 130.16 5.39 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -167.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.81 168.04 24.92 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.927 3.085 . . . . 0.0 111.175 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 441' ' ' ALA . 67.4 m-20 -74.18 120.0 19.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 11.9 mm -95.59 46.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.183 1.468 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ILE . . . . . . . . . . . . . 6.2 pt -54.03 156.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 142.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 3.5 t 67.16 9.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.917 -1.114 . . . . 0.0 111.48 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -57.5 138.95 47.43 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.339 -1.476 . . . . 0.0 113.88 -168.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -158.24 157.44 32.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.057 0.943 . . . . 0.0 112.198 -166.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -91.21 -174.93 43.68 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.602 1.572 . . . . 0.0 113.907 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 125.579 1.551 . . . . 0.0 111.298 177.799 . . . . . . . . 0 0 . 1 stop_ save_